← Back to Home

All Lab Tests

Browse our complete directory of medical markers and understand your results.

Metabolic

1-Hour Post-Load Glucose

Part of the Glucose Tolerance Test (GTT), this measures the blood sugar level exactly 60 minutes after consuming a standardized glucose load (usually 75g or 100g). It evaluates the body's peak insulin response and its ability to manage a carbohydrate challenge. It is a critical metric for diagnosing Gestational Diabetes and identifying early-stage glucose intolerance.
View Interpretation
Endocrinology

17-Alpha Hydroxy Progesterone

17-hydroxyprogesterone (17-OHP) is a precursor hormone in the synthesis of cortisol. The enzyme 21-hydroxylase is required to convert 17-OHP into the next stage of cortisol production. If this enzyme is deficient, 17-OHP builds up in the blood. This pathway is critical for the adrenal glands' ability to produce life-sustaining steroid hormones. This test is primarily used to screen for and diagnose Congenital Adrenal Hyperplasia (CAH). While newborns are routinely screened, the test is also used in adults to detect 'Late-Onset' (Non-classic) CAH, which can cause symptoms later in life such as hirsutism (excess hair growth), irregular periods, and infertility in women, or early puberty in children. It is also used to rule out adrenal tumors.
  • Congenital Adrenal Hyperplasia (CAH): Specifically the 21-hydroxylase deficiency type.
  • Polycystic Ovary Syndrome (PCOS): 17-OHP is often tested to differentiate PCOS from non-classic CAH, as symptoms overlap.
  • Adrenal Tumors: Some tumors may secrete high levels of hormone precursors.
  • Hirsutism and Virilization: Excess 17-OHP is shunted into androgen production, causing male-pattern hair growth in females.
View Interpretation
Metabolic

2-Hour Post-Load Glucose

This component is part of the Oral Glucose Tolerance Test (OGTT). It measures how effectively the body clears a standardized 75-gram glucose load from the bloodstream after two hours. It is considered more sensitive than fasting glucose for identifying Impaired Glucose Tolerance (IGT) and early-stage Type 2 Diabetes, as it specifically tests the insulin response to a carbohydrate challenge.
View Interpretation
Metabolic

2-Hour Post-Prandial Blood Sugar (PPBS)

The 2-Hour Post-Prandial Blood Sugar (PPBS) test measures the body's ability to metabolize glucose following a meal. Specifically, it assesses the effectiveness of the insulin response in clearing glucose from the bloodstream. In a healthy individual, insulin levels spike after eating to transport glucose into cells, returning blood sugar to near-baseline levels within two hours. This component is critical within the FBS & PPBS panel to diagnose Impaired Glucose Tolerance (IGT) and monitor the management of Type 1 and Type 2 Diabetes Mellitus. It provides a more dynamic view of metabolic health than a Fasting Blood Sugar (FBS) alone.
View Interpretation
Metabolic

24 Hours Urine Protein

The 24-hour urine protein test measures the total amount of protein excreted in the urine over a full day. In a healthy kidney, the glomeruli (filtering units) prevent large proteins like albumin from passing into the urine. Detecting protein in the urine, known as proteinuria, is one of the earliest and most sensitive markers of kidney damage or systemic disease affecting the renal system. This test is a gold standard for quantifying protein loss when a random 'dipstick' test shows positive results. It is ordered to diagnose or monitor chronic kidney disease (CKD), evaluate the severity of kidney damage in patients with diabetes or hypertension, and to screen for pre-eclampsia in pregnant women. It provides a more accurate picture than a spot urine test because protein excretion fluctuates throughout the day.
  • Diabetic Nephropathy: Long-term high blood sugar damages the kidney's filters.
  • Nephrotic Syndrome: Characterized by very high protein loss (>3.5g/day), swelling (edema), and low blood albumin.
  • Glomerulonephritis: Inflammation of the kidney's filtering units.
  • Multiple Myeloma: May produce Bence-Jones proteins that appear in the urine.
  • Preeclampsia: A serious pregnancy complication marked by high blood pressure and proteinuria.
View Interpretation
Endocrinology

24-Hour Urinary VMA

Vanillylmandelic Acid (VMA) is one of the primary breakdown products (metabolites) of catecholamines, specifically epinephrine (adrenaline) and norepinephrine. These hormones are produced by the adrenal glands and are central to the body's 'fight or flight' response. The 24-hour urine test measures the total amount of VMA excreted over a full day, providing a window into catecholamine production. Physicians order a VMA test primarily to screen for rare tumors that secrete catecholamines. It is a critical diagnostic tool when a patient presents with episodic high blood pressure, severe headaches, or palpitations. It is also used to monitor the effectiveness of treatment in patients known to have these neuroendocrine tumors.
  • Pheochromocytoma: A usually benign tumor of the adrenal gland that causes excessive adrenaline release.
  • Neuroblastoma: One of the most common solid tumors in children, arising from immature nerve cells.
  • Ganglioneuroma: A rare, benign tumor of the autonomic nervous system.
  • Severe Stress: Significant physical or emotional stress can transiently elevate catecholamine metabolites.
View Interpretation
Renal

24-Hour Urine Albumin

Albumin is a major protein found in the blood. In healthy kidneys, the filtering units (glomeruli) prevent albumin from passing into the urine. However, when the kidneys are damaged, small amounts of albumin leak through the filters, a condition known as microalbuminuria. The 24-Hour Urine Albumin test is the gold standard for quantifying this leakage over a full day, providing a more stable and accurate assessment than a random spot check. It serves as an early 'canary in the coal mine' for kidney disease, often detecting damage years before standard creatinine tests show an abnormality. This test is essential for screening and monitoring patients with chronic conditions that risk kidney damage, most notably Diabetes Mellitus (Type 1 and 2) and Hypertension (High Blood Pressure). The American Diabetes Association recommends annual screening to detect early-stage Diabetic Nephropathy. Identifying albuminuria early allows for aggressive intervention with ACE inhibitors or ARBs, which can slow or even reverse the progression of kidney disease. It is also used to evaluate systemic vascular health, as albuminuria is a known marker for increased cardiovascular risk.
  • Diabetic Nephropathy: Kidney damage specifically caused by long-term high blood sugar.
  • Hypertensive Nephrosclerosis: Damage to the kidney's small blood vessels due to high blood pressure.
  • Glomerulonephritis: Inflammation of the kidney's filtering units.
  • Preeclampsia: A pregnancy complication characterized by high blood pressure and protein in the urine.
  • Systemic Lupus Erythematosus (SLE): An autoimmune disease that can cause lupus nephritis.
View Interpretation
Metabolic

24-Hour Urine Calcium

The 24-hour Urine Calcium test measures the total amount of calcium excreted in the urine over a full day. This provides a much more accurate picture of calcium metabolism than a random 'spot' urine sample, as calcium levels fluctuate throughout the day based on diet and activity. It reflects the balance between calcium intake, intestinal absorption, bone resorption, and renal (kidney) excretion. This test is primarily used for:
  • Kidney Stone Evaluation: High urine calcium (hypercalciuria) is a leading cause of calcium oxalate or calcium phosphate stones.
  • Parathyroid Disorders: To differentiate between causes of high blood calcium (e.g., Primary Hyperparathyroidism vs. Familial Hypocalciuric Hypercalcemia).
  • Bone Health: Assessing patients with osteoporosis to see if they are 'wasting' too much calcium in their urine.
  • Vitamin D Toxicity: Monitoring patients on high-dose Vitamin D therapy.
Hypercalciuria (High) is often linked to hyperparathyroidism, sarcoidosis, or excessive vitamin D intake. It is also found in 'idiopathic hypercalciuria,' a genetic tendency to leak calcium into the urine. Hypocalciuria (Low) is associated with Vitamin D deficiency, malabsorption syndromes (like Celiac disease), or the use of thiazide diuretics. It is also a key marker for Familial Hypocalciuric Hypercalcemia (FHH), a benign genetic condition that can be mistaken for more serious parathyroid disease.
View Interpretation
Metabolic

24-Hour Urine Copper

Copper is a vital trace mineral that serves as a cofactor for several enzymes involved in energy production, iron metabolism, and neurotransmitter synthesis. Under normal conditions, the liver regulates copper levels by excreting excess amounts into the bile. Only a very small fraction of copper is normally excreted in the urine. However, when the liver's ability to process copper is compromised, urinary excretion increases significantly. This test is most commonly used to diagnose or monitor Wilson Disease, a rare genetic disorder where copper accumulates in the liver, brain, and other vital organs. It is also used to evaluate symptomatic patients presenting with tremors, hepatitis, or Kayser-Fleischer rings in the eyes. Additionally, it helps monitor patients receiving 'chelating agents'—medications designed to strip excess copper from the body.
  • Wilson Disease: Characterized by high urinary copper excretion (often >100 µg/24h).
  • Chronic Active Hepatitis: Inflammatory liver states can disrupt copper metabolism.
  • Biliary Cirrhosis: Obstruction of bile flow forces copper to be excreted through the kidneys instead of the stool.
  • Nephrotic Syndrome: Severe kidney protein loss can sometimes lead to increased copper in the urine.
View Interpretation
Renal

24-Hour Urine for Creatinine Clearance Test

The Creatinine Clearance (CrCl) test measures how effectively the kidneys filter creatinine from the blood into the urine. It provides a clinical estimate of the Glomerular Filtration Rate (GFR). This test compares the concentration of creatinine in a 24-hour urine collection to the concentration of creatinine in the blood.
  • Early Kidney Disease Detection: CrCl can often detect declining kidney function before blood creatinine levels rise above the normal range.
  • Dosing Medications: Many drugs (like antibiotics or anticoagulants) are cleared by the kidneys and require dose adjustments based on CrCl.
  • Monitoring Disease Progression: Used to track the health of patients with known chronic kidney disease, diabetes, or hypertension.
  • Chronic Kidney Disease (CKD): A gradual loss of kidney function over time.
  • Acute Renal Failure: A sudden drop in filtration due to injury or toxins.
  • Congestive Heart Failure: Reduced blood flow to the kidneys can lower clearance.
  • Glomerulonephritis: Inflammation of the kidney's filtering units.
This test is a more dynamic measurement of renal health than a static blood test, as it accounts for the actual volume of waste processed over a full day.
View Interpretation
Metabolic

24-Hour Urine for Uric Acid

Uric acid is the final oxidation product of purine metabolism in humans. Purines are nitrogenous bases found in certain foods and are also components of human DNA. Most uric acid is dissolved in the blood, filtered by the kidneys, and excreted in the urine. The 24-hour urine collection provides a more accurate assessment of the total daily production and excretion of uric acid than a random 'spot' sample, as levels fluctuate throughout the day based on activity and intake. This test is primarily used to investigate the cause of high blood uric acid levels (hyperuricemia) or to evaluate patients who suffer from recurrent kidney stones. It helps clinicians determine if the body is overproducing uric acid or if the kidneys are failing to excrete it properly. It is also used to monitor patients undergoing chemotherapy, as the rapid breakdown of cancer cells can release massive amounts of purines into the bloodstream.
  • Gout: Excessive uric acid can crystallize in joints, causing intense pain.
  • Urolithiasis: High urinary uric acid is a major risk factor for uric acid kidney stones.
  • Renal Failure: Impaired kidney function leads to decreased excretion.
  • Metabolic Syndrome: Often associated with insulin resistance and obesity.
View Interpretation
Metabolic

24-Hours Urine For Creatinine

Creatinine is a waste product produced at a constant rate by the breakdown of creatine phosphate in muscle tissue. Because the body produces it at a steady rate and the kidneys excrete it almost entirely through filtration, it is an excellent marker for measuring the Glomerular Filtration Rate (GFR). A 24-hour urine collection allows for the calculation of 'Creatinine Clearance,' comparing urine levels to blood levels to see how well the kidneys are cleaning the blood. This test is ordered to evaluate kidney function, monitor the progression of renal disease, and assess the impact of medications on the kidneys. It is more accurate than a spot urine test because it accounts for fluctuations in creatinine concentration throughout the day. It is often requested when a patient has abnormal blood creatinine levels or symptoms of kidney dysfunction like edema or decreased urine output.
  • Kidney Disease: Declining creatinine clearance indicates stages of Chronic Kidney Disease (CKD).
  • Muscle Disorders: Since creatinine comes from muscle, conditions like muscular dystrophy or rhabdomyolysis (muscle breakdown) significantly alter levels.
  • Obstruction: Kidney stones or prostate issues can hinder urine flow, affecting the total 24-hour volume and creatinine count.
The total volume of urine collected over the 24 hours is as important as the concentration of creatinine itself. Low volume may indicate dehydration or renal failure, while high volume (polyuria) may indicate diabetes or other metabolic issues.
View Interpretation
Immunology

A.S.O. Titre

The Antistreptolysin O (ASO) titre measures the amount of antibodies the body produces against streptolysin O, a toxin released by Group A Streptococcus bacteria. It does not detect the bacteria itself but rather confirms that a person has had a recent or past infection with 'Strep'. This test is vital for diagnosing complications that arise after a strep throat or skin infection has cleared. These are known as post-streptococcal sequelae. If a patient (often a child) develops joint pain, heart palpitations, or kidney swelling weeks after a sore throat, the ASO titre helps prove the link to a previous Strep infection.
  • Rheumatic Fever: An inflammatory disease that can affect the heart, joints, brain, and skin.
  • Post-Streptococcal Glomerulonephritis: A kidney disease that follows a strep infection.
  • Bacterial Endocarditis: Infection of the heart valves.
  • Scarlet Fever: If symptoms persist or complications are suspected.
View Interpretation
Metabolic

A/G Ratio

The A/G ratio is a calculated value representing the relationship between two major types of proteins found in the blood: albumin and globulin. Albumin is produced by the liver and accounts for about 60% of total protein; it maintains oncotic pressure and transports various substances. Globulins are a diverse group of proteins, including enzymes, transport proteins, and antibodies (immunoglobulins). The ratio is determined by dividing the albumin level by the globulin level (Total Protein minus Albumin). This ratio is a standard part of a Liver Function Test (LFT) or a Comprehensive Metabolic Panel (CMP). It is used to:
  • Screen for liver and kidney disease.
  • Evaluate nutritional status.
  • Investigate unexplained weight loss or edema (swelling).
  • Monitor chronic inflammatory conditions or certain blood cancers like Multiple Myeloma.
A disturbed A/G ratio is often a red flag for underlying systemic issues. A low ratio (low albumin or high globulin) is frequently associated with cirrhosis of the liver, nephrotic syndrome (kidney loss of protein), or autoimmune diseases. A high ratio (high albumin or low globulin) is less common but can be seen in cases of severe dehydration or genetic immunodeficiencies where antibody production is impaired.
View Interpretation
Metabolic

A/G Ratio (Albumin/Globulin Ratio)

The A/G ratio is a calculated value comparing the amount of Albumin to Globulins (Total Protein minus Albumin). In the Proteins & A/G Ratio panel, it serves as a sensitive indicator of liver and kidney health as well as nutritional status and plasma cell disorders. A shift in this ratio often precedes clinical symptoms of systemic disease.
View Interpretation
Biochemical

ADA (Adenosine Deaminase) Levels

Adenosine Deaminase (ADA) is an enzyme involved in purine metabolism. Its primary biological role is the proliferation and differentiation of lymphocytes, particularly T-lymphocytes. Because ADA activity increases significantly during a cellular immune response, it serves as a surrogate marker for diseases that trigger T-cell activation. The ADA test is most frequently performed on pleural fluid, ascitic fluid, or cerebrospinal fluid (CSF) to help diagnose Extrapulmonary Tuberculosis (TB). It is a rapid, cost-effective alternative to culture, which can take weeks. It is also used in serum to help investigate certain immune deficiencies or liver diseases.
  • Tuberculous Pleurisy: Very high ADA levels in pleural fluid are highly indicative of TB.
  • Malignancy: Certain cancers, such as lymphomas, can cause elevated ADA.
  • Rheumatoid Arthritis: Can cause elevated ADA in synovial fluid.
  • ADA Deficiency: A rare genetic condition leading to Severe Combined Immunodeficiency (SCID).
View Interpretation
Microbiology

AFB Culture & Sensitivity (Conventional)

The AFB Culture and Sensitivity test is the 'gold standard' for diagnosing tuberculosis (TB) and other mycobacterial infections. Unlike the smear, which only looks for the presence of bacteria, the culture involves growing the organisms on specialized media (like Lowenstein-Jensen or Middlebrook). Once grown, 'Sensitivity' testing (Drug Susceptibility Testing) is performed to determine which antibiotics will effectively kill the specific strain. It is ordered for patients with clinical or radiological suspicion of TB, especially those with negative smears. It is vital for:
  • Confirming a diagnosis of active TB.
  • Identifying the specific species of Mycobacterium.
  • Determining if the strain is Multi-Drug Resistant (MDR-TB).
  • Monitoring the effectiveness of ongoing treatment.
  • Pulmonary Tuberculosis: The most common form of TB.
  • Extrapulmonary TB: Infection in the kidneys, spine, or lymph nodes.
  • MAC (Mycobacterium avium complex): Common in HIV/AIDS patients.
Because mycobacteria grow very slowly, 'conventional' cultures can take 3 to 8 weeks to provide a result. Despite the wait, it is indispensable for tailoring the 6-to-9-month antibiotic regimen required for TB treatment. Finding the right drug prevents the spread of resistant strains in the community.
View Interpretation
Microbiology

AFB Culture & Sensitivity (Radiometric)

AFB (Acid-Fast Bacilli) Culture and Sensitivity is the gold standard for diagnosing infections caused by Mycobacterium species, most notably Mycobacterium tuberculosis. The radiometric method (like BACTEC) uses a liquid medium containing radio-labeled substrates to detect the growth of bacteria much faster (1-2 weeks) than traditional solid media (4-8 weeks). This test is ordered for patients with symptoms of Tuberculosis (TB), such as chronic cough, weight loss, and night sweats, or for those with abnormal chest X-rays. The 'Sensitivity' portion is critical; it tests which antibiotics successfully kill the specific strain of bacteria isolated, ensuring the patient is not treated with drugs to which the bacteria are resistant.
  • Pulmonary Tuberculosis: The most common form of TB affecting the lungs.
  • Extrapulmonary TB: Infection in the kidneys, spine, or lymph nodes.
  • Non-Tuberculous Mycobacteria (NTM): Environmental bacteria that can cause lung disease in immunocompromised individuals.
  • MDR-TB: Multi-drug resistant tuberculosis strains.
View Interpretation
Microbiology

AFB Culture (Conventional)

The Acid-Fast Bacilli (AFB) Culture is a laboratory test used to grow and identify mycobacteria, most notably Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). Unlike standard bacterial cultures, mycobacteria have waxy cell walls that require specific staining (Ziehl-Neelsen) and specialized culture media. The 'conventional' method involves solid media (like Lowenstein-Jensen) and can take several weeks due to the slow growth rate of these organisms. Physicians order an AFB culture when a patient presents with chronic cough, weight loss, night sweats, or abnormal chest X-rays. It is the gold standard for diagnosing active TB and is also used to monitor the effectiveness of treatment. It can also identify Non-Tuberculous Mycobacteria (NTM) which can cause lung disease in immunocompromised individuals.
  • Pulmonary Tuberculosis: The most common form of TB affecting the lungs.
  • Extrapulmonary TB: Infection in kidneys, spine, or lymph nodes.
  • MAC (Mycobacterium avium complex): Common in patients with HIV/AIDS.
  • Leprosy: Caused by Mycobacterium leprae (though usually diagnosed via biopsy).
Because conventional cultures take 6-8 weeks for a final negative result, they are often paired with rapid molecular tests (like PCR) and AFB smears. However, the culture remains vital for performing drug susceptibility testing (DST), which determines which antibiotics will be effective against the specific strain of bacteria isolated.
View Interpretation
Microbiology

AFB Culture (Radiometric)

The AFB (Acid-Fast Bacilli) Culture using radiometric methods (such as the BACTEC system) is designed to detect the presence of Mycobacterium tuberculosis and other non-tuberculous mycobacteria (NTM). The radiometric technique detects the metabolic activity of the bacteria by measuring the release of radioactive CO2 from a labeled substrate in the growth medium, allowing for much faster detection than traditional solid media cultures. This test is the 'gold standard' for diagnosing active Tuberculosis (TB). It is ordered for patients presenting with chronic cough, weight loss, night sweats, or abnormal chest X-rays. It is also used to determine the effectiveness of anti-TB treatment and to confirm that a patient is no longer infectious.
  • Pulmonary Tuberculosis: The most common infection caused by M. tuberculosis.
  • Extrapulmonary TB: Infection in the kidneys, spine, or brain.
  • MAC Infection: Mycobacterium avium complex, often seen in immunocompromised individuals (e.g., those with HIV/AIDS).
  • Leprosy: Caused by Mycobacterium leprae, though usually diagnosed via biopsy rather than culture.
Because mycobacteria grow very slowly, the radiometric culture is essential for early diagnosis, reducing the time to result from 6-8 weeks to as little as 1-2 weeks for positive samples.
View Interpretation
Hematology

ALCD Flowcytometry

ALCD (Acute Leukemia Characterization and Diagnosis) Flow Cytometry is a highly specialized test used to identify and characterize cell types based on the antigens (markers) present on their surface. By using laser-based technology and fluorescent antibodies, it can distinguish between normal blood cells and malignant 'blasts'. This test is critical when a clinician suspects a blood cancer such as leukemia or lymphoma. It is used to differentiate between Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML), which require vastly different treatment protocols. It is also used to monitor 'Minimal Residual Disease' (MRD) after chemotherapy.
  • Acute Myeloid Leukemia (AML): Characterized by the presence of myeloid markers (e.g., CD33, CD13).
  • Acute Lymphoblastic Leukemia (ALL): Characterized by lymphoid markers (e.g., CD19, CD10).
  • Myelodysplastic Syndromes (MDS): Often shows abnormal maturation patterns.
  • Lymphoma: Identification of monoclonal B-cell or T-cell populations.
Flow cytometry provides a 'molecular fingerprint' of a patient's blood or bone marrow, allowing for precise diagnosis and targeted therapy in hematologic malignancies.
View Interpretation
Genetics

ALL Multiplex PCR 28 Translocations (MedGenome)

This is a highly specialized molecular diagnostic test using Multiplex Polymerase Chain Reaction (PCR) to screen for 28 of the most common chromosomal translocations associated with Acute Lymphoblastic Leukemia (ALL). Translocations occur when parts of two different chromosomes break and swap places, creating 'fusion genes' (like BCR-ABL1) that drive the uncontrolled growth of leukemic blasts. In cases of suspected or confirmed ALL, this test is essential for risk stratification. Identifying the specific genetic driver allows oncologists to determine the aggressiveness of the leukemia, the likelihood of relapse, and the appropriate treatment intensity. It is also used to identify patients eligible for targeted 'smart' drugs (e.g., Tyrosine Kinase Inhibitors for Philadelphia-positive ALL).
  • B-Cell Acute Lymphoblastic Leukemia (B-ALL): Various translocations like t(12;21) or t(9;22).
  • T-Cell Acute Lymphoblastic Leukemia (T-ALL): Specific rearrangements involving T-cell receptor loci.
  • Minimal Residual Disease (MRD): This test can sometimes provide baseline markers for monitoring treatment success.
The genetic makeup of ALL is the single most important prognostic factor. For instance, the ETV6-RUNX1 translocation generally carries a favorable prognosis, while the MLL (KMT2A) rearrangement indicates a high-risk profile requiring more intensive therapy or bone marrow transplant. This 'Multiplex' approach is efficient, as it tests for 28 variations simultaneously, saving critical time in the acute setting.
View Interpretation
Genetics & Oncology

ALL Multiplex Panel

The ALL (Acute Lymphoblastic Leukemia) Multiplex Panel is a specialized molecular diagnostic tool used to identify specific genetic rearrangements and chromosomal translocations within leukemic cells. By utilizing technologies like Multiplex PCR or Next-Generation Sequencing (NGS), this panel screens for hallmark abnormalities such as BCR-ABL1 (Philadelphia chromosome), ETV6-RUNX1, TCF3-PBX1, and MLL (KMT2A) rearrangements. These genetic markers are the primary drivers of leukemogenesis, influencing how lymphocyte precursors proliferate uncontrollably. This panel is standard protocol following a preliminary diagnosis of ALL via morphology and flow cytometry. It is ordered to:
  • Risk Stratification: Determine if the leukemia is low-risk or high-risk.
  • Targeted Therapy: Identify patients who will benefit from specific inhibitors (e.g., Tyrosine Kinase Inhibitors for BCR-ABL1 positive cases).
  • Prognostication: Certain mutations, like ETV6-RUNX1, generally suggest a better prognosis in pediatric populations, whereas MLL rearrangements often indicate a more aggressive course.
The primary condition associated with this test is Acute Lymphoblastic Leukemia, the most common childhood cancer. However, it is also utilized in adult ALL cases. Results are used in conjunction with Minimal Residual Disease (MRD) monitoring to track the effectiveness of chemotherapy or stem cell transplants. Understanding the genetic architecture of the tumor allows oncologists to move away from 'one-size-fits-all' treatments toward precision medicine.
View Interpretation
Oncology

AML Characterization Panel

The Acute Myeloid Leukemia (AML) Characterization Panel is a comprehensive set of diagnostic tests used to define the specific subtype and molecular profile of AML. This is not a single test but a combination of morphology (looking at cells), Flow Cytometry (identifying surface markers), Cytogenetics (looking at chromosomes like t(8;21)), and Molecular Testing (checking for mutations like FLT3, NPM1, or IDH1/2). This characterization is the cornerstone of 'Precision Medicine' in leukemia. Once a preliminary diagnosis of leukemia is made, this panel is essential for:
  • Risk Stratification: Determining if the leukemia is 'favorable', 'intermediate', or 'adverse' risk.
  • Targeted Therapy: Identifying if specific drugs (like FLT3 inhibitors) will be effective.
  • Prognostic Mapping: Predicting the likelihood of remission and the necessity of a stem cell transplant.
  • Baseline for MRD: Establishing the unique markers used to track 'Minimal Residual Disease' after treatment.
  • Acute Myeloid Leukemia (AML): The primary condition, characterized by the rapid growth of abnormal myeloblasts.
  • Myelodysplastic Syndrome (MDS): Often a precursor to AML; the panel helps determine if transformation has occurred.
  • Leukemoid Reaction: A severe but non-cancerous increase in white blood cells that this panel can rule out.
View Interpretation
Hematology

AML Comboquest 9

AML Comboquest 9 is a specialized molecular panel designed to identify key genetic mutations and chromosomal abnormalities associated with Acute Myeloid Leukemia (AML). This panel utilizes advanced techniques like Polymerase Chain Reaction (PCR) or Next-Generation Sequencing (NGS) to look for specific 'driver' mutations that influence how leukemia develops and responds to treatment. When a patient is newly diagnosed with AML, determining the genetic profile of the leukemia cells is the single most important factor for prognosis. This test is ordered to risk-stratify patients into 'favorable,' 'intermediate,' or 'adverse' categories. The results help oncologists decide whether a patient requires standard chemotherapy alone or if they are a candidate for targeted therapies or a stem cell transplant.
  • Acute Myeloid Leukemia (AML): The primary condition being profiled.
  • Myelodysplastic Syndromes (MDS): Sometimes ordered if there is a progression from MDS to AML.
  • Targeted Therapy Selection: Identifying mutations like FLT3, NPM1, or CEBPA allows for the use of specific inhibitors.
The AML Comboquest 9 panel is a cornerstone of precision medicine in hematology. By understanding the molecular 'blueprint' of the cancer, clinicians can move beyond a one-size-fits-all approach to leukemia treatment, significantly improving the chances of achieving and maintaining remission.
View Interpretation
Immunology

ANA Profile (ENA Panel - Qualitative)

The ANA (Antinuclear Antibody) Profile, specifically the ENA (Extractable Nuclear Antigen) Panel, is a follow-up test used to identify specific autoantibodies in the blood. While a general ANA test confirms the presence of antibodies attacking the body's own cell nuclei, the ENA panel differentiates between them, targeting antigens like Sm, RNP, Ro (SS-A), La (SS-B), Scl-70, and Jo-1. This panel is ordered when a patient has a positive ANA screen and symptoms suggestive of a Systemic Autoimmune Rheumatic Disease (SARD). Symptoms may include joint pain, butterfly rashes, photosensitivity, dry eyes/mouth, or Raynaud's phenomenon. It helps clinicians narrow down a broad diagnosis into a specific autoimmune condition.
  • Systemic Lupus Erythematosus (SLE): Characterized by Anti-Sm and Anti-dsDNA.
  • Mixed Connective Tissue Disease (MCTD): Strongly associated with high titers of Anti-RNP.
  • Sjögren’s Syndrome: Identified by Anti-Ro (SS-A) and Anti-La (SS-B).
  • Systemic Sclerosis (Scleroderma): Associated with Anti-Scl-70.
  • Polymyositis/Dermatomyositis: Associated with Anti-Jo-1.
Identifying the specific antibody profile is essential for prognosis and management. For example, Anti-Ro antibodies are significant in pregnant women due to the risk of neonatal heart block. The qualitative nature of this panel provides a 'Yes/No' answer for each specific antigen, allowing for highly specific diagnostic pathways.
View Interpretation
Hematology

Absolute Basophil Count

The Absolute Basophil Count (ABC) measures the actual number of basophils circulating in the blood, rather than their percentage relative to other white cells. Basophils are the least common granulocyte and contain granules filled with histamine and heparin. Within a Differential Count, the ABC is a sensitive indicator of type I hypersensitivity reactions and myeloproliferative disorders. Basophils play a critical role in 'priming' the immune response and are often elevated in conditions involving chronic inflammation or bone marrow dysfunction.
View Interpretation
Hematology

Absolute Eosinophil Count

Eosinophils are a specialized type of white blood cell (leukocyte) that play a dual role in the immune system. They are primarily responsible for combating multicellular parasites and certain infections in vertebrates. Additionally, they are key mediators of allergic reactions and asthma pathogenesis, releasing granules containing enzymes that can destroy pathogens but also cause tissue damage. An Absolute Eosinophil Count (AEC) is ordered to investigate allergic disorders, skin diseases (like dermatitis), or suspected parasitic infections. It is also used to monitor the severity of eosinophilic esophagitis or hypereosinophilic syndrome and to assess the response to certain medications like corticosteroids. Abnormal AEC levels are linked to:
  • Allergies and Asthma: Common causes of moderate elevation.
  • Parasitic Infections: Helminth (worm) infestations often trigger high counts.
  • Autoimmune Diseases: Such as Churg-Strauss syndrome.
  • Certain Cancers: Including Hodgkin's lymphoma and some leukemias.
  • Adrenal Insufficiency: Which can lead to unexpectedly high eosinophil levels.
View Interpretation
Hematology

Absolute Eosinophil Count

The Absolute Eosinophil Count (AEC) calculates the actual number of eosinophils per unit of blood (rather than just the percentage). Eosinophils are specialized white blood cells involved in the body's response to parasitic infections, allergic reactions, and chronic inflammation. In a Differential Count, AEC is critical because a high percentage (eosinophilia) might be misleading if the total WBC count is low; the absolute count provides the definitive clinical picture.
View Interpretation
Hematology

Absolute Lymphocyte Count

The Absolute Lymphocyte Count (ALC) measures the actual number of lymphocytes (T-cells, B-cells, and NK cells) per unit of blood. In COVID Panel Hematology, the ALC is a critical prognostic marker; lymphopenia (low ALC) is strongly associated with increased severity and poor outcomes in viral pneumonia, as it reflects the consumption or destruction of immune cells during the cytokine storm.
View Interpretation
Hematology

Absolute Lymphocyte Count

The Absolute Lymphocyte Count (ALC) is a calculation derived from the total white blood cell count and the percentage of lymphocytes. It is a critical marker of immune status. Lymphocytes (T-cells, B-cells, and NK-cells) are responsible for the body's adaptive immune response. Within a Differential Count, ALC helps identify viral infections, monitor chronic lymphocytic leukemia (CLL), and assess the severity of immunodeficiencies like HIV/AIDS or the effects of immunosuppressive chemotherapy.
View Interpretation
Hematology

Absolute Monocyte Count

Monocytes are the largest type of white blood cell and serve as the precursors to macrophages and dendritic cells. In the context of a Differential Count, the absolute monocyte count is a critical indicator of the body's response to chronic inflammation, stress, and certain infections. They play a pivotal role in phagocytosis and antigen presentation. Monitoring this value helps in differentiating between acute bacterial infections (where neutrophils typically dominate) and chronic conditions or recovery phases where monocytes become more prominent.
View Interpretation
Hematology

Absolute Neutrophil Count

The Absolute Neutrophil Count (ANC) is a critical component of the White Blood Cell (WBC) differential. Neutrophils are the 'first responders' of the innate immune system. The ANC measures the total number of these cells in a microliter of blood. Clinically, it is used to assess a patient's risk of infection (especially during chemotherapy) and to monitor bone marrow function. A low ANC (neutropenia) significantly increases susceptibility to life-threatening bacterial and fungal infections, while a high count (neutrophilia) typically indicates acute physiological stress, bacterial infection, or inflammation.
View Interpretation
Hematology

Absolute Neutrophil Count (ANC)

The ANC measures the total number of neutrophils—the body's primary defense against bacterial and fungal infections. In the context of a COVID Panel, it is used to assess the inflammatory response. While COVID-19 is viral, severe cases often show neutrophilia (high ANC) correlated with cytokine storms and secondary bacterial pneumonia, or lymphopenia, which shifts the neutrophil-to-lymphocyte ratio (NLR), a key prognostic marker.
View Interpretation
Immunology

Acetylcholine Receptor (AChR) Antibody

The Acetylcholine Receptor (AChR) antibody test is a blood assay used to identify autoantibodies that interfere with the transmission of nerve impulses to muscles. In a healthy neuromuscular junction, acetylcholine is released from nerve endings and binds to AChR on the muscle surface, triggering contraction. These autoantibodies block, alter, or destroy these receptors, leading to muscle weakness. This test is the primary diagnostic tool for Myasthenia Gravis (MG). It is ordered for patients exhibiting symptoms such as:
  • Ptosis: Drooping of one or both eyelids.
  • Diplopia: Double vision.
  • Bulbar Symptoms: Difficulty swallowing, impaired speech, or chewing fatigue.
  • Proximal Muscle Weakness: Difficulty climbing stairs or lifting arms, which typically worsens with activity and improves with rest.
  • Generalized Myasthenia Gravis: Approximately 85% of patients with generalized MG test positive for these antibodies.
  • Ocular Myasthenia: About 50% of patients whose symptoms are restricted to the eyes will have positive AChR antibodies.
  • Thymoma: There is a strong association between AChR antibodies and tumors of the thymus gland. High titers in an older patient often prompt chest imaging (CT/MRI).
  • Lambert-Eaton Myasthenic Syndrome (LEMS): Though distinct (usually involving calcium channel antibodies), AChR may be checked during the differential diagnosis of neuromuscular junction disorders.
View Interpretation
Oncology

Acid Phosphatase

Acid Phosphatase (ACP) is an enzyme found in various tissues, including the bone, liver, spleen, and red blood cells, but its highest concentration is found in the prostate gland. It functions best in acidic environments and is responsible for breaking down phosphate esters. Historically, this test was the primary marker for diagnosing and monitoring prostate cancer. However, it has largely been superseded by the more sensitive Prostate-Specific Antigen (PSA) test. Today, it is ordered to:
  • Monitor the progression of advanced prostate cancer, especially when it has metastasized to the bone.
  • Investigate certain bone diseases (e.g., Paget's disease).
  • Assist in forensic investigations, as it is found in high concentrations in seminal fluid.
  • Prostate Cancer: Specifically metastatic stages where the enzyme leaks into the bloodstream.
  • Bone Disorders: Conditions like Gaucher's disease or metastatic bone lesions can elevate the non-prostatic fraction of the enzyme.
  • Blood Disorders: Hemolytic anemia or thrombocytosis can cause elevations due to enzyme release from damaged blood cells.
  • Prostatitis: Inflammation or trauma to the prostate can cause temporary spikes.
While ACP is less specific than PSA, it remains a valuable tool in specific clinical contexts and as part of a comprehensive oncology panel.
View Interpretation
Microbiology

Acid-Fast Bacilli Staining

Acid-Fast Bacilli (AFB) staining, also known as the Ziehl-Neelsen stain, is a laboratory technique used to identify bacteria that have a high lipid (mycolic acid) content in their cell walls. These 'acid-fast' organisms resist decolorization by acids during the staining process, appearing bright red against a blue background under a microscope. The primary reason for ordering an AFB stain is to screen for Mycobacterium tuberculosis, the causative agent of TB. It is also used to detect other mycobacteria (NTM) and Nocardia. It is ordered for patients with a persistent cough, weight loss, night sweats, or abnormal chest X-rays. Because TB is highly contagious, rapid identification is vital for public health.
  • Pulmonary Tuberculosis: The most common cause of a positive sputum AFB.
  • Leprosy: Caused by Mycobacterium leprae.
  • MAI/MAC Complex: Opportunistic infections often seen in HIV/AIDS patients.
  • Nocardiosis: A rare bacterial infection that can mimic TB.
View Interpretation
Hematology

Activated Partial Thromboplastin Time (APTT)

The Activated Partial Thromboplastin Time (APTT) is a functional measure of the 'intrinsic' and 'common' pathways of blood coagulation. Specifically, it evaluates the activity of factors XII, XI, IX, VIII, X, V, II (prothrombin), and I (fibrinogen). It measures the time in seconds it takes for a clot to form in a plasma sample after reagents are added. Clinicians order an APTT for several critical reasons:
  • Unfractionated Heparin Monitoring: It is the primary tool for adjusting heparin dosage to ensure therapeutic anticoagulation without causing excessive bleeding.
  • Pre-surgical Screening: To assess a patient's baseline clotting ability before invasive procedures.
  • Unexplained Bleeding or Bruising: To investigate potential bleeding disorders.
  • Recurrent Miscarriages: Often ordered alongside Lupus Anticoagulant testing to screen for Antiphospholipid Syndrome.
A prolonged APTT may indicate a variety of underlying issues. These include genetic deficiencies like Hemophilia A (Factor VIII) or Hemophilia B (Factor IX), and von Willebrand disease. Acquired conditions such as liver disease (where clotting factors are produced), Vitamin K deficiency (though PT is usually more sensitive), or the presence of inhibitors (like Lupus Anticoagulant) can also extend the time. Conversely, a shortened APTT is less common but can be seen in acute-phase reactions where Factor VIII levels are significantly elevated, potentially indicating a pro-thrombotic state.
View Interpretation
Microbiology

Adenoid Tissue For Culture And Sensitivity

The adenoids are a patch of lymphoid tissue located high in the throat, just behind the nose. They play a crucial role in the immune system, particularly in children, by trapping pathogens that enter through the mouth or nose. An Adenoid Tissue Culture and Sensitivity test involves taking a sample of this tissue to identify the specific bacteria or fungi causing a chronic infection (adenoiditis). This test is primarily ordered when a patient suffers from chronic or recurrent adenoiditis that does not respond to standard antibiotic treatments. It is often performed post-operatively after an adenoidectomy to confirm the presence of specific pathogens or to guide systemic treatment if the infection is suspected to have spread. Doctors use this to identify antibiotic-resistant strains like MRSA.
  • Chronic Adenoiditis: Persistent inflammation of the adenoid tissue.
  • Sleep Apnea: Enlarged, infected adenoids can block airways.
  • Chronic Otitis Media: Infections from the adenoids can travel through the eustachian tubes to the middle ear.
  • Sinusitis: Persistent nasal infections linked to a bacterial reservoir in the adenoids.
The 'Sensitivity' portion of the test is vital. Once a pathogen is grown in the lab, various antibiotics are applied to see which ones effectively kill the organism. This prevents the misuse of antibiotics and ensures the patient receives the most effective targeted therapy.
View Interpretation
Body Fluids

Adenosine Deaminase (ADA), Ascitic Fluid

Adenosine Deaminase (ADA) is an enzyme involved in purine metabolism, primarily produced by T-lymphocytes. In the context of ascitic fluid analysis, it is a highly sensitive and specific biomarker for Tuberculous Peritonitis. Elevated levels indicate a cellular immune response triggered by Mycobacterium tuberculosis. While the Gold Standard for diagnosis remains a peritoneal biopsy or culture, ADA provides a rapid, non-invasive surrogate to differentiate TB from other causes of ascites like cirrhosis or portal hypertension.
View Interpretation
Metabolic

Alanine Aminotransferase (ALT)

Alanine Aminotransferase (ALT) is an enzyme found predominantly in the hepatocytes. In a Liver Function Test (LFT), ALT is considered a more specific indicator of liver injury than AST. It is released into the bloodstream when liver cells are damaged or die. It is critical for screening for hepatitis, fatty liver disease (NAFLD/NASH), and drug-induced liver injury (DILI).
View Interpretation
Microbiology

Albert's Stain

Albert's Stain is a specialized differential staining technique used in microbiology to identify Corynebacterium diphtheriae, the causative agent of Diphtheria. The stain specifically targets metachromatic granules (also known as Volutin or Babes-Ernst granules) which are storage bodies of polyphosphate found in the bacteria. These granules stain bluish-black, while the body of the bacilli stains green, creating a characteristic appearance. This test is ordered when a patient presents with symptoms of Diphtheria, most notably a thick, gray pseudomembrane covering the throat and tonsils, along with sore throat, fever, and swollen lymph nodes ('bull neck' appearance). Because Diphtheria is a medical emergency with high mortality due to toxin-mediated heart and nerve damage, rapid presumptive identification via Albert's stain is critical while awaiting culture results.
  • Diphtheria: An acute, highly contagious bacterial disease.
  • Pharyngitis/Tonsillitis: Differential diagnosis for severe throat infections.
  • Myocarditis and Neuropathy: Complications of the diphtheria toxin that occur if the infection is not treated promptly with antitoxin.
The presence of green-colored, club-shaped bacilli arranged in 'Chinese letter' or 'L and V' patterns with bluish-black polar granules is strongly suggestive of C. diphtheriae. However, other non-pathogenic diphtheroids can also show granules, so this must be confirmed with biochemical tests and toxigenicity assays (like the Elek test).
View Interpretation
Metabolic

Albumin

Albumin is the most abundant protein found in blood plasma, produced exclusively by the liver. It serves two primary functions: maintaining oncotic pressure (which prevents fluid from leaking out of blood vessels into surrounding tissues) and acting as a carrier protein for hormones, vitamins, and drugs. Because of its high concentration, it is a primary indicator of nutritional status and hepatic synthetic function. Physicians order an albumin test as part of a Liver Function Test (LFT) or Comprehensive Metabolic Panel (CMP). It is used to screen for or monitor liver disease (like cirrhosis or hepatitis) and kidney disease (like nephrotic syndrome, where albumin is lost in the urine). It is also a hallmark marker for assessing malnutrition in hospitalized patients or those with chronic illnesses.
  • Liver Cirrhosis: Reduced production of albumin due to liver scarring.
  • Nephrotic Syndrome: The kidneys' filters are damaged, allowing albumin to leak into urine.
  • Inflammatory Bowel Disease (IBD): Protein-losing enteropathy where albumin is lost through the gut.
  • Ascites: Low albumin levels lead to fluid accumulation in the abdominal cavity.
Albumin has a long half-life (about 20 days), meaning it reflects the body's status over the past few weeks rather than acute, immediate changes. Therefore, it is better for monitoring chronic conditions than acute injuries.
View Interpretation
Body Fluids

Albumin

Albumin in ascitic fluid is primarily measured to calculate the Serum-Ascites Albumin Gradient (SAAG). SAAG = (Serum Albumin) - (Ascitic Fluid Albumin). A SAAG score ≥ 1.1 g/dL indicates portal hypertension (e.g., cirrhosis), while a SAAG < 1.1 g/dL suggests other causes such as malignancy, tuberculosis, or nephrotic syndrome.
View Interpretation
Infectious Disease

Albumin

Albumin is the most abundant plasma protein, responsible for maintaining oncotic pressure and transporting hormones/drugs. In a COVID Panel, Albumin serves as a 'negative acute-phase reactant.' Its concentration typically decreases during severe inflammation due to capillary leak syndrome and suppressed hepatic synthesis, making it a valuable prognostic marker for disease severity and nutritional status.
View Interpretation
Metabolic

Albumin

Albumin is the most abundant plasma protein, synthesized exclusively by the liver. In a Liver Function Test, it serves as a biomarker for the liver's synthetic capacity and the patient's nutritional status. It is critical for maintaining colloid osmotic pressure, preventing fluid from leaking out of blood vessels into tissues (edema), and acts as a transport protein for hormones, vitamins, and drugs.
View Interpretation
Metabolic

Albumin

Albumin is the most abundant protein in human blood plasma and is synthesized exclusively by the liver. In the context of a Proteins & A/G Ratio panel, it serves as a primary indicator of nutritional status and hepatic synthetic function. It maintains oncotic pressure (keeping fluid in the blood vessels) and acts as a transport protein for hormones, vitamins, and drugs. It is considered a 'negative acute-phase reactant,' meaning levels drop during periods of acute inflammation or injury.
View Interpretation
Hematology

Albumin

In Serum Protein Electrophoresis (SPEP), Albumin appears as the largest, tallest peak. It is synthesized by the liver and maintains oncotic pressure. Monitoring the albumin fraction in an SPEP panel is essential for identifying 'monoclonal gammopathies', 'nephrotic syndrome' (where albumin is lost in urine), or chronic liver disease (where production is decreased).
View Interpretation
Immunology

Albumin (SPEP)

In Serum Protein Electrophoresis (SPEP), albumin represents the largest and fastest-moving peak. It is synthesized by the liver and maintains oncotic pressure and transport of molecules. In this specific panel, it serves as an internal reference point to quantify other globulin fractions and to screen for liver disease, malnutrition, or protein-losing conditions. A decrease in the albumin peak often accompanies a 'polyclonal' increase in gamma globulins during chronic inflammation.
View Interpretation
Hematology

Albumin/Globulin (A/G) Ratio

The A/G ratio is a calculated value derived from a Serum Protein Electrophoresis or Liver Function Test. Albumin is produced by the liver and maintains osmotic pressure, while globulins include enzymes, transport proteins, and antibodies (gamma globulins). A shift in this ratio is often the first sign of liver disease (where albumin production drops) or plasma cell dyscrasias like Multiple Myeloma (where globulin production spikes).
View Interpretation
Immunology

Albumin/Globulin (A/G) Ratio

The Albumin/Globulin (A/G) ratio is a calculated value used to evaluate the balance between the two major protein fractions in the serum. Albumin, produced primarily by the liver, maintains oncotic pressure, while the globulin fraction represents a heterogeneous group including enzymes, transport proteins, and immunoglobulins (antibodies). In the context of Serum Protein Electrophoresis (SPEP), the A/G ratio serves as a preliminary screen for dysproteinemias. A shift in this ratio often precedes clinical symptoms of liver dysfunction, renal protein loss (nephrotic syndrome), or plasma cell dyscrasias like multiple myeloma.
View Interpretation
Endocrinology

Aldosterone

Aldosterone is a steroid hormone produced by the adrenal cortex. Its primary function is to regulate the balance of sodium and potassium in the blood. By signaling the kidneys to retain sodium and excrete potassium, it indirectly controls water retention and blood pressure. It is a key component of the Renin-Angiotensin-Aldosterone System (RAAS). Physicians order an aldosterone test primarily to diagnose disorders of blood pressure and electrolyte balance. It is often ordered alongside a Renin test to calculate the Aldosterone-to-Renin Ratio (ARR). Common reasons include:
  • Resistant Hypertension: High blood pressure that doesn't respond to standard medications.
  • Hypokalemia: Unexplained low potassium levels.
  • Adrenal Screening: To check for tumors or overactivity of the adrenal glands.
  • Primary Hyperaldosteronism (Conn's Syndrome): Excessive production of aldosterone, usually by an adrenal tumor, leading to high blood pressure and low potassium.
  • Secondary Hyperaldosteronism: High aldosterone caused by factors outside the adrenal gland, such as heart failure, liver cirrhosis, or kidney disease.
  • Addison's Disease (Adrenal Insufficiency): Low production of aldosterone, leading to low blood pressure and high potassium levels.
View Interpretation
Endocrinology

Aldosterone-Renin Ratio

The Aldosterone-Renin Ratio (ARR) is the most reliable screening test for Primary Aldosteronism (PA), a condition where the adrenal glands produce too much aldosterone. In a clinical context, aldosterone promotes sodium retention and potassium excretion, while renin is an enzyme that regulates blood pressure. When aldosterone is high and renin is low, the ratio increases, suggesting autonomous aldosterone production that is independent of the renin-angiotensin system. This is a critical screening tool for patients with resistant hypertension or unexplained hypokalemia.
View Interpretation
Metabolic

Alkaline Phosphatase

Alkaline Phosphatase (ALP) is an enzyme found in various tissues throughout the body, with the highest concentrations located in the liver, bile ducts, and bones. Its primary physiological role involves dephosphorylation, a process essential for the breakdown of proteins and the mineralization of bone matrix. In the liver, ALP is found on the edges of cells that join to form bile ducts. In the bone, it is produced by osteoblasts—cells responsible for the formation of new bone. The ALP test is a staple of the Comprehensive Metabolic Panel (CMP) and Liver Function Test (LFT). Physicians order it to evaluate liver health or to detect bone disorders. Symptoms necessitating this test include jaundice (yellowing of eyes/skin), abdominal pain, nausea, or bone-related issues such as unexplained pain or frequent fractures. It is particularly sensitive in detecting cholestasis (bile flow obstruction). Elevated levels are frequently associated with:
  • Hepatobiliary Diseases: Hepatitis, cirrhosis, liver cancer, or gallstones obstructing the bile duct.
  • Bone Disorders: Paget's disease, osteomalacia, or bone metastasis where rapid bone turnover occurs.
  • Other Factors: Hyperparathyroidism and certain types of leukemia.
Conversely, low levels, while rarer, may indicate malnutrition, zinc deficiency, or the genetic condition hypophosphatasia. Understanding ALP levels helps clinicians differentiate between obstructive liver disease and intrinsic cellular damage.
View Interpretation
Metabolic

Alkaline Phosphatase (ALP)

Alkaline Phosphatase (ALP) is a hydrolase enzyme found primarily in the liver (lining of the biliary ducts) and bone. Within a Liver Function Test Without GGT, ALP serves as a primary indicator of cholestasis (bile flow obstruction). When bile ducts are damaged or obstructed, ALP is induced and spills into the bloodstream. It is also crucial for identifying infiltrative liver diseases like sarcoidosis or certain malignancies. However, because it is also produced by osteoblasts, its significance in this panel is to differentiate between hepatobiliary origin and bone turnover.
View Interpretation
Genetics

All Translocation Panel (Oncquest Lab)

The All Translocation Panel is a sophisticated molecular genetic test designed to detect chromosomal rearrangements (translocations) associated with Acute Lymphoblastic Leukemia (ALL). Translocations occur when a piece of one chromosome breaks off and attaches to another chromosome, often creating 'fusion genes' that drive the uncontrolled growth of white blood cells. This panel is critical for the diagnosis, classification, and risk-stratification of ALL. Identifying specific translocations helps oncologists determine the aggressiveness of the cancer and select targeted therapies. It is also used to monitor 'Minimal Residual Disease' (MRD) following chemotherapy or bone marrow transplantation.
  • Philadelphia Chromosome (t(9;22)): This involves the BCR-ABL1 fusion and is a hallmark of certain high-risk leukemias, requiring specific TKI inhibitors.
  • t(12;21): Associated with the ETV6-RUNX1 fusion, generally indicating a more favorable prognosis in pediatric ALL.
  • t(4;11): Involves the KMT2A (MLL) gene, often seen in infant leukemias and associated with a more aggressive course.
Modern oncology relies on these genetic markers to move away from 'one-size-fits-all' chemotherapy toward precision medicine. The presence or absence of these translocations can fundamentally change the duration and intensity of the treatment protocol.
View Interpretation
Immunology

Allergy Profile (Veg) + Total IgE

This panel combines a Total IgE measurement with specific IgE tests for a variety of plant-based (vegetarian) foods. Total IgE is an umbrella marker of the body's allergic reactivity, while specific IgE tests (ImmunoCAP or RAST) measure the immune system's response to specific proteins found in vegetables, grains, legumes, or fruits. It is ordered when a patient experiences symptoms like hives, swelling, wheezing, or digestive distress after consuming certain plant-based foods. It is particularly useful for individuals following vegetarian or vegan diets who may be consuming high amounts of soy, nuts, or specific grains and are trying to identify a trigger for their symptoms.
  • Food Allergy (Type I Hypersensitivity): Immediate allergic reactions.
  • Oral Allergy Syndrome (OAS): Itchy mouth caused by cross-reactivity between pollen and certain raw vegetables/fruits.
  • Atopic Dermatitis: Eczema that may be exacerbated by food triggers.
  • Anaphylaxis: A life-threatening systemic allergic reaction.
A high Total IgE suggests an 'atopic' constitution (prone to allergies), while specific IgE results indicate 'sensitization.' It is critical to note that sensitization does not always equal clinical allergy; many people have specific IgE antibodies but can eat the food without symptoms. Results must be interpreted alongside a detailed clinical history.
View Interpretation
Allergy and Immunology

Allergy Profile (Veg+Non-Veg) + Total IgE

This comprehensive panel measures specific Immunoglobulin E (IgE) antibodies against a variety of vegetarian and non-vegetarian food sources, alongside the Total IgE level. IgE is the antibody responsible for Type I hypersensitivity reactions. When an individual with an allergy is exposed to a specific protein (allergen), the immune system produces IgE, which triggers mast cells to release histamine, leading to allergic symptoms. This profile is diagnostic for individuals suffering from unexplained symptoms that occur after eating. It is ordered to:
  • Pinpoint Triggers: Distinguish between common food allergens like legumes, dairy, eggs, meats, or seafood.
  • Assess Atopy: Total IgE serves as a general marker for the body's 'allergic tilt' or atopic state.
  • Differentiate Intolerance: Help distinguish between a true immune-mediated food allergy and a non-immune food intolerance (like lactose intolerance).
High specific IgE levels are associated with clinical food allergies, which can manifest as urticaria (hives), angioedema (swelling), gastrointestinal distress, or life-threatening anaphylaxis. Chronically elevated Total IgE can be seen in asthma, atopic dermatitis (eczema), and allergic rhinitis. However, Total IgE can also be elevated in non-allergic conditions such as parasitic infections (helminths) or certain rare immunodeficiencies like Hyper-IgE Syndrome (Job's Syndrome).
View Interpretation
Immunology

Allergy Profile (Veg, Non-Veg, Inhalants) + Total IgE

This comprehensive allergy profile measures the level of Immunoglobulin E (IgE) antibodies in the blood. It includes 'Total IgE,' which represents the overall state of allergic sensitization, and 'Specific IgE' for various panels (Vegetarian foods, Non-Vegetarian foods, and Inhalants like pollen, dust, or dander). IgE is the antibody responsible for Type I hypersensitivity reactions. This test is ordered for individuals suffering from chronic symptoms that suggest an allergic origin, such as:
  • Persistent sneezing, runny nose, or itchy eyes (Allergic Rhinitis).
  • Chronic hives (Urticaria) or eczema.
  • Gastrointestinal distress after eating specific foods.
  • Shortness of breath or wheezing (Allergic Asthma).
  • Atopic Dermatitis: Chronic skin inflammation driven by allergens.
  • Allergic Asthma: Airway constriction triggered by environmental inhalants.
  • Anaphylaxis Risk: Identifying high levels of specific IgE helps assess the risk of life-threatening reactions to foods like nuts or shellfish.
  • Allergic Rhinitis: Seasonal or perennial allergies to pollen or mold.
  • Inhalants: Tests for sensitivity to dust mites, pet dander, molds, and various grasses/trees.
  • Food Panels: Screens for common proteins in vegetables, grains, meats, and seafood that trigger immune responses.
View Interpretation
Immunology

Allergy Profile With Drugs

The Allergy Profile for Drugs measures the levels of allergen-specific Immunoglobulin E (IgE) antibodies in the blood directed against specific medications. When an individual is sensitized to a drug, their immune system produces IgE antibodies that recognize that drug. Upon re-exposure, these antibodies trigger the release of histamine and other chemicals from mast cells, leading to an allergic reaction. This panel is ordered when a patient has a suspected Type I hypersensitivity reaction to a specific drug (commonly Penicillin, Amoxicillin, Insulin, or NSAIDs). Symptoms may include hives, swelling (angioedema), wheezing, or anaphylaxis. It is a safer alternative or a preliminary step before performing a 'drug provocation test' or 'skin prick test,' especially in patients at high risk for severe reactions.
  • Drug Allergy: Confirmed sensitization to specific pharmacological agents.
  • Anaphylaxis Risk: High IgE levels indicate a significant risk for life-threatening systemic reactions.
  • Cross-Reactivity: The test helps identify if a patient might react to chemically similar drugs (e.g., cross-reactivity between different penicillins).
  • Urticaria: Chronic or acute hives resulting from medication ingestion.
View Interpretation
Immunology

Allergy Profile Without Drugs

The Allergy Profile Without Drugs is a panel of blood tests that measures the concentration of specific IgE antibodies in response to common environmental and food allergens, excluding pharmaceutical agents. IgE is the antibody class responsible for Type I hypersensitivity reactions, commonly known as allergies. This panel is ordered to identify the triggers of allergic symptoms such as hay fever, asthma, hives, or digestive issues. Unlike skin prick testing, this blood test is safe for patients with severe eczema or those at risk of anaphylaxis. It provides a quantitative measure of sensitization to various triggers like pollen, dust mites, pet dander, and common foods.
  • Allergic Rhinitis: Sensitivity to airborne allergens like grass or tree pollen.
  • Atopic Dermatitis: Eczema flared by environmental or food triggers.
  • Allergic Asthma: Bronchoconstriction triggered by inhaled allergens.
  • Food Allergy: IgE-mediated reactions to peanuts, milk, eggs, or shellfish.
View Interpretation
Hematology

Alpha-1 Globulin

Fraction of serum protein.
View Interpretation
Hematology

Alpha-1 Globulin

Alpha-1 globulin is a fraction of serum proteins identified during electrophoresis. Over 90% of this fraction consists of Alpha-1 Antitrypsin (A1AT), a protease inhibitor that protects tissues (especially the lungs) from enzymes like neutrophil elastase. It is also an 'acute-phase reactant,' meaning its levels rise during systemic inflammation. Measuring this fraction helps screen for genetic A1AT deficiency or monitor inflammatory states.
View Interpretation
Immunology

Alpha-1 Globulin

Alpha-1 Globulin is a fraction of serum proteins identified during electrophoresis. It primarily consists of Alpha-1 Antitrypsin (AAT), an acute-phase reactant. This fraction increases during systemic inflammation, infection, or trauma. A decrease in this fraction is a critical screening marker for Alpha-1 Antitrypsin Deficiency, which can lead to early-onset emphysema and liver cirrhosis.
View Interpretation
Hematology

Alpha-2 Globulin

Fraction of serum protein.
View Interpretation
Hematology

Alpha-2 Globulin

The Alpha-2 globulin fraction consists primarily of Alpha-2 Macroglobulin and Haptoglobin. In Serum Electrophoresis, this band is particularly useful for identifying acute phase responses and protein-losing enteropathies or nephropathies. Because Alpha-2 macroglobulin is a large molecule, it is often retained and even upregulated in conditions where smaller proteins like albumin are lost.
View Interpretation
Immunology

Alpha-2 Globulin

Alpha-2 globulin is a fraction of serum proteins identified during electrophoresis. This group includes important proteins such as alpha-2 macroglobulin and haptoglobin. Alpha-2 macroglobulin is a large protease inhibitor, and haptoglobin binds free hemoglobin. This fraction acts as an 'acute phase reactant.' In clinical practice, monitoring this fraction helps in diagnosing inflammatory states and renal disorders like nephrotic syndrome.
View Interpretation
Tumor Markers

Alpha-Fetoprotein (AFP)

Alpha-Fetoprotein (AFP) is a protein produced primarily by the liver and yolk sac of a developing fetus. In healthy non-pregnant adults, AFP levels are typically very low or undetectable. However, AFP serves as a critical biomarker in two primary medical contexts: oncology and obstetrics. In oncology, doctors order the AFP test to screen for, diagnose, or monitor treatment for certain types of cancers. It is most commonly used for Hepatocellular Carcinoma (liver cancer) and germ cell tumors of the ovaries or testes. In chronic liver disease patients (such as those with Hepatitis B or C), rising AFP levels can be an early warning sign of malignant transformation. In obstetrics, it is part of the 'quad screen' to assess the risk of neural tube defects or chromosomal abnormalities in the fetus. High levels of AFP are associated with several conditions:
  • Hepatocellular Carcinoma: Primary liver cancer.
  • Germ Cell Tumors: Non-seminomatous germ cell tumors of the testes or ovaries.
  • Liver Cirrhosis/Hepatitis: Chronic inflammation can cause moderate elevations.
  • Pregnancy Complications: Abnormally high levels in maternal blood may indicate neural tube defects (like spina bifida), while low levels might suggest Down Syndrome.
View Interpretation
Oncology

Alpha-Fetoprotein (AFP)

AFP is a protein normally produced by the fetal liver and yolk sac. In the context of an Ovarian Cancer Panel, it is used as a specialized tumor marker. While most commonly associated with liver cancer, it is specifically elevated in certain 'germ cell' ovarian tumors (like Yolk Sac Tumors). It is used for diagnosis, staging, and monitoring the effectiveness of treatment.
View Interpretation
Immunology

Alternaria Alternata (Mold) Specific IgE

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies in the blood directed against Alternaria alternata, a common outdoor mold. Alternaria is a major risk factor for the development and exacerbation of allergic rhinitis and extrinsic asthma. High levels indicate sensitization, which, when correlated with symptoms, confirms an allergic profile.
View Interpretation
Toxicology

Amphetamines

This component of a toxicology panel screens for the presence of amphetamine-class stimulants. It is used in clinical settings for overdose evaluation, workplace drug testing, and monitoring adherence to ADHD medications. The test typically uses an immunoassay technique to detect the drug or its metabolites above a specific concentration threshold.
View Interpretation
Metabolic

Amylase

Amylase is an enzyme produced primarily by the pancreas and the salivary glands. Its main job is to help the body break down complex carbohydrates (starches) into simple sugars. While small amounts of amylase are normally found in the blood, a large 'leak' of this enzyme into the bloodstream usually indicates damage to the cells that produce it. The amylase test is most frequently used to diagnose and monitor acute pancreatitis (inflammation of the pancreas). It is often ordered alongside a Lipase test when a patient experiences severe abdominal pain, fever, loss of appetite, or nausea. It can also help evaluate conditions affecting the salivary glands.
  • Acute Pancreatitis: Levels often rise 4-6 times higher than the upper limit.
  • Pancreatic Cancer or Duct Obstruction: Caused by gallstones blocking the pancreatic duct.
  • Mumps: Inflammation of the salivary glands increases salivary amylase.
  • Macroamylasemia: A benign condition where amylase binds to proteins in the blood, causing high levels without disease.
View Interpretation
Body Fluids

Amylase

Amylase is an enzyme primarily secreted by the pancreas and salivary glands to digest starch. In clinical practice, it is a key diagnostic marker for acute pancreatitis. While not as specific as lipase, it is often used in panels to evaluate acute abdominal pain and pancreatic injury.
View Interpretation
Microbiology

Anaerobic Culture

Anaerobic cultures are designed to detect bacteria that can only survive in environments with little to no oxygen. These organisms are often part of the body's normal flora (in the gut or mouth) but can cause severe infection if they enter deep tissues. The culture process involves specialized 'anaerobic jars' or chambers that remove all oxygen to allow these specific pathogens to grow. Anaerobic infections often present with foul-smelling discharge, gas in the tissue (crepitus), or necrosis. This test is ordered for:
  • Deep tissue abscesses (e.g., intra-abdominal or brain abscesses).
  • Puncture wounds (like animal bites or stepping on a nail).
  • Suspected gangrene or necrotizing fasciitis.
  • Chronic sinusitis or pelvic inflammatory disease (PID).
  • Bacteroides infections: Often following abdominal surgery.
  • Clostridium perfringens: The cause of gas gangrene.
  • Actinomycosis: Chronic infections characterized by 'sulfur granules' in pus.
View Interpretation
Metabolic

Angiotensin Converting Enzyme

Angiotensin-Converting Enzyme (ACE) is a critical enzyme primarily produced by epithelial cells in the lungs. Its fundamental physiological role is the conversion of angiotensin I into angiotensin II, a potent vasoconstrictor that regulates blood pressure and fluid balance. Additionally, ACE breaks down bradykinin, a peptide that promotes vasodilation. Together, these actions make ACE a central component of the renin-angiotensin-aldosterone system (RAAS). The ACE test is primarily used as a biomarker for granulomatous diseases. Clinicians order this test when a patient presents with symptoms of sarcoidosis, such as chronic cough, shortness of breath, red/teary eyes, or skin bumps. Because ACE is produced by the cells that make up granulomas (small clumps of inflammatory cells), elevated levels often reflect the total 'granuloma burden' in the body. It is also used to monitor the effectiveness of corticosteroid treatment in patients already diagnosed with sarcoidosis.
  • Sarcoidosis: The most common cause of high ACE levels. Approximately 50-80% of patients with active sarcoidosis show elevated ACE.
  • Gaucher Disease: A rare genetic disorder involving lipid metabolism often shows significantly high ACE.
  • Hyperthyroidism: Elevated thyroid hormones can stimulate ACE production.
  • Liver Disease: Conditions like cirrhosis or hepatitis can occasionally influence ACE levels.
  • Lyme Disease and Leprosy: Other granulomatous infections that may lead to moderate elevations.
View Interpretation
Hematology

Anti Cardiolipin AB-Profile

Anti-cardiolipin antibodies are autoantibodies directed against cardiolipin, a phospholipid found in the inner mitochondrial membrane. These antibodies interfere with the normal function of vascular cells and blood clotting factors, shifting the body toward a pro-thrombotic (clot-forming) state. This profile is a core component in diagnosing Antiphospholipid Syndrome (APS). It is typically ordered for patients who experience unexplained blood clots (Deep Vein Thrombosis or Stroke), or for women with a history of recurrent miscarriages or pregnancy complications like pre-eclampsia. It is also used to evaluate patients with Systemic Lupus Erythematosus (SLE), as these antibodies frequently co-occur.
  • Antiphospholipid Syndrome (APS): Characterized by thrombosis and pregnancy loss.
  • Systemic Lupus Erythematosus (SLE): About 30-40% of SLE patients have these antibodies.
  • Recurrent Pregnancy Loss: Related to placental vascular issues caused by the antibodies.
  • Thrombocytopenia: Low platelet counts are often associated with the presence of these antibodies.
View Interpretation
Serology

Anti HAV Antibodies

The Anti-HAV (Hepatitis A Virus) antibody test detects the presence of antibodies produced by the immune system in response to the Hepatitis A virus. This test can measure Total antibodies (IgM and IgG combined) to determine overall immunity or specific IgM to detect acute infection. This test is primarily used to diagnose acute viral hepatitis or to assess a person's immune status. It is ordered for:
  • Jaundice Investigation: When a patient has yellowing of eyes/skin, dark urine, and elevated liver enzymes.
  • Outbreak Screening: Testing individuals exposed to contaminated food or water.
  • Pre-Vaccination Screening: To see if a person is already immune, potentially saving the cost of a vaccine series.
  • Employment/Travel: For healthcare workers or travelers going to endemic areas.
  • Acute Hepatitis A: A highly contagious liver infection spread through the fecal-oral route. Unlike Hep B or C, it does not become chronic.
  • Fulminant Hepatic Failure: A rare but life-threatening complication where the liver fails rapidly.
  • Immunity: Indicates either a past resolved infection or successful vaccination.
Understanding the HAV status is vital for public health, as acute cases require reporting to health authorities to prevent community-wide outbreaks.
View Interpretation
Infectious Disease

Anti HBe Antibodies

The Anti-HBe (Hepatitis B e-antibody) test detects antibodies produced by the body against the 'e' antigen of the Hepatitis B virus (HBV). The presence of these antibodies usually signifies a transition in the course of a chronic HBV infection, moving from a state of high viral replication to a period of lower viral activity. This test is used to monitor the progression of chronic Hepatitis B and the effectiveness of antiviral therapy. When a patient 'seroconverts' from HBeAg (antigen) positive to Anti-HBe positive, it generally indicates a favorable prognosis, suggesting that the immune system is gaining control over the virus and the risk of liver damage is decreasing.
  • Chronic Hepatitis B: Monitoring the 'inactive carrier' state.
  • HBV Seroconversion: The shift from active replication to a dormant state.
  • Pre-core Mutant HBV: A specific strain of the virus where Anti-HBe is present but viral loads remain high, requiring specialized management.
View Interpretation
Immunology

Anti HBs Titres

The Anti-HBs (Hepatitis B Surface Antibody) test detects the presence and concentration of antibodies against the Hepatitis B surface antigen. The presence of these antibodies indicates that the person has developed immunity to the Hepatitis B virus (HBV). This test is primarily used to determine if a person is protected against HBV. It is ordered after a full course of the Hepatitis B vaccine to confirm 'seroconversion' (successful vaccination). It is also used in 'Hepatitis Panels' to determine if a person has recovered from a past acute infection, as opposed to being a chronic carrier.
  • Post-Vaccination Immunity: A titre >10 mIU/mL is the international standard for protection.
  • Recovery from Infection: If Anti-HBs is positive along with Anti-HBc (Core antibody), it indicates natural immunity from a resolved infection.
  • Non-responder Status: Some individuals do not develop antibodies even after multiple vaccine series.
  • Chronic Hepatitis B: In chronic cases, the surface antibody is usually absent while the surface antigen (HBsAg) remains present.
Healthcare workers are routinely screened for these titres to ensure workplace safety. If titres drop below 10 mIU/mL over several years, a booster dose may be recommended, although 'immunological memory' often persists even when titres are low.
View Interpretation
Immunology

Anti Mitochondrial Antibody (ELISA)

The Anti-Mitochondrial Antibody (AMA) test is a serological marker primarily used to detect autoantibodies directed against the E2 subunit of the pyruvate dehydrogenase complex located on the inner mitochondrial membrane. In healthy individuals, the immune system distinguishes between self and non-self; however, in certain autoimmune conditions, the body produces AMA, which specifically targets highly metabolic cells, particularly those in the bile ducts of the liver. Physicians order this test when a patient presents with unexplained signs of liver dysfunction, such as elevated alkaline phosphatase (ALP) levels, jaundice, fatigue, or pruritus (intense itching). It is the hallmark diagnostic tool for Primary Biliary Cholangitis (PBC), an autoimmune disease where the small bile ducts in the liver become inflamed and eventually destroyed, leading to cholestasis and potential cirrhosis.
  • Primary Biliary Cholangitis (PBC): AMA is present in approximately 90-95% of patients with PBC.
  • Autoimmune Hepatitis: Occasionally seen in 'overlap syndromes'.
  • Systemic Sclerosis: Some variants of scleroderma may show low-level AMA positivity.
  • Idiopathic Liver Cirrhosis: In cases where the underlying cause of scarring is initially unknown.
While highly specific for PBC, a positive result must be correlated with liver function tests and sometimes a liver biopsy to determine the stage of the disease.
View Interpretation
Immunology

Anti Nuclear Antibodies (ELISA)

Anti-Nuclear Antibodies (ANA) are a group of autoantibodies produced by the immune system that mistakenly target the nucleus of the body's own cells. The ELISA (Enzyme-Linked Immunosorbent Assay) method provides a quantitative or semi-quantitative screening to detect the presence of these antibodies in the blood. While the presence of ANA indicates immune system overactivity, it does not point to a specific disease without further testing. Physicians order an ANA test when a patient exhibits symptoms suggestive of a systemic autoimmune disorder. These symptoms may include:
  • Persistent joint pain and swelling
  • Unexplained fatigue and low-grade fever
  • Butterfly-shaped skin rashes (malar rash)
  • Muscle pain or sensitivity to light
  • Raynaud’s phenomenon (fingers turning blue/white in the cold)
A positive ANA test is a hallmark of several connective tissue diseases, most notably:
  1. Systemic Lupus Erythematosus (SLE): ANA is positive in about 95% of SLE cases.
  2. Sjogren’s Syndrome: Causes dry eyes and dry mouth.
  3. Scleroderma: Leads to hardening of skin and connective tissues.
  4. Mixed Connective Tissue Disease (MCTD): An overlap of several conditions.
  5. Autoimmune Hepatitis: A condition where the immune system attacks the liver.
It is important to note that ANA can also be positive in patients with chronic infections (like tuberculosis or endocarditis) or those taking certain medications (hydralazine, isoniazid). Furthermore, a small percentage of healthy individuals, particularly the elderly, may test positive for ANA without any underlying disease.
View Interpretation
Immunology

Anti Nuclear Antibodies (IFA)

The Anti-Nuclear Antibody (ANA) test using Indirect Fluorescent Antibody (IFA) is the 'gold standard' screening tool for systemic autoimmune diseases. It detects antibodies that target the contents of the cell nucleus. The IFA method involves placing patient serum on a slide of human cells (HEp-2) and observing the patterns of fluorescence under a microscope. Physicians order an ANA test when a patient exhibits signs of a systemic autoimmune disorder, such as:
  • Unexplained fever and persistent fatigue
  • Joint pain and swelling (arthritis)
  • A butterfly-shaped red rash across the cheeks and nose (malar rash)
  • Sensitivity to sunlight and hair loss
  • Numbness or color changes in fingers when cold (Raynaud's phenomenon)
A positive ANA is highly sensitive for Systemic Lupus Erythematosus (SLE), with over 95% of lupus patients testing positive. It is also associated with Scleroderma, Sjogren's Syndrome, Mixed Connective Tissue Disease (MCTD), and Autoimmune Hepatitis. It is important to note that a positive result is not a definitive diagnosis; it indicates that the immune system is active against self-tissues and requires further specific testing (like Anti-dsDNA or Anti-Smith).
View Interpretation
Immunology

Anti Phospholipid Antibody

Anti-Phospholipid Antibodies (APA) are autoantibodies that mistakenly target the body's own phospholipids and proteins associated with cell membranes. Their presence interferes with the normal blood clotting process. This test typically looks for several types of antibodies, including Anticardiolipin (IgG, IgM) and Lupus Anticoagulant. They are key markers for an autoimmune pro-thrombotic state. Physicians order this test when a patient experiences unexplained blood clots (Deep Vein Thrombosis or Stroke) or recurrent pregnancy loss (miscarriages), particularly in the second or third trimester. It is also used in the diagnostic workup for Systemic Lupus Erythematosus (SLE) or other connective tissue diseases to assess the risk of thrombotic complications.
  • Antiphospholipid Syndrome (APS): A disorder characterized by recurrent arterial or venous thrombosis and/or pregnancy losses.
  • Systemic Lupus Erythematosus (SLE): Many Lupus patients carry these antibodies.
  • Thrombocytopenia: A low platelet count is often seen alongside these antibodies.
  • Preeclampsia: Increased risk of early-onset or severe high blood pressure during pregnancy.
View Interpretation
Endocrinology

Anti Thyroglobulin Antibodies

Anti-Thyroglobulin (Anti-Tg) antibodies are autoantibodies produced by the immune system that mistakenly attack thyroglobulin, a protein found in the thyroid gland used to produce thyroid hormones. Under normal conditions, thyroglobulin remains within the thyroid follicles. However, if the thyroid is damaged by an autoimmune process, thyroglobulin may leak into the bloodstream, triggering the production of these antibodies. This test is primarily ordered to help diagnose autoimmune thyroid disorders. It is often requested alongside Anti-Thyroid Peroxidase (Anti-TPO) antibodies. Common reasons for ordering include investigating the cause of a goiter, evaluating symptoms of hypothyroidism or hyperthyroidism, and monitoring patients who have undergone treatment for differentiated thyroid cancer. In the context of thyroid cancer, Anti-Tg antibodies are monitored because their presence can interfere with thyroglobulin tests used to detect cancer recurrence.
  • Hashimoto’s Thyroiditis: The most common cause of hypothyroidism in iodine-sufficient areas. High levels are found in 60-90% of patients.
  • Graves’ Disease: An autoimmune cause of hyperthyroidism. About 30% of these patients test positive for Anti-Tg.
  • Thyroid Cancer: While not a diagnostic tool for cancer itself, its levels are crucial for post-surgical follow-up.
  • Other Autoimmune Disorders: Occasionally, levels may be elevated in individuals with Type 1 Diabetes or Rheumatoid Arthritis.
Monitoring Anti-Tg is essential for a complete thyroid profile. While a small percentage of the healthy population may have low levels of these antibodies, high titers almost always indicate an underlying autoimmune response that requires clinical correlation with TSH and Free T4 levels.
View Interpretation
Immunology

Anti Tissue Transglutaminase IgA (Anti-TTG IgA)

The Anti-Tissue Transglutaminase (tTG) IgA test is the primary screening blood test for Celiac Disease. Tissue Transglutaminase is an enzyme involved in the repair of cells. In individuals with Celiac Disease, the ingestion of gluten (a protein found in wheat, barley, and rye) triggers an autoimmune response where the body produces IgA antibodies against this enzyme, leading to inflammation and destruction of the small intestinal lining (villi). This test is ordered for patients exhibiting symptoms of malabsorption, such as chronic diarrhea, abdominal bloating, weight loss, or unexplained iron-deficiency anemia. It is also used to screen high-risk individuals, such as those with Type 1 Diabetes, Down Syndrome, or a first-degree relative with Celiac Disease. In pediatric patients, it is often used to investigate 'failure to thrive.'
  • Celiac Disease: Gluten-sensitive enteropathy.
  • Dermatitis Herpetiformis: A skin manifestation of gluten sensitivity.
  • Malabsorption Syndromes: Leading to Vitamin D, B12, or Iron deficiencies.
  • IgA Deficiency: About 2-3% of people with Celiac disease also have a selective IgA deficiency, which can cause a false negative on this specific test.
A positive tTG-IgA result is usually followed by a small bowel biopsy to confirm the diagnosis (showing villous atrophy). Once diagnosed, the test is used periodically to monitor compliance with a gluten-free diet; antibody levels should drop significantly when gluten is removed from the diet.
View Interpretation
Immunology

Anti-CCP Antibody

The Anti-Cyclic Citrullinated Peptide (Anti-CCP) antibody test detects autoantibodies produced by the immune system that mistakenly attack the body's own healthy tissues. Citrullination is a natural process in the body, but in certain individuals, the immune system views these citrullinated proteins as foreign invaders. This test is primarily used to diagnose Rheumatoid Arthritis (RA). It is highly specific (around 95-98%), meaning if a person tests positive, they almost certainly have RA. It is often ordered alongside Rheumatoid Factor (RF). It is particularly useful in the early stages of the disease, as Anti-CCP can appear in the blood years before clinical symptoms manifest.
  • Rheumatoid Arthritis: A chronic inflammatory disorder affecting joints.
  • Palindromic Rheumatism: A rare form of inflammatory arthritis.
  • Sjogren's Syndrome: Occasionally positive in this systemic autoimmune disease.
View Interpretation
Hematology

Anti-Cardiolipin Antibody, IgA

Anti-Cardiolipin (aCL) IgA is an autoantibody associated with Antiphospholipid Syndrome (APS). While IgG and IgM are the primary diagnostic criteria for APS, IgA is tested when clinical suspicion remains high despite negative IgG/IgM results. These antibodies interfere with coagulation processes, leading to an increased risk of arterial/venous thrombosis and pregnancy complications like recurrent miscarriage.
View Interpretation
Hematology

Anti-Cardiolipin Antibody, IgG

Anti-Cardiolipin (aCL) IgG is an autoantibody directed against phospholipids. It is a core component of the Anti Cardiolipin AB-Profile used to diagnose Antiphospholipid Syndrome (APS). IgG is clinically more significant and strongly associated with venous and arterial thrombosis, as well as pregnancy complications like recurrent miscarriages and pre-eclampsia. It works by interfering with the coagulation cascade on the surface of vascular endothelial cells.
View Interpretation
Hematology

Anti-Cardiolipin Antibody, IgM

Anti-Cardiolipin (aCL) IgM antibodies are a primary component of the Antiphospholipid Syndrome (APS) workup. These autoantibodies target cardiolipin, a negatively charged phospholipid. In the context of a clinical profile, elevated IgM levels are associated with an increased risk of venous and arterial thrombosis, as well as pregnancy-related morbidities such as recurrent miscarriage or pre-eclampsia. While IgM is often associated with an acute phase response, persistent elevation over 12 weeks is required for a formal diagnosis of APS.
View Interpretation
Immunology

Anti-Centromere B

Anti-Centromere B antibodies target proteins associated with the centromere of chromosomes. This test is a critical component of an ANA (Antinuclear Antibody) Profile. It is highly specific for Limited Cutaneous Systemic Sclerosis, formerly known as CREST Syndrome (Calcinosis, Raynaud's, Esophageal dysmotility, Sclerodactyly, and Telangiectasia). Its presence helps differentiate limited scleroderma from diffuse systemic sclerosis and other connective tissue diseases.
View Interpretation
Infectious Disease

Anti-HBc IgM

Anti-HBc IgM is the IgM antibody to the Hepatitis B core antigen. Unlike the IgG antibody, which persists for life after infection, the IgM class is produced only during the early, acute phase of a Hepatitis B virus (HBV) infection. It is a critical marker for identifying recent exposure and the onset of clinical symptoms. This test is ordered to distinguish between an acute (recent) infection and a chronic (long-term) HBV infection. It is also used during the 'window period'—a timeframe where the Hepatitis B Surface Antigen (HBsAg) has disappeared but the Surface Antibody (Anti-HBs) has not yet developed. In such cases, Anti-HBc IgM may be the only detectable marker of a recent infection.
  • Acute Hepatitis B: The primary condition identified by this marker.
  • Chronic HBV Flare: Occasionally, a patient with chronic Hepatitis B may test positive for IgM during a sudden reactivation or 'flare' of the virus.
  • Fulminant Hepatitis: A rare, severe form of acute hepatitis where rapid liver failure occurs.
View Interpretation
Infectious Disease

Anti-HEV Antibodies

The Anti-HEV (Hepatitis E Virus) Antibodies test detects the body's immune response to an infection with the Hepatitis E virus. HEV is a common cause of acute viral hepatitis worldwide, typically transmitted via the fecal-oral route through contaminated water or undercooked meat (particularly pork or venison). The test usually distinguishes between two types of antibodies: IgM and IgG. Anti-HEV IgM appears early in the course of infection and indicates an acute or recent infection. Anti-HEV IgG appears later and persists for years, indicating a past infection and providing some level of immunity. This test is ordered for patients presenting with symptoms of acute hepatitis—such as jaundice (yellowing of the skin/eyes), dark urine, fatigue, nausea, and abdominal pain—especially if they have recently traveled to endemic areas or have a history of consuming high-risk foods. It is particularly crucial for pregnant women, as HEV infection in the third trimester carries a high risk of fulminant hepatic failure and mortality. It is also used to screen immunocompromised patients (like organ transplant recipients) who may develop chronic Hepatitis E, a condition that can lead to rapid cirrhosis.
  • Acute Hepatitis E: The primary illness caused by the virus, usually self-limiting in healthy individuals.
  • Fulminant Hepatic Failure: A severe, life-threatening complication, most common in pregnant women or those with pre-existing liver disease.
  • Chronic Hepatitis E: Occurs almost exclusively in immunocompromised patients, potentially leading to liver scarring.
  • Neurological Manifestations: HEV has been linked to conditions like Neuralgic Amyotrophy and Guillain-Barré Syndrome.
View Interpretation
Immunology

Anti-Jo-1 Antibody

The Anti-Jo-1 antibody targets histidyl-tRNA synthetase and is a hallmark marker within the ANA Profile (ENA Panel). It is specifically associated with Anti-Synthetase Syndrome, a subset of idiopathic inflammatory myopathies (IIM). Its presence is strongly predictive of polymyositis or dermatomyositis, often accompanied by interstitial lung disease (ILD), Raynaud's phenomenon, and 'mechanic's hands'. Screening for this is vital when a patient presents with unexplained proximal muscle weakness and pulmonary symptoms.
View Interpretation
Endocrinology

Anti-Mullerian Hormone (AMH)

Anti-Mullerian Hormone (AMH) is a protein hormone produced by the granulosa cells within the ovarian follicles. Its primary role in adult women is to serve as a marker for ovarian reserve—the remaining egg supply. Unlike FSH, AMH levels remain relatively stable throughout the menstrual cycle, making it a convenient and reliable marker for fertility assessment. AMH testing is most frequently used in the context of assisted reproductive technology (ART), such as Invitro Fertilization (IVF). It helps predict how a woman will respond to ovarian stimulation medication. It is also used to assess the onset of menopause or to evaluate conditions like Polycystic Ovary Syndrome (PCOS), where follicle counts are abnormally high.
  • Ovarian Reserve Depletion: Low AMH indicates a declining egg count, which is natural with age but concerning if premature.
  • PCOS: Characterized by very high AMH levels due to the abundance of small antral follicles.
  • Ovarian Cancer: Certain types of ovarian tumors (granulosa cell tumors) secrete AMH, making it a useful tumor marker for monitoring recurrence.
  • Primary Ovarian Insufficiency: Very low or undetectable AMH in women under 40.
View Interpretation
Immunology

Anti-RNP

Anti-Ribonucleoprotein (RNP) antibodies are a type of Extractable Nuclear Antigen (ENA). They are the diagnostic hallmark of Mixed Connective Tissue Disease (MCTD), where high titers are almost always present. They may also be found in Systemic Lupus Erythematosus (SLE) and systemic sclerosis. Testing for Anti-RNP helps differentiate between various systemic autoimmune rheumatic diseases (SARDs).
View Interpretation
Immunology

Anti-SSA (Ro) Antibody

Anti-SSA (Ro) is an Extractable Nuclear Antigen (ENA) antibody commonly associated with Sjögren's Syndrome (present in 60-90% of cases) and Systemic Lupus Erythematosus (SLE). It targets the Ro60 and Ro52 ribonucleoprotein complexes. Within an ANA Profile, its detection is critical for identifying patients at risk for photosensitive skin rashes and, most importantly, for pregnant women, as these antibodies can cross the placenta and cause neonatal lupus or congenital heart block in the fetus.
View Interpretation
Immunology

Anti-SSB (La)

Anti-SSB (La) antibodies are autoantibodies directed against small ribonucleoproteins. They are a critical component of the ENA (Extractable Nuclear Antigen) Panel. Their primary clinical utility is in the diagnosis of Sjögren’s Syndrome, where they are found in 40-50% of cases, and Systemic Lupus Erythematosus (SLE), appearing in 10-15% of cases. In pregnant women, the presence of Anti-SSB (often co-occurring with Anti-SSA) is a significant marker for the risk of neonatal lupus and congenital heart block in the fetus.
View Interpretation
Immunology

Anti-Scl-70

Anti-Scl-70 (anti-topoisomerase I) is an autoantibody found in the serum of patients with Systemic Sclerosis (Scleroderma). It is highly specific for the diffuse cutaneous form of the disease. In an ANA/ENA profile, the presence of Scl-70 is a critical marker for diagnosing scleroderma and is also associated with an increased risk of developing interstitial lung disease (pulmonary fibrosis).
View Interpretation
Immunology

Anti-Sm (Smith) Antibody

Anti-Sm is an autoantibody directed against core proteins of small nuclear ribonucleoproteins (snRNPs). It is considered highly specific (nearly 99%) for Systemic Lupus Erythematosus (SLE). Within an ANA Profile, its presence is a major ACR classification criterion for Lupus, even though it is only present in about 15-30% of SLE patients.
View Interpretation
Immunology

Anti-Sm Antibody (ELISA)

The Anti-Sm (Anti-Smith) antibody test is a highly specific serological marker used primarily in the diagnostic workup of autoimmune connective tissue diseases. Smith antibodies are directed against small nuclear ribonucleoproteins (snRNPs), which are essential components of the spliceosome machinery within the cell nucleus. While they are part of the broader family of Extractable Nuclear Antigens (ENA), their presence is uniquely significant in clinical medicine. Physicians order this test when a patient presents with clinical symptoms suggestive of Systemic Lupus Erythematosus (SLE). This test is rarely ordered in isolation and is typically part of an ENA panel following a positive Antinuclear Antibody (ANA) screen. Symptoms that trigger this order include the classic malar (butterfly) rash, unexplained joint pain and swelling (arthritis), photosensitivity, persistent low-grade fever, and evidence of renal involvement like protein in the urine. The most prominent association for Anti-Sm is Systemic Lupus Erythematosus (SLE). It is considered one of the ACR (American College of Rheumatology) criteria for the classification of SLE. While it is only present in approximately 10% to 30% of SLE patients, its specificity is nearly 99%, meaning a positive result almost certainly confirms an SLE diagnosis. It is rarely found in other conditions, though very low titers might occasionally appear in Mixed Connective Tissue Disease (MCTD) or systemic sclerosis. Unlike Anti-dsDNA, Anti-Sm levels do not typically fluctuate with disease activity or flares, making it a stable diagnostic marker rather than a tool for monitoring disease progression.
View Interpretation
Hematology

Anti-Thrombin III

Antithrombin III (ATIII) is a non-vitamin K-dependent glycoprotein that functions as a natural anticoagulant. It is primarily produced by the liver and acts by inactivating several enzymes in the coagulation cascade, most notably thrombin (Factor IIa) and Factor Xa. Its activity is significantly enhanced (by up to 1,000 times) in the presence of heparin, which is the physiological basis for heparin therapy in clinical medicine. Physicians order an ATIII test to investigate the cause of recurrent blood clots (thrombosis), such as Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE). It is also used to evaluate individuals who show resistance to heparin therapy—meaning they require unusually high doses of heparin to achieve adequate anticoagulation. Screening may also be performed in families with a history of hereditary antithrombin deficiency.
  • Hereditary Deficiency: A genetic mutation leading to chronically low levels and high risk of venous thromboembolism.
  • Acquired Deficiency: Often seen in liver disease (decreased production), nephrotic syndrome (loss through urine), or Disseminated Intravascular Coagulation (DIC) (excessive consumption during widespread clotting).
  • Hypercoagulability: Low levels directly correlate with a 'pro-thrombotic' state, where the blood clots too easily.
View Interpretation
Immunology

Anti-dsDNA

Anti-dsDNA antibodies are a subset of Antinuclear Antibodies (ANA) that specifically target the double-stranded DNA within cell nuclei. This test is a hallmark for diagnosing Systemic Lupus Erythematosus (SLE), as it is highly specific (approximately 95-100%). Within an ENA or ANA profile, it serves as a critical confirmatory marker. Furthermore, levels often fluctuate with disease activity; a rise in titer frequently precedes a clinical 'flare,' particularly Lupus Nephritis (kidney involvement), making it vital for monitoring treatment efficacy.
View Interpretation
Immunology

Anti-dsDNA Antibodies

Anti-double-stranded DNA (anti-dsDNA) antibodies are a type of antinuclear antibody (ANA) that specifically target the genetic material (DNA) inside the cell nucleus. They are highly specific markers for autoimmune processes, where the immune system loses the ability to distinguish self from non-self. This test is primarily used to support a diagnosis of Systemic Lupus Erythematosus (SLE). It is often ordered as a follow-up to a positive ANA test. Because anti-dsDNA levels often fluctuate with disease activity, it is also used to monitor 'flares' and the risk of kidney involvement (Lupus Nephritis).
  • Systemic Lupus Erythematosus (SLE): Highly specific; ~70% of SLE patients test positive.
  • Lupus Nephritis: High titers of anti-dsDNA are strongly associated with inflammation of the kidneys.
  • Drug-Induced Lupus: Some medications can cause a lupus-like syndrome, though anti-dsDNA is less common here than anti-histone antibodies.
While a positive result is strong evidence for SLE, a negative result does not rule it out. Diagnosis requires a combination of clinical symptoms (rash, joint pain, kidney issues) and laboratory findings.
View Interpretation
Immunology

Antimitochondrial Antibody (AMA)

Antimitochondrial antibodies (AMA) are highly specific biomarkers primarily used in the diagnosis of Primary Biliary Cholangitis (PBC). Within an Autoimmune Hepatitis (AIH) panel, AMA is measured to differentiate AIH from PBC or to identify 'Overlap Syndrome' (where a patient exhibits features of both conditions). AMA targets the E2 subunit of the pyruvate dehydrogenase complex (PDC) on the inner mitochondrial membrane. Elevated titers are found in approximately 95% of patients with PBC, making it a critical component for diagnosing chronic cholestatic liver disease.
View Interpretation
Rheumatology

Antinuclear Antibody (ANA) Screen

The ANA Screen is a fundamental screening test for Systemic Autoimmune Rheumatic Diseases (SARD). In an Arthritis Basic Screen, it is used to identify the presence of autoantibodies that attack the body's own cell nuclei. While highly sensitive for Systemic Lupus Erythematosus (SLE) (95-98% sensitivity), it is not specific and can be positive in various conditions like Sjogren's syndrome, scleroderma, or even healthy individuals.
View Interpretation
Immunology

Antinuclear Antibody (ANA) Screen

The ANA Screen is a fundamental test for detecting autoantibodies that target the nucleus of the host's own cells. In the context of an Autoimmune Hepatitis (AIH) Panel, a positive ANA is one of the hallmark diagnostic criteria for Type 1 AIH. It indicates that the immune system is mounting an attack against liver tissue. The 'Titer' indicates the concentration of these antibodies; higher titers (e.g., 1:160) are more clinically significant than low-level positives.
View Interpretation
Microbiology

Antral Wash for Culture & Sensitivity

Antral Wash for Culture and Sensitivity is a diagnostic procedure where the maxillary sinus (antrum) is irrigated with sterile saline, and the fluid is collected for microbiological analysis. The goal is to identify specific bacterial or fungal pathogens residing within the sinus cavity and determine which antimicrobial agents are effective against them. This is not a routine test for simple sinusitis. It is reserved for complex cases, including:
  • Chronic Sinusitis: Infections lasting longer than 12 weeks that fail to respond to standard therapy.
  • Treatment Failure: When empirical antibiotics have failed to clear the infection.
  • Immunocompromised Patients: To rule out opportunistic or fungal infections (like Mucormycosis).
  • Severe Complications: If the infection is suspected of spreading to the orbit or intracranial space.
  • Bacterial Sinusitis: Common isolates include Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
  • Fungal Sinusitis: Often seen in diabetic or immunocompromised individuals (e.g., Aspergillus).
  • Cystic Fibrosis: Patients often have recalcitrant sinus infections with Pseudomonas aeruginosa.
  • Odontogenic Sinusitis: Infections originating from dental roots often show anaerobic bacteria in the antral wash.
View Interpretation
Metabolic

Appearance

The visual assessment of urine clarity is a fundamental part of a urinalysis. Normal urine is clear. Turbidity or cloudiness suggests the presence of suspended particles such as bacteria, white blood cells (pyuria), red blood cells (hematuria), epithelial cells, crystals, or mucus. It is the first indicator of potential urinary tract infections (UTI) or renal calculi.
View Interpretation
Respiratory

Arterial Blood Gas (ABG)

An Arterial Blood Gas (ABG) test measures the levels of oxygen and carbon dioxide in the blood, as well as the blood's pH (acidity). Unlike most blood tests which use venous blood, the ABG uses blood from an artery, providing a real-time snapshot of how efficiently the lungs are moving oxygen into the blood and removing carbon dioxide from it. It also assesses the kidneys' ability to maintain a balanced pH. Physicians order an ABG for patients experiencing respiratory distress, shortness of breath, or suspected metabolic imbalances. It is a critical tool in emergency rooms and intensive care units (ICUs) for monitoring patients on ventilators, diagnosing acid-base disorders, and evaluating lung diseases like COPD, asthma, or cystic fibrosis.
  • Respiratory Acidosis: Often caused by hypoventilation (COPD, pneumonia).
  • Respiratory Alkalosis: Caused by hyperventilation, anxiety, or high altitudes.
  • Metabolic Acidosis: Seen in diabetic ketoacidosis (DKA) or kidney failure.
  • Hypoxemia: Low blood oxygen levels which can lead to organ failure if untreated.
View Interpretation
Rheumatology

Arthritis Basic Screen

The Arthritis Basic Screen is a multi-parameter diagnostic tool designed to detect systemic inflammation and specific biomarkers associated with autoimmune joint disorders. Typically, this screen includes Rheumatoid Factor (RF), C-Reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR), and sometimes Uric Acid. These tests work together to distinguish between inflammatory arthritis, such as Rheumatoid Arthritis (RA), and non-inflammatory conditions like osteoarthritis. Physicians order this profile when a patient presents with persistent joint pain, morning stiffness lasting more than 30 minutes, swelling in the small joints of the hands or feet, or unexplained fatigue. It is essential for:
  • Differential Diagnosis: Distinguishing between autoimmune causes and metabolic causes (like gout).
  • Baseline Assessment: Establishing the severity of inflammation before starting treatment.
  • Monitoring: Tracking the effectiveness of Disease-Modifying Anti-Rheumatic Drugs (DMARDs).
  • Rheumatoid Arthritis: An autoimmune disease where the body attacks joint linings.
  • Systemic Lupus Erythematosus (SLE): A multi-organ autoimmune disease that often manifests with joint pain.
  • Gout: Caused by high uric acid levels leading to crystal deposition.
  • Ankylosing Spondylitis: Chronic inflammation affecting the spine and large joints.
  1. RF: An antibody found in approximately 70-80% of RA patients.
  2. CRP: A protein produced by the liver that rises rapidly during acute inflammation.
  3. ESR: Measures how quickly red blood cells settle, indicating chronic inflammatory states.
View Interpretation
Cytopathology

Ascitic Fluid - Malignant Cells

This test involves the microscopic examination of fluid aspirated from the peritoneal cavity (ascites) to look for the presence of cancer cells. Cytopathologists use specialized staining techniques, such as Papanicolaou (Pap) or May-Grünwald-Giemsa (MGG), to identify cellular abnormalities, nuclear changes, and architectural patterns indicative of malignancy. Ascites, the abnormal accumulation of fluid in the abdomen, can be caused by benign conditions (like cirrhosis or heart failure) or malignant ones. This test is ordered when a patient has new-onset ascites of unknown origin, particularly if they have a history of cancer. It helps differentiate between 'portal hypertensive' ascites and 'malignant' ascites caused by peritoneal carcinomatosis.
  • Peritoneal Carcinomatosis: The spread of cancer throughout the lining of the abdominal cavity, common in ovarian, gastric, and pancreatic cancers.
  • Ovarian Cancer: Often presents with significant ascites containing malignant cells.
  • Mesothelioma: A rare cancer of the lining of the lung or abdomen.
  • Lymphoma: Malignant white blood cells may occasionally be found in ascitic fluid.
The presence of malignant cells in the ascitic fluid usually signifies advanced (Stage IV) disease in many solid tumors. It changes the prognosis and guides the treatment plan from curative surgery toward palliative chemotherapy or targeted biological therapies.
View Interpretation
Fluid Analysis

Ascitic Fluid ADA Levels

Adenosine Deaminase (ADA) is an enzyme involved in purine metabolism. It is primarily released by T-lymphocytes and macrophages during their activation and proliferation. In the context of ascitic fluid (fluid collected from the peritoneal cavity), the ADA level serves as a surrogate marker for cellular immune responses. This test is crucial in the differential diagnosis of ascites, particularly when Tuberculosis Peritonitis (TBP) is suspected. In many regions where TB is endemic, ADA provides a rapid, cost-effective alternative to fluid cultures (which take weeks) or peritoneal biopsy (which is invasive). It helps clinicians distinguish between tuberculous ascites and other causes such as cirrhosis or malignancy.
  • Tuberculous Peritonitis: Characterized by very high ADA levels (often >30-40 U/L).
  • Peritoneal Carcinomatosis: Some cancers involving the peritoneum can cause moderately elevated ADA.
  • Lymphoma: Certain hematologic malignancies can lead to increased T-cell activity in the fluid.
  • Cirrhosis: Typically presents with very low ADA levels unless a secondary infection is present.
  • Bacterial Peritonitis: Non-TB bacterial infections may cause mild elevations due to neutrophil activity.
View Interpretation
Body Fluids

Ascitic Fluid Bilirubin

Measuring bilirubin in ascitic fluid is a specialized test used to diagnose biliary perforation or leak into the peritoneal cavity. In a healthy state, ascitic bilirubin is lower than serum bilirubin. If the ascitic fluid bilirubin is higher than the serum level (often with a ratio >1.0), it strongly suggests a 'choleperitoneum' (bile leak).
View Interpretation
Body Fluids

Ascitic Fluid Biochemical Analysis

Ascitic fluid biochemical analysis involves the laboratory evaluation of fluid accumulated within the peritoneal cavity (ascites). The primary goal is to determine the underlying cause of fluid accumulation, which usually involves measuring albumin, total protein, glucose, and lactate dehydrogenase (LDH). This test is essential for patients presenting with new-onset ascites or those with known ascites who experience clinical deterioration (e.g., fever, abdominal pain). It helps differentiate between causes related to portal hypertension (like cirrhosis) and those not related (like malignancy or infection). The Serum-Ascites Albumin Gradient (SAAG) is the most useful calculation derived from this analysis. It is calculated by subtracting the ascitic fluid albumin concentration from the serum albumin concentration measured on the same day.
  • High SAAG (≥ 1.1 g/dL): Indicates portal hypertension, common in cirrhosis, alcoholic hepatitis, and congestive heart failure.
  • Low SAAG (< 1.1 g/dL): Suggests causes other than portal hypertension, such as peritoneal carcinomatosis, tuberculosis, or nephrotic syndrome.
  • Spontaneous Bacterial Peritonitis (SBP): Characterized by a high neutrophil count in the fluid.
  • Cirrhosis: The most common cause of ascites in the Western world.
  • Pancreatitis: Suggested by high levels of amylase in the fluid.
View Interpretation
Pathology

Ascitic Fluid Cytology

Ascitic Fluid Cytology involves the microscopic examination of fluid collected from the peritoneal cavity (the space between the abdominal lining and the organs). The primary goal is to identify abnormal cells, particularly malignant (cancerous) cells, which may shed into the fluid from nearby organs. This process involves centrifuging the fluid to concentrate the cellular material, which is then stained and reviewed by a pathologist. This test is a standard part of a 'paracentesis' workup when the cause of fluid buildup (ascites) is unknown. It is specifically ordered to:
  • Detect Malignancy: To confirm if the ascites is 'malignant ascites,' often caused by peritoneal carcinomatosis.
  • Staging: To help stage certain cancers, such as ovarian or gastric cancer.
  • Differential Diagnosis: To distinguish between portal hypertension (cirrhosis) and inflammatory or neoplastic causes of fluid accumulation.
The presence of malignant cells in ascitic fluid is most commonly associated with:
  • Ovarian Cancer: One of the most frequent causes of malignant ascites in women.
  • Gastrointestinal Malignancies: Including stomach, pancreatic, and colorectal cancers.
  • Mesothelioma: A rare cancer of the lining of the abdomen often linked to asbestos exposure.
  • Lymphoma: Which can cause a milky (chylous) ascites containing lymphocytes. While the test is highly specific (meaning a positive result is almost certainly cancer), it has moderate sensitivity, meaning some cancers may not shed enough cells to be detected in a single sample.
View Interpretation
Microbiology

Ascitic Fluid For Culture And Sensitivity

This test involves the culturing of peritoneal fluid (ascites) accumulated in the abdominal cavity. The purpose is to detect the presence of microorganisms, usually bacteria, and to test their susceptibility to various antibiotics. This is a critical diagnostic step for patients with ascites who show signs of clinical deterioration. The test is most commonly performed during a paracentesis when a clinician suspects Spontaneous Bacterial Peritonitis (SBP), a life-threatening infection of the ascitic fluid. Symptoms include:
  • Fever and chills.
  • Abdominal pain or tenderness.
  • Worsening hepatic encephalopathy (confusion).
  • Unexplained decline in renal function in a patient with cirrhosis.
  • Cirrhosis: The most common cause of ascites susceptible to infection.
  • Spontaneous Bacterial Peritonitis (SBP): Infection occurring without an obvious intra-abdominal source.
  • Secondary Peritonitis: Infection resulting from a perforated organ (e.g., ruptured appendix or gallbladder).
  • Tuberculous Peritonitis: A chronic infection of the peritoneum by Mycobacterium tuberculosis.
  • Fungal Peritonitis: Often seen in patients on long-term peritoneal dialysis.
View Interpretation
Clinical Chemistry

Ascitic Fluid For Proteins

Measuring protein levels in ascitic fluid (fluid buildup in the abdomen) is a critical step in determining the underlying cause of ascites. While modern medicine often prioritizes the Serum-Ascites Albumin Gradient (SAAG), total protein concentration remains a vital diagnostic tool to differentiate between transudative and exudative processes. This test is performed via paracentesis when a patient presents with new-onset ascites or when there is suspicion of an infection like Spontaneous Bacterial Peritonitis (SBP). It helps clinicians narrow down the differential diagnosis for abdominal swelling. It is specifically used to:
  • Distinguish Causes: Differentiate between cirrhosis, heart failure, and malignancy.
  • Assess Infection Risk: Patients with very low ascitic protein (<1 g/dL) are at a significantly higher risk for developing SBP.
  • Evaluate Malignancy: High protein levels often point toward inflammatory or cancerous origins.
Traditionally, ascitic fluid with a total protein level greater than 2.5 or 3.0 g/dL is classified as an 'exudate,' which is common in conditions like tuberculosis, peritoneal carcinomatosis, or Budd-Chiari syndrome. Conversely, levels below 2.5 g/dL suggest a 'transudate,' typically caused by portal hypertension or cirrhosis. When combined with other markers like LDH and glucose, this test provides a comprehensive picture of peritoneal health and the permeability of the abdominal lining.
View Interpretation
Biochemical Analysis

Ascitic Fluid LDH Levels

Lactate Dehydrogenase (LDH) is an enzyme found in almost all body tissues. When cells are damaged or destroyed, LDH is released into the surrounding fluid. In the context of ascitic fluid (fluid accumulation in the abdomen), measuring LDH levels is a critical step in differentiating the cause of the effusion. Physicians order an ascitic fluid LDH test to help distinguish between transudative and exudative ascites. It is part of 'Light’s Criteria' (modified for peritoneal fluid) to evaluate the severity of inflammation or to detect the presence of malignancy and infection.
  • Spontaneous Bacterial Peritonitis (SBP): Elevated LDH levels, combined with high neutrophil counts, often indicate an active infection within the peritoneal cavity.
  • Malignancy: High levels of LDH in the fluid are frequently associated with peritoneal carcinomatosis (cancer that has spread to the abdominal lining).
  • Secondary Peritonitis: Very high LDH levels (often greater than the upper limit of normal for serum) may suggest a hollow viscus perforation or an abscess.
  • Cirrhosis: Typically presents with lower LDH levels in the fluid unless a secondary complication is present.
Understanding the LDH concentration in ascitic fluid allows clinicians to determine if the fluid buildup is due to systemic pressure changes (like heart failure or cirrhosis) or local abdominal pathology (like infection or cancer).
View Interpretation
Body Fluids

Ascitic Fluid Total Protein

This test measures the concentration of protein in fluid accumulated in the abdominal cavity. In the context of Ascitic Fluid Analysis, it helps categorize the fluid as a transudate or exudate. While the Serum-Ascites Albumin Gradient (SAAG) is now preferred, total protein remains vital for identifying 'High Protein' ascites (e.g., heart failure) versus 'Low Protein' ascites (e.g., cirrhosis).
View Interpretation
Infectious Disease

Aspartate Aminotransferase (AST)

AST is an enzyme found in high concentrations in the liver, heart, and skeletal muscle. In the context of a COVID-19 Panel, AST is used as a biomarker for systemic inflammation and multi-organ involvement. While less specific to the liver than ALT, elevated AST in COVID-19 patients is often correlated with increased disease severity, cytokine release syndrome, or drug-induced liver injury (DILI) from therapeutic interventions.
View Interpretation
Metabolic

Aspartate Aminotransferase (AST)

Aspartate Aminotransferase (AST), formerly known as SGOT, is an enzyme present in metabolically active tissues, including the liver, myocardium, skeletal muscle, kidneys, and brain. In the context of a Liver Function Test (LFT), it serves as a sensitive marker for hepatocellular injury. When hepatocytes are damaged or die, AST leaks into the bloodstream. While less specific to the liver than ALT (Alanine Aminotransferase), the AST/ALT ratio (De Ritis ratio) is clinically significant; an AST level significantly higher than ALT (ratio >2:1) is often suggestive of alcoholic liver disease or advanced cirrhosis.
View Interpretation
Immunology

Aspergillus Fumigatus IgE

The Aspergillus Fumigatus IgE test is a blood-based assay that measures the concentration of specific Immunoglobulin E (IgE) antibodies directed against the mold Aspergillus fumigatus. This fungus is ubiquitous in the environment, found in soil, decomposing plant matter, and household dust. In susceptible individuals, the immune system identifies Aspergillus proteins as threats, triggering a Type I hypersensitivity reaction. This test is a critical component in diagnosing mold-related respiratory conditions. It is specifically ordered when a patient presents with symptoms such as chronic coughing, wheezing, or shortness of breath that does not respond to standard asthma treatments. Key indications include:
  • Allergic Bronchopulmonary Aspergillosis (ABPA): A complex hypersensitivity reaction often occurring in patients with asthma or cystic fibrosis.
  • Allergic Rhinitis: To confirm if mold exposure is the trigger for seasonal or perennial hay fever.
  • Extrinsic Asthma: To identify environmental triggers that may lead to exacerbations.
High levels of Aspergillus-specific IgE are strongly associated with ABPA, a condition that, if left untreated, can lead to permanent lung damage (bronchiectasis). It is also used to differentiate between an actual allergic sensitization and an invasive infection (aspergilloma), although IgG tests are often used in conjunction for the latter. Patients with compromised immune systems or those living in damp, water-damaged buildings are at higher risk for sensitization. Monitoring these levels helps clinicians adjust environmental controls and pharmacological interventions like corticosteroids or antifungal agents.
View Interpretation
Immunology

Aspergillus IgE

The Aspergillus IgE test measures the level of Immunoglobulin E (IgE) antibodies in the blood specific to Aspergillus fumigatus, a common mold found both indoors and outdoors. IgE is the antibody responsible for type I hypersensitivity reactions (allergic reactions). Physicians order this test when a patient exhibits symptoms of respiratory distress, chronic coughing, or wheezing that may be related to mold exposure. It is particularly important for patients with asthma or cystic fibrosis who may develop a more severe reaction known as Allergic Bronchopulmonary Aspergillosis (ABPA). It helps differentiate between a simple mold allergy and more invasive fungal complications.
  • Allergic Rhinitis: Classic hay fever symptoms caused by inhaling mold spores.
  • Asthma: Aspergillus exposure can trigger or worsen asthmatic episodes.
  • Allergic Bronchopulmonary Aspergillosis (ABPA): A condition where the immune system overreacts to the mold in the lungs, leading to inflammation and potential lung damage.
  • Hypersensitivity Pneumonitis: Inflammation of the lung air sacs due to inhaled organic dust.
Positive results indicate sensitization to Aspergillus. However, a positive test does not automatically mean a person has a clinical allergy; it must be correlated with physical symptoms and exposure history. For those with chronic lung diseases, this test is a vital component of ongoing pulmonary management.
View Interpretation
Audiology

Audiometric Test

An Audiometric Test is a non-invasive diagnostic procedure used to evaluate an individual's hearing sensitivity across a range of frequencies. It determines the quietest sounds (thresholds) a person can hear at specific pitches, ranging from low to high frequencies. This test measures both air conduction (how sound moves through the ear canal) and bone conduction (how sound vibrates through the skull to the inner ear). This test is ordered to screen for hearing loss in adults, monitor the effects of noise exposure in occupational settings, or investigate symptoms like tinnitus (ringing in the ears), dizziness, or a sensation of fullness in the ear. It is also used to differentiate between conductive hearing loss (middle ear issues) and sensorineural hearing loss (inner ear or nerve damage).
  • Presbycusis: Age-related hearing loss.
  • Noise-Induced Hearing Loss: Damage from chronic or sudden loud noise.
  • Otosclerosis: Abnormal bone growth in the middle ear.
  • Meniere's Disease: An inner ear disorder affecting balance and hearing.
  • Ototoxicity: Hearing damage caused by certain medications (e.g., high-dose aspirin or some antibiotics).
View Interpretation
Diagnostics

Audiometry Test

Audiometry is a non-invasive diagnostic test used to measure a person's ability to hear sounds of varying intensities (loudness) and frequencies (pitch). Pure-tone audiometry, the most common form, determines the softest sound a person can hear at least 50% of the time. This evaluates the entire auditory system, from the outer ear through the middle ear to the inner ear and the auditory nerve. This test is the gold standard for diagnosing hearing loss. It is ordered when a patient reports hearing difficulty, tinnitus (ringing in the ears), or balance issues (vertigo). It is also used in occupational health to monitor workers exposed to loud noises and in geriatric care to assess the need for hearing aids. By comparing air conduction and bone conduction, clinicians can pinpoint the anatomical location of the hearing deficit.
  • Sensorineural Hearing Loss: Damage to the hair cells in the cochlea or the auditory nerve, often due to aging (presbycusis) or noise exposure.
  • Conductive Hearing Loss: Problems with the ear canal, eardrum, or middle ear bones, such as fluid from an infection or otosclerosis.
  • Meniere's Disease: An inner ear disorder that causes episodes of vertigo and fluctuating hearing loss.
  • Acoustic Neuroma: A benign tumor on the vestibular nerve that can cause unilateral hearing loss.
View Interpretation
Immunology

Autoimmune Hepatitis Panel

The Autoimmune Hepatitis (AIH) Panel is a comprehensive group of tests designed to detect various autoantibodies that characterize immune-mediated liver disease. Unlike a single test, the panel looks for multiple markers including Antinuclear Antibody (ANA), Smooth Muscle Antibody (ASMA), Liver-Kidney Microsome (LKM-1) antibody, and sometimes Soluble Liver Antigen (SLA). Diagnosis of AIH is complex because its symptoms—fatigue, nausea, and joint pain—overlap with many other liver diseases, including viral hepatitis and fatty liver. This panel is ordered to differentiate AIH from these other conditions. It helps clinicians classify the disease into Type 1 (ANA/ASMA positive) or Type 2 (LKM-1 positive), which determines the treatment approach and prognosis.
  • Autoimmune Hepatitis (AIH): The primary condition. Type 1 is more common in adults; Type 2 is common in children.
  • Primary Biliary Cholangitis (PBC): Sometimes markers overlap, though PBC usually features Anti-Mitochondrial Antibodies (AMA).
  • Systemic Lupus Erythematosus (SLE): ANA is positive in SLE and can sometimes be associated with 'Lupoid Hepatitis.'
  • Infectious Hepatitis: Hepatitis C can occasionally cause positive results on these panels without AIH being present.
View Interpretation
Genetics/Oncology

BCR-ABL Gene Rearrangement

The BCR-ABL test detects a specific genetic abnormality known as the Philadelphia chromosome. This occurs when pieces of chromosome 9 and chromosome 22 break off and switch places, creating a fusion gene (BCR-ABL1). This fusion gene produces an abnormal protein (tyrosine kinase) that causes white blood cells to grow uncontrollably. This test is primary used for:
  • Diagnosis: To confirm a diagnosis of Chronic Myeloid Leukemia (CML) or a specific type of Acute Lymphoblastic Leukemia (ALL).
  • Monitoring: To evaluate the effectiveness of treatment with Tyrosine Kinase Inhibitors (TKIs) like imatinib.
  • Detection of Relapse: To check if the disease is returning after a period of remission.
  • Chronic Myeloid Leukemia (CML): Almost all patients with CML have the BCR-ABL gene.
  • Acute Lymphoblastic Leukemia (ALL): About 25-30% of adults and a smaller percentage of children with ALL have this mutation.
  • Acute Myeloid Leukemia (AML): Rarely, this mutation can be found in AML cases.
The quantitative version of this test (RT-qPCR) is extremely sensitive, capable of detecting one leukemic cell among 100,000 to 1,000,000 normal cells. This allows clinicians to achieve 'Major Molecular Response' (MMR) monitoring, which is the gold standard for long-term survival in CML patients.
View Interpretation
Hematology

BCR-ABL Translocation

The BCR-ABL test is a highly specific molecular test that looks for a genetic abnormality known as the Philadelphia chromosome. This occurs when pieces of chromosomes 9 and 22 break off and switch places. This translocation creates a fusion gene, BCR-ABL, which produces a tyrosine kinase protein that causes white blood cells to grow uncontrollably. This test usually employs Quantitative Polymerase Chain Reaction (qPCR) to detect the number of fusion gene copies. This test is the definitive tool for diagnosing Chronic Myeloid Leukemia (CML) and a specific subtype of Acute Lymphoblastic Leukemia (Ph+ ALL). Beyond diagnosis, it is used to monitor the effectiveness of therapy with Tyrosine Kinase Inhibitors (TKIs). The goal of treatment is 'Molecular Response,' where the BCR-ABL levels become undetectable or extremely low.
  • Chronic Myeloid Leukemia (CML): Over 95% of CML patients have this translocation.
  • Acute Lymphoblastic Leukemia (ALL): Found in about 25% of adult ALL cases.
  • Minimal Residual Disease (MRD): Used to check for remaining cancer cells after treatment.
View Interpretation
Genetics

BCR-ABL1 Translocation [t(9;22)]

The BCR-ABL1 fusion gene, resulting from the translocation between chromosomes 9 and 22 (the Philadelphia Chromosome), encodes a constitutively active tyrosine kinase. This is the diagnostic hallmark of Chronic Myeloid Leukemia (CML) and is found in a subset of Acute Lymphoblastic Leukemia (ALL). Detecting this translocation is critical for initiating targeted therapy with Tyrosine Kinase Inhibitors (TKIs) like imatinib and for monitoring Minimal Residual Disease (MRD).
View Interpretation
Genetics

BCR/ABL FISH

The BCR/ABL FISH (Fluorescence In Situ Hybridization) test is a cytogenetic analysis used to detect a specific genetic abnormality known as the Philadelphia Chromosome. This occurs when a piece of chromosome 9 (containing the ABL1 gene) breaks off and attaches to chromosome 22 (containing the BCR gene), creating the BCR-ABL1 fusion gene. This gene produces a protein that signals white blood cells to divide uncontrollably. This test is a critical diagnostic tool in hematology. It is ordered to:
  • Confirm a diagnosis of Chronic Myeloid Leukemia (CML).
  • Identify a specific subtype of Acute Lymphoblastic Leukemia (ALL).
  • Monitor 'Minimal Residual Disease' (MRD) in patients undergoing treatment.
  • Determine the effectiveness of Tyrosine Kinase Inhibitor (TKI) therapy.
The primary condition associated with a positive BCR/ABL FISH result is Chronic Myeloid Leukemia (CML), where the Philadelphia chromosome is present in about 95% of cases. It is also found in a subset of adult and pediatric patients with Acute Lymphoblastic Leukemia (ALL), where its presence often indicates a more aggressive disease course requiring specific targeted therapies. Because FISH can detect individual cells containing the fusion gene, it is much more sensitive than standard karyotyping. In the modern era of oncology, this test is used to track 'molecular response'—if the percentage of positive cells drops to zero, the patient is considered to be in complete cytogenetic remission.
View Interpretation
Molecular Genetics

BCR/ABL Quantification

The BCR-ABL1 quantification test uses Real-Time Quantitative PCR (RQ-PCR) to measure the amount of the BCR-ABL1 fusion transcript in the blood or bone marrow. This transcript is the result of a genetic translocation known as the Philadelphia Chromosome (t(9;22)), which creates an abnormal tyrosine kinase protein that causes uncontrolled white blood cell growth. This is the 'gold standard' test for monitoring patients with Chronic Myeloid Leukemia (CML) and some types of Acute Lymphoblastic Leukemia (ALL). It is used for:
  • Baseline Assessment: Quantifying the disease burden at diagnosis.
  • Monitoring Therapy: Assessing the response to Tyrosine Kinase Inhibitors (TKIs) like Imatinib.
  • Detecting Relapse: Identifying 'Molecular Relapse' long before physical symptoms or abnormal blood counts appear.
  • Achieving MMR: Monitoring for Major Molecular Response (defined as BCR-ABL1 < 0.1% on the International Scale).
  • Chronic Myeloid Leukemia (CML): The primary condition associated with this marker.
  • Ph+ Acute Lymphoblastic Leukemia (ALL): A subset of ALL patients carry this mutation.
  • Minimal Residual Disease (MRD): Assessing trace amounts of cancer cells during remission.
View Interpretation
Molecular Diagnostics

BCR/ABL Quantitative PCR

The BCR-ABL1 quantitative test measures the amount of the BCR-ABL1 fusion transcript in the blood or bone marrow. This transcript is the product of the 'Philadelphia Chromosome,' a translocation between chromosomes 9 and 22, which is the hallmark of Chronic Myeloid Leukemia (CML) and some cases of Acute Lymphoblastic Leukemia (ALL). This test is primarily used to monitor the response to treatment with Tyrosine Kinase Inhibitors (TKIs), such as imatinib, dasatinib, or nilotinib. It is the most sensitive tool for measuring 'Minimal Residual Disease' (MRD). Results are expressed as a percentage on the International Scale (IS).
  • Major Molecular Response (MMR): Defined as a BCR-ABL1/ABL ratio of ≤ 0.1% on the IS.
  • Deep Molecular Response (DMR): Ratios of ≤ 0.01% (MR4.0) or ≤ 0.0032% (MR4.5). Achieving DMR is a prerequisite for considering treatment-free remission (TFR).
Monitoring occurs every 3 months during initial treatment. A rising level of BCR-ABL1 transcripts can indicate a loss of response, poor medication adherence, or the development of kinase domain mutations that cause drug resistance.
View Interpretation
Genetics

BRAF V600 Mutation Analysis

The BRAF gene provides instructions for making a protein that helps transmit chemical signals from outside the cell to the cell's nucleus. This protein is part of the RAS/MAPK pathway, which controls cell growth, proliferation, and differentiation. The V600 mutation (most commonly V600E) causes the BRAF protein to be permanently 'turned on,' leading to uncontrolled cell division and tumor growth. This test is primarily ordered for patients diagnosed with specific types of cancer, most notably metastatic melanoma, colorectal cancer, papillary thyroid carcinoma, and non-small cell lung cancer (NSCLC). Identifying a BRAF mutation is crucial for determining eligibility for targeted therapies. For instance, melanoma patients with a V600E or V600K mutation can be treated with BRAF inhibitors (like vemurafenib or dabrafenib) often in combination with MEK inhibitors. In colorectal cancer, the mutation is also a significant prognostic marker.
  • Metastatic Melanoma: Approximately 50% of melanomas harbor a BRAF mutation.
  • Colorectal Cancer: Associated with a poorer prognosis but helps in deciding against certain EGFR-inhibitor therapies.
  • Papillary Thyroid Carcinoma: Associated with more aggressive tumor behavior.
  • Erdheim-Chester Disease: A rare blood cancer frequently linked to BRAF mutations.
Identifying these mutations allows for 'precision medicine,' where treatment is tailored to the genetic profile of the tumor rather than a one-size-fits-all approach.
View Interpretation
Genetics

BRCA 1 & 2 Gene Analysis

The BRCA1 and BRCA2 (BReast CAncer genes 1 and 2) are tumor suppressor genes. Their primary function is to produce proteins that help repair damaged DNA, ensuring the stability of each cell’s genetic material. When either of these genes is mutated, the DNA damage may not be repaired properly, leading to the accumulation of genetic alterations that can cause cells to become cancerous. This test is primarily ordered for individuals with a strong family history of breast, ovarian, tubal, or peritoneal cancer. It is also utilized for patients diagnosed with cancer at a young age or those with triple-negative breast cancer to determine if a hereditary mutation is present. Identifying a mutation helps in calculating the risk of future cancers and informs surgical or chemotherapeutic decisions.
  • Hereditary Breast and Ovarian Cancer (HBOC) Syndrome: This is the primary condition associated with BRCA mutations. Mutations significantly increase the lifetime risk of developing breast and ovarian cancer.
  • Other Malignancies: BRCA2 mutations, in particular, are linked to increased risks of prostate cancer in men, pancreatic cancer, and melanoma.
  • Fanconi Anemia: Rare, biallelic mutations in BRCA2 can lead to this severe condition characterized by bone marrow failure and developmental abnormalities.
View Interpretation
Respiratory

Base Excess (BE)

Base Excess (BE) measures the deviation of the actual bicarbonate concentration from the normal range under standard conditions. It is a critical parameter in Arterial Blood Gas (ABG) analysis to determine the metabolic component of an acid-base imbalance. A positive value indicates a surplus of base (alkalosis), while a negative value (base deficit) indicates a shortage of base or an excess of acid (acidosis). This helps clinicians differentiate between respiratory-driven pH changes and primary metabolic derangements.
View Interpretation
Metabolic

Basic Kidney Profile

The Basic Kidney Profile (often referred to as Renal Function Test) measures key electrolytes and waste products filtered by the kidneys, specifically Creatinine and Blood Urea Nitrogen (BUN). It assesses the Glomerular Filtration Rate (eGFR), which is the gold standard for determining how well the kidneys are cleaning the blood. This profile is used for routine screening, monitoring patients with known kidney disease, or checking the side effects of medications that can be toxic to the kidneys (like NSAIDs or certain antibiotics). It is also vital for patients with diabetes or hypertension, as these are leading causes of kidney failure.
  • Chronic Kidney Disease (CKD): Gradual loss of function.
  • Acute Kidney Injury (AKI): Rapid decline in filtration.
  • Dehydration: Causes a disproportionate rise in BUN compared to creatinine.
  • Glomerulonephritis: Inflammation of the kidney's filtering units.
View Interpretation
Hematology

Basophils

Component of White Blood Cell differential.
View Interpretation
Hematology

Basophils

Basophils are the least common granulocyte in the peripheral blood. They play a pivotal role in the immediate hypersensitivity response by releasing histamine, heparin, and proteolytic enzymes via IgE-mediated degranulation. In a differential count, a persistent elevation (basophilia) is a sensitive marker for myeloproliferative neoplasms, particularly Chronic Myeloid Leukemia (CML), or systemic mastocytosis. They also increase in chronic inflammation and certain endocrinopathies like hypothyroidism.
View Interpretation
Hematology

Basophils

Basophils are a type of white blood cell (leukocyte) that plays a critical role in the immune system's inflammatory response, particularly in allergic reactions and asthma. Within the Hb, Tc, Dc & ESR panel, the Differential Count (Dc) of basophils helps clinicians identify myeloproliferative disorders or chronic inflammatory states. Basophils contain granules filled with histamine and heparin, which are released during an immune response to increase blood flow and prevent immediate clotting.
View Interpretation
Hematology

Basophils

Basophils are the least common granulocyte. They contain granules filled with heparin and histamine, playing a central role in allergic responses and immediate hypersensitivity reactions. Within a differential count, they serve as markers for chronic inflammation and are particularly sensitive indicators for certain myeloproliferative neoplasms.
View Interpretation
Hematology

Basophils

Basophils are the least common type of white blood cell. They play a key role in the immune system's response to allergens and parasites by releasing histamine and heparin. Within a Differential Count (TCDC), basophil levels are monitored to detect chronic inflammation or rare bone marrow disorders. While their exact function is still being studied, they are essential markers for type I hypersensitivity reactions.
View Interpretation
Hematology

Basophils (%)

Basophils are the rarest type of white blood cell, representing less than 1% of the total leukocyte count. They contain granules filled with histamine and heparin and play a vital role in Type I hypersensitivity (allergic) reactions and the defense against ectoparasites. In the context of a differential count, an elevation (basophilia) is a sensitive marker for myeloproliferative neoplasms, particularly Chronic Myeloid Leukemia (CML).
View Interpretation
Hematology

Basophils (Absolute)

Basophils are the least common leukocyte in a Complete Blood Picture. They contain granules filled with histamine and heparin, playing a role in immediate hypersensitivity reactions and chronic inflammation. While their role in general infection is limited, they are key markers for specific myeloid pathologies.
View Interpretation
Hematology

Basophils (Absolute)

Basophils are the least common type of white blood cell, representing a small fraction of the total leukocyte count. They contain granules filled with histamine and heparin and play a key role in allergic responses and the body's innate immune response to parasites. In the context of a differential count, the absolute number is more clinically useful than the percentage. Monitoring basophils is particularly important in diagnosing myeloproliferative neoplasms, such as Chronic Myeloid Leukemia (CML).
View Interpretation
Hematology

Basophils (DC)

Basophils are the least common type of white blood cell, involved in allergic responses and inflammatory reactions through the release of histamine. In a differential count, they are vital for identifying myeloproliferative disorders. Basophilia (increased basophils) is a hallmark of Chronic Myeloid Leukemia (CML).
View Interpretation
Metabolic

Benedict's Test

Benedict's test is a biochemical assay used to detect the presence of reducing sugars in the urine. While historically used to monitor glucose in diabetic patients, its primary modern application is in pediatric screening to identify inborn errors of metabolism. The test utilizes Benedict's reagent—a deep-blue alkaline solution containing cupric sulfate, sodium carbonate, and sodium citrate. When heated in the presence of reducing sugars (such as glucose, galactose, lactose, or fructose), the blue cupric ions are reduced to insoluble red cuprous oxide, causing a visible color change ranging from green to brick red. This test is frequently ordered for neonates and infants who exhibit failure to thrive, persistent vomiting, or jaundice, as these can be symptoms of metabolic disorders. It is particularly crucial for identifying Galactosemia, a condition where the body cannot process galactose, which can lead to liver damage and intellectual disability if untreated. It is also used to differentiate between glucose (detected by specific dipsticks) and other reducing substances that might indicate rare genetic conditions.
  • Galactosemia: A life-threatening condition in newborns requiring immediate dietary intervention.
  • Fructosuria: A benign condition where fructose is excreted in the urine.
  • Lactosuria: Often seen in late pregnancy or during lactation.
  • Alkaptonuria: Where homogentisic acid acts as a reducing agent.
  • Glucosuria: Often associated with Diabetes Mellitus or low renal threshold for glucose.
View Interpretation
Immunology

Bermuda Grass Specific IgE

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies in the blood directed against Bermuda Grass pollen. Within an Allergy Profile, it helps identify Type I hypersensitivity (allergic) reactions. Unlike skin prick testing, this blood test is not affected by antihistamine use and is safer for patients at risk of anaphylaxis.
View Interpretation
Oncology

Beta 2 Microglobulin

Beta-2 Microglobulin (B2M) is a protein found on the surface of nearly all nucleated cells and is part of the MHC Class I molecule. It is shed into the blood in small amounts. Since it is cleared by the kidneys, its concentration reflects both cell turnover and renal filtration efficiency. In oncology, B2M is used as a prognostic marker for certain blood cancers. While it cannot diagnose cancer on its own, its level correlates with tumor burden and growth rate. It is also used to assess kidney function, particularly tubular damage.
  • Multiple Myeloma: Used for staging (International Staging System).
  • Chronic Lymphocytic Leukemia (CLL) & Lymphoma: Indicators of disease activity.
  • Kidney Disease: High levels can indicate renal failure or tubular injury.
  • Inflammatory States: Elevated in HIV and certain autoimmune conditions.
View Interpretation
Hematology

Beta Globulin

Fraction of serum protein.
View Interpretation
Hematology

Beta Globulin

Beta globulins are a group of globular proteins in serum that move in the beta-fraction during electrophoresis. This fraction consists mainly of Transferrin (beta-1) and Complement C3 (beta-2). It is measured to evaluate nutritional status, iron transport, and immune system function.
View Interpretation
Immunology

Beta Globulin

Beta globulins are a group of globular proteins in the plasma that are more mobile in alkaline solutions than gamma globulins but less mobile than alpha globulins. This fraction primarily consists of transferrin (the iron-transport protein), complement components (C3, C4), and beta-lipoproteins. Within the context of a Serum Protein Electrophoresis (SPEP), the Beta fraction is typically split into Beta-1 and Beta-2. Monitoring these levels helps clinicians identify iron-deficiency anemias (where transferrin increases), chronic liver disease, or plasma cell dyscrasias like multiple myeloma, where a 'beta-spike' may indicate the presence of a monoclonal protein (M-protein).
View Interpretation
Endocrinology

Beta HCG

Human Chorionic Gonadotropin (hCG) is a glycoprotein hormone produced by the trophoblastic cells of the placenta shortly after implantation. Its primary function is to maintain the corpus luteum, ensuring the continued production of progesterone, which is vital for maintaining the uterine lining during early pregnancy. In a normal pregnancy, Beta-hCG levels double approximately every 48 to 72 hours during the first trimester. This test is primarily ordered to confirm pregnancy and estimate gestational age. However, it serves several other critical diagnostic purposes:
  • Ectopic Pregnancy Screening: Slow-rising levels may indicate a pregnancy located outside the uterus.
  • Miscarriage Monitoring: Dropping levels can suggest a non-viable pregnancy.
  • Tumor Marker: In non-pregnant individuals (including men), elevated Beta-hCG can indicate germ cell tumors of the ovaries or testes, or gestational trophoblastic disease (molar pregnancy).
  • Prenatal Screening: It is used as part of the 'triple' or 'quad' screen to assess the risk of chromosomal abnormalities like Down Syndrome.
  • Molar Pregnancy: Extremely high levels often indicate a hydatidiform mole.
  • Multiple Gestation: Twins or triplets typically result in higher-than-average hCG levels.
  • Germ Cell Tumors: Choriocarcinoma or testicular cancer can produce measurable hCG.
  • Ovarian Cysts: Occasionally associated with slightly elevated levels in rare syndromes.
View Interpretation
Metabolic

Beta HCG (Tumor Marker)

While Human Chorionic Gonadotropin (HCG) is most famous as the 'pregnancy hormone,' its Beta subunit is also a potent tumor marker. In a non-pregnant state, HCG should be nearly undetectable. Certain tumors secrete HCG into the bloodstream, allowing it to be used for diagnosis and treatment monitoring. In oncology, this test is ordered to:
  • Diagnose Germ Cell Tumors: It is a key marker for testicular cancer in men and certain ovarian cancers in women.
  • Monitor Gestational Trophoblastic Disease: Such as hydatidiform moles or choriocarcinoma.
  • Evaluate Treatment Efficacy: If a tumor is successfully removed or treated with chemo, HCG levels should drop to near zero.
  • Screen for Recurrence: Routine testing post-treatment to catch a returning cancer early.
Elevated Beta HCG in a non-pregnant person can indicate seminomatous or non-seminomatous germ cell tumors, hepatoblastoma, or some lung and pancreatic cancers. It is often paired with Alpha-Fetoprotein (AFP) and Lactate Dehydrogenase (LDH) for a comprehensive 'triple marker' oncology panel. In men, any detectable level of HCG is considered abnormal and warrants immediate investigation for testicular malignancy.
View Interpretation
Immunology

Beta-2 Glycoprotein I Antibody, IgG

Beta-2 Glycoprotein I (β2GPI) antibodies are a subset of antiphospholipid antibodies. The IgG isotype is highly specific for Antiphospholipid Syndrome (APS), an autoimmune condition characterized by recurrent arterial or venous thrombosis and pregnancy complications (unexplained miscarriages). Within a Phospholipid Screen, this test helps differentiate APS from other transiently positive autoimmune markers.
View Interpretation
Immunology

Beta-2 Glycoprotein I Antibody, IgM

This test measures IgM class antibodies against Beta-2 Glycoprotein I (B2GPI), a phospholipid-binding protein. It is a core component of the Antiphospholipid Syndrome (APS) diagnostic workup. High titers are associated with an increased risk of arterial and venous thrombosis, as well as pregnancy-related complications like recurrent miscarriages. Within the Phospholipid Screen, the IgM isotype may indicate an early or acute immune response, although it is sometimes considered less specific for thrombosis than the IgG isotype.
View Interpretation
Oncology

Beta-hCG (Human Chorionic Gonadotropin)

In the context of an Ovarian Cancer Panel, beta-hCG serves as a tumor marker rather than a pregnancy test. It is specifically secreted by germ cell tumors of the ovary, such as dysgerminomas and non-dysgerminomatous germ cell tumors (e.g., choriocarcinoma, embryonal carcinoma). Monitoring levels helps in initial diagnosis, staging, and tracking response to therapy or detecting recurrence in post-treatment patients.
View Interpretation
Respiratory

Bicarbonate (HCO3)

Bicarbonate is a vital byproduct of the body's metabolism and acts as a buffer to maintain the blood's pH. In an Arterial Blood Gas (ABG) analysis, the HCO3 level represents the metabolic component of acid-base balance. It helps clinicians determine if a patient has metabolic acidosis or alkalosis and whether the kidneys are effectively compensating for respiratory disturbances.
View Interpretation
Metabolic

Bicarbonate (Total CO2)

Total CO2 represents approximately 95% bicarbonate (HCO3-) in the serum, regulated by the kidneys and lungs. It is a vital component of the electrolyte panel to evaluate acid-base balance. It helps identify metabolic acidosis (e.g., diabetic ketoacidosis, renal failure) or metabolic alkalosis (e.g., severe vomiting, diuretic use) and monitors the body's compensatory response to respiratory disorders.
View Interpretation
Hepatology

Bile Pigments (Urinary Bilirubin)

Bilirubin should not be detectable in the urine of a healthy individual. Because only conjugated bilirubin is water-soluble, its presence in urine always signifies an increase in serum conjugated bilirubin levels. This makes it a highly specific early indicator of liver disease or biliary obstruction, often appearing before clinical jaundice is visible.
View Interpretation
Hepatology

Bile Salts

Bile salts (primarily glycocholate and taurocholate) are normally absent in urine. Their presence indicates a disruption in the enterohepatic circulation, typically due to obstructive jaundice (cholestasis). This test is a critical qualitative marker for liver and biliary tract patency.
View Interpretation
Hepatology

Bile Salts & Pigments - Urine

This test detects the presence of bile salts and bile pigments (specifically conjugated bilirubin) in the urine. In a healthy individual, bilirubin is processed by the liver and excreted into the bile ducts and then the intestines; it should not be present in the urine. Bile salts assist in the digestion of fats and are also normally absent from urine. It is ordered when a patient shows signs of liver dysfunction or biliary obstruction, such as jaundice (yellowing of eyes/skin), dark-colored urine, light-colored stools, or abdominal pain in the upper right quadrant. It helps clinicians distinguish between different types of jaundice. For instance, unconjugated bilirubin (from hemolysis) cannot pass into urine, but conjugated bilirubin (from liver disease or obstruction) can.
  • Obstructive Jaundice: Gallstones or tumors blocking the bile duct.
  • Hepatitis: Viral or toxic inflammation of the liver.
  • Cirrhosis: Advanced scarring of the liver tissue.
  • Cholestasis: A condition where bile flow from the liver stops or slows down.
View Interpretation
Nephrology

Bilirubin

Bilirubin in the urine (bilirubinuria) is always considered an abnormal finding. Only conjugated bilirubin (water-soluble) can pass through the glomerular filter. Its presence in urine indicates that conjugated bilirubin levels in the blood are elevated, usually due to hepatobiliary disease, indicating an issue with liver excretion or bile duct patency.
View Interpretation
Metabolic

Bilirubin (Total And Direct)

Bilirubin is a yellowish pigment made during the normal breakdown of red blood cells (hemoglobin). Total Bilirubin is the sum of Unconjugated (Indirect) and Conjugated (Direct) bilirubin. The liver processes indirect bilirubin into direct bilirubin so it can be excreted in bile. This test is a staple of Liver Function Tests (LFTs). It is used to investigate jaundice (yellowing of skin/eyes), monitor liver disease (hepatitis, cirrhosis), check for blockages in the bile ducts (gallstones), and evaluate for hemolytic anemia (accelerated destruction of red blood cells).
  • Gilbert's Syndrome: A benign genetic condition causing mild elevations in indirect bilirubin.
  • Hepatitis: Inflammation of the liver affecting bilirubin processing.
  • Choledocholithiasis: Gallstones blocking the common bile duct, raising direct bilirubin.
  • Hemolytic Anemia: Conditions like Sickle Cell or G6PD deficiency that flood the system with bilirubin.
View Interpretation
Metabolic

Bilirubin (Urine)

Under normal physiological conditions, bilirubin (specifically conjugated bilirubin) is not detectable in the urine. Bilirubin is a byproduct of hemoglobin breakdown. Only conjugated (water-soluble) bilirubin can pass through the glomerular basement membrane into the urine. Its presence in a urinalysis is an early and sensitive indicator of hepatobiliary disease, often appearing before the patient exhibits clinical jaundice. It indicates that bilirubin levels in the blood are elevated because the liver is unable to excrete it into the bile or the bile ducts are obstructed.
View Interpretation
Pathology

Biopsy (Large Tissue)

A 'Large Biopsy' refers to the histopathological examination of a significant portion of tissue, often obtained through an excisional biopsy (removing an entire lump) or an incisional biopsy (removing a large wedge of a lesion). Unlike a Fine Needle Aspiration (FNA), a large biopsy preserves the 'architecture' of the tissue—how cells relate to each other and the surrounding blood vessels and connective tissue. This architectural context is vital for definitive diagnosis. Large tissue biopsies are ordered when smaller samples are inconclusive or when a definitive diagnosis of a tumor is required. It is the 'Gold Standard' for:
  • Cancer Grading and Staging: Determining not just if a tumor is malignant, but how aggressive it is and how deep it has invaded.
  • Chronic Inflammatory Diseases: Such as diagnosing Crohn’s disease or Sarcoidosis through larger tissue samples.
  • Organ Specific Pathology: Evaluating the health of the liver, kidney, or large skin lesions where a small punch biopsy might miss the primary pathology.
This test is central to the diagnosis of virtually all solid tumors (breast, colon, lung, etc.). It is also used to identify autoimmune conditions like vasculitis or complex infections like deep fungal mycoses. The resulting pathology report will include a microscopic description, a diagnosis, and often immunohistochemical (IHC) staining results to identify specific cell markers.
View Interpretation
Anatomical Pathology

Biopsy (Medium)

A 'Biopsy (Medium)' refers to the histopathological examination of a medium-sized tissue specimen. This involves processing the tissue, slicing it into microscopic sections, staining it (usually with H&E), and examining it under a microscope to determine the cellular architecture and identify any abnormalities. Biopsies are ordered whenever there is a suspicious mass, lesion, or persistent inflammatory condition that cannot be diagnosed via blood work or imaging alone. The 'medium' designation often relates to specimens like a thyroid lobe, a segment of the colon, or a large skin excision. It provides the definitive 'tissue diagnosis' required for cancer staging and treatment planning.
  • Malignancy: Identification of carcinomas, sarcomas, or lymphomas.
  • Benign Tumors: Differentiating non-cancerous growths like fibromas or lipomas.
  • Inflammatory Diseases: Diagnosing conditions like Crohn's disease or sarcoidosis through tissue patterns.
  • Infections: Identifying granulomas or viral cytopathic effects within the tissue.
View Interpretation
Hematology

Bleeding Time (Ivy Method)

Bleeding Time is a functional test that assesses the primary hemostatic response, which involves platelet adhesion, activation, and aggregation to form a platelet plug. It evaluates both platelet function and the integrity of the vascular wall. It is traditionally used to screen for Von Willebrand Disease (vWD) and qualitative platelet disorders, though it has largely been replaced by automated assays like PFA-100 in modern labs.
View Interpretation
Hematology

Bleeding Time and Clotting Time

The Bleeding Time (BT) and Clotting Time (CT) tests are fundamental screening tools used to assess the body's hemostatic mechanisms. Bleeding Time primarily measures the vascular phase and platelet function—essentially how quickly small blood vessels constrict and platelets form a 'plug' to stop bleeding. Clotting Time measures the efficiency of the coagulation cascade and the formation of a stable fibrin clot. These tests are frequently ordered as part of a pre-operative workup to ensure a patient can safely undergo surgery without excessive blood loss. They are also used to investigate symptoms of bleeding disorders, such as frequent nosebleeds, easy bruising, or heavy menstrual cycles. While more sophisticated tests like PT/INR or PTT have largely superseded CT in modern labs, BT remains a bedside indicator of platelet activity. Abnormal results in these tests are associated with several conditions:
  • Thrombocytopenia: A low platelet count leads to prolonged bleeding time.
  • Von Willebrand Disease: A common hereditary disorder affecting platelet adhesion.
  • Hemophilia: Genetic disorders (A or B) that deficiency specific clotting factors (VIII or IX), primarily affecting the clotting time.
  • Vitamin K Deficiency: Essential for the synthesis of several coagulation factors.
  • Liver Disease: Since the liver produces most clotting factors, hepatic failure significantly prolongs clotting time.
  • Medication Effects: The use of aspirin, NSAIDs, or anticoagulants (Warfarin, Heparin) will alter these results significantly.
View Interpretation
Metabolic

Blood (Hemoglobin)

This component of a Complete Urine Examination detects the presence of red blood cells (hematuria), free hemoglobin (hemoglobinuria), or myoglobin (myoglobinuria). Hematuria indicates bleeding within the urinary tract—ranging from the glomerulus to the urethra—due to stones, infection, trauma, or malignancy. Hemoglobinuria suggests intravascular hemolysis where free hemoglobin is filtered by the kidney.
View Interpretation
Hematology

Blood Cell Morphology

Blood Cell Morphology is a qualitative microscopic examination of a blood smear. A pathologist or specialized technician examines the shape, size, and structure of red blood cells (RBCs), white blood cells (WBCs), and platelets. While an automated CBC provides numbers, morphology provides the 'visual story' behind those numbers. This test is typically triggered when an automated Complete Blood Count (CBC) detects abnormalities like unexplained anemia, low platelet counts, or immature white blood cells. It is essential for diagnosing specific types of blood disorders that machines cannot definitively categorize.
  • Sickle Cell Anemia: Characterized by crescent-shaped RBCs.
  • Iron Deficiency Anemia: Characterized by small (microcytic) and pale (hypochromic) RBCs.
  • Leukemia: Identified by the presence of 'blasts' or immature, malignant WBCs.
  • Thrombocytopenia: Abnormalities in platelet size or clumping.
  • Vitamin B12/Folate Deficiency: Characterized by large (macrocytic) RBCs and hypersegmented neutrophils.
Detailed morphology can pinpoint the exact cause of symptoms like chronic fatigue, bruising, or persistent infections. For example, finding 'schistocytes' (fragmented cells) can indicate a medical emergency like Microangiopathic Hemolytic Anemia, requiring immediate intervention.
View Interpretation
Hematology

Blood Grouping and Rh Typing

Blood Grouping and Rh Typing is a foundational test used to identify a person's blood type based on the presence or absence of specific antigens (A and B) on the surface of red blood cells. The Rh typing specifically looks for the 'D' antigen. This classification system is vital for ensuring compatibility between donors and recipients. This test is a standard procedure in several critical medical scenarios:
  • Transfusion Safety: To prevent life-threatening hemolytic reactions when a patient needs blood.
  • Pregnancy Management: To identify Rh incompatibility between an Rh-negative mother and an Rh-positive fetus, which can lead to Hemolytic Disease of the Newborn (HDN).
  • Organ Transplantation: Matching donor and recipient blood types is a prerequisite for most transplants.
  • Surgical Planning: Pre-operative screening to ensure blood is available if needed.
While blood type itself is a genetic trait rather than a condition, it relates to:
  • Rh Incompatibility: Where the mother requires Rho(D) immune globulin (RhoGAM) to prevent sensitization.
  • Hemolytic Reactions: Occurs if the wrong blood type is administered.
  • Genetic Studies: Used in paternity testing or tracing lineage (though DNA testing has largely superseded this).
There are four main groups: A, B, AB, and O. Each is further classified as Rh-positive or Rh-negative. O-negative is known as the 'universal donor,' while AB-positive is the 'universal recipient.'
View Interpretation
Vital Signs

Blood Pressure

Blood pressure (BP) measures the force of blood pushing against the walls of the arteries. It is recorded with two numbers: Systolic (pressure during heartbeats) and Diastolic (pressure between beats). It is a primary indicator of cardiovascular health and hemodynamic stability. BP is measured at almost every medical encounter because it is a vital sign. Chronic monitoring is essential for diagnosing hypertension, which is often asymptomatic (the 'silent killer') until it causes significant organ damage. It is also used to assess the effectiveness of antihypertensive medications.
  • Hypertension: High BP, leading to stroke, heart attack, and kidney failure.
  • Hypotension: Low BP, which can cause fainting, dizziness, or shock.
  • Preeclampsia: High BP during pregnancy.
  • Cardiovascular Disease: General risk assessment for atherosclerosis.
Managing blood pressure involves a combination of sodium restriction, regular aerobic exercise, stress management, and, in many cases, pharmacotherapy (e.g., ACE inhibitors, beta-blockers). Frequent home monitoring is often recommended to capture 'real-world' data outside of the stressful clinical environment.
View Interpretation
Metabolic

Blood Urea

Blood Urea is a waste product formed in the liver when protein is broken down into amino acids. This process produces ammonia, which is then converted into urea, a less toxic substance. The kidneys are primarily responsible for filtering urea from the blood and excreting it in urine. Therefore, measuring Blood Urea levels is a fundamental way to assess how well the kidneys and liver are functioning. This test is frequently ordered as part of a Basic Metabolic Panel (BMP) or Renal Function Test (RFT). Doctors use it to:
  • Evaluate kidney health and monitor the progression of kidney disease.
  • Determine the effectiveness of dialysis treatment.
  • Check for dehydration or bowel obstructions.
  • Monitor patients taking medications that may affect kidney function.
Abnormal Blood Urea levels are associated with several conditions. Elevated levels (Azotemia) are commonly linked to chronic kidney disease (CKD), acute kidney injury, congestive heart failure, or recent myocardial infarction. It can also rise due to high protein intake or gastrointestinal bleeding. Low levels are less common but may indicate severe liver disease, malnutrition, or overhydration. It is important to note that Blood Urea is often interpreted alongside Creatinine; a high Urea-to-Creatinine ratio can specifically point toward pre-renal causes like dehydration rather than intrinsic kidney damage.
View Interpretation
Metabolic

Blood Urea Nitrogen

Blood Urea Nitrogen (BUN) measures the amount of urea nitrogen in the blood. Urea is a waste product created in the liver when the body breaks down proteins. It is then transported through the blood to the kidneys, which filter it out of the blood and into the urine. The BUN test is a fundamental indicator of how well the kidneys and liver are functioning. The BUN test is frequently ordered as part of a Basic or Comprehensive Metabolic Panel (BMP/CMP) during routine check-ups. It is also used to monitor patients with chronic conditions like kidney disease, heart failure, or diabetes. Doctors use it to evaluate the effectiveness of dialysis treatment or to help diagnose the cause of symptoms like fatigue, swelling (edema), or changes in urination.
  • Kidney Dysfunction: High levels often indicate reduced glomerular filtration rate (GFR).
  • Dehydration: Dehydration leads to higher concentration of urea in the blood.
  • Congestive Heart Failure: Reduced blood flow to the kidneys can elevate BUN.
  • Gastrointestinal Bleed: Digestion of blood proteins can significantly spike BUN levels.
  • Liver Disease: Very low BUN levels may indicate impaired liver function (as the liver cannot produce urea).
View Interpretation
Metabolic

Blood Urea Nitrogen (BUN)

BUN measures the amount of nitrogen in the blood that comes from the waste product urea. In a Basic Kidney Profile, it is used alongside creatinine to assess renal excretory function. BUN is particularly sensitive to protein intake and hydration status, making the BUN/Creatinine ratio a key indicator for differentiating pre-renal (dehydration) from intrinsic renal failure.
View Interpretation
Microbiology

Blood for Culture & Sensitivity

A Blood Culture is a laboratory test used to detect the presence of microorganisms, such as bacteria or fungi, in the blood. Since blood is normally sterile, the presence of these pathogens indicates an active infection. 'Sensitivity' testing involves exposing the grown pathogens to various antibiotics to determine which drug is most effective at killing them. This test is critical for patients showing signs of systemic infection or sepsis, such as high fever, chills, rapid heart rate, or confusion. It is also used to diagnose endocarditis (infection of the heart valves) and to monitor the effectiveness of treatment for bloodstream infections.
  • Sepsis (Septicemia): A life-threatening immune response to a bloodstream infection.
  • Endocarditis: Bacterial infection of the lining of the heart or heart valves.
  • Osteomyelitis: Infection of the bone that has spread via the blood.
  • Fungemia: The presence of fungi or yeast in the blood, common in immunocompromised patients.
View Interpretation
Microbiology

Blood for Culture & Sensitivity (Radiometric)

Blood Culture and Sensitivity (Radiometric) is a sophisticated microbiological test designed to detect the presence of bacteria or fungi in the blood (bacteremia or fungemia). The 'radiometric' method involves using specialized culture media containing carbon-14 labeled substrates. When microorganisms grow, they metabolize these substrates and release radioactive CO2, which is detected by automated sensors, allowing for faster detection than traditional visual methods. This test is critical when a systemic infection (sepsis) is suspected. It is often ordered for patients exhibiting:
  • High fever, chills, and rapid breathing.
  • Confusion or extreme fatigue.
  • Signs of organ dysfunction.
  • Potential endocarditis (infection of heart valves).
  • Sepsis: A life-threatening reaction to infection.
  • Bacteremia: Presence of bacteria in the blood, often originating from UTI, pneumonia, or abdominal infections.
  • Endocarditis: Inflammation of the inner lining of the heart chambers.
  • Osteomyelitis: Bone infection that has entered the bloodstream.
Once a pathogen is identified, the 'sensitivity' portion of the test determines which antibiotics are most effective at killing that specific organism, guiding targeted therapy.
View Interpretation
Metabolic

Body Mass Index (BMI)

Body Mass Index (BMI) is a surrogate marker for body fatness based on an individual's mass (weight) and height. While it does not measure body fat directly, research has shown that BMI is moderately correlated with more direct measures of body fat obtained from skinfold thickness measurements, bioelectrical impedance, underwater weighing, and dual-energy X-ray absorptiometry (DXA). BMI is used as a screening tool to identify possible weight problems for adults. However, BMI is not a diagnostic tool. For example, a person may have a high BMI but to determine if excess weight is a health risk, a healthcare provider would need to perform further assessments. These assessments might include skinfold thickness measurements, evaluations of diet, physical activity, family history, and other appropriate health screenings. BMI is widely used to categorize health status and predict risks for several chronic conditions.
  • High BMI (Overweight/Obese): Associated with an increased risk of Type 2 Diabetes, Hypertension (high blood pressure), Dyslipidemia, Coronary Heart Disease, Stroke, Osteoarthritis, and certain cancers (endometrial, breast, and colon).
  • Low BMI (Underweight): Associated with risk for osteoporosis, decreased immune function, iron-deficiency anemia, and malnutrition.
It is important to note that BMI does not distinguish between muscle mass and fat mass. Athletes or individuals with high muscle mass may have a BMI that classifies them as 'overweight' despite having very low body fat. Conversely, older adults who have lost muscle mass may fall into a 'normal' BMI range while possessing high levels of visceral fat.
View Interpretation
Hematology

Bone Marrow Biopsy

A Bone Marrow Biopsy involves the removal of a small solid core of bone marrow tissue (usually from the pelvic bone) to examine the architecture, cellularity, and presence of abnormal cells. Unlike an aspiration (which looks at liquid cells), the biopsy provides a 'snapshot' of the bone marrow's physical structure, showing how cells are arranged and the state of the supporting stroma. This procedure is the gold standard for diagnosing and staging various blood-related disorders. It is ordered when blood tests (CBC) show unexplained high or low counts, or when abnormal cells are found in the peripheral blood. Key reasons include:
  • Diagnosing Leukemias and Lymphomas: Determining the type and extent of cancer.
  • Unexplained Anemia or Thrombocytopenia: Finding out why the body isn't producing enough blood cells.
  • Fever of Unknown Origin: Checking for infections like tuberculosis or fungal diseases in the marrow.
  • Staging: Seeing if a cancer from elsewhere has spread to the bone marrow.
  • Myelofibrosis: Scarring of the bone marrow.
  • Aplastic Anemia: A condition where the marrow stops producing new cells.
  • Myelodysplastic Syndromes (MDS): Poorly formed or dysfunctional blood cells.
  • Multiple Myeloma: Cancer of the plasma cells.
Pathologists look for 'Cellularity' (the ratio of blood-producing cells to fat), which naturally decreases with age. They also look for 'Fibrosis' (scarring), 'Granulomas' (signs of infection), and 'Infiltration' (presence of metastatic cancer cells). The absence of blasts (immature cancer cells) and the presence of maturing erythroid, myeloid, and megakaryocytic lines indicate health.
View Interpretation
Pathology

Breast Lump Histopathology

Histopathology is the microscopic examination of tissue to study the manifestations of disease. When a breast lump is detected via physical exam or imaging (Mammogram/Ultrasound), a small piece of the tissue is removed via biopsy. A pathologist then examines the cellular structure to determine if the lump is benign (non-cancerous) or malignant (cancerous). This is the definitive 'gold standard' test for breast cancer diagnosis. While imaging can suggest a lump looks suspicious, only histopathology can confirm the presence of cancer cells. It also identifies the type of cancer (e.g., Infiltrating Ductal Carcinoma) and the grade (how aggressive the cells look), which dictates the entire treatment plan.
  • Fibroadenoma: A common benign breast tumor.
  • Fibrocystic Changes: Non-cancerous lumps related to hormonal cycles.
  • Invasive Ductal Carcinoma (IDC): The most common form of breast cancer.
  • Ductal Carcinoma In Situ (DCIS): Non-invasive cancer cells in the milk ducts.
View Interpretation
Microbiology

Bronchial Washing for AFB

The Bronchial Washing for Acid-Fast Bacilli (AFB) test is a critical diagnostic tool used to detect the presence of mycobacteria, most notably Mycobacterium tuberculosis, the causative agent of Tuberculosis (TB). Bronchial washing involves instilling sterile saline into a specific segment of the lung during a bronchoscopy and then suctioning it back out. This process collects cells, secretions, and potential pathogens from the lower respiratory tract that might not be present in a standard expectorated sputum sample. Clinicians order this test when a patient exhibits symptoms suggestive of pulmonary TB—such as chronic cough, night sweats, weight loss, and hemoptysis—but cannot produce adequate sputum, or when previous sputum smears were inconclusive. It is also used to diagnose Non-Tuberculous Mycobacteria (NTM) infections, which can mimic TB symptoms, particularly in immunocompromised individuals or those with underlying lung disease like COPD or bronchiectasis.
  • Pulmonary Tuberculosis: The primary target of the AFB smear and culture.
  • NTM Lung Disease: Caused by environmental mycobacteria like M. avium complex.
  • Miliary Tuberculosis: A disseminated form of TB that may require deep sampling for detection.
  • Immunocompromised States: Patients with HIV/AIDS are at higher risk for atypical mycobacterial presentations requiring bronchial washing for definitive diagnosis.
The sample undergoes Ziehl-Neelsen or Kinyoun staining. The 'acid-fast' property refers to the ability of these bacteria to resist decolorization by acids during staining due to the high lipid (mycolic acid) content in their cell walls. A positive smear indicates an active infection and high potential for transmission.
View Interpretation
Inflammatory Marker

C-Reactive Protein (CRP)

C-Reactive Protein (CRP) is an acute-phase reactant protein produced by the liver. Its levels rise rapidly in response to inflammation caused by infection, injury, or chronic disease. It is part of the innate immune system and helps the body's defense mechanisms clear pathogens. CRP is a highly sensitive but non-specific marker. It is used to:
  • Detect or monitor serious bacterial infections (like sepsis).
  • Monitor the activity of chronic inflammatory conditions (like Rheumatoid Arthritis or Lupus).
  • Evaluate the response to antibiotic or anti-inflammatory treatment.
  • Differentiate between viral (usually low CRP) and bacterial (usually high CRP) infections.
  • Infections: Bacterial, viral, or fungal infections.
  • Autoimmune Diseases: Rheumatoid arthritis, Vasculitis, or IBD (Crohn's/Colitis).
  • Tissue Injury: Trauma, surgery, or myocardial infarction (heart attack).
  • Malignancy: Certain cancers can cause elevated CRP.
CRP must be interpreted alongside clinical symptoms. While a high CRP confirms inflammation, it does not point to the specific location or cause. Recent trends use 'hs-CRP' (High-Sensitivity CRP) for cardiovascular risk assessment, whereas standard CRP is used for clinical inflammation.
View Interpretation
Rheumatology

C-Reactive Protein (CRP)

C-Reactive Protein (CRP) is an acute-phase reactant synthesized by the liver in response to interleukin-6. In an Arthritis Basic Screen, CRP is a non-specific but sensitive marker for systemic inflammation. It is used to distinguish inflammatory arthritides (like Rheumatoid Arthritis) from non-inflammatory conditions (like Osteoarthritis) and to monitor the therapeutic response to anti-inflammatory or biological agents.
View Interpretation
Infectious Disease

C-Reactive Protein (CRP)

CRP is an acute-phase reactant protein synthesized by the liver in response to interleukin-6. It is a highly sensitive but non-specific marker of systemic inflammation. Within a COVID-19 panel, CRP is used to gauge the severity of the inflammatory response ('cytokine storm'), monitor disease progression, and evaluate the efficacy of anti-inflammatory treatments like dexamethasone or IL-6 inhibitors.
View Interpretation
Oncology

CA 125 (Cancer Antigen 125)

CA 125 is a protein that is a so-called tumor marker. It is found in greater concentration in ovarian cancer cells than in other cells. While it is produced by the surface of the ovary, it can also be produced by other tissues such as the lining of the uterus and the abdominal cavity. The primary use of CA 125 is to monitor the effectiveness of treatment for ovarian cancer and to check for recurrence. It is also used to evaluate pelvic masses in postmenopausal women to assess the risk of malignancy. It is generally not recommended as a screening tool for the general population because of its low specificity.
  • Ovarian Cancer: Significantly elevated in roughly 80% of epithelial ovarian cancers.
  • Endometrial Cancer: May show elevated levels.
  • Endometriosis: A common benign cause of elevation in premenopausal women.
  • Pelvic Inflammatory Disease (PID): Infection can cause localized inflammation leading to CA 125 release.
  • Cirrhosis: Liver disease can cause elevations due to peritoneal irritation (ascites).
In oncology, the 'trend' of CA 125 is often more important than a single value. A falling level during chemotherapy usually indicates that the tumor is responding to treatment, while a rising level may suggest the cancer is growing or returning.
View Interpretation
Tumor Markers

CA 15-3

Cancer Antigen 15-3 (CA 15-3) is a protein produced by normal breast cells. However, in many patients with cancerous breast tumors, there is an increased production of CA 15-3 and the related antigen CA 27.29. This protein is shed into the bloodstream, making it a measurable tumor marker in clinical oncology. CA 15-3 is primarily utilized to monitor the treatment of invasive breast cancer and to watch for recurrence. It is not generally used as a screening tool for early-stage breast cancer because many early-stage cancers do not cause elevated levels, and levels can be high in individuals with non-cancerous conditions. It is most valuable for:
  • Monitoring Therapy: Observing the efficacy of chemotherapy or hormonal therapy in advanced breast cancer.
  • Recurrence Surveillance: Detecting the return of cancer after successful initial treatment.
  • Disease Progression: Gauging the extent of metastatic disease.
While most closely linked with breast cancer, elevated CA 15-3 levels are associated with several other conditions:
  • Malignant Conditions: Lung, pancreatic, ovarian, and prostate cancers.
  • Benign Conditions: Endometriosis, pelvic inflammatory disease, cirrhosis, and benign breast disease.
  • Inflammatory States: Certain systemic inflammatory conditions can cause transient elevations.
Clinicians typically use CA 15-3 in conjunction with physical exams, imaging (like mammograms or CT scans), and other laboratory findings to form a complete clinical picture. A declining level usually indicates a positive response to treatment, while a rising level may suggest tumor growth or recurrence.
View Interpretation
Oncology

CA 19.9

Carbohydrate Antigen 19-9 (CA 19-9) is a tumor-associated antigen, specifically a sialylated Lewis blood group antigen. While it is produced in small amounts by normal cells in the biliary tract and pancreas, it is shed in significantly higher quantities by certain tumor cells. It is not used as a primary screening tool for the general population but is an invaluable biomarker for monitoring disease progression. CA 19-9 is most frequently ordered for patients diagnosed with pancreatic adenocarcinoma. It helps clinicians assess the effectiveness of chemotherapy, radiation, or surgical intervention. If levels drop during treatment, it generally suggests the therapy is working. It is also used to monitor for cancer recurrence after treatment has been completed. Occasionally, it may be ordered alongside other imaging to evaluate masses in the pancreas or bile ducts.
  • Pancreatic Cancer: The primary use for this marker.
  • Cholangiocarcinoma: Cancer of the bile ducts frequently elevates CA 19-9.
  • Benign Biliary Obstruction: Gallstones or bile duct inflammation (cholangitis) can cause significant elevations.
  • Cirrhosis and Hepatitis: Chronic liver diseases can result in moderate increases.
  • Cystic Fibrosis: Some patients with this genetic condition show elevated levels without malignancy.
View Interpretation
Oncology

CA-125 (Cancer Antigen 125)

The CA-125 test measures the amount of the protein Cancer Antigen 125 in the blood. Within an Ovarian Cancer Panel, it serves as a primary tumor marker. It is most useful for monitoring the effectiveness of treatment and checking for recurrence in patients already diagnosed with epithelial ovarian cancer. It is not generally used as a primary screening tool for asymptomatic individuals because many non-cancerous conditions can cause elevations.
View Interpretation
Immunology

CD3+ Absolute Count

CD3 is a protein complex and T-cell co-receptor that is present on all mature T-lymphocytes. The absolute CD3+ count measures the total number of T-cells in the blood. This is a foundational metric for assessing immune competence, monitoring patients with HIV/AIDS, assessing primary immunodeficiency, and managing patients on immunosuppressive therapy post-organ transplant.
View Interpretation
Immunology

CD3+ Percentage

The CD3+ percentage measures the proportion of total lymphocytes that are mature T-cells. Within the CD3, CD4 & CD8 Count panel, this serves as a foundational metric for cellular immunity. It is used to evaluate immune system competence, monitor patients with HIV/AIDS, and assess recovery post-bone marrow transplant or response to immunosuppressive therapy.
View Interpretation
Immunology

CD3, CD4 & CD8 Count

The CD3, CD4, and CD8 panel measures the specific subsets of T-lymphocytes in the blood. CD3 is a marker for all T-cells. CD4 cells (T-helper cells) coordinate the immune response, while CD8 cells (Cytotoxic T-cells) directly kill infected or cancerous cells. The ratio of CD4 to CD8 is a vital indicator of immune system balance and health. This test is most commonly used to monitor the progression of HIV/AIDS and to assess the effectiveness of Antiretroviral Therapy (ART). It is also ordered to evaluate primary immunodeficiencies, monitor patients after organ transplants to prevent rejection, and assess immune recovery following chemotherapy or bone marrow transplants.
  • HIV/AIDS: Characterized by a progressive decline in CD4 counts.
  • Lymphoma: Certain types of blood cancers can alter T-cell distributions.
  • Sarcoidosis: Often associated with lymphopenia (low T-cells).
  • Acute Viral Infections: Such as Mononucleosis, which can temporarily increase CD8 counts and invert the CD4/CD8 ratio.
View Interpretation
Immunology

CD4 & CD8 Count

This test measures the number of CD4 and CD8 T-lymphocytes in the blood. CD4 cells, often called 'helper T-cells,' are the 'generals' of the immune system, signaling other cells to fight infections. CD8 cells, or 'cytotoxic T-cells,' are the 'soldiers' that directly kill cells infected by viruses or cancer. The ratio between these two is a fundamental indicator of immune health and balance. The CD4/CD8 panel is most famously used in the management of HIV/AIDS, as the HIV virus specifically targets and destroys CD4 cells. However, it is also ordered to:
  • Monitor HIV Progression: Determining when to start or change antiretroviral therapy (ART).
  • Evaluate Immune Deficiency: Checking for primary immunodeficiency disorders.
  • Monitor Organ Transplants: Assessing if immunosuppressive drugs are working or if the body is rejecting an organ.
  • Assess Chronic Infections: Understanding the body's response to viruses like Epstein-Barr (EBV) or Cytomegalovirus (CMV).
A low CD4 count is the hallmark of AIDS, making the body susceptible to opportunistic infections like PCP pneumonia or Kaposi's sarcoma. A high CD8 count often occurs during an active viral infection as the body ramps up its defense. A low CD4/CD8 ratio (less than 1.0) is frequently seen in chronic viral infections and is an independent marker of immune aging and increased inflammation.
View Interpretation
Immunology

CD4 Absolute Count

The CD4 Absolute Count measures the number of CD4+ T-helper cells in the blood, which are primary targets of HIV. In the context of a CD4 & CD8 Count panel, it is the gold standard for assessing immune competence. It is used to stage HIV infection, determine the risk of opportunistic infections (like Pneumocystis jirovecii), and monitor the effectiveness of Antiretroviral Therapy (ART). A declining count indicates progressive immune failure, while a rising count suggests immune reconstitution.
View Interpretation
Immunology

CD4 Count

The CD4 count is a test that measures the number of CD4 T-lymphocytes (helper T cells) in the blood. These cells are the 'conductors' of the immune system, signaling other immune cells to fight off infections. This test is the primary marker used to assess the health of the immune system, particularly in patients with Human Immunodeficiency Virus (HIV).
  • HIV Management: To determine the stage of HIV infection and the risk of opportunistic infections.
  • Treatment Monitoring: To evaluate the effectiveness of Antiretroviral Therapy (ART).
  • Organ Transplant: To monitor immune suppression in transplant recipients.
  • Immunodeficiency Evaluation: To investigate chronic, recurrent infections in non-HIV patients.
  • HIV/AIDS: HIV specifically targets and destroys CD4 cells.
  • Lymphoma: Certain cancers of the lymphatic system can lower T-cell counts.
  • Opportunistic Infections: When CD4 counts drop below 200, the body becomes susceptible to rare infections like PCP pneumonia or Toxoplasmosis.
  • Sepsis: Severe acute infections can cause a temporary drop in lymphocyte counts.
  • >500 cells/mm³: Generally considered a healthy immune system.
  • 200-500 cells/mm³: Indicates a weakened immune system.
  • <200 cells/mm³: Classified as AIDS (in HIV-positive individuals), indicating a high risk for life-threatening opportunistic infections.
View Interpretation
Immunology

CD4 Percentage

The CD4 Percentage measures the proportion of lymphocytes that are CD4+ T-helper cells. Within the 'CD4 & CD8 Count' panel, this is often considered more stable than the absolute CD4 count because it is not influenced by fluctuations in the total white blood cell count or total lymphocyte count. It is a critical marker for monitoring immune status in HIV/AIDS patients, particularly in pediatric populations where absolute counts vary significantly by age. It helps clinicians determine the risk of opportunistic infections and the effectiveness of Antiretroviral Therapy (ART).
View Interpretation
Immunology

CD4+ Absolute Count

The CD4+ Absolute Count calculates the total number of T-helper lymphocytes per microliter of blood. It is the gold standard for clinical staging of HIV infection and for determining the necessity of prophylactic treatment for various opportunistic infections (e.g., PJP, MAC). It reflects the current capacity of the adaptive immune system to orchestrate a response against pathogens.
View Interpretation
Immunology

CD4+ Percentage

The CD4+ percentage represents the proportion of total lymphocytes that are T-helper cells. In clinical immunology, particularly in HIV/AIDS management, the percentage is often more stable than the absolute CD4 count, as it is less affected by diurnal variation or total white blood cell fluctuations. It is a critical marker for assessing immune system competence and the risk of opportunistic infections.
View Interpretation
Immunology

CD4/CD8 Ratio

The CD4/CD8 ratio is a calculated value measuring the balance between T-helper cells (CD4) and T-cytotoxic cells (CD8). It is a hallmark of immune system health. In healthy individuals, the ratio is typically above 1.0. A reversal of the ratio (less than 1.0) is a classic indicator of immune exhaustion or suppression, most notably used to monitor the progression of HIV infection and the effectiveness of Antiretroviral Therapy (ART). It is also used in investigating sarcoidosis and certain autoimmune conditions.
View Interpretation
Immunology

CD4/CD8 Ratio

The CD4/CD8 ratio is a key biomarker for immune system health. CD4 cells (T-helper cells) coordinate the immune response, while CD8 cells (cytotoxic T-cells) kill infected or cancerous cells. A healthy ratio indicates a balanced immune system. In the context of the CD4 & CD8 Count panel, this ratio is primary used to monitor HIV progression, recovery after bone marrow transplant, or the presence of chronic viral infections.
View Interpretation
Immunology

CD8 Absolute Count

CD8+ T-lymphocytes, or cytotoxic T-cells, are vital for the immune response against intracellular pathogens (viruses) and tumor cells. In a CD4 & CD8 Count panel, the absolute CD8 count is used to assess immune system activation or exhaustion. In HIV monitoring, CD8 counts often rise during the early stages as the body attempts to fight the virus. The ratio of CD4 to CD8 is a critical marker of immune health; an inverted ratio (more CD8 than CD4) is a hallmark of immune senescence and chronic inflammation.
View Interpretation
Immunology

CD8 Percentage

CD8 Percentage measures the proportion of T-lymphocytes that are 'cytotoxic' or 'suppressor' cells. These cells are responsible for killing virally infected and tumor cells. In an immunology panel, the CD8 percentage is used to monitor immune system competence, particularly in patients with HIV/AIDS, or to evaluate the CD4/CD8 ratio, which is an indicator of immune exhaustion or chronic inflammation.
View Interpretation
Immunology

CD8+ Absolute Count

The CD8+ Absolute Count measures the total number of cytotoxic T-lymphocytes in the blood. These cells are essential for the cell-mediated immune response, specifically targeting and killing virally infected cells and tumor cells. In the context of a 'CD3, CD4 & CD8 Count' panel, it is used to calculate the CD4/CD8 ratio, which is a critical biomarker for immune health, particularly in monitoring HIV progression and recovery under Antiretroviral Therapy (ART). A balanced CD8 count indicates a functional cellular immune defense mechanism.
View Interpretation
Immunology

CD8+ Percentage

The CD8+ percentage measures the proportion of T-lymphocytes that are cytotoxic T cells. These cells are responsible for destroying virus-infected cells and tumor cells. In the context of a CD3/CD4/CD8 count, this value is critical for calculating the CD4/CD8 ratio, which is a hallmark indicator of immune system health, particularly in managing HIV/AIDS and monitoring post-transplant immunosuppression.
View Interpretation
Cardiac Biomarkers

CK-MB (Creatine Kinase-MB)

Creatine Kinase-MB (CK-MB) is a specific isoenzyme found primarily in the heart muscle (myocardium). While Creatine Kinase (CK) exists in various tissues including the brain and skeletal muscles, the MB fraction is the most specific indicator for cardiac tissue injury. Its primary function is to catalyze the conversion of creatine and use adenosine triphosphate (ATP) to create phosphocreatine and adenosine diphosphate (ADP), a process vital for energy homeostasis in muscle cells. Historically, CK-MB was the 'gold standard' for diagnosing acute myocardial infarction (heart attack). Today, it is often ordered alongside or after Troponin tests to:
  • Detect a second heart attack occurring shortly after the first (re-infarction).
  • Monitor the extent of heart muscle damage.
  • Differentiate between skeletal muscle damage and cardiac injury when total CK levels are elevated.
  • Assess the success of reperfusion therapy.
Elevated levels are primarily associated with Acute Myocardial Infarction (AMI). However, because small amounts of CK-MB are found in skeletal muscle, extreme physical exertion or trauma can cause elevations. Other conditions include:
  • Myocarditis (inflammation of the heart muscle).
  • Pericarditis.
  • Cardiac trauma (e.g., from a car accident or thoracic surgery).
  • Congestive heart failure.
  • Severe skeletal muscle injury or muscular dystrophy (though the CK-MB relative index usually remains low).
View Interpretation
Genetics

CLL Cytogenetics

CLL Cytogenetics utilizes techniques like FISH (Fluorescence In Situ Hybridization) and Karyotyping to examine the chromosomal structure of leukemic cells in Chronic Lymphocytic Leukemia (CLL). It looks for specific abnormalities—deletions, additions, or translocations—that drive the progression of the disease. Unlike many cancers where genetics are used for diagnosis, in CLL, cytogenetics are primarily used for prognostication and treatment selection. Because CLL is a highly variable disease (some patients live for decades without treatment, while others progress rapidly), knowing the genetic 'signature' helps oncologists decide whether to start aggressive therapy or use a 'watch and wait' approach.
  • 13q deletion: Associated with a favorable prognosis and long survival times.
  • Trisomy 12: Associated with an intermediate prognosis.
  • 11q deletion (ATM gene): Associated with more extensive lymph node involvement and a more aggressive course.
  • 17p deletion (TP53 gene): This is the most critical finding; it indicates resistance to standard chemotherapy and usually requires targeted therapies like BTK inhibitors.
View Interpretation
Hematology

CLL Flow Cytometry

Flow Cytometry is a sophisticated biophysical technology used to analyze the physical and chemical characteristics of particles in a fluid as they pass through at least one laser. In the context of Chronic Lymphocytic Leukemia (CLL), it is used to identify the 'immunophenotype' of lymphocytes—specifically, which proteins (antigens) are expressed on the surface of the cells. This test is ordered when a patient has a persistently high white blood cell count (specifically lymphocytosis) or enlarged lymph nodes. It is the 'gold standard' for diagnosing CLL. CLL cells have a unique signature: they typically express B-cell markers (CD19, CD20, CD23) alongside a T-cell marker (CD5), which is unusual for normal B-lymphocytes. The test also helps differentiate CLL from other types of non-Hodgkin lymphomas.
  • Chronic Lymphocytic Leukemia (CLL): Confirmed by the presence of a clonal B-cell population with CD5/CD23 positivity.
  • Small Lymphocytic Lymphoma (SLL): The tissue-based equivalent of CLL.
  • Monoclonal B-cell Lymphocytosis (MBL): A precursor condition where CLL-like cells are present but at a very low concentration.
  • Mantle Cell Lymphoma: Often confused with CLL, but usually CD23 negative and requires differentiation via flow cytometry.
Beyond diagnosis, flow cytometry can look for markers like ZAP-70 or CD38, which provide prognostic information regarding how aggressively the disease might progress.
View Interpretation
Hematology

CLL Flow Cytometry

Flow Cytometry is a sophisticated laboratory technique used to identify and characterize cells based on the proteins (antigens) expressed on their surface. For Chronic Lymphocytic Leukemia (CLL), flow cytometry analyzes peripheral blood to see if a specific 'clone' or population of abnormal B-lymphocytes is present. It looks for a specific 'immunophenotype' that defines CLL. This test is ordered when a routine Complete Blood Count (CBC) shows an unexplained, persistent increase in the absolute lymphocyte count (Lymphocytosis). It is used to:
  • Distinguish between a reactive (normal) immune response and a malignancy.
  • Diagnose CLL vs. other B-cell lymphomas (e.g., Mantle Cell Lymphoma).
  • Provide prognostic information based on markers like CD38 or ZAP-70.
The primary condition diagnosed is Chronic Lymphocytic Leukemia (CLL), the most common leukemia in adults. It can also identify Monoclonal B-cell Lymphocytosis (MBL), a precursor state where clonal cells are present but the count is too low for a CLL diagnosis. The test identifies the classic CLL 'signature': cells that express B-cell markers (CD19, CD23) while also abnormally expressing the T-cell marker CD5.
View Interpretation
Infectious Disease

CMV DNA Quantitative

The Cytomegalovirus (CMV) DNA Quantitative test, often performed via Polymerase Chain Reaction (PCR), measures the actual viral load (the amount of CMV DNA) present in the patient's blood. CMV is a member of the herpesvirus family. In healthy individuals, the immune system usually keeps the virus dormant after an initial infection. However, in immunocompromised individuals, the virus can reactivate and cause severe systemic disease. This test is primarily used to monitor patients who are at high risk for CMV disease, such as organ transplant recipients, bone marrow transplant patients, and individuals with advanced HIV/AIDS. It is used to:
  • Diagnose an active CMV infection.
  • Monitor the effectiveness of antiviral therapy (e.g., Ganciclovir).
  • Predict the risk of CMV-related organ damage (like pneumonia, hepatitis, or retinitis) before symptoms appear.
  • CMV Syndrome: Characterized by fever, malaise, and leukopenia in transplant patients.
  • Invasive CMV Disease: Including CMV Colitis, CMV Pneumonitis, and CMV Retinitis.
  • Congenital CMV: In newborns, though usually tested via urine or saliva.
  • Mononucleosis-like Syndrome: In immunocompetent adults during primary infection.
View Interpretation
Immunology

CMV IgM

The CMV IgM test detects IgM antibodies to Cytomegalovirus. These antibodies are the first type produced by the body in response to a new CMV infection. They typically appear within 1-2 weeks of exposure and remain detectable for several months, though they can sometimes persist longer. This test is used to determine if a patient has a current or very recent primary CMV infection. It is frequently ordered for:
  • Pregnant women who exhibit symptoms of a viral infection or have had a known exposure.
  • Individuals with symptoms of mononucleosis (fever, fatigue, swollen glands) who test negative for the Epstein-Barr virus (EBV).
  • Organ donors and recipients to determine serostatus.
  • Primary CMV Infection: The first time an individual is exposed to the virus.
  • Reactivation/Reinfection: In some cases, IgM can reappear when a latent infection reactivates, though this is less common than in primary infection.
  • Congenital Infection: Testing of the mother and infant can help identify risk factors for birth defects or developmental delays caused by the virus.
View Interpretation
Infectious Disease

COVID Panel Bio Chemistry

The COVID Biochemistry Panel is a cluster of laboratory tests used to monitor the physiological impact of a SARS-CoV-2 infection. Unlike a PCR test which detects the virus itself, this panel assesses the body's systemic inflammatory response and organ function. Common markers included are C-Reactive Protein (CRP), Lactate Dehydrogenase (LDH), D-Dimer, and Ferritin. This panel is ordered to determine the severity of COVID-19 and to predict the risk of complications like the 'cytokine storm.' It helps clinicians decide on the level of care required (home monitoring vs. hospitalization) and the necessity for anticoagulants or corticosteroids. Abnormal results in this panel are associated with:
  • Hyperinflammation: Indicated by high CRP and Ferritin.
  • Coagulopathy: Risk of blood clots indicated by elevated D-Dimer.
  • Tissue Damage: Indicated by high LDH levels.
  • Multi-organ Failure: Monitoring hepatic and renal markers within the panel.
  • Severe Viral Pneumonia: Assessing the extent of pulmonary involvement.
View Interpretation
Hematology

COVID Panel Hematology

The COVID Panel Hematology is not a single test but a specialized grouping of hematological markers used to assess the severity and progression of a SARS-CoV-2 infection. The focus is primarily on the White Blood Cell (WBC) differential, specifically the Absolute Lymphocyte Count (ALC) and the Neutrophil-to-Lymphocyte Ratio (NLR). These markers reflect the body's systemic inflammatory response and immune competence. Clinicians order these panels to risk-stratify patients diagnosed with COVID-19. Early in the pandemic, it was discovered that specific hematological changes could predict which patients were likely to develop severe respiratory failure or cytokine release syndrome (cytokine storm). It helps in making decisions regarding hospitalization, the need for intensive care, and the initiation of corticosteroids or immunomodulators.
  • Lymphopenia: A hallmark of severe COVID-19, where the virus directly or indirectly depletes T-cells.
  • Neutrophilia: Indicates a heightened inflammatory response or a secondary bacterial infection.
  • Thrombocytopenia: Low platelet counts in COVID patients are associated with increased mortality and coagulopathy.
  • Hyperinflammation: High NLR is a strong predictor of poor clinical outcomes and lung injury.
View Interpretation
Infectious Disease

COVID RT PCR

The COVID-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test is the 'gold standard' for detecting the SARS-CoV-2 virus. It works by amplifying specific genetic sequences (RNA) of the virus. Because the PCR process creates millions of copies of the viral genetic material, it can detect even minute amounts of the virus in a patient's system, making it far more sensitive than rapid antigen tests. This test is ordered to diagnose an active COVID-19 infection in symptomatic individuals or those with known exposure. It is also used for screening in high-risk settings (hospitals, nursing homes), for international travel clearance, and for pre-operative clearance. Unlike antibody tests, the RT-PCR tells you if you are currently infected, not if you had a past infection.
  • COVID-19 (SARS-CoV-2 Infection): The primary target of the assay.
  • Pneumonia/ARDS: Complications arising from severe viral replication in the lower respiratory tract.
  • Long COVID: Patients may occasionally remain PCR-positive for extended periods, though this does not always imply infectivity.
The sample is typically collected via a nasopharyngeal or oropharyngeal swab. In the lab, the RNA is extracted and converted to DNA using the enzyme reverse transcriptase. The DNA is then amplified through thermal cycling. If the virus is present, a fluorescent signal is generated that exceeds a specific threshold (the Cycle Threshold or Ct value).
View Interpretation
Serology

COVID-19 - Antibody

The COVID-19 Antibody test (also known as a serology test) looks for antibodies (IgG, IgM, or IgA) produced by the immune system in response to SARS-CoV-2, the virus that causes COVID-19. Unlike PCR or Antigen tests, this does not detect the virus itself but rather the body's 'memory' of the infection or vaccination. It is ordered to determine if an individual has had a past infection, to assess the immune response following vaccination, or to help diagnose 'Long COVID' in patients who had symptoms but were never tested during the acute phase. It can also be used in public health surveillance to estimate the percentage of the population previously infected.
  • Post-Acute Sequelae of SARS-CoV-2 (PASC): Also known as Long COVID.
  • Multisystem Inflammatory Syndrome (MIS-C/A): A rare but serious inflammatory condition following COVID-19.
  • Immune Status Evaluation: Checking for the presence of spike protein antibodies vs. nucleocapsid antibodies to distinguish between vaccine response and natural infection.
View Interpretation
Infectious Disease

COVID-19 RT-PCR

The Reverse Transcription Polymerase Chain Reaction (RT-PCR) is the gold standard for detecting the SARS-CoV-2 virus. It works by amplifying specific genetic sequences (RNA) of the virus to detectable levels. This method is highly sensitive and can detect the presence of the virus even in the early stages of infection or in asymptomatic individuals. This test is used for definitive diagnosis of COVID-19 in symptomatic patients, screening of exposed individuals, and pre-operative or travel clearance. It distinguishes COVID-19 from other respiratory infections like Influenza or RSV, which present with similar symptoms.
  • SARS-CoV-2 Infection: The primary target of the test.
  • Post-Acute Sequelae of SARS-CoV-2 (PASC): Also known as Long COVID, though the PCR usually turns negative long before symptoms resolve.
  • Secondary Pneumonia: PCR helps confirm if the viral infection was the primary trigger for lung complications.
The RT-PCR test provides a binary result: 'Detected' (Positive) or 'Not Detected' (Negative). In some laboratory settings, a 'Cycle Threshold' (Ct) value is produced; lower Ct values typically indicate a higher viral load. However, Ct values are generally not used for clinical decision-making because they vary based on swab technique and the specific lab equipment used.
View Interpretation
Biochemistry

CSF ADA Levels

Adenosine Deaminase (ADA) is an enzyme involved in purine metabolism. It is primarily found in T-lymphocytes and plays a crucial role in the immune response. When the central nervous system is affected by certain infections, particularly those that trigger a cellular immune response, the levels of ADA in the Cerebrospinal Fluid (CSF) rise. The CSF ADA test is most frequently used as a rapid screening tool for Tuberculous Meningitis (TBM). TBM is notoriously difficult to diagnose because traditional cultures for Mycobacterium tuberculosis can take weeks. ADA provides a much faster, albeit indirect, indication of infection. It is ordered when a patient presents with:
  • Chronic headache and fever.
  • Neck stiffness.
  • Neurological deficits of unknown origin.
  • Tuberculous Meningitis: High sensitivity and specificity for this condition.
  • Bacterial Meningitis: Can cause moderate elevations.
  • Neurobrucellosis: Another infectious cause of raised ADA.
  • CNS Lymphoma: Non-infectious cause of significantly high ADA levels.
While ADA is a powerful tool, it must be interpreted alongside CSF glucose, protein, and cell counts to distinguish between tuberculosis and other types of meningitis.
View Interpretation
Neurology

CSF Albumin

Albumin is not produced in the central nervous system; therefore, its presence in the Cerebrospinal Fluid (CSF) is derived entirely from the blood. In the 'CSF Biochemical Analysis' panel, it is the gold standard marker for assessing the integrity of the Blood-Brain Barrier (BBB). An increase in CSF albumin indicates that the barrier is 'leaky,' which occurs in infections, tumors, or inflammatory conditions.
View Interpretation
Neurology

CSF Appearance

Cerebrospinal Fluid (CSF) appearance is the initial visual macroscopic assessment of the fluid surrounding the brain and spinal cord. It is a critical diagnostic step in cases of suspected meningitis, encephalitis, or subarachnoid hemorrhage. Normal CSF is 'crystal clear.' Changes in color or clarity provide immediate clues to the presence of blood, high protein, or infectious organisms.
View Interpretation
Neurology

CSF Biochemical Analysis

Cerebrospinal fluid (CSF) is a clear, colorless liquid that bathes the brain and spinal cord, providing mechanical protection and immunological stability. Biochemical analysis of CSF typically involves measuring protein and glucose levels, as well as electrolytes like chloride. These parameters are tightly regulated by the blood-brain barrier (BBB). This analysis is a critical diagnostic tool for central nervous system (CNS) disorders. It is primarily ordered when a clinician suspects meningitis (bacterial, viral, or fungal), encephalitis, or a subarachnoid hemorrhage. It is also used in the diagnosis of autoimmune conditions like Multiple Sclerosis (MS) or inflammatory polyneuropathies like Guillain-Barré syndrome.
  • Bacterial Meningitis: Characterized by very high protein levels, low glucose (as bacteria consume it), and elevated white cell counts.
  • Multiple Sclerosis: May show mildly elevated protein and the presence of oligoclonal bands (detected via electrophoresis).
  • Subarachnoid Hemorrhage: Indicated by the presence of blood or xanthochromia (yellow tint from hemoglobin breakdown) in the fluid.
  • Viral Infections: Usually show moderately elevated protein but normal glucose levels.
The relationship between serum glucose and CSF glucose is vital. Normally, CSF glucose is about 60-70% of the blood glucose level. Therefore, a blood glucose sample should ideally be drawn shortly before the lumbar puncture for accurate comparison.
View Interpretation
Neurology

CSF Chloride

Chloride levels in the Cerebrospinal Fluid (CSF) generally mirror those in the blood plasma, but with slightly higher concentrations due to the electrochemical balance across the blood-brain barrier. In a CSF Biochemical Analysis, chloride is primarily monitored to differentiate types of meningitis. A marked decrease in CSF chloride is a classic, though not exclusive, indicator of Tuberculous Meningitis or fungal infections.
View Interpretation
Microbiology

CSF Culture and Sensitivity

The Cerebrospinal Fluid (CSF) Culture and Sensitivity (C/S) test is a critical diagnostic tool used to identify the presence of pathogenic microorganisms, such as bacteria, fungi, or viruses, within the central nervous system. The CSF acts as a protective cushion for the brain and spinal cord, and it is normally sterile. When an infection occurs, pathogens breach the blood-brain barrier, leading to serious inflammation. This test is primarily ordered when a patient presents with symptoms of meningitis or encephalitis. Symptoms often include:
  • Severe headache and sudden high fever
  • Nuchal rigidity (stiff neck)
  • Altered mental status or confusion
  • Photophobia (sensitivity to light)
  • Seizures or unexplained lethargy
The most common conditions detected via CSF culture include:
  • Bacterial Meningitis: Caused by organisms like Neisseria meningitidis, Streptococcus pneumoniae, or Haemophilus influenzae. This is a medical emergency.
  • Fungal Meningitis: Often seen in immunocompromised patients (e.g., Cryptococcus).
  • Brain Abscess: Localized infections that may leak pathogens into the CSF space.
  • Viral Encephalitis: While cultures specifically look for bacteria/fungi, the lack of growth alongside high white cell counts may suggest a viral etiology.
Identifying the specific organism through culture allows clinicians to perform 'sensitivity' testing, which determines which antibiotics or antifungals will most effectively kill the specific strain of pathogen involved, ensuring targeted and effective treatment.
View Interpretation
Clinical Pathology

CSF Differential Count

The Cerebrospinal Fluid (CSF) Differential Count identifies and quantifies the various types of white blood cells (WBCs) present in the fluid that bathes the brain and spinal cord. In a healthy state, CSF contains very few cells, primarily lymphocytes and monocytes. This test is a critical component of a lumbar puncture (spinal tap) evaluation. It is ordered when a patient presents with symptoms of central nervous system (CNS) irritation, such as severe headache, stiff neck (nuchal rigidity), fever, or altered mental status. It helps distinguish between various causes of meningitis and encephalitis.
  • Bacterial Meningitis: Typically characterized by a high percentage of neutrophils (polymorphonuclear leukocytes).
  • Viral Meningitis: Often shows a predominance of lymphocytes (lymphocytic pleocytosis).
  • Multiple Sclerosis: May show slightly elevated lymphocyte counts and the presence of plasma cells.
  • Malignancy: The presence of 'blasts' or atypical cells can indicate leukemia, lymphoma, or metastatic cancer involving the meninges.
View Interpretation
Microbiology

CSF For Culture & Sensitivity (Radiometric)

Culture and Sensitivity (C&S) of Cerebrospinal Fluid (CSF) is used to identify the specific bacterial or fungal pathogens causing an infection of the central nervous system. The 'Radiometric' method utilizes automated systems that detect CO2 production (via radioactive carbon isotopes) by metabolizing microorganisms, allowing for faster detection than traditional manual plating. This is a critical, often emergency, test ordered when a physician suspects meningitis or encephalitis. Symptoms prompting this test include:
  • Sudden high fever and severe headache.
  • Nuchal rigidity (stiff neck).
  • Altered mental status or confusion.
  • Photophobia (sensitivity to light).
Detection of pathogens in the CSF is diagnostic for bacterial meningitis (e.g., S. pneumoniae, N. meningitidis), fungal meningitis (e.g., Cryptococcus), or neonatal sepsis (GBS). The 'Sensitivity' portion of the test determines which antibiotics are most effective against the identified organism. This is life-saving, as bacterial meningitis can be fatal within hours if not treated with the correct antimicrobial agent. A negative culture with high clinical suspicion may prompt testing for viral causes via PCR.
View Interpretation
Microbiology

CSF For Grams Stain

The Cerebrospinal Fluid (CSF) Gram Stain is a rapid laboratory test used to detect the presence of bacteria or fungi in the fluid that surrounds the brain and spinal cord. It is a critical diagnostic tool in the emergency assessment of the central nervous system (CNS). The staining process involves applying specific dyes to a CSF sample, which allows microbiologists to differentiate between Gram-positive (purple) and Gram-negative (pink/red) organisms based on their cell wall composition. This test is primarily ordered when a clinician suspects meningitis or encephalitis—life-threatening conditions involving inflammation of the brain membranes. Symptoms necessitating this test include:
  • Severe headache and stiff neck (nuchal rigidity)
  • High fever and chills
  • Altered mental status or confusion
  • Sensitivity to light (photophobia)
  • Seizures or focal neurological deficits
The presence of organisms in the CSF is almost always pathological. Associated conditions include:
  • Bacterial Meningitis: Caused by pathogens like Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae.
  • Fungal Meningitis: Often seen in immunocompromised patients, caused by Cryptococcus neoformans.
  • Brain Abscess: An infection that may leak inflammatory markers or organisms into the subarachnoid space.
  • Neonatal Sepsis: In newborns, Group B Streptococcus is a common find.
View Interpretation
Neurology

CSF Glucose

Cerebrospinal Fluid (CSF) Glucose is analyzed to diagnose central nervous system (CNS) pathologies. It is derived from blood glucose via facilitated transport and simple diffusion. Its primary utility is in the differential diagnosis of meningitis. Bacterial, fungal, and tuberculous meningitis typically result in decreased CSF glucose (hypoglycorrhachia) because these organisms and the accompanying white blood cells consume glucose. Viral meningitis, however, usually presents with a normal CSF glucose level.
View Interpretation
Neurology

CSF Lactate

CSF Lactate is a biomarker used to differentiate between bacterial and viral meningitis. Lactate levels in the Cerebrospinal Fluid (CSF) are independent of blood lactate levels and reflect the metabolic state of the Central Nervous System. Bacterial, fungal, and tubercular meningitis cause anaerobic metabolism, significantly raising CSF lactate, whereas viral meningitis typically does not.
View Interpretation
Neurology

CSF Lactate Dehydrogenase (LDH)

Lactate Dehydrogenase (LDH) in Cerebrospinal Fluid (CSF) is an enzyme released during cellular damage or death within the Central Nervous System. It is used as a biomarker to differentiate between bacterial and viral meningitis; bacterial infections typically show much higher LDH levels. It also helps assess CNS involvement in leukemia/lymphoma and can be elevated following stroke or intracranial hemorrhage.
View Interpretation
Clinical Pathology

CSF Lymphocytes

This test measures the percentage of lymphocytes within the Cerebrospinal Fluid (CSF). In a CSF Differential Count, a predominance of lymphocytes (lymphocytic pleocytosis) is a hallmark of certain types of meningitis. While neutrophils dominate in bacterial meningitis, lymphocytes typically dominate in viral, fungal, or tuberculous meningitis, as well as in multiple sclerosis (MS).
View Interpretation
Neurology

CSF Total Protein

The CSF Total Protein measurement is a cornerstone of CSF Biochemical Analysis. Normally, the blood-brain barrier (BBB) restricts the entry of large proteins into the cerebrospinal fluid. Elevated protein levels indicate increased permeability of the BBB or local immunoglobulin synthesis within the central nervous system. It is vital for diagnosing meningitis, multiple sclerosis, Guillain-Barré syndrome, and CNS tumors.
View Interpretation
Pathology

CSF for Cytology

Cerebrospinal Fluid (CSF) Cytology is a specialized laboratory examination used to identify and characterize cells present in the fluid that cushions the brain and spinal cord. Unlike a standard cell count, cytology focuses on the morphological features of the cells to detect abnormalities, particularly malignancy. The primary function of this test is to determine if cancer cells have spread to the central nervous system (CNS) or if an inflammatory process is occurring within the meningeal layers. Physicians order CSF cytology when they suspect leptomeningeal carcinomatosis (the spread of cancer to the membranes surrounding the brain) or primary CNS tumors. It is also utilized in the diagnostic workup for lymphoma and leukemia to check for CNS involvement. Beyond oncology, it helps in evaluating chronic meningitis, certain autoimmune neurological conditions, and infectious diseases where cellular morphology provides clues to the underlying pathogen.
  • Malignancy: Primary brain tumors, metastatic breast or lung cancer, and melanoma.
  • Hematologic Cancers: Acute lymphoblastic leukemia (ALL) and various non-Hodgkin lymphomas.
  • Inflammatory States: Sarcoidosis of the CNS or multiple sclerosis (though cytology is less specific here than other tests).
  • Infections: Fungal or tuberculous meningitis often present with specific cellular patterns that cytology can highlight.
By examining the size, shape, and staining characteristics of cells, pathologists can provide a definitive diagnosis that guides oncological treatment, such as the need for intrathecal chemotherapy or targeted radiation.
View Interpretation
Endocrinology

Calcitonin

Calcitonin is a 32-amino acid hormone produced by the parafollicular cells (also known as C-cells) of the thyroid gland. Its primary physiological role is to assist in calcium homeostasis by inhibiting bone resorption (the breakdown of bone) and increasing calcium excretion by the kidneys, effectively lowering blood calcium levels. However, in humans, its role in daily calcium regulation is minor compared to Parathyroid Hormone (PTH). In clinical practice, Calcitonin serves as a highly specific tumor marker. It is primarily ordered to diagnose Medullary Thyroid Carcinoma (MTC), a specific type of thyroid cancer that originates from the C-cells. It is also used to screen family members of patients with Multiple Endocrine Neoplasia type 2 (MEN2), a genetic syndrome that predisposes individuals to MTC. Post-operatively, it is used to monitor for cancer recurrence or the presence of residual disease.
  • Medullary Thyroid Carcinoma (MTC): Characterized by significantly elevated calcitonin.
  • C-cell Hyperplasia: A precursor state to MTC, often found in familial cases.
  • Chronic Renal Failure: Can cause secondary elevations due to decreased clearance.
  • Hypergastrinemia: Conditions like Zollinger-Ellison syndrome can stimulate C-cells to produce more calcitonin.
Due to its specificity for C-cells, calcitonin is one of the most reliable markers in thyroid oncology for this specific subset of cancers.
View Interpretation
Metabolic

Calcium

Calcium is one of the most vital minerals in the human body, playing a central role in several physiological processes beyond bone health. Roughly 99% of the body's calcium is stored in the teeth and bones, while the remaining 1% circulates in the blood. This circulating calcium is essential for muscle contraction, nerve signal transmission, blood coagulation, and the proper functioning of the heart. Calcium levels are typically measured as part of a Basic Metabolic Panel (BMP) or Comprehensive Metabolic Panel (CMP) during routine check-ups. It is also ordered to investigate symptoms of bone disease, kidney stones, neurological issues, or cardiac arrhythmias. Doctors use it to monitor patients with known parathyroid disorders, certain types of cancer, or those taking medications that affect mineral balance, such as diuretics or lithium. Abnormal calcium levels are frequently linked to the parathyroid glands, which regulate calcium via Parathyroid Hormone (PTH).
  • Hypercalcemia (High Calcium): Often caused by primary hyperparathyroidism or malignancies (bone metastasis). It can lead to 'moans, groans, stones, and bones'—psychiatric overtones, abdominal pain, kidney stones, and bone aches.
  • Hypocalcemia (Low Calcium): Frequently caused by Vitamin D deficiency, hypoparathyroidism, or chronic kidney disease. It can lead to muscle cramps, tetany (uncontrolled muscle spasms), and tingling in the extremities.
View Interpretation
Metabolic

Calcium

Calcium is a vital mineral measured in the Basic Kidney Profile to evaluate mineral metabolism, which is often disrupted in renal disease. The kidneys play a major role in calcium homeostasis by activating Vitamin D and regulating calcium reabsorption. Monitoring calcium is essential for diagnosing CKD-MBD (Chronic Kidney Disease—Mineral and Bone Disorder), hyperparathyroidism, and potential bone density loss associated with kidney failure.
View Interpretation
Metabolic

Carbon Dioxide (Bicarbonate)

In a Basic Kidney Profile, the Carbon Dioxide test primarily measures the amount of bicarbonate (HCO3-) in the blood. Bicarbonate is an electrolyte that acts as a buffer to maintain the body's pH balance (acid-base balance). The kidneys play a central role in regulating this by excreting or reabsorbing bicarbonate. Abnormal levels are early indicators of metabolic alkalosis/acidosis, kidney dysfunction, or respiratory issues that affect gas exchange.
View Interpretation
Oncology

Carcinoembryonic Antigen

Carcinoembryonic Antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced in gastrointestinal tissue during fetal development, but production stops or drops to very low levels after birth. In adults, elevated levels of CEA are often associated with certain types of cancer, particularly those originating in the digestive tract. CEA is not typically used as a general cancer screening tool for asymptomatic individuals because many non-cancerous conditions can raise its levels. Instead, it is used for:
  • Monitoring Cancer Treatment: Assessing the response to surgery, chemotherapy, or radiation.
  • Recurrence Surveillance: Following up with patients after successful treatment to catch early signs of cancer returning.
  • Staging: Helping to determine the extent of disease in patients already diagnosed with cancer.
  • Colorectal Cancer: The most common association.
  • Other Malignancies: Pancreatic, gastric, lung, breast, and ovarian cancers.
  • Benign Conditions: Inflammation of the gut (IBD), cirrhosis, pancreatitis, and heavy smoking.
View Interpretation
Oncology

Carcinoembryonic Antigen (CEA)

CEA is a glycoprotein involved in cell adhesion. While primarily associated with colorectal cancer, within an Ovarian Cancer Panel, it is utilized as a tumor marker to differentiate between primary ovarian malignancies (where CEA is typically low) and metastatic mucinous tumors originating from the gastrointestinal tract (where CEA is often elevated). It is also used to monitor the effectiveness of treatment and to screen for recurrence in patients with known mucinous ovarian carcinomas.
View Interpretation
Immunology

Cardiolipin Antibody, IgG

Cardiolipin IgG is one of the primary autoantibodies tested for Antiphospholipid Syndrome (APS). APS is characterized by clinical episodes of venous or arterial thrombosis and/or recurrent pregnancy loss. IgG is generally considered more clinically significant and more strongly associated with thrombosis than the IgM isotype.
View Interpretation
Immunology

Cardiolipin Antibody, IgM

Cardiolipin IgM antibodies are autoantibodies directed against phospholipids in the mitochondrial membranes. They are a primary marker for Antiphospholipid Syndrome (APS), a condition characterized by recurrent arterial or venous thrombosis and pregnancy complications (miscarriage/pre-eclampsia). In the context of the Phospholipid Screen, the IgM isotype often represents an acute response or a transient elevation, though persistent presence (tested 12 weeks apart) is required for a definitive APS diagnosis. This test helps differentiate between autoimmune-mediated clotting disorders and other hypercoagulable states.
View Interpretation
Metabolic

Casts

Casts are cylindrical structures formed in the distal convoluted tubule and collecting ducts of the kidney. Their presence in urine sediment (Complete Urine Examination) provides a 'mold' of the nephron. While hyaline casts can be normal after exercise, cellular casts (RBC, WBC, Granular, Waxy) are hallmark indicators of renal parenchymal disease, such as glomerulonephritis or acute tubular necrosis.
View Interpretation
Nephrology

Casts

Casts are cylindrical structures produced by the kidney and secreted in the urine. They are formed in the lumen of the distal convoluted tubule and collecting ducts. Their presence in the 'Urine Routine' panel indicates a breakdown in the renal filtration or tubular system. Different types have distinct meanings: Hyaline casts can be normal (after exercise), while Red Blood Cell (RBC) casts indicate glomerulonephritis, and Granular or Waxy casts suggest chronic renal disease or stasis.
View Interpretation
Immunology

Cat Dander Specific IgE

This test measures the concentration of Immunoglobulin E (IgE) antibodies specifically directed against cat dander proteins (e.g., Fel d 1). In the context of an Allergy Profile, it quantifies the degree of sensitization. When an individual with high specific IgE is exposed to cat dander, it triggers mast cell degranulation, leading to allergic rhinitis, conjunctivitis, or asthma symptoms.
View Interpretation
Pathology

Cell Block Preparation

Cell Block Preparation is a technique used in cytopathology to process fluid specimens into a solid paraffin block, similar to a tissue biopsy. While traditional smears look at individual cells, cell blocks preserve the architectural patterns (how cells relate to each other), which is crucial for a more accurate diagnosis. It involves centrifuging the fluid and 'fixing' the sedimented cells in a medium that can be sliced and stained. This procedure is performed on fluids obtained via Fine Needle Aspiration (FNA) or from body cavities (e.g., pleural fluid from the lungs or ascitic fluid from the abdomen). It is ordered to:
  • Identify the presence of malignant (cancerous) cells in body fluids.
  • Allow for Immunohistochemistry (IHC) staining, which helps determine the 'primary' source of a cancer that has spread.
  • Differentiate between reactive mesothelial cells and metastatic adenocarcinoma.
  • Provide a stable specimen that can be archived for future molecular testing (e.g., EGFR or ALK mutations in lung cancer).
A cell block is vital in the staging of various cancers, including lung, breast, ovarian, and gastrointestinal malignancies. It is also used to diagnose certain infectious or inflammatory conditions, such as tuberculosis or sarcoidosis, by revealing granulomatous structures that are not visible on a simple liquid smear.
View Interpretation
Pathology

Cervical Biopsy

A cervical biopsy is a diagnostic procedure in which a small sample of tissue is removed from the cervix (the lower part of the uterus) for histological examination. Unlike a Pap smear, which cytologically screens for abnormal cells, a biopsy allows a pathologist to see the tissue architecture and determine the exact nature of an abnormality. It is the 'gold standard' for diagnosing cervical cancer and its precursors. This procedure is typically performed following an abnormal Pap smear or a positive Human Papillomavirus (HPV) test. Reasons for ordering include:
  • Colposcopy Findings: To sample suspicious areas seen during a colposcopic exam.
  • High-Risk HPV: Persistent infection with strains like HPV 16 or 18.
  • Visible Lesions: When a doctor sees a growth or ulcer on the cervix during a routine exam.
  • Unexplained Bleeding: Post-coital or intermenstrual bleeding.
  • Cervical Intraepithelial Neoplasia (CIN): Precancerous changes graded 1 (mild) to 3 (severe).
  • Cervical Adenocarcinoma/Squamous Cell Carcinoma: Malignant growths.
  • Cervical Polyps: Benign growths that can cause bleeding.
  • Cervicitis: Inflammation of the cervical tissue, often due to infection (e.g., Chlamydia).
View Interpretation
Pathology

Cervical Biopsy

A cervical biopsy is a diagnostic procedure where a small sample of tissue is removed from the cervix for microscopic examination by a pathologist. It is the definitive 'gold standard' for diagnosing cervical abnormalities that were previously detected by screening tools like a Pap smear or HPV (Human Papillomavirus) test. This procedure is ordered when a screening test shows abnormal (dysplastic) cells or when a physician observes suspicious lesions on the cervix during a colposcopy. Its purpose is to differentiate between benign inflammation, pre-cancerous changes (dysplasia), and invasive cervical cancer. The results of a cervical biopsy are categorized into:
  • CIN (Cervical Intraepithelial Neoplasia): Graded 1 (mild) to 3 (severe/carcinoma in situ).
  • HPV Infection: Often the underlying cause of cellular changes.
  • Cervical Adenocarcinoma: Cancer originating in the glandular cells.
  • Squamous Cell Carcinoma: The most common type of cervical cancer.
  • Cervicitis: Inflammation of the cervix due to infection or irritation.
View Interpretation
Allergy and Immunology

Chicken Meat (Specific IgE)

This test measures specific IgE antibodies against proteins found in chicken meat. Within an Allergy Profile, it helps differentiate between true food allergies and cross-reactivity. While chicken allergy is less common than egg allergy, it can cause symptoms ranging from urticaria (hives) to anaphylaxis. It is also relevant in 'Bird-Egg Syndrome,' where sensitization occurs through inhalation of bird antigens followed by cross-reaction with egg yolk or poultry meat.
View Interpretation
Serology

Chikungunya IgM

The Chikungunya IgM test detects Immunoglobulin M antibodies against the Chikungunya virus (CHIKV). IgM antibodies typically become detectable 3 to 5 days after the onset of symptoms and persist for about 2 to 3 months. This test is a critical diagnostic tool for identifying an acute or recent infection. Physicians order this test for patients presenting with sudden onset of high fever and severe joint pain (arthralgia), particularly if they have traveled to regions where the virus is endemic (transmitted via Aedes mosquitoes). It helps differentiate Chikungunya from other tropical diseases with similar presentations.
  • Acute Chikungunya Fever: Characterized by debilitating joint pain, rash, and headache.
  • Chronic Arthralgia: Some patients experience joint pain for months or years after the initial infection.
  • Differential Diagnosis: Used to rule out Dengue fever or Zika virus, which share geographical ranges and symptoms.
View Interpretation
Metabolic

Chloride

Chloride is the major extracellular anion and works closely with sodium to maintain osmotic pressure and acid-base balance. In a 'Basic Kidney Profile', chloride helps evaluate renal function and fluid status. It is essential for determining the 'Anion Gap' in metabolic acidosis. Abnormalities usually mirror sodium changes but can occur independently in certain acid-base disorders or renal tubular pathologies.
View Interpretation
Metabolic

Chloride

Serum Chloride is a major extracellular anion that works closely with sodium, potassium, and bicarbonate to maintain electrical neutrality, osmotic pressure, and acid-base balance. Within the Serum Electrolytes panel, it is used to calculate the 'Anion Gap,' which is crucial for identifying the cause of metabolic acidosis. It is particularly important in monitoring patients with kidney disease, heart failure, or those receiving intravenous fluids.
View Interpretation
Metabolic

Chloride, Urine

Urine Chloride is a vital measurement for evaluating the body's acid-base balance and electrolyte status. In the context of a Urine Electrolytes panel, it is most frequently used to differentiate between causes of metabolic alkalosis (chloride-responsive vs. chloride-resistant). It also assists in the diagnosis of salt-wasting conditions and the assessment of volume status when sodium measurements may be confounded by recent sodium intake.
View Interpretation
Metabolic

Chlorides

Chloride is one of the most important electrolytes in the blood. It helps maintain the balance of fluids inside and outside of cells, maintains proper blood volume, blood pressure, and the pH (acid-base balance) of body fluids. It is often measured alongside sodium, potassium, and bicarbonate. This test is part of a basic or comprehensive metabolic panel (BMP/CMP). It is used to evaluate symptoms like prolonged vomiting, diarrhea, weakness, or difficulty breathing. It is also used to monitor treatment for kidney disease or high blood pressure.
  • Dehydration: Often leads to high chloride levels.
  • Metabolic Acidosis/Alkalosis: Chloride levels shift to compensate for changes in blood pH.
  • Kidney Disease: The kidneys are responsible for excreting or retaining chloride.
  • Addison's Disease: Adrenal insufficiency can lead to low chloride levels.
Because chloride usually follows sodium (as NaCl), an isolated change in chloride without a change in sodium often points toward an acid-base disturbance. For example, in metabolic alkalosis (often caused by vomiting), the body loses chloride, leading to hypochloremia.
View Interpretation
Endocrinology

Chromogranin A

Chromogranin A (CgA) is a protein found inside neuroendocrine cells. These specialized cells receive messages from the nervous system and respond by releasing hormones into the blood. CgA is stored in the secretory granules of these cells and is co-released with various hormones. Because most neuroendocrine tumors (NETs) secrete CgA, it serves as a sensitive, albeit non-specific, circulating tumor marker. This test is primarily used in the management of Neuroendocrine Tumors (NETs). It is ordered for:
  • Diagnosis: Helping identify tumors like carcinoid tumors, pheochromocytomas, or neuroblastomas.
  • Monitoring: Assessing the effectiveness of treatment (surgery or chemotherapy).
  • Surveillance: Detecting early recurrence in patients previously treated for NETs.
Elevated CgA levels are associated with several clinical states:
  • Carcinoid Tumors: Often found in the GI tract or lungs.
  • Pancreatic Islet Cell Tumors: Such as insulinomas or gastrinomas.
  • Pheochromocytoma: A tumor of the adrenal glands.
  • Non-Neoplastic Conditions: Chronic atrophic gastritis, liver disease, and renal failure can also cause elevations.
View Interpretation
Genetics

Clinical Exome Panel

The Clinical Exome Panel uses Next-Generation Sequencing (NGS) to examine the 'exome'—the approximately 1-2% of the genome that contains the protein-coding regions (exons). While small, this area contains roughly 85% of known disease-causing mutations. This panel focuses specifically on genes known to be associated with clinical phenotypes. This test is typically reserved for patients with complex, undiagnosed medical conditions where traditional testing has failed to provide a diagnosis (often called a 'diagnostic odyssey'). It is highly effective for identifying rare genetic disorders, developmental delays, and multi-systemic congenital anomalies.
  • Mendelian Disorders: Conditions caused by a single gene mutation (e.g., Cystic Fibrosis, Marfan Syndrome).
  • Neurological Disorders: Undiagnosed epilepsy, ataxia, or neuromuscular degeneration.
  • Metabolic Errors: Inborn errors of metabolism that manifest in childhood.
  • Rare Syndromes: Dysmorphic features combined with intellectual disability.
View Interpretation
Hematology

Clotting Time

Clotting Time (CT) is a functional assay used to evaluate the intrinsic and common pathways of the coagulation cascade. It measures the time required for blood to form a stable fibrin clot outside the body. While historically used as a primary screen, it remains relevant in resource-limited settings or specific bedside monitoring. A prolonged CT indicates deficiencies in clotting factors (specifically factors I, II, V, VIII, IX, X, XI, and XII) or the presence of circulating anticoagulants like heparin. In the context of the Bleeding Time and Clotting Time panel, it helps differentiate between platelet-related disorders (prolonged bleeding time) and coagulation factor deficiencies (prolonged clotting time).
View Interpretation
Toxicology

Cocaine Metabolite

This test specifically detects Benzoylecgonine, the primary metabolite of cocaine. Because cocaine itself is metabolized very rapidly, measuring Benzoylecgonine provides a longer detection window (typically 2 to 4 days after use). In a DOA 5 panel, this is the gold standard for confirming cocaine exposure.
View Interpretation
Immunology

Cockroach (German) Specific IgE

This test detects IgE antibodies against Blattella germanica (German Cockroach) allergens. Cockroach allergens are a major indoor cause of perennial allergic rhinitis and are strongly linked to the development and exacerbation of asthma, especially in urban environments. It helps clinicians identify environmental triggers for respiratory distress.
View Interpretation
Metabolic

Color

The visual assessment of urine color is the first step in a Complete Urine Examination (Physical) Routine. Standard color is due to the pigment urochrome. Changes in color can provide immediate diagnostic clues regarding hydration status, metabolic disorders, presence of blood, or the intake of specific drugs and foods.
View Interpretation
Immunology

Common Ragweed Specific IgE

This test measures the concentration of IgE antibodies directed against Ambrosia artemisiifolia. It is used to identify Type I hypersensitivity to ragweed, a leading cause of seasonal allergic rhinitis (hay fever). Higher levels generally correlate with a higher probability of clinical symptoms upon exposure during the fall pollination season.
View Interpretation
Immunology

Complement - 3

The Complement C3 test measures the amount of C3 protein in the blood. C3 is a central component of the complement system, a complex group of proteins that form part of the innate immune system. Its primary role is to 'complement' or assist antibodies and phagocytic cells in clearing pathogens like bacteria and viruses from the body. It also triggers inflammation and helps remove damaged cells. Physicians order this test to monitor and diagnose autoimmune disorders. Because C3 is consumed during the inflammatory response, low levels often signal that an autoimmune process is highly active. It is particularly useful for tracking the progression of Systemic Lupus Erythematosus (SLE) and various forms of kidney inflammation (glomerulonephritis).
  • Systemic Lupus Erythematosus (SLE): Low C3 levels are a hallmark of lupus 'flares,' indicating the immune system is attacking the body's own tissues.
  • Glomerulonephritis: Inflammation of the kidney's filtering units can deplete C3 levels.
  • Recurrent Infections: Inherited C3 deficiencies are rare but lead to a significantly increased risk of severe bacterial infections.
  • Rheumatoid Arthritis: While C3 is often elevated in early inflammation, chronic consumption can occur in severe cases.
View Interpretation
Immunology

Complement C4

Complement C4 is a protein that is part of the body's complement system, a complex group of proteins that work with the immune system to clear pathogens and promote inflammation. C4 is specifically involved in the 'classical pathway' of complement activation, which is often triggered by antibodies binding to antigens. The C4 test is primarily used to diagnose and monitor autoimmune diseases. Because complement proteins are 'consumed' (used up) during an inflammatory immune response, low levels of C4 often indicate that the immune system is overactive or attacking the body's own tissues.
  • Systemic Lupus Erythematosus (SLE): C4 levels are often low during a lupus flare-up and are used to monitor disease activity and treatment effectiveness.
  • Hereditary Angioedema: A genetic condition characterized by low C4 levels even when the patient is not having an attack.
  • Rheumatoid Arthritis: May occasionally show altered complement levels.
  • Chronic Hepatitis: Certain viral infections can deplete complement proteins through the formation of immune complexes.
By measuring C4 alongside C3, doctors can determine which pathway of the immune system is active, helping to differentiate between various types of kidney disease or autoimmune syndromes.
View Interpretation
Hematology

Complete Blood Count

The Complete Blood Count (CBC) is one of the most common and essential diagnostic tests in medicine. It evaluates the three major types of cells in the blood: Red Blood Cells (RBCs), White Blood Cells (WBCs), and Platelets. Each component provides vital information about the body's ability to transport oxygen, fight infection, and stop bleeding. A CBC is often part of a routine check-up but is also used to diagnose symptoms like fatigue, bruising, or fever. It is critical for monitoring patients undergoing treatments like chemotherapy, which can suppress bone marrow function.
  • Anemia: Characterized by low Hemoglobin or RBC count, often causing exhaustion.
  • Infection: Elevated WBC counts (leukocytosis) usually signal an immune response to bacteria or viruses.
  • Leukemia/Lymphoma: Significant abnormalities in WBC types and counts can indicate blood cancers.
  • Thrombocytopenia: A low platelet count that puts a patient at risk for internal bleeding.
A CBC includes the 'Differential,' which breaks down WBCs into neutrophils, lymphocytes, monocytes, eosinophils, and basophils. It also includes RBC indices (MCV, MCH, MCHC) which help classify the type of anemia (e.g., iron deficiency vs. B12 deficiency).
View Interpretation
Hematology

Complete Blood Count (CBC)

The Complete Blood Count (CBC) is a fundamental diagnostic panel that measures the various components of the blood, including red blood cells (RBCs), white blood cells (WBCs), and platelets. It provides a snapshot of the body's hematologic health and its ability to transport oxygen, fight infection, and maintain hemostasis. A CBC is ordered as part of routine physicals, to monitor ongoing treatments (like chemotherapy), and to diagnose symptoms such as fatigue, bruising, or fever. It is the gold standard for screening for anemia and systemic infections.
  • Anemia: Low RBC or Hemoglobin counts indicating iron deficiency, B12 deficiency, or chronic disease.
  • Infection and Inflammation: Elevated WBC counts (Leukocytosis) suggest the body is responding to pathogens or inflammatory stimuli.
  • Leukemia/Lymphoma: Significant abnormalities in WBC morphology or counts.
  • Clotting Disorders: Abnormal platelet counts (Thrombocytopenia or Thrombocytosis) can lead to excessive bleeding or inappropriate clot formation.
View Interpretation
Hematology

Complete Blood Picture

The Complete Blood Picture (CBP), also known as a Complete Blood Count (CBC), is one of the most fundamental blood tests in clinical medicine. It evaluates the three major types of cells circulating in the blood: Red Blood Cells (RBCs) which carry oxygen, White Blood Cells (WBCs) which fight infection, and Platelets (PLTs) which assist in blood clotting. It also includes indices like MCV and MCH that describe the size and hemoglobin content of RBCs. CBP is the first-line test for almost any physical complaint. It is used to diagnose anemia, monitor patients undergoing chemotherapy, screen for leukemia, check for infections, and evaluate the cause of unexplained bruising or weakness.
  • Anemia: Low RBC count or Hemoglobin, often causing fatigue.
  • Leukemia: Malignant overproduction of abnormal white blood cells.
  • Thrombocytopenia: Low platelet count, increasing the risk of spontaneous bleeding.
  • Polycythemia: Overproduction of red blood cells, which can thicken the blood.
  • Infection: Indicated by a high WBC count (Leukocytosis).
View Interpretation
Gastroenterology

Complete Stool Examination

A Complete Stool Examination is a series of tests performed on a stool sample to help diagnose conditions affecting the digestive tract. It involves macroscopic (physical), chemical, and microscopic evaluations. Physically, it assesses color, consistency, and odor. Chemically, it checks for pH and occult (hidden) blood. Microscopically, it identifies white blood cells, red blood cells, undigested fats, fibers, and pathogens like parasites or eggs. Physicians order this test when a patient presents with chronic diarrhea, persistent abdominal pain, bloating, or unexplained weight loss. It is the gold standard for identifying gastrointestinal infections (bacterial, viral, or parasitic) and screening for colorectal cancer via the detection of occult blood. It also helps assess malabsorption syndromes where the body fails to digest fats or proteins properly.
  • Infectious Diarrhea: Caused by pathogens like Giardia, Salmonella, or Entamoeba histolytica.
  • Inflammatory Bowel Disease (IBD): Such as Crohn's disease or Ulcerative Colitis, often indicated by the presence of fecal leukocytes and blood.
  • Malabsorption: Conditions like Celiac disease or chronic pancreatitis, suggested by high fat content (steatorrhea).
  • Gastrointestinal Bleeding: Detected through positive occult blood, potentially indicating ulcers, polyps, or malignancy.
View Interpretation
Metabolic

Complete Urine Examination

The Complete Urine Examination (CUE), also known as Urinalysis, is a fundamental diagnostic tool that provides a snapshot of the body's metabolic state and renal health. It consists of three phases: physical examination (color, clarity), chemical screening (using reagent strips for pH, protein, glucose, etc.), and microscopic sediment analysis (looking for cells, casts, and crystals). CUE is a versatile test used for:
  • Routine Screening: Part of general physical exams to detect early signs of kidney or liver disease.
  • UTI Diagnosis: Identifying bacteria, leukocyte esterase, and nitrites.
  • Metabolic Monitoring: Detecting glycosuria (glucose in urine) in diabetics or ketonuria (ketones) in metabolic distress.
  • Renal Health: Monitoring for proteinuria which signals damage to the kidney's filtration system.
  • Symptom Investigation: Evaluating abdominal pain, back pain, or painful urination.
  • Urinary Tract Infection (UTI): Indicated by white blood cells and bacteria.
  • Kidney Stones: Suggested by the presence of specific crystals (e.g., calcium oxalate).
  • Diabetes Mellitus: Suggested by glucose and ketones in the urine.
  • Liver Disease: Indicated by the presence of bilirubin or urobilinogen.
View Interpretation
Gastroenterology

Consistency

Consistency is a macroscopic evaluation of stool texture, categorized using the Bristol Stool Scale. It reflects intestinal transit time and the colon's ability to reabsorb water. In a Complete Stool Examination, it helps differentiate between malabsorption, inflammatory bowel disease (IBD), and functional disorders like Irritable Bowel Syndrome (IBS).
View Interpretation
Microbiology

Corneal Scraping For C/S

Corneal Scraping for Culture and Sensitivity (C/S) is a critical diagnostic procedure used to identify the specific causative agent (bacteria, fungi, or protozoa like Acanthamoeba) of a corneal ulcer or keratitis. A small sample of the infected corneal tissue is carefully 'scraped' by an ophthalmologist and placed onto various growth media to see what organism grows. This test is vital for sight-threatening infections. It is ordered when:
  • Infection is Severe: Large or central corneal ulcers require precise identification to save the patient's vision.
  • Treatment Failure: The patient is not responding to broad-spectrum antibiotic drops.
  • History of Risk: The patient wears contact lenses (increased risk of Pseudomonas or Acanthamoeba) or has had vegetable matter trauma (increased risk of fungal keratitis).
The results guide the use of targeted antimicrobial therapy. Common isolates include Staphylococcus aureus, Pseudomonas aeruginosa (often aggressive), and Fusarium species. Determining 'Sensitivity' is just as important as identifying the organism, as it tells the doctor which specific antibiotics or antifungals will successfully kill the pathogen, preventing corneal perforation and permanent blindness.
View Interpretation
Immunology

Cow's Milk Specific IgE

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies against cow's milk proteins (like casein and whey). In an Allergy Profile, it identifies Type I hypersensitivity. It is critical for distinguishing between milk allergy (immune-mediated) and milk intolerance (enzyme-deficiency mediated like lactose intolerance), helping to manage the risk of anaphylaxis.
View Interpretation
Metabolic

Creatine Phosphokinase (CPK)

Creatine Phosphokinase (CPK), also known as Creatine Kinase (CK), is an essential enzyme found primarily in the heart, brain, and skeletal muscles. Its primary biological function is to catalyze the conversion of creatine and use adenosine triphosphate (ATP) to create phosphocreatine and adenosine diphosphate (ADP). This reaction is vital for energy homeostasis in tissues that consume energy rapidly, acting as a reservoir for high-energy phosphates for quick regeneration of ATP. Physicians order a CPK test when they suspect damage to muscle tissue or the heart. It is a standard diagnostic tool for patients presenting with muscle weakness, localized pain, or dark urine (suggestive of myoglobinuria). In emergency settings, it was historically used to diagnose myocardial infarction (heart attack), though it has largely been superseded by Troponin; however, it remains vital for monitoring skeletal muscle diseases. High levels of CPK are frequently associated with:
  • Rhabdomyolysis: Rapid breakdown of skeletal muscle tissue.
  • Myocardial Infarction: Damage to heart muscle cells.
  • Muscular Dystrophy: Genetic diseases causing progressive weakness and loss of muscle mass.
  • Polymyositis: An inflammatory muscle disease.
  • Strenuous Exercise: Intense physical activity can cause transient spikes in CPK levels.
View Interpretation
Body Fluids

Creatinine

Creatinine measurement in Ascitic Fluid is a specialized diagnostic tool used primarily to identify 'uroperitoneum' (urine leaking into the peritoneal cavity). Under normal circumstances, creatinine levels in ascitic fluid should be equivalent to serum creatinine levels. If the fluid creatinine is significantly higher than the serum level (usually a ratio > 2:1), it confirms that the abdominal fluid is actually accumulated urine resulting from bladder or ureter trauma or perforation.
View Interpretation
Metabolic

Creatinine

Creatinine is a waste product produced by the muscles from the breakdown of a compound called creatine. It is filtered out of the blood by the kidneys and excreted in urine. Measuring serum creatinine is a critical component of the Basic Kidney Profile as it is used to estimate the Glomerular Filtration Rate (eGFR). It serves as a primary marker for kidney function; however, it is influenced by muscle mass, age, and sex.
View Interpretation
Infectious Disease

Creatinine

Creatinine is a byproduct of creatine phosphate metabolism in muscle and is excreted primarily by glomerular filtration in the kidneys. In a COVID-19 Bio Chemistry panel, it serves as a vital marker for monitoring Acute Kidney Injury (AKI), which is a common complication in severe viral infections. Elevated levels indicate a reduction in the Glomerular Filtration Rate (GFR), signaling renal distress or failure which may necessitate adjustments in drug dosing.
View Interpretation
Metabolic

Creatinine Clearance Test

The Creatinine Clearance (CrCl) test is used to estimate the Glomerular Filtration Rate (GFR), which is the primary measure of how well the kidneys are filtering waste from the blood. Creatinine is a waste product of muscle metabolism that is filtered by the glomeruli and generally not reabsorbed by the tubules. By comparing the concentration of creatinine in a 24-hour urine collection to the concentration in the blood (serum), clinicians can calculate the volume of blood cleared of creatinine per minute. This test is ordered to monitor the progression of kidney disease, assess the impact of medications on renal function, and determine appropriate dosing for drugs cleared by the kidneys. It is more accurate than serum creatinine alone, especially in patients with unusual muscle mass or those in early stages of renal impairment.
  • Chronic Kidney Disease (CKD): Characterized by a progressive decline in clearance rates.
  • Acute Renal Failure: A sudden drop in clearance due to injury, dehydration, or obstruction.
  • Congestive Heart Failure: Reduced blood flow to the kidneys can lower clearance.
  • Glomerulonephritis: Inflammation of the kidney's filtering units reduces efficiency.
View Interpretation
Metabolic

Creatinine, Urine

Creatinine is a waste product from the normal breakdown of muscle tissue and is filtered by the kidneys. In a Urine Electrolytes panel, measuring urine creatinine is crucial for calculating the fractional excretion of electrolytes and for normalizing the concentration of other substances in spot or 24-hour samples. It serves as an internal standard to ensure the specimen is representative of the patient's renal filtration rate and to correct for variations in urine concentration.
View Interpretation
Hematology

Crenated RBC's

Crenated Red Blood Cells (RBCs), also known as echinocytes or burr cells, are erythrocytes that have lost their smooth, biconcave shape and developed small, evenly spaced thorny projections across their surface. In a physiological context, RBCs must maintain a specific surface-area-to-volume ratio to remain flexible enough to pass through tiny capillaries. Crenation occurs when the cell is placed in a hypertonic environment, causing water to leave the cell via osmosis, resulting in a shriveled appearance. Identifying crenated RBCs is rarely the primary goal of a blood test but is often noted during a peripheral blood smear examination. This observation is critical for:
  • Distinguishing Artifact from Pathology: Determining if the shape is due to improper slide preparation (glass effect) or a systemic medical condition.
  • Renal Assessment: High numbers of echinocytes are frequently associated with uremia or acute kidney injury.
  • Metabolic Screening: Evaluating potential electrolyte imbalances or liver dysfunction.
Several clinical states are linked to the presence of crenated RBCs:
  • Uremia: Common in chronic kidney disease where metabolic waste products alter the RBC membrane.
  • Liver Disease: Particularly in cases where cholesterol or lipid metabolism is disrupted.
  • Hypophosphatemia: Low phosphorus levels can deplete ATP, affecting the cell membrane's structural integrity.
  • Dehydration: Severe hypertonic dehydration can lead to systemic cell crenation.
  • Artifact: Prolonged storage of blood in EDTA tubes or high pH from glass slides often causes 'pseudo-crenation'.
View Interpretation
Metabolic

Crystals

The identification of crystals in urine (crystalluria) is a crucial component of a microscopic urinalysis. While some crystals like calcium oxalate or uric acid can appear in healthy individuals depending on diet and hydration, others are strictly pathological. The presence of cystine, tyrosine, or leucine crystals suggests metabolic disorders or liver disease. Additionally, specific crystal morphology can indicate a predisposition to nephrolithiasis (kidney stones) or provide clues to the composition of existing stones. In the context of a Complete Urine Examination, this helps differentiate between benign metabolic fluctuations and systemic conditions like gout or ethylene glycol poisoning.
View Interpretation
Nephrology

Crystals

The identification of crystals in urine (crystalluria) is a key component of a routine urinalysis. It indicates that the urine is supersaturated with specific solutes. While some crystals like calcium oxalate or uric acid can be seen in healthy individuals depending on diet and hydration, others like cystine, leucine, or tyrosine are strictly pathological. In the context of a 'Urine Routine' panel, the presence, type, and quantity of crystals help clinicians assess the risk of nephrolithiasis (kidney stones), metabolic disorders, or potential drug toxicities (e.g., sulfonamides).
View Interpretation
Microbiology

Culture and Sensitivity

The Culture and Sensitivity (C&S) test is the gold standard in microbiology for diagnosing bacterial and fungal infections. The process involves two steps: first, the 'Culture,' where the specimen is placed in a growth medium to see if any organisms multiply; and second, the 'Sensitivity,' where the isolated organism is exposed to various antibiotics to see which ones effectively kill it. This test is ordered whenever an infection is suspected and the clinician needs to know exactly what is causing it and how to treat it. It is commonly used for Urinary Tract Infections (UTIs), respiratory infections, bloodstream infections (sepsis), and wound infections. It moves treatment from 'empiric' (best guess) to 'definitive' (targeted).
  • Bacteremia/Sepsis: Growth of bacteria in the blood.
  • Urinary Tract Infections (UTI): Growth of coliforms like E. coli in urine.
  • Pneumonia: Identification of S. pneumoniae or Klebsiella in sputum.
  • Skin/Soft Tissue Infections: Identification of Staph aureus or Streptococcus.
With the global rise of multi-drug resistant organisms (MDROs), the sensitivity profile is indispensable. It allows for 'Antibiotic Stewardship,' ensuring that broad-spectrum drugs are reserved for severe cases and that the patient receives the most narrow-spectrum, effective drug possible, reducing side effects and the risk of fostering further resistance.
View Interpretation
Microbiology

Cyst Culture and Sensitivity

A Cyst Culture and Sensitivity test is performed to identify the presence of pathogenic microorganisms (bacteria or fungi) within a cyst or abscess and to determine which antibiotics or antifungals effectively inhibit their growth. This test is ordered when a patient has a localized swelling or cyst that appears infected (redness, pain, warmth, or purulent drainage). It is crucial for guiding targeted antibiotic therapy, especially in an era of increasing antibiotic resistance.
  1. Culture: The aspirated fluid is placed on various growth media to see if bacteria grow.
  2. Identification: If growth occurs, the specific organism is identified using biochemical or molecular methods.
  3. Sensitivity (Susceptibility): The identified organism is exposed to various antibiotics to see which ones work. Results are usually reported as 'Sensitive' (the drug works), 'Intermediate', or 'Resistant' (the drug does not work).
  • Infected Sebaceous Cysts: Often contain skin flora like Staphylococcus aureus.
  • Abscesses: Can contain anaerobic bacteria or MRSA.
  • Bartholin’s Cyst Infection: May involve various aerobic and anaerobic organisms.
  • Hydatid Cyst: While usually diagnosed via imaging, culture helps rule out secondary bacterial infection.
View Interpretation
Gastroenterology

Cysts and Trophozoites

This test involves the microscopic examination of stool samples to identify the presence of parasitic organisms in two distinct life stages: Cysts (the dormant, infective stage) and Trophozoites (the active, motile, feeding stage). This is a critical component of a Complete Stool Examination for diagnosing intestinal protozoal infections such as Entamoeba histolytica (amebiasis) or Giardia lamblia (giardiasis). Identifying these structures helps determine the chronicity and type of infection, as trophozoites are more commonly found in liquid stools during acute illness, whereas cysts are often found in formed stools.
View Interpretation
Pathology

Cytology

Cytology is the branch of pathology that examines individual cells or small groups of cells under a microscope to look for signs of disease, particularly cancer. Unlike a biopsy, which looks at the 'architecture' of a tissue chunk, cytology focuses on the 'morphology' (shape, size, and internal structure) of single cells. Cytology tests are frequently used as screening tools (like the Pap smear) or as a minimally invasive way to investigate lumps or fluid accumulation. Doctors order cytology when a patient has a suspicious mass, a persistent cough (sputum cytology), or unexplained fluid in the lungs (pleural effusion) or abdomen (ascites). It is the 'gold standard' for determining if a fluid collection is inflammatory or malignant.
  • Malignancy: Detection of carcinomas, lymphomas, or sarcomas.
  • Infections: Identification of fungal elements, viral inclusion bodies (like Herpes), or bacterial colonies.
  • Inflammatory Conditions: Distinguishing between different types of inflammation (e.g., eosinophilic vs. neutrophilic).
  • Pre-cancerous Changes: Identifying dysplasia (abnormal growth) before it becomes invasive cancer.
View Interpretation
Hematology

D-Dimer

D-Dimer is a protein fragment (fibrin degradation product) that is made when a blood clot dissolves in the body. It is normally undetectable or present at very low levels unless the body is actively forming and breaking down blood clots. The primary clinical use of the D-Dimer test is to 'rule out' inappropriate blood clots. It is used in emergency settings to evaluate patients suspected of having Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), or Disseminated Intravascular Coagulation (DIC).
  • Venous Thromboembolism (VTE): Includes DVT and PE.
  • DIC: A complex condition where blood clots form throughout the body, followed by bleeding.
  • Malignancy: Certain cancers can activate the coagulation system.
  • Sepsis: Severe infections often trigger systemic clotting and fibrinolysis.
D-Dimer is highly sensitive but poorly specific. This means that while a negative result is very reliable for ruling out a clot, a positive result does not prove a clot is present. It merely indicates that fibrin degradation is occurring, which can happen for many reasons, including recent surgery, trauma, or inflammation.
View Interpretation
Infectious Disease

D-Dimer

D-Dimer is a fibrin degradation product, a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis. In a COVID-19 panel, D-Dimer serves as a critical biomarker for coagulopathy and disease severity. COVID-19 is associated with a hypercoagulable state; significantly elevated D-Dimer levels correlate with an increased risk of venous thromboembolism (VTE), disseminated intravascular coagulation (DIC), and poor clinical outcomes.
View Interpretation
Hematology

D-Dimer

D-Dimer is a fibrin degradation product (FDP), a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis. Within the context of a COVID-19 Hematology panel, it serves as a critical prognostic marker. Elevated levels indicate a state of hypercoagulability and are strongly associated with the risk of venous thromboembolism (VTE), disseminated intravascular coagulation (DIC), and severe inflammatory responses that characterize advanced COVID-19 infections.
View Interpretation
Infectious Disease

DNA TB PCR

The DNA TB PCR (Polymerase Chain Reaction) test is a rapid molecular diagnostic tool used to detect the genetic material (DNA) of the Mycobacterium tuberculosis complex. Unlike traditional sputum cultures, which can take weeks because TB bacteria grow very slowly, PCR can provide results within hours. Many modern PCR assays (like GeneXpert) also simultaneously detect genetic mutations that confer resistance to rifampin, a first-line TB drug. This test is ordered when a patient is suspected of having active pulmonary tuberculosis. Clinical signs include a persistent cough lasting more than three weeks, chest pain, coughing up blood (hemoptysis), night sweats, and weight loss. It is a critical tool in public health for the rapid identification and isolation of infectious cases to prevent community spread. The primary condition detected is Tuberculosis (TB), specifically active infections. While TB most commonly affects the lungs (pulmonary TB), PCR can also be performed on other samples (like cerebrospinal fluid or tissue biopsies) to detect extrapulmonary TB. A positive result in the context of clinical symptoms is considered definitive for an active infection requiring immediate treatment.
View Interpretation
Endocrinology

Dehydroepiandrosterone Sulfate (DHEAS)

DHEAS is an androgenic steroid hormone produced almost exclusively by the adrenal cortex. It serves as a precursor for more potent androgens like testosterone and estrogens like estradiol. Unlike DHEA, the sulfated form (DHEAS) has a long half-life and stable serum concentrations, making it an excellent marker for adrenal androgen production. This test is primarily used to evaluate adrenal gland function and to distinguish between adrenal-origin and ovarian-origin androgen excess. It is commonly ordered for women exhibiting signs of virilization, hirsutism (excess body hair), or irregular menses, and for children with premature pubarche (early pubic hair).
  • Polycystic Ovary Syndrome (PCOS): While primarily ovarian, many women with PCOS have mildly elevated DHEAS.
  • Adrenal Tumors: Very high levels are often seen in adrenal carcinomas or adenomas.
  • Congenital Adrenal Hyperplasia (CAH): Genetic enzyme deficiencies leading to overproduction of androgens.
  • Adrenal Insufficiency: Low levels may indicate Addison’s disease or secondary pituitary failure.
DHEAS levels peak in the early 20s and naturally decline with age. Therefore, interpretation must always be done using age-matched reference ranges. It is a critical tool in the workup of hyperandrogenism and infertility.
View Interpretation
Endocrinology

Dehydroepiandrosterone Sulphate (DHEAS)

DHEAS is an androgenic steroid hormone produced almost exclusively by the adrenal cortex, with small amounts produced by the testes/ovaries. It is the sulfated form of DHEA, which serves as a precursor for more potent androgens like testosterone and estrogens like estradiol. Unlike DHEA, which fluctuates throughout the day, DHEAS stays stable in the blood, making it an excellent marker for overall adrenal androgen production. This test is primarily used to evaluate adrenal gland function and to distinguish adrenal-sourced androgens from those produced by the gonads. It is frequently ordered for women presenting with symptoms of virilization (excessive hair growth, acne, or irregular periods) to rule out conditions like Polycystic Ovary Syndrome (PCOS) or adrenal tumors. In children, it is used to investigate precocious puberty or ambiguous genitalia.
  • Adrenal Hyperplasia (CAH): A genetic disorder affecting hormone production.
  • Adrenal Tumors: Both benign adenomas and malignant carcinomas can overproduce DHEAS.
  • PCOS: While primarily ovarian, some women with PCOS also show elevated adrenal androgens.
  • Addison's Disease: Adrenal insufficiency leading to pathologically low DHEAS levels.
View Interpretation
Infectious Disease

Dengue ELISA

The Dengue ELISA (Enzyme-Linked Immunosorbent Assay) is a diagnostic tool used to detect the presence of Dengue virus antigens (NS1) or antibodies (IgM and IgG) in the blood. Dengue is a mosquito-borne viral infection caused by the Flavivirus. The test helps distinguish between an acute infection, a recent infection, or a past exposure to one of the four serotypes of the virus. This test is ordered when a patient presents with symptoms suggestive of Dengue fever, such as high fever, severe headache (retro-orbital), muscle and joint pains (breakbone fever), and rash. It is critical for early diagnosis to monitor for complications like Dengue Hemorrhagic Fever (DHF) or Dengue Shock Syndrome (DSS), which require intensive supportive care.
  • Acute Dengue Fever: Characterized by positive NS1 and/or IgM.
  • Secondary Dengue Infection: Characterized by a rapid rise in IgG levels. This is clinically significant as secondary infections with a different serotype increase the risk of severe disease.
  • Differential Diagnosis: Helps differentiate Dengue from other tropical fevers like Malaria, Typhoid, or Zika virus infection.
View Interpretation
Infectious Disease

Dengue IgG, IgM, NS1 (Rapid Test)

The Dengue Rapid Test is a diagnostic panel designed to detect the presence of the Dengue virus or the body's immune response to it. The panel includes three components: NS1 Antigen (a protein released by the virus), and IgM/IgG antibodies (produced by the immune system). This combination allows for detection throughout different stages of the infection, from the first day of symptoms through the recovery phase. This test is ordered when a patient presents with symptoms suggestive of Dengue fever, especially after traveling to or living in tropical regions. Symptoms include high fever, severe headache, 'breakbone' joint pain, and rash. It is crucial for:
  • Early Diagnosis: The NS1 antigen can be detected as early as 1 day after fever onset.
  • Staging Infection: Differentiating between a primary infection and a secondary infection (which carries a higher risk of Dengue Hemorrhagic Fever).
  • Epidemiological Tracking: Monitoring outbreaks in specific regions.
  • Primary Dengue Infection: Typically characterized by a positive NS1 and/or IgM, with a negative IgG early on.
  • Secondary Dengue Infection: Often shows a rapid and high rise in IgG levels, sometimes even in the absence of IgM. This increases the risk of severe complications.
  • Dengue Hemorrhagic Fever (DHF): A severe progression of the disease that requires immediate hospitalization.
View Interpretation
Vital Signs

Diastolic Blood Pressure

Diastolic Blood Pressure (DBP) measures the pressure in the arteries when the heart muscle is resting between beats and refilling with blood. In the context of a Blood Pressure panel, it is a critical indicator of peripheral vascular resistance. While systolic pressure reflects the heart's pumping power, the diastolic value provides insight into the health of the blood vessels and the minimum pressure the system is constantly under. Consistently high diastolic pressure (Isolated Diastolic Hypertension) can lead to arterial stiffening and increased risk of heart failure or stroke.
View Interpretation
Hematology

Differential Count

The Differential Count (or WBC Diff) measures the percentage and absolute number of each type of white blood cell in the blood: neutrophils, lymphocytes, monocytes, eosinophils, and basophils. Each cell type has a specific role in the immune system, from fighting bacteria (neutrophils) to attacking viruses and producing antibodies (lymphocytes) and responding to allergens (eosinophils and basophils). This test is a fundamental part of the Complete Blood Count (CBC). It is used to diagnose infections, inflammation, leukemia, and immune system disorders. It helps clinicians differentiate between viral and bacterial infections and monitor the body's response to treatments like chemotherapy or immunosuppressive drugs.
  • Neutrophilia: Often indicates bacterial infection or acute stress.
  • Lymphocytosis: Common in viral infections (like mono) or certain leukemias.
  • Eosinophilia: Associated with allergic reactions, asthma, or parasitic infections.
  • Leukopenia: A low total count, which can occur during severe infection, bone marrow failure, or autoimmune disease.
  • Left Shift: The presence of immature neutrophils (bands), signifying that the bone marrow is working hard to fight a severe infection.
View Interpretation
Respiratory

Diffusing Capacity for Carbon Monoxide (DLCO)

The DLCO test measures the ability of the lungs to transfer gas from inhaled air to the red blood cells in the pulmonary capillaries. It is a critical component of a Pulmonary Function Test (PFT) because it assesses the integrity of the alveolar-capillary membrane. It depends on three factors: the total surface area available for gas exchange, the thickness of the membrane, and the volume of blood (hemoglobin) in the pulmonary capillaries. It is often corrected for alveolar volume (DLCO/VA) to differentiate between intrinsic lung disease and restrictive patterns caused by extrapulmonary factors.
View Interpretation
Metabolic

Direct Bilirubin

Direct (conjugated) bilirubin measures the portion of bilirubin that has been processed by the liver and made water-soluble. Within a Liver Function Test (LFT) panel, it is a critical marker for distinguishing between pre-hepatic, intra-hepatic, and post-hepatic jaundice. Elevated levels specifically point toward cholestasis (bile flow obstruction) or direct hepatocellular damage where the liver's ability to conjugate is intact, but its ability to excrete into the bile duct is impaired.
View Interpretation
Hematology

Direct Coombs Test

The Direct Coombs Test, also known as the Direct Antiglobulin Test (DAT), is used to determine whether antibodies (IgG) or complement proteins have attached to the surface of red blood cells (RBCs). Normally, antibodies should circulate in the plasma; when they bind directly to RBCs, it signals the immune system to destroy those cells, leading to hemolysis (the premature breakdown of blood cells). This test is a critical tool in several specific clinical scenarios:
  • Autoimmune Hemolytic Anemia (AIHA): When the body produces antibodies against its own RBCs.
  • Hemolytic Disease of the Newborn (HDN): To check if a mother's antibodies have crossed the placenta and are attacking the baby's RBCs.
  • Transfusion Reactions: If a patient develops a fever or dark urine after a blood transfusion, the DAT determines if the donor blood is being rejected.
  • Drug-Induced Hemolysis: Certain drugs (like penicillin or methyldopa) can cause antibodies to bind to RBCs.
A positive Direct Coombs test is associated with Systemic Lupus Erythematosus (SLE), Chronic Lymphocytic Leukemia (CLL), and various lymphomas. It is also the definitive test for diagnosing Rh incompatibility in neonates. In the context of drug reactions, it may explain sudden-onset anemia in patients taking high-dose antibiotics or certain hypertension medications.
View Interpretation
Microbiology

Discharge From Nipple For Culture And Sensitivity

This test involves collecting fluid discharged from the nipple to identify pathogenic bacteria or fungi through culture. Once an organism is grown, 'sensitivity' testing is performed to determine which specific antibiotics will effectively kill the pathogen. It is primarily ordered when a patient has nipple discharge that is purulent (pus-like), foul-smelling, or associated with breast pain, redness, or warmth—all signs of mastitis or a breast abscess. It helps clinicians differentiate between an infectious cause and non-infectious causes like hormonal imbalances (galactorrhea) or ductal ectasia.
  • Lactational Mastitis: Common in breastfeeding women due to skin bacteria entering the milk duct.
  • Breast Abscess: A localized collection of pus requiring drainage and targeted antibiotics.
  • Subareolar Abscess: Often associated with smoking and squamous metaplasia of the lactiferous ducts.
  • Periductal Mastitis: Inflammation of the ducts usually seen in non-lactating women.
Identifying the specific organism (e.g., Staphylococcus aureus, Streptococcus, or anaerobes) is crucial, especially as antibiotic resistance (like MRSA) becomes more common. The sensitivity report allows the physician to switch from broad-spectrum 'best guess' antibiotics to targeted therapy, ensuring faster resolution and preventing recurrence.
View Interpretation
Immunology

Dog Dander Specific IgE

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies in the blood directed against dog dander (Canis familiaris). In the context of an Allergy Profile, it identifies whether a patient has a Type I immediate hypersensitivity to canine-derived proteins (such as Can f 1). High levels indicate sensitization, which, when correlated with clinical symptoms like rhinitis, asthma, or urticaria, confirms a clinical allergy. This is crucial for distinguishing between animal-related respiratory issues and non-allergic triggers like irritants or viral infections.
View Interpretation
Toxicology

Drugs of Abuse 5-Panel (DOA 5)

The Drugs of Abuse 5-Panel (DOA 5) is a rapid screening test used to detect the presence of five specific classes of illegal drugs or prescription medications in a patient's urine. The standard five panels typically screen for Amphetamines, Cocaine, Opiates, Phencyclidine (PCP), and Cannabinoids (THC). The test uses immunoassay technology to identify the presence of these substances or their metabolites above a specific concentration cutoff. This panel is frequently utilized in various settings:
  • Workplace Screening: Pre-employment or post-accident testing to ensure a drug-free environment.
  • Clinical Toxicology: Assessment of patients in emergency rooms presenting with altered mental status.
  • Legal/Forensic: Monitoring individuals on probation or in child custody cases.
  • Pain Management: Ensuring patients are taking their prescribed medications and not utilizing illicit substances.
  • Substance Use Disorder (SUD): Recurrent use of drugs causing clinically significant impairment.
  • Acute Intoxication: Identifying the cause of symptoms like tachycardia, hallucinations, or respiratory depression.
  • Drug-Induced Psychosis: Specifically linked to high levels of stimulants or PCP.
View Interpretation
Prenatal Screening

Dual Marker

The Dual Marker test (also known as the First Trimester Screening) is a predictive blood test performed between weeks 11 and 14 of pregnancy. It measures two specific analytes: Pregnancy-Associated Plasma Protein-A (PAPP-A) and Free Beta-human Chorionic Gonadotropin (fβ-hCG). The results are converted into a 'Multiple of the Median' (MoM) and combined with maternal age and ultrasound findings (Nuchal Translucency) to calculate a statistical risk score. This test is ordered to screen for chromosomal abnormalities in the fetus. It is a non-invasive way to assess the likelihood of specific genetic conditions without the immediate risks associated with amniocentesis or chorionic villus sampling (CVS). It provides expectant parents with early information regarding the health of the pregnancy.
  • Trisomy 21 (Down Syndrome): Typically characterized by low PAPP-A levels and high Free Beta-hCG levels.
  • Trisomy 18 (Edwards Syndrome) and Trisomy 13 (Patau Syndrome): Generally associated with low levels of both PAPP-A and Free Beta-hCG.
  • Placental Insufficiency: Very low PAPP-A levels in the first trimester have been linked to later complications such as preeclampsia or fetal growth restriction.
View Interpretation
Cardiology

ECG With Report

An Electrocardiogram (ECG or EKG) is a non-invasive medical test that records the electrical activity of the heart over a period of time using electrodes placed on the skin. These electrodes detect the tiny electrical changes on the skin that arise from the heart muscle's electrophysiologic pattern of depolarizing and repolarizing during each heartbeat. It is the gold standard for diagnosing cardiac rhythms and provides essential information about the heart's structure and function. Physicians order an ECG to investigate symptoms such as chest pain, palpitations, shortness of breath, dizziness, or fainting. It is also used as part of routine physical exams, pre-operative screening, or to monitor the effectiveness of heart medications and pacemakers. Specifically, it helps in identifying:
  • Arrhythmias: Irregular heartbeats like Atrial Fibrillation (AFib).
  • Myocardial Infarction: Evidence of a current or previous heart attack.
  • Structural Abnormalities: Enlargement of heart chambers (hypertrophy).
  • Electrolyte Imbalances: Changes in potassium or calcium that affect heart rhythm.
A formal ECG report interprets specific waveforms: the P-wave (atrial contraction), the QRS complex (ventricular contraction), and the T-wave (ventricular recovery). Abnormalities in these intervals (like a prolonged QT interval) can indicate a high risk for sudden cardiac arrest. Chronic conditions like hypertension often lead to Left Ventricular Hypertrophy (LVH), which is frequently visible on an ECG. It is also vital for diagnosing Pericarditis or Pulmonary Embolism, which may show specific patterns like S1Q3T3.
View Interpretation
Genetics

EGFR Gene Mutation Analysis

The Epidermal Growth Factor Receptor (EGFR) is a protein on the surface of cells that helps them grow and divide. Mutations in the EGFR gene can cause the receptor to be constantly 'turned on,' leading to the uncontrolled cell growth characteristic of cancer. This test uses molecular techniques (like PCR or Next-Generation Sequencing) to identify specific mutations in exons 18, 19, 20, and 21 of the EGFR gene. This test is a critical component of 'Personalized Medicine' for patients diagnosed with Non-Small Cell Lung Cancer (NSCLC), particularly adenocarcinoma. Knowing the mutation status allows oncologists to determine if the patient will respond to targeted therapies known as Tyrosine Kinase Inhibitors (TKIs), such as erlotinib, gefitinib, or osimertinib. Patients with specific mutations often respond significantly better to these drugs than to traditional chemotherapy.
  • Non-Small Cell Lung Cancer (NSCLC): The primary condition where this test is utilized.
  • Acquired Resistance: Tests are often repeated (e.g., looking for the T790M mutation) if a patient stops responding to their initial targeted therapy.
View Interpretation
Oncology

EGFR Mutation Analysis

The Epidermal Growth Factor Receptor (EGFR) is a protein on the surface of cells that helps them grow and divide. Mutations in the EGFR gene can cause the receptor to be permanently 'turned on,' leading to the uncontrolled cell proliferation characteristic of certain cancers, particularly Non-Small Cell Lung Cancer (NSCLC). This test is vital for patients diagnosed with advanced NSCLC. It is a 'companion diagnostic' used to determine if the cancer is likely to respond to Tyrosine Kinase Inhibitors (TKIs) like Erlotinib, Gefitinib, or Osimertinib. Testing for specific mutations (like Exon 19 deletions or L858R) allows for personalized targeted therapy.
  • Non-Small Cell Lung Cancer (NSCLC): The primary condition where EGFR testing is standard of care.
  • Acquired Resistance: The T790M mutation is a specific variant that often develops after initial treatment, causing resistance to first-generation TKIs.
  • Adenocarcinoma: EGFR mutations are most commonly found in lung adenocarcinomas, particularly in non-smokers and women.
View Interpretation
Oncology

EGFR by ARMS PCR

The EGFR (Epidermal Growth Factor Receptor) mutation test using ARMS PCR (Amplification Refractory Mutation System) is a molecular diagnostic tool. It identifies specific mutations in the DNA of tumor cells. In certain cancers, the EGFR protein is overactive, causing cells to divide uncontrollably. ARMS PCR is a highly sensitive method capable of detecting low levels of mutant DNA in a background of wild-type (normal) DNA. This test is vital for patients diagnosed with Non-Small Cell Lung Cancer (NSCLC), particularly adenocarcinomas. It is used to:
  • Select Targeted Therapy: Patients with specific EGFR mutations (like Exon 19 deletions or L858R) respond exceptionally well to Tyrosine Kinase Inhibitors (TKIs) like Osimertinib or Erlotinib.
  • Identify Resistance: Detecting the T790M mutation helps explain why a patient might stop responding to first-generation TKIs.
  • NSCLC (Non-Small Cell Lung Cancer): The primary condition where EGFR testing is standard of care.
  • Adenocarcinoma: The histological subtype most likely to harbor these mutations.
Determining the EGFR status is a cornerstone of personalized medicine, allowing clinicians to bypass standard chemotherapy for more effective, targeted treatments.
View Interpretation
Oncology

ER/PR & HER2 Neu IHC Markers

This panel measures Estrogen Receptor (ER), Progesterone Receptor (PR), and Human Epidermal Growth Factor Receptor 2 (HER2) status in breast cancer tissue using Immunohistochemistry (IHC). These markers are essential 'biomarkers' that determine how a tumor grows and how it can be most effectively treated. This test is mandatory for every new diagnosis of invasive breast cancer. It guides the oncology team in developing a personalized treatment plan:
  • Hormone Receptor Status (ER/PR): Determines if the cancer cells grow in response to estrogen or progesterone. If positive, hormone-blocking therapies (like Tamoxifen) are effective.
  • HER2 Status: Determines if the cancer overexpresses the HER2 protein. If positive (3+), targeted therapies like Trastuzumab (Herceptin) are used.
  • Luminal A/B Breast Cancer: Usually ER/PR positive, indicating a generally better prognosis.
  • HER2-Enriched Cancer: High HER2 expression; historically aggressive but now highly treatable with targeted biologics.
  • Triple-Negative Breast Cancer (TNBC): Negative for ER, PR, and HER2. These are often more aggressive and require aggressive chemotherapy as they lack specific targets for hormonal or HER2-directed drugs.
View Interpretation
Oncology

ER/PR IHC Markers

The Estrogen Receptor (ER) and Progesterone Receptor (PR) Immunohistochemistry (IHC) markers are essential diagnostic tools used primarily in the management of breast cancer. These tests detect the presence of hormone receptors on the surface of cancer cells. When hormones like estrogen and progesterone bind to these receptors, they can stimulate the growth of the tumor. This test is standard practice following a breast cancer diagnosis. It helps oncologists determine the specific subtype of breast cancer and predict the tumor's likely response to hormone therapy. If a tumor is 'ER-positive' or 'PR-positive,' it means the cancer cells grow in response to these hormones, making the patient a candidate for targeted endocrine therapies.
  • Hormone Receptor-Positive Breast Cancer: Indicates that the cancer is likely to respond to treatments that block hormone signals (e.g., Tamoxifen or Aromatase inhibitors).
  • Triple-Negative Breast Cancer: Defined by the absence of ER, PR, and HER2 receptors. This subtype requires different treatment strategies, such as chemotherapy, as it does not respond to hormone therapy.
  • Prognostic Assessment: Generally, ER/PR positive tumors are associated with a better prognosis and lower recurrence rates compared to receptor-negative tumors.
The results of the IHC markers directly dictate the therapeutic roadmap. Patients with positive markers are often prescribed long-term hormonal therapy to reduce the risk of recurrence. Understanding these markers is critical for personalized medicine in oncology.
View Interpretation
Genetics

ETV6-RUNX1 (TEL-AML1) Translocation [t(12;21)]

The ETV6-RUNX1 (formerly TEL-AML1) translocation, involving chromosomes 12 and 21, is the most common genetic abnormality in childhood B-cell precursor Acute Lymphoblastic Leukemia (ALL), occurring in approximately 25% of cases. Its detection is critical for risk stratification; it is generally associated with a favorable prognosis, high sensitivity to L-asparaginase, and excellent long-term survival rates. In the context of the All Translocation Panel, this test helps clinicians confirm a diagnosis and tailor chemotherapy intensity, as patients with this fusion may require less intensive regimens compared to high-risk subtypes.
View Interpretation
Infectious Disease

Ear Clipping For AFB

The Ear Clipping for AFB (Acid-Fast Bacilli) test, also known as a Slit-Skin Smear (SSS), is a diagnostic procedure used to detect Mycobacterium leprae, the causative agent of Leprosy (Hansen's Disease). Because the bacteria prefer cooler areas of the body, the earlobes are primary sites for sampling. The procedure involves making a small, shallow incision (slit) and scraping the internal tissue to obtain serum and cells, which are then stained using the Ziehl-Neelsen technique. This test is ordered when a patient presents with suspicious skin lesions, localized loss of sensation, or thickened nerves. It is used to confirm a diagnosis of leprosy and to classify the disease into Paucibacillary (PB) or Multibacillary (MB) types. This classification is vital for determining the duration and intensity of Multi-Drug Therapy (MDT). It is also used during treatment to monitor the reduction in the bacterial load (Bacteriologic Index).
  • Lepromatous Leprosy: Characterized by high bacterial loads and widespread skin involvement.
  • Tuberculoid Leprosy: Characterized by few lesions and low to zero bacterial detection in smears.
  • Hansen’s Disease reactions: Monitoring the status of the infection during inflammatory episodes.
View Interpretation
Microbiology

Ear Pus for Culture and Sensitivity

The Ear Pus Culture and Sensitivity test is a critical diagnostic tool used to identify the specific bacterial or fungal pathogens responsible for infections in the external or middle ear (Otitis Externa or Otitis Media). When an infection leads to suppuration (pus formation), collecting a sample allows microbiologists to isolate the causative agent and determine which antimicrobial agents are most effective at inhibiting its growth. Physicians order this test when a patient presents with symptoms of ear infection such as severe pain (otalgia), discharge (otorrhea), hearing loss, or swelling. It is particularly important in chronic cases, infections that do not respond to empirical first-line antibiotics, or in patients with underlying conditions like diabetes or immunosuppression where 'Malignant Otitis Externa' (a severe necrotizing infection) is a risk.
  • Otitis Externa (Swimmer's Ear): Often caused by Pseudomonas aeruginosa or Staphylococcus aureus.
  • Otitis Media with Effusion: Common in children, involving organisms like Streptococcus pneumoniae or Haemophilus influenzae.
  • Fungal Otomycosis: Often caused by Aspergillus or Candida species, typically following prolonged antibiotic use.
  • Chronic Suppurative Otitis Media (CSOM): Persistent inflammation of the middle ear and mastoid cavity.
The 'Sensitivity' portion of the test (Antibiogram) is vital in the era of antibiotic resistance. It provides a roadmap for targeted therapy, ensuring that the patient receives the correct medication, thereby preventing complications like mastoiditis, eardrum perforation, or intracranial spread of infection.
View Interpretation
Allergy and Immunology

Egg White (Specific IgE)

Egg white is one of the most common food allergens, especially in children. This test measures IgE antibodies against specific proteins in egg whites (like ovomucoid and ovalbumin). Inclusion in an Allergy Profile is vital because egg allergy can impact vaccination schedules (some vaccines use egg components) and requires strict dietary management.
View Interpretation
Immunology

Egg White Specific IgE

The Egg White Specific IgE test measures the concentration of IgE antibodies specifically sensitized to proteins found in egg whites (such as ovomucoid and ovalbumin). Unlike a 'Total IgE' test, this is highly specific to one allergen source. It helps clinicians confirm if a patient’s symptoms (hives, wheezing, GI distress) after eating eggs are mediated by an IgE-allergic pathway, which carries a risk of anaphylaxis.
View Interpretation
Hematology

Eosinophils

Component of White Blood Cell differential.
View Interpretation
Clinical Pathology

Eosinophils

Eosinophils are a type of white blood cell usually involved in allergic reactions and parasitic infections. In a CSF Differential Count, their presence is highly abnormal (eosinophilic pleocytosis). Normally, there are zero eosinophils in the cerebrospinal fluid. Their detection indicates a specific inflammatory response within the central nervous system, often helping to distinguish between common bacterial meningitis and rarer causes.
View Interpretation
Hematology

Eosinophils

Eosinophils are a type of white blood cell primarily involved in the response to parasitic infections and allergic diseases. In a Differential Count, the eosinophil percentage helps clinicians distinguish between types of inflammation. They contain granules with cytotoxic proteins intended to kill multicellular parasites but can also cause tissue damage in chronic allergic conditions like asthma or eosinophilic esophagitis.
View Interpretation
Hematology

Eosinophils

Eosinophils are a type of white blood cell (granulocyte) primarily responsible for combating multicellular parasites and modulating Type I immediate hypersensitivity (allergic) reactions. In a differential count, the percentage of eosinophils helps clinicians identify allergic asthma, hay fever, drug reactions, or parasitic infestations (helminths). They also play a role in chronic inflammatory conditions like Eosinophilic Esophagitis.
View Interpretation
Hematology

Eosinophils

Eosinophils are specialized granulocytes that play a dual role in the immune system: they combat multicellular parasites and participate in allergic reactions. As part of a TC & DC (Total Count & Differential Count), eosinophil levels provide a diagnostic window into Type I hypersensitivity reactions (like asthma or hay fever) and are a primary marker for parasitic infestations (like helminths). They also contribute to the inflammatory process in various autoimmune diseases.
View Interpretation
Hematology

Eosinophils

Eosinophils are a specialized type of white blood cell (leukocyte) primarily involved in the body's response to allergic diseases, parasitic infections, and certain types of inflammation. As part of a TCDC-X (Differential Count), the eosinophil percentage helps clinicians differentiate between bacterial infections (where neutrophils typically rise) and allergic or parasitic conditions. They also play a role in the pathology of asthma and certain autoimmune conditions.
View Interpretation
Hematology

Eosinophils (%)

Eosinophils are specialized leukocytes primarily involved in the response to parasitic infections and allergic diseases (Type I hypersensitivity). Within the Differential Count, the percentage helps clinicians identify eosinophilia, which is a hallmark of asthma, hay fever, drug reactions, or helminthic infestations. They also play a role in modulating inflammatory responses.
View Interpretation
Hematology

Eosinophils (Absolute)

Eosinophils are a specialized type of white blood cell (granulocyte) primarily responsible for combating multicellular parasites and certain infections. They play a major role in the mediation of allergic reactions and asthma. In a Complete Blood Picture (CBP), the absolute count (rather than the percentage) provides the most accurate assessment of eosinophilia. They contain granules filled with cytotoxic proteins that are released to destroy pathogens, but this can also cause tissue damage in chronic inflammatory states.
View Interpretation
Hematology

Eosinophils (Absolute)

This component measures the total number of eosinophils per microliter of blood. Within a differential count, it is used to investigate allergic diseases, monitor the severity of asthma, or screen for parasitic infestations. It is a critical metric for diagnosing Hypereosinophilic Syndrome (HES). The count is more reliable than the differential percentage because it is not affected by fluctuations in other white cell types (like neutrophils).
View Interpretation
Hematology

Eosinophils (DC)

Eosinophils are a specialized type of white blood cell involved in the immune response against multicellular parasites and certain infections. In a Differential Count (DC), the percentage of eosinophils helps clinicians identify allergic inflammatory processes or parasitic infestations. They also play a role in the pathogenesis of diseases like asthma and eczema.
View Interpretation
Metabolic

Epithelial Cells

This component of a urinalysis identifies cells shedding from the urinary tract. Squamous epithelial cells are common and usually represent skin/vaginal contamination. Transitional cells originate from the bladder or ureters. The most significant are Renal Tubular Epithelial (RTE) cells, which indicate damage to the nephrons of the kidney.
View Interpretation
Hematology

Erythrocyte Sedimentation Rate

The Erythrocyte Sedimentation Rate (ESR) is a common hematology test that measures how quickly red blood cells (erythrocytes) sink to the bottom of a tall, thin vertical tube. Under normal conditions, RBCs fall slowly. However, when inflammation is present in the body, certain proteins (like fibrinogen and globulins) cause RBCs to clump together into 'rouleaux' formations. These clumps are heavier than individual cells and sediment much faster, resulting in a higher ESR value. Physicians order an ESR when they suspect an inflammatory condition but need to confirm the presence of systemic activity. It is frequently used to monitor the progression or treatment efficacy of chronic inflammatory diseases. Common reasons for the test include unexplained fever, joint pain, muscle stiffness, or persistent headaches that might suggest temporal arteritis. It is often paired with the C-Reactive Protein (CRP) test for a more comprehensive inflammatory profile. A high ESR is associated with a wide variety of conditions, which can be categorized into:
  • Autoimmune Diseases: Rheumatoid arthritis, Systemic Lupus Erythematosus (SLE), and Polymyalgia Rheumatica.
  • Infections: Bacterial infections (endocarditis, osteomyelitis) and tuberculosis.
  • Malignancies: Multiple myeloma, lymphomas, and various metastatic cancers.
  • Tissue Damage: Myocardial infarction (heart attack) or major trauma.
View Interpretation
Rheumatology

Erythrocyte Sedimentation Rate (ESR)

ESR measures the distance red blood cells fall in a tube over one hour. In an Arthritis Basic Screen, it serves as a non-specific marker of systemic inflammation. Inflammation increases the concentration of fibrinogen and other acute-phase proteins, which causes RBCs to clump (rouleaux formation) and sink faster. While it cannot pinpoint the cause, it is vital for monitoring disease activity in conditions like Rheumatoid Arthritis or Polymyalgia Rheumatica.
View Interpretation
Hematology

Erythrocyte Sedimentation Rate (ESR)

The Erythrocyte Sedimentation Rate (ESR) is a non-specific marker of systemic inflammation. It measures how quickly red blood cells sink to the bottom of a tube of anticoagulated blood. In the presence of acute-phase reactants (like fibrinogen), RBCs aggregate into 'rouleaux' and fall faster. It is particularly useful for monitoring the activity of Temporal Arteritis, Polymyalgia Rheumatica, Rheumatoid Arthritis, and certain chronic infections or malignancies.
View Interpretation
Hematology

Erythrocyte Sedimentation Rate (ESR)

ESR is a non-specific marker of systemic inflammation. It measures the rate at which red blood cells (RBCs) sink to the bottom of a tube in one hour. When inflammation is present, high levels of fibrinogen and globulins cause RBCs to stick together (rouleaux), making them heavier and faster-settling. Within a hematology panel, it serves as a 'sickness indicator' that helps clinicians track the activity of chronic inflammatory diseases like Temporal Arteritis, Polymyalgia Rheumatica, and Rheumatoid Arthritis.
View Interpretation
Clinical Pathology

Erythrocytes

Erythrocytes (Red Blood Cells) in the Cerebrospinal Fluid (CSF) are not normally present. Their presence indicates either a subarachnoid hemorrhage (SAH) or a traumatic tap (bleeding caused by the spinal needle during the procedure). Analyzing the erythrocyte count across successive collection tubes helps differentiate these two. In a traumatic tap, the RBC count usually decreases significantly from tube 1 to tube 4, whereas in SAH, the count remains relatively constant.
View Interpretation
Endocrinology

Erythropoietin Levels

Erythropoietin (EPO) is a glycoprotein hormone produced primarily by the peritubular cells of the kidneys. Its primary function is to act as a growth factor for erythrocyte (red blood cell) precursors in the bone marrow. When oxygen levels in the blood decrease (hypoxia), the kidneys increase the production of EPO, which then signals the bone marrow to produce more red blood cells to increase oxygen-carrying capacity. This test is vital in distinguishing between different types of anemia and polycythemia (an overproduction of red blood cells). It is commonly ordered for:
  • Evaluating Anemia: To determine if the kidneys are responding appropriately to low red blood cell counts.
  • Differentiating Polycythemia: To distinguish between Polycythemia Vera (where EPO is usually low) and secondary polycythemia (where EPO is high due to smoking, high altitude, or tumors).
  • Monitoring Chronic Kidney Disease (CKD): As kidney function declines, EPO production drops, often requiring synthetic EPO supplementation.
  • Chronic Renal Failure: Leading cause of EPO deficiency.
  • Polycythemia Vera: A myeloproliferative disorder.
  • Erythropoietin-Producing Tumors: Certain renal or hepatic tumors can inappropriately secrete EPO.
  • Bone Marrow Disorders: Myelodysplastic syndromes.
View Interpretation
Endocrinology

Estradiol (E2)

Estradiol (E2) is the most potent form of estrogen and the primary female sex hormone. In women, it is produced mainly in the ovaries; in men, it is produced in the testes and through the conversion of testosterone in peripheral tissues. It is vital for the growth and development of female reproductive organs and secondary sexual characteristics. Estradiol testing is used to evaluate ovarian function and assess the cause of menstrual irregularities or infertility. It is also used to monitor follicle development during In Vitro Fertilization (IVF). In men, it may be ordered to investigate feminization (gynecomastia) or to monitor hormonal therapy.
  • Ovarian Failure: Low levels may indicate menopause or primary ovarian insufficiency.
  • Polycystic Ovary Syndrome (PCOS): May involve imbalances in the estradiol-to-estrone ratio.
  • Gynecomastia: High levels in men can lead to breast tissue development.
  • Precocious Puberty: Early onset of puberty in children.
  • Estrogen-secreting Tumors: Both ovarian and testicular tumors can lead to abnormally high levels.
View Interpretation
Microbiology

Eye Swab For C/S (Left)

The Eye Swab for Culture and Sensitivity (C/S) is a microbiological procedure used to identify the specific pathogen—usually bacteria or fungi—causing an infection in the eye (conjunctivitis, keratitis, or blepharitis). The 'Sensitivity' portion of the test determines which antibiotics or antifungal agents are most effective at killing the identified organism, ensuring targeted and effective treatment. Ophthalmologists order this test when an eye infection is severe, chronic, or not responding to standard broad-spectrum antibiotic drops. It is particularly important for:
  • Contact lens wearers (who are at risk for aggressive infections like Pseudomonas).
  • Patients with suspected corneal ulcers.
  • Neonates with eye discharge (to rule out specialized infections like Chlamydia).
  • Pre-operative screening before major ocular surgery.
The test is primarily associated with infectious Conjunctivitis ('Pink Eye'). Common bacterial isolates include Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae. In more severe cases involving the cornea (Keratitis), the test may find more dangerous pathogens like Acanthamoeba or various fungal species. A 'Culture and Sensitivity' is the gold standard for preventing vision loss; by identifying the exact 'enemy,' doctors can avoid the 'trial and error' approach of using different eye drops, which can lead to antibiotic resistance and prolonged inflammation of the ocular surface.
View Interpretation
Microbiology

Eye Swab For C/S (Right)

An eye swab for Culture and Sensitivity (C/S) involves collecting discharge or secretions from the conjunctiva or eyelid margin of the right eye using a sterile swab. Unlike corneal scraping, this is non-invasive and primarily targets surface-level infections like conjunctivitis (pink eye) or blepharitis (eyelid inflammation). While most conjunctivitis is viral and self-limiting, swabs are ordered to:
  • Identify Bacterial Pathogens: Differentiate between viral, bacterial, and allergic causes of red-eye.
  • Neonatal Screening: Test newborns for Gonorrhea or Chlamydia infections acquired during birth.
  • Chronic Infections: Investigate recurring infections that don't respond to standard hygiene or over-the-counter drops.
  • Hospital Protocol: Check for multi-drug resistant organisms in a healthcare setting.
Commonly identified bacteria include Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella. In cases of hyper-acute discharge, Neisseria gonorrhoeae is a serious concern. The 'Sensitivity' portion of the test ensures that the prescribed eye drops are effective against the specific strain found, preventing the development of antibiotic resistance and ensuring rapid recovery of the ocular surface.
View Interpretation
Microbiology

Eye Swab for C/S

The Eye Swab for Culture and Sensitivity (C/S) is a diagnostic procedure performed to identify the presence of pathogenic microorganisms—such as bacteria or fungi—in the conjunctiva or cornea. After the specimen is collected, it is placed in a growth medium (Culture) to see if organisms multiply. If a pathogen is found, it is then tested against various antibiotics (Sensitivity) to determine which medication effectively kills the infection. This test is vital for treating ocular infections that do not respond to broad-spectrum drops. It is specifically used for:
  • Bacterial Conjunctivitis: Identifying highly contagious bacterial strains.
  • Keratitis: Inflammation of the cornea that can lead to blindness if not treated with targeted therapy.
  • Endophthalmitis: A severe internal eye infection, often occurring after surgery.
  • Neonatal Conjunctivitis: Testing newborns who may have contracted infections during birth.
  • Staphylococcus aureus: A common cause of bacterial eye infections.
  • Neisseria gonorrhoeae: A rare but sight-threatening cause of hyperacute conjunctivitis.
  • Pseudomonas aeruginosa: Often associated with contact lens contamination.
View Interpretation
Pathology

F.N.A.C Procedure

Fine Needle Aspiration Cytology (FNAC) is a rapid, minimally invasive diagnostic procedure used to investigate lumps or masses located just under the skin (e.g., in the thyroid, breast, or lymph nodes). The primary function is to determine whether a lesion is inflammatory, benign, or malignant by extracting a small sample of cells using a thin, hollow needle. Physicians order an FNAC when a patient presents with a palpable nodule or an abnormality detected during imaging (like an ultrasound or CT scan). It is the first-line investigation for:
  • Thyroid Nodules: To distinguish between benign goiter and thyroid cancer.
  • Breast Lumps: To evaluate suspicious masses found during a mammogram.
  • Lymphadenopathy: To check for lymphoma or metastatic spread from other organs.
  • Salivary Gland Masses: To evaluate swellings in the parotid or submandibular glands.
Results from an FNAC can lead to the diagnosis of various conditions, including:
  • Malignancy: Carcinomas, lymphomas, and sarcomas.
  • Benign Tumors: Fibroadenomas or lipomas.
  • Infections: Tuberculosis (characterized by granulomatous inflammation) or abscesses.
  • Cysts: Simple fluid-filled sacs that resolve upon aspiration.
FNAC is highly valued for its high sensitivity and specificity, often sparing patients from more invasive surgical biopsies if the result is clearly benign or diagnostic of a specific condition.
View Interpretation
Metabolic

FBS & PPBS

This combined test measures glucose levels at two distinct states: Fasting Blood Sugar (FBS), measured after at least 8 hours of no caloric intake, and Post-Prandial Blood Sugar (PPBS), measured exactly 2 hours after a meal. Together, they assess the body's ability to maintain glucose homeostasis and the effectiveness of insulin response to a glucose load. These tests are the primary tools for:
  • Screening for Type 2 Diabetes and Pre-diabetes.
  • Monitoring glucose control in known diabetics.
  • Evaluating 'Reactive Hypoglycemia' (low sugar after eating).
  • Assessing the risk of metabolic syndrome.
Persistent elevations in FBS and PPBS are diagnostic of Diabetes Mellitus. Pre-diabetes is identified when levels are higher than normal but not yet in the diabetic range. Chronic hyperglycemia is associated with long-term damage to the heart, kidneys (nephropathy), nerves (neuropathy), and eyes (retinopathy). Conversely, consistently low FBS levels may indicate an insulinoma (insulin-secreting tumor) or hormonal deficiencies like Addison’s disease.
View Interpretation
Respiratory

FEV1/FVC Ratio

Ratio used to distinguish obstructive from restrictive lung disease.
View Interpretation
Respiratory

FEV1/FVC Ratio

The FEV1/FVC ratio (Tiffeneau-Pinelli index) is a fundamental parameter in spirometry used to differentiate between obstructive and restrictive lung diseases. It represents the proportion of the person's vital capacity they can expire in the first second of a forced exhalation. In obstructive diseases (like asthma or COPD), air flows out of the lungs slowly, reducing the FEV1 more than the FVC, thus lowering the ratio.
View Interpretation
Genetics

FISH - MDS In-Situ

Fluorescence In Situ Hybridization (FISH) is a molecular cytogenetic technique that uses fluorescent probes that bind to only those parts of a nucleic acid sequence with a high degree of sequence complementarity. In the context of Myelodysplastic Syndromes (MDS), FISH is used to detect specific chromosomal abnormalities. MDS is a group of cancers in which immature blood cells in the bone marrow do not mature or become healthy blood cells. FISH is ordered to identify chromosomal deletions, trisomies, or translocations that are characteristic of MDS. This helps in confirming the diagnosis, determining the specific subtype of MDS, and assessing the prognosis.
  • del(5q): Often associated with a better prognosis and response to specific drugs like lenalidomide.
  • del(7q) / -7: Associated with a poorer prognosis.
  • Trisomy 8 (+8): A common but non-specific abnormality.
  • del(20q): Generally carries a favorable prognosis.
The results of FISH are integral to the International Prognostic Scoring System (IPSS-R) for MDS, which clinicians use to decide on the aggressiveness of the treatment, ranging from 'watch and wait' to stem cell transplantation.
View Interpretation
Metabolic

Fasting Blood Sugar

The Fasting Blood Sugar (FBS) test measures the amount of glucose in the blood after an overnight fast. Glucose is the primary source of energy for the body's cells, regulated primarily by the hormones insulin (which lowers blood sugar) and glucagon (which raises it). This is a foundational screening tool for Diabetes Mellitus and Prediabetes. It is ordered during routine physicals or when a patient presents with symptoms of hyperglycemia, such as excessive thirst (polydipsia), frequent urination (polyuria), or unexplained weight loss.
  • Type 2 Diabetes: Consistently high levels indicate insulin resistance or insufficient insulin production.
  • Prediabetes: Levels between 100-125 mg/dL suggest a high risk for developing full-blown diabetes.
  • Insulinoma: A rare pancreatic tumor that can cause dangerously low blood sugar.
  • Metabolic Syndrome: FBS is a key diagnostic criterion for this cluster of conditions that increase heart disease risk.
Maintaining glucose within a narrow range is vital for organ health, particularly the brain and kidneys. Chronic hyperglycemia leads to microvascular damage, affecting the eyes, nerves, and cardiovascular system. Conversely, severe hypoglycemia can lead to loss of consciousness and is an acute medical emergency.
View Interpretation
Metabolic

Fasting Blood Sugar (FBS)

Fasting Blood Sugar measures the circulating glucose in the blood after an 8 to 12-hour period of no caloric intake. Within the FBS & PPBS panel, it serves as the baseline for evaluating glucose homeostasis. It is the primary screening tool for diagnosing Diabetes Mellitus and Impaired Fasting Glucose (Prediabetes). It reflects the balance between hepatic glucose production and peripheral glucose uptake regulated by insulin.
View Interpretation
Metabolic

Fasting Plasma Glucose

The Fasting Plasma Glucose (FPG) serves as the baseline measurement in a Glucose Tolerance Test. It represents the blood sugar level after an 8-12 hour fast, reflecting the body's ability to maintain glucose homeostasis through hepatic gluconeogenesis and basal insulin secretion. It is the primary screening tool for Prediabetes and Diabetes Mellitus.
View Interpretation
Gastroenterology

Fat Globules

The detection of fat globules (neutral fats/triglycerides) in a Complete Stool Examination is a marker for steatorrhea. It indicates significant fat malabsorption or maldigestion. This component is part of the microscopic examination where Sudan III or similar stains are used. It helps clinicians differentiate between simple diarrhea and disorders of the pancreas or small intestine.
View Interpretation
Anemia/Minerals

Ferritin

Ferritin is a universal intracellular protein that stores iron and releases it in a controlled fashion. It acts as a buffer against iron deficiency and iron overload. While most ferritin is found inside cells, a small amount circulates in the blood, which serves as an accurate reflection of the body's total iron stores. Physicians order a Ferritin test to evaluate iron metabolism. It is the most sensitive marker for detecting iron deficiency anemia in its early stages, often before hemoglobin levels drop. Conversely, it is used to monitor conditions of iron overload, such as hemochromatosis. Because ferritin is also an 'acute-phase reactant,' it may be ordered to assess inflammation or chronic disease states.
  • Iron Deficiency Anemia: Low ferritin is almost always diagnostic of depleted iron stores.
  • Hemochromatosis: A genetic condition leading to excessive iron absorption.
  • Chronic Diseases: Conditions like rheumatoid arthritis or certain cancers can elevate ferritin levels.
  • Liver Disease: Since the liver is a primary storage site for ferritin, hepatic inflammation can cause the protein to leak into the bloodstream.
  • Restless Legs Syndrome (RLS): Low iron levels in the brain, often reflected by low serum ferritin, are linked to RLS symptoms.
View Interpretation
Infectious Disease

Ferritin

Ferritin is the primary intracellular protein that stores iron and releases it in a controlled fashion. In a COVID-19 profile, Ferritin serves as an Acute Phase Reactant. It is a marker of the 'Cytokine Storm' and hyperinflammation. High levels in COVID-19 patients correlate with increased disease severity, lung injury, and poor prognosis, independent of iron stores.
View Interpretation
Hematology

Ferritin

Ferritin is the primary intracellular iron-storage protein and reflects total body iron stores. It is the most sensitive and specific marker for iron deficiency. However, it also acts as an acute-phase reactant, meaning its concentration increases during systemic inflammation, regardless of iron status.
View Interpretation
Hematology

Fibrinogen

Fibrinogen, also known as Factor I, is a glycoprotein produced by the liver that plays a central role in the blood coagulation cascade. When a blood vessel is injured, the enzyme thrombin converts fibrinogen into fibrin. Fibrin molecules then link together to form a mesh-like structure that traps platelets and red blood cells, creating a stable blood clot. Without adequate fibrinogen, the body cannot effectively stop bleeding. The fibrinogen test is typically ordered as part of a workup for bleeding disorders or abnormal clotting events. It is used to investigate a prolonged Prothrombin Time (PT) or Activated Partial Thromboplastin Time (aPTT). It is also vital in emergency settings to screen for Disseminated Intravascular Coagulation (DIC), a life-threatening condition where the body's clotting factors are rapidly consumed.
  • Liver Disease: Since the liver produces fibrinogen, cirrhosis or hepatitis can lead to low levels.
  • DIC: Characterized by widespread clotting followed by severe bleeding due to factor depletion.
  • Acute Phase Response: Fibrinogen levels rise during systemic inflammation, infection, or after major surgery.
  • Afibrinogenemia: A rare genetic condition where fibrinogen is completely absent.
View Interpretation
Hematology

Fibrinogen

Fibrinogen, also known as Factor I, is a soluble plasma glycoprotein synthesized in the liver. It is a critical component of the coagulation cascade. When a blood vessel is injured, the enzyme thrombin converts fibrinogen into fibrin, which forms a fibrous mesh that stabilizes blood clots and stops bleeding. Beyond clotting, fibrinogen is an 'acute-phase reactant,' meaning its levels rise significantly in response to systemic inflammation or tissue injury. This test is primarily used to evaluate bleeding disorders or abnormal blood clotting events. It is ordered if a patient has unexplained or prolonged bleeding, frequent bruising, or as part of a workup for Disseminated Intravascular Coagulation (DIC). It is also used to assess the risk of cardiovascular disease, as chronically elevated levels are associated with increased arterial plaque formation.
  • Hypofibrinogenemia: Low levels often seen in severe liver disease or malnutrition.
  • Disseminated Intravascular Coagulation (DIC): A life-threatening condition where fibrinogen is consumed rapidly by widespread clotting.
  • Hyperfibrinogenemia: High levels linked to acute infections, rheumatoid arthritis, or myocardial infarction.
  • Afibrinogenemia: A rare congenital absence of fibrinogen causing severe bleeding tendencies.
View Interpretation
Hematology

Fibrinogen

Fibrinogen is a soluble plasma glycoprotein (Factor I) that is converted to fibrin by thrombin during the clotting process. In a COVID Panel Hematology, it serves as an acute-phase reactant. High levels are a hallmark of the hyperinflammatory state and hypercoagulability associated with severe COVID-19, contributing to the risk of thrombosis. Conversely, a sudden drop can signal the onset of Disseminated Intravascular Coagulation (DIC) or consumption coagulopathy.
View Interpretation
Pathology

Final Diagnosis Panel By IHC

Immunohistochemistry (IHC) is a sophisticated diagnostic technique that uses antibodies to detect specific antigens (proteins) in a tissue sample. By applying dye-labeled antibodies to a biopsy section, pathologists can visualize the presence, location, and quantity of specific proteins under a microscope. This is the 'gold standard' for differentiating between cell types that look identical under standard staining (H&E). IHC is primarily ordered when a routine biopsy indicates the presence of a tumor but cannot definitively identify the primary site of origin or the specific subtype of cancer. It is crucial for determining the prognosis and selecting targeted therapies (e.g., HER2 testing in breast cancer or PD-L1 testing for immunotherapy).
  • Carcinomas of Unknown Primary (CUP): Helping find where a cancer started.
  • Lymphoma Subtyping: Distinguishing between B-cell, T-cell, and Hodgkin lymphomas.
  • Breast Cancer: Checking for ER (Estrogen Receptor), PR (Progesterone Receptor), and HER2 status.
  • Infectious Diseases: Identifying specific viral particles (like CMV or HPV) within tissue cells.
Modern oncology relies on IHC to determine if a patient will respond to specific 'smart drugs.' If a protein like HER2 is overexpressed, specific monoclonal antibodies can be used for treatment.
View Interpretation
Pathology

Fine Needle Aspiration Cytology (FNAC)

FNAC is a diagnostic procedure where a thin needle is inserted into a lump or mass to extract cells for microscopic examination. Unlike a core biopsy, it collects individual cells or small clusters rather than a solid piece of tissue. It is a rapid, minimally invasive way to determine if a lesion is inflammatory, benign, or malignant. It is the first-line investigation for palpable masses in the thyroid, breast, lymph nodes, and salivary glands. It is used to decide whether a patient needs surgery or if a 'watch and wait' approach is appropriate. It is particularly valued for its high specificity in identifying carcinomas.
  • Thyroid Nodules: Assessing for papillary or follicular carcinoma.
  • Lymphadenopathy: Distinguishing between reactive lymph nodes, lymphoma, or metastatic cancer.
  • Breast Lumps: Evaluating cysts versus solid tumors.
  • Salivary Gland Tumors: Categorizing pleomorphic adenomas vs. malignancies.
View Interpretation
Biochemistry

Fluid Albumin

Fluid Albumin measurement is essential for calculating the Serum-Ascites Albumin Gradient (SAAG). This calculation (Serum Albumin minus Fluid Albumin) is the gold standard for determining if fluid accumulation (ascites or pleural effusion) is due to portal hypertension (transudate) or other causes like malignancy or infection (exudate).
View Interpretation
Biochemistry

Fluid Amylase

This test measures the concentration of the enzyme amylase in body fluids other than blood (e.g., pleural fluid, ascitic fluid). In pleural fluid, elevated amylase is highly suggestive of acute pancreatitis, esophageal rupture, or malignancy. In ascitic fluid (peritoneal fluid), high levels are typically indicative of pancreatic injury, such as acute pancreatitis or a pancreatic pseudocyst. Comparing fluid amylase to serum amylase levels is a critical diagnostic step in identifying the source of an effusion.
View Interpretation
Biochemistry

Fluid Biochemical Analysis

Fluid Biochemical Analysis involves the chemical examination of fluids accumulated in body cavities (pleural, peritoneal, or pericardial). By measuring levels of protein, lactate dehydrogenase (LDH), glucose, and pH, doctors can apply criteria (like Light's Criteria) to determine the mechanism of fluid accumulation. This test is ordered when a patient has an effusion (abnormal fluid buildup). The primary goal is to differentiate between a Transudate (fluid leaking due to pressure imbalances) and an Exudate (fluid leaking due to inflammation or injury).
  • Transudates: Commonly caused by Congestive Heart Failure (CHF), Cirrhosis (Ascites), or Nephrotic Syndrome.
  • Exudates: Commonly caused by Bacterial Pneumonia (Parapneumonic effusion), Malignancy (Cancer metastasis), Pulmonary Embolism, or Tuberculosis.
  • Chylothorax: Identified by high triglyceride levels in the fluid.
Analysis of glucose levels can also point toward specific causes; for instance, very low glucose in pleural fluid is often associated with Rheumatoid Arthritis or complicated infections. This analysis is the first step in diagnosing the root cause of organ dysfunction or systemic disease manifesting as fluid collection, guiding whether the patient needs diuretics (for transudates) or antibiotics/drainage (for exudates).
View Interpretation
Electrolytes

Fluid Chlorides

Chloride is a major extracellular anion that helps maintain osmotic pressure, acid-base balance, and proper hydration. When measured in body fluids other than blood (such as pleural, ascitic, or cerebrospinal fluid), it helps clinicians understand the electrochemical neutrality of that fluid. Because chloride often follows sodium to maintain electrical balance, its concentration in serous fluids usually mirrors that of the plasma unless a specific metabolic process is occurring within the cavity. Fluid chloride testing is less common than protein or LDH testing but is ordered in specific scenarios:
  • CSF Analysis: To help distinguish between bacterial and viral meningitis (historically, though less common now).
  • Metabolic Evaluation: To calculate the 'Anion Gap' within a specific fluid compartment.
  • Fluid Identification: To help identify unknown drainage (e.g., checking if clear nasal drainage is actually Cerebrospinal Fluid, which has a high chloride content compared to mucus).
  • CSF Leak: High chloride levels in drainage from the nose or ear after trauma can confirm the presence of CSF.
  • Bacterial Meningitis: Historically associated with decreased chloride levels in the CSF, though this is now considered a non-specific finding.
  • Metabolic Alkalosis: May lead to compensatory changes in fluid chloride levels. In most serous fluids (like those from the abdomen or chest), chloride levels remain fairly static and are used primarily to ensure the biochemical profile of the fluid is consistent with the patient's systemic electrolyte status.
View Interpretation
Biochemistry

Fluid Cholesterol

Fluid Cholesterol measurement is utilized in Fluid Biochemical Analysis to differentiate between transudative and exudative effusions (pleural or ascitic). While Light's Criteria (using Protein and LDH) is the gold standard, Fluid Cholesterol is an excellent adjunct. Cholesterol levels in the fluid are higher in exudates because of increased capillary permeability and the breakdown of local cells (mesothelial cells and leukocytes). A threshold of >45 mg/dL is often used to identify exudates with high specificity.
View Interpretation
Microbiology

Fluid For AFB Staining

Acid-Fast Bacilli (AFB) staining is a laboratory technique used to identify bacteria that have a unique waxy cell wall (rich in mycolic acids). These bacteria do not stain well with standard Gram stains but 'hold onto' certain dyes even when washed with acid-alcohol—hence the name 'acid-fast.' The most famous of these is Mycobacterium tuberculosis. This test is ordered when a patient is suspected of having tuberculosis (TB) or other mycobacterial infections. When TB spreads beyond the lungs (extrapulmonary TB), it can cause fluid to build up in the lining of the lungs (pleural effusion), around the heart (pericardial effusion), or in the abdomen. Testing this fluid directly for AFB is a rapid way to check for active infection.
  • Tuberculosis (TB): Caused by M. tuberculosis. This is a major global health concern.
  • Nontuberculous Mycobacteria (NTM): Environmental bacteria that can cause infections in people with weakened immune systems or lung disease.
  • Leprosy: Caused by Mycobacterium leprae.
  • MAI/MAC Infection: Common in advanced HIV/AIDS patients.
View Interpretation
Microbiology

Fluid For C/S

The Culture and Sensitivity (C/S) test on body fluids is a critical microbiological procedure used to identify the presence of pathogenic microorganisms (bacteria or fungi) in normally sterile body compartments. This includes fluids like pleural fluid (lungs), ascitic fluid (abdomen), or synovial fluid (joints). It is ordered when an infection is suspected in a specific cavity, a condition known as an 'effusion.' If a patient presents with localized swelling, pain, and fever, clinicians must determine if the fluid accumulation is 'sterile' (due to inflammation or pressure) or 'infected' (due to bacteria). The sensitivity portion of the test is vital, as it determines which specific antibiotics will effectively kill the identified pathogen.
  • Septic Arthritis: Infection in a joint space.
  • Bacterial Peritonitis: Infection of the abdominal lining, common in patients with liver cirrhosis.
  • Empyema: A collection of pus in the pleural space (around the lungs).
  • Meningitis: If the fluid is Cerebrospinal fluid (CSF).
The fluid is incubated in growth media. If growth occurs, it is identified using biochemical tests or mass spectrometry, and then tested against various antibiotic discs to observe zones of inhibition.
View Interpretation
Clinical Pathology

Fluid For Cell Count / Celltype

Fluid analysis for cell count and differential (cell type) involves the microscopic examination of fluid collected from body cavities (like the space around the lungs, heart, or abdomen). It quantifies the number of White Blood Cells (WBCs) and Red Blood Cells (RBCs) and identifies the percentage of neutrophils, lymphocytes, and other cells. This test is vital for determining the cause of abnormal fluid accumulation (effusion). It is ordered for:
  • Pleural Effusion: Fluid around the lungs causing shortness of breath.
  • Ascites: Fluid in the abdomen, often seen in liver cirrhosis or heart failure.
  • Septic Arthritis: To check for infection in joint fluid (Synovial).
  • Meningitis: Analysis of Cerebrospinal Fluid (CSF) to distinguish between bacterial and viral causes.
  • Infection (Exudate): High WBC count with a high percentage of neutrophils suggests bacterial infection (e.g., Spontaneous Bacterial Peritonitis).
  • Malignancy: Presence of atypical or cancerous cells in the fluid.
  • Congestive Heart Failure (Transudate): Typically results in low cell counts.
  • Tuberculosis: Often characterized by a high count of lymphocytes in the fluid.
By categorizing the fluid as either a 'transudate' (systemic pressure issues) or an 'exudate' (local inflammatory/infectious issues), doctors can narrow down the diagnosis significantly.
View Interpretation
Microbiology

Fluid For Culture & Sensitivity (Radiometric)

A Culture and Sensitivity (C&S) test of body fluids (such as pleural, peritoneal, pericardial, or synovial fluid) is designed to identify the presence of pathogenic microorganisms. The 'Radiometric' method refers to an automated system that detects carbon dioxide produced by metabolizing bacteria using radioactive isotopes or sensitive infrared sensors, allowing for faster detection than traditional visual methods. This test is critical when a clinician suspects an infection in a sterile body cavity. It is ordered to:
  • Diagnose bacterial, fungal, or mycobacterial infections.
  • Determine the most effective antibiotic treatment (Sensitivity testing).
  • Differentiate between infectious and non-infectious causes of fluid accumulation (effusions).
  • Monitor the effectiveness of ongoing antimicrobial therapy.
Specific conditions identified through this test include:
  • Septic Arthritis: Infection in a joint space.
  • Peritonitis: Infection of the abdominal lining, often following a ruptured organ.
  • Pleural Empyema: A collection of pus in the space between the lung and chest wall.
  • Meningitis: If the fluid is cerebrospinal (CSF).
  • Bacteremia: When the source of systemic infection is localized to a specific fluid compartment.
View Interpretation
Parasitology

Fluid For Hydatid Scolices

This laboratory examination involves the microscopic analysis of cystic fluid—typically obtained from the liver or lungs—to identify the presence of scolices, which are the head portions of the tapeworm Echinococcus granulosus. This parasite is the causative agent of Cystic Echinococcosis, also known as Hydatid Disease. The identification of these scolices or 'hydatid sand' provides definitive proof of a parasitic infection. The test is ordered when imaging (such as an Ultrasound or CT scan) reveals a cystic lesion that has characteristics suspicious of a hydatid cyst. It is used to:
  • Confirm Diagnosis: To definitively distinguish a parasitic cyst from a simple cyst or a malignant tumor.
  • Post-Surgical Verification: To ensure the contents of a removed cyst were indeed parasitic and to assess the viability of the parasite.
  • Differential Diagnosis: To rule out other parasitic infections like amoebic liver abscesses.
The presence of scolices is diagnostic of:
  • Cystic Echinococcosis: A condition where larvae form slow-growing cysts in the body, which can eventually cause pressure on organs, rupture, and lead to anaphylactic shock or secondary cyst formation throughout the body.
Note: Aspiration of a suspected hydatid cyst is generally discouraged due to the high risk of fluid leakage, which can cause life-threatening allergic reactions. Modern diagnosis usually relies on serology (IgG) and imaging.
View Interpretation
Cytopathology

Fluid For Malignant Cells

Cytological examination of body fluids is a specialized laboratory process where a pathologist examines cells suspended in fluids (like those from the chest or abdomen) under a microscope. The goal is to identify morphological changes indicative of cancer. This test is ordered when a patient has an abnormal accumulation of fluid (effusion). The presence of fluid can be the first sign of an underlying malignancy. Identifying malignant cells allows for a definitive diagnosis of 'malignant effusion,' which significantly impacts cancer staging and treatment planning.
  • Metastatic Adenocarcinoma: Frequently found in pleural and ascitic fluids, often originating from the lungs, breast, or ovaries.
  • Mesothelioma: A primary cancer of the lining (mesothelium) often associated with asbestos exposure.
  • Lymphoma: Malignant white blood cells can sometimes be identified in fluid samples.
  • Inflammatory Conditions: While the test looks for cancer, it also identifies reactive mesothelial cells caused by pneumonia or tuberculosis, which can mimic malignancy.
Fluid cytology is a minimally invasive yet powerful diagnostic tool. A positive result provides direct evidence of cancer spread, while a negative result, though reassuring, may sometimes require follow-up biopsies if clinical suspicion remains high.
View Interpretation
Metabolic

Fluid Glucose

Fluid Glucose testing measures the level of sugar in body fluids other than blood, most commonly Cerebrospinal Fluid (CSF), pleural fluid (around the lungs), or peritoneal fluid (in the abdomen). Glucose enters these fluids by diffusion from the blood. In healthy states, fluid glucose levels are typically proportional to blood glucose levels. However, certain pathological processes, particularly infections and cancers, can rapidly consume this glucose, leading to abnormally low levels in the fluid. This test is vital for differential diagnosis in several scenarios:
  • Meningitis Differentiation: In CSF, low glucose (hypoglycorrhachia) strongly suggests bacterial or fungal meningitis, whereas viral meningitis usually presents with normal glucose.
  • Pleural Effusion Analysis: Helps distinguish between transudates and exudates. Very low glucose in pleural fluid can indicate rheumatoid arthritis or empyema.
  • Peritonitis: Used to assess for bacterial infection in the abdominal cavity.
  • Bacterial Meningitis: Massive consumption of glucose by bacteria and white blood cells.
  • Empyema: A collection of pus in the pleural space.
  • Rheumatoid Pleurisy: Characterized by extremely low glucose (often < 30 mg/dL).
  • Malignant Effusions: Cancer cells consuming glucose for rapid growth.
View Interpretation
Biochemistry

Fluid Glucose

In the context of Fluid Biochemical Analysis (e.g., pleural, peritoneal, or pericardial fluid), glucose levels are measured to differentiate between transudates and exudates and to identify specific underlying pathologies. Normally, glucose levels in serous fluids mirror serum levels. However, a decrease in fluid glucose (hypoglycorrachia-like state in serous fluid) suggests increased metabolic activity by bacteria (infection/empyema), malignant cells, or significant synovial/serous inflammation (such as Rheumatoid Arthritis or SLE). It is a critical marker for diagnosing bacterial peritonitis or pleural empyema.
View Interpretation
Biochemistry

Fluid Proteins

Fluid protein analysis is a diagnostic procedure used to determine the concentration of total protein in various body fluids, such as pleural (lung), peritoneal (abdominal), or cerebrospinal fluid (CSF). The primary function of this test is to differentiate between two types of fluid accumulation: transudates and exudates. Transudates are typically caused by systemic factors that alter hydrostatic or oncotic pressure (like heart failure), while exudates are caused by local inflammatory or neoplastic processes that increase capillary permeability. Physicians order this test when a patient presents with an abnormal accumulation of fluid (effusion). It is critical for narrowing down the cause of symptoms like shortness of breath (pleural effusion) or abdominal swelling (ascites). By comparing fluid protein levels to serum protein levels, clinicians apply 'Light’s Criteria' to pinpoint whether the issue is systemic or localized to the organ lining.
  • Transudative causes: Congestive heart failure, Cirrhosis, Nephrotic syndrome.
  • Exudative causes: Bacterial pneumonia, Malignancy (lung or breast cancer), Pulmonary embolism, Tuberculosis.
  • CSF specific: Meningitis, Multiple Sclerosis, or Guillain-Barré syndrome if protein is elevated in the spinal fluid.
View Interpretation
Biochemistry

Fluid Total Protein

Fluid Total Protein is a critical parameter in the biochemical analysis of effusions (pleural, ascitic, or pericardial). It is used to categorize the fluid as either a 'transudate' (low protein) or an 'exudate' (high protein). Transudates are typically caused by systemic pressure changes (e.g., heart failure), while exudates result from local disease causing capillary permeability (e.g., infection or malignancy).
View Interpretation
Biochemistry

Fluid Triglycerides

This test measures triglyceride concentration in aspirated body fluids (pleural, ascitic, or pericardial). In Fluid Biochemical Analysis, it is the primary diagnostic tool for identifying a chylous effusion (chylothorax or chylous ascites). A milky fluid with high triglycerides (>110 mg/dL) confirms the presence of chyle, typically resulting from thoracic duct leakage, trauma, or lymphatic obstruction (often by lymphoma).
View Interpretation
Metabolic

Fluid for Amylase

Amylase is an enzyme primarily produced by the pancreas and salivary glands to break down complex carbohydrates into simple sugars. While typically measured in the blood, testing for amylase in various body fluids (ascitic, pleural, or pericardial) serves as a specialized diagnostic tool to identify localized pathology. In healthy individuals, amylase levels in these fluids are generally low, mirroring or remaining below serum concentrations. Physicians order a Fluid Amylase test when there is an unexplained accumulation of fluid (effusion) in the chest or abdominal cavity. It is critical for:
  • Pancreatitis Diagnosis: Detecting if an abdominal effusion is caused by acute pancreatitis or a pancreatic pseudocyst.
  • Esophageal Perforation: High levels in pleural fluid can indicate a rupture of the esophagus (where salivary amylase leaks into the chest).
  • Malignancy Screening: Certain tumors, particularly of the lungs or ovaries, can cause elevated amylase in accumulated fluids.
High levels of amylase in body fluids are strongly associated with:
  • Acute Pancreatitis: Levels often exceed serum levels by several fold.
  • Pancreatic Pseudocyst: Fluid within the cyst or leaking from it will show extremely high amylase activity.
  • Esophageal Rupture: Pleural fluid amylase rises due to the presence of saliva.
  • Chronic Pancreatitis: May show persistent elevations if a ductal leak is present.
View Interpretation
Biochemistry

Fluid pH

Measurement of pH in body fluids (most commonly pleural fluid) is a critical diagnostic tool in biochemical analysis. In pleural effusions, a low pH (<7.2) is a strong indicator of an 'uncomplicated' vs 'complicated' parapneumonic effusion, often necessitating chest tube drainage. It helps differentiate causes such as malignancy, rheumatoid arthritis, or esophageal rupture from simpler transudative processes.
View Interpretation
Endocrinology

Follicle Stimulating Hormone (FSH)

FSH is a gonadotropin synthesized by the anterior pituitary. In the LH, FSH Panel, it is used to evaluate reproductive health: in females, it triggers the growth of ovarian follicles; in males, it stimulates spermatogenesis. It is the primary marker used to diagnose menopause, PCOS, and primary testicular or ovarian failure.
View Interpretation
Endocrinology

Follicle Stimulating Hormone (FSH)

FSH is a gonadotropin synthesized and secreted by the anterior pituitary gland. In females, it stimulates the growth of ovarian follicles and the production of estrogen; in males, it acts on Sertoli cells to support spermatogenesis. Measuring FSH alongside LH is vital for evaluating infertility, menstrual irregularities, pituitary disorders, and determining the onset of menopause or premature ovarian failure.
View Interpretation
Endocrinology

Follicle Stimulating Hormone (FSH)

FSH is a pituitary glycoprotein essential for reproductive function. In females, it stimulates the growth of ovarian follicles and the secretion of estrogen. In males, it acts on Sertoli cells to support spermatogenesis. FSH is the primary laboratory marker used to diagnose menopause, primary ovarian insufficiency, and male infertility.
View Interpretation
Endocrinology

Follicle-Stimulating Hormone (FSH)

FSH is a gonadotropin synthesized and secreted by the anterior pituitary gland. In females, it stimulates the growth of ovarian follicles and estrogen production. In males, it acts on Sertoli cells to support spermatogenesis. In the context of the 'LH, FSH, PRL Profile', it is used to diagnose primary vs. secondary hypogonadism, evaluate infertility, investigate menstrual irregularities, and confirm menopause.
View Interpretation
Endocrinology

Follicular Stimulating Hormone (FSH)

Follicle-Stimulating Hormone (FSH) is a gonadotropin produced by the anterior pituitary gland. In women, FSH stimulates the growth and recruitment of immature ovarian follicles in the ovary. In men, FSH acts on the Sertoli cells of the testes to stimulate spermatogenesis (sperm production). FSH testing is used to evaluate fertility issues, irregular menstrual cycles, and pituitary gland disorders. In women, it is a primary marker used to confirm the onset of menopause or to diagnose Polycystic Ovary Syndrome (PCOS). In men, it is used to investigate low sperm counts or testicular failure.
  • Menopause: Characterized by very high FSH levels as the body tries to stimulate non-responsive ovaries.
  • Polycystic Ovary Syndrome (PCOS): Often shows an abnormal LH to FSH ratio.
  • Primary Ovarian Insufficiency (POI): High FSH in women under 40.
  • Hypopituitarism: Low FSH levels resulting in secondary infertility.
  • Klinefelter Syndrome: High FSH levels in males due to testicular failure.
FSH is a cornerstone of reproductive endocrinology, acting as a messenger between the brain and the reproductive organs to ensure proper gamete development.
View Interpretation
Respiratory

Forced Expiratory Flow 25-75% (FEF 25-75%)

This parameter measures the average flow rate during the middle half of a Forced Vital Capacity (FVC) maneuver. In Pulmonary Function Testing, it is traditionally considered a sensitive indicator of 'small airway disease' (airways < 2mm in diameter). It can be early evidence of obstructive lung disease even when the FEV1/FVC ratio is still within normal limits.
View Interpretation
Respiratory

Forced Expiratory Volume (1s) (FEV1)

Volume of air exhaled in the first second of forced expiration.
View Interpretation
Respiratory

Forced Expiratory Volume in 1 Second (FEV1)

FEV1 is the volume of air that can be forcibly exhaled from the lungs in the first second of a forced expiratory maneuver. It is the most critical parameter in Pulmonary Function Testing for identifying obstructive lung diseases. It measures how quickly the lungs can be emptied, which is directly impacted by airway resistance and lung recoil.
View Interpretation
Respiratory

Forced Vital Capacity (FVC)

Total amount of air exhaled during the FEV test.
View Interpretation
Respiratory

Forced Vital Capacity (FVC)

FVC is the total amount of air that can be forcibly exhaled from the lungs after taking the deepest breath possible. It is a cornerstone of Pulmonary Function Testing (PFT) used to identify restrictive lung diseases and to assess the severity of obstructive diseases when combined with FEV1.
View Interpretation
Prenatal Screening

Free Beta-human Chorionic Gonadotropin (Free Beta-hCG)

Free Beta-hCG is the unbound subunit of the hCG hormone. In the context of a Dual Marker screen (usually performed between 11-14 weeks of gestation), it is used to calculate the statistical risk of fetal chromosomal abnormalities. It is a vital biomarker for identifying Trisomy 21 (Down Syndrome) and Trisomy 18 (Edwards Syndrome). Its value is typically combined with PAPP-A and ultrasound findings (Nuchal Translucency).
View Interpretation
Endocrinology

Free T3, Free T4

Free T3 (Triiodothyronine) and Free T4 (Thyroxine) are the 'active' forms of thyroid hormones that circulate in the blood unbound to proteins. T4 is the primary hormone produced by the thyroid gland, while T3 is the more potent hormone, largely created by the conversion of T4 in the liver and other tissues. These hormones regulate the body's metabolic rate, heart function, digestion, muscle control, and brain development. These tests are ordered to evaluate thyroid function, specifically when TSH (Thyroid Stimulating Hormone) levels are abnormal. Measuring 'Free' hormones is more accurate than 'Total' hormones because it isn't affected by changes in protein levels caused by pregnancy, liver disease, or certain medications.
  • Hyperthyroidism: Overactive thyroid (Graves' disease, toxic nodules), characterized by high FT3/FT4.
  • Hypothyroidism: Underactive thyroid (Hashimoto's thyroiditis), characterized by low FT3/FT4.
  • T3 Toxicosis: A specific form of hyperthyroidism where only T3 is elevated.
  • Central Hypothyroidism: A pituitary issue where TSH is low and FT4 is also low.
View Interpretation
Endocrinology

Free T4 and TSH

This combined panel measures the two most critical indicators of thyroid health. Thyroid Stimulating Hormone (TSH) is produced by the pituitary gland to signal the thyroid to produce hormones. Free T4 (Thyroxine) is the active, unbound form of the primary hormone produced by the thyroid gland itself. Together, they form a feedback loop: when T4 levels drop, TSH rises, and vice versa. This panel is the gold standard for evaluating thyroid function. It is ordered for patients experiencing symptoms of an overactive or underactive thyroid, or to monitor those on thyroid replacement therapy.
  • Symptoms of Hypothyroidism: Weight gain, fatigue, cold intolerance, dry skin, and depression.
  • Symptoms of Hyperthyroidism: Weight loss, rapid heartbeat, anxiety, heat intolerance, and tremors.
  • Hashimoto's Thyroiditis: The most common cause of hypothyroidism (High TSH, Low FT4).
  • Graves' Disease: A common cause of hyperthyroidism (Low TSH, High FT4).
  • Central Hypothyroidism: A rarer condition involving pituitary failure (Low TSH, Low FT4).
  • Subclinical Hypothyroidism: An early stage where TSH is elevated but FT4 is still within the normal range.
View Interpretation
Endocrinology

Free Testosterone

Free Testosterone measures the amount of testosterone in the blood that is not bound to Sex Hormone-Binding Globulin (SHBG) or albumin. While total testosterone represents the whole reservoir, free testosterone is the 'bioavailable' portion—the hormone that is actually free to enter cells and trigger biological effects. It plays a critical role in libido, bone density, muscle mass, and mood regulation. This test is ordered when Total Testosterone results are borderline or when a patient has conditions that alter SHBG levels (like obesity, liver disease, or thyroid issues), which can make Total Testosterone results misleading. In men, it is used to investigate erectile dysfunction or low libido. In women, it is primarily used to investigate symptoms of 'virilization' such as excess facial hair (hirsutism) or irregular periods.
  • Hypogonadism (Men): Low levels lead to fatigue, muscle loss, and sexual dysfunction.
  • Polycystic Ovary Syndrome (PCOS): High levels in women are a hallmark of this endocrine disorder.
  • Androgen Insensitivity: High levels of testosterone with low clinical effect.
  • Hirsutism: Excessive hair growth in women due to elevated bioavailable androgens.
View Interpretation
Endocrinology

Free Thyroxine (FT4)

Free Thyroxine (FT4) is the active, unbound form of the hormone T4 produced by the thyroid gland. Unlike total T4, FT4 is not affected by changes in levels of binding proteins (like TBG), making it a much more accurate reflection of thyroid function. Within the Free T3, Free T4 panel, it is the primary tool for diagnosing hyperthyroidism and hypothyroidism and monitoring treatment with synthetic thyroid hormones.
View Interpretation
Endocrinology

Free Thyroxine (FT4)

Free Thyroxine (FT4) measures the concentration of thyroxine that is not bound to carrier proteins (like Thyroid-Binding Globulin). It is the biologically active form of T4 available to body tissues. Within a Thyroid Function Panel, FT4 is superior to Total T4 because it is unaffected by changes in protein levels (e.g., during pregnancy or use of oral contraceptives). It is essential for diagnosing hypothyroidism and hyperthyroidism and for monitoring patients on thyroid replacement therapy.
View Interpretation
Endocrinology

Free Thyroxine (FT4)

Free Thyroxine (FT4) measures the unbound, metabolically active portion of the T4 hormone produced by the thyroid gland. Unlike Total T4, FT4 is not affected by changes in blood protein levels (such as during pregnancy or liver disease). In a TSH and FT4 Panel, it is used to assess thyroid function directly. It helps distinguish between primary thyroid disorders (where TSH and FT4 move in opposite directions) and central/secondary disorders (where they may move in the same direction).
View Interpretation
Endocrinology

Free Thyroxine (FT4)

Free Thyroxine (FT4) is the metabolically active, unbound fraction of thyroxine. Unlike total T4, FT4 is not affected by changes in the concentration of thyroid-binding proteins (like TBG), which can fluctuate due to pregnancy, estrogen therapy, or liver disease. In a panel including TSH, FT4 is critical for distinguishing between primary thyroid disorders (where TSH and FT4 move in opposite directions) and central/secondary thyroid disorders (where TSH and FT4 may move in the same direction).
View Interpretation
Endocrinology

Free Thyroxine (FT4)

Free Thyroxine (FT4) measures the unbound portion of thyroxine, which is the biologically active form of the hormone available to tissues. Unlike Total T4, FT4 is not influenced by changes in the concentration of thyroid-binding globulin (TBG). This makes it a superior diagnostic tool for assessing thyroid status, especially in patients who are pregnant, taking oral contraceptives, or have liver/kidney disease. Within a Thyroid Function Test panel, FT4 is used alongside TSH to diagnose hyperthyroidism (high FT4, low TSH), primary hypothyroidism (low FT4, high TSH), or central hypothyroidism (low FT4, low/normal TSH).
View Interpretation
Endocrinology

Free Triiodothyronine (FT3)

Triiodothyronine (T3) is one of the two major hormones produced by the thyroid gland. While the gland produces more T4, T3 is significantly more potent. 'Free' T3 refers to the portion of the hormone that is not bound to carrier proteins, making it biologically active and available to body tissues. It plays a central role in regulating basal metabolic rate, body temperature, and heart rate. FT3 is primarily used to diagnose hyperthyroidism and to determine the severity of the condition. It is particularly useful in cases of 'T3 Thyrotoxicosis,' where TSH is low and T4 is normal, but T3 is elevated. It is less useful for diagnosing hypothyroidism, as it is often the last value to drop in failing thyroid function.
  • Graves' Disease: An autoimmune condition causing hyperthyroidism.
  • Toxic Nodular Goiter: Small lumps in the thyroid that overproduce hormones.
  • Thyroiditis: Inflammation that can cause a temporary release of excess T3.
  • Non-Thyroidal Illness Syndrome: A state where FT3 levels drop during severe systemic illness despite a healthy thyroid.
View Interpretation
Endocrinology

Free Triiodothyronine (FT3)

FT3 is the metabolically active, unbound fraction of T3. While T4 is more abundant, T3 is much more potent at the cellular level. This test is vital for diagnosing hyperthyroidism (specifically T3-toxicosis) and for monitoring patients on thyroid replacement therapy. It bypasses the confounding effects of binding proteins (like TBG) that affect Total T3 levels.
View Interpretation
Endocrinology

Free Triiodothyronine (FT3)

Free T3 measures the unbound, metabolically active form of triiodothyronine. While T4 is produced in higher quantities, T3 is the more potent thyroid hormone. In the Thyroid Function Panel, FT3 is essential for diagnosing 'T3 toxicosis' (where T3 is elevated but T4 is normal) and for monitoring the severity of hyperthyroidism. It provides a clearer picture of thyroid status than Total T3 because it is not affected by changes in thyroid-binding globulin (TBG) levels caused by pregnancy or medications.
View Interpretation
Endocrinology

Free Triiodothyronine (FT3)

Free T3 is the unbound and biologically active form of the hormone triiodothyronine. While T4 is produced in greater quantities, T3 is significantly more potent at the cellular level. In a Thyroid Function Test (TFT) panel, FT3 is primarily used to diagnose hyperthyroidism and to assess the severity of thyrotoxicosis. It is particularly useful in 'T3 Toxicosis,' where TSH is low and FT4 is normal, but FT3 is elevated.
View Interpretation
Microbiology

Fungal Culture

A Fungal Culture is used to diagnose fungal infections (mycoses) of the skin, nails, hair, or internal systems. Because fungi grow much slower than bacteria, this test may take several weeks to complete. The test identifies the specific genus and species of the fungus, allowing for precise antifungal prescription. Fungal cultures are ordered when a visual examination (or a KOH prep) is inconclusive or when the infection is persistent despite treatment. It is commonly used for:
  • Tinea Corporis/Pedis: Common ringworm or athlete's foot.
  • Onychomycosis: Fungal infection of the nails which is notoriously difficult to treat.
  • Candidiasis: Yeast infections in various body sites.
  • Systemic Mycoses: Deep tissue or blood infections in immunocompromised individuals.
  • Dermatophytosis: Infections caused by fungi that require keratin for growth.
  • Aspergillosis: A serious infection that can affect the lungs.
  • Histoplasmosis: A fungal infection often associated with bird or bat droppings.
View Interpretation
Microbiology

Fungal Culture and Sensitivity

A fungal culture is used to determine if a fungus is causing an infection in the skin, nails, lungs, or bloodstream. Because fungi grow much more slowly than bacteria, the lab 'cultures' the sample in specialized media for up to several weeks. 'Sensitivity' testing involves exposing the grown fungus to various antifungal medications to see which drug most effectively kills it. It is ordered when a patient has symptoms of a persistent infection that does not respond to antibacterial treatment. Symptoms include itchy, red skin, thickened or yellowed nails, or white patches in the mouth. It is essential for identifying the specific species (e.g., Candida, Aspergillus, or Dermatophytes) to ensure the correct antifungal medication is prescribed.
  • Dermatophytosis: Tinea (ringworm), athlete's foot, or jock itch.
  • Onychomycosis: Fungal infection of the nails.
  • Candidiasis: Yeast infections (oral thrush or vaginal).
  • Systemic Mycoses: Deep tissue or blood fungal infections, often in immunocompromised patients.
View Interpretation
Hematology

G6PD Estimation

Glucose-6-Phosphate Dehydrogenase (G6PD) is an essential enzyme found in red blood cells (RBCs). Its primary role is to protect RBCs from oxidative stress—damage caused by reactive oxygen species. G6PD helps produce a molecule called NADPH, which keeps glutathione in its active form. Without enough G6PD, RBCs become vulnerable to premature destruction when exposed to certain triggers. This test is ordered to screen for G6PD deficiency, a common genetic condition, particularly in individuals of Mediterranean, African, or Asian descent. It is typically performed after a patient experiences an episode of hemolytic anemia (jaundice, dark urine, fatigue) following the ingestion of certain foods (like fava beans), infections, or specific medications. It is also part of newborn screening in many regions.
  • G6PD Deficiency: An X-linked recessive disorder.
  • Hemolytic Anemia: Acute breakdown of red blood cells.
  • Neonatal Jaundice: Severe jaundice in newborns which can lead to kernicterus if untreated.
  • Favism: An acute hemolytic reaction to fava beans.
Patients with low G6PD must avoid oxidative triggers, including antimalarial drugs (like primaquine), sulfonamides, naphthalene (mothballs), and certain high-dose vitamins. Understanding one's G6PD status is vital for preventing life-threatening hemolytic crises during medical treatments.
View Interpretation
Genetics

GIST Mutation Analysis Exon 9 & Exon 11

Gastrointestinal Stromal Tumors (GISTs) are the most common mesenchymal tumors of the digestive tract. Approximately 85% of GISTs harbor mutations in the KIT proto-oncogene. The GIST Mutation Analysis specifically targets Exon 9 and Exon 11 of the KIT gene. These exons encode the regulatory and juxtamembrane domains of the KIT receptor tyrosine kinase. Identifying these mutations is essential for predicting the tumor's behavior and its response to targeted therapies. This genetic analysis is not a screening tool but a diagnostic and prognostic test ordered after a biopsy has confirmed a GIST. It is ordered to:
  • Guide Targeted Therapy: Mutations in Exon 11 generally respond very well to standard doses of Imatinib (Gleevec), whereas Exon 9 mutations often require a higher dose for efficacy.
  • Predict Prognosis: Exon 11 mutations are the most common, while Exon 9 mutations are often associated with an intestinal primary site and more aggressive behavior.
  • Identify Wild-Type GISTs: If no mutations are found in KIT or PDGFRA, the tumor is considered 'wild-type,' which may require different therapeutic strategies or investigation into rarer genetic syndromes like Carney-Stratakis syndrome.
The presence of these mutations is diagnostic for GIST. This information is vital for the multidisciplinary oncology team to determine if a patient is a candidate for neoadjuvant therapy (to shrink a tumor before surgery) or adjuvant therapy (to prevent recurrence after surgery). Understanding the specific exon mutation helps in managing metastatic disease and anticipating potential resistance to certain tyrosine kinase inhibitors.
View Interpretation
Infectious Disease

Galactomannan Antigen for Aspergillus

Galactomannan is a polysaccharide component found in the cell walls of most Aspergillus species. As the fungus grows in host tissue, this antigen is released into the bloodstream or other body fluids. The Galactomannan Antigen test is a non-invasive immunoassay designed to detect this specific molecule, facilitating the early diagnosis of Invasive Aspergillosis (IA), a severe and often fatal fungal infection. This test is a critical component of the diagnostic workup for immunocompromised patients, including:
  • Stem Cell/Organ Transplant Recipients: Who are at the highest risk for invasive fungal infections.
  • Leukemia Patients: Particularly those experiencing prolonged periods of neutropenia (low white blood cell counts).
  • Early Detection: Because clinical symptoms of fungal pneumonia are non-specific, detecting galactomannan can allow for earlier initiation of antifungal therapy before imaging shows definitive signs.
  • Monitoring: To track the efficacy of antifungal medications.
  • Invasive Aspergillosis (IA): The primary condition detected, usually involving the lungs but potentially spreading to the brain or other organs.
  • Chronic Pulmonary Aspergillosis: Though the test is less sensitive for the chronic form compared to the invasive form.
View Interpretation
Hematology

Gamma Globulin

Fraction of serum protein.
View Interpretation
Hematology

Gamma Globulin

The gamma globulin fraction on a Serum Protein Electrophoresis (SPEP) primarily consists of immunoglobulins (IgG, IgA, IgM, IgD, and IgE). Measurement is critical for identifying monoclonal gammopathies (like Multiple Myeloma), polyclonal gammopathies (chronic inflammation/infection), or immunodeficiencies (hypogammaglobulinemia). In the context of liver disease, a 'beta-gamma bridge' can be a hallmark sign of cirrhosis.
View Interpretation
Immunology

Gamma Globulin

Gamma globulins represent the fraction of serum proteins that primarily contain immunoglobulins (IgG, IgA, IgM, IgD, IgE). In Serum Protein Electrophoresis, this region is scrutinized for 'M-spikes' (monoclonal spikes), which indicate the overproduction of a single antibody by a clonal population of plasma cells. Evaluation of this component is critical for diagnosing multiple myeloma, Waldenström macroglobulinemia, and chronic inflammatory states.
View Interpretation
Metabolic

Gamma-Glutamyl Transferase (GGT)

Gamma-Glutamyl Transferase (GGT) is an enzyme found in high concentrations in the liver, bile ducts, and kidney. While it is highly sensitive to liver damage, it is not found in bone tissue. This makes GGT a vital diagnostic tool for differentiating between bone disease and liver disease when Alkaline Phosphatase (ALP) levels are elevated. Its primary biological role involves the metabolism of glutathione and the transport of amino acids across cell membranes. Doctors order a GGT test to:
  • Screen for chronic or acute liver disease.
  • Investigate the cause of an elevated ALP level.
  • Detect bile duct obstructions (cholestasis).
  • Screen for or monitor alcohol abuse (as GGT is highly sensitive to alcohol consumption).
  • Monitor patients taking potentially hepatotoxic medications.
Elevated GGT is associated with several hepatobiliary and systemic conditions:
  • Biliary Obstruction: Such as gallstones or tumors blocking the bile duct.
  • Alcoholic Liver Disease: Even small amounts of alcohol can trigger GGT production.
  • Non-Alcoholic Fatty Liver Disease (NAFLD): Now a common cause of mild GGT elevation.
  • Cirrhosis and Hepatitis: General inflammation or scarring of the liver.
  • Congestive Heart Failure: Due to liver congestion.
  • Pancreatitis: Inflammation of the pancreas.
View Interpretation
Metabolic

Globulin

Globulins are a diverse group of proteins in the blood that play vital roles in liver function, blood clotting, and fighting infection. They are generally categorized into alpha-1, alpha-2, beta, and gamma globulins. While the liver produces most globulins, gamma globulins (immunoglobulins) are produced by the immune system's plasma cells. They are essential for maintaining osmotic pressure and transporting lipids and hormones through the bloodstream. This test is rarely ordered alone; it is usually part of a Total Protein or Liver Function Test (LFT) panel. It is calculated by subtracting albumin from the total protein. It is ordered to screen for liver and kidney disease, nutritional deficiencies, or blood disorders like multiple myeloma. It is also a key indicator of chronic inflammation or immune system overactivity.
  • Chronic Inflammation: High levels often point to persistent infections or autoimmune flares.
  • Liver Disease: Cirrhosis can cause a compensatory rise in globulins as albumin production fails.
  • Multiple Myeloma: A cancer of plasma cells that results in an overproduction of a specific monoclonal globulin.
  • Nephrotic Syndrome: Kidney damage can lead to a loss of specific protein fractions, altering the globulin ratio.
  • Hypogammaglobulinemia: Genetic or acquired conditions leading to low globulin and increased infection risk.
View Interpretation
Metabolic

Globulin

Globulin is a calculated value (Total Protein minus Albumin). It comprises diverse proteins including gamma globulins (antibodies) and alpha/beta globulins (transport proteins/acute phase reactants). It is essential for assessing the immune system and liver synthetic function. The A/G (Albumin/Globulin) ratio is a key indicator of chronic inflammation or plasma cell disorders.
View Interpretation
Metabolic

Glucose

Glucose is the primary source of energy for the body's cells and the only energy source for the brain and nervous system. The body maintains blood glucose levels within a narrow range through a complex interplay of hormones, primarily insulin (which lowers blood sugar) and glucagon (which raises it). Glucose testing is fundamental for screening, diagnosing, and monitoring metabolic health. It is routinely ordered as part of a Basic Metabolic Panel (BMP) or Comprehensive Metabolic Panel (CMP). It is used to:
  • Screen for and diagnose Diabetes Mellitus and Prediabetes.
  • Monitor patients with known hyperglycemia or hypoglycemia.
  • Investigate symptoms such as excessive thirst (polydipsia), frequent urination (polyuria), and unexplained fatigue.
  • Diabetes Mellitus (Type 1 and 2): Characterized by chronic hyperglycemia.
  • Insulinoma: A rare tumor that produces excess insulin, leading to severe hypoglycemia.
  • Cushing Syndrome: Excess cortisol can lead to elevated glucose levels.
  • Pancreatitis: Inflammation of the pancreas can impair insulin production.
Chronic high glucose (hyperglycemia) leads to long-term damage to the kidneys, eyes, nerves, and cardiovascular system. Conversely, acute low glucose (hypoglycemia) can be life-threatening, causing confusion, seizures, or loss of consciousness.
View Interpretation
Metabolic

Glucose

Glucose is the primary energy source for the body's cells and is the key marker for carbohydrate metabolism. In a clinical panel, it is used to diagnose and monitor Diabetes Mellitus (Type 1, Type 2, and Gestational) and to evaluate metabolic disorders. Precise regulation is maintained by insulin and glucagon; chronic elevation (hyperglycemia) leads to systemic microvascular and macrovascular damage, while acute drops (hypoglycemia) can cause immediate neurological impairment.
View Interpretation
Body Fluids

Glucose (Ascitic Fluid)

In Ascitic Fluid analysis, glucose levels are compared to serum levels to help identify the cause of ascites. Bacteria and white blood cells consume glucose; therefore, low glucose levels in the peritoneal fluid are strongly suggestive of Spontaneous Bacterial Peritonitis (SBP), secondary peritonitis, or peritoneal carcinomatosis (cancer).
View Interpretation
Metabolic

Glucose Tolerance Test (1 Sample)

The Glucose Tolerance Test (GTT) measures the body's ability to metabolize a specific dose of glucose. While a full GTT involves multiple blood draws, a '1 Sample' GTT typically refers to a measurement taken at a specific interval (usually 1 or 2 hours) after consuming a standardized 75g or 50g glucose drink. It evaluates how quickly insulin is released and how effectively it clears glucose from the bloodstream. This test is a more sensitive indicator of glucose intolerance than a simple fasting glucose test. It is frequently used for:
  • Screening for Gestational Diabetes in pregnant women (usually between 24-28 weeks).
  • Diagnosing Prediabetes or Type 2 Diabetes when fasting results are borderline.
  • Evaluating 'Reactive Hypoglycemia' if the sample is taken later in the process.
  • Impaired Glucose Tolerance (IGT): A 'prediabetic' state where levels are higher than normal but not yet in the diabetic range.
  • Gestational Diabetes Mellitus (GDM): High blood sugar that develops during pregnancy.
  • Metabolic Syndrome: A cluster of conditions including high blood sugar, hypertension, and obesity.
High results on a GTT indicate that the body is struggling with 'insulin resistance' or insufficient insulin production. Early detection through this test allows for lifestyle interventions (diet/exercise) that can prevent the progression to full-blown Type 2 Diabetes.
View Interpretation
Metabolic

Glucose Tolerance Test (3 Samples)

The Glucose Tolerance Test (GTT) is a gold-standard diagnostic tool used to evaluate how the body metabolizes glucose. It measures the body's ability to clear a specific concentrated dose of glucose from the bloodstream over a set period. By taking three samples (usually fasting, 1-hour post-ingestion, and 2-hours post-ingestion), clinicians can observe the kinetics of insulin response and glucose disposal. This test is primarily ordered to diagnose Gestational Diabetes Mellitus (GDM) in pregnant women, typically between 24 and 28 weeks of gestation. It is also used to identify Prediabetes or Type 2 Diabetes when fasting plasma glucose levels are inconclusive but clinical suspicion remains high. It helps in identifying 'impaired glucose tolerance,' a state where blood sugar is high but not yet at the threshold of overt diabetes.
  • Gestational Diabetes: High levels during pregnancy that increase risks for both mother and child.
  • Insulin Resistance: A condition where cells do not respond properly to insulin.
  • Metabolic Syndrome: A cluster of conditions that increase the risk of heart disease and stroke.
  • Polycystic Ovary Syndrome (PCOS): Often associated with insulin processing issues.
  • Reactive Hypoglycemia: Where blood sugar drops to abnormally low levels after a glucose load.
Patients must fast for 8–12 hours. A baseline blood sample is drawn, followed by the consumption of a standardized glucose drink (usually 75g or 100g). Subsequent blood draws occur at intervals to map the glycemic curve. This longitudinal view is far more descriptive than a single static measurement.
View Interpretation
Metabolic

Glycosylated Hb% (HbA1c)

Hemoglobin A1c (HbA1c) measures the percentage of hemoglobin that has glucose attached to it. Because red blood cells live for approximately 120 days, this test provides a weighted average of blood glucose levels over the preceding 2 to 3 months, making it superior to daily finger-prick tests for long-term monitoring. It is the gold standard for diagnosing Prediabetes and Type 2 Diabetes. It is also the primary tool for monitoring glycemic control in known diabetics. Unlike a fasting glucose test, HbA1c does not require fasting and is not affected by short-term lifestyle changes (like a single high-sugar meal the night before).
  • Diabetes Mellitus: Diagnosed at an HbA1c of 6.5% or higher.
  • Prediabetes: HbA1c between 5.7% and 6.4%, indicating a high risk of progression to diabetes.
  • Metabolic Syndrome: Often associated with elevated HbA1c and insulin resistance.
  • Cardiovascular Disease: Chronic hyperglycemia (high A1c) is a major risk factor for heart attacks and strokes.
For most adults with diabetes, a target of <7% is recommended to prevent complications like retinopathy (eye damage) or nephropathy (kidney damage).
View Interpretation
Microbiology

Gram's Stain

The Gram's Stain is a rapid laboratory test used to identify the general type of bacteria present in a clinical sample (such as sputum, blood, or cerebrospinal fluid). By applying a series of dyes, bacteria are classified as 'Gram-positive' (purple) or 'Gram-negative' (pink/red) based on the chemical and physical properties of their cell walls. It is ordered as an emergency or initial diagnostic step when an infection is suspected. Because full cultures can take 24–72 hours, the Gram's Stain provides immediate clues—often within minutes—allowing doctors to start 'empiric' antibiotic therapy that targets the specific class of bacteria identified.
  • Bacterial Pneumonia: Identified via sputum Gram stain.
  • Meningitis: Rapid identification of bacteria in cerebrospinal fluid (CSF).
  • Sepsis: Used to look for bacteria in the blood or at the source of infection.
  • Urinary Tract Infections (UTI): Identifying morphology (cocci vs. bacilli) in urine samples.
View Interpretation
Endocrinology

Growth Hormone (HGH)

Human Growth Hormone (HGH), secreted by the anterior pituitary gland, is essential for growth, body composition, cell repair, and metabolism. In children, it is the primary driver of height; in adults, it helps maintain bone density, muscle mass, and healthy adipose tissue distribution. HGH levels fluctuate throughout the day in a pulsatile manner, heavily influenced by the circadian rhythm and physiological stressors. HGH testing is rarely performed as a single random draw because of its pulsatile nature. It is typically ordered as part of stimulation or suppression tests. It is used to investigate growth delays in children, or in adults to diagnose GH deficiency or excess. Symptoms of excess include enlarging hands and feet or coarsening facial features, while deficiency symptoms include decreased vitality, increased body fat, and decreased bone mass.
  • Acromegaly: GH excess in adults, usually caused by a benign pituitary tumor.
  • Gigantism: GH excess in children before the closure of epiphyseal plates.
  • GH Deficiency: Resulting from pituitary damage, trauma, or congenital issues.
  • Pituitary Adenomas: Tumors that can either hyper-secrete HGH or crush HGH-producing cells.
Because HGH levels can be undetectable in healthy individuals during 'troughs,' clinicians often use Insulin-like Growth Factor-1 (IGF-1) as a proxy, as it provides a more stable reflection of 24-hour HGH activity.
View Interpretation
Infectious Disease

H.C.V. ELISA

The HCV ELISA (Enzyme-Linked Immunosorbent Assay) is a screening test used to detect antibodies (anti-HCV) produced by the body in response to infection with the Hepatitis C Virus. This test identifies whether an individual has ever been exposed to the virus, though it does not distinguish between an active, chronic infection and a resolved one. This test is ordered for:
  • Screening high-risk populations (IV drug users, recipients of blood transfusions before 1992).
  • Evaluating patients with elevated liver enzymes (ALT/AST).
  • Routine prenatal screening in some regions.
  • Post-exposure follow-up for healthcare workers after a needle-stick injury.
A reactive ELISA result is associated with Hepatitis C infection. If positive, it necessitates follow-up testing with an HCV RNA PCR test to determine if the virus is currently replicating in the blood. Chronic HCV can lead to progressive liver damage, including cirrhosis, liver failure, and hepatocellular carcinoma (liver cancer). Because HCV is often 'silent' for decades, the ELISA is a critical tool for early detection and prevention of end-stage liver disease. Modern antiviral therapies (DAAs) can cure HCV in over 95% of cases, making early screening via ELISA highly effective for public health.
View Interpretation
Infectious Disease

H.I.V. ELISA

The HIV ELISA (Enzyme-Linked Immunosorbent Assay) is a screening test designed to detect antibodies produced by the body in response to infection with HIV-1 and HIV-2. Modern versions (4th generation) also detect the p24 antigen, a protein that is part of the virus itself, allowing for earlier detection than older antibody-only tests. This is the standard first-line screening test for HIV. It is recommended as part of routine healthcare for adults, for prenatal screening in pregnant women, and following potential occupational or sexual exposure to the virus. Because of its high sensitivity, it is excellent at 'ruling out' the virus.
  • HIV-1/HIV-2 Infection: The primary condition detected.
  • Acute Retroviral Syndrome: The initial symptomatic stage of infection.
  • Asymptomatic HIV: The long period where the virus is active but symptoms are absent.
A 'Reactive' ELISA is not a final diagnosis. Per CDC guidelines, a reactive screening result must be followed by a confirmatory 'differentiation' assay (to distinguish between HIV-1 and HIV-2) and/or a Nucleic Acid Test (PCR) to confirm the presence of the virus.
View Interpretation
Molecular Diagnostics

HBV DNA PCR Viral Load

The HBV DNA PCR (Polymerase Chain Reaction) test is a highly sensitive molecular assay that quantifies the actual amount of Hepatitis B virus circulating in the blood. Unlike antibody tests which show the body's reaction to the virus, this test measures the 'viral load.' This test is essential for managing patients with chronic Hepatitis B. It is used to determine when to start antiviral therapy, to monitor the effectiveness of treatment, and to assess the risk of disease progression to cirrhosis or hepatocellular carcinoma (liver cancer). A high viral load usually indicates active viral replication and higher infectivity.
  • Chronic Hepatitis B: Long-term infection of the liver.
  • HBeAg-negative Chronic Hepatitis: A variant where the virus mutates but still replicates.
  • Cirrhosis: Severe scarring of the liver often linked to high viral loads.
  • Liver Cancer: Patients with high DNA levels are at a significantly increased risk.
During treatment (e.g., with Tenofovir or Entecavir), the goal is to reach 'Undetectable' levels. Sudden spikes in viral load during treatment can indicate drug resistance or poor patient compliance.
View Interpretation
Serology

HBeAg

HBeAg (Hepatitis B e-Antigen) is a soluble protein that is a byproduct of Hepatitis B Virus (HBV) replication. Its presence in the blood serves as a marker of active viral replication and high levels of HBV DNA in the serum. This test is used to manage patients already diagnosed with Chronic Hepatitis B. It helps determine how infectious the patient is (contagiousness) and monitors the effectiveness of antiviral therapy. A 'seroconversion' from HBeAg-positive to HBeAg-negative (and HBeAb-positive) is often a primary goal of treatment, signaling a transition to a less active state of the virus.
  • Chronic Hepatitis B (Active): High viral load and high risk of liver damage.
  • Acute Hepatitis B: Present during the early stages of infection.
  • HBeAg-Negative Chronic Hepatitis: A variant where the virus has mutated and does not produce the e-antigen despite high replication; this is a more aggressive form of the disease.
View Interpretation
Hepatology

HBsAg (Australia Antigen)

The Hepatitis B Surface Antigen (HBsAg), historically known as the Australia Antigen, is the earliest serum marker for an active Hepatitis B Virus (HBV) infection. Its presence indicates that the virus is replicating and that the individual is infectious to others. HBsAg is the cornerstone of HBV screening. It is ordered for:
  • General Screening: In populations at high risk for HBV.
  • Prenatal Care: Routine screening for all pregnant women to prevent mother-to-child transmission.
  • Blood Donation: To ensure the safety of the blood supply.
  • Symptom Evaluation: For patients showing signs of hepatitis, such as jaundice, dark urine, and fatigue.
  • Acute Hepatitis B: The initial short-term infection phase.
  • Chronic Hepatitis B: Defined by the persistence of HBsAg for more than six months, increasing the risk of cirrhosis and hepatocellular carcinoma (liver cancer).
  • Fulminant Hepatitis: A rare but life-threatening rapid liver failure.
Early detection through HBsAg allows for antiviral intervention and lifestyle modifications to prevent liver damage and viral spread.
View Interpretation
Infectious Disease

HBsAg (ELISA)

The Hepatitis B Surface Antigen (HBsAg) test is the primary diagnostic tool used to identify an active infection with the Hepatitis B Virus (HBV). HBsAg is a protein located on the surface of the virus. When this antigen is detected in the blood, it indicates that the virus is present and the individual is potentially infectious to others. Using the ELISA (Enzyme-Linked Immunosorbent Assay) method provides a highly sensitive and specific way to detect even minute amounts of this protein during the early stages of infection. Physicians order the HBsAg test for several critical reasons:
  • Screening: To check for infection in high-risk groups, pregnant women (to prevent mother-to-child transmission), or blood donors.
  • Diagnosis: To evaluate patients presenting with symptoms of acute hepatitis, such as jaundice, dark urine, or extreme fatigue.
  • Monitoring: To determine if a known HBV infection has become chronic. If HBsAg persists for more than six months, the patient is diagnosed with chronic Hepatitis B.
  • Pre-treatment Screening: Before initiating immunosuppressive therapy or chemotherapy, which could reactivate a latent HBV infection.
The presence of HBsAg is directly associated with:
  • Acute Hepatitis B: The initial stage of infection where the antigen appears before symptoms develop.
  • Chronic Hepatitis B: A long-term infection that can lead to severe liver damage, including cirrhosis and hepatocellular carcinoma (liver cancer).
  • Carrier State: Individuals who do not show symptoms but can still transmit the virus.
View Interpretation
Infectious Disease

HCV (Tridot)

The HCV (Tridot) test is a rapid visual antigen-antibody immunoassay used for the qualitative detection of antibodies to the Hepatitis C Virus (HCV) in human serum or plasma. It utilizes a flow-through technology where specific HCV antigens are immobilized on a membrane. When a patient's sample passes through, if antibodies against HCV are present, they bind to these antigens, creating a visible dot after the addition of a protein-A conjugate. This test is primarily ordered as a screening tool for individuals at risk of Hepatitis C infection. This includes people with history of intravenous drug use, recipients of blood transfusions before 1992, healthcare workers exposed to needle sticks, or individuals with unexplained elevations in liver enzymes (ALT/AST). Because HCV is often asymptomatic for decades (the 'silent killer'), screening is vital for preventing progressive liver damage.
  • Chronic Hepatitis C: Long-term inflammation of the liver which can lead to permanent scarring.
  • Liver Cirrhosis: Extensive scarring of liver tissue that impairs function.
  • Hepatocellular Carcinoma (HCC): A primary type of liver cancer highly associated with chronic HCV infection.
  • Cryoglobulinemia: A condition where abnormal proteins in the blood thicken in cold temperatures, often triggered by HCV.
It is important to note that a 'Reactive' Tridot result indicates the presence of antibodies, meaning the person was infected at some point. However, it does not distinguish between an active, current infection and a resolved past infection. A positive screening must always be followed by an HCV RNA PCR test to confirm the presence of the virus itself.
View Interpretation
Serology

HCV IgM

The HCV IgM test detects Immunoglobulin M antibodies against the Hepatitis C virus. IgM is the first antibody the immune system produces when it encounters a new infection. While HCV RNA (PCR) and HCV Total Ab (IgG) are more common, the IgM assay specifically helps in identifying recent exposure. This test is ordered when a physician suspects an acute (recent) Hepatitis C infection. Most cases of HCV are asymptomatic in the early stages, but some patients present with jaundice, dark urine, and extreme fatigue. Distinguishing between a new, acute infection and the exacerbation of a long-standing chronic infection is the primary clinical goal.
  • Acute Hepatitis C: The primary condition where HCV IgM would be elevated.
  • Liver Enzyme Elevation: Often ordered alongside ALT and AST tests to investigate the cause of liver inflammation.
  • Chronic Hepatitis Flare: In some cases, patients with chronic HCV may show transient IgM positivity during a viral flare-up, though this is less common than in Hepatitis B.
  • Recent Needle Stick/Exposure: Part of a post-exposure protocol for healthcare workers or individuals with high-risk exposure.
View Interpretation
Metabolic

HDL Cholesterol

High-Density Lipoprotein (HDL) is frequently referred to as 'good' cholesterol. Its primary function is 'reverse cholesterol transport,' a process where it collects excess cholesterol from the blood and arterial walls and transports it back to the liver for excretion or recycling. HDL is measured as part of a lipid panel to assess an individual's risk of developing cardiovascular disease (CVD). Unlike LDL (the 'bad' cholesterol), higher levels of HDL are generally associated with a lower risk of heart attacks, strokes, and atherosclerosis.
  • Coronary Artery Disease: Low HDL is a significant independent risk factor for plaque buildup in the heart's arteries.
  • Metabolic Syndrome: Characterized by low HDL, high triglycerides, abdominal obesity, and insulin resistance.
  • Tangier Disease: A rare genetic disorder resulting in extremely low levels of HDL.
  • Hyperalphalipoproteinemia: A condition where HDL levels are exceptionally high, which is usually cardioprotective but can sometimes be associated with specific genetic variations.
Maintaining high levels of HDL through aerobic exercise, healthy fats (like olive oil), and smoking cessation is a key strategy in preventative cardiology. It serves as a vital marker for long-term vascular health.
View Interpretation
Oncology

HE4 (Human Epididymis Protein 4)

Human Epididymis Protein 4 (HE4) is a glycoprotein primarily used as a tumor marker for monitoring the progression or recurrence of epithelial ovarian cancer. In the context of an Ovarian Cancer Panel, it is often utilized alongside CA-125 in the ROMA (Risk of Ovarian Malignancy Algorithm) score. HE4 is superior to CA-125 in premenopausal women because it is less likely to be elevated by benign conditions like endometriosis or pelvic inflammatory disease. It provides critical insight into the likelihood of malignancy in patients presenting with an adnexal mass.
View Interpretation
Oncology

HER2/Neu by FISH

HER2 (Human Epidermal Growth Factor Receptor 2) is a protein that promotes the growth of cancer cells. Fluorescent In Situ Hybridization (FISH) is a molecular test used to see if the cancer cells have extra copies of the HER2 gene. More gene copies lead to more HER2 protein, making the cancer more aggressive. This test is standard of care for all newly diagnosed breast cancers and some gastric cancers. It is used to determine if a patient is a candidate for HER2-targeted therapies, such as Trastuzumab (Herceptin) or Pertuzumab (Perjeta). It is often performed after an IHC (Immunohistochemistry) test returns an 'equivocal' (2+) result.
  • HER2-Positive Breast Cancer: A subtype of breast cancer that grows faster but responds well to targeted therapy.
  • Gastric Adenocarcinoma: Some stomach cancers also overexpress HER2 and can be treated with targeted biologics.
View Interpretation
Serology

HEV IgM

The Hepatitis E Virus (HEV) IgM test is a serological assay used to detect Immunoglobulin M antibodies against the Hepatitis E virus. IgM is the first antibody the body produces when it encounters a new infection. Its presence in the blood is a hallmark of an acute or very recent infection, as these antibodies typically disappear within 3 to 6 months after the initial exposure. This test is ordered for patients exhibiting signs of acute viral hepatitis, especially if they have recently traveled to endemic areas (Asia, Africa, Central America) or have consumed undercooked pork or venison. Symptoms often include jaundice (yellowing of eyes and skin), dark urine, extreme fatigue, and abdominal pain. It is particularly vital for pregnant women, as HEV infection in the third trimester can lead to fulminant hepatic failure with high mortality rates.
  • Acute Hepatitis E: The primary condition identified by a positive IgM.
  • Chronic Hepatitis E: Rare, but can occur in immunosuppressed individuals (though IgM may be negative here).
  • Zoonotic Transmission: Infection via contaminated food sources.
View Interpretation
Virology

HIV Proviral DNA PCR

The HIV Proviral DNA PCR test detects the genetic material of the HIV-1 virus that has been integrated into the DNA of the host's immune cells (provirus). Unlike viral load tests (RNA), which measure free virus in the plasma, DNA PCR looks for the 'blueprint' of the virus hidden inside cells. This is the definitive test for diagnosing HIV in infants born to HIV-positive mothers, as standard antibody tests (ELISA) will return false positives due to maternal antibodies. It is also used in cases of indeterminate Western Blot results or very early post-exposure diagnosis.
  • HIV-1 Infection: Confirms the presence of the virus at a cellular level.
  • Vertical Transmission: Screening of newborns to initiate early antiretroviral therapy (ART).
  • Early Infection: Detection during the 'window period' before seroconversion.
View Interpretation
Infectious Disease

HIV RNA PCR

The HIV RNA PCR (Polymerase Chain Reaction) test, often called a 'Viral Load' test, is a molecular assay that quantifies the actual genetic material (RNA) of the Human Immunodeficiency Virus in the blood. Unlike antibody tests, which look for the immune response, the PCR test detects the virus itself, providing a direct measurement of viral replication activity. This test serves two primary purposes. First, it is used for early diagnosis during the 'window period' (usually 9-11 days after exposure), before antibodies have developed. Second, and most commonly, it is used to monitor patients already diagnosed with HIV who are on Antiretroviral Therapy (ART). The goal of treatment is to achieve an 'undetectable' viral load, which means the virus is suppressed to levels lower than the machine can count.
  • Acute HIV Infection: High viral loads are typically seen in the weeks following initial infection.
  • Chronic HIV Management: Used to assess treatment efficacy.
  • Treatment Failure: A rising viral load in a patient on ART may indicate drug resistance or poor adherence.
  • Neonatal HIV: Used to test infants born to HIV-positive mothers, as maternal antibodies can persist in the baby's blood, making antibody tests unreliable.
Maintaining an undetectable viral load is critical not only for the health of the individual but also for preventing transmission (Undetectable = Untransmittable).
View Interpretation
Infectious Disease

HIV Viral Load

The HIV Viral Load test measures the amount of HIV-1 RNA (genetic material) in the blood. Unlike the HIV antibody test used for screening, the viral load test quantifies the actual number of viral particles circulating in the plasma. This measurement is the most critical metric for assessing the health of a person living with HIV and the efficacy of their treatment. This test is a cornerstone of HIV management. It is used to:
  • Assess the baseline viral activity before starting Antiretroviral Therapy (ART).
  • Monitor the effectiveness of ART (the goal is to reach 'Undetectable' levels).
  • Identify potential drug resistance or treatment failure.
  • Evaluate the risk of transmission (Undetectable = Untransmittable, or U=U).
The results are interpreted in the context of:
  • Acute HIV Infection: Very high viral loads are seen shortly after exposure.
  • Clinical Latency: The period where the virus is reproducing at low levels.
  • AIDS Progression: Viral loads typically rise significantly as the immune system (CD4 count) fails.
  • Opportunistic Infections: Increased viral replication can coincide with secondary infections like TB or pneumonia.
View Interpretation
Genetics

HLA B 27 Disease Association PCR

HLA-B27 (Human Leukocyte Antigen B27) is a specific surface antigen found on white blood cells. It is part of the Major Histocompatibility Complex (MHC) and plays a role in how the immune system recognizes foreign substances. The PCR (Polymerase Chain Reaction) test is a highly sensitive molecular method used to detect the presence of the HLA-B27 gene. This test is ordered when a patient presents with symptoms of inflammatory arthritis, particularly affecting the spine and sacroiliac joints. It is the primary genetic marker for a group of autoimmune diseases known as seronegative spondyloarthropathies. While not a definitive diagnostic test on its own (many healthy people carry the gene), it provides strong supporting evidence when combined with clinical symptoms and imaging (like X-rays or MRI of the pelvis).
  • Ankylosing Spondylitis (AS): Over 90% of patients with AS are HLA-B27 positive.
  • Reactive Arthritis (Reiter’s Syndrome): Often triggered by an infection in another part of the body.
  • Psoriatic Arthritis: Inflammation associated with the skin condition psoriasis.
  • Acute Anterior Uveitis: Inflammation of the middle layer of the eye.
View Interpretation
Immunology

HLA B27

The HLA-B27 (Human Leukocyte Antigen B27) is a specific protein, known as a class I surface antigen, found on the surface of white blood cells. It is part of the Major Histocompatibility Complex (MHC), which plays a pivotal role in the immune system's ability to distinguish between its own cells and foreign invaders like bacteria or viruses. While the presence of HLA-B27 is normal in a small percentage of the healthy population, its existence is strongly linked to several autoimmune and inflammatory conditions, particularly those involving the spine and joints. Physicians order the HLA-B27 test when a patient exhibits symptoms of chronic inflammatory arthritis, such as persistent back pain, joint stiffness, or inflammation of the eyes (uveitis). It is not a diagnostic test on its own but serves as a critical piece of the puzzle when Suspecting Seronegative Spondyloarthropathies. It helps differentiate these conditions from other forms of arthritis like Rheumatoid Arthritis. The presence of the HLA-B27 antigen is most notably associated with:
  • Ankylosing Spondylitis (AS): A form of arthritis that primarily affects the spine, leading to fusion of the vertebrae.
  • Reactive Arthritis: Joint inflammation triggered by an infection in another part of the body (formerly known as Reiter's Syndrome).
  • Psoriatic Arthritis: Inflammation associated with the skin condition psoriasis.
  • Acute Anterior Uveitis: Sudden inflammation of the middle layer of the eye.
  • Juvenile Idiopathic Arthritis: Inflammation in children that can mimic adult spondyloarthropathies.
View Interpretation
Infectious Disease

HSV 1 & 2 DNA Qualitative PCR

The Herpes Simplex Virus (HSV) 1 & 2 DNA Qualitative PCR test uses Polymerase Chain Reaction technology to detect the genetic material (DNA) of the herpes virus. This method is far more sensitive and specific than older viral culture methods, allowing for the detection of the virus even when it is present in small quantities or when a lesion has begun to heal. This test is ordered to confirm a diagnosis of herpes infection in patients with active sores or blisters on the mouth (oral herpes) or genitals (genital herpes). It is also used in critical care settings to test Cerebrospinal Fluid (CSF) if HSV encephalitis or meningitis is suspected. Distinguishing between Type 1 and Type 2 is important for prognosis and counseling regarding transmission risks.
  • HSV-1: Traditionally associated with orofacial lesions (cold sores), though it is increasingly a cause of genital herpes through oral-genital contact.
  • HSV-2: Primarily associated with genital infections and is almost exclusively sexually transmitted.
  • Neonatal Herpes: Testing is critical for newborns exposed during delivery, as the virus can cause severe neurological damage or death.
  • HSV Encephalitis: A life-threatening brain infection that requires rapid PCR testing of CSF for immediate antiviral intervention.
  • Herpetic Whitlow: HSV infection of the finger.
PCR testing remains the gold standard for clinical diagnosis of active infection over antibody testing, which only indicates past exposure.
View Interpretation
Immunology

HSV 1 & 2 IgG

The Herpes Simplex Virus (HSV) Type 1 and 2 IgG test detects long-term antibodies against the viruses responsible for cold sores (HSV-1) and genital herpes (HSV-2). IgG antibodies typically develop within weeks to months of infection and remain for life. It is ordered to determine if a person has ever been infected with HSV. It is particularly useful for pregnant women, individuals with partners who have herpes, or those presenting with atypical genital or oral sores.
  • HSV-1: Primarily associated with oral herpes (cold sores) but increasingly a cause of genital herpes.
  • HSV-2: Primarily associated with genital herpes.
  • Neonatal Herpes: Risk assessment for transmission during childbirth.
  • Aseptic Meningitis: Occasionally associated with HSV-2 primary infections.
View Interpretation
Infectious Disease

HSV 1 & 2 IgM

The Herpes Simplex Virus (HSV) 1 and 2 IgM test detects immunoglobulin M antibodies, which are the first type of antibody produced by the immune system in response to a new infection. HSV-1 is typically associated with oral herpes (cold sores), while HSV-2 is more commonly associated with genital herpes, though both can infect either site. This test is ordered to determine if a patient has recently been exposed to or is experiencing a primary (first-time) outbreak of HSV. It is often requested when a patient presents with:
  • Painful blisters or sores in the oral or genital regions.
  • Flu-like symptoms (fever, swollen glands) accompanying a new outbreak.
  • Unexplained neurological symptoms if encephalitis is suspected.
  • Primary HSV Infection: The initial infection with the virus.
  • Reactivation: While IgM is primarily a marker of recent infection, it can reappear during flare-ups in some individuals.
  • Neonatal Herpes: Screening may be conducted in newborns or pregnant women to prevent transmission.
It is important to note that IgM testing is increasingly discouraged by some health organizations in favor of HSV IgG (type-specific) and PCR testing due to the high rate of cross-reactivity and the fact that IgM does not distinguish well between type 1 and type 2.
View Interpretation
Infectious Disease

HSV 1 (IgG, IgM)

The HSV 1 (IgG, IgM) test is a serological assay used to detect antibodies against the Herpes Simplex Virus Type 1. HSV-1 is primarily associated with oral herpes (cold sores), although it is increasingly a cause of genital herpes. The test distinguishes between two types of antibodies: IgM, which typically appears shortly after initial infection, and IgG, which develops later and remains in the body for life. This test is ordered when a patient exhibits symptoms of a primary herpes infection, such as oral blisters, fever, or swollen glands. It is also used to screen pregnant individuals or those with compromised immune systems who may be at risk for severe complications. In some cases, it is part of a broader sexually transmitted infection (STI) panel or used to differentiate between HSV-1 and HSV-2.
  • Herpes Labialis: Common cold sores around the mouth.
  • Herpetic Keratitis: An infection of the eye that can cause scarring.
  • Gingivostomatitis: Infection of the mouth and gums, often seen in children.
  • Herpetic Whitlow: Painful infection on the fingers.
  • Encephalitis: A rare but severe brain inflammation caused by the virus.
A positive IgG result indicates a past infection or chronic carrier status, while a positive IgM result suggests a recent exposure or a reactivation of the virus. Because HSV-1 is highly prevalent in the adult population, a positive IgG result without symptoms is common and often does not require immediate treatment unless the patient is symptomatic or at high risk for transmission.
View Interpretation
Infectious Disease

HSV 1 IgG

The HSV 1 IgG test detects antibodies produced by the immune system in response to infection with the Herpes Simplex Virus Type 1. IgG antibodies typically appear several weeks after the initial infection and persist for life, serving as a marker of 'past' or 'latent' exposure rather than an active, primary outbreak. This test is used to determine if a person has ever been infected with HSV-1. It is often requested by patients concerned about cold sores or genital lesions, though HSV-1 is most commonly associated with oral herpes. It helps distinguish between HSV-1 and HSV-2 (genital herpes), although HSV-1 can also cause genital infections through oral-genital contact.
  • Oral Herpes (Cold Sores): The most common manifestation of HSV-1.
  • Herpetic Keratitis: An eye infection that can lead to scarring of the cornea.
  • Herpetic Whitlow: An infection of the finger.
  • Genital Herpes: Increasingly caused by HSV-1 via oral-genital transmission.
View Interpretation
Immunology

HSV 1 IgM

The HSV 1 IgM test is a serological assay used to detect Immunoglobulin M antibodies against Herpes Simplex Virus Type 1. IgM is generally the first antibody produced by the immune system in response to a new infection. HSV-1 is traditionally associated with orofacial lesions (cold sores), though it is increasingly a cause of genital herpes. This test is typically ordered when a patient presents with active sores or blisters to determine if they are experiencing an acute, primary infection. It is also used in neonatal settings where a mother has active lesions, or in cases of suspected viral encephalitis.
  • Primary HSV-1 Infection: Indicated by high IgM levels with negative IgG.
  • Reactivation: While IgM is associated with new infections, it can reappear during the reactivation of a latent virus in some individuals.
  • Cross-Reactivity: It is important to note that IgM tests can sometimes cross-react with HSV-2 or other herpesviruses like Varicella-Zoster (VZV).
IgM testing for HSV is often discouraged by many health organizations (like the CDC) in favor of PCR or type-specific IgG testing. This is because IgM cannot reliably distinguish between a first-time infection and a flare-up, and it may stay elevated for months, leading to confusion regarding the timing of the infection.
View Interpretation
Serology

HSV 2 IgG

The HSV 2 IgG test is a blood test used to detect type-specific antibodies against the Herpes Simplex Virus Type 2. Unlike the IgM antibody, which rises shortly after an initial infection and then fades, IgG antibodies develop more slowly (usually 4 to 12 weeks after exposure) and persist for life. This test distinguishes between HSV-1 (typically associated with oral cold sores) and HSV-2 (the primary cause of genital herpes) by targeting glycoprotein G2, which is unique to the HSV-2 virus. This test is used to determine if a person has ever been infected with HSV-2. It is particularly useful in several scenarios:
  • Evaluating patients with recurrent genital symptoms but negative viral cultures.
  • Screening individuals with a high-risk profile or partners of people known to have genital herpes.
  • Pregnancy screening to manage the risk of neonatal herpes transmission during delivery.
  • Differentiating between HSV-1 and HSV-2 infections to provide accurate counseling on transmission and prognosis.
A positive result indicates a chronic or past infection with Herpes Simplex Virus Type 2. Once acquired, the virus remains latent in the sacral nerve ganglia and can periodically reactivate, causing symptomatic outbreaks (genital sores) or asymptomatic viral shedding. While many people with HSV-2 are asymptomatic, they can still transmit the virus to sexual partners. Management often involves antiviral suppressive therapy (like acyclovir or valacyclovir) to reduce the frequency of outbreaks and the risk of transmission. It is also important to note that HSV-2 infection can increase the biological risk of acquiring or transmitting HIV.
View Interpretation
Infectious Disease

HSV 2 IgM

Herpes Simplex Virus Type 2 (HSV-2) is the primary cause of genital herpes. The IgM test is designed to detect early-stage antibodies produced by the immune system in response to a recent infection. IgM is typically the first antibody to appear after exposure to the virus, usually appearing within 1-2 weeks and potentially staying detectable for several months. This test is ordered when a patient presents with symptoms of a primary genital herpes infection, such as painful blisters, sores, or flu-like symptoms. It is used to distinguish between a new (acute) infection and a long-standing (chronic) infection. However, modern clinical guidelines often favor Type-Specific IgG testing or PCR swabs of active lesions due to the cross-reactivity and potential for false positives in IgM testing.
  • Primary Genital Herpes: The initial infection with the HSV-2 virus.
  • Neonatal Herpes: Screening in pregnant women to prevent transmission to the newborn during delivery.
  • Meningitis/Encephalitis: In rare cases, HSV-2 can cause neurological inflammation, requiring antibody testing in the blood or CSF.
View Interpretation
Infectious Disease

HSV-2 (IgG, IgM)

Herpes Simplex Virus Type 2 (HSV-2) is the primary cause of genital herpes. This test detects two types of antibodies: IgM and IgG. IgM usually appears within the first few weeks of infection and then declines, while IgG appears later and stays in the blood for life. Detecting these antibodies helps distinguish between a new, acute infection and a chronic, long-term carrier state. Testing is ordered for individuals presenting with genital sores or blisters, those who have a partner with known herpes, or individuals undergoing a comprehensive STI screening. Because HSV-2 can be transmitted even when no symptoms are present (asymptomatic shedding), serology is the only way to identify carriers in the absence of active lesions.
  • Genital Herpes: Chronic viral infection characterized by periodic outbreaks of painful sores.
  • Neonatal Herpes: Transmission of the virus from mother to baby during childbirth, which can be life-threatening for the infant.
  • Aseptic Meningitis: A potential neurological complication of HSV-2 infection.
  • Increased HIV Risk: Active HSV-2 lesions can increase the risk of contracting or transmitting HIV.
View Interpretation
Hematology

Haemoglobin

Haemoglobin (Hb) is the iron-containing protein found within red blood cells (RBCs). Its primary function is the transport of oxygen from the lungs to the body's tissues and the transport of carbon dioxide from the tissues back to the lungs. Each haemoglobin molecule can bind four oxygen molecules, a process facilitated by the presence of heme groups. The haemoglobin test is one of the most common medical tests, usually performed as part of a Complete Blood Count (CBC). It is ordered to:
  • Screen for Anemia: Detecting a low oxygen-carrying capacity.
  • Evaluate Fatigue: Investigating symptoms of weakness or shortness of breath.
  • Monitor Chronic Disease: Checking patients with kidney disease or inflammatory conditions.
  • Assess Blood Loss: Monitoring patients after surgery or trauma.
  • Check Polycythemia: Screening for overproduction of RBCs.
  • Iron Deficiency Anemia: The most common cause of low Hb globally.
  • Vitamin B12/Folate Deficiency: Leads to megaloblastic anemia.
  • Chronic Kidney Disease: Reduced erythropoietin production.
  • Sickle Cell Disease and Thalassemia: Genetic disorders affecting Hb structure or production.
  • Polycythemia Vera: A bone marrow disorder causing excess RBC production.
Low haemoglobin levels (anemia) indicate that the body's tissues may not be receiving adequate oxygen, leading to clinical symptoms like pallor and tachycardia. High levels (polycythemia) can increase blood viscosity, raising the risk of clots and strokes. Interpreting Hb requires looking at other indices like MCV (Mean Corpuscular Volume) to determine the 'type' of anemia present.
View Interpretation
Microbiology

Hair Clipping For Fungal Elements

Microscopic examination and culture of hair clippings are used to detect dermatophytes (fungi) that infect the hair shaft and follicle. This often involves a KOH (Potassium Hydroxide) mount, which dissolves keratin to reveal fungal hyphae or spores, and a fungal culture for definitive identification of the species. It is ordered when a patient shows signs of Tinea Capitis (scalp ringworm), which includes patchy hair loss (alopecia), scaling, itching, and inflammatory crusting (kerion). Clinical diagnosis alone can be difficult as it mimics psoriasis or seborrheic dermatitis; laboratory confirmation ensures that potentially toxic antifungal medications are only prescribed when necessary.
  • Tinea Capitis: Fungal infection of the scalp hair.
  • Tinea Barbae: Fungal infection of the beard area.
  • Favus: A severe form of tinea capitis causing yellow crusts (scutula).
  • Alopecia Areata: Often a differential diagnosis that this test helps rule out.
View Interpretation
Hematology

Hb, Tc, Dc & Esr

This profile is a baseline hematological screen consisting of Hemoglobin (Hb), Total Count of WBCs (Tc), Differential Count (Dc), and Erythrocyte Sedimentation Rate (ESR). Together, these parameters provide a snapshot of the blood's oxygen-carrying capacity, the status of the immune system, and the presence of non-specific systemic inflammation. It is one of the most common 'general health' panels ordered during routine checkups or when a patient presents with vague symptoms like fatigue, fever, or weight loss. Hb detects anemia; Tc/Dc identifies bacterial or viral infections and allergic reactions; ESR acts as a sensitive (though non-specific) indicator of inflammatory activity in the body.
  • Anemia: Indicated by low Hb, which could be due to iron deficiency or chronic blood loss.
  • Infection/Leukocytosis: Indicated by high Tc/Dc (e.g., high Neutrophils for bacteria, high Lymphocytes for viruses).
  • Inflammatory Disorders: A high ESR is seen in conditions like Temporal Arteritis, Polymyalgia Rheumatica, or systemic Lupus.
  • Allergies/Parasites: Indicated by an elevation in Eosinophils within the Differential Count.
View Interpretation
Hematology

Hematocrit (Hct)

Hematocrit measures the volume percentage of red blood cells in whole blood. It is a fundamental component of the CBC used to evaluate anemia, polycythemia, and hydration status. It represents the oxygen-carrying capacity of the blood relative to its total volume.
View Interpretation
Hematology

Hematocrit (Hct)

Hematocrit measures the volume percentage of red blood cells (RBCs) in whole blood. It is a critical indicator of oxygen-carrying capacity and blood viscosity. In a Complete Blood Picture, the Hct is used to screen for, diagnose, and monitor anemia or polycythemia. Because it is a ratio of cells to plasma, it is highly sensitive to the patient's hydration status.
View Interpretation
Hematology

Hematocrit (Hct)

Hematocrit represents the percentage of whole blood volume that is made up of red blood cells (RBCs). Part of a Complete Blood Count (CBC), it is a vital measure of the blood's oxygen-carrying capacity. It is used to diagnose anemia, monitor response to treatment for blood disorders, and assess hydration status.
View Interpretation
Hematology

Hemoglobin

Hemoglobin (Hb) is the iron-containing protein in red blood cells responsible for transporting oxygen to tissues. In a COVID Panel, Hemoglobin levels are prognostic markers. Patients with lower Hb levels (anemia) often face worse outcomes with COVID-19 due to reduced oxygen-carrying capacity, which exacerbates the hypoxemia caused by viral pneumonia. It also helps monitor for secondary complications like cytokine storm-induced hemophagocytosis or occult bleeding due to anticoagulation therapy.
View Interpretation
Hematology

Hemoglobin

Hemoglobin (Hb) is the iron-containing protein in red blood cells that transports oxygen from the lungs to the tissues. In a Hemoglobin/CBC Panel, it is the primary metric for diagnosing anemia. It provides a more direct measure of the blood's oxygen-carrying capacity than a simple red cell count.
View Interpretation
Hematology

Hemoglobin

Hemoglobin (Hb) is the iron-containing protein in red blood cells (RBCs) responsible for transporting oxygen from the lungs to the tissues. In a complete blood count (CBC) panel, it is the primary indicator of anemia or polycythemia. Measurement is vital for diagnosing fatigue, screening for nutritional deficiencies (iron, B12, folate), monitoring chronic kidney disease, and evaluating blood loss after surgery or trauma.
View Interpretation
Hematology

Hemoglobin

Hemoglobin (Hb) is the iron-containing protein in red blood cells responsible for transporting oxygen from the lungs to the rest of the body. It is the most critical component of the Hemoglobin, TC, DC, ESR & Platelet Count panel for diagnosing anemia. Hb levels determine the blood's oxygen-carrying capacity and are used to guide blood transfusion decisions and monitor chronic conditions like kidney disease or iron deficiency.
View Interpretation
Hematology

Hemoglobin (Hb)

Hemoglobin is the iron-containing protein in Red Blood Cells (RBCs) responsible for oxygen transport from the lungs to the rest of the body. Within a Complete Blood Picture, Hb is the primary metric used to diagnose anemia. It reflects the blood's oxygen-carrying capacity. Low levels impair cellular metabolism and energy production, while high levels can increase blood viscosity, potentially leading to clotting issues.
View Interpretation
Hematology

Hemoglobin (Hb)

Hemoglobin is the iron-containing protein in red blood cells (RBCs) responsible for transporting oxygen from the lungs to the body's tissues and carrying carbon dioxide back to the lungs. It is the primary indicator of anemia (low Hb) or polycythemia (high Hb). In the panel context (Hb, Tc, Dc & Esr), it provides the baseline for the blood's oxygen-carrying capacity and is essential for evaluating overall health, nutritional status, and chronic disease impact.
View Interpretation
Hematology

Hemoglobin (Hgb)

Hemoglobin is the iron-containing protein in red blood cells (RBCs) responsible for transporting oxygen from the lungs to the tissues. As a core component of the Complete Blood Count (CBC), it is the primary indicator used to diagnose anemia (low Hgb) or polycythemia (high Hgb). It reflects the blood's oxygen-carrying capacity and is essential for monitoring chronic diseases, nutritional deficiencies, and acute blood loss.
View Interpretation
Hematology

Hemoglobin (Hgb)

Hemoglobin is the iron-containing protein in red blood cells responsible for transporting oxygen from the lungs to the tissues. It is the primary indicator of anemia or polycythemia within a Complete Blood Count (CBC). Measuring Hgb levels is essential for evaluating the blood's oxygen-carrying capacity and monitoring response to blood loss or nutritional deficiencies.
View Interpretation
Hematology

Hemoglobin A

Hemoglobin A (HbA) is the predominant form of hemoglobin in adults (alpha2-beta2). In the context of HPLC electrophoresis, quantifying HbA is essential for diagnosing hemoglobinopathies and thalassemias. A reduction in HbA percentages indicates that other forms (like HbF, HbA2, or variant hemoglobins like HbS) are occupying a larger proportion of the total hemoglobin, which is a hallmark of Beta-Thalassemia or Sickle Cell Trait/Disease.
View Interpretation
Hematology

Hemoglobin A

Hemoglobin A (HbA) is the major adult form of hemoglobin, consisting of two alpha and two beta chains. In healthy adults, it should comprise the vast majority of total hemoglobin. This test is part of an electrophoresis panel used to screen for hemoglobinopathies like Sickle Cell Disease or Thalassemia. A decrease in the percentage of HbA indicates the presence of variant hemoglobins (HbS, HbC) or a defect in chain synthesis.
View Interpretation
Hematology

Hemoglobin A2

Hemoglobin A2 (HbA2) is a minor component of adult hemoglobin. Measuring its percentage via HPLC is the gold standard for diagnosing Beta-Thalassemia trait (Minor). In patients with Beta-Thalassemia trait, the production of beta-globin chains is reduced, leading to a compensatory increase in the delta-globin chains that form HbA2. It is essential for genetic counseling and distinguishing thalassemia from simple iron deficiency anemia.
View Interpretation
Hematology

Hemoglobin A2

Hemoglobin A2 (HbA2) is a minor variant of adult hemoglobin (composed of two alpha and two delta chains). In Hemoglobin Electrophoresis, its quantification is the gold standard for screening and diagnosing Beta-thalassemia trait (minor). Because Beta-thalassemia involves a reduction in beta-chain synthesis, the body compensates by producing more delta chains, leading to a characteristic rise in HbA2.
View Interpretation
Hematology

Hemoglobin C

Hemoglobin C is an abnormal variant of hemoglobin caused by a substitution in the beta-globin chain. Using High-Performance Liquid Chromatography (HPLC), this test quantifies the percentage of HbC. It is used to diagnose Hemoglobin C trait (HbAC) or Hemoglobin C disease (HbCC). While often milder than sickle cell disease, its identification is crucial for genetic counseling and for identifying compound heterozygous states like HbSC disease.
View Interpretation
Hematology

Hemoglobin C

Hemoglobin C is an abnormal hemoglobin variant caused by a specific mutation in the beta-globin gene. This component is measured via Hemoglobin Electrophoresis to screen for Hemoglobin C Disease or Hemoglobin C Trait. While typically less severe than Sickle Cell Disease (Hemoglobin S), the presence of Hemoglobin C can lead to mild chronic hemolytic anemia and splenomegaly (enlarged spleen).
View Interpretation
Hematology

Hemoglobin E

Hemoglobin E (HbE) is an abnormal hemoglobin variant caused by a point mutation in the beta-globin chain. Using HPLC (High-Performance Liquid Chromatography), clinicians can quantify the percentage of HbE. It is highly prevalent in Southeast Asia and parts of India. Identifying HbE is crucial for diagnosing HbE trait, HbE disease, or E-Beta Thalassemia, which can range from asymptomatic to severe hemolytic anemia.
View Interpretation
Hematology

Hemoglobin Electrophoresis

Hemoglobin electrophoresis is a blood test used to measure and identify the different types of hemoglobin in the bloodstream. Hemoglobin is the protein inside red blood cells responsible for transporting oxygen to tissues and organs. In a healthy adult, most hemoglobin is Hemoglobin A (HbA). However, genetic variations can result in abnormal types of hemoglobin or abnormal quantities of standard types. This test is primarily ordered to diagnose hemoglobinopathies and thalassemias. Doctors utilize it when a patient presents with symptoms of unexplained anemia, such as fatigue, pale skin, or jaundice. It is also a critical component of newborn screening programs and prenatal screening for parents who may carry a genetic trait for conditions like sickle cell disease.
  • Sickle Cell Disease: Identified by the presence of Hemoglobin S (HbS).
  • Hemoglobin C Disease: A genetic disorder that causes a mild form of hemolytic anemia.
  • Thalassemia: Characterized by low levels of HbA and elevated levels of HbA2 or HbF. Alpha and Beta thalassemia result from the body's inability to produce enough of the specific globin chains.
  • Hemoglobin E: Common in Southeast Asian populations, often causing mild anemia or no symptoms unless combined with other traits.
View Interpretation
Hematology

Hemoglobin Electrophoresis by HPLC

Hemoglobin Electrophoresis by High-Performance Liquid Chromatography (HPLC) is a sophisticated technique used to separate and quantify different types of hemoglobin in the blood. Hemoglobin is the protein in red blood cells that carries oxygen. Normal adults primarily have Hemoglobin A (HbA), with small amounts of HbA2 and HbF (fetal hemoglobin). This test is essential for diagnosing hemoglobinopathies—genetic disorders that lead to the production of abnormal hemoglobin or insufficient production of normal hemoglobin. It is ordered for:
  • Newborn Screening: Identifying sickle cell disease early.
  • Anemia Workup: When a CBC shows low MCV (small red cells) that does not respond to iron therapy.
  • Prenatal Screening: Determining if parents carry traits for Thalassemia or Sickle Cell.
  • Unexplained Hemolysis: Investigating why red blood cells are breaking down prematurely.
  • Sickle Cell Disease (HbSS) and Trait (HbAS): Presence of Hemoglobin S.
  • Beta-Thalassemia: Characterized by elevated Hemoglobin A2 and sometimes elevated Hemoglobin F.
  • Alpha-Thalassemia: May show Hemoglobin H or Bart's (in newborns), though HPLC is sometimes combined with DNA testing for confirmation.
  • Hemoglobin C, D, or E Variants: Common structural variants found in specific ethnic populations that can cause mild to severe hemolytic anemia.
View Interpretation
Hematology

Hemoglobin F

Hemoglobin F (HbF), or fetal hemoglobin, is the primary oxygen transport protein in the human fetus, characterized by its high affinity for oxygen. In the context of Hemoglobin Electrophoresis, it is measured to diagnose various hemoglobinopathies. While it should be less than 1-2% in adults, elevated levels are significant markers for Beta-Thalassemia, Sickle Cell Anemia, or Hereditary Persistence of Fetal Hemoglobin (HPFH). Monitoring HbF is also crucial for patients on Hydroxyurea therapy, as the drug's efficacy is often measured by its ability to induce HbF production.
View Interpretation
Hematology

Hemoglobin F (HbF)

Hemoglobin F is the primary oxygen carrier in a fetus, but it is typically replaced by Hemoglobin A shortly after birth. In adults, HbF usually constitutes less than 1-2% of total hemoglobin. This test is a critical component of Hemoglobin Electrophoresis to diagnose Beta-thalassemia (where HbF is elevated to compensate for lack of HbA) and Sickle Cell Disease. It is also used to monitor the effectiveness of Hydroxyurea therapy, which works by increasing HbF levels.
View Interpretation
Hematology

Hemoglobin S

Hemoglobin S (HbS) is an abnormal variant of hemoglobin caused by a specific mutation in the beta-globin gene. This component is the hallmark of Sickle Cell Disease. On an electrophoresis panel, its presence confirms either Sickle Cell Trait (HbAS) or Sickle Cell Disease (HbSS). HbS causes red blood cells to take on a rigid, sickle shape under deoxygenated conditions, leading to microvascular occlusion, hemolytic anemia, and multi-organ damage.
View Interpretation
Hematology

Hemoglobin S (HbS)

Hemoglobin S is an abnormal variant of hemoglobin that causes red blood cells to become sickle-shaped under low oxygen conditions. In Hemoglobin Electrophoresis by HPLC, measuring the percentage of HbS is the definitive method to diagnose Sickle Cell Trait (HbAS) or Sickle Cell Disease (HbSS). It helps in assessing the severity of the disease and monitoring the effectiveness of exchange transfusions.
View Interpretation
Hematology

Hemoglobin, TC, DC, ESR & Platelet Count

This panel is a comprehensive hematological assessment. It includes Hemoglobin (Hb) for oxygen transport capacity, Total Count (TC) of White Blood Cells for immune status, Differential Count (DC) to identify specific types of immune cells (neutrophils, lymphocytes, etc.), Erythrocyte Sedimentation Rate (ESR) as a non-specific marker of inflammation, and Platelet Count for clotting capability. It is one of the most common screening panels used to evaluate general health. It helps in diagnosing anemia, identifying bacterial or viral infections, monitoring inflammatory conditions, and screening for bleeding disorders. It is also used pre-operatively and during routine physicals.
  • Anemia: Low Hemoglobin levels.
  • Infection/Leukemia: Abnormal Total and Differential counts (e.g., Neutrophilia in bacterial infection).
  • Inflammatory Diseases: Elevated ESR is common in Rheumatoid Arthritis, Lupus, or systemic infections.
  • Thrombocytopenia: Low platelets, which may lead to bruising or bleeding risks.
View Interpretation
Hematology

Hemoglobin, Total Count, Differential Count

This panel, often referred to as a subset of the Complete Blood Count (CBC), evaluates the primary components of blood. Hemoglobin (Hb) is the iron-containing protein in red blood cells responsible for transporting oxygen from the lungs to the body's tissues and returning carbon dioxide. The Total Leucocyte Count (TLC) measures the total number of white blood cells (WBCs), which are the primary defense mechanism of the immune system. The Differential Count (DLC) further breaks down the WBCs into five types: Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils. Physicians order this test to screen for a wide range of conditions, including anemia, infection, inflammation, and leukemia. It is a standard part of routine health check-ups and is essential for monitoring patients undergoing treatments like chemotherapy or those with chronic inflammatory diseases.
  • Anemia: Indicated by low hemoglobin levels, which can be caused by iron deficiency, vitamin B12 deficiency, or chronic blood loss.
  • Leukocytosis: A high TLC, often signaling an acute infection (bacterial or viral) or physical stress.
  • Leukopenia: A low TLC, which may result from bone marrow failure, autoimmune diseases, or certain medications.
  • Eosinophilia: An elevation in eosinophils, commonly associated with allergic reactions or parasitic infections.
  • Neutrophilia: High neutrophil counts, typically pointing toward acute bacterial infections.
View Interpretation
Hematology

Hemoglobin, Total Count, Differential Count, and Platelet Count

This panel, often referred to as a Complete Blood Count (CBC) component, evaluates the three primary cellular elements of blood: Red Blood Cells (via Hemoglobin), White Blood Cells (Total and Differential Counts), and Platelets. It provides a comprehensive snapshot of the body's oxygen-carrying capacity, immune status, and clotting ability. It is one of the most common screening tests used for routine health checkups, pre-operative assessments, and diagnostic workups. It is ordered to investigate symptoms like fatigue, bruising, fever, or weight loss. It is essential for monitoring patients undergoing chemotherapy or those with chronic inflammatory conditions.
  • Anemia: Low hemoglobin indicating reduced oxygen delivery to tissues.
  • Infections: Elevated WBC (Leukocytosis) or specific shifts in the Differential Count (e.g., high Neutrophils for bacteria, high Lymphocytes for viruses).
  • Leukemia/Lymphoma: Significant abnormalities in WBC morphology and count.
  • Thrombocytopenia: Low platelet count, increasing the risk of spontaneous bleeding.
  • Polycythemia: Excess red blood cells, which can thicken the blood.
The Differential Count (DC) breaks down the WBCs into Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils. This granularity allows clinicians to distinguish between an acute bacterial infection, a chronic viral state, an allergic reaction, or a parasitic infestation.
View Interpretation
Infectious Disease

Hepatitis A Virus IgM

The Hepatitis A Virus (HAV) IgM test is a serological assay used to detect IgM antibodies produced by the immune system in response to an acute infection with the Hepatitis A virus. IgM is the first antibody the body creates when it encounters a new infection, making this test the gold standard for diagnosing early-stage Hepatitis A. This test is primarily ordered when a patient presents with symptoms of acute viral hepatitis, such as:
  • Jaundice (yellowing of the skin and eyes)
  • Dark-colored urine and pale stools
  • Severe abdominal pain, particularly in the upper right quadrant
  • Fever, fatigue, and loss of appetite It is also used during outbreak investigations to identify recently infected individuals who may be spreading the virus through contaminated food or water.
Hepatitis A is a highly contagious liver infection caused by the HAV. Unlike Hepatitis B or C, it does not cause chronic liver disease and is rarely fatal, though it can cause debilitating symptoms and acute liver failure in rare cases (especially in older adults or those with pre-existing liver conditions). The presence of IgM antibodies confirms an active or very recent infection (typically within the last 6 months). Once the infection resolves, IgM levels fade, and IgG antibodies develop, providing lifelong immunity.
View Interpretation
Infectious Disease

Hepatitis A, B, C, & E, Profile

A Hepatitis profile is a comprehensive panel of blood tests designed to detect current or past infections with various hepatitis viruses (A, B, C, and E). These viruses cause inflammation of the liver but are transmitted differently and have varying clinical outcomes. The profile typically checks for antigens (viral parts) and antibodies (the body's immune response). This panel is ordered when a patient presents with symptoms of liver dysfunction, such as jaundice (yellowing of the skin/eyes), dark urine, pale stools, fatigue, and abdominal pain. It is also used for screening high-risk individuals, prenatal screening, or following an accidental needle stick. Identifying the specific virus is crucial because the treatment for Hepatitis B is vastly different from Hepatitis C, and Hepatitis A/E are usually acute and self-limiting.
  • Hepatitis A (HAV): Usually spread via contaminated food/water; causes acute liver inflammation.
  • Hepatitis B (HBV): Spread via blood/body fluids; can lead to chronic infection, cirrhosis, and liver cancer.
  • Hepatitis C (HCV): Primarily blood-borne; high rate of chronic infection leading to liver damage.
  • Hepatitis E (HEV): Similar to Hep A; particularly dangerous for pregnant women in certain geographic regions.
Early detection through this profile allows for therapeutic intervention that can prevent permanent liver scarring (cirrhosis) and reduce the risk of hepatocellular carcinoma.
View Interpretation
Infectious Disease

Hepatitis B Surface Antigen (HBsAg)

The Hepatitis B Surface Antigen (HBsAg) test is the earliest immunological marker of an acute Hepatitis B virus (HBV) infection. HBsAg is a protein found on the surface of the virus; its presence in the blood indicates that the person is currently infected and can pass the virus to others. This test is the primary screening tool for HBV. It is ordered for individuals with elevated liver enzymes (ALT/AST), those who have been exposed to blood or body fluids of an infected person, pregnant women (to prevent mother-to-child transmission), and individuals in high-risk groups. It is also used to monitor the status of chronic HBV patients.
  • Acute Hepatitis B: The initial stage of infection. If HBsAg persists for more than six months, the infection is classified as chronic.
  • Chronic Hepatitis B: A long-term infection that can lead to significant liver damage, including cirrhosis and hepatocellular carcinoma (liver cancer).
  • Carrier Status: Some individuals remain HBsAg positive without active liver inflammation, but they remain infectious to others.
View Interpretation
Genetics

Her2/neu By FISH

HER2 (Human Epidermal Growth Factor Receptor 2) by Fluorescence In Situ Hybridization (FISH) is a molecular test used to determine the amplification of the HER2 gene. In certain cancers, particularly breast and gastric cancers, the HER2 gene is over-replicated, leading to an overabundance of the HER2 protein on the cell surface. This protein signals the cells to grow and divide uncontrollably. While Immunohistochemistry (IHC) measures the protein, FISH measures the actual number of gene copies, making it the 'gold standard' for precision. This test is critical for oncology treatment planning. It is ordered for:
  • All newly diagnosed invasive breast cancers.
  • Recurrent or metastatic breast cancer cases.
  • Advanced or metastatic gastric or gastroesophageal junction adenocarcinomas.
  • Clarifying 'equivocal' (IHC 2+) results from immunohistochemistry tests.
The primary focus is HER2-positive Breast Cancer and HER2-positive Gastric Cancer. HER2-positive tumors tend to be more aggressive and grow faster than HER2-negative tumors. However, the identification of HER2 amplification is a significant clinical opportunity because these cancers respond exceptionally well to targeted therapies such as Trastuzumab (Herceptin), Pertuzumab, and T-DM1. Determining HER2 status is a prerequisite for prescribing these life-saving HER2-targeted agents, which have drastically improved the prognosis for patients who would otherwise have a poor outlook.
View Interpretation
Genetics

Hereditary Cancer Gene Panel - Focused

The Hereditary Cancer Gene Panel is a specialized genetic test that utilizes Next-Generation Sequencing (NGS) to look for mutations in a specific set of genes (e.g., BRCA1, BRCA2, MLH1, TP53) known to increase the risk of developing certain cancers. Unlike a broad panel, a 'focused' panel targets only the most clinically actionable genes related to a patient's personal or family history. This test is ordered for individuals who have a strong family history of cancer or who have been diagnosed with cancer at an unusually young age. The goals are:
  • To determine if a cancer is hereditary.
  • To guide surgical decisions (e.g., bilateral vs. unilateral mastectomy).
  • To prompt aggressive screening or prophylactic measures for relatives.
  • To qualify patients for specific targeted therapies (e.g., PARP inhibitors).
  • Hereditary Breast and Ovarian Cancer (HBOC): Linked to BRCA mutations.
  • Lynch Syndrome: Increased risk of colorectal and endometrial cancers.
  • Li-Fraumeni Syndrome: A rare disorder that greatly increases the risk of developing several types of cancer.
View Interpretation
Metabolic

High-Density Lipoprotein (HDL) Cholesterol

HDL cholesterol is often referred to as 'good' cholesterol because it facilitates reverse cholesterol transport, carrying excess cholesterol from the peripheral tissues and arterial walls back to the liver for excretion. Within a Lipid Profile, HDL is a major negative risk factor for coronary artery disease (CAD). Higher levels are associated with lower cardiovascular risk, while low levels are a component of metabolic syndrome and are predictive of atherosclerosis, even when LDL levels are within a normal range.
View Interpretation
Immunology

Hiv 1&2 (Tri-Dot)

The HIV 1&2 Tri-Dot is a rapid visual test for the qualitative detection of antibodies to Human Immunodeficiency Virus Type 1 and Type 2. It is a 'point-of-care' screening tool used to identify exposure to the virus that causes AIDS. This test is used for rapid screening in clinical settings, emergency rooms, or blood banks. It is often ordered for routine health screenings, following a high-risk exposure, or in expectant mothers to prevent mother-to-child transmission. Because it provides results in minutes, it is invaluable for immediate decision-making.
  • HIV-1 Infection: The most common strain worldwide.
  • HIV-2 Infection: Less common, found primarily in West Africa, but requires different clinical management.
  • Acquired Immunodeficiency Syndrome (AIDS): The advanced stage of untreated HIV infection.
The test uses a flow-through technology where HIV antigens are immobilized on a membrane. If antibodies are present in the patient's serum, they bind to these antigens, creating a visible dot after the addition of a signal reagent. While highly sensitive, any 'Reactive' result must be confirmed with a more specific test like the Western Blot or a 4th Generation ELISA.
View Interpretation
Metabolic

Homocysteine

Homocysteine is a sulfur-containing amino acid produced during the metabolism of methionine. Under normal conditions, homocysteine is quickly converted into other products with the help of Vitamin B12, Vitamin B6, and Folate. It serves as a critical junction point in the methylation cycle, which is essential for DNA synthesis and cellular repair. Homocysteine levels are measured to assess the risk of cardiovascular disease, stroke, and peripheral arterial disease. High levels are toxic to the lining of blood vessels and may promote blood clot formation. It is also used to screen for vitamin B12 or folate deficiencies, as homocysteine levels rise before these vitamins fall below their respective normal ranges. In infants, it is used to screen for the rare genetic disorder homocystinuria.
  • Hyperhomocysteinemia: Elevated levels linked to atherosclerosis and venous thrombosis.
  • B-Vitamin Deficiency: Specifically B12 (cobalamin) and B9 (folate).
  • MTHFR Genetic Mutations: Variants like C677T can impair the body's ability to process folate, leading to higher homocysteine.
  • Chronic Kidney Disease: Reduced clearance of homocysteine increases systemic levels.
  • Cognitive Decline: High levels are associated with an increased risk of Alzheimer's disease.
View Interpretation
Immunology

House Dust Mite (D. pteronyssinus) Specific IgE

This test measures the concentration of allergen-specific Immunoglobulin E (sIgE) antibodies directed against Dermatophagoides pteronyssinus, a major species of house dust mite. In sensitized individuals, IgE binds to mast cells; subsequent exposure triggers the release of histamine and leukotrienes. This is a primary driver for allergic rhinitis, perennial asthma, and atopic dermatitis. Levels correlate with the probability of clinical symptoms upon exposure, though they do not strictly predict the severity of an allergic reaction.
View Interpretation
Immunology

Immunoglobulin G (IgG), Serum

IgG is the most abundant antibody in the serum. In an Autoimmune Hepatitis (AIH) Panel, IgG is a critical diagnostic marker; a selective elevation (hypergammaglobulinemia) is a classic feature of AIH and is included in the International Autoimmune Hepatitis Group scoring system. It is also used to monitor treatment response, as levels should normalize with successful immunosuppressive therapy.
View Interpretation
Immunology

Immunoglobulin IgE

Immunoglobulin E (IgE) is a class of antibodies produced by the immune system that plays a central role in the body's allergic response. It is typically found in very small amounts in the blood. IgE binds to mast cells and basophils; when it encounters an allergen (like pollen or dander), it triggers these cells to release histamine and other chemicals, causing allergic symptoms. Total IgE testing is used as a screening tool to assess a person's 'allergic status.' It is ordered for patients suffering from chronic asthma, hay fever, eczema (atopic dermatitis), or persistent hives. It is also a critical diagnostic tool when a parasitic infection is suspected, as IgE levels often rise significantly as the body attempts to fight off helminths (worms).
  • Allergic Rhinitis and Asthma: High levels are common in individuals with seasonal or perennial allergies.
  • Atopic Dermatitis: Severe eczema is often associated with very high total IgE.
  • Parasitic Infections: Elevations occur in response to parasites like hookworm or Ascaris.
  • Hyper-IgE Syndrome (Job's Syndrome): A rare genetic disorder characterized by extremely high IgE levels and recurrent skin/lung infections.
  • Allergic Bronchopulmonary Aspergillosis (ABPA): A serious allergic reaction to the fungus Aspergillus.
View Interpretation
Pathology

Immunohistochemistry

Immunohistochemistry (IHC) is a laboratory technique used to visualize the distribution and localization of specific proteins (antigens) within a tissue section. By using antibodies that bind specifically to these proteins, and tagging those antibodies with a visible color or fluorescent dye, pathologists can see exactly which cells are expressing which markers under a microscope. IHC is the gold standard for characterizing tumors. When a biopsy is taken, a standard stain (H&E) shows what the cells look like, but IHC tells the pathologist what the cells are. It is used to determine if a cancer is a carcinoma, sarcoma, or lymphoma, and to identify the primary site of a cancer that has spread (metastasis). It is also used to test for specific 'targets' like HER2 in breast cancer to see if certain drugs will work.
  • Cancer Subtyping: Distinguishing between different types of lung or breast cancer.
  • Predictive Markers: Checking for ER/PR (Estrogen/Progesterone) receptors in breast tissue.
  • Infectious Disease: Detecting viral proteins (like CMV or HPV) directly within tissue cells.
  • Lynch Syndrome Screening: Testing for DNA mismatch repair (MMR) proteins in colon cancer specimens.
View Interpretation
Microbiology

India Ink Preparation

India Ink Preparation is a rapid microscopic diagnostic test used primarily to identify the presence of encapsulated fungi. The carbon particles in India ink cannot penetrate the thick polysaccharide capsule surrounding certain organisms, such as Cryptococcus neoformans. Under a microscope, the fungus appears as a clear halo against a dark, ink-stained background. This test is an emergency procedure usually performed on Cerebrospinal Fluid (CSF) when a patient presents with symptoms of meningitis (headache, stiff neck, fever, confusion), especially if they are immunocompromised. It is critical for:
  • Rapidly diagnosing Cryptococcal meningitis.
  • Screening patients with HIV/AIDS who have neurological symptoms.
  • Distinguishing fungal infections from bacterial or viral meningitis.
The primary condition associated with a positive India Ink test is Cryptococcosis. Cryptococcus neoformans is an opportunistic pathogen that can cause severe life-threatening infections of the central nervous system. While the test is highly specific (a positive result almost certainly means infection), it has moderate sensitivity, meaning a negative result does not completely rule out the disease, particularly in early stages or low-fungal-load infections.
View Interpretation
Hematology

Indirect Coombs Test (Antibody Screen)

The Indirect Coombs Test, also known as the Indirect Antiglobulin Test (IAT), is primarily used to detect circulating antibodies against red blood cells (RBCs) in the recipient's or mother's serum. Unlike the Direct Coombs test, which looks for antibodies already attached to RBCs, this test identifies free-floating antibodies that could potentially attack foreign red cells. It is a cornerstone of pre-transfusion compatibility testing and prenatal screening.
  1. Prenatal Screening: It is routinely performed on pregnant women to check for Rh-incompatibility. If an Rh-negative mother carries an Rh-positive fetus, her body may produce antibodies (isoimmunization) that could cross the placenta and attack the baby's blood cells, leading to Hemolytic Disease of the Newborn (HDN).
  2. Blood Transfusion: Before a patient receives a blood transfusion, a 'cross-match' is performed using the indirect Coombs method to ensure the recipient does not have antibodies that will react against the donor's blood.
  3. Autoimmune Diagnosis: It helps in identifying certain types of autoimmune hemolytic anemias where the body produces antibodies against its own blood cells.
  • Hemolytic Disease of the Newborn (HDN): Occurs when maternal antibodies destroy fetal RBCs.
  • Hemolytic Transfusion Reaction: A life-threatening reaction following an incompatible blood transfusion.
  • Systemic Lupus Erythematosus (SLE): An autoimmune condition that can lead to positive antibody screens.
  • Chronic Lymphocytic Leukemia (CLL): Certain blood cancers can trigger the production of autoantibodies.
View Interpretation
Oncology

Inhibin A

Inhibin A is a peptide hormone produced by the granulosa cells of the ovary. In the context of an Ovarian Cancer Panel, it serves as a serum tumor marker specifically for Granulosa Cell Tumors (GCT) and some mucinous epithelial ovarian cancers. It is also used in prenatal screening (Quad Screen) to assess the risk of Down Syndrome, but its oncology application is focused on monitoring disease recurrence and treatment response.
View Interpretation
Oncology

Inhibin B

Inhibin B is a peptide hormone produced by the granulosa cells of the ovaries (in females) and Sertoli cells (in males). In an Ovarian Cancer Panel, it serves as a specific tumor marker for mucinous and granulosa cell tumors. Beyond oncology, it is a primary marker for ovarian reserve and function, as its levels reflect the number and health of developing follicles.
View Interpretation
Endocrinology

Inhibin-A

Inhibin-A is a peptide hormone produced primarily by the granulosa cells of the ovaries in women and the Sertoli cells of the testes in men. Its primary biological role is the feedback inhibition of Follicle-Stimulating Hormone (FSH) secretion from the anterior pituitary gland. In pregnant women, Inhibin-A is produced by the placenta and levels rise significantly during the second trimester. This test is most commonly ordered for two reasons: as part of the 'Quad Screen' during prenatal testing and as a tumor marker. In prenatal care, it is used between the 15th and 20th weeks of pregnancy to assess the risk of chromosomal abnormalities. Outside of pregnancy, it is utilized to monitor patients with suspected or previously treated ovarian granulosa cell tumors.
  • Down Syndrome (Trisomy 21): Elevated Inhibin-A levels in the second trimester are associated with an increased risk of Down Syndrome.
  • Ovarian Cancer: Specifically, mucinous and granulosa cell tumors often secrete high levels of Inhibin-A, making it a valuable tool for monitoring recurrence or response to therapy.
  • Preeclampsia: Some research suggests that abnormally high levels in early pregnancy may correlate with a higher risk of developing preeclampsia later in the term.
While not a standalone diagnostic tool for cancer or chromosomal issues, Inhibin-A serves as a critical biomarker that, when combined with other data, provides a clear picture of reproductive health and fetal development.
View Interpretation
Endocrinology

Inhibin-B

Inhibin-B is a peptide hormone produced by the granulosa cells in the ovaries of women and the Sertoli cells in the testes of men. Its primary biological function is to provide negative feedback to the pituitary gland to inhibit the secretion of Follicle-Stimulating Hormone (FSH). By regulating FSH, Inhibin-B plays a pivotal role in the control of gametogenesis—the production of eggs in women and sperm in men. This test is a cornerstone of reproductive health assessments. In women, it is primarily ordered to evaluate ovarian reserve, which reflects the quantity and quality of remaining eggs. It is often measured on day 3 of the menstrual cycle alongside FSH and Anti-Müllerian Hormone (AMH). In men, it is used to assess spermatogenesis and testicular function, particularly in cases of unexplained infertility or to evaluate the success of a testicular biopsy. Additionally, it serves as a tumor marker for certain types of ovarian cancers, specifically granulosa cell tumors.
  • Ovarian Insufficiency: Low levels in women suggest a declining egg count, often associated with perimenopause or Premature Ovarian Failure (POF).
  • Male Infertility: Reduced levels in men correlate with impaired sperm production and Sertoli cell dysfunction.
  • Ovarian Neoplasms: Abnormally high levels can indicate the presence of specific germ-cell or sex cord-stromal tumors.
  • Assisted Reproduction: Used to predict the response to ovulation induction in IVF protocols.
View Interpretation
Immunology

Interleukin 6

Interleukin 6 (IL-6) is a versatile pro-inflammatory cytokine produced by various cells, including T-cells, macrophages, and endothelial cells. It plays a pivotal role in the body's acute phase response, acting as a messenger that signals the liver to produce C-reactive protein (CRP) and fibrinogen. IL-6 is involved in the transition from acute inflammation to chronic inflammation and is a key driver of B-cell differentiation into antibody-producing plasma cells. While essential for fighting infections and healing injuries, chronic overproduction of IL-6 can lead to tissue destruction and systemic disease. IL-6 testing is frequently used to assess the severity of systemic inflammation. In recent years, it became a critical biomarker for identifying 'cytokine storm' in severe COVID-19 patients, helping clinicians decide when to use IL-6 inhibitors like tocilizumab. It is also used in rheumatology to monitor disease activity in rheumatoid arthritis and systemic juvenile idiopathic arthritis. Other indications include the evaluation of patients with suspected Castleman disease, sepsis, or localized infections that have become systemic.
  • Rheumatoid Arthritis (RA): High IL-6 levels contribute to joint destruction and systemic symptoms like fatigue.
  • Sepsis: IL-6 is an early marker of the systemic inflammatory response syndrome (SIRS).
  • Cytokine Release Syndrome (CRS): Often seen after CAR-T cell therapy or severe viral infections.
  • Castleman Disease: A rare lymphoproliferative disorder driven by excessive IL-6.
  • Chronic Stress and Obesity: Both conditions are associated with low-grade, chronic elevations of IL-6.
View Interpretation
Metabolic

Ionized Calcium

Ionized calcium represents the 'free' form of calcium in the blood that is not bound to proteins (like albumin) or anions. This is the physiologically active form of calcium, meaning it is the portion available for vital functions such as myocardial contraction, nerve impulse transmission, and blood coagulation. While a 'Total Calcium' test is common, the Ionized Calcium test provides a more accurate picture of calcium homeostasis, especially when protein levels are abnormal. Clinicians order ionized calcium when a patient has abnormal albumin levels (common in liver or kidney disease), during major surgeries (especially heart surgery or transplants), or in critically ill patients in the ICU. It is also used to investigate symptoms of parathyroid disorders or to monitor patients with chronic kidney disease who may have complex mineral-bone disorders.
  • Hyperparathyroidism: Overactive parathyroid glands pulling too much calcium into the blood.
  • Hypoparathyroidism: Insufficient parathyroid hormone leading to dangerously low calcium.
  • Malignancy: Certain cancers produce proteins that mimic parathyroid hormone, raising ionized calcium.
  • Renal Failure: The kidneys' inability to process vitamin D and phosphorus leads to calcium imbalances.
  • Vitamin D Toxicity or Deficiency: Vitamin D is the primary regulator of calcium absorption.
View Interpretation
Hematology

Iron Deficiency Profile

The Iron Deficiency Profile is a comprehensive panel that typically includes Serum Iron, Total Iron Binding Capacity (TIBC), Transferrin Saturation, and Ferritin. Iron is a foundational element required for the production of hemoglobin, the protein in red blood cells that carries oxygen. Ferritin acts as the body's storage 'bank' for iron, while transferrin is the 'truck' that transports iron through the bloodstream. This panel is ordered to investigate symptoms of anemia, such as chronic fatigue, dizziness, and pale skin. It is far more diagnostic than a simple hemoglobin test because it can detect 'pre-anemic' iron depletion before the red blood cell count actually drops. It is also used to monitor response to iron supplementation and to screen for iron overload disorders.
  • Iron Deficiency Anemia (IDA): The most common form of anemia, often caused by blood loss (menstrual or GI), pregnancy, or poor diet.
  • Anemia of Chronic Disease: A condition where iron is present but 'locked away' due to chronic inflammation.
  • Hemochromatosis: A genetic disorder causing the body to absorb too much iron, leading to organ damage.
  • Malabsorption Syndromes: Conditions like Celiac disease that prevent the gut from absorbing dietary iron.
View Interpretation
Molecular Hematology

JAK-2 Mutation (Exon 14, 12)

The Janus Kinase 2 (JAK2) gene provides instructions for making a protein that promotes the growth and division of cells. This test looks for mutations in Exon 14 (V617F) and Exon 12. These mutations act like a 'broken switch,' keeping the JAK2 protein constantly active, which leads to the overproduction of blood cells. This test is crucial when a patient has a high red blood cell count (erythrocytosis), high platelets (thrombocytosis), or high white cells, and the doctor suspects a Myeloproliferative Neoplasm (MPN). It helps distinguish between a primary bone marrow disorder and a 'secondary' reaction (like high red cells due to smoking).
  • Polycythemia Vera (PV): Over 95% of patients with PV have the JAK2 V617F mutation.
  • Essential Thrombocythemia (ET): About 50-60% of patients carry this mutation.
  • Primary Myelofibrosis (PMF): Frequently associated with JAK2 mutations.
Identifying the JAK2 mutation is a major diagnostic criterion in the WHO classification of blood cancers. It confirms that the cell proliferation is 'clonal' (cancerous) rather than a response to another condition.
View Interpretation
Genetics

KMT2A-AFF1 (MLL-AF4) Translocation [t(4;11)]

The KMT2A-AFF1 (formerly MLL-AF4) translocation involves the rearrangement of the KMT2A gene on chromosome 11q23. In the All Translocation Panel, this is identified as a hallmark of high-risk B-cell Acute Lymphoblastic Leukemia, particularly in infants (<1 year old) and some adults. It is associated with hyperleukocytosis (very high white cell counts), a high incidence of Central Nervous System (CNS) involvement, and a generally poor prognosis with standard chemotherapy, often necessitating bone marrow transplantation.
View Interpretation
Genetics

KMT2A-MLLT3 (MLL-AF9) Translocation [t(9;11)]

This molecular test detects the fusion gene resulting from the translocation between chromosomes 9 and 11. This specific abnormality, t(9;11)(p22;q23), is most commonly associated with Acute Myeloid Leukemia (AML), particularly the M4 (myelomonocytic) and M5 (monocytic) subtypes. It is a critical marker for diagnosis, prognostic stratification, and monitoring Minimal Residual Disease (MRD). Patients with this translocation generally have an intermediate prognosis.
View Interpretation
Microbiology

KOH Mount

The Potassium Hydroxide (KOH) Mount is a rapid bedside or laboratory test used to identify fungal infections of the skin, hair, and nails. KOH is a strong alkali; when applied to a clinical sample, it dissolves keratin and cellular debris, leaving the sturdy chitinous cell walls of fungi intact and visible under a microscope. This test is ordered when a patient presents with itchy, scaly, or discolored skin patches, brittle nails, or unexplained hair loss. It helps clinicians differentiate between fungal infections (like ringworm or yeast infections) and other skin conditions like psoriasis or eczema, which may look similar but require vastly different treatments.
  • Dermatophytosis (Tinea): Includes athlete’s foot (tinea pedis), jock itch (tinea cruris), and ringworm of the body (tinea corporis).
  • Candidiasis: Yeast infections caused by Candida species, often occurring in moist skin folds.
  • Tinea Versicolor: A common fungal infection that causes small, discolored patches of skin.
  • Onychomycosis: Fungal infection of the fingernails or toenails, causing thickening and yellowing.
View Interpretation
Molecular Genetics

KRAS Gene Analysis

The KRAS gene analysis looks for mutations in the Kirsten rat sarcoma viral oncogene homolog. This gene provides instructions for making a protein that regulates cell division. In many cancers, mutations keep this protein 'switched on,' causing cells to grow and divide uncontrollably. This is a 'companion diagnostic' test. It is primarily ordered for patients with metastatic colorectal cancer or non-small cell lung cancer (NSCLC). Knowing the KRAS status is essential before starting targeted therapies like EGFR inhibitors (e.g., Cetuximab or Panitumumab). If a KRAS mutation is present, these specific drugs will not work, saving the patient from unnecessary side effects and costs.
  • Colorectal Cancer: Roughly 40% of cases involve KRAS mutations.
  • Non-Small Cell Lung Cancer: KRAS is a common driver mutation, particularly G12C.
  • Pancreatic Cancer: Over 90% of pancreatic adenocarcinomas harbor KRAS mutations.
  • Cholangiocarcinoma: Also frequently associated with KRAS alterations.
View Interpretation
Genetics

Karyotyping Analysis

Karyotyping Analysis is a cytogenetic test used to examine the full complement of chromosomes in a person's cells. It maps the 22 pairs of autosomes and the pair of sex chromosomes to identify abnormalities in number or structure. The process involves culturing cells (usually lymphocytes), arresting them during metaphase, staining them, and photographing them under a microscope to create a 'karyogram'. Karyotyping is a foundational tool in clinical genetics used for:
  • Prenatal Screening: Detecting chromosomal disorders like Down Syndrome in a fetus.
  • Infertility Investigations: Evaluating couples with recurrent pregnancy loss or primary amenorrhea.
  • Developmental Delays: Assessing children with unexplained physical or cognitive delays.
  • Oncology: Identifying specific chromosomal translocations (e.g., the Philadelphia chromosome) that guide treatment in leukemias.
  • Trisomy 21 (Down Syndrome): An extra copy of chromosome 21.
  • Turner Syndrome (45,X): A missing X chromosome in females.
  • Klinefelter Syndrome (47,XXY): An extra X chromosome in males.
  • Balanced Translocations: Structural rearrangements that may cause infertility or risk to offspring.
  • Trisomy 18 (Edwards Syndrome) and Trisomy 13 (Patau Syndrome): Severe developmental conditions.
View Interpretation
Nephrology

Ketones

Urine ketones are a product of fat metabolism, occurring when the body utilizes fat rather than glucose for energy. In the context of a Urine Routine panel, the presence of ketones (ketonuria) is a critical marker for metabolic derangement. It is most commonly associated with Diabetic Ketoacidosis (DKA), a life-threatening complication of diabetes. It also serves as an indicator of starvation, carbohydrate-restricted diets, or metabolic disorders in pediatric patients. Measuring acetoacetate and acetone levels helps clinicians differentiate between simple hyperglycemia and true ketoacidosis.
View Interpretation
Metabolic

Ketones (Urine)

In a Complete Urine Examination, the presence of ketones (ketonuria) indicates that the body is using fat for energy instead of glucose. This occurs when insulin levels are insufficient or when carbohydrate intake is severely restricted. It is a critical marker for diagnosing Diabetic Ketoacidosis (DKA), monitoring weight loss, or assessing metabolic stress during pregnancy and acute illness.
View Interpretation
Oncology

Ki-67 IHC Marker

The Ki-67 protein is a cellular marker strictly associated with cell proliferation. It is present during all active phases of the cell cycle (G1, S, G2, and mitosis) but is absent from resting cells (G0). Because of this, the Ki-67 IHC (Immunohistochemistry) marker serves as a direct indicator of the 'growth fraction' of a given cell population. In oncology, measuring the rate at which cancer cells divide is crucial for determining the aggressiveness of a tumor. It is most commonly ordered for patients diagnosed with breast cancer, neuroendocrine tumors, lymphomas, and prostate cancer. The Ki-67 index helps clinicians decide between conservative management and aggressive chemotherapy.
  • Breast Cancer: Used to distinguish between Luminal A (low Ki-67) and Luminal B (high Ki-67) subtypes.
  • Neuroendocrine Tumors (NETs): Essential for grading the tumor (Grade 1, 2, or 3).
  • Lymphoma: High levels often correlate with more aggressive forms like Burkitt lymphoma.
  • Prognostic Value: Generally, a higher Ki-67 index suggests a more aggressive clinical course and potentially a higher responsiveness to chemotherapy, which targets rapidly dividing cells.
The Ki-67 score provides a snapshot of how many cells in a tumor sample are currently dividing. While it is a powerful tool for prognosis, it is usually interpreted alongside other markers (like HER2 or ER/PR status in breast cancer) to form a complete clinical picture.
View Interpretation
Nephrology

Kidney Biopsy Panel 1

A Kidney Biopsy Panel involves the microscopic examination of renal tissue, typically using three modalities: Light Microscopy (LM), Immunofluorescence (IF), and Electron Microscopy (EM). This panel is the 'gold standard' for diagnosing complex renal diseases that cannot be identified through blood or urine tests alone. It examines the glomeruli, tubules, interstitium, and blood vessels of the kidney. Physicians order a biopsy panel when there is unexplained:
  • Proteinuria: High levels of protein in the urine suggesting glomerular basement membrane damage.
  • Hematuria: Persistent blood in the urine indicating possible inflammation (glomerulonephritis).
  • Rapidly Declining GFR: To determine the cause of acute kidney injury (AKI).
  • Systemic Diseases: To evaluate kidney involvement in Lupus (Lupus Nephritis) or Vasculitis.
  • Transplant Monitoring: To check for signs of organ rejection.
  • Glomerulonephritis: Inflammation of the kidney's filtering units.
  • Nephrotic Syndrome: Minimal Change Disease, Focal Segmental Glomerulosclerosis (FSGS), or Membranous Nephropathy.
  • Amyloidosis: Deposition of abnormal proteins in the kidney tissue.
  • Diabetic Nephropathy: Structural damage caused by chronic high blood sugar.
View Interpretation
Hematology

L.E. Cells (Lupus Erythematosus Cells)

The L.E. Cell test is a historical laboratory procedure used to detect Systemic Lupus Erythematosus (SLE). An L.E. cell is a neutrophil or macrophage that has ingested the denatured nuclear material of another cell. This phenomenon occurs in the presence of antinuclear antibodies (specifically anti-histone antibodies) that coat the nucleus of damaged cells. While largely replaced by more sensitive tests like ANA and Anti-dsDNA, the L.E. cell test may still be encountered in specific clinical settings or in regions where modern immunological assays are unavailable. It serves as a visual confirmation of the autoimmune process where antibodies are actively promoting the phagocytosis of nuclear material.
  • Systemic Lupus Erythematosus (SLE): Positive in approximately 50-75% of active cases.
  • Rheumatoid Arthritis: Occasionally positive.
  • Hepatitis (Autoimmune): Can sometimes show L.E. cell presence.
  • Drug-Induced Lupus: Certain medications can trigger the formation of these cells.
The L.E. cell test is less sensitive than the ANA test, meaning a negative result does not rule out Lupus. However, a positive result is quite specific for SLE. Due to the requirement for manual microscopic examination and the subjective nature of identifying the cells, modern rheumatology favors standardized ELISA or Immunofluorescence assays over the L.E. cell preparation.
View Interpretation
Hematology

LAP Score

The Leukocyte Alkaline Phosphatase (LAP) score is a cytochemical test performed on a peripheral blood smear. It measures the amount of the enzyme alkaline phosphatase present within the granules of mature neutrophils. A technician stains the blood slide and scores 100 mature neutrophils on a scale of 0 to 4 based on the intensity of the stain, resulting in a final score between 0 and 400. The LAP score is primarily used to differentiate between two conditions that present with a very high white blood cell count:
  1. Chronic Myeloid Leukemia (CML): Where the malignant neutrophils are enzyme-deficient (Low LAP).
  2. Leukemoid Reaction: A normal, vigorous response to severe infection or stress where neutrophils are highly active (High LAP).
  • Chronic Myeloid Leukemia (CML): Classically presents with an extremely low LAP score.
  • Polycythemia Vera: Often shows an elevated LAP score.
  • Leukemoid Reaction: Caused by pneumonia, sepsis, or severe inflammation.
  • Pregnancy/Stress: Can physiologicaly increase the LAP score.
View Interpretation
Oncology

LDH (Lactate Dehydrogenase)

LDH is an enzyme involved in energy production found in almost all body tissues. In the context of an Ovarian Cancer Panel, LDH serves as a crucial tumor marker. Specifically, it is frequently elevated in certain germ cell tumors, such as dysgerminomas. While non-specific on its own, its serial measurement is vital for monitoring treatment response and detecting recurrence in patients with established ovarian malignancies.
View Interpretation
Metabolic

LDL Cholesterol

Low-Density Lipoprotein (LDL) cholesterol is often referred to as "bad" cholesterol. Its primary function is to transport cholesterol from the liver to the peripheral tissues for use in cell membrane synthesis and hormone production. However, when LDL levels are excessive, these particles can become oxidized and trapped within the arterial walls. LDL measurement is a cornerstone of cardiovascular risk assessment. It is ordered during routine physicals or for patients with risk factors such as hypertension, diabetes, or a family history of heart disease. It is the primary target for lipid-lowering therapies (like statins). Monitoring LDL helps clinicians calculate the risk of Atherosclerotic Cardiovascular Disease (ASCVD).
  • Atherosclerosis: The buildup of plaques in the arteries.
  • Coronary Artery Disease (CAD): Leading to heart attacks.
  • Peripheral Artery Disease (PAD): Reduced blood flow to the limbs.
  • Hyperlipidemia: Elevated levels of lipids in the blood.
  • Metabolic Syndrome: A cluster of conditions that increase the risk of heart disease and stroke.
Guidelines from the AHA/ACC suggest that for primary prevention, an LDL level below 100 mg/dL is optimal. For individuals with existing heart disease or diabetes, targets are often much lower (e.g., <70 mg/dL or even <55 mg/dL).
View Interpretation
Hematology

LE Cell

The Lupus Erythematosus (LE) cell is a neutrophil or macrophage that has ingested the denatured nuclear material of another cell. This phenomenon occurs when antinuclear antibodies (ANA) in the patient's serum react with damaged nuclei. While historically significant, this test is now largely considered obsolete, having been replaced by more sensitive and specific tests like ANA (Antinuclear Antibody) and anti-dsDNA. In modern medicine, the LE cell test is rarely the first line of investigation. It might be ordered in resource-limited settings or as a confirmatory finding in specific cases of suspected Systemic Lupus Erythematosus (SLE). It was originally designed to help diagnose lupus, but its lack of sensitivity (it is negative in 20-30% of SLE patients) and lack of specificity (it can be positive in other diseases) makes it less reliable than newer assays.
  • Systemic Lupus Erythematosus (SLE): The primary condition associated with a positive LE cell prep.
  • Other Autoimmune Diseases: Positive results may occur in Rheumatoid Arthritis, Scleroderma, or Chronic Active Hepatitis.
  • Drug-Induced Lupus: Certain medications (like hydralazine or procainamide) can induce the formation of LE cells.
Because the LE cell requires specific laboratory manipulation and subjective microscopic identification, it is prone to technician error. Rheumatologists now rely on the 'American College of Rheumatology' criteria, which favor ANA titers and specific antibody profiles over the LE cell prep.
View Interpretation
Endocrinology

LH (Luteinizing Hormone)

Luteinizing Hormone (LH) is a gonadotropin produced by the anterior pituitary gland. In both men and women, it is essential for reproduction. In women, an acute rise of LH—the 'LH surge'—triggers ovulation and development of the corpus luteum. In men, LH stimulates Leydig cells in the testes to produce testosterone. Healthcare providers order this test to investigate infertility, evaluate menstrual irregularities, or diagnose disorders of the pituitary gland or hypothalamus. In pediatrics, it is used to evaluate precocious or delayed puberty. It is also a core component of the workup for Polycystic Ovary Syndrome (PCOS).
  • Polycystic Ovary Syndrome (PCOS): Often characterized by a high LH to FSH ratio.
  • Primary Ovarian Failure: High LH levels as the body tries to stimulate non-responsive ovaries.
  • Hypogonadism: Low levels may indicate pituitary or hypothalamic dysfunction (secondary hypogonadism), while high levels suggest testicular or ovarian failure (primary hypogonadism).
  • Menopause: Naturally elevated LH levels due to the cessation of ovarian feedback loops.
Understanding LH levels helps clinicians map the Hypothalamic-Pituitary-Gonadal (HPG) axis. Because LH is secreted in pulses, a single measurement is often interpreted alongside FSH, Estradiol, or Testosterone to provide a complete picture of hormonal health.
View Interpretation
Endocrinology

LH and FSH (Luteinizing Hormone and Follicle Stimulating Hormone)

Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) are gonadotropins produced by the anterior pituitary gland. They are essential for the proper functioning of the reproductive system. In women, FSH stimulates the growth of ovarian follicles before the release of an egg from one follicle at ovulation. LH triggers ovulation and helps with the production of progesterone. In men, FSH stimulates sperm production (spermatogenesis), and LH stimulates the interstitial cells of the testes to produce testosterone. Healthcare providers order these tests to investigate various reproductive health issues. They are standard tools for evaluating infertility in both men and women, assessing irregular menstrual cycles, and diagnosing disorders of the pituitary or hypothalamus. In children, these tests are used to evaluate precocious (early) or delayed puberty.
  • Infertility: Abnormal levels can indicate ovulatory failure or low sperm count.
  • Polycystic Ovary Syndrome (PCOS): Often characterized by an elevated LH to FSH ratio.
  • Primary Ovarian Insufficiency (POI) or Menopause: High levels of FSH/LH as the body attempts to stimulate unresponsive ovaries.
  • Hypogonadism: Low levels suggest secondary failure (pituitary/hypothalamic), while high levels suggest primary failure (testes/ovaries).
  • Pituitary Adenomas: Tumors can disrupt the secretion of these hormones.
View Interpretation
Endocrinology

LH, FSH Panel

Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) are gonadotropins produced by the anterior pituitary gland. In women, FSH stimulates the growth of ovarian follicles, while LH triggers ovulation. In men, FSH stimulates sperm production (spermatogenesis), and LH stimulates the production of testosterone by the Leydig cells in the testes. This panel is standard for evaluating infertility, irregular menstrual cycles, or symptoms of menopause in women. In men, it is used to investigate low testosterone, low sperm count, or decreased libido. It is also used to diagnose pituitary disorders or premature/delayed puberty in adolescents.
  • Polycystic Ovary Syndrome (PCOS): Often characterized by an elevated LH to FSH ratio (e.g., 2:1 or 3:1).
  • Menopause/Premature Ovarian Failure: Marked by significantly elevated FSH levels as the pituitary tries to stimulate unresponsive ovaries.
  • Hypogonadotropic Hypogonadism: Low levels of both LH and FSH, suggesting a problem with the hypothalamus or pituitary gland.
  • Testicular Failure: High LH and FSH in men with low testosterone indicates the problem is within the testes themselves.
View Interpretation
Endocrinology

LH, FSH, PRL Profile

This profile measures three critical hormones regulated by the pituitary gland: Luteinizing Hormone (LH), Follicle-Stimulating Hormone (FSH), and Prolactin (PRL). LH and FSH are gonadotropins that coordinate the reproductive cycle in women (ovulation) and sperm production in men. Prolactin primarily regulates lactation but also modulates the reproductive axis. The profile is standard for evaluating infertility, menstrual irregularities (amenorrhea), and pituitary disorders. In women, it helps diagnose Polycystic Ovary Syndrome (PCOS), where the LH:FSH ratio is often elevated, or Premature Ovarian Failure, characterized by high FSH. In men, it assesses low libido or erectile dysfunction. Prolactin is specifically checked to rule out prolactinomas (benign tumors) which can suppress LH/FSH and cause infertility.
  • Hyperprolactinemia: Elevated prolactin causing milk discharge (galactorrhea) or infertility.
  • Menopause/Ovarian Failure: Marked by significant elevations in FSH and LH.
  • Hypopituitarism: Low levels of all three hormones indicating pituitary exhaustion.
  • PCOS: Often characterized by an LH to FSH ratio greater than 2:1 or 3:1.
View Interpretation
Microbiology

LPCB Mount

The Lactophenol Cotton Blue (LPCB) Mount is the most widely used staining and mounting medium for the microscopic examination of fungi. It serves three vital functions: the phenol kills any live organisms, the lactic acid preserves the fungal structures, and the cotton blue stains the chitin in the fungal cell walls, providing a clear, blue-colored contrast against the background. This test is ordered when a fungal infection is suspected, particularly when a culture has shown growth and the laboratory needs to identify the specific genus and species. By examining the morphology of hyphae, spores, and conidia under the LPCB mount, microbiologists can distinguish between various molds and yeasts.
  • Dermatophytosis: Ringworm or nail infections (tinea).
  • Aspergillosis: Respiratory infections caused by Aspergillus species.
  • Systemic Mycoses: Deep tissue infections in immunocompromised patients.
  • Zygomycosis: Serious infections involving mucormycosis.
Proper identification via LPCB mount is crucial for determining the appropriate antifungal therapy, as different fungi respond differently to medications like fluconazole, amphotericin B, or terbinafine. It is often the definitive step in the mycological diagnostic workflow.
View Interpretation
Metabolic

Lactate

Lactate (lactic acid) is a byproduct of anaerobic metabolism, produced when cells do not receive enough oxygen to perform aerobic respiration. Under normal conditions, lactate is cleared by the liver and kidneys. When production exceeds clearance, lactic acidosis occurs, serving as a critical biomarker for tissue hypoxia. Lactate is one of the most important tests in emergency and intensive care settings. It is used for:
  • Sepsis Screening: A core component of the Sepsis-3 bundle to identify patients at high risk of septic shock.
  • Shock Management: Monitoring the adequacy of fluid resuscitation in cardiogenic, hypovolemic, or distributive shock.
  • Ischemia Detection: Assessing for mesenteric ischemia (bowel infarction) or limb ischemia.
  • Metabolic Evaluation: Investigating unexplained metabolic acidosis.
  • Type A Lactic Acidosis: Caused by tissue hypoperfusion (Sepsis, MI, severe hemorrhage, heart failure).
  • Type B Lactic Acidosis: Caused by cellular dysfunction or toxins rather than hypoxia (Malignancy, Liver failure, Metformin toxicity, Cyanide poisoning).
  • Diabetic Ketoacidosis (DKA): Lactate may be elevated alongside ketones.
  • Strenuous Exercise: Temporary, physiological elevation due to muscle exertion.
View Interpretation
Metabolic

Lactate Dehydrogenase (LDH)

Lactate dehydrogenase (LDH) is an enzyme found in nearly all living cells. It plays a critical role in cellular respiration, the process by which glucose from food is converted into energy for the cells. Specifically, LDH catalyzes the conversion of lactate to pyruvate and back, as it converts NAD+ to NADH and back. Although LDH is abundant in tissue cells, under normal conditions, only small amounts are found in the blood. When tissues are damaged or diseased, they release LDH into the bloodstream. Physicians order an LDH test to identify the presence and location of tissue damage in the body. It serves as a general marker of cellular injury. It is frequently used to monitor progressive conditions such as hemolytic or pernicious anemias, to help stage certain cancers (like lymphoma or leukemia), and to evaluate fluid buildup (effusions) in the lungs or heart. It is a non-specific marker, meaning it tells a doctor that damage is occurring, but not exactly where or what caused it. High levels of LDH are associated with a wide array of conditions because of the enzyme's ubiquitous nature. These include:
  • Myocardial Infarction (Heart Attack): Historically used to detect heart damage, though troponin is now preferred.
  • Liver Disease: Such as hepatitis or cirrhosis.
  • Hemolytic Anemia: Where red blood cells are destroyed prematurely.
  • Pulmonary Infarction: Tissue death in the lungs.
  • Cancer: Including germ cell tumors, lymphoma, and leukemia.
  • Muscle Trauma: Severe injury or muscular dystrophy.
View Interpretation
Infectious Disease

Lactate Dehydrogenase (LDH)

Lactate Dehydrogenase (LDH) is an intracellular enzyme found in nearly all organ systems, including the heart, liver, muscles, and lungs. When tissues are damaged or inflamed, LDH is released into the bloodstream. Within a COVID-19 Biochemistry Panel, LDH serves as a critical biomarker for disease severity and lung injury. Elevated levels are frequently associated with the 'cytokine storm' and are a strong predictor of poor prognosis, indicating extensive cellular destruction or pulmonary tissue damage.
View Interpretation
Biochemistry

Lactate Dehydrogenase (LDH)

Lactate Dehydrogenase is an intracellular enzyme that catalyzes the conversion of lactate to pyruvate. It is found in nearly all tissues. In Fluid Biochemical Analysis (e.g., pleural or ascetic fluid), LDH levels are used to apply 'Light's Criteria' to differentiate between a transudate (usually systemic cause like heart failure) and an exudate (local cause like infection or malignancy). High fluid LDH is indicative of local tissue damage or inflammation.
View Interpretation
Body Fluids

Lactate Dehydrogenase (LDH), Ascitic Fluid

Lactate Dehydrogenase (LDH) in ascitic fluid is a key marker used to differentiate between transudative and exudative effusions. In the context of ascites, LDH levels are indicative of the degree of inflammation or tissue damage within the peritoneal cavity. While the Serum-Ascites Albumin Gradient (SAAG) is the gold standard for classifying ascites, ascitic LDH provides complementary data. An ascitic LDH level greater than two-thirds of the upper limit of normal for serum LDH, or an ascitic/serum LDH ratio > 0.6, typically suggests an exudative process such as malignancy, tuberculosis, or secondary bacterial peritonitis (where LDH rises due to neutrophil lysis).
View Interpretation
Infectious Disease

Leptospira ELISA

The Leptospira ELISA (Enzyme-Linked Immunosorbent Assay) is a serological test designed to detect specific antibodies (IgM and IgG) produced by the immune system in response to an infection with Leptospira bacteria. These spirochetes are typically transmitted through the urine of infected animals, particularly rodents and livestock, often via contaminated water or soil. The test serves as a primary tool for diagnosing Leptospirosis, a zoonotic disease that can range from mild flu-like symptoms to severe organ failure. Physicians order this test when a patient presents with symptoms suggestive of Leptospirosis, especially if they have a history of high-risk exposure (e.g., floods, farming, sewer work, or water sports). Symptoms include:
  • High fever and severe headache
  • Muscle aches (particularly in the calves and lower back)
  • Jaundice (yellowing of eyes and skin)
  • Redness in the eyes (conjunctival suffusion)
  • Abdominal pain and vomiting
Leptospirosis can progress into Weil's Disease, characterized by kidney failure, liver damage, and pulmonary hemorrhage. It is also associated with aseptic meningitis and uveitis. Early detection via ELISA allows for prompt antibiotic intervention, which is critical in preventing these life-threatening complications. The IgM antibodies usually appear within 3-10 days of symptom onset, making this test useful during the acute phase of the illness.
View Interpretation
Metabolic

Leukocyte Esterase

Leukocyte Esterase is an enzyme produced by white blood cells (neutrophils). Its presence in urine, detected during a Complete Urine Examination, is a primary indicator of pyuria (white cells in the urine). This is most commonly associated with a Urinary Tract Infection (UTI), though it can also indicate non-infectious inflammation of the kidneys or bladder (e.g., interstitial cystitis, nephrolithiasis). In the context of a urinalysis panel, it is evaluated alongside Nitrites and microscopic WBC counts to confirm infection.
View Interpretation
Nephrology

Leukocyte Esterase

Leukocyte Esterase (LE) is an enzyme produced by neutrophils. Its presence in the urine indicates pyuria (white blood cells in the urine), which is a hallmark of inflammation in the urinary tract. It is used as a primary screening tool for Urinary Tract Infections (UTI). When combined with a Nitrite test, it has a high negative predictive value for ruling out bacterial cystitis or pyelonephritis.
View Interpretation
Metabolic

Lipase

Lipase is a digestive enzyme primarily produced by the pancreas. It is secreted into the small intestine, where it plays a crucial role in breaking down dietary fats (triglycerides) into fatty acids and glycerol, allowing for absorption. While small amounts of lipase are found in the blood, significant levels typically indicate damage or blockage in the pancreas. The lipase test is the gold standard for diagnosing acute pancreatitis. It is more specific and stays elevated longer than amylase. Doctors order this test when a patient exhibits symptoms of a pancreatic disorder, such as:
  • Severe abdominal pain that radiates to the back.
  • Nausea and vomiting.
  • Fever.
  • Loss of appetite or oily/fatty stools (steatorrhea).
  • Acute Pancreatitis: Levels usually rise to 3-10 times the upper limit of normal within 24 hours of an attack.
  • Chronic Pancreatitis: Levels may be slightly elevated or even low if the pancreas is severely damaged and can no longer produce enzymes.
  • Pancreatic Cancer: Obstruction of the pancreatic duct can cause lipase to leak into the blood.
  • Gastrointestinal Issues: Bowel obstruction or celiac disease can sometimes cause moderate elevations.
  • Kidney Disease: Because lipase is cleared by the kidneys, reduced renal function can lead to higher circulating levels.
View Interpretation
Metabolic

Lipid Profile

A Lipid Profile is a panel of blood tests used to measure the amount of specific fat molecules (lipids) in the blood. It typically includes Total Cholesterol, High-Density Lipoprotein (HDL - 'good' cholesterol), Low-Density Lipoprotein (LDL - 'bad' cholesterol), and Triglycerides. These lipids are essential for cell membrane integrity and hormone production, but in excess, they contribute to the formation of plaques in the arteries (atherosclerosis). This panel is a cornerstone of cardiovascular risk assessment. It is ordered as part of routine physicals to screen for dyslipidemia, which often has no symptoms. It is also used to monitor the effectiveness of lipid-lowering therapies like statins or dietary interventions. Patients with risk factors such as diabetes, hypertension, or a family history of heart disease require more frequent monitoring.
  • Hyperlipidemia: High levels of LDL or Triglycerides, increasing the risk of heart attack and stroke.
  • Metabolic Syndrome: A cluster of conditions including high triglycerides and low HDL associated with insulin resistance.
  • Pancreatitis: Extremely high triglyceride levels (usually >500 mg/dL) can cause acute inflammation of the pancreas.
  • Hypolipidemia: Pathologically low cholesterol, which can occur in malabsorption or hyperthyroidism.
View Interpretation
Reproductive Health

Liquefaction Time

During a Semen Analysis, the liquefaction time evaluates the enzymatic process required for the coagulated semen to transform into a liquid state. This process is primarily mediated by enzymes secreted by the prostate gland (e.g., PSA). Proper liquefaction is essential for sperm to regain full motility and navigate the female reproductive tract. Delayed liquefaction may indicate prostatic dysfunction or infection.
View Interpretation
Cytopathology

Liquid Based Cytology

Liquid-Based Cytology (LBC) is a method of preparing cervical samples for examination under a microscope. Unlike the traditional Pap smear, where cells are smeared directly onto a slide, LBC collects cells into a preservative vial. This process filters out debris, blood, and mucus, allowing for a much clearer view of the cervical cells. LBC is the primary screening tool for cervical cancer and precancerous lesions. It is ordered as part of routine gynecological wellness exams. The main advantage of LBC is that the remaining liquid sample can be used for reflex testing of Human Papillomavirus (HPV) without needing the patient to return for a second collection.
  • Cervical Dysplasia: The presence of abnormal cells (ASCUS, LSIL, HSIL).
  • Cervical Cancer: Early detection of squamous cell carcinoma or adenocarcinoma.
  • Infections: Can identify yeast (Candida), Bacterial Vaginosis, or Trichomoniasis.
  • Atrophic Vaginitis: Common in postmenopausal women.
Modern guidelines often recommend LBC in combination with HPV testing for women aged 30-65 every five years, or LBC alone every three years. It has significantly reduced the incidence of cervical cancer globally by catching cellular changes years before they turn into invasive cancer.
View Interpretation
Genetics

Liquid Biopsy EGFR

Liquid Biopsy for EGFR (Epidermal Growth Factor Receptor) is a non-invasive test that analyzes circulating tumor DNA (ctDNA) shed into the blood by cancerous cells. EGFR is a protein on the surface of cells that helps them grow. In certain types of cancer, particularly Non-Small Cell Lung Cancer (NSCLC), mutations in the EGFR gene cause the receptor to be permanently 'on,' leading to rapid cell proliferation. This 'liquid' approach allows for genetic profiling of the tumor without the need for a traditional, invasive tissue biopsy. This test is a cornerstone of precision medicine in lung cancer. It is ordered to:
  • Identify actionable mutations (like Exon 19 deletions or L858R) in patients where tissue biopsy is difficult or impossible.
  • Monitor patients currently on EGFR-Tyrosine Kinase Inhibitors (TKIs) for the development of resistance mutations, specifically the T790M or C797S mutations.
  • Track the 'molecular response' to treatment in real-time.
  • Screen for recurrence in patients who have previously completed treatment.
The test is specifically associated with Non-Small Cell Lung Cancer (NSCLC). The detection of sensitizing EGFR mutations indicates that the patient is a candidate for first- or second-generation TKIs (like Erlotinib or Gefitinib) or third-generation TKIs (like Osimertinib). Liquid biopsy is particularly revolutionary because tumors are heterogeneous; a single tissue biopsy might miss a mutation that a liquid biopsy—which captures DNA from all tumor sites in the body—might detect.
View Interpretation
Therapeutic Drug Monitoring

Lithium

Lithium is a mood stabilizer primarily used for the long-term treatment of bipolar disorder. Because lithium has a very 'narrow therapeutic window'—meaning the difference between a therapeutic dose and a toxic dose is small—regular monitoring of serum levels is mandatory. It acts on the central nervous system, though its exact mechanism involves modulating neurotransmitters like glutamate and interfering with intracellular signaling pathways. This test is ordered to ensure the patient is receiving a dose that is high enough to be effective but low enough to avoid toxicity. Monitoring is most frequent when starting the medication or changing doses. It is also ordered if a patient shows signs of toxicity (confusion, tremors) or if they have developed kidney issues, as lithium is cleared entirely by the kidneys.
  • Bipolar Disorder: Used to prevent both manic and depressive episodes.
  • Major Depressive Disorder: Sometimes used as an augmenting agent when standard antidepressants fail.
  • Lithium Toxicity: Occurs when levels exceed 1.5 mmol/L, leading to neurological and renal complications.
  • Diabetes Insipidus: A potential side effect of long-term lithium use where the kidneys cannot concentrate urine.
View Interpretation
Immunology

Liver Cytosol Type 1 (LC-1) Antibody

The LC-1 antibody is a specific serological marker for Autoimmune Hepatitis (AIH) Type 2. While Anti-LKM-1 is the primary marker for AIH Type 2, LC-1 antibodies are found in approximately 30-50% of these patients and are occasionally the only marker present. Detection of LC-1 is highly specific and is often associated with more severe, rapidly progressive liver disease, particularly in younger patients and children. Within an Autoimmune Hepatitis panel, it helps differentiate AIH from chronic viral hepatitis or drug-induced liver injury.
View Interpretation
Metabolic

Liver Function Test Without GGT

The Liver Function Test (LFT) without GGT is a panel of blood tests used to evaluate the health and functional capacity of the liver. It typically includes measurements of Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Alkaline Phosphatase (ALP), Bilirubin, and Albumin. These enzymes and proteins provide a snapshot of liver cell integrity and the liver's ability to process waste and synthesize essential blood components. This panel is ordered for routine health screenings, to monitor the side effects of medications known to be hepatotoxic (like statins or NSAIDs), or to investigate symptoms such as jaundice (yellowing of eyes/skin), dark urine, or abdominal pain. Omitting Gamma-Glutamyl Transferase (GGT) is common in standard panels as the other markers often provide sufficient information for general screening, though GGT is more specific for biliary obstruction or alcohol consumption.
  • Fatty Liver Disease (NAFLD): Often characterized by mild elevations in ALT and AST.
  • Hepatitis (Viral or Toxic): Causes significant 'spikes' in liver enzymes due to acute cell death.
  • Cirrhosis: Long-term scarring that leads to decreased albumin and increased bilirubin.
  • Gallstones: Can cause an increase in ALP and Bilirubin due to bile duct blockage.
Understanding LFT results requires looking at the pattern of elevations. For example, an ALT much higher than AST often points to liver-specific injury, whereas a high AST/ALT ratio might suggest alcoholic liver disease. Because the liver has massive regenerative capacity, early damage may present with only subtle changes in these markers.
View Interpretation
Immunology

Liver-Kidney Microsome (LKM)-1 Antibody (ELISA)

The Liver-Kidney Microsome Type 1 (LKM-1) antibody test is a specialized immunological assay used primarily to identify the presence of autoantibodies directed against the enzyme cytochrome P450 2D6. In a healthy immune system, antibodies protect the body from external pathogens. However, in autoimmune conditions, the body loses self-tolerance and begins attacking its own cellular components. The LKM-1 antibody specifically targets proteins within the hepatocytes (liver cells) and renal proximal tubular cells (kidney cells). This test is crucial when a physician suspects Autoimmune Hepatitis (AIH), specifically Type 2. AIH is a chronic condition where the immune system attacks the liver, leading to inflammation and potential scarring (cirrhosis). While Type 1 AIH is more common in adults and associated with ANA (Antinuclear Antibodies), Type 2 AIH is more frequently seen in children and adolescents. Doctors order this test when a patient presents with unexplained jaundice, fatigue, abdominal pain, or elevated liver enzymes (ALT/AST) that do not respond to standard viral hepatitis treatments.
  • Autoimmune Hepatitis Type 2: This is the primary condition associated with LKM-1. It is often more aggressive than Type 1 and requires long-term immunosuppression.
  • Chronic Hepatitis C: A subset of patients with Hepatitis C virus (HCV) may develop LKM-1 antibodies, though usually at lower titers than those seen in AIH.
  • Drug-Induced Liver Injury: Certain medications can trigger an immune response that mimics the appearance of LKM-1 antibodies.
  • AIRE Deficiency: Part of the Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) syndrome.
View Interpretation
Immunology

Liver-Kidney Microsome Type 1 (LKM-1) Antibody

The LKM-1 antibody is a hallmark serological marker for Autoimmune Hepatitis (AIH) Type 2. This form of AIH typically affects children and young adults and often presents with more severe clinical features than Type 1. The antibody targets the cytochrome P450 2D6 enzyme. Testing is vital for differentiating autoimmune liver disease from viral hepatitis or drug-induced liver injury.
View Interpretation
Metabolic

Low-Density Lipoprotein (LDL) Cholesterol

LDL Cholesterol, often termed 'bad' cholesterol, is a primary component of the lipid profile used to assess cardiovascular risk. LDL particles transport cholesterol to peripheral tissues; when present in excess, they penetrate the arterial wall, undergo oxidation, and lead to atherosclerosis (plaque buildup). Managing LDL levels is a cornerstone of preventing myocardial infarction (heart attack) and stroke. Within a lipid profile, LDL is usually calculated via the Friedewald equation or measured directly.
View Interpretation
Hematology

Lupus Anticoagulant

The Lupus Anticoagulant (LA) test is a functional assay used to detect specific autoantibodies that interfere with the phospholipid-dependent coagulation process. Despite its name, it is a pro-thrombotic factor, meaning it promotes blood clotting rather than preventing it. These antibodies belong to the antiphospholipid antibody family and are often found in patients with systemic lupus erythematosus (SLE) and other autoimmune conditions. Physicians typically order the LA test when a patient experiences unexplained blood clots (thrombosis), recurrent miscarriages, or a prolonged Activated Partial Thromboplastin Time (aPTT) that does not correct when mixed with normal plasma. It is a critical component in the diagnosis of Antiphospholipid Syndrome (APS), a condition characterized by both laboratory evidence of antibodies and clinical events like arterial or venous thrombosis.
  • Antiphospholipid Syndrome (APS): The primary condition associated with persistent positive LA results.
  • Systemic Lupus Erythematosus (SLE): Approximately 30% of SLE patients may test positive for LA.
  • Thrombophilia: Increased risk for Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).
  • Obstetric Complications: Including pre-eclampsia and unexplained fetal loss.
Testing usually involves a multi-step process: a screening test (like the Dilute Russell Viper Venom Time - dRVVT), followed by a mixing study to exclude factor deficiencies, and finally a confirmation test adding excess phospholipids. A positive result is only clinically significant if it persists for more than 12 weeks.
View Interpretation
Endocrinology

Luteinizing Hormone (LH)

Luteinizing Hormone (LH) is a gonadotropin produced by the anterior pituitary gland. In females, a sharp rise in LH (the 'LH surge') triggers ovulation and the development of the corpus luteum. In males, LH stimulates the Leydig cells in the testes to produce testosterone. It is a key regulator of the hypothalamic-pituitary-gonadal axis. LH testing is fundamental in investigating infertility in both men and women. In women, it is used to track ovulation, evaluate menstrual irregularities, and diagnose menopause or Polycystic Ovary Syndrome (PCOS). In men, it helps determine if low testosterone is due to a primary testicular failure or a secondary pituitary/hypothalamic issue. It is also used in pediatrics to evaluate precocious or delayed puberty.
  • PCOS: Often characterized by an elevated LH to FSH ratio.
  • Primary Ovarian Failure/Menopause: LH levels rise significantly as the body attempts to stimulate non-responsive ovaries.
  • Hypogonadotropic Hypogonadism: Low LH levels resulting in low sex hormone production due to pituitary or hypothalamic failure.
  • Pituitary Adenomas: Tumors can either over-secrete LH or suppress its production.
View Interpretation
Endocrinology

Luteinizing Hormone (LH)

Luteinizing Hormone (LH) is a gonadotropin produced by the anterior pituitary gland. In females, a mid-cycle surge of LH triggers ovulation and the development of the corpus luteum. In males, LH stimulates Leydig cells in the testes to produce testosterone. Within the LH/FSH panel, it is essential for diagnosing infertility, polycystic ovary syndrome (PCOS), pituitary disorders, and primary or secondary gonadal failure.
View Interpretation
Endocrinology

Luteinizing Hormone (LH)

LH is a gonadotropin produced by the anterior pituitary gland. In females, a sharp rise in LH (the LH surge) triggers ovulation and the development of the corpus luteum. In males, LH stimulates Leydig cells to produce testosterone. In the context of a fertility profile, it helps diagnose primary vs. secondary hypogonadism, polycystic ovary syndrome (PCOS)—where LH is often elevated relative to FSH—and evaluates pituitary function or the onset of menopause.
View Interpretation
Endocrinology

Luteinizing Hormone (LH)

Luteinizing Hormone (LH) is a gonadotropin produced by the anterior pituitary gland. In females, a mid-cycle surge of LH triggers ovulation and the development of the corpus luteum. In males, LH stimulates Leydig cells in the testes to produce testosterone. Within an LH and FSH Panel, it is essential for diagnosing primary vs. secondary hypogonadism, investigating infertility, polycystic ovary syndrome (PCOS), and evaluating pituitary disorders.
View Interpretation
Endocrinology

Luteinizing Hormone (LH)

LH is a gonadotropin produced by the anterior pituitary. In females, a mid-cycle surge of LH triggers ovulation and the development of the corpus luteum. In males, LH stimulates Leydig cells to produce testosterone. Within an endocrine panel (TFT, FSH, Prolactin), LH helps differentiate between primary gonadal failure and secondary (pituitary/hypothalamic) disorders.
View Interpretation
Hematology

Lymphocytes

Component of White Blood Cell differential.
View Interpretation
Hematology

Lymphocytes

Lymphocytes (B-cells, T-cells, and NK-cells) are the primary components of the adaptive immune system. In a Differential Count, the lymphocyte percentage helps determine if the body is mounting a response to a viral infection, chronic inflammation, or a hematologic malignancy. It is a fundamental marker for identifying lymphocytosis or lymphopenia.
View Interpretation
Hematology

Lymphocytes

Lymphocytes are a type of white blood cell (WBC) crucial for the immune system, consisting of T-cells, B-cells, and natural killer (NK) cells. In the context of a Differential Count (DC), the percentage of lymphocytes helps identify the nature of an immune response. They are primarily responsible for adaptive immunity, including antibody production and direct destruction of infected or cancerous cells. Monitoring lymphocyte levels is essential for diagnosing viral infections, autoimmune disorders, and certain hematological malignancies.
View Interpretation
Hematology

Lymphocytes

Lymphocytes are a type of white blood cell (leukocyte) crucial for the adaptive immune system. In the context of a Differential Count (DC), this component measures the percentage of lymphocytes (including T cells, B cells, and Natural Killer cells) relative to the total white blood cell count. They are primary responders to viral infections and are responsible for antibody production and cell-mediated immunity. Tracking this percentage helps differentiate between viral, bacterial, and inflammatory conditions.
View Interpretation
Hematology

Lymphocytes

Lymphocytes are a type of white blood cell (WBC) essential for the immune system, comprising T cells, B cells, and Natural Killer (NK) cells. In a Differential Count, the lymphocyte percentage reflects the body's ability to mount a specific immune response, particularly against viral infections and intracellular pathogens. They are responsible for antibody production and cell-mediated immunity.
View Interpretation
Hematology

Lymphocytes (%)

This measures the percentage of total WBCs that are lymphocytes (T cells, B cells, and NK cells). Lymphocytes are the primary cells of the adaptive immune system, responsible for antibody production and cellular immunity against viruses and tumors. In a differential count, the percentage helps categorize the type of immune response currently active in the body.
View Interpretation
Hematology

Lymphocytes (Absolute Count)

Lymphocytes are a type of white blood cell (WBC) crucial for the adaptive immune system, including T cells, B cells, and Natural Killer (NK) cells. In a Complete Blood Picture (CBC), the absolute count provides more diagnostic value than the percentage. It helps clinicians differentiate between bacterial infections (which typically increase neutrophils) and viral infections or chronic inflammatory conditions (which often increase lymphocytes). It is also vital for monitoring immunocompromised patients, such as those with HIV or undergoing chemotherapy.
View Interpretation
Hematology

Lymphocytes (Absolute)

Absolute Lymphocytes represent the total count of B-cells, T-cells, and Natural Killer (NK) cells per microliter of blood. Within a Complete Blood Count (CBC), lymphocytes are the primary components of the adaptive immune system. In many viral infections, lymphocyte counts initially drop (lymphopenia). In the context of severe infections like COVID-19, a persistent low absolute lymphocyte count is a recognized prognostic indicator of disease severity and potential for respiratory failure.
View Interpretation
Hematology

Lymphocytes (DC)

Lymphocytes are a type of White Blood Cell (WBC) critical for the adaptive immune system. This 'Differential Count' (DC) measures the percentage of lymphocytes relative to the total WBC count. They include T-cells (cell-mediated immunity), B-cells (antibody production), and Natural Killer cells. In a complete blood picture, lymphocyte levels help distinguish between viral infections, bacterial infections, and chronic inflammatory or hematological conditions.
View Interpretation
Molecular Genetics

MGMT Methylation Test - Glioblastoma

The MGMT (O6-methylguanine-DNA methyltransferase) test measures the methylation status of the promoter region of the MGMT gene. The MGMT gene produces a protein that repairs DNA damage. In the context of cancer treatment, specifically glioblastoma, this repair mechanism can actually be detrimental because it 'fixes' the DNA damage caused by chemotherapy drugs like Temozolomide. This is a predictive biomarker test. If the MGMT promoter is 'methylated,' the gene is essentially switched off. This means the tumor cells cannot repair the damage caused by chemotherapy, making the treatment much more effective. If the promoter is 'unmethylated,' the gene is active, and the tumor is more likely to be resistant to standard chemotherapy.
  • Glioblastoma Multiforme (GBM): The primary brain tumor where this test is standard of care.
  • Anaplastic Astrocytoma: Other high-grade gliomas where treatment decisions rely on DNA repair capacity.
  • Temozolomide Resistance: Unmethylated status is a primary driver of resistance to alkylating agents.
View Interpretation
Immunology

MMR Profile (Measles, Mumps, Rubella)

The MMR Profile measures the presence of IgG antibodies against three viral infections: Measles (Rubeola), Mumps, and Rubella (German Measles). These antibodies are produced either by prior exposure to the viruses or through vaccination (the MMR vaccine). The presence of IgG antibodies indicates long-term immunity, protecting the individual from future infections by these specific pathogens. This panel is frequently required for healthcare workers, students, and travelers to ensure they are protected against these highly contagious diseases. It is also critical for women planning pregnancy, as Rubella infection during pregnancy can lead to Congenital Rubella Syndrome, causing severe birth defects. It helps determine if a booster shot is necessary.
  • Measles: A respiratory infection causing a characteristic rash, high fever, and cough; can lead to pneumonia or encephalitis.
  • Mumps: Known for causing swelling of the salivary (parotid) glands; can lead to orchitis or meningitis.
  • Rubella: Generally mild in children but dangerous during pregnancy due to its teratogenic effects.
  • Vaccine Non-Response: A small percentage of individuals do not develop immunity even after vaccination.
View Interpretation
Hematology

MRD Flow Cytometry (Minimal Residual Disease)

Minimal Residual Disease (MRD) testing via flow cytometry is a highly sensitive method used to detect a very small number of cancer cells that remain in a patient's body during or after treatment. While traditional microscopy might show a 'complete remission,' flow cytometry can look at millions of cells to find 1 malignant cell in 10,000 or 100,000. MRD is the single most powerful predictor of relapse in blood cancers. It is ordered to:
  • Evaluate the effectiveness of chemotherapy or bone marrow transplants.
  • Determine if additional 'consolidation' therapy is required.
  • Monitor for early signs of cancer recurrence before physical symptoms appear.
  • Acute Lymphoblastic Leukemia (ALL): MRD status is standard of care for prognosticating ALL.
  • Acute Myeloid Leukemia (AML): Used to guide the intensity of post-remission therapy.
  • Multiple Myeloma: Achieving MRD-negative status is a key goal for survival.
  • Chronic Lymphocytic Leukemia (CLL): Helps in deciding when treatment can be safely paused.
By identifying residual disease at a molecular level, clinicians can personalize treatment plans—escalating therapy for those at high risk of relapse and sparing others from unnecessary toxic treatments.
View Interpretation
Microbiology

MTB PCR Any Sample

The Mycobacterium tuberculosis (MTB) Polymerase Chain Reaction (PCR) test is a molecular diagnostic tool designed to detect the DNA of the MTB complex. Unlike traditional culture methods that can take weeks, PCR provides rapid results by amplifying specific genetic sequences unique to the tuberculosis bacteria. It is ordered for patients suspected of having active pulmonary or extra-pulmonary tuberculosis. Symptoms often include chronic cough, weight loss, night sweats, and fever. PCR is particularly useful for rapid screening and for detecting TB in samples where the bacterial load might be too low for a standard smear microscopy (AFB smear). Detection of MTB DNA is associated with:
  • Pulmonary Tuberculosis: The most common form affecting the lungs.
  • Extra-pulmonary Tuberculosis: Infection in the lymph nodes, spine (Pott's disease), or kidneys.
  • Miliary Tuberculosis: A life-threatening form where bacteria spread through the bloodstream.
  • Multidrug-Resistant TB (MDR-TB): Some PCR platforms (like GeneXpert) also detect resistance to Rifampicin.
View Interpretation
Clinical Pathology

Macrophages (CSF)

In the Cerebrospinal Fluid (CSF) Differential Count, macrophages are not typically present in significant numbers. Their appearance indicates the clearance of foreign material, microorganisms, or cellular debris. Specifically, finding macrophages containing ingested red blood cells (erythrophagocytosis) or breakdown products like hemosiderin or hematoidin crystals is a vital indicator of a prior subarachnoid hemorrhage, helping to differentiate it from a 'traumatic tap'.
View Interpretation
Parasitology

Malaria Parasite - QBC Method

The Quantitative Buffy Coat (QBC) method is a specialized fluorescent microscopy technique used for the rapid detection of malaria parasites in the blood. It involves a capillary tube coated with acridine orange (a fluorescent stain) and a precision float. When the blood is centrifuged, the parasites concentrate in the 'buffy coat' layer (near the white blood cells) and can be visualized under a UV light source. This test is ordered when a patient presents with symptoms suggestive of malaria, such as cyclic fevers, chills, sweating, and headache, particularly if they have traveled to an endemic region. The QBC method is often preferred in settings where rapid screening is needed because it is more sensitive than a standard thick film for detecting low levels of parasitemia (parasite load).
  • Plasmodium falciparum: The most dangerous form, leading to cerebral malaria or organ failure.
  • Plasmodium vivax/ovale: Known for causing relapsing fevers.
  • Plasmodium malariae: Causes chronic, lower-intensity infections.
The QBC method is highly effective for screening because the fluorescent stain makes the parasites 'glow,' allowing even relatively inexperienced microscopists to spot them faster than with traditional Giemsa stains. However, while it is excellent for detecting the presence of parasites, it is often less effective than traditional thin smears for identifying the exact species of Plasmodium, which is necessary for choosing the correct anti-malarial medication.
View Interpretation
Immunology

Mantoux Test

The Mantoux Test, also known as the PPD (Purified Protein Derivative) skin test, measures the body's immune response to proteins derived from Mycobacterium tuberculosis. It is a Type IV delayed-type hypersensitivity reaction. If the person has been infected with TB, their T-cells will recognize the PPD and cause a localized inflammatory response (induration). It is primarily used as a screening tool for Latent Tuberculosis Infection (LTBI). It is often required for healthcare workers, students, or individuals who have been in close contact with someone who has active TB. It helps identify people who are infected but not yet sick, allowing for preventative treatment.
  • Latent Tuberculosis: Infection is present but the patient is not contagious and has no symptoms.
  • Active Tuberculosis: In some cases, the test is positive during active disease, though other diagnostics are required.
  • BCG Vaccination History: Individuals vaccinated with the BCG vaccine (common outside the US) may show a positive result without having a true TB infection.
  • Immunosuppression: Conditions like HIV or medications like steroids can cause a 'false negative' because the immune system is too weak to react to the test.
View Interpretation
Toxicology

Marijuana Metabolite (THC)

This test measures the primary inactive metabolite of Tetrahydrocannabinol (THC), specifically 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH), in the urine. As part of a DOA 5-Panel, it is used to screen for cannabis consumption. Because THC is lipophilic, it is stored in fat cells and released slowly, allowing for a detection window ranging from a few days for occasional users to several weeks for chronic users. It identifies exposure rather than acute impairment.
View Interpretation
Hematology

Mean Corpuscular Hemoglobin (MCH)

MCH calculates the average amount (mass) of hemoglobin per individual red blood cell. It is a critical parameter in the Complete Blood Count (CBC) used to classify anemias. It typically mirrors the Mean Corpuscular Volume (MCV); if cells are small (microcytic), they usually contain less hemoglobin (hypochromic).
View Interpretation
Hematology

Mean Corpuscular Hemoglobin (MCH)

MCH calculates the average amount of hemoglobin contained within a single red blood cell. As part of a Complete Blood Picture (CBP), it is a calculated index (Hb/RBC count). It is essential for the morphological classification of anemias. It tells the clinician whether the red cells are 'hypochromic' (pale, lacking hemoglobin) or 'normochromic'. This helps narrow down the cause of anemia before more expensive tests (like ferritin or B12) are ordered.
View Interpretation
Hematology

Mean Corpuscular Hemoglobin (MCH)

MCH measures the average mass of hemoglobin per red blood cell. As part of a 'Complete Blood Count (CBC)', it is a red cell index used to categorize anemias. While it often tracks with the Mean Corpuscular Volume (MCV), it specifically highlights the concentration of oxygen-carrying pigment. Low MCH (hypochromic) suggests an iron deficiency or hemoglobin synthesis issue.
View Interpretation
Hematology

Mean Corpuscular Hemoglobin Concentration (MCHC)

The Mean Corpuscular Hemoglobin Concentration (MCHC) is a calculation of the average concentration of hemoglobin within a single red blood cell relative to the size (volume) of the cell. Within a Complete Blood Count (CBC), MCHC is vital for classifying anemias. It helps distinguish between hypochromic anemia (where cells are pale and lack hemoglobin) and normochromic anemia. It is particularly useful in identifying conditions like hereditary spherocytosis or evaluating the severity of iron deficiency.
View Interpretation
Hematology

Mean Corpuscular Hemoglobin Concentration (MCHC)

MCHC measures the average concentration of hemoglobin in a given volume of packed red blood cells (RBCs). It is a key red cell index in a Complete Blood Picture for the morphological classification of anemia. It helps determine if RBCs are normochromic (normal color/concentration) or hypochromic (pale/low concentration). Unlike MCH, MCHC accounts for the size of the cell, making it a more accurate measure of the 'density' of hemoglobin within the RBC.
View Interpretation
Hematology

Mean Corpuscular Hemoglobin Concentration (MCHC)

MCHC is a calculated parameter in a Complete Blood Count (CBC) that represents the average concentration of hemoglobin in a given volume of packed red blood cells. It is a 'quality control' metric for RBCs; it helps clinicians distinguish between different types of anemia. Unlike MCH, MCHC accounts for the size of the cell, making it vital for identifying conditions like hereditary spherocytosis or iron deficiency.
View Interpretation
Hematology

Mean Corpuscular Volume (MCV)

Mean Corpuscular Volume (MCV) is a measure of the average volume (size) of a single red blood cell (RBC). It is a standard component of the Complete Blood Count (CBC) and is the most useful parameter for the morphological classification of anemia. MCV is used to help diagnose the cause of anemia. When the hemoglobin or hematocrit is low, the MCV tells the clinician whether the red cells are unusually small (microcytic), normal-sized (normocytic), or unusually large (macrocytic). This narrow focus allows doctors to pinpoint nutritional deficiencies or bone marrow issues.
  • Microcytic Anemia (Low MCV): Most commonly caused by iron deficiency anemia, thalassemia, or lead poisoning.
  • Normocytic Anemia (Normal MCV): Anemia of chronic disease, acute blood loss, or kidney failure.
  • Macrocytic Anemia (High MCV): Vitamin B12 deficiency (Pernicious anemia), folate deficiency, alcoholism, or certain medications (like chemotherapy).
Beyond anemia, MCV can be an early indicator of health shifts before hemoglobin levels even drop. For instance, a rising MCV in an individual with heavy alcohol consumption can indicate liver stress or direct marrow toxicity. In contrast, a low MCV with a high RBC count often points toward Thalassemia rather than simple iron deficiency, a distinction critical for avoiding unnecessary iron supplementation.
View Interpretation
Hematology

Mean Corpuscular Volume (MCV)

MCV measures the average size/volume of a single red blood cell. It is the most critical RBC index in the Complete Blood Count (CBC) for the morphological classification of anemia. By determining if RBCs are small (microcytic), normal (normocytic), or large (macrocytic), clinicians can narrow down the cause of anemia (e.g., iron deficiency vs. B12 deficiency) before ordering more expensive specialized tests.
View Interpretation
Hematology

Mean Corpuscular Volume (MCV)

MCV measures the average size (volume) of a single red blood cell (RBC). It is a vital RBC index used to classify anemias. By determining if cells are too small (microcytic), normal (normocytic), or too large (macrocytic), clinicians can narrow down the etiology of anemia, ranging from iron deficiency to DNA maturation defects caused by vitamin deficiencies.
View Interpretation
Hematology

Mean Corpuscular Volume (MCV)

MCV is a measure of the average volume (size) of a single red blood cell. It is a critical parameter in the Complete Blood Count (CBC) used to morphologically classify anemias. By categorizing anemia based on cell size, clinicians can narrow down the differential diagnosis: Microcytic (small cells), Normocytic (normal size), or Macrocytic (large cells). It serves as a vital first step in determining whether an anemia is likely due to iron deficiency, genetic hemoglobinopathies, or nutritional deficiencies like B12/Folate.
View Interpretation
Hematology

Mean Platelet Volume (MPV)

MPV measures the average size of platelets in the blood. Younger platelets are generally larger than older ones. MPV is used to differentiate between causes of thrombocytopenia (low platelet count). If the platelet count is low but the MPV is high, it suggests the bone marrow is rapidly producing new platelets to compensate for peripheral destruction.
View Interpretation
Hematology

Mean Platelet Volume (MPV)

MPV measures the average size of platelets in the blood. Since larger platelets are typically younger and more metabolically active, MPV serves as an indicator of platelet production (thrombopoiesis) in the bone marrow. In a CBC, the MPV must be interpreted alongside the total platelet count. It helps distinguish between causes of thrombocytopenia (e.g., bone marrow failure vs. peripheral destruction).
View Interpretation
Immunology

Measles Virus IgG Antibody

The Measles IgG test detects antibodies that indicate long-term immunity to the Rubeola virus. In an MMR Profile, it is used to confirm a patient's immune status, either from previous vaccination or past natural infection. It is not used to diagnose an acute infection (which would require IgM).
View Interpretation
Wellness/Screening

Medcis Male Profile

The Medcis Male Profile is a comprehensive diagnostic panel specifically designed to evaluate the overall health status of men. It typically includes a battery of tests covering metabolic function, cardiovascular risk, hormonal balance, and organ health. This profile serves as a baseline for preventive medicine and early detection of gender-specific health issues. This panel is ordered as part of an annual executive check-up or when a male patient presents with non-specific symptoms like fatigue, weight changes, or decreased libido. It helps clinicians screen for silent killers like hypertension, hyperlipidemia, and diabetes, while also assessing markers like PSA (Prostate-Specific Antigen) for prostate health and Testosterone for endocrine function.
  • Cardiovascular Disease: Assessed via lipid profiles (Cholesterol, LDL, HDL).
  • Diabetes Mellitus: Monitored through Blood Glucose and HbA1c.
  • Liver/Kidney Dysfunction: Evaluated through enzymes like ALT/AST and Creatinine/BUN levels.
  • Prostate Disorders: Screened via PSA levels.
  • Anemia: Identified through a Complete Blood Count (CBC).
View Interpretation
Hematology

Microfilaria - QBC Method

The Microfilaria test using the Quantitative Buffy Coat (QBC) method is a diagnostic technique used to detect the presence of larval stages (microfilariae) of filarial parasites in the blood. These parasites, such as Wuchereria bancrofti and Brugia malayi, are responsible for lymphatic filariasis. The QBC method utilizes a specialized capillary tube coated with acridine orange (a fluorescent stain) and a high-speed centrifuge to concentrate the parasites in the buffy coat layer, making them easier to visualize under a microscope. This test is ordered for patients living in or traveling from tropical or subtropical regions who present with:
  • Lymphedema: Swelling of the limbs or genitals (Elephantiasis).
  • Hydrocele: Accumulation of fluid in the scrotum.
  • Tropical Pulmonary Eosinophilia: Characterized by coughing and wheezing.
  • Fever and Lymphadenitis: Recurrent episodes of inflamed lymph nodes.
  • Lymphatic Filariasis: The primary disease caused by these parasites, leading to significant disability and social stigma.
  • Loiasis: Caused by Loa loa, often associated with eye worms or localized swellings.
  • Onchocerciasis (River Blindness): Though microfilariae are usually found in skin snips, some species may appear in blood.
  • Bancroftian Filariasis: Specific to the Wuchereria species.
View Interpretation
Microbiology

Microfilariae

The Microfilariae test is a microscopic examination of blood to identify the presence of larval stages (microfilariae) of filarial parasites. These parasites are nematodes (roundworms) that inhabit the lymphatic system or subcutaneous tissues of humans, transmitted via the bites of infected mosquitoes or flies. This test is ordered for patients presenting with symptoms of Lymphatic Filariasis (Elephantiasis), such as severe limb swelling, scrotal swelling (hydrocele), or tropical pulmonary eosinophilia. It is particularly relevant for individuals living in or traveling from endemic regions in Asia, Africa, and South America.
  • Wuchereria bancrofti: Responsible for the majority of lymphatic filariasis cases.
  • Brugia malayi/timori: Other causes of lymphatic swelling.
  • Loa loa: Known as the 'African eye worm,' where microfilariae are found in the blood but adults migrate under the skin/eye.
Detection often requires specialized techniques like the Knott’s concentration method or membrane filtration to increase sensitivity. Because microfilariae often exhibit 'nocturnal periodicity,' blood must be drawn between 10:00 PM and 2:00 AM for certain species (like W. bancrofti) when the larvae migrate from internal organs into the peripheral bloodstream.
View Interpretation
Oncology

Microsatellite Instability Testing by Immunohistochemistry

Microsatellite Instability (MSI) testing by Immunohistochemistry (IHC) is a specialized pathological assessment used to detect deficiencies in DNA mismatch repair (MMR) proteins. The test evaluates the presence of four specific proteins: MLH1, MSH2, MSH6, and PMS2. When these proteins are absent, the cell's ability to fix DNA replication errors is compromised, leading to a state called MSI-High (MSI-H). This test is primarily ordered for patients diagnosed with colorectal, endometrial, or gastric cancers. It serves two main purposes: screening for Lynch Syndrome (a hereditary cancer predisposition) and determining eligibility for immunotherapy. Tumors that are MSI-High or MMR-deficient (dMMR) often respond exceptionally well to immune checkpoint inhibitors like pembrolizumab.
  • Lynch Syndrome: An inherited condition that significantly increases the risk of various cancers.
  • Colorectal Cancer: Roughly 15% of sporadic colorectal cancers are dMMR.
  • Endometrial Carcinoma: MSI status helps in prognostic stratification.
Identifying a loss of protein expression guides the clinical team toward either further genetic germline testing or specific targeted oncological therapies. It provides vital information regarding the aggressiveness of the tumor and the potential success of the treatment plan.
View Interpretation
Allergy and Immunology

Milk (Cow) IgE

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies to cow's milk proteins (such as casein and whey). It is used to identify Type I hypersensitivity (allergic) reactions. It is a cornerstone of allergy profiling to differentiate between true milk allergy (immune-mediated) and milk intolerance (enzymatic/digestive issue).
View Interpretation
Hematology

Monocytes

Component of White Blood Cell differential.
View Interpretation
Clinical Pathology

Monocytes

In the context of a Cerebrospinal Fluid (CSF) differential count, monocytes are phagocytic leukocytes. While a small percentage (0-5%) is normal, an increase (monocytosis) typically signifies chronic inflammatory processes, granulomatous diseases, or specific infections such as tuberculous or fungal meningitis. They are also seen in the resolving stages of bacterial meningitis and can indicate reaction to foreign material (e.g., a CNS shunt).
View Interpretation
Hematology

Monocytes

Monocytes are the largest type of white blood cell and are precursors to macrophages and dendritic cells. In a Differential Count, they represent the innate immune system's response to chronic infections, inflammation, and tissue repair. They play a critical role in phagocytosis (engulfing pathogens) and antigen presentation to T-cells.
View Interpretation
Hematology

Monocytes

Monocytes are the largest type of white blood cell and serve as precursors to macrophages and myeloid lineage dendritic cells. Within a Differential Count (DC), they are vital for the immune response against chronic infections, viral pathogens, and inflammation. They assist in 'clearing' cellular debris and presenting antigens to T-cells.
View Interpretation
Hematology

Monocytes

Monocytes are the largest of the white blood cells and serve as precursors to tissue macrophages. They play a vital role in phagocytosis and antigen presentation. In a Differential Count, the monocyte percentage helps identify chronic inflammatory states, recovery phases from acute infections, or bone marrow disorders. They are the 'clean-up crew' of the immune system, responding to cellular debris and persistent pathogens.
View Interpretation
Hematology

Monocytes

Monocytes are the largest type of white blood cell (leukocyte) and are key components of the innate immune system. In the TCDC-X panel, the Monocyte percentage indicates the body's response to chronic inflammation or necrosis. They eventually migrate into tissues to become macrophages, which 'eat' pathogens and debris. Monitoring monocyte counts is essential for detecting the recovery phase of acute infections or the presence of chronic infections like tuberculosis or autoimmune disorders.
View Interpretation
Hematology

Monocytes (%)

Monocytes are the largest type of white blood cell and are precursors to macrophages. They play a vital role in phagocytosis (engulfing debris and pathogens) and antigen presentation. Their percentage in the differential count is particularly useful for identifying chronic infections, the recovery phase of acute infections, and certain hematologic malignancies.
View Interpretation
Hematology

Monocytes (Absolute)

Monocytes are the largest white blood cells and serve as precursors to macrophages and dendritic cells. In a Complete Blood Picture (CBP), the absolute monocyte count is more clinically relevant than the percentage. Monocytes are key in phagocytosis and presenting antigens to T-cells. Elevations (monocytosis) provide clues to chronic infections, inflammatory conditions, and certain hematologic malignancies like Chronic Myelomonocytic Leukemia (CMML).
View Interpretation
Hematology

Monocytes (Absolute)

Monocytes are the largest type of white blood cell and serve as precursors to macrophages and dendritic cells. They are critical for phagocytosis and antigen presentation. An absolute count (rather than a percentage) provides the actual number of cells per microliter of blood. In a full Hemogram, monocytosis is often a hallmark of chronic inflammation, recovery from acute infection, or certain hematologic malignancies like CMML (Chronic Myelomonocytic Leukemia).
View Interpretation
Hematology

Monocytes (DC)

Monocytes are the largest type of white blood cell and serve as the precursors to macrophages. As part of the Differential Count (DC), the percentage of monocytes helps identify chronic inflammatory states, recovery phases of acute infections, and certain hematologic malignancies like CMML.
View Interpretation
Hematopathology

Mpo Stain

The Myeloperoxidase (MPO) Stain is a cytochemical test used to detect the enzyme myeloperoxidase, which is primarily found in the primary granules of myeloid cells (neutrophils, monocytes, and their precursors). It is a gold-standard tool in the microscopic differentiation of immature blood cells. This test is critically important when a patient is suspected of having acute leukemia. It helps hematopathologists distinguish between Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL). Since the treatment protocols for AML and ALL are vastly different, an accurate MPO stain result is essential for choosing the correct chemotherapy regimen.
  • Acute Myeloid Leukemia (AML): Most AML subtypes (M1, M2, M3, M4) show strong MPO positivity.
  • Acute Lymphoblastic Leukemia (ALL): Characteristically MPO-negative.
  • Myelodysplastic Syndromes (MDS): May show varying degrees of MPO activity.
  • Congenital MPO Deficiency: A rare condition where cells lack the enzyme, potentially leading to increased infection risk.
View Interpretation
Gastroenterology

Mucus (Stool)

The presence of mucus in stool is an indicator of inflammation or irritation in the intestinal mucosa. While the colon naturally produces mucus to lubricate the passage of stool, it is usually not visible to the naked eye. Visible mucus can indicate that the gut is producing excess protective lining in response to pathogens, chronic inflammatory conditions, or mechanical irritation.
View Interpretation
Immunology

Mumps Virus IgG Antibody

The Mumps Virus IgG (Immunoglobulin G) test is used to determine immune status against the mumps virus. A positive IgG result indicates that the individual has either had a past infection or has been successfully vaccinated (usually via the MMR vaccine). Within the MMR profile, this test ensures that the patient is protected against mumps, which is particularly important for healthcare workers, students, and travelers to prevent outbreaks.
View Interpretation
Allergy and Immunology

Mutton (Lamb) Specific IgE

This test measures the concentration of allergen-specific IgE antibodies in the serum directed against mutton (lamb) proteins. It is used to identify Type I hypersensitivity (allergic) reactions. While lamb is generally considered one of the least allergenic meats, sensitization can occur, leading to symptoms ranging from urticaria (hives) to anaphylaxis. In a multi-allergen profile, this component helps differentiate meat-specific allergies from other food or environmental triggers.
View Interpretation
Microbiology

Mycoplasma Pneumoniae Antigen Detection

Mycoplasma pneumoniae is a unique bacterium that lacks a cell wall, making it naturally resistant to many common antibiotics like penicillin. It is a leading cause of upper and lower respiratory tract infections. Antigen detection tests use antibodies to identify specific proteins (antigens) of the bacteria directly from respiratory secretions. This test is ordered when a patient presents with symptoms of 'walking pneumonia,' such as a persistent dry cough, fever, headache, and malaise. Because M. pneumoniae grows very slowly in culture (taking up to 3 weeks), antigen detection or PCR-based methods are preferred for rapid diagnosis to initiate appropriate macrolide or tetracycline therapy.
  • Community-Acquired Pneumonia (CAP): Often seen in school-aged children and young adults.
  • Tracheobronchitis: Inflammatory condition of the windpipe and bronchi.
  • Extrapulmonary Complications: In rare cases, it can cause skin rashes (Stevens-Johnson syndrome) or neurological issues.
Rapid identification is crucial for public health, as Mycoplasma outbreaks are common in crowded environments like dormitories or barracks. Since the bacteria lacks a cell wall, identifying it early ensures the doctor does not waste time prescribing ineffective beta-lactam antibiotics.
View Interpretation
Oncology

Myeloma Profile

A Myeloma Profile is a comprehensive panel of tests designed to detect, quantify, and monitor monoclonal (M) proteins. These proteins are abnormal immunoglobulins (antibodies) produced in excess by a single clone of malignant plasma cells. The profile typically includes Serum Protein Electrophoresis (SPEP), Immunofixation (IFE), and often the Serum Free Light Chain (SFLC) assay. Doctors order this profile when a patient presents with symptoms suggestive of plasma cell dyscrasias, often summarized by the 'CRAB' acronym: Calcium elevation, Renal insufficiency, Anemia, and Bone lesions. It is also used to differentiate between malignant Multiple Myeloma and benign conditions like Monoclonal Gammopathy of Undetermined Significance (MGUS).
  • Multiple Myeloma: Characterized by a significant 'M-spike' on electrophoresis and bone marrow infiltration.
  • MGUS: A precursor condition where an M-protein is present but diagnostic criteria for cancer are not yet met.
  • Waldenström Macroglobulinemia: A type of lymphoma that produces an excess of IgM monoclonal proteins.
  • AL Amyloidosis: A condition where misfolded light chain proteins deposit in organs, causing damage.
View Interpretation
Genetics

NIPT (Non-Invasive Prenatal Testing)

Non-Invasive Prenatal Testing (NIPT), also known as cell-free DNA (cfDNA) screening, analyzes small fragments of DNA that are circulating in a pregnant woman's blood. Most of this DNA comes from the mother, but a small percentage (the fetal fraction) comes from the placenta. Since the placenta usually has the same genetic makeup as the fetus, analyzing this DNA allows for the screening of certain genetic abnormalities without risk to the pregnancy. NIPT is a screening tool used to assess the risk of chromosomal disorders. It is most commonly used to screen for Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome). It can also screen for sex chromosome abnormalities (like Turner or Klinefelter syndrome) and can determine the biological sex of the fetus as early as 10 weeks into pregnancy.
  • Aneuploidies: Abnormal number of chromosomes.
  • Microdeletions: Small missing pieces of chromosomes (e.g., DiGeorge syndrome), though NIPT is less accurate for these than for whole-chromosome issues.
  • Triploidy: Three sets of every chromosome.
NIPT is a screening test, not a diagnostic test. A 'High Risk' result requires confirmation via invasive procedures like Amniocentesis or Chorionic Villus Sampling (CVS).
View Interpretation
Genetics

NRAS Gene Analysis

The NRAS Gene Analysis test identifies mutations in the NRAS gene, which belongs to the RAS oncogene family. This gene provides instructions for making a protein that is involved in cell signaling pathways that control cell growth, cell division, and cell survival. When the NRAS gene is mutated, it can produce an overactive protein that leads to uncontrolled cell proliferation, a hallmark of cancer. NRAS testing is primarily ordered for patients diagnosed with certain types of cancer, most notably metastatic colorectal cancer and melanoma. In colorectal cancer, knowing the mutation status of the NRAS gene (along with KRAS) is critical for determining whether the patient will respond to certain targeted therapies, such as anti-EGFR (Epidermal Growth Factor Receptor) monoclonal antibodies like cetuximab or panitumumab. In melanoma, NRAS mutations occur in about 15-20% of cases and help in prognostic assessment and the identification of clinical trial eligibility.
  • Colorectal Cancer: Mutations in NRAS are predictive markers for resistance to anti-EGFR therapies.
  • Melanoma: NRAS mutations are the second most common genetic driver after BRAF mutations.
  • Thyroid Cancer: NRAS mutations are occasionally found in follicular thyroid carcinomas.
  • Hematologic Malignancies: Certain types of leukemia may exhibit NRAS mutations affecting disease progression.
View Interpretation
Microbiology

Nail Clipping for Fungus (KOH Mount and Culture)

The Nail Clipping for Fungus test is a diagnostic procedure used to identify fungal infections of the fingernails or toenails, a condition medically known as onychomycosis. The process involves two primary methods: the Potassium Hydroxide (KOH) mount and a fungal culture. The KOH mount serves as a rapid screening tool; the chemical dissolves the tough keratin of the nail, allowing the laboratory technician to see fungal structures like hyphae or spores under a microscope. The culture, while slower, identifies the specific species of fungus causing the infection. Physicians order this test when a patient presents with nails that are thickened, brittle, crumbly, ragged, or discolored (yellow, brown, or white). Since other conditions like psoriasis or trauma can mimic fungal infections, confirmation is essential before starting long-term antifungal treatments, which can sometimes have systemic side effects.
  • Onychomycosis: The primary fungal infection of the nail plate.
  • Tinea Pedis (Athlete's Foot): Often exists concurrently with nail fungus.
  • Psoriasis: Frequently confused with fungus; testing helps differentiate the two.
  • Secondary Bacterial Infections: Can occur if the fungal infection breaks the skin barrier.
View Interpretation
Microbiology

Nail Scraping for C/S

Nail Scraping for Culture and Sensitivity (C/S) is the definitive method for identifying the specific pathogens responsible for nail infections. While visual inspection can suggest a fungal infection, a culture is necessary to distinguish between dermatophytes, yeasts, and non-dermatophyte molds, as well as to rule out bacterial involvement. This test is ordered when a patient presents with onychomycosis (fungal nail infection) symptoms: thickened, brittle, ragged, or distorted nails with discoloration (yellow, brown, or white). Since long-term oral antifungal therapy (like Terbinafine) carries risks of liver toxicity, clinicians use C/S to confirm the diagnosis and ensure the organism is sensitive to the prescribed medication before starting treatment.
  • Onychomycosis: The most common cause of nail plate destruction.
  • Tinea Unguium: Fungal infection specifically caused by dermatophytes.
  • Paronychia: Bacterial or fungal infection of the nail fold.
  • Psoriasis of the Nail: Can mimic fungal infections; a negative culture helps differentiate the two.
The laboratory places the scrapings on specialized media (like Sabouraud Agar). Because fungi grow slowly, the culture may be monitored for up to 3-4 weeks. If bacteria are suspected, a separate aerobic culture is performed to determine antibiotic sensitivity.
View Interpretation
Microbiology

Nasal Discharge For Culture and Sensitivity

The Nasal Culture and Sensitivity (C/S) test is designed to identify pathogenic bacteria or fungi residing in the nasal cavity or sinuses. The 'culture' portion involves growing the organisms in a lab, while the 'sensitivity' portion determines which antibiotics are most effective at killing the specific strain identified. This test is primarily used for patients suffering from chronic or severe sinusitis that does not respond to initial empirical antibiotic therapy. It is also used to screen for healthcare-associated pathogens, such as Methicillin-resistant Staphylococcus aureus (MRSA), in pre-operative patients or healthcare workers.
  • Bacterial Sinusitis: Often caused by Streptococcus pneumoniae or Haemophilus influenzae.
  • MRSA Colonization: Identifying carriers of resistant staph bacteria to prevent spread.
  • Fungal Sinusitis: More common in immunocompromised individuals.
  • Nasal Vestibulitis: Infection of the nasal entrance.
Accurate identification is vital for antibiotic stewardship. By knowing exactly which bacteria are present and which drugs they are susceptible to, clinicians can avoid using broad-spectrum antibiotics that contribute to global resistance. It helps differentiate between viral infections (which won't grow on standard bacterial media) and bacterial infections.
View Interpretation
Hematology

Neutrophil-To-Lymphocyte Ratio (NLR)

NLR is a calculated biomarker derived by dividing the absolute neutrophil count by the absolute lymphocyte count. It serves as a rapid indicator of systemic inflammation and physiological stress. In the context of COVID-19 and other viral pneumonias, a rising NLR is a significant prognostic marker for disease severity, cytokine storm risk, and mortality.
View Interpretation
Hematology

Neutrophils

Component of White Blood Cell differential.
View Interpretation
Hematology

Neutrophils

Neutrophils are the most abundant white blood cell type and act as the primary defense against bacterial infections. They are phagocytes that migrate to sites of inflammation and infection. Their percentage in a differential count is a key indicator of acute physiological stress and bacterial invasion.
View Interpretation
Hematology

Neutrophils

Neutrophils are the most abundant type of white blood cell and serve as the primary responders to acute bacterial infection and tissue inflammation. In a TC/DC panel, the percentage of neutrophils indicates the proportion of total WBCs that are dedicated to this immediate 'innate' immune response. A 'shift to the left' (increase in immature bands) often accompanies an increase in this percentage during acute infection.
View Interpretation
Hematology

Neutrophils

Neutrophils are the most abundant white blood cell type and the first responders to the site of infection or tissue injury. In a Differential Count, the percentage of neutrophils reflects the body's acute inflammatory response. They utilize phagocytosis and the release of antimicrobial enzymes to neutralize pathogens, particularly bacteria and fungi. An increase in the percentage (Neutrophilia) often signals an active bacterial infection.
View Interpretation
Hematology

Neutrophils (%)

Neutrophils are the most abundant type of white blood cell and serve as the primary responders to acute bacterial infections and tissue injury. Within a Differential Count, this percentage indicates the relative proportion of neutrophils to other leukocytes. A 'left shift' (increased bands) often signals a bone marrow response to severe infection. This metric is critical for assessing the immune system's current inflammatory status.
View Interpretation
Hematology

Neutrophils (Absolute)

Absolute Neutrophil Count (ANC) measures the actual number of neutrophil granulocytes in the blood. As the primary responders to acute bacterial infection and systemic stress, they are the most abundant leukocyte. In a Complete Blood Picture, this value is more clinically significant than the percentage, as it determines the body's immune competence and risk for life-threatening infections.
View Interpretation
Hematology

Neutrophils (Absolute)

The Absolute Neutrophil Count (ANC) measures the actual number of neutrophils—the most abundant type of white blood cell—circulating in the blood. Neutrophils are the body's 'first responders' to bacterial infection and acute inflammation. In a CBC panel, the ANC is more clinically relevant than the percentage, as it determines the patient's actual immune competency. It is essential for monitoring patients undergoing chemotherapy or those with suspected sepsis.
View Interpretation
Clinical Pathology

Neutrophils (CSF)

Neutrophils are a type of white blood cell (WBC). In the context of a CSF Differential Count, the presence of neutrophils is highly significant. Normal cerebrospinal fluid (CSF) contains very few WBCs (0-5 cells/µL), and these are almost exclusively lymphocytes or monocytes. The presence of neutrophils (neutrophilic pleocytosis) is a primary indicator of acute bacterial meningitis. It may also be seen in the early stages of viral meningitis or in response to CNS hemorrhage and certain inflammatory conditions.
View Interpretation
Hematology

Neutrophils (DC)

Neutrophils are the most abundant type of White Blood Cell (WBC) and serve as the primary innate immune responders to bacterial infections and acute inflammation. In a Differential Count (DC), the percentage of neutrophils is measured relative to other leukocytes. High levels typically indicate an active bacterial infection, tissue necrosis (such as myocardial infarction), or physiological stress. Conversely, low levels (neutropenia) significantly increase the risk of life-threatening opportunistic infections and may indicate bone marrow suppression or autoimmune destruction.
View Interpretation
Hematology

Neutrophils (Relative)

Neutrophils are the most abundant type of white blood cell and serve as the primary responders to acute bacterial infections and tissue injury. This percentage (relative count) reflects the proportion of neutrophils within the total white blood cell population. A shift in this percentage is often the first indicator of a systemic inflammatory response or an acute 'left shift' (immature cells) in response to infection.
View Interpretation
Metabolic

Nitrite

The Nitrite test is a biochemical marker used during a Complete Urine Examination to screen for asymptomatic bacteriuria or symptomatic Urinary Tract Infections (UTIs). Most common uropathogens (specifically Gram-negative Enterobacteriaceae like E. coli) produce the enzyme nitrate reductase, which converts dietary nitrates into nitrites. A positive result is highly specific for the presence of bacteria in the urinary tract.
View Interpretation
Nephrology

Nitrite

The Nitrite test is a biochemical marker for bacteriuria, specifically involving organisms that possess the enzyme nitrate reductase. These bacteria (mostly Gram-negative such as E. coli, Klebsiella, and Proteus) convert dietary nitrates into nitrites while residing in the bladder. Within a Urine Routine panel, a positive nitrite result is highly specific for a Urinary Tract Infection (UTI), although it is not highly sensitive, as it requires the urine to be held in the bladder for at least 4 hours for the conversion to occur.
View Interpretation
Gastroenterology

Occult Blood (FOBT)

The Fecal Occult Blood Test (FOBT) is a biochemical analysis used to detect the presence of hemoglobin in the stool that is not visible to the naked eye. Within a Complete Stool Examination, it serves as a primary screening tool for gastrointestinal (GI) bleeding. Chronic, low-volume bleeding can be an early indicator of colorectal polyps, colorectal cancer, diverticulitis, or inflammatory bowel disease (IBD). Since many colorectal lesions bleed intermittently, this test is critical for identifying pathologies before they become symptomatic.
View Interpretation
Microbiology

Operating Theatre Swabs (Anaerobic Culture)

This test involves culturing swabs taken from surgical environments (Operating Theatre) specifically for anaerobic bacteria—microorganisms that thrive in the absence of oxygen. It serves as an environmental monitoring tool to ensure sterility and prevent Surgical Site Infections (SSIs). It is ordered as part of hospital infection control protocols or during an outbreak investigation. If multiple patients develop post-operative infections with the same anaerobic organism (like Clostridium species), environmental swabbing helps identify the source of contamination, whether it be surgical instruments, ventilation systems, or surfaces.
  • Iatrogenic Infections: Infections caused by medical treatment or surgical contamination.
  • Gas Gangrene: Caused by Clostridium perfringens, an anaerobe that can contaminate surgical fields if sterilization fails.
  • Sepsis: If environmental pathogens enter a sterile body cavity during surgery, they can lead to systemic infection.
View Interpretation
Toxicology

Opiates

This assay screens for the presence of natural opiates, primarily morphine and codeine, in the urine. Within a Drugs of Abuse 5-Panel (DOA 5), it is used to identify the use of heroin (which metabolizes to morphine) or prescription opiates. It measures the concentration against a specific cutoff (typically 300 or 2000 ng/mL). It is vital for identifying substance use disorders or monitoring compliance in pain management programs.
View Interpretation
Allergy and Immunology

Orange

This test measures the concentration of allergen-specific IgE antibodies against Orange (Citrus sinensis) proteins. Within an Allergy Profile, it helps distinguish between true IgE-mediated food allergy (which carries a risk of anaphylaxis) and non-immunological food intolerance or Oral Allergy Syndrome (OAS).
View Interpretation
Metabolic

Osmolality (Serum)

Serum Osmolality measures the concentration of dissolved particles in the blood, primarily sodium, glucose, and urea (BUN). It is a critical indicator of the body's water-electrolyte balance. The body maintains osmolality within a very narrow range through the action of Antidiuretic Hormone (ADH) and the thirst mechanism. This test is essential for evaluating disorders of hydration and sodium balance. Specific reasons for ordering include:
  • Investigating hyponatremia (low blood sodium) to determine if it is 'true' hyponatremia.
  • Evaluating suspected Diabetes Insipidus (where the body cannot conserve water).
  • Assessing for the presence of 'unmeasured osmols' (the Osmolal Gap), which suggests poisoning by substances like ethanol, methanol, or ethylene glycol.
  • Monitoring treatment for dehydration or hypernatremia.
  • Dehydration: Causes increased concentration of particles.
  • SIADH: Syndrome of Inappropriate Antidiuretic Hormone, leading to low serum osmolality.
  • Diabetes Insipidus: Leads to high serum osmolality and low urine osmolality.
  • Toxic Ingestion: Ingestion of glycols or alcohols significantly increases the osmolal gap.
View Interpretation
Metabolic

Osmolality (Urine)

Urine osmolality is a measure of the concentration of particles dissolved in the urine, providing a precise evaluation of the kidney's ability to concentrate or dilute urine. Unlike specific gravity, which is influenced by the weight of particles (like protein or glucose), osmolality measures the number of particles per kilogram of solvent. This test is vital for assessing the body's water balance and the functionality of Antidiuretic Hormone (ADH), also known as vasopressin. Physicians order this test primarily to investigate electrolyte imbalances, particularly sodium abnormalities (hyponatremia or hypernatremia). It is a cornerstone in the diagnostic workup for:
  • Syndrome of Inappropriate Antidiuretic Hormone (SIADH): Where the body retains too much water.
  • Diabetes Insipidus (DI): A condition characterized by extreme thirst and the excretion of large amounts of highly diluted urine.
  • Acute Kidney Injury (AKI): To differentiate between pre-renal and intrinsic renal failure.
  • Dehydration Evaluation: To assess how hard the kidneys are working to conserve water.
Abnormal urine osmolality is frequently associated with systemic disorders. High levels may indicate congestive heart failure, liver cirrhosis, or SIADH. Low levels are classically seen in central or nephrogenic diabetes insipidus, where the kidneys cannot concentrate urine despite high blood osmolality. It is also used to evaluate the effectiveness of treatments for these conditions and to monitor patients on certain medications like diuretics or lithium, which can impair urinary concentrating ability.
View Interpretation
Hematology

Other Hemoglobin Variants

This component identifies and quantifies non-standard hemoglobins during High-Performance Liquid Chromatography (HPLC). Normal adult hemoglobin is primarily HbA (>95%), HbA2 (<3.5%), and trace HbF. 'Other' variants include HbS (Sickle Cell), HbC, HbE, or HbD. Detecting these is vital for diagnosing hemoglobinopathies and thalassemias, which affect red blood cell stability, oxygen-carrying capacity, and lifespan.
View Interpretation
Gastroenterology

Ova and Parasites

A microscopic examination used to detect the presence of parasites (protozoa or helminths) and their eggs (ova) in a stool sample. Within a Complete Stool Examination, this test is the gold standard for diagnosing parasitic infections like Giardia, Entamoeba, or Hookworm, which cause chronic diarrhea, abdominal pain, and malabsorption.
View Interpretation
Oncology

Ovarian Cancer Panel

An Ovarian Cancer Panel typically consists of a combination of tumor markers, most commonly CA-125 (Cancer Antigen 125) and HE4 (Human Epidermal Protein 4). These markers are used in conjunction with clinical algorithms like the ROMA (Risk of Ovarian Malignancy Algorithm) score to estimate the likelihood of a pelvic mass being malignant. While CA-125 is the traditional marker, HE4 is less likely to be elevated in benign conditions, making the combination more specific than either test alone. This panel is not intended for screening the general population. It is specifically ordered for:
  • Evaluating women who have a documented pelvic mass or ovarian cyst detected by imaging.
  • Distinguishing between benign gynecological conditions (like endometriosis or fibroids) and ovarian cancer.
  • Monitoring response to therapy in patients already diagnosed with ovarian cancer.
  • Surveillance for recurrence in patients in remission.
The primary condition of concern is Epithelial Ovarian Cancer. Ovarian cancer is often called the 'silent killer' because symptoms are vague and it is frequently diagnosed at an advanced stage. Elevated markers in this panel, especially in post-menopausal women, significantly increase the suspicion of malignancy. However, it is important to note that CA-125 can also be elevated in non-cancerous conditions such as menstruation, pregnancy, pelvic inflammatory disease (PID), and cirrhosis. The inclusion of HE4 helps filter out some of these false positives, providing a clearer picture for the surgical oncologist.
View Interpretation
Respiratory

Oxygen Saturation (SaO2)

SaO2, measured via Arterial Blood Gas (ABG), represents the percentage of hemoglobin binding sites occupied by oxygen in arterial blood. Unlike pulse oximetry (SpO2), SaO2 is a direct measurement and is the gold standard for assessing a patient's oxygenation status. It is vital in evaluating respiratory failure, monitoring patients on ventilators, and managing chronic conditions like COPD or interstitial lung disease.
View Interpretation
Oncology

PDL1 IHC Marker

Programmed Death-Ligand 1 (PD-L1) is a protein that acts as a 'brake' to keep the body’s immune responses in check. Some cancer cells produce high amounts of PD-L1 to hide from the immune system’s T-cells. Immunohistochemistry (IHC) is a laboratory technique used to visualize the expression of this protein on the surface of tumor cells. This test is a 'companion diagnostic' used to determine if a patient is a candidate for immunotherapy, specifically immune checkpoint inhibitors like Pembrolizumab (Keytruda) or Nivolumab (Opdivo). It is commonly ordered for:
  • Non-Small Cell Lung Cancer (NSCLC)
  • Urothelial Carcinoma
  • Triple-Negative Breast Cancer
  • Gastric and Esophageal Cancers
PD-L1 testing is relevant in various malignancies where the immune system's ability to recognize the tumor is compromised. The result is typically reported as a Tumor Proportion Score (TPS) or Combined Positive Score (CPS), which reflects the percentage of cells staining positive for the marker. High expression of PD-L1 often correlates with a higher likelihood of responding to specific immunotherapy drugs, which can significantly improve survival outcomes compared to traditional chemotherapy in certain patient populations.
View Interpretation
Hematology

Packed Cell Volume (PCV)

Packed Cell Volume (PCV), also known as hematocrit (Hct), measures the proportion of whole blood that is made up of red blood cells (RBCs). Its primary function is to assess the blood's ability to transport oxygen throughout the body. Because RBCs contain hemoglobin, which binds to oxygen, the PCV is a critical indicator of oxygen-carrying capacity. Physicians order a PCV test to screen for, diagnose, or monitor conditions affecting the red blood cells. It is a standard part of a Complete Blood Count (CBC). It is essential for:
  • Evaluating unexplained fatigue, weakness, or pale skin (anemia).
  • Monitoring patients with chronic lung or heart disease.
  • Assessing dehydration levels.
  • Checking for polycythemia vera (overproduction of RBCs).
  • Monitoring response to treatments like erythropoietin or blood transfusions.
Abnormal PCV levels are associated with several clinical states. Low PCV is the hallmark of anemia, which can be caused by iron deficiency, B12/folate deficiency, chronic kidney disease, or blood loss. High PCV, or erythrocytosis, may indicate primary polycythemia vera or secondary causes like chronic hypoxia (common in smokers or high-altitude residents), dehydration, or erythropoietin-secreting tumors. Monitoring PCV is vital in trauma cases to assess internal bleeding and fluid resuscitation needs.
View Interpretation
Biochemistry

Pandy's Test

Pandy’s test is a bedside qualitative diagnostic test used to detect elevated levels of proteins, specifically globulins, in the cerebrospinal fluid (CSF). The test involves adding CSF to a solution of saturated phenol. If globulins are present in high concentrations, they react with the phenol to form a white, cloudy precipitate (turbidity). This test is often used as a rapid screening tool in settings where sophisticated quantitative protein electrophoresis is unavailable. It is primarily ordered when a healthcare provider suspects an inflammatory, infectious, or degenerative process affecting the central nervous system (CNS) that would cause a breakdown of the blood-brain barrier or local protein production.
  • Meningitis: Bacterial, viral, or fungal infections often lead to significantly elevated CSF protein.
  • Neurosyphilis: Historically, Pandy's test was a hallmark for detecting the increased globulins associated with syphilis of the CNS.
  • Multiple Sclerosis (MS): While not specific, MS can cause increased globulins in the CSF.
  • Guillain-Barré Syndrome: Characterized by albuminocytologic dissociation (high protein with normal cell count).
  • Brain Tumors: May cause leakage of proteins into the spinal fluid.
View Interpretation
Cytopathology

Pap Smear

The Papanicolaou test, commonly known as a Pap Smear, is a screening procedure for cervical cancer. It involves collecting cells from the cervix—the lower, narrow end of the uterus at the top of the vagina. These cells are examined under a microscope to look for abnormal growth patterns or changes that could indicate precancerous or cancerous conditions. It is the most successful cancer screening tool in medical history. The primary goal of the Pap smear is the early detection of cervical changes caused by High-Risk Human Papillomavirus (HPV). Because cervical cancer often develops slowly over many years, finding abnormal cells early (dysplasia) allows for treatment before they turn into invasive cancer. Routine screening is recommended starting at age 21, and its frequency depends on age, health history, and whether it is combined with HPV testing.
  • Cervical Dysplasia: Abnormal cell growth (CIN 1, 2, or 3).
  • Cervical Cancer: Squamous cell carcinoma or adenocarcinoma.
  • HPV Infection: The primary driver of most cervical cellular changes.
  • Inflammation/Infection: Results may also show signs of yeast infections, bacterial vaginosis, or trichomoniasis.
View Interpretation
Cytology

Pap Smear for Cytology

The Papanicolaou (Pap) smear is a screening tool used to detect precancerous and cancerous changes in the cells of the cervix. It identifies cytological abnormalities that might indicate Human Papillomavirus (HPV) infection or early-stage cervical cancer. It is the primary screening method for cervical cancer prevention. Regular screening allows for the detection of Abnormal Squamous Cells (ASC) or Intraepithelial Lesions (SIL) long before they develop into invasive cancer, at a stage where they are highly treatable.
  • Cervical Cancer: Early detection of squamous cell carcinoma or adenocarcinoma.
  • HPV Infection: Identifying cellular changes (koilocytosis) associated with high-risk HPV types.
  • Dysplasia: Grading the severity of cervical intraepithelial neoplasia (CIN).
View Interpretation
Histopathology

Paraffin Blocks (Histopathology Processing)

Paraffin blocks are a critical step in the histopathological examination of tissue samples removed during surgery or biopsy. The process involves 'embedding' the tissue in paraffin wax, which provides a rigid support structure. This allows pathologists to cut extremely thin slices (microns thick) of the tissue, which are then placed on glass slides, stained, and examined under a microscope. This is not a diagnostic test in itself but a fundamental processing requirement for:
  • Cancer Diagnosis: Determining if a tumor is benign or malignant.
  • Inflammatory Diseases: Identifying the cause of organ dysfunction or chronic inflammation.
  • Archiving: Paraffin blocks are stable for decades, allowing for retrospective studies or second opinions years after the initial procedure.
  • Molecular Testing: Modern techniques like Immunohistochemistry (IHC) or DNA/RNA extraction for personalized medicine are performed directly on sections from these blocks.
  • Oncology: All suspected cancers require paraffin embedding for definitive grading and staging.
  • Gastroenterology: Biopsies from endoscopies (e.g., Celiac disease, H. pylori).
  • Dermatology: Skin lesions and moles requiring microscopic evaluation.
View Interpretation
Respiratory

Partial Pressure of Carbon Dioxide (pCO2)

pCO2 is a measurement of the pressure of carbon dioxide dissolved in arterial blood. It serves as the primary marker for the respiratory component of acid-base balance. It indicates how effectively the lungs are removing CO2, which is a byproduct of cellular metabolism. It is essential for managing patients with respiratory failure, COPD, or metabolic disturbances.
View Interpretation
Respiratory

Partial Pressure of Oxygen (pO2)

The pO2 measures the pressure exerted by dissolved oxygen in the arterial blood. It is a direct indicator of how well the lungs are able to move oxygen from the atmosphere into the bloodstream. Within an ABG panel, it is essential for diagnosing hypoxemia, assessing the severity of respiratory failure (like COPD or ARDS), and monitoring the effectiveness of supplemental oxygen therapy.
View Interpretation
Hematology

Partial Thromboplastin Time (PTT)

The Partial Thromboplastin Time (PTT) test measures the time it takes for a blood clot to form. It specifically evaluates the integrity of the intrinsic and common pathways of the coagulation cascade. These pathways involve several clotting factors, including XII, XI, IX, VIII, X, V, II (prothrombin), and I (fibrinogen). By assessing these factors, the PTT test helps clinicians understand how effectively the body can stop bleeding through the formation of fibrin clots. Physicians order a PTT test for several critical reasons:
  • Unexplained Bleeding or Bruising: To investigate the cause of frequent nosebleeds, heavy menstrual periods, or easy bruising.
  • Heparin Monitoring: It is the standard test for monitoring patients on unfractionated heparin therapy to ensure the dosage is therapeutic and not causing excessive bleeding risk.
  • Pre-Surgical Screening: To ensure a patient’s blood clots normally before an invasive procedure.
  • Evaluation of Clotting Disorders: To screen for conditions like Hemophilia A or B, or von Willebrand disease.
Abnormal PTT results are often linked to specific medical conditions. A prolonged PTT may indicate Hemophilia, liver disease (where clotting factors are produced), or Vitamin K deficiency. It is also highly sensitive to the presence of Lupus Anticoagulant, an antibody associated with autoimmune disorders that can paradoxically increase the risk of blood clots while prolonging the PTT in a lab setting. Conversely, a shortened PTT is less common but may be seen in the early stages of Disseminated Intravascular Coagulation (DIC) or following acute hemorrhage.
View Interpretation
Genetics

Pdgfra Mutation Analysis - Gist (Qualitative)

This molecular test analyzes the PDGFRA (Platelet-Derived Growth Factor Receptor Alpha) gene for mutations in patients with Gastrointestinal Stromal Tumors (GIST). PDGFRA mutations are found in approximately 5-10% of GIST cases, particularly those that are negative for KIT mutations. Identifying the specific mutation is critical for determining the prognosis and selecting the most effective targeted therapy. For instance, the D842V mutation in PDGFRA is notoriously resistant to standard imatinib therapy but may respond to newer drugs like avapritinib.
  • Gastrointestinal Stromal Tumors (GIST): Specifically those occurring in the stomach (where PDGFRA mutations are most common).
  • Precision Medicine: Used to guide the use of Tyrosine Kinase Inhibitors (TKIs).
Knowing the mutation status allows oncologists to avoid ineffective treatments and move directly to therapies that target the specific molecular driver of the tumor.
View Interpretation
Respiratory

Peak Expiratory Flow (PEF)

PEF measures the maximum speed of expiration. It is a vital component of a Pulmonary Function Test for monitoring large airway patency. It is primarily used in the management of asthma to detect early signs of exacerbation and to assess the effectiveness of bronchodilator therapy.
View Interpretation
Allergy and Immunology

Peanut (Specific IgE)

This test measures the concentration of Specific Immunoglobulin E (sIgE) antibodies to peanut allergens in the blood. Within an Allergy Profile, it helps diagnose Type I hypersensitivity. Peanut allergies are among the most common and severe food allergies, often associated with a risk of life-threatening anaphylaxis.
View Interpretation
Immunology

Peanut Specific IgE

This measures the concentration of IgE antibodies directed specifically against peanut proteins (e.g., Ara h 1, 2, 3). In an Allergy Profile, this identifies sensitization. High levels are strongly associated with Type I hypersensitivity, including the risk of life-threatening anaphylaxis upon exposure.
View Interpretation
Hematology

Peripheral Blood Morphology

Peripheral Blood Morphology, often referred to as a peripheral blood smear, is a diagnostic procedure where a drop of blood is spread thinly onto a glass slide, stained, and examined under a microscope. This test provides a detailed visual assessment of the three primary components of blood: red blood cells (RBCs), white blood cells (WBCs), and platelets. While automated counters provide numbers, morphology provides the "story" behind those numbers, revealing abnormalities in cell size, shape, and internal structures. This test is rarely a screening tool; it is usually ordered as a follow-up to an abnormal Complete Blood Count (CBC). Clinical indications include:
  • Unexplained Anemia: To distinguish between iron deficiency (microcytic), B12 deficiency (macrocytic), or hemolytic anemia (presence of schistocytes).
  • Leukemia Suspicion: To identify 'blast' cells or immature white cells that suggest bone marrow failure or malignancy.
  • Thrombocytopenia: To rule out "pseudothrombocytopenia" (platelet clumping) or to identify giant platelets.
  • Infection and Parasites: To detect blood-borne parasites like Malaria or Babesia, or to see 'toxic granulation' in neutrophils during severe sepsis.
Abnormal morphology can point to a wide range of conditions. For instance, Sickle Cell Disease is identified by crescent-shaped RBCs. Target cells may indicate liver disease or Thalassemia. Schistocytes (fragmented cells) are critical markers for medical emergencies like Thrombotic Thrombocytopenic Purpura (TTP) or Disseminated Intravascular Coagulation (DIC). Identifying these morphological markers allows for rapid, life-saving interventions that automated machines might miss.
View Interpretation
Hematology

Peripheral Smear

A Peripheral Smear (or Peripheral Blood Film) is a manual microscopic examination of a thin layer of blood spread on a glass slide. While automated machines count cells, the smear allows a trained pathologist to see the actual shape, size, and health of Red Blood Cells (RBCs), White Blood Cells (WBCs), and Platelets. It serves as a visual confirmation of automated CBC results. It is ordered when an automated CBC shows abnormal results, such as a very low platelet count or the presence of immature cells. It is also used to investigate suspected blood disorders, parasitic infections (like malaria), or unexplained jaundice and anemia.
  • Sickle Cell Disease: Identified by the characteristic sickle-shaped RBCs.
  • Leukemia: Suggested by the presence of 'blasts' (immature, cancerous white cells).
  • Malaria: The parasites can be seen directly inside the red blood cells.
  • Thalassemia: Indicated by 'target cells' and significant variation in cell size.
  • Hemolytic Anemia: Characterized by fragmented red cells (schistocytes).
This test provides information that machines often miss, such as the specific way platelets clump together or the presence of subtle inclusions within cells that indicate lead poisoning or specific vitamin deficiencies.
View Interpretation
Hematology

Peripheral Smear for MP

The Peripheral Smear for Malarial Parasite (MP) is the gold standard diagnostic tool for malaria. It involves preparing thin and thick blood films on a glass slide, staining them (usually with Giemsa stain), and examining them under a microscope to identify Plasmodium species within red blood cells. This test is ordered urgently for any patient with unexplained fever, chills, and flu-like symptoms, especially if they have recently traveled to a malaria-endemic region. It allows the clinician to determine two things: if the parasite is present and the 'parasite density' (the percentage of infected red blood cells).
  • Plasmodium Falciparum: The most dangerous species, capable of causing cerebral malaria and organ failure.
  • Plasmodium Vivax/Ovale: Known for causing relapsing malaria due to dormant stages in the liver.
  • Plasmodium Malariae: Typically causes a milder, chronic form of malaria.
  • Thick Smear: Concentrates a larger volume of blood; used to screen for the presence of parasites (higher sensitivity).
  • Thin Smear: Preserves the morphology of the red blood cells; used to identify the specific species of Plasmodium and calculate the percentage of infection (parasitemia).
View Interpretation
Toxicology

Phencyclidine (PCP)

Phencyclidine (PCP) is a dissociative drug that was once used as an anesthetic but is now strictly a drug of abuse. Within a DOA 5-Panel, this test screens for recent ingestion of the substance. PCP acts on the central nervous system, causing hallucinations, agitation, and potentially violent behavior. Monitoring is essential in emergency settings for patients presenting with altered mental status or in occupational/forensic drug screening to ensure safety and compliance.
View Interpretation
Immunology

Phospholipid Screen IgG, IgM

The Phospholipid Screen (specifically Cardiolipin antibodies) detects autoantibodies produced by the immune system that mistakenly target the body's own phospholipids. Phospholipids are essential lipid components of cell membranes and platelets. When these antibodies are present, they can interfere with the blood clotting process, paradoxically increasing the risk of inappropriate clot formation (thrombosis). This test is a critical component in the diagnosis of Antiphospholipid Syndrome (APS). It is typically ordered when a patient experiences unexplained blood clots (Deep Vein Thrombosis or Pulmonary Embolism), recurrent miscarriages (especially in the second or third trimester), or an unexplained prolonged PTT (Partial Thromboplastin Time) test. It is also used to evaluate patients with Systemic Lupus Erythematosus (SLE), as these antibodies frequently co-occur.
  • Antiphospholipid Syndrome (APS): A systemic autoimmune disorder characterized by arterial or venous thrombosis.
  • Systemic Lupus Erythematosus (SLE): Many Lupus patients carry these antibodies, increasing their risk for stroke.
  • Recurrent Pregnancy Loss: The antibodies can interfere with placental attachment and blood flow.
  • Thrombocytopenia: Low platelet counts caused by antibody-mediated destruction.
Clinicians look at two classes of antibodies: IgG and IgM. IgG is generally considered more clinically significant for predicting thrombotic events. Because these antibodies can appear transiently during infections (like syphilis or certain viral illnesses), a diagnosis of APS requires two positive tests at least 12 weeks apart.
View Interpretation
Endocrinology

Plasma Aldosterone

Aldosterone is a mineralocorticoid hormone produced by the adrenal cortex that regulates sodium and potassium balance. In the context of a 'Plasma Renin Activity' panel, it is used to calculate the Aldosterone-Renin Ratio (ARR). This is the primary screening tool for Primary Aldosteronism (Conn's Syndrome), a common but underdiagnosed cause of secondary hypertension. Elevated aldosterone in the presence of suppressed renin strongly suggests an autonomous adrenal source.
View Interpretation
Endocrinology

Plasma Renin Activity

Plasma Renin Activity (PRA) measures the capacity of the enzyme renin to generate angiotensin I from angiotensinogen. Renin is secreted by the juxtaglomerular cells of the kidneys in response to low blood pressure, low sodium levels, or sympathetic nervous system activation. This test is a critical component of the Renin-Angiotensin-Aldosterone System (RAAS), which regulates long-term blood pressure and fluid balance. The PRA test is primarily ordered to evaluate patients with hypertension (high blood pressure), especially those who do not respond to standard medications or those suspected of having primary aldosteronism (Conn's syndrome). It is often performed alongside a plasma aldosterone concentration (PAC) test to calculate the Aldosterone-to-Renin Ratio (ARR).
  • Primary Aldosteronism: Characterized by low PRA and high aldosterone.
  • Renovascular Hypertension: High PRA caused by narrowed renal arteries.
  • Addison's Disease: Often presents with high PRA due to low blood volume and sodium.
  • Essential Hypertension: Most patients have normal or low renin levels.
Monitoring PRA helps clinicians distinguish between different types of hypertension and guides the selection of antihypertensive therapy, such as ACE inhibitors or mineralocorticoid receptor antagonists.
View Interpretation
Endocrinology

Plasma Renin Activity

Plasma Renin Activity (PRA) measures the rate of formation of Angiotensin I from Angiotensinogen, reflecting the functional activity of the renin enzyme. It is a cornerstone in the evaluation of the Renin-Angiotensin-Aldosterone System (RAAS). In clinical practice, it is primarily used to differentiate between primary and secondary hyperaldosteronism. When interpreted alongside plasma aldosterone levels (the Aldosterone-Renin Ratio or ARR), it helps diagnose Primary Aldosteronism (Conn's Syndrome), a potentially curable cause of hypertension.
View Interpretation
Hematology

Platelet Count

Platelets, or thrombocytes, are small cell fragments in the blood that are essential for normal blood clotting. When a blood vessel is injured, platelets migrate to the site, adhere to the damaged surface, and clump together to form a 'platelet plug.' They also release chemicals that activate the clotting cascade. The platelet count measures the number of these fragments per microliter of blood, serving as a primary indicator of the body's ability to maintain hemostasis. A platelet count is part of a standard Complete Blood Count (CBC). It is specifically ordered for:
  • Surgical Clearance: To ensure a patient can clot properly during and after an operation.
  • Unexplained Bruising/Bleeding: Investigating petechiae (small red dots), frequent nosebleeds, or heavy menstrual cycles.
  • Monitoring Bone Marrow: To check the impact of chemotherapy or radiation on blood cell production.
  • Monitoring Chronic Conditions: Managing patients with known liver disease or autoimmune disorders.
Abnormal platelet counts are linked to various health states. Thrombocytopenia (low count) can be caused by immune destruction (ITP), sequestration in an enlarged spleen, or bone marrow failure. Thrombocytosis (high count) may be 'reactive' (due to inflammation, iron deficiency, or infection) or 'essential' (a primary bone marrow disorder like Essential Thrombocythemia). Extremely high counts increase the risk of inappropriate blood clots (thrombosis), while extremely low counts (<20,000) carry a high risk of spontaneous internal bleeding.
View Interpretation
Hematology

Platelet Count

Platelets (thrombocytes) are essential for primary hemostasis and clot formation. Within a Complete Blood Picture, the platelet count is fundamental for assessing bleeding risk or thrombotic tendency. It is a sensitive indicator of bone marrow health and is often reactive to systemic inflammation or iron deficiency.
View Interpretation
Hematology

Platelet Count

Platelets are essential for primary hemostasis and thrombus formation. In a COVID Panel Hematology, platelet count is a critical prognostic marker. While COVID-19 is often associated with a pro-thrombotic state, a falling platelet count (thrombocytopenia) in severe cases often indicates consumptive coagulopathy (DIC) or severe systemic inflammation, correlating with increased mortality and disease severity.
View Interpretation
Hematology

Platelet Count

Platelets (thrombocytes) are cell fragments essential for blood clotting and hemostasis. This count is a fundamental part of the CBC and Hematology panels. Low counts increase bleeding risks, while excessively high counts may lead to inappropriate clotting or indicate underlying bone marrow disorders.
View Interpretation
Hematology

Platelet Count

Platelets (thrombocytes) are small cell fragments essential for primary hemostasis. When blood vessel damage occurs, platelets aggregate to form a 'plug' and initiate the clotting cascade. This test measures the absolute number of platelets per microliter of blood. In a comprehensive panel (Hb, TC, DC, ESR), the platelet count is vital for assessing the body's ability to clot and identifying risks for spontaneous bleeding or excessive thrombosis.
View Interpretation
Hematology

Platelet Count (PLT)

Platelets (thrombocytes) are specialized cell fragments essential for hemostasis (blood clotting). When a vessel is injured, platelets adhere to the site and aggregate to form a primary plug. The platelet count is a fundamental part of the CBC, used to screen for bleeding disorders, bone marrow diseases, and to monitor the effects of chemotherapy or heparin therapy. Proper platelet numbers are required to prevent spontaneous bleeding and to ensure surgical safety.
View Interpretation
Hematology

Platelet Count (PLT)

Platelets (thrombocytes) are essential components of the Hemostatic system, responsible for primary clot formation. Within a Complete Blood Count (CBC), the platelet count is used to evaluate the body's ability to stop bleeding and to monitor bone marrow function. A decrease in platelets can lead to spontaneous bruising or hemorrhage, while an increase may predispose a patient to thrombosis (clotting) or signify an underlying myeloproliferative disorder.
View Interpretation
Microbiology

Pleural Fluid - AFB Smear

The Pleural Fluid Acid-Fast Bacilli (AFB) Smear is a critical diagnostic tool used to detect the presence of Mycobacteria, most notably Mycobacterium tuberculosis, in the fluid surrounding the lungs. The pleural space normally contains a small amount of lubricating fluid; however, infections or inflammatory processes can cause an abnormal buildup known as pleural effusion. This test involves a microscopic examination using specialized staining techniques (like Ziehl-Neelsen or Kinyoun) that allow these specific bacteria to resist decolorization by acid, hence the term "acid-fast." Physicians order an AFB smear of pleural fluid when a patient presents with symptoms of tuberculosis (TB) involving the pleura (Tuberculous Pleurisy). Common indicators include persistent cough, chest pain that worsens with deep breathing, fever, night sweats, and unexplained weight loss. It is also used to differentiate TB from other causes of pleural effusion, such as congestive heart failure, malignancy, or bacterial pneumonia.
  • Tuberculous Pleurisy: The primary condition where AFB may be detected in the fluid.
  • Nontuberculous Mycobacteria (NTM) Infections: In immunocompromised individuals, other species of Mycobacteria may cause similar effusions.
  • Pleuritis: Inflammation of the pleural lining, which can be infectious or non-infectious.
It is important to note that the sensitivity of an AFB smear on pleural fluid is relatively low (often less than 10-20%). This means a negative result does not rule out tuberculosis. Culture and pleural biopsy are often required for a definitive diagnosis.
View Interpretation
Biochemical

Pleural Fluid - Biochemical Analysis

Biochemical analysis of pleural fluid is a comprehensive battery of tests performed on fluid aspirated from the pleural cavity. The primary goal is to apply Light’s Criteria to distinguish between a 'transudate' and an 'exudate'. Transudates are caused by systemic factors (pressure changes), while exudates are caused by local lung or pleural disease (inflammation or capillary leak). When a patient has a pleural effusion, clinicians must determine the cause to provide treatment. Analysis typically includes:
  • Total Protein and Albumin: To compare with serum levels.
  • Lactate Dehydrogenase (LDH): A marker of inflammation and cell turnover.
  • Glucose: Low levels can indicate infection (bacteria consuming glucose) or malignancy.
  • pH: Acidic pleural fluid (pH < 7.2) often indicates a complicated infection requiring drainage.
  • Congestive Heart Failure (CHF): Most common cause of transudates.
  • Pneumonia: Leads to parapneumonic effusions (exudate).
  • Malignancy: Lung or breast cancer spreading to the pleura.
  • Pulmonary Embolism: Can cause either transudates or exudates.
According to Light's Criteria, an effusion is an exudate if: 1) Pleural fluid protein/serum protein ratio > 0.5; 2) Pleural fluid LDH/serum LDH ratio > 0.6; or 3) Pleural fluid LDH > 2/3 the upper limit of normal for serum LDH. Exudates require extensive workup for infection or cancer, while transudates usually respond to treating the underlying systemic condition (like diuretics for heart failure).
View Interpretation
Biochemistry

Pleural Fluid ADA Levels

Adenosine Deaminase (ADA) is an enzyme involved in purine metabolism. It is primarily found in T-lymphocytes, and its activity increases significantly during a cellular immune response. In the context of pleural fluid (the fluid between the layers of the tissue that line the lungs and chest cavity), measuring ADA levels is a rapid and non-invasive way to screen for specific inflammatory or infectious processes, most notably Tuberculosis (TB). ADA testing is ordered when a patient has a pleural effusion (excess fluid around the lungs) of unknown origin. It is particularly useful in regions where Tuberculosis is prevalent or when traditional TB tests (like sputum smears) are negative. It helps clinicians differentiate between different causes of fluid accumulation without immediately resorting to a pleural biopsy.
  • Tuberculous Pleurisy: High ADA levels are highly suggestive of TB involvement in the pleura. It has a high sensitivity for this condition.
  • Empyema: Bacterial infections that result in pus in the pleural space can cause very high ADA levels.
  • Malignancy: Certain types of lung cancer or lymphomas can moderately elevate ADA.
  • Rheumatoid Pleuritis: Autoimmune conditions affecting the lungs can cause increased lymphocyte activity and subsequent ADA elevation.
  • Parapneumonic Effusions: Fluid buildup secondary to pneumonia.
ADA is a 'rule-in' test; while a low level strongly suggests TB is unlikely, a high level requires further investigation to confirm the specific cause.
View Interpretation
Pathology

Pleural Fluid Cytology

Pleural fluid cytology is a laboratory examination of the fluid surrounding the lungs (the pleural space) to detect the presence of abnormal or cancerous cells. Normally, only a tiny amount of lubricant exists in this space. When excess fluid accumulates (pleural effusion), it often indicates an underlying pathological process. Cytology focuses on the morphology of cells exfoliated into this fluid to differentiate between benign inflammatory processes and malignancy. Physicians order this test when a patient presents with an unexplained pleural effusion, often characterized by shortness of breath, chest pain, or a persistent cough. The primary goal is to determine the etiology of the fluid buildup. It is particularly crucial in patients with a history of cancer or those whose imaging (X-ray or CT) suggests an invasive process. It helps distinguish between transudates (fluid leaked due to pressure imbalances) and exudates (fluid leaked due to inflammation or tissue damage), though its highest utility is in identifying malignant exudates.
  • Primary Lung Cancer: Adenocarcinomas are the most common cause of malignant pleural effusions.
  • Metastatic Cancer: Breast cancer and lymphomas frequently metastasize to the pleura.
  • Mesothelioma: A specific cancer of the pleural lining often associated with asbestos exposure.
  • Infectious Diseases: Tuberculosis or severe pneumonia (parapneumonic effusions) can cause significant cellular changes.
  • Autoimmune Disorders: Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis can lead to characteristic inflammatory cell profiles.
View Interpretation
Microbiology

Pleural Fluid For Culture And Sensitivity

The pleural space is the thin gap between the lungs and the chest wall, containing a small amount of lubricating fluid. When an infection or inflammatory process occurs, fluid can accumulate (pleural effusion). Analyzing this fluid through culture and sensitivity is the gold standard for identifying the causative agent of an infection within that space. This test is ordered when a patient presents with a pleural effusion and clinical signs of infection (fever, chest pain, productive cough). It is used to differentiate between a simple parapneumonic effusion (fluid associated with pneumonia) and an empyema (pus in the pleural space). Identifying the specific pathogen allows for targeted antibiotic therapy and determines if surgical drainage is necessary.
  • Empyema: A collection of pus in the pleural cavity, often requiring aggressive drainage.
  • Bacterial Pneumonia: The most common precursor to infected pleural fluid.
  • Tuberculosis: TB can cause chronic pleural effusions that require specialized culture media.
  • Fungal Pleuritis: Rare, but seen in immunocompromised individuals.
The fluid is obtained via thoracentesis (needle aspiration). In the lab, it is placed on various agar plates to grow aerobic and anaerobic bacteria. If growth occurs, the sensitivity portion determines which antibiotics can penetrate the pleural space and kill the bacteria.
View Interpretation
Body Fluid Analysis

Pleural Fluid LDH

Lactate Dehydrogenase (LDH) is an enzyme involved in energy production found in almost all body tissues. When fluid accumulates in the space between the lungs and the chest wall (pleural effusion), measuring the LDH level in that fluid is essential for categorization. Pleural fluid LDH is a marker of the degree of inflammation within the pleural space. The primary reason for ordering Pleural Fluid LDH is to apply Light’s Criteria. This set of rules helps clinicians distinguish between an 'Exudate' (fluid caused by active disease, like infection or cancer) and a 'Transudate' (fluid caused by pressure imbalances, like heart failure). This distinction is the most important step in determining the cause of a pleural effusion.
  • Exudative Effusions (High LDH):
    • Pneumonia (parapneumonic effusion).
    • Malignancy (lung cancer, breast cancer, lymphoma).
    • Pulmonary Embolism.
    • Tuberculosis.
  • Transudative Effusions (Low LDH):
    • Congestive Heart Failure.
    • Cirrhosis (Hepatic Hydrothorax).
    • Nephrotic Syndrome.
If the LDH is extremely high (e.g., >1000 U/L), it often suggests empyema (pus in the pleural space), malignancy, or rheumatoid pleurisy.
View Interpretation
Fluid Analysis

Pleural Fluid Proteins

Pleural fluid protein measurement is used to evaluate the composition of fluid accumulated in the space between the lungs and the chest wall (pleural effusion). The protein concentration is a primary component of 'Light’s Criteria,' which is the gold standard for distinguishing between two types of effusions: transudates and exudates. This distinction is the most critical step in narrowing down the cause of lung-related fluid buildup. This test is performed on fluid obtained via thoracentesis. It is ordered to:
  • Determine the Pathophysiology: To see if the fluid is leaking due to pressure imbalances (transudate) or local inflammation/injury (exudate).
  • Guide Treatment: The treatment for heart failure-related fluid is vastly different from the treatment for pneumonia-related fluid.
  • Diagnostic Narrowing: Helping to decide if further tests (like cytology or cultures) are necessary.
  • Transudative Effusions (Low Protein): Usually caused by systemic factors like Congestive Heart Failure (CHF), Cirrhosis, or Nephrotic Syndrome. In these cases, the pleural protein to serum protein ratio is usually ≤ 0.5.
  • Exudative Effusions (High Protein): Caused by local disease. Common causes include Pneumonia, Malignancy (lung or breast cancer), Pulmonary Embolism, or autoimmune diseases like Rheumatoid Arthritis. These typically have a fluid protein to serum protein ratio > 0.5. Identifying the protein level allows the physician to stop looking at systemic pressure issues and start looking for local infections or tumors.
View Interpretation
Biochemical

Pleural Fluid for Amylase

The Pleural Fluid Amylase test measures the concentration of the enzyme amylase within the fluid collected from the pleural space (the area between the lungs and the chest wall). Under normal physiological conditions, very little fluid exists in this space, and its amylase concentration should not exceed that of the blood. Amylase is primarily produced by the pancreas and salivary glands to digest carbohydrates. This test is ordered when a patient develops a pleural effusion (excess fluid around the lungs) and the physician suspects a specific underlying cause related to the pancreas or the esophagus. It is a critical diagnostic tool for differentiating the etiology of an 'exudative' effusion. Specifically, it helps identify:
  • Acute or Chronic Pancreatitis: Where enzymes leak into the pleural space.
  • Esophageal Rupture: A medical emergency where salivary amylase enters the chest cavity.
  • Malignancy: Certain lung or ovarian cancers can produce amylase.
  • Pancreatic Pseudocyst: Fluid collections from the pancreas can track into the thorax.
  • Boerhaave Syndrome: Spontaneous esophageal perforation usually following forceful vomiting.
  • Paraneoplastic Syndrome: Ectopic production of amylase by tumor cells.
High levels (often defined as greater than the upper limit of serum amylase or >100 U/L) are highly suggestive of pancreatic disease or esophageal perforation. In pancreatic cases, the amylase is usually the pancreatic isoenzyme, whereas in esophageal rupture or malignancy, it is often the salivary isoenzyme. Clinicians use this result alongside Light’s Criteria to manage the effusion effectively.
View Interpretation
Cytology

Pleural Fluid for Cell Count & Cell Type

The pleural space is a thin, fluid-filled area between the two layers of the pleura (visceral and parietal) that surround the lungs. In a healthy state, only a small amount of lubricant fluid exists. When excess fluid accumulates (pleural effusion), a thoracentesis is performed to collect a sample. The cell count and differential (cell type) are fundamental steps in determining the underlying cause of the effusion. Physicians order this test to differentiate between transudates (fluid leaking due to pressure imbalances, like heart failure) and exudates (fluid caused by inflammation, infection, or malignancy). It is crucial for patients presenting with shortness of breath, chest pain, or abnormal findings on a chest X-ray or CT scan.
  • High Neutrophil Count: Often indicates acute inflammation, such as parapneumonic effusion, pneumonia, or pulmonary infarction.
  • High Lymphocyte Count: Frequently associated with tuberculosis, malignancy (cancer), or sarcoidosis.
  • Eosinophilia: May suggest the presence of air (pneumothorax) or blood (hemothorax) in the pleural space, or parasitic infections.
  • Malignant Cells: The presence of abnormal cytology can confirm lung cancer, breast cancer, or lymphoma metastasis to the pleural lining.
By combining the cell count with protein and LDH levels (Light's Criteria), clinicians can pinpoint whether the problem is systemic (heart, liver, or kidney failure) or localized to the lung and pleura (infection or tumor).
View Interpretation
Immunology

Pleural Fluid for Rheumatoid Factor

This test measures the concentration of Rheumatoid Factor (RF)—an autoantibody—within the fluid found in the pleural space (the area between the lungs and the chest wall). While RF is usually measured in the blood, testing the pleural fluid directly helps determine if a lung-related complication is specifically caused by Rheumatoid Arthritis (RA). When a patient with or without a known history of RA develops a pleural effusion (fluid buildup around the lungs), doctors must determine the cause. Potential causes range from congestive heart failure and pneumonia to cancer or autoimmune disease. This test is ordered via thoracentesis (a procedure to drain and sample the fluid) when 'Rheumatoid Pleuritis' is suspected. A high level of RF in pleural fluid is strongly associated with Rheumatoid Pleuritis, a condition where RA affects the lining of the lungs. This condition is often characterized by very low glucose levels and high LDH in the fluid as well. Other conditions that can occasionally cause elevated pleural RF include Systemic Lupus Erythematosus (SLE), bacterial pneumonia (parapneumonic effusion), and certain malignancies, though levels are typically highest in RA-related cases.
View Interpretation
Metabolic

Post Dinner Blood Sugar

The Post Dinner (Postprandial) Blood Sugar test measures the level of glucose in the blood exactly two hours after the start of a meal. This timing is critical because it reflects how efficiently the body—specifically the pancreas and insulin receptors—manages the glucose load provided by food. It is primarily used to screen for Type 2 Diabetes and Prediabetes. In many individuals, fasting glucose levels may remain normal while post-meal levels spike significantly (impaired glucose tolerance). It is also a vital tool for diabetic patients to monitor the effectiveness of their insulin regimen or dietary choices in controlling 'glucose excursions' after eating.
  • Diabetes Mellitus: Chronic high blood sugar.
  • Insulin Resistance: A condition where cells don't respond well to insulin.
  • Reactive Hypoglycemia: Low blood sugar occurring after a meal.
  • Metabolic Syndrome: A cluster of conditions increasing heart disease risk.
View Interpretation
Endocrinology

Post Prandial Insulin

The Post Prandial Insulin test measures the amount of insulin produced by the pancreas in response to a glucose load, typically two hours after a meal. Insulin is a vital hormone that facilitates the uptake of glucose into cells for energy production. Monitoring insulin levels post-meal provides a dynamic view of pancreatic beta-cell function and the body's sensitivity to insulin, which fasting levels alone may not reveal. Physicians order this test to investigate several metabolic conditions. It is primarily used to diagnose insulin resistance, where cells fail to respond effectively to insulin, leading the pancreas to overcompensate. It is also instrumental in evaluating 'reactive hypoglycemia'—a condition where insulin spikes too high after eating, causing blood sugar to crash. Additionally, it helps in the early detection of Type 2 Diabetes and the evaluation of Polycystic Ovary Syndrome (PCOS), where hyperinsulinemia is a common underlying factor.
  • Insulin Resistance: Characterized by elevated post-meal insulin despite normal or slightly high glucose.
  • Metabolic Syndrome: A cluster of conditions including high blood pressure and excess body fat.
  • Insulinoma: A rare pancreatic tumor that secretes excessive insulin.
  • Type 2 Diabetes: Early stages often show high post-prandial insulin, while late stages show declining levels due to pancreatic exhaustion.
  • PCOS: Often associated with exaggerated insulin responses to carbohydrates.
View Interpretation
Metabolic

Postprandial Glucose

Postprandial glucose measures the level of sugar in the blood specifically after a meal (usually 2 hours after). This test assesses how well the body manages the influx of glucose by secreting insulin and utilizing sugar in the tissues. While fasting glucose is standard, postprandial glucose is often a more sensitive marker for early-stage Type 2 Diabetes and impaired glucose tolerance. It is also used to monitor the effectiveness of mealtime insulin or oral hypoglycemic agents in patients already diagnosed with diabetes.
  • Prediabetes: Characterized by glucose levels between 140 and 199 mg/dL after 2 hours.
  • Diabetes Mellitus: Confirmed by levels ≥ 200 mg/dL.
  • Reactive Hypoglycemia: Low blood sugar levels following a meal, often seen in early insulin resistance or after gastric bypass surgery.
  • Gestational Diabetes: Postprandial monitoring is the gold standard for managing glucose in pregnancy.
The "2-hour" mark is critical because, in healthy individuals, insulin should have returned blood glucose levels to near-normal by this time. Persistent elevation indicates 'postprandial spikes,' which are highly correlated with cardiovascular risk and oxidative stress.
View Interpretation
Metabolic

Potassium

Potassium is a critical mineral and electrolyte that facilitates nerve transmission and the contraction of muscles, most importantly the heart. It works in tandem with sodium to maintain the electrical potential of cell membranes and regulate fluid balance within the body. Because potassium levels have a narrow therapeutic window, even slight deviations can be life-threatening. This test is ordered for patients taking diuretics or heart medications, those with kidney disease (as kidneys regulate potassium excretion), and during routine physicals to screen for electrolyte imbalances.
  • Chronic Kidney Disease (CKD): Failure to excrete potassium leads to dangerous buildup.
  • Hyperkalemia: High potassium, which can lead to cardiac arrest.
  • Hypokalemia: Low potassium, often caused by diarrhea, vomiting, or diuretics.
  • Addison’s Disease: Adrenal insufficiency affecting electrolyte balance.
View Interpretation
Metabolic

Potassium

Potassium (K+) is the primary intracellular cation and is essential for maintaining the resting membrane potential of cells. In the Basic Kidney Profile, it is monitored because the kidneys are the main regulators of potassium balance. Dysregulation can lead to life-threatening cardiac arrhythmias and muscle paralysis.
View Interpretation
Metabolic

Potassium

Potassium (K+) is the primary intracellular cation, essential for maintaining the resting membrane potential of cells, particularly in the heart and nervous system. In Serum Electrolytes, monitoring potassium is critical because even minor deviations (hypokalemia or hyperkalemia) can lead to life-threatening cardiac arrhythmias and muscle paralysis.
View Interpretation
Metabolic

Potassium, 24-Hour Urine

Urine potassium measurement is essential in the diagnostic workup of hypokalemia and hypertension. It helps clinicians distinguish between renal potassium wasting (e.g., hyperaldosteronism, RTA, or diuretic use) and extra-renal loss (e.g., diarrhea or poor dietary intake). In a patient with low serum potassium, a high urine potassium indicates that the kidneys are inappropriately excreting the mineral.
View Interpretation
Allergy and Immunology

Potato Specific IgE

This component measures the levels of IgE antibodies specifically directed against potato proteins. As part of an Allergy Profile, it identifies Type I hypersensitivity. While cooked potatoes are rarely allergenic due to protein denaturation, raw potato exposure or specific heat-stable proteins can trigger reactions.
View Interpretation
Metabolic

Pre-Dinner Blood Sugar

Pre-dinner blood sugar (or pre-prandial glucose) measures the amount of glucose circulating in the blood after the effects of lunch have subsided but before the evening meal is consumed. This measurement is a cornerstone of diabetes self-management, helping to assess how well the body (or medication) managed the glucose load from the previous meal and the basal metabolic requirements during the afternoon. This test is vital for patients with Type 1 or Type 2 Diabetes to:
  • Adjust Insulin Dosage: Short-acting insulin doses for dinner are often calculated based on this reading.
  • Evaluate Basal Insulin: If pre-dinner levels are consistently high despite a moderate lunch, it may indicate a need to adjust long-acting (basal) insulin.
  • Identify Trends: It helps map the 'dawn phenomenon' or 'Somogyi effect' by providing a mid-day data point in the glucose profile.
  • Safety: To ensure the patient is not hypoglycemic before starting another meal cycle.
  • Hyperglycemia: Chronic high pre-dinner readings increase the risk of long-term complications like retinopathy, neuropathy, and nephropathy.
  • Hypoglycemia: Low pre-dinner readings may indicate excessive insulin or inadequate carbohydrate intake during lunch.
  • Metabolic Syndrome: Difficulty maintaining stable glucose throughout the day is often linked to insulin resistance and cardiovascular risk.
View Interpretation
Metabolic

Pre-Lunch Blood Sugar

Pre-Lunch Blood Sugar, also known as a pre-prandial glucose check, measures the concentration of glucose in the blood immediately before the midday meal. This measurement is a key component of 'structured testing' for individuals with Diabetes Mellitus. It helps determine how well the body (and any medications) managed the glucose from the morning meal and the basal glucose production throughout the forenoon. This specific timing is utilized to:
  • Assess the adequacy of the morning basal or bolus insulin dose.
  • Identify 'dawn phenomenon' or 'Somogyi effect' consequences that persist into the day.
  • Guide meal-time insulin dosing (sliding scale).
  • Help healthcare providers understand the patient's daily glucose fluctuations.
Abnormal results are primarily associated with:
  • Type 1 and Type 2 Diabetes: Poorly controlled glucose levels.
  • Gestational Diabetes: Monitoring during pregnancy.
  • Hyperinsulinemia: Excess insulin production leading to pre-meal drops.
  • Pre-diabetes: Impaired glucose regulation.
View Interpretation
Prenatal Screening

Pregnancy-Associated Plasma Protein A (PAPP-A) & Beta Human Chorionic Gonadotropin (Beta-hCG)

Pregnancy-Associated Plasma Protein A (PAPP-A) and Beta Human Chorionic Gonadotropin (beta-hCG) are biochemical markers used primarily in the first-trimester screening (FTS) between the 11th and 14th weeks of gestation. PAPP-A is a protein produced by the placenta that plays a vital role in bone development and insulin-like growth factor (IGF) signaling. Beta-hCG is a hormone produced by the syncytiotrophoblast of the placenta, essential for maintaining the corpus luteum and progesterone production during early pregnancy. This panel is a non-invasive screening tool used to assess the statistical probability of chromosomal abnormalities in the fetus. When combined with a nuchal translucency (NT) ultrasound scan, it provides a detection rate of approximately 85-90% for certain trisomies. It is routinely offered to pregnant individuals to determine if further invasive diagnostic testing, like chorionic villus sampling (CVS) or amniocentesis, is warranted.
  • Trisomy 21 (Down Syndrome): Typically characterized by low PAPP-A levels and high free beta-hCG levels.
  • Trisomy 18 (Edwards Syndrome) & Trisomy 13 (Patau Syndrome): Generally associated with low levels of both PAPP-A and beta-hCG.
  • Placental Insufficiency: Isolated low PAPP-A (below 0.4 MoM) in the first trimester is linked to increased risks of preeclampsia, fetal growth restriction (IUGR), and preterm birth later in pregnancy.
  • Ectopic Pregnancy: Sub-optimal rises in hCG can indicate a non-viable or extrauterine pregnancy.
View Interpretation
Prenatal Screening

Pregnancy-Associated Plasma Protein-A (PAPP-A)

PAPP-A is a zinc-binding enzyme produced by the trophoblast (placenta) during pregnancy. In a Dual Marker screen (typically performed between weeks 11 and 14), PAPP-A levels are used alongside Free Beta-hCG to assess the statistical risk of chromosomal abnormalities, specifically Down Syndrome (Trisomy 21) and Edwards Syndrome (Trisomy 18). It also serves as an early marker for placental health and potential late-pregnancy complications like preeclampsia.
View Interpretation
Infectious Disease

Procalcitonin

Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin. In healthy individuals, PCT is produced only in the C-cells of the thyroid gland. However, during a severe systemic bacterial infection, inflammatory cytokines trigger the nearly universal expression of the PCT gene in various tissues throughout the body, leading to a rapid rise in blood levels. Interestingly, viral infections typically stimulate interferon-gamma, which actually inhibits the production of PCT, making this test a highly specific marker for bacterial vs. viral etiology. PCT is a critical biomarker in acute care settings (Emergency Department and ICU). It is ordered to:
  • Assist in the diagnosis of bacterial sepsis and septic shock.
  • Distinguish between bacterial and viral pneumonia.
  • Guide 'Antibiotic Stewardship'—deciding when to start or, more importantly, when to safely discontinue antibiotics in respiratory infections or sepsis.
  • Monitor the response to treatment in patients with severe infections.
  • Sepsis: High levels (>2.0 ng/mL) indicate a high risk of systemic infection and organ dysfunction.
  • Bacterial Pneumonia: Elevated PCT helps clinicians decide if a patient with a cough and fever needs antibiotics.
  • Meningitis: Used to differentiate bacterial meningitis (high PCT) from viral meningitis (low/normal PCT).
  • Secondary Infections: Monitoring patients after major surgery or trauma for the onset of bacterial complications.
View Interpretation
Infectious Disease

Procalcitonin (PCT)

Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin. In healthy individuals, it is produced by thyroid C-cells, but in response to bacterial endotoxins and inflammatory cytokines, it is produced by nearly all tissues. Within a COVID Panel, PCT serves as a critical biomarker to differentiate between viral pneumonia and secondary bacterial co-infection. While viral infections (like COVID-19) typically suppress PCT levels, an elevated level often indicates a bacterial complication, guiding clinicians in the judicious use of antibiotics and assessing the risk of progression to sepsis.
View Interpretation
Endocrinology

Progesterone

Progesterone is a steroid hormone primarily produced by the corpus luteum in the ovaries following ovulation and by the placenta during pregnancy. Its chief function is to prepare the endometrium (lining of the uterus) for the implantation of a fertilized egg and to maintain the pregnancy by preventing uterine contractions. This test is a cornerstone of reproductive health assessments. It is ordered to:
  • Confirm if ovulation has occurred during a menstrual cycle.
  • Evaluate the health of an early pregnancy, especially if spotting or cramping occurs.
  • Diagnose the cause of infertility or recurrent miscarriages.
  • Monitor high-risk pregnancies or patients receiving progesterone supplementation.
  • Help diagnose ectopic pregnancies (in conjunction with hCG levels).
Abnormal progesterone levels are associated with several conditions. Low levels during the luteal phase may indicate Luteal Phase Deficiency (LPD), which is a common cause of infertility. High levels outside of pregnancy may be seen in cases of congenital adrenal hyperplasia or certain ovarian tumors. During pregnancy, consistently low levels are a significant marker for potential miscarriage or ectopic pregnancy, while elevated levels are expected as the pregnancy progresses.
View Interpretation
Reproductive Health

Progressive Motility

Progressive motility measures the percentage of sperm that move actively, either linearly or in a large circle. This is a critical predictor of fertility, as only progressively motile sperm are likely to penetrate the cervical mucus and reach the oocyte for fertilization.
View Interpretation
Endocrinology

Prolactin

Prolactin is a peptide hormone produced by the anterior pituitary gland, primarily responsible for inducing and maintaining lactation. In non-pregnant individuals, it helps regulate the reproductive system. Abnormal levels can disrupt the secretion of Gonadotropin-Releasing Hormone (GnRH), leading to infertility, irregular menstrual cycles in women, and erectile dysfunction or gynecomastia in men. Within this panel, it is evaluated alongside thyroid and other pituitary hormones to pinpoint the cause of endocrine dysfunction.
View Interpretation
Endocrinology

Prolactin (PRL)

Prolactin is a peptide hormone produced by the anterior pituitary gland, primarily known for its role in stimulating lactation. In the context of an LH/FSH profile, Prolactin is measured to investigate hypothalamic-pituitary-gonadal axis dysfunction. High prolactin levels (hyperprolactinemia) can inhibit the secretion of Gonadotropin-Releasing Hormone (GnRH), which in turn leads to decreased LH and FSH levels, causing symptoms like infertility, irregular menstrual cycles, and erectile dysfunction.
View Interpretation
Tumor Markers

Prostatic Specific Antigen (Total)

Prostate-Specific Antigen (PSA) is a protein produced by both normal and malignant cells of the prostate gland. PSA liquefies semen, allowing sperm to swim freely. While most PSA is found in semen, small amounts circulate in the blood, which can be measured to monitor prostate health. The Total PSA test is used primarily to screen for prostate cancer in men. It is also utilized to monitor patients with a known history of prostate cancer to check for recurrence after surgery or radiation. Additionally, it helps in diagnosing and monitoring inflammation of the prostate (prostatitis) or non-cancerous enlargement (Benign Prostatic Hyperplasia, or BPH).
  • Prostate Cancer: Higher levels of PSA correlate with an increased risk of malignancy.
  • Benign Prostatic Hyperplasia (BPH): As the prostate grows larger with age, PSA levels naturally rise.
  • Prostatitis: Infection or inflammation of the gland can cause sharp, temporary spikes in PSA levels.
PSA is not a definitive 'cancer test.' Many men with elevated PSA do not have cancer, and some men with low PSA do. Doctors look at the 'PSA Velocity' (rate of change over time) and 'PSA Density' (PSA level relative to the size of the prostate) to make more informed clinical decisions.
View Interpretation
Nephrology

Protein

Protein in a urine routine (proteinuria) is a fundamental indicator of renal health. In a healthy state, the glomerular basement membrane prevents large proteins like albumin from entering the filtrate. This component measures the presence of proteins, primarily albumin, in the urine. Sustained proteinuria is a hallmark of chronic kidney disease (CKD), glomerular damage, or systemic conditions affecting the kidneys like Diabetes Mellitus or Hypertension. It is also used to screen for preeclampsia in pregnancy.
View Interpretation
Metabolic

Protein (Urine)

Measuring protein in the urine is a primary screen for kidney function. Normally, the glomerular basement membrane prevents large proteins like albumin from passing into the urine. The presence of protein (proteinuria) in a Complete Urine Examination is often the earliest sign of renal disease, including diabetic nephropathy, glomerulonephritis, or hypertensive kidney damage.
View Interpretation
Hematology

Protein C Assay

Protein C is a vitamin K-dependent protein produced in the liver that serves as a natural anticoagulant. When activated (as Activated Protein C), it degrades Factors Va and VIIIa, which are essential components of the blood clotting cascade. The Protein C Assay measures the functional activity of this protein to ensure the body can properly regulate and prevent excessive blood clot formation. This test is primarily used in the workup of 'thrombophilia'—a tendency to develop blood clots. It is ordered for patients who have experienced unexplained Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), or clots at an unusually young age (under 50). It is also used to investigate 'Warfarin-induced skin necrosis,' a rare but serious complication of blood-thinning medication, and to screen family members of individuals with known Protein C deficiency.
  • Congenital Protein C Deficiency: A hereditary risk factor for venous thromboembolism.
  • Disseminated Intravascular Coagulation (DIC): Where Protein C is consumed rapidly.
  • Liver Disease: Since the liver produces Protein C, levels drop in cirrhosis or hepatitis.
  • Vitamin K Deficiency: Necessary for the synthesis of functional Protein C.
View Interpretation
Metabolic

Protein Creatinine Ratio

The Protein Creatinine Ratio (PCR) is a diagnostic tool used to estimate the amount of protein excreted in the urine over a 24-hour period without requiring a cumbersome 24-hour collection. Under normal physiological conditions, the glomeruli (the kidney's filtering units) prevent large proteins like albumin from leaking into the urine. Creatinine, a waste product of muscle metabolism, is excreted at a relatively constant rate. By comparing the concentration of protein to creatinine in a single random urine sample, clinicians can normalize for variations in urine concentration. This test is primarily ordered to screen for, diagnose, and monitor kidney disease. It is a standard of care for patients with chronic conditions that risk renal damage, such as Diabetes Mellitus and Hypertension. It is also used in pregnancy to screen for preeclampsia, a condition characterized by high blood pressure and proteinuria.
  • Chronic Kidney Disease (CKD): Persistent elevation indicates progressive renal damage.
  • Diabetic Nephropathy: Early detection of protein leakage allows for intervention with ACE inhibitors or ARBs.
  • Glomerulonephritis: Inflammation of the kidney's filters.
  • Nephrotic Syndrome: Characterized by very high PCR levels (typically >3000 mg/g), edema, and low serum albumin.
  • Multiple Myeloma: May cause the presence of Bence-Jones proteins in the urine.
The PCR is preferred over a simple dipstick because the dipstick only measures albumin concentration and can be misleading if the urine is very dilute or very concentrated. The PCR provides a more accurate quantitative assessment of total protein loss, which is critical for staging kidney disease and assessing the efficacy of therapeutic interventions.
View Interpretation
Hematology

Protein Electrophoresis

Serum Protein Electrophoresis (SPEP) is a laboratory technique used to separate the proteins in the blood into five distinct groups: albumin, alpha-1, alpha-2, beta, and gamma globulins. This separation is based on the electrical charge and size of the protein molecules. These proteins serve various roles, from maintaining osmotic pressure (albumin) to immune defense (gamma globulins). This test is primarily utilized to screen for, diagnose, and monitor monoclonal gammopathies, such as Multiple Myeloma and Waldenström macroglobulinemia. It is also ordered to investigate unexplained high total protein, bone pain, high calcium levels, or anemia. Furthermore, it can provide insights into chronic inflammation, liver disease, and protein-losing enteropathies.
  • Multiple Myeloma: Characterized by a sharp 'M-spike' in the gamma or beta region.
  • Monoclonal Gammopathy of Undetermined Significance (MGUS): A precursor condition to myeloma.
  • Inflammatory Diseases: Result in a broad (polyclonal) increase in the gamma region.
  • Liver Cirrhosis: Leads to decreased albumin and a characteristic 'beta-gamma bridge.'
  • Nephrotic Syndrome: Identified by a loss of albumin and an increase in alpha-2 globulins.
View Interpretation
Hematology

Protein S Assay

Protein S is a Vitamin K-dependent plasma glycoprotein that serves as a critical cofactor for Activated Protein C (APC). Together, they inactivate factors Va and VIIIa in the coagulation cascade, thereby acting as a natural anticoagulant. Without sufficient Protein S, the body is unable to effectively 'turn off' the clotting process, leading to a prothrombotic state. This assay is used to investigate hypercoagulable states (thrombophilia). It is typically ordered for:
  • Unexplained Blood Clots: Patients who experience Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE), especially at a young age.
  • Family History: Individuals with a strong family history of clotting disorders.
  • Recurrent Miscarriage: As some clotting disorders are linked to pregnancy complications.
  • Protein S Deficiency: Can be hereditary (genetic mutations) or acquired.
  • Liver Disease: Since Protein S is produced in the liver.
  • Vitamin K Deficiency: Necessary for the synthesis of functional Protein S.
  • Disseminated Intravascular Coagulation (DIC): Where clotting factors are consumed rapidly.
View Interpretation
Metabolic

Proteins & A/G Ratio

This test measures Total Protein in the blood, which is composed primarily of Albumin and Globulin. The Albumin/Globulin (A/G) ratio is a calculation that compares the amount of albumin (produced by the liver) to globulins (which include enzymes and antibodies produced by the liver and immune system). This balance is critical for maintaining osmotic pressure in the blood and protecting the body from disease. It is ordered to assess nutritional status and screen for liver or kidney disease. If a patient has edema (swelling), symptoms of liver disease (jaundice), or suspected bone marrow disorders like Multiple Myeloma, this test provides essential diagnostic clues.
  • Liver Disease: Cirrhosis or hepatitis often leads to low albumin, resulting in a low A/G ratio.
  • Kidney Disease: Nephrotic syndrome causes the loss of albumin in urine, lowering the ratio.
  • Multiple Myeloma: A cancer of plasma cells that produces excessive globulins, significantly lowering the A/G ratio.
  • Dehydration: Can cause a 'false' increase in total proteins and sometimes a high A/G ratio.
View Interpretation
Hematology

Prothrombin Time

Prothrombin Time (PT) measures how long it takes for the liquid portion (plasma) of your blood to clot. It specifically evaluates the extrinsic and common coagulation pathways, which involve clotting factors I, II, V, VII, and X. Because many of these factors are produced in the liver and are Vitamin K-dependent, the PT is a vital indicator of both blood clotting efficiency and liver synthetic function. The PT test is one of the most frequently performed coagulation studies. It is used for:
  • Warfarin (Coumadin) Monitoring: Ensuring the dose of blood thinners is within the therapeutic range (usually via the INR calculation derived from PT).
  • Liver Function Assessment: Since the liver produces clotting factors, a prolonged PT can indicate liver disease or failure.
  • Pre-Surgical Screening: Identifying potential bleeding risks before an invasive procedure.
  • Diagnostic Workup: Investigating unexplained bleeding, easy bruising, or suspected Vitamin K deficiency.
A prolonged PT (high value) can be caused by various conditions, including Vitamin K deficiency, liver cirrhosis, bile duct obstruction, or Disseminated Intravascular Coagulation (DIC). Conversely, a shortened PT (low value) is less common but may be seen in conditions related to hypercoagulability or excessive intake of Vitamin K-rich foods (like leafy greens), which can counteract anticoagulant therapy.
View Interpretation
Hematology

Prothrombin Time

Prothrombin Time (PT) measures the time it takes for blood to clot via the extrinsic and common pathways of the coagulation cascade. In a COVID Panel, PT is used to screen for coagulopathy and Disseminated Intravascular Coagulation (DIC), which are common complications in severe viral infections. It primarily assesses factors I, II, V, VII, and X.
View Interpretation
Respiratory

Pulmonary Function Test

Pulmonary Function Tests (PFTs) are a non-invasive group of tests that measure how well the lungs are working. The most common component is spirometry, which measures the volume of air an individual can inhale or exhale as a function of time. These tests assess lung capacity, volume, rates of flow, and gas exchange. By comparing a patient's results to 'predicted values' based on age, height, sex, and ethnicity, clinicians can determine the presence and severity of respiratory impairment. Physicians order PFTs for several critical reasons:
  • Diagnosis: To differentiate between obstructive lung diseases (like asthma or COPD) and restrictive lung diseases (like pulmonary fibrosis).
  • Symptom Investigation: To evaluate the cause of chronic cough, wheezing, or shortness of breath.
  • Monitoring: To track the progression of chronic lung conditions or the effectiveness of treatments like bronchodilators or steroids.
  • Pre-operative Assessment: To ensure a patient has sufficient respiratory reserve to undergo major surgery.
  • Occupational Health: To screen individuals exposed to hazardous dust or chemicals in the workplace.
PFTs are essential in managing various pathologies. Obstructive patterns (where air is difficult to exhale) are seen in Asthma, COPD, and Bronchitis. Restrictive patterns (where the lungs cannot expand fully) are associated with Interstitial Lung Disease (ILD), Sarcoidosis, and Scoliosis. Additionally, tests measuring Diffusion Capacity (DLCO) can identify damage to the alveolar-capillary membrane, common in Emphysema or Pulmonary Hypertension.
View Interpretation
Gastroenterology

Pus Cells (Leukocytes) in Stool

The presence of Pus Cells (Leukocytes) in a stool sample is a significant indicator of intestinal wall inflammation. In a healthy digestive tract, white blood cells are typically absent or present in very low numbers. When found in significant quantities, it suggests that the immune system is responding to an insult in the gastrointestinal tract, most commonly caused by invasive bacterial infections (like Shigella, Salmonella, or Campylobacter) rather than viral pathogens. It is also a key marker in monitoring Inflammatory Bowel Disease (IBD) such as Ulcerative Colitis or Crohn’s Disease during flare-ups.
View Interpretation
Microbiology

Pus Culture & Sensitivity

A Pus Culture and Sensitivity test is used to identify the specific aerobic and facultative anaerobic bacteria causing an infection in an abscess, wound, or surgical site. 'Culture' refers to growing the bacteria in a lab setting, while 'Sensitivity' (or Susceptibility) involves testing which antibiotics are most effective at killing the isolated strain. This test is vital for 'Antibiotic Stewardship.' Doctors order it when a patient presents with an infected wound or a localized collection of pus (abscess). It ensures that the patient is not prescribed a broad-spectrum antibiotic that might be ineffective against a specific resistant strain, such as MRSA (Methicillin-resistant Staphylococcus aureus).
  • Abscesses: Localized collections of pus under the skin or within organs.
  • Cellulitis: Deep skin infections.
  • Post-operative Infections: Monitoring for bacterial growth at a surgical incision site.
  • Osteomyelitis: If the pus is associated with bone infection.
View Interpretation
Prenatal Screening

Quad Marker Screen

The Quad Marker Screen is a prenatal blood test performed during the second trimester (usually weeks 15-22). It measures four specific substances in the mother's blood: Alpha-fetoprotein (AFP), Human chorionic gonadotropin (hCG), Unconjugated estriol (uE3), and Inhibin-A. Unlike diagnostic tests, this is a screening tool used to estimate the statistical probability of certain chromosomal abnormalities. The test is offered to pregnant women to screen for potential fetal health issues without the risks associated with invasive procedures like amniocentesis. It evaluates the risk of:
  • Neural Tube Defects: Such as spina bifida or anencephaly.
  • Trisomy 21 (Down Syndrome): A chromosomal disorder causing intellectual disability and developmental delays.
  • Trisomy 18 (Edwards Syndrome): A more severe chromosomal abnormality.
  • High AFP: May indicate neural tube defects, multiple pregnancies, or an underestimated gestational age.
  • Low AFP, High hCG, Low uE3, High Inhibin: This specific pattern is associated with an increased risk for Down Syndrome.
  • Low AFP, Low hCG, Low uE3: This pattern may suggest an increased risk for Trisomy 18.
View Interpretation
Hematology

RBC Count

The Red Blood Cell (RBC) count measures the number of erythrocytes in a microliter of whole blood. RBCs contain hemoglobin, the protein responsible for transporting oxygen from the lungs to the body's tissues and carrying carbon dioxide back to the lungs for excretion. Maintaining an optimal number of RBCs is critical for aerobic metabolism and cellular energy production. An RBC count is a standard component of the Complete Blood Count (CBC). It is ordered during routine physicals, prior to surgery, and to investigate symptoms such as chronic fatigue, weakness, shortness of breath, or pale skin (pallor). It is also essential for monitoring patients with known blood disorders, kidney disease (as kidneys produce erythropoietin), or those undergoing chemotherapy.
  • Anemia (Low RBC): Can result from iron, B12, or folate deficiency, chronic bleeding, bone marrow suppression, or hemolytic diseases where RBCs are destroyed prematurely.
  • Polycythemia (High RBC): May be 'primary' (Polycythemia Vera, a bone marrow disorder) or 'secondary' due to chronic hypoxia. Secondary polycythemia is common in heavy smokers, patients with COPD, or those living at high altitudes, as the body produces more RBCs to compensate for lower oxygen levels.
View Interpretation
Vitamins

RBC Folate Level

Red Blood Cell (RBC) Folate measures the amount of folate (Vitamin B9) stored inside red blood cells. Unlike serum folate, which fluctuates based on recent dietary intake, RBC folate reflects the folate status at the time the red blood cell was formed. Because RBCs live for approximately 120 days, this test provides a long-term (3-4 month) average of folate tissue stores, making it a more stable indicator of chronic deficiency. This test is primarily ordered to investigate macrocytic anemia (where red blood cells are abnormally large) and to differentiate between Vitamin B12 and folate deficiencies. It is also used in prenatal screening to ensure adequate folate levels, which are essential for preventing neural tube defects in developing fetuses. Patients with malabsorption syndromes (like Celiac disease) or those taking medications that interfere with folate metabolism (like methotrexate) are frequently monitored using this test.
  • Megaloblastic Anemia: Red blood cells cannot divide properly due to lack of folate.
  • Malabsorption: Conditions like Crohn's or Celiac disease preventing nutrient uptake.
  • Alcoholism: Chronic alcohol consumption severely inhibits folate absorption.
  • Pregnancy Complications: Low folate is a risk factor for spina bifida and anencephaly.
View Interpretation
Oncology

ROS 1 IHC Marker

The ROS1 Immunohistochemistry (IHC) marker is a specialized laboratory test performed on tumor tissue to detect the overexpression of the ROS1 protein. ROS1 is a receptor tyrosine kinase; in certain cancers, the ROS1 gene undergoes a rearrangement (fusion) with other genes, leading to constitutive activation of the protein. This activation drives uncontrolled cell growth and survival. The IHC test uses specific antibodies that bind to the ROS1 protein, producing a color change visible under a microscope. This test is a critical component of 'Precision Medicine' for patients diagnosed with Non-Small Cell Lung Cancer (NSCLC), specifically those with adenocarcinoma histology. Identifying a ROS1 rearrangement is transformative for treatment, as these patients typically do not respond well to traditional chemotherapy but show dramatic, durable responses to targeted therapies known as Tyrosine Kinase Inhibitors (TKIs), such as Crizotinib or Entrectinib.
  • Non-Small Cell Lung Cancer (NSCLC): Occurs in approximately 1-2% of all NSCLC cases, often in younger patients or 'never-smokers'.
  • Glioblastoma: ROS1 fusions have been occasionally identified in brain tumors.
  • Cholangiocarcinoma: Rare instances of ROS1 fusions found in bile duct cancers.
View Interpretation
Infectious Disease

RVAB DNA PCR

RVAB DNA PCR (often referring to a specific viral DNA such as Rotavirus DNA or a less common Rabies Viral DNA variant/research-specific PCR) utilizes Polymerase Chain Reaction to amplify and detect the genetic material of the virus. This molecular technique provides a high level of sensitivity and specificity, detecting the virus directly rather than the immune response (antibodies). PCR testing is ordered when a rapid and definitive diagnosis of a viral infection is required, particularly in immunocompromised patients or cases where antibody testing is inconclusive. It is used to:
  • Confirm active viral replication.
  • Quantify the 'viral load' to monitor treatment efficacy.
  • Distinguish between different viral strains or species.
The presence of viral DNA in blood or stool (depending on the specific 'RV' target) is indicative of an acute infection. For Rotavirus (RV), this correlates with severe gastroenteritis, particularly in pediatric populations. For other 'RV' designations like Rabies (rarely DNA PCR, usually RNA), it indicates a lethal neurological infection. PCR is the gold standard for early detection, as it can identify the pathogen days or weeks before antibodies appear.
View Interpretation
Histopathology

Radical Specimen

A 'Radical Specimen' refers to a large tissue sample obtained through radical surgery (e.g., radical mastectomy, radical prostatectomy, or radical neck dissection). The primary function of examining this specimen is to provide a definitive histopathological diagnosis, determine the extent of disease (staging), and assess the adequacy of surgical margins. Pathological examination of a radical specimen is mandatory following major oncological surgery. It is ordered to:
  • Confirm the tumor type and grade.
  • Determine if the entire tumor was removed (clear margins).
  • Check for lymph node involvement (metastasis).
  • Identify specific biomarkers (like HER2 or PD-L1) that guide chemotherapy or immunotherapy.
This is primarily associated with the management of cancer. The pathology report for a radical specimen is the 'gold standard' for cancer staging (TNM classification). It determines the prognosis and the necessity of adjuvant therapy (radiation or chemotherapy). For instance, finding 'positive margins' means cancer cells remain at the edge of the surgical site, necessitating further treatment. The detailed microscopic analysis looks for vascular invasion, perineural invasion, and the degree of cellular differentiation, all of which are critical for the patient's long-term care plan.
View Interpretation
Metabolic

Random Blood Sugar

Random Blood Sugar (RBS) measures the amount of glucose circulating in the blood at any given time of the day, regardless of when the last meal was consumed. Glucose is the primary energy source for the body's cells, particularly the brain. The regulation of blood glucose is primarily managed by insulin and glucagon, hormones secreted by the pancreas. The RBS test is typically used as a screening tool to identify potential cases of diabetes mellitus or to monitor glucose levels in individuals with known diabetes during acute symptoms. It is frequently ordered during emergency visits if a patient presents with confusion, fainting, or extreme thirst. Unlike the Fasting Blood Sugar (FBS) or HbA1c, it provides a 'snapshot' of glycemic status at a specific moment.
  • Type 1 and Type 2 Diabetes: Consistently high random levels are indicative of impaired insulin production or sensitivity.
  • Hyperglycemia: Often associated with stress, infection, or pancreatitis.
  • Hypoglycemia: Can be caused by excessive insulin medication, liver disease, or prolonged starvation.
  • Gestational Diabetes: Elevated levels during pregnancy require further diagnostic testing like the Oral Glucose Tolerance Test (OGTT).
Monitoring RBS is critical for preventing long-term complications such as neuropathy, retinopathy, and cardiovascular disease. While not diagnostic on its own without symptoms, a result ≥200 mg/dL is strongly suggestive of diabetes.
View Interpretation
Hematology

Red Blood Cell Count

The RBC count measures the actual number of red blood cells in a volume of blood. Within a Complete Blood Count (CBC), it is used to assess the body's ability to transport oxygen. It helps differentiate between types of anemia and erythrocytosis when combined with Hemoglobin and Hematocrit.
View Interpretation
Hematology

Red Blood Cell Count (RBC)

The Red Blood Cell (RBC) count measures the absolute number of erythrocytes per microliter of blood. Within a Complete Blood Count (CBC), it is fundamental for determining the oxygen-carrying capacity of the blood. It serves as a primary indicator for diagnosing various forms of anemia, polycythemia, and the effects of bone marrow suppression. While Hemoglobin and Hematocrit are often prioritized, the RBC count is critical for calculating indices like MCV and MCH, which differentiate between microcytic, normocytic, and macrocytic anemias.
View Interpretation
Hematology

Red Blood Cell Count (RBC)

The Red Blood Cell (RBC) count measures the total number of erythrocytes in a microliter or liter of blood. As part of a Complete Blood Picture (CBC), it is fundamental for evaluating the blood's capacity to transport oxygen from the lungs to peripheral tissues via hemoglobin. It is a primary indicator for diagnosing anemia, polycythemia, and monitoring the bone marrow's response to various therapeutic interventions or chronic diseases.
View Interpretation
Metabolic

Red Blood Cells (Microscopic)

The presence of Red Blood Cells (RBCs) in the urine, known as hematuria, is a critical finding in a Complete Urine Examination. Microscopic analysis quantifies the number of erythrocytes per high-power field (HPF). It helps differentiate between glomerular diseases (where dysmorphic RBCs are often seen) and non-glomerular causes such as infections, calculi, or malignancies of the urinary tract. In the context of a routine screen, it serves as an early indicator of renal parenchymal injury or urological pathologies.
View Interpretation
Nephrology

Red Blood Cells (Microscopic)

This component measures the presence of intact erythrocytes in the urine sediment using high-power field (HPF) microscopy. Within a Urine Routine panel, it is the gold standard for identifying microscopic hematuria. The presence of RBCs can indicate damage to the glomerular basement membrane, physical trauma to the urinary tract (kidney stones), infection (cystitis), or malignant processes. Distinguishing dysmorphic RBCs from isomorphic ones can further help localize the source of bleeding to the renal parenchyma versus the lower urinary tract.
View Interpretation
Gastroenterology

Red Blood Cells (RBCs)

The presence of intact Red Blood Cells in a stool sample (microscopic examination) indicates bleeding in the lower gastrointestinal tract. Unlike fecal occult blood tests which detect hemoglobin, microscopic RBC identification confirms the presence of whole cells, often associated with inflammatory bowel disease, bacterial dysentery, hemorrhoids, or anal fissures.
View Interpretation
Hematology

Red Cell Distribution Width (RDW)

RDW is a numerical measure of anisocytosis, or the variation in size of circulating red blood cells (RBCs). In a healthy individual, RBCs are relatively uniform in size. A high RDW indicates a wide range of cell sizes (small, normal, and large). In the context of a CBC, RDW is invaluable for differentiating between types of microcytic anemia; for example, Iron Deficiency Anemia typically shows a high RDW, whereas Thalassemia minor often presents with a normal RDW despite low MCV.
View Interpretation
Hematology

Red Cell Distribution Width (RDW)

RDW is a numerical measure of the variation in size (volume) of red blood cells, a condition known as anisocytosis. Within a Complete Blood Picture, RDW is a vital tool for the differential diagnosis of anemia. While the MCV (Mean Corpuscular Volume) tells you the average size, the RDW tells you how much the sizes vary. It is often the first indicator of nutritional deficiencies (Iron, B12, or Folate) before the hemoglobin level even drops.
View Interpretation
Hematology

Red Cell Distribution Width (RDW)

RDW measures the variation in the size (volume) of red blood cells (RBCs), a phenomenon known as anisocytosis. In a healthy individual, RBCs are relatively uniform in size. RDW is a critical component of the Complete Blood Count (CBC) because it helps differentiate between various types of anemia. For instance, a high RDW with a low Mean Corpuscular Volume (MCV) typically points toward iron deficiency anemia, whereas a normal RDW with low MCV might suggest Thalassemia or anemia of chronic disease. It is also an emerging prognostic marker for cardiovascular health and inflammatory status.
View Interpretation
Gastroenterology

Reducing Substances

The stool reducing substances test is primarily used to screen for carbohydrate malabsorption, most notably lactose intolerance. In normal digestion, carbohydrates are broken down into monosaccharides by enzymes like lactase and absorbed in the small intestine. If these enzymes are deficient, undigested sugars remain in the lumen, acting as osmotic agents that draw water into the gut (causing diarrhea) and are fermented by bacteria into 'reducing' compounds. This test is critical in pediatric settings to differentiate between viral gastroenteritis and congenital or secondary enzyme deficiencies.
View Interpretation
Respiratory

Residual Volume (RV)

Residual Volume is the amount of air remaining in the lungs after a forceful, maximal exhalation. In a Pulmonary Function Test (PFT), it is a critical measure to diagnose 'air trapping.' RV cannot be measured by simple spirometry and requires body plethysmography or gas dilution techniques. It helps differentiate between obstructive and restrictive lung diseases.
View Interpretation
Hematology

Reticulocyte Count

Reticulocytes are immature red blood cells (RBCs) that have just been released from the bone marrow into the bloodstream. They circulate for about one to two days before maturing into fully functional erythrocytes. Measuring them provides a 'snapshot' of the bone marrow's current ability to produce new red blood cells. This test is a critical follow-up to an abnormal Complete Blood Count (CBC). It helps determine if anemia is caused by a failure in production (bone marrow problem) or an increase in loss (bleeding or hemolysis). It is also used to monitor how a patient is responding to treatments for iron, B12, or folate deficiencies.
  • Hemolytic Anemia: Increased destruction of RBCs leads the marrow to compensate with a high reticulocyte count.
  • Aplastic Anemia: Bone marrow failure leading to a low count despite low RBC levels.
  • Iron Deficiency Anemia: Characterized by a low reticulocyte count due to lack of raw materials.
  • Hemorrhage: Acute blood loss triggers a rise in reticulocyte production.
View Interpretation
Hematology

Rh Antibody Titre

The Rh Antibody Titre test measures the concentration of antibodies against the Rh factor (specifically the D antigen) in a person's blood. This is most critical in Rh-negative pregnant women who may have been exposed to Rh-positive fetal blood, a process known as sensitization. This test is a staple of prenatal care for Rh-negative mothers. It is used to monitor for 'Rh Isoimmunization.' If a mother develops these antibodies, they can cross the placenta and attack the red blood cells of an Rh-positive fetus, leading to Hemolytic Disease of the Fetus and Newborn (HDFN).
  • Rh Sensitization: Occurs after a previous pregnancy, miscarriage, or blood transfusion where Rh-negative blood met Rh-positive blood.
  • Hemolytic Disease of the Fetus and Newborn (HDFN): A condition that can cause fetal anemia, jaundice, brain damage (kernicterus), or even fetal death (hydrops fetalis).
  • Transfusion Reactions: Occurs if an Rh-sensitized person receives Rh-positive blood.
If the titre is low (e.g., 1:4), the pregnancy is monitored closely with repeat testing. If the titre rises to a critical level (often 1:16 or higher), specialized procedures like middle cerebral artery (MCA) Doppler ultrasounds are performed to check for fetal anemia.
View Interpretation
Immunology

Rheumatoid Factor (IgG and IgM)

Rheumatoid Factor (RF) is an autoantibody, an immune system protein that mistakenly attacks the body's own healthy tissues. This test specifically measures the IgG and IgM isotypes of RF. While RF is most famous for its association with Rheumatoid Arthritis (RA), it is essentially a marker of systemic inflammation and immune activation. The IgM isotype is the most commonly measured version in standard screens, but the inclusion of IgG can provide a more comprehensive immunological profile. Physicians order this test when a patient presents with symptoms of inflammatory arthritis, such as:
  • Symmetrical Joint Pain: Pain affecting the same joints on both sides of the body.
  • Morning Stiffness: Stiffness lasting more than 30-60 minutes after waking.
  • Nodules: Small bumps under the skin near joints.
  • Extra-articular Symptoms: Unexplained fatigue or low-grade fever coupled with joint distress.
While a high RF is a hallmark of Rheumatoid Arthritis, it is not exclusive to it. High levels are also found in Sjögren’s Syndrome (often very high levels), Systemic Lupus Erythematosus (SLE), and Mixed Connective Tissue Disease. Interestingly, chronic infections like Hepatitis C, Endocarditis, and Tuberculosis can also trigger a rise in RF. It is important to note that roughly 20% of RA patients are 'seronegative,' meaning they have the disease despite a normal RF test result.
View Interpretation
Immunology

Rheumatoid Factor (RA Factor)

Rheumatoid Factor (RF) is an autoantibody, specifically an immunoglobulin (usually IgM) that targets the Fc portion of the patient's own IgG antibodies. The presence of these autoantibodies leads to the formation of immune complexes that deposit in tissues, primarily the synovium of joints, triggering a cascade of inflammatory responses and tissue damage. The RF test is primarily ordered when a clinician suspects Rheumatoid Arthritis (RA) or Sjögren's Syndrome. It is used as part of a diagnostic panel alongside Anti-CCP antibodies and inflammatory markers like ESR and CRP. It is particularly useful for differentiating inflammatory arthritis from non-inflammatory conditions like osteoarthritis.
  • Rheumatoid Arthritis: Approximately 70-80% of patients with RA will test positive for RF, though a negative result does not rule out the disease (seronegative RA).
  • Sjögren's Syndrome: A high percentage of patients with this autoimmune disorder also present with elevated RF.
  • Chronic Infections: RF can be elevated in conditions such as Hepatitis C, Endocarditis, and Tuberculosis.
  • Other Autoimmune Diseases: Systemic Lupus Erythematosus (SLE) and Mixed Connective Tissue Disease (MCTD) can show positive RF levels.
  • Healthy Aging: A small percentage of healthy elderly individuals may naturally have low levels of RF without clinical disease.
View Interpretation
Immunology

Rheumatoid Factor (RF)

Rheumatoid Factor (RF) is an autoantibody—an antibody directed against the body's own tissues. Specifically, RF is an antibody (usually IgM) that binds to the Fc portion of IgG. It is one of the primary biomarkers used in the diagnosis and management of autoimmune disorders, particularly those affecting the joints. Physicians order an RF test when a patient presents with symptoms such as joint pain, stiffness (especially in the morning), swelling, and warmth in the small joints of the hands and feet. It helps distinguish Rheumatoid Arthritis (RA) from other types of arthritis, such as osteoarthritis or gout. It is also used in the evaluation of Sjögren’s syndrome.
  • Rheumatoid Arthritis (RA): Approximately 70-80% of RA patients are RF-positive.
  • Sjögren's Syndrome: Frequently associated with very high RF levels.
  • Systemic Lupus Erythematosus (SLE): Some lupus patients will test positive for RF.
  • Chronic Infections: Conditions like Hepatitis C, endocarditis, and tuberculosis can cause transient elevations in RF.
  • Cryoglobulinemia: RF is often part of the cryoglobulin complex.
While highly useful, a positive RF test is not a definitive 'yes' for RA. Some healthy individuals, especially the elderly, may have low-level positive RF results without any underlying disease. Conversely, a negative result does not completely rule out RA (Seronegative RA). Clinicians usually combine RF results with Anti-CCP antibody tests for higher diagnostic accuracy.
View Interpretation
Rheumatology

Rheumatoid Factor (RF)

Rheumatoid Factor (RF) is an autoantibody (most commonly IgM) directed against the Fc portion of IgG. As a core component of the Arthritis Basic Screen, it serves as a primary marker for Rheumatoid Arthritis (RA). Higher titers are associated with more aggressive disease, extra-articular manifestations (like nodules), and worse long-term joint destruction.
View Interpretation
Immunology

Rheumatoid Factor IgG (ELISA)

Rheumatoid Factor (RF) is an autoantibody—an antibody directed against the body's own tissues. Specifically, RF targets the Fc portion of IgG molecules. While the standard RF test usually measures the IgM isotype, the IgG isotype (measured here via ELISA) can provide additional diagnostic depth in specific clinical scenarios. It is ordered when Rheumatoid Arthritis (RA) is suspected, particularly in patients who have joint pain and swelling but may have tested negative for standard IgM RF (seronegative RA). The IgG variant of RF is sometimes associated with more severe, systemic manifestations of the disease, such as vasculitis.
  • Rheumatoid Arthritis (RA): The primary association, especially in erosive disease.
  • Sjogren’s Syndrome: Often presents with very high RF levels.
  • Chronic Infections: Hepatitis C, endocarditis, and tuberculosis can cause 'false positive' RF elevations.
  • Cryoglobulinemia: IgG RF is often a component of mixed cryoglobulins.
RF is not specific to RA. About 5% of healthy individuals and up to 20% of the elderly may have low-level positive RF without any autoimmune disease. Therefore, it must be interpreted alongside Anti-CCP antibodies and clinical symptoms.
View Interpretation
Allergy and Immunology

Rice (Specific IgE)

This test measures the level of allergen-specific IgE antibodies to rice in the blood. While rice is generally considered a low-allergen food, sensitization can occur, leading to symptoms ranging from atopic dermatitis to gastrointestinal distress or respiratory issues. In an Allergy Profile, this helps distinguish rice-specific sensitivity from other cereal grains or environmental triggers.
View Interpretation
Immunology

Rubella Virus IgG Antibody

This test measures the level of Immunoglobulin G (IgG) antibodies to the Rubella virus. Within an MMR Profile, it is used to determine immune status. A positive result indicates long-term immunity, either from a previous infection or successful vaccination. For pregnant women, ensuring Rubella immunity is critical because primary Rubella infection during the first trimester can lead to Congenital Rubella Syndrome (CRS), causing severe birth defects, deafness, or fetal demise.
View Interpretation
Metabolic

SGOT

SGOT (Serum Glutamic Oxaloacetic Transaminase), also known as AST (Aspartate Aminotransferase), is an enzyme found in high concentrations in the liver, heart, muscles, and kidneys. When these tissues are damaged or diseased, SGOT is released into the bloodstream. While it is a key component of Liver Function Tests (LFTs), it is less specific to the liver than SGPT (ALT) because it is also found in muscle tissue. This test is used to identify liver damage and monitor treatment for liver disease. It is often ordered when a patient has:
  • Symptoms of liver disorders (jaundice, dark urine, abdominal pain).
  • A history of alcohol abuse.
  • Exposure to hepatitis viruses.
  • Been taking medications known to be hepatotoxic (e.g., statins, high-dose acetaminophen).
Very high levels of SGOT (more than 10 times normal) are often due to acute hepatitis, sometimes from a viral infection or drug exposure. In cases of chronic alcoholism, SGOT is typically higher than SGPT (an AST:ALT ratio > 2:1). Moderate elevations are seen in fatty liver disease (NAFLD), cirrhosis, and bile duct obstruction. Because SGOT is also found in muscles, an elevated level can also be seen following a myocardial infarction (heart attack) or strenuous physical exercise that causes muscle breakdown (rhabdomyolysis). It is therefore essential to look at the clinical context and other markers like ALT and CK (Creatine Kinase) to determine the source of the enzyme elevation.
View Interpretation
Metabolic

SGPT (Alanine Aminotransferase)

SGPT, now more commonly known as ALT (Alanine Aminotransferase), is an enzyme found primarily in the liver. It plays a crucial role in cellular energy production by catalyzing the transfer of an amino group. While small amounts are always present in the blood, the enzyme leaks out of liver cells into the bloodstream when the liver is damaged or inflamed. This test is a staple of the Liver Function Test (LFT) panel. It is used to screen for liver injury, monitor the progression of liver diseases like hepatitis, and track the potential side effects of hepatotoxic medications (such as statins or high-dose acetaminophen). It is often compared to SGOT (AST) to determine the specific cause of liver distress.
  • Viral Hepatitis: Very high levels are seen in acute Hepatitis A, B, or C.
  • Non-Alcoholic Fatty Liver Disease (NAFLD): Now the leading cause of mild elevations in the Western world.
  • Cirrhosis: Long-term scarring of the liver.
  • Biliary Obstruction: Gallstones blocking bile ducts.
Because ALT is more specific to the liver than AST, it is the preferred marker for liver-specific necrosis. Significant elevations (over 10x the upper limit) usually point to acute injury, while modest elevations suggest chronic conditions or lifestyle factors like obesity and alcohol consumption.
View Interpretation
Genetics

STIL-TAL1 Fusion (SIL-TAL1)

The STIL-TAL1 fusion (previously known as SIL-TAL1) results from a submicroscopic interstitial deletion on chromosome 1p32. This genetic rearrangement is found in approximately 10-25% of pediatric T-cell Acute Lymphoblastic Leukemia (T-ALL) cases. It leads to the ectopic expression of the TAL1 transcription factor under the control of the STIL promoter, driving leukemogenesis. Detecting this fusion is crucial for the molecular subtyping of T-ALL, prognostic stratification, and monitoring Minimal Residual Disease (MRD) following chemotherapy or stem cell transplantation.
View Interpretation
Infectious Disease

Scrub Typhus (IgM/IgG)

This test detects antibodies (IgM and IgG) against Orientia tsutsugamushi, the causative bacterium of Scrub Typhus. This organism is transmitted to humans through the bite of infected larval mites (chiggers). The test helps identify an immune response to the pathogen. It is ordered when a patient presents with symptoms common in endemic areas: high fever, severe headache, muscle pain, and especially the presence of an 'eschar' (a dark, scab-like sore at the bite site). It is vital for differentiating Scrub Typhus from other tropical fevers like Malaria, Dengue, or Typhoid.
  • Scrub Typhus (Tsutsugamushi Disease): The primary condition diagnosed.
  • Multi-organ Dysfunction: If left untreated, the infection can lead to respiratory distress, renal failure, or meningoencephalitis.
  • Acute Febrile Illness: A broad category for undifferentiated fevers in tropical regions.
IgM antibodies usually appear within the first week of symptoms, indicating an acute infection. IgG antibodies appear later and may persist for years, indicating previous exposure. Testing 'paired sera' (two samples taken 2 weeks apart) is the most accurate way to confirm a diagnosis via a four-fold increase in antibody titer.
View Interpretation
Reproductive Health

Semen Analysis

Semen analysis is the cornerstone of male fertility evaluation. It provides a comprehensive look at the quantity and quality of sperm produced. The test evaluates several parameters: sperm concentration (count), motility (movement), morphology (shape), total volume, and pH. This test is primarily ordered for couples struggling with conception to determine if male factor infertility is contributing to the issue. It is also routinely performed after a vasectomy to confirm the success of the procedure (checking for the absence of sperm, or azoospermia).
  • Oligospermia: Low sperm count, which can be caused by hormonal imbalances, varicoceles (enlarged veins in the scrotum), or environmental toxins.
  • Azoospermia: Total absence of sperm, potentially due to ductal obstruction or primary testicular failure.
  • Asthenozoospermia: Poor sperm motility, making it difficult for sperm to reach and fertilize an egg.
  • Teratozoospermia: Abnormal sperm shape, which can impede the sperm's ability to penetrate the egg.
  • Infections: Presence of white blood cells in semen (pyospermia) may indicate an infection in the prostate or reproductive tract.
  • Lifestyle Factors: High heat exposure (saunas, tight clothing), smoking, excessive alcohol, and anabolic steroid use are known to negatively impact results.
View Interpretation
Reproductive Health

Semen Volume

Semen volume measures the total amount of ejaculate produced. It is a critical component of the Semen Analysis panel as it reflects the secretory activity of the seminal vesicles and prostate gland. Sufficient volume is necessary to transport sperm through the female reproductive tract and buffer the acidic environment of the vagina.
View Interpretation
Microbiology

Semen for Culture and Sensitivity

The Semen Culture and Sensitivity test is a microbiological procedure used to detect and identify pathogenic bacteria or fungi in the male reproductive tract. Once a pathogen is grown (culture), 'sensitivity' testing is performed to determine which specific antibiotics are most effective at killing that particular strain of bacteria. This test is a cornerstone in the evaluation of male infertility and chronic pelvic pain. Bacteria in the semen can lead to 'leukocytospermia' (white blood cells in semen), which releases reactive oxygen species that damage sperm DNA and reduce motility. It is frequently ordered for patients suspected of having prostatitis, epididymitis, or orchitis, and for those experiencing painful ejaculation or blood in the semen (hematospermia).
  • Chronic Bacterial Prostatitis: Persistent infection of the prostate gland.
  • Male Infertility: Infections can cause ductal obstructions or direct sperm damage.
  • Asymptomatic Bacteriospermia: Presence of bacteria without overt symptoms, which can still affect fertility.
  • STIs: Detection of pathogens like Neisseria gonorrhoeae or Chlamydia (though specific PCR is often preferred).
View Interpretation
Metabolic

Serum Bicarbonate

Serum Bicarbonate (HCO3-) is a vital electrolyte and a critical component of the body's buffering system. It plays a central role in maintaining the pH of the blood within a very narrow, slightly alkaline range (7.35 to 7.45). Bicarbonate is primarily regulated by the kidneys, which excrete or reabsorb it to compensate for acid-base imbalances, and the lungs, which manage carbon dioxide (CO2) levels. This test is typically included in a Basic Metabolic Panel (BMP) or Comprehensive Metabolic Panel (CMP). It is used to evaluate the patient's electrolyte balance and respiratory or metabolic health. It is particularly important for patients with kidney disease, respiratory distress, or severe vomiting and diarrhea, as these conditions rapidly shift the body's acid-base status.
  • Metabolic Acidosis: Characterized by low bicarbonate levels; causes include diabetic ketoacidosis (DKA), kidney failure, and severe diarrhea.
  • Metabolic Alkalosis: Characterized by high bicarbonate levels; causes include prolonged vomiting (loss of stomach acid) and excessive use of diuretics.
  • Respiratory Compensation: In chronic lung diseases like COPD, the kidneys may retain bicarbonate to compensate for high CO2 levels (respiratory acidosis).
  • Renal Tubular Acidosis (RTA): A condition where the kidneys fail to properly acidify the urine, leading to low serum bicarbonate.
View Interpretation
Endocrinology

Serum C-Peptide

C-peptide is a byproduct created when the pancreas produces insulin. Proinsulin is cleaved into one molecule of insulin and one molecule of C-peptide. Because C-peptide is secreted in equimolar amounts to insulin but has a longer half-life and is not cleared by the liver as quickly, it provides a much more stable and accurate reflection of endogenous insulin production. This test is primarily used to distinguish between Type 1 and Type 2 Diabetes. In Type 1, the pancreas produces little to no insulin (and thus no C-peptide). In Type 2, the body is resistant to insulin, often resulting in normal or high C-peptide levels. It is also used to investigate the cause of hypoglycemia (low blood sugar)—for instance, to see if a patient is secreting too much of their own insulin (Insulinoma) or if they took too much exogenous insulin (where C-peptide would be low).
  • Type 1 Diabetes: Characterized by low or undetectable C-peptide.
  • Type 2 Diabetes/Insulin Resistance: Characterized by normal to high C-peptide.
  • Insulinoma: A pancreatic tumor that secretes excessive insulin and C-peptide.
  • Factitious Hypoglycemia: Use of external insulin causes low blood sugar but low C-peptide.
View Interpretation
Oncology

Serum CEA (Carcinoembryonic Antigen)

Carcinoembryonic Antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development, but production stops or decreases significantly after birth. In adults, elevated levels of CEA are often associated with certain types of cancer, particularly those originating in the gastrointestinal tract. While not used for general cancer screening due to its lack of specificity, it serves as a powerful biomarker for disease management. CEA is primarily used as a longitudinal tool rather than a diagnostic one:
  • Monitoring Treatment: To assess how well a patient is responding to cancer therapy (surgery, chemotherapy, or radiation).
  • Recurrence Surveillance: Following successful treatment, rising CEA levels are often the first sign that a cancer has returned, sometimes months before imaging can detect a tumor.
  • Prognosis: High baseline CEA levels at the time of diagnosis may correlate with a more advanced stage of cancer and a poorer clinical outlook.
  • Staging: Assisting in determining the extent of cancer spread, especially in colorectal malignancies.
Elevated CEA levels are most significantly associated with:
  • Colorectal Cancer: The primary use case for this marker.
  • Other Malignancies: Including pancreatic, lung, breast, and thyroid cancers.
  • Non-Malignant Conditions: CEA can also rise in benign conditions such as heavy smoking, inflammatory bowel disease (IBD), cirrhosis of the liver, and chronic obstructive pulmonary disease (COPD).
View Interpretation
Metabolic

Serum Ceruloplasmin

Ceruloplasmin is a ferroxidase enzyme that carries about 95% of the copper in the plasma. It is produced in the liver. Its primary role is to convert ferrous iron (Fe2+) to ferric iron (Fe3+), allowing iron to bind to transferrin for transport. It also plays a vital role in regulating copper metabolism. This test is primarily used as a screening tool for Wilson's Disease, a rare genetic disorder where copper accumulates in the liver, brain, and other vital organs. It may also be ordered for patients showing symptoms of copper deficiency or in the evaluation of unexplained liver disease or neurological symptoms (like tremors or psychiatric changes).
  • Wilson's Disease: Characterized by very low levels of ceruloplasmin.
  • Menkes Syndrome: A genetic disorder of copper absorption (low levels).
  • Liver Failure: Since the protein is made in the liver, advanced cirrhosis can lower levels.
  • Inflammatory States: Ceruloplasmin is an 'acute phase reactant,' meaning levels rise during infection, pregnancy, or trauma.
View Interpretation
Endocrinology

Serum Cortisol

Cortisol is often referred to as the 'stress hormone' and is a vital steroid hormone produced by the adrenal glands. It is regulated by the hypothalamic-pituitary-adrenal (HPA) axis. Its primary functions include regulating metabolism, reducing inflammation, assisting with memory formulation, and controlling the salt and water balance. It also plays a critical role in the 'fight or flight' response, increasing blood glucose to provide immediate energy during stressful situations. This test is primarily ordered when a healthcare provider suspects an overproduction or underproduction of cortisol. Symptoms of overproduction (Cushing's Syndrome) include rapid weight gain in the face and torso, high blood pressure, and skin changes. Symptoms of underproduction (Addison’s Disease) include fatigue, muscle weakness, loss of appetite, and low blood pressure. It is also used to monitor individuals being treated for adrenal or pituitary disorders.
  • Cushing's Syndrome: Caused by excess cortisol, often due to an adrenal tumor or a pituitary tumor (Cushing’s Disease).
  • Addison’s Disease: Primary adrenal insufficiency where the glands do not produce enough cortisol.
  • Secondary Adrenal Insufficiency: A problem with the pituitary gland's ability to signal the adrenals.
  • Ectopic ACTH Syndrome: Tumors outside the HPA axis producing ACTH.
View Interpretation
Metabolic

Serum Creatinine

Serum Creatinine is a waste product of muscle metabolism excreted primarily by the kidneys. When measured as part of a 24-Hour Urine Creatinine Clearance test, the serum level is paired with the urine level to calculate the volume of blood cleared of creatinine per unit of time. This provides a direct clinical measurement of the Glomerular Filtration Rate (GFR), which is more precise than estimation formulas in certain clinical scenarios.
View Interpretation
Metabolic

Serum Electrolytes

Electrolytes are electrically charged minerals found in your blood and other body fluids. They affect how your body functions in many ways, including the amount of water in your body, the acidity of your blood (pH), your muscle function, and other important processes. The primary electrolytes measured are Sodium (Na+), Potassium (K+), Chloride (Cl-), and Bicarbonate (HCO3-). This test is a staple in medical care, ordered for patients with acute illnesses, heart failure, kidney disease, or those experiencing symptoms like confusion, weakness, or cardiac arrhythmias. It is also used to monitor the effects of medications like diuretics (water pills) and blood pressure treatments.
  • Dehydration/Overhydration: Reflected primarily in sodium levels.
  • Kidney Failure: The kidneys are responsible for excreting excess potassium; failure leads to dangerous potassium buildup.
  • Hypertension: Often managed by monitoring sodium and potassium balance.
  • Metabolic Acidosis/Alkalosis: Indicated by abnormal bicarbonate and chloride levels.
Potassium is particularly critical; even slight deviations can impact the electrical signals of the heart, potentially leading to life-threatening heart rhythms.
View Interpretation
Hematology

Serum Electrophoresis

Serum Protein Electrophoresis (SPEP) is a laboratory technique used to separate proteins in the blood serum based on their net charge, size, and shape. By applying an electric field, the proteins migrate into five distinct fractions: Albumin, Alpha-1, Alpha-2, Beta, and Gamma globulins. This test provides a visual and quantitative profile of the body's protein status. SPEP is primarily used to screen for monoclonal gammopathies. It is ordered if a patient has symptoms of:
  • Unexplained bone pain or fractures.
  • Persistent anemia or fatigue.
  • Unexplained high calcium levels.
  • Recurrent infections.
  • Abnormal total protein or albumin levels on a metabolic panel.
  • Multiple Myeloma: Characterized by a sharp 'M-spike' in the Gamma or Beta region.
  • Waldenström Macroglobulinemia: A type of non-Hodgkin lymphoma.
  • Monoclonal Gammopathy of Undetermined Significance (MGUS): A precursor condition to myeloma.
  • Liver Disease: Cirrhosis often shows a 'Beta-Gamma bridge'.
  • Chronic Inflammation: Results in a broad-based increase in the gamma globulin fraction (polyclonal gammopathy).
View Interpretation
Endocrinology

Serum Estradiol

Estradiol (E2) is the most potent and prevalent form of estrogen in the human body. In non-pregnant females, it is primarily produced by the ovaries, while in males, it is produced in small amounts by the testes and through the conversion of testosterone in peripheral tissues (adipose). It is responsible for the development of secondary sexual characteristics, regulation of the menstrual cycle, and maintenance of bone density in both sexes. Serum Estradiol testing is fundamental in reproductive medicine. It is ordered to:
  • Assess ovarian function and egg reserve.
  • Monitor follicular development during In-Vitro Fertilization (IVF).
  • Investigate the cause of amenorrhea or abnormal menstrual bleeding.
  • Diagnose symptoms of menopause (hot flashes, night sweats).
  • Evaluate gynecomastia (breast tissue growth) in men.
  • Monitor hormone replacement therapy or anti-estrogen treatment in breast cancer patients.
Abnormal levels are linked to several clinical states. High levels in women can indicate ovarian tumors, PCOS (rarely E2 alone), or hyperthyroidism. In men, high E2 can lead to feminization and fertility issues. Low levels are characteristic of menopause, Turner syndrome, or significant weight loss and extreme exercise (hypothalamic amenorrhea).
View Interpretation
Hematology

Serum Ferritin

Ferritin is a blood protein that contains iron. It is the primary way your body stores iron for future use. The amount of ferritin in the blood (serum ferritin) is directly proportional to the total amount of iron stored in your body. It acts as a buffer against iron deficiency and iron overload. This test is fundamental for assessing iron status. It is ordered to:
  • Diagnose Anemia: Specifically to distinguish iron deficiency anemia from other types.
  • Monitor Iron Overload: In conditions like hemochromatosis.
  • Inflammation Marker: Since it is an acute-phase reactant, it rises during inflammation or infection.
  • Assess Nutritional Status: Especially in vegetarians, pregnant women, or those with malabsorption issues.
  • Iron Deficiency Anemia: Characterized by very low ferritin.
  • Hemochromatosis: A genetic disorder causing excessive iron absorption.
  • Chronic Kidney Disease: Often involves complex iron management.
  • Liver Disease: As ferritin is stored in the liver, damage can release it into the blood.
  • Still's Disease: Often presents with extremely high (thousands) ferritin levels.
Understanding ferritin levels is essential for determining if a patient requires iron supplementation or, conversely, iron removal (phlebotomy).
View Interpretation
Vitamins

Serum Folic Acid

Serum Folic Acid (Vitamin B9) is essential for the synthesis of DNA and RNA, the production of red blood cells, and the metabolism of amino acids. It is particularly crucial during periods of rapid cell division and growth, such as pregnancy and fetal development. Because the human body cannot synthesize folate, it must be obtained through diet (leafy greens, fruits, beans) or supplementation. This test is primarily used to diagnose the cause of anemia, specifically 'Megaloblastic Anemia,' where red blood cells are abnormally large and poorly functioning. It is also ordered to assess nutritional status in patients with malabsorption syndromes (like Celiac disease), chronic alcoholism, or those taking medications that interfere with folate metabolism (such as methotrexate). Testing is also vital for women planning pregnancy to ensure adequate levels to prevent neural tube defects.
  • Folate Deficiency Anemia: Leads to fatigue, weakness, and shortness of breath.
  • Malabsorption Syndromes: Conditions like Crohn's disease or Celiac disease that prevent nutrient uptake.
  • Neural Tube Defects: Low levels during early pregnancy are linked to spina bifida in infants.
  • Vitamin B12 Deficiency: Folate and B12 are closely linked; high folate can mask the neurological symptoms of a B12 deficiency.
Measuring folate levels ensures that deficiencies are corrected before they lead to permanent neurological or hematological damage.
View Interpretation
Hematology

Serum Haptoglobulin

Haptoglobin is a protein produced by the liver that functions as a scavenger for free hemoglobin in the blood. When red blood cells (RBCs) are destroyed (hemolysis), they release hemoglobin into the plasma. Free hemoglobin is toxic and can cause kidney damage. Haptoglobin binds to this free hemoglobin, forming a complex that is rapidly cleared by the liver. Physicians order the Serum Haptoglobin test when they suspect a patient is suffering from hemolytic anemia. It is usually part of a 'hemolysis panel' which includes LDH, Bilirubin, and a Reticulocyte count. Symptoms that trigger this test include:
  • Unexplained jaundice (yellowing of skin/eyes)
  • Dark or tea-colored urine
  • Fatigue and shortness of breath
  • Pale skin (pallor)
Conditions affecting haptoglobin levels include:
  • Autoimmune Hemolytic Anemia: The body's immune system destroys its own RBCs.
  • Transfusion Reactions: Incompatibility between donor and recipient blood.
  • Sickle Cell Disease or Thalassemia: Genetic disorders leading to abnormal RBC destruction.
  • Malaria: A parasitic infection that ruptures red blood cells.
  • Acute Phase Response: Since haptoglobin is also an acute-phase reactant, levels can rise during systemic inflammation or infection, potentially masking underlying hemolysis.
View Interpretation
Endocrinology

Serum Insulin

Insulin is a vital hormone produced by the beta cells of the pancreas. Its primary role is to regulate the amount of glucose (sugar) in the blood. It facilitates the transport of glucose from the bloodstream into the body's cells, where it is used for energy or stored for future use. The Serum Insulin test measures the concentration of this hormone in the blood, usually after a period of fasting. Doctors order this test to investigate the cause of hypoglycemia (low blood sugar), to monitor insulin production in patients with Type 2 diabetes, and to diagnose insulin resistance. It is often paired with a glucose test to calculate the HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) score.
  • Insulin Resistance: A condition where the body's cells do not respond effectively to insulin, leading to Metabolic Syndrome and Type 2 Diabetes.
  • Insulinoma: A rare, usually benign tumor of the pancreas that secretes excessive insulin, causing severe hypoglycemia.
  • Polycystic Ovary Syndrome (PCOS): Often associated with hyperinsulinemia and insulin resistance.
  • Type 1 Diabetes: Characterized by very low or absent insulin production due to autoimmune destruction of pancreatic cells.
Tracking insulin levels is crucial for managing metabolic health. High fasting insulin is often an early warning sign of metabolic dysfunction long before blood sugar levels actually rise to diabetic ranges.
View Interpretation
Metabolic

Serum Iron

Serum iron measures the amount of circulating iron that is bound to transferrin in the blood. Iron is a vital mineral required for the production of hemoglobin, the protein in red blood cells that carries oxygen from the lungs to the rest of the body. It also plays a key role in muscle metabolism and healthy connective tissue. This test is rarely used in isolation; it is typically part of an Iron Panel (including Ferritin and TIBC). It is ordered to:
  • Investigate the cause of anemia (low red blood cell count).
  • Evaluate suspected iron deficiency or iron overload (hemochromatosis).
  • Monitor the nutritional status of patients with chronic diseases.
  • Assess the effectiveness of iron supplementation therapy.
  • Iron Deficiency Anemia: Characterized by low serum iron, low ferritin, and high TIBC. It can be caused by blood loss, poor diet, or malabsorption (e.g., Celiac disease).
  • Hemochromatosis: A genetic condition where the body absorbs too much iron, leading to dangerously high levels that can damage the liver and heart.
  • Chronic Disease Anemia: Inflammation can cause the body to sequester iron, leading to low serum levels despite adequate total body stores.
  • Lead Poisoning: Can interfere with iron metabolism and hemoglobin synthesis.
  • Sideroblastic Anemia: Where the body has iron but cannot incorporate it into hemoglobin.
Understanding serum iron levels is the first step in diagnosing complex blood disorders and ensuring proper oxygenation of tissues.
View Interpretation
Hematology

Serum Iron

This test measures the amount of circulating iron that is bound to the transport protein transferrin. In the context of an Iron Deficiency Profile, it must be interpreted alongside Ferritin and TIBC. Iron is essential for hemoglobin synthesis; low levels lead to microcytic anemia, while excess levels can lead to organ damage (hemosiderosis).
View Interpretation
Metabolic

Serum Magnesium

Magnesium is a vital intracellular cation involved in over 300 enzymatic reactions in the human body. It plays a critical role in energy production (ATP), DNA synthesis, muscle contraction, and maintaining a steady heart rhythm. Physicians order serum magnesium to investigate:
  • Muscle weakness, tremors, or cramping.
  • Cardiac arrhythmias (irregular heartbeats).
  • Seizures or neurological irritability.
  • Malabsorption issues or chronic alcoholism.
  • Monitoring patients on certain medications like diuretics or proton pump inhibitors (PPIs).
  • Hypomagnesemia (Low): Often linked to chronic diarrhea, Crohn's disease, alcoholism, or excessive use of diuretics.
  • Hypermagnesemia (High): Primarily seen in advanced kidney failure or excessive intake of magnesium-containing antacids or laxatives.
Magnesium balance is tightly regulated by the kidneys. Because only about 1% of the body's total magnesium is found in the blood (the rest is in bones and cells), a serum test may sometimes show 'normal' levels even if total body stores are depleted.
View Interpretation
Metabolic

Serum Osmolality

Serum osmolality is a measure of the concentration of dissolved particles in the blood, primarily sodium, chloride, bicarbonate, proteins, glucose, and urea. It reflects the body's water-electrolyte balance. The body regulates osmolality tightly through Antidiuretic Hormone (ADH) and the thirst mechanism. This test is vital for evaluating hyponatremia (low sodium) and investigating disorders of water metabolism. It is also used to calculate the 'osmolal gap'—the difference between measured osmolality and calculated osmolality—which can help detect the presence of toxins like methanol, ethylene glycol (antifreeze), or isopropyl alcohol.
  • Dehydration: Leads to high concentration (high osmolality).
  • Diabetes Insipidus: A condition where the kidneys cannot conserve water, leading to high serum osmolality and dilute urine.
  • SIADH (Syndrome of Inappropriate ADH): The body retains too much water, diluting the blood and causing low osmolality.
  • Toxic Ingestion: Consumption of alcohols or glycols increases the number of particles in the blood, raising osmolality.
View Interpretation
Endocrinology

Serum Parathyroid Hormone (PTH)

Parathyroid Hormone (PTH) is secreted by the four parathyroid glands located in the neck. Its primary role is to maintain stable concentrations of calcium in the blood. When calcium levels drop, the parathyroid glands release PTH, which acts on the bones (releasing calcium), the kidneys (reducing calcium excretion), and the intestines (increasing calcium absorption via Vitamin D activation). This test is crucial for investigating the cause of abnormal calcium levels (hypocalcemia or hypercalcemia). It is also used to monitor patients with chronic kidney disease (CKD), as they often develop secondary hyperparathyroidism. Evaluating PTH helps distinguish between problems originating in the parathyroid glands versus other issues like Vitamin D deficiency or malignancy.
  • Primary Hyperparathyroidism: Usually caused by a benign tumor on the gland, leading to high PTH and high calcium.
  • Secondary Hyperparathyroidism: Occurs when the body raises PTH to compensate for low calcium, often due to Vitamin D deficiency or kidney failure.
  • Hypoparathyroidism: Low PTH levels resulting in low calcium, often following neck surgery or autoimmune damage.
View Interpretation
Metabolic

Serum Phosphorus

Phosphorus is a vital mineral that works closely with calcium to build strong bones and teeth. Beyond its structural role, it is a key component of DNA, RNA, and ATP (the body's primary energy molecule). It also helps regulate the body’s acid-base balance and facilitates muscle contraction and nerve signaling. Serum Phosphorus testing is frequently ordered to investigate kidney disorders, as the kidneys are responsible for excreting excess phosphorus. It is also used to evaluate bone health, parathyroid gland function, and nutritional status. Patients with chronic kidney disease (CKD), diabetes, or those receiving intravenous nutrition (TPN) are monitored closely for phosphorus imbalances.
  • Chronic Kidney Disease: The most common cause of high phosphorus (hyperphosphatemia) due to reduced excretion.
  • Hyperparathyroidism: Overactive parathyroid glands lead to low phosphorus levels by increasing urinary excretion.
  • Vitamin D Deficiency: Reduced Vitamin D leads to poor intestinal absorption of phosphorus.
  • Diabetic Ketoacidosis: Can cause significant shifts in phosphorus levels between intracellular and extracellular compartments.
  • Malnutrition/Alcoholism: Often leads to depleted total body phosphorus stores.
View Interpretation
Endocrinology

Serum Progesterone

Progesterone is a steroid hormone primarily produced by the corpus luteum in the ovaries during the second half of the menstrual cycle and by the placenta during pregnancy. Its chief role is to prepare the endometrial lining of the uterus for the implantation of a fertilized egg and to maintain the pregnancy.
  • Ovulation Confirmation: A mid-luteal phase (Day 21) test is the gold standard for confirming that ovulation has occurred.
  • Infertility Evaluation: To check if the corpus luteum is producing enough hormone to support a potential pregnancy.
  • Early Pregnancy Monitoring: To assess the risk of miscarriage or ectopic pregnancy if a patient experiences spotting or pain.
  • Abnormal Uterine Bleeding: To evaluate hormonal imbalances in non-pregnant women.
Low progesterone levels are associated with 'Luteal Phase Deficiency,' which can prevent implantation or lead to early pregnancy loss. It is also low in cases of ectopic pregnancy. High levels are seen during normal pregnancy, multiple gestations (twins), and occasionally in rare types of ovarian cysts or adrenal tumors. In men, progesterone is produced in small amounts by the adrenal glands and testes, serving as a precursor to testosterone and cortisol. In women, levels fluctuate wildly based on the phase of the menstrual cycle, necessitating precise timing for accurate interpretation.
View Interpretation
Endocrinology

Serum Prolactin

Prolactin is a hormone produced by the anterior pituitary gland in the brain. Its primary biological role is to stimulate and maintain lactation (breast milk production) in women after childbirth. However, it also plays a role in reproductive health, immune regulation, and metabolic homeostasis in both men and women. In non-pregnant individuals, prolactin levels are usually kept low by dopamine, a brain chemical that inhibits prolactin secretion. Clinicians order a prolactin test for several reasons:
  • In Women: To investigate unexplained nipple discharge (galactorrhea), irregular menstrual cycles (amenorrhea), or infertility.
  • In Men: To evaluate decreased libido, erectile dysfunction, or gynecomastia (breast tissue enlargement).
  • Both Sexes: To screen for a pituitary tumor called a prolactinoma, which can cause vision problems and headaches due to its location near the optic nerve.
  • Monitoring: To track the effectiveness of dopamine agonist medications.
  • Prolactinoma: A benign tumor of the pituitary gland that overproduces prolactin.
  • Hyperprolactinemia: High levels that can interfere with the production of estrogen and testosterone, leading to bone loss or sexual dysfunction.
  • Hypothyroidism: Low thyroid hormone levels can trigger an increase in Thyroid-Releasing Hormone (TRH), which also stimulates prolactin release.
  • Polycystic Ovary Syndrome (PCOS): Sometimes associated with mild prolactin elevations.
  • Kidney or Liver Disease: Reduced clearance of the hormone can lead to elevated levels.
View Interpretation
Immunology

Serum Protein Electrophoresis

Serum Protein Electrophoresis (SPEP) is a laboratory technique that separates proteins in the blood based on their electrical charge and size. It divides proteins into five main fractions: Albumin, Alpha-1, Alpha-2, Beta, and Gamma globulins. This 'map' of proteins helps identify imbalances in immune function and nutrition. Doctors order an SPEP when they suspect conditions that affect protein production, such as multiple myeloma or other 'plasma cell dyscrasias.' It is also useful for investigating unexplained high total protein, high calcium, or low white blood cell counts.
  • Multiple Myeloma: Characterized by an 'M-Spike' in the Gamma or Beta region.
  • MGUS: Monoclonal Gammopathy of Undetermined Significance.
  • Inflammation: Increases in Alpha globulins.
  • Liver Disease: Seen as 'Beta-Gamma bridging' in cirrhosis.
View Interpretation
Metabolic

Serum Sodium

Sodium is the primary extracellular electrolyte and is vital for maintaining fluid balance, blood pressure, and the proper functioning of nerves and muscles. It works in tandem with potassium and chloride to regulate the body's electrical signals. This test is a staple of the Basic Metabolic Panel (BMP) and is used to:
  • Investigate symptoms of confusion, lethargy, or weakness.
  • Monitor patients taking diuretics or blood pressure medications.
  • Evaluate kidney function and adrenal health.
  • Assess hydration status in cases of severe vomiting or diarrhea.
  • Hyponatremia (Low): Can be caused by SIADH (Syndrome of Inappropriate Antidiuretic Hormone), heart failure, liver cirrhosis, or excessive water intake.
  • Hypernatremia (High): Usually caused by dehydration, diabetes insipidus, or excessive salt intake.
  • Kidney Disease: The kidneys are the primary regulators of sodium excretion; dysfunction leads to imbalances.
Sodium levels are critical because rapid changes can cause brain cells to swell (hyponatremia) or shrink (hypernatremia), leading to permanent neurological damage or death. Correction of sodium imbalances must be done slowly and carefully by medical professionals.
View Interpretation
Hematology

Serum Total Iron Binding Capacity

Total Iron Binding Capacity (TIBC) is a blood test that measures the blood's capacity to bind iron with transferrin. Transferrin is a protein produced by the liver that transports iron throughout the body. TIBC indirectly measures the amount of transferrin available in the blood. Physicians order TIBC when they suspect iron deficiency or iron overload (hemochromatosis). It is rarely ordered alone and is usually part of an 'Iron Panel' that includes serum iron, ferritin, and transferrin saturation. Symptoms justifying this test include chronic fatigue, pale skin (pallor), dizziness, or joint pain.
  • Iron Deficiency Anemia: In this state, the body produces more transferrin to 'hunt' for scarce iron, leading to an elevated TIBC.
  • Hemochromatosis: A genetic condition where the body stores too much iron; here, transferrin sites are saturated, leading to a low TIBC.
  • Anemia of Chronic Disease: Conditions like cancer or chronic infections often show low TIBC because the body purposefully sequesters iron away from pathogens.
  • Liver Disease: Since the liver produces transferrin, cirrhosis or hepatitis can lead to decreased TIBC levels.
Understanding TIBC helps differentiate between different types of anemia, which is vital because treating the wrong type of anemia with iron supplements can be toxic.
View Interpretation
Hematology

Serum Transferrin

Transferrin is the main protein in the blood that binds to iron and transports it throughout the body. It is synthesized in the liver. By measuring transferrin, clinicians can assess the body's iron-carrying capacity. It is inversely related to iron stores; when iron stores are low, the liver produces more transferrin to maximize iron transport. It is ordered as part of an iron panel (including Ferritin and TIBC) to evaluate suspected iron deficiency anemia, iron overload (hemochromatosis), or to monitor nutritional status. It is a 'negative acute-phase reactant,' meaning its levels drop during inflammation or chronic disease.
  • Iron Deficiency Anemia: High transferrin, low iron.
  • Hemochromatosis: Low transferrin due to iron saturation.
  • Liver Disease: Decreased production of the protein.
  • Protein-Energy Malnutrition: Reduced synthesis due to lack of amino acids.
View Interpretation
Metabolic

Serum Uric Acid

Uric acid is a waste product created when the body breaks down purines—natural substances found in the body's cells and in many foods (like red meat, organ meats, and seafood). Most uric acid dissolves in the blood, travels to the kidneys, and leaves the body through urine. If the body produces too much or the kidneys excrete too little, uric acid levels rise. The primary reason for ordering this test is to diagnose and monitor Gout, a form of arthritis characterized by the crystallization of uric acid in the joints. It is also used to monitor patients undergoing chemotherapy or radiation (which causes rapid cell turnover and purine release) and to investigate the cause of recurrent kidney stones.
  • Gout: High levels lead to needle-like crystals in joints (often the big toe).
  • Urolithiasis (Kidney Stones): Uric acid crystals can form stones in the urinary tract.
  • Tumor Lysis Syndrome: A medical emergency where cancer treatment causes a massive release of uric acid into the blood.
  • Renal Failure: The kidneys lose the ability to clear uric acid from the bloodstream.
Diet plays a significant role in uric acid levels. High-fructose corn syrup, alcohol (especially beer), and purine-rich foods can significantly spike levels, making dietary management a cornerstone of treatment for hyperuricemia.
View Interpretation
Vitamins

Serum Vitamin B12

Vitamin B12 (Cobalamin) is an essential nutrient required for proper red blood cell formation, neurological function, and DNA synthesis. Since the body cannot produce B12, it must be obtained from animal-based foods or fortified supplements. It is bound to intrinsic factor in the stomach and absorbed in the small intestine. This test is used to investigate several symptoms and conditions:
  • Anemia: Specifically Megaloblastic/Macrocytic anemia, where red blood cells are abnormally large.
  • Neuropathy: Numbness, tingling, or weakness in the hands and feet.
  • Cognitive Issues: Memory loss or confusion.
  • Malabsorption screening: For patients with Crohn's or Celiac disease.
  • Pernicious Anemia: An autoimmune condition where the body lacks intrinsic factor.
  • Vitamin B12 Deficiency: Common in strict vegans or those with reduced stomach acid (common in the elderly).
  • Hypervitaminosis B12: High levels, often from over-supplementation or underlying liver/kidney issues.
View Interpretation
Endocrinology

Sex Hormone Binding Globulin (SHBG)

SHBG is a protein produced by the liver that binds tightly to three sex hormones: testosterone, dihydrotestosterone (DHT), and estradiol. While bound to SHBG, these hormones are 'inactive' and cannot be used by the body's tissues. Therefore, SHBG acts as a regulator, controlling the amount of 'free' or bioavailable hormones circulating in the blood. This test is rarely ordered alone; it is usually part of a 'Free Testosterone Index' or used to investigate symptoms of hormone imbalance. In women, it is used to evaluate Poly cystic Ovary Syndrome (PCOS) or hirsutism (excess hair growth). In men, it helps explain why a patient might have symptoms of low testosterone despite having 'normal' total testosterone levels.
  • PCOS: Often associated with low SHBG and high free testosterone.
  • Hyperthyroidism: Frequently causes high SHBG levels.
  • Liver Cirrhosis: Can cause significant elevations in SHBG.
  • Insulin Resistance: High insulin levels typically suppress SHBG production.
A high SHBG level means more testosterone is 'locked up' and unavailable, which can lead to symptoms of androgen deficiency in men. Conversely, low SHBG means more free testosterone is available, which in women can lead to acne, weight gain, and menstrual irregularities.
View Interpretation
Immunology

Shrimp Specific IgE

This test measures the concentration of IgE antibodies specifically directed against shrimp allergens (e.g., Pen a 1, tropomyosin). In the context of an Allergy Profile, it identifies Type I immediate hypersensitivity. It is used to assess the risk of clinical allergy, which can range from mild urticaria to life-threatening anaphylaxis. High levels correlate with a higher probability of a symptomatic reaction upon exposure.
View Interpretation
Infectious Disease

Skin Clip For A.F.B. (Acid-Fast Bacilli)

An Acid-Fast Bacilli (AFB) skin clip or slit-skin smear is a specialized microbiological test used to detect bacteria that have waxy cell walls, making them resistant to standard Gram staining. This test specifically looks for organisms like Mycobacterium leprae (the cause of leprosy) or other atypical mycobacteria. This test is ordered when a patient presents with suspicious skin lesions, localized loss of sensation, or thickened nerves. It is the gold standard for classifying and monitoring the treatment of Leprosy (Hansen's Disease). The 'clip' or 'smear' involves taking a small sample of tissue fluid from the dermis of the earlobes or the lesion itself.
  • Leprosy (Hansen’s Disease): Categorized into paucibacillary (low bacterial load) or multibacillary (high load) based on the AFB results.
  • Buruli Ulcer: Caused by Mycobacterium ulcerans.
  • Atypical Mycobacterial Infections: Chronic skin infections that do not respond to standard antibiotics.
The test is repeated periodically during multi-drug therapy (MDT) to ensure the Bacteriological Index is decreasing, indicating successful treatment.
View Interpretation
Microbiology

Skin Clip For AFB/Ear

The Skin Clip (or Slit-Skin Smear) for Acid-Fast Bacilli (AFB) is a specialized diagnostic test used primarily to detect Mycobacterium leprae, the causative agent of Leprosy (Hansen's Disease). The procedure involves taking a small scrape or 'clip' from the earlobe or skin lesions to look for bacteria that retain red dye after an acid wash (Acid-Fast). It is ordered when a patient presents with suspicious dermatological and neurological symptoms, such as:
  • Hypopigmented Patches: Skin areas that have lost color and, crucially, lost sensation.
  • Thickened Nerves: Enlargement of peripheral nerves (e.g., ulnar or peroneal).
  • Nodules: Skin-colored or reddish lumps on the face or ears.
  • Loss of Eyebrows: A classic sign of advanced lepromatous leprosy.
  • Paucibacillary Leprosy: A form with few bacteria where the smear might be negative despite disease presence.
  • Multibacillary Leprosy: A more severe form where the smear is usually strongly positive.
  • Atypical Mycobacterial Infections: Rarely, other acid-fast organisms can be found in the skin.
This test is essential for classifying the type of leprosy, which determines the duration and intensity of the Multi-Drug Therapy (MDT) required for a cure.
View Interpretation
Microbiology

Skin Clip for A.F.B. 4 Sites

The Skin Clip or Slit-Skin Smear (SSS) for Acid-Fast Bacilli (A.F.B.) is a specialized diagnostic procedure primarily used to detect Mycobacterium leprae, the causative agent of leprosy (Hansen's disease). Unlike Mycobacterium tuberculosis, M. leprae cannot be cultured in vitro, making microscopic examination of skin samples essential for diagnosis and classification. This test is ordered when a patient presents with suspicious skin lesions, localized loss of sensation, or thickened nerves. By taking samples from four different sites—typically the earlobes and active lesion borders—clinicians can calculate the Bacteriological Index (BI), which quantifies the bacterial load, and the Morphological Index (MI), which assesses the viability of the bacilli. It is crucial for:
  • Confirming a diagnosis of leprosy.
  • Distinguishing between Paucibacillary (PB) and Multibacillary (MB) forms of the disease.
  • Monitoring the effectiveness of Multi-Drug Therapy (MDT).
  • Identifying potential relapses in treated patients.
  • Lepromatous Leprosy: Characterized by high bacterial loads (High BI) and widespread skin involvement.
  • Tuberculoid Leprosy: Characterized by few or no visible bacilli (Low or Zero BI) but strong immune response.
  • Atypical Mycobacterial Infections: Occasionally, other acid-fast organisms can be identified in skin samples, requiring correlation with clinical findings.
  • Erythema Nodosum Leprosum (ENL): A type 2 reaction in leprosy patients that may necessitate repeat testing to monitor bacterial clearance.
View Interpretation
Dermatology

Skin Clipping (3 Sites)

A skin clipping test involves taking small pieces of the stratum corneum (the outermost layer of skin) or nail fragments from three distinct anatomical sites. These samples are then examined microscopically, often using a KOH (potassium hydroxide) prep or specialized stains, to identify fungal hyphae, yeast, or parasites. Dermatologists order this when a patient presents with persistent rashes, thickening of the skin, or nail discoloration. Sampling three sites increases the 'diagnostic yield,' as fungal infections like tinea corporis or parasites like scabies may not be uniformly distributed across the body. It is particularly useful for diagnosing onychomycosis (nail fungus) and distinguishing it from psoriasis.
  • Onychomycosis: Fungal infection of the nails.
  • Tinea Pedis/Corporis: Athlete's foot or ringworm.
  • Scabies: A parasitic infestation of mites.
  • Candidiasis: Yeast infections in skin folds.
The results guide therapy. If fungal elements are found, topical or oral antifungals are prescribed. If the test is negative despite symptoms, the clinician may look for non-infectious causes like eczema or lichen planus. Using three sites ensures that a single localized 'miss' doesn't result in an incorrect diagnosis.
View Interpretation
Microbiology

Skin Scraping For Fungal Culture

The Skin Scraping for Fungal Culture is a diagnostic laboratory procedure used to identify pathogenic fungi infecting the skin, hair, or nails. Unlike a rapid KOH (potassium hydroxide) prep which provides immediate but preliminary results, a culture allows for the specific identification of the fungal species (genus and species) by growing the organism in a controlled environment over several weeks. Physicians order this test when a patient presents with symptoms of a superficial fungal infection (dermatomycosis) that does not respond to standard treatments or when the exact species must be known to tailor systemic antifungal therapy. It is commonly used to diagnose conditions like Tinea Pedis (athlete's foot), Tinea Corporis (ringworm), and Onychomycosis (nail fungus). It is also critical for differentiating fungal infections from other skin conditions like psoriasis or eczema which can mimic fungal presentations.
  • Dermatophytosis: Infections caused by fungi like Trichophyton, Microsporum, or Epidermophyton.
  • Candidiasis: Yeast infections caused by Candida species in skin folds or intertriginous areas.
  • Tinea Versicolor: A common condition caused by Malassezia furfur.
  • Deep Fungal Infections: In rare cases, skin scrapings can help identify systemic fungi manifesting on the skin in immunocompromised individuals.
View Interpretation
Microbiology

Skin Scraping For Fungal Elements

Skin Scraping for Fungal Elements, often involving a KOH (Potassium Hydroxide) preparation, is a diagnostic procedure used to visualize fungal structures such as hyphae, budding yeast cells, or spores. The KOH dissolves the keratin in the skin cells, making it easier to see the fungi under a microscope. This is the primary method for confirming superficial fungal infections. This test is ordered when a patient presents with skin lesions that are itchy, red, scaly, or ring-shaped. It is used to differentiate fungal infections from other skin conditions like psoriasis or eczema, which may look similar but require entirely different treatments. It is also used to diagnose infections of the nails (onychomycosis) or hair.
  • Tinea Corporis (Ringworm): Fungal infection of the body skin.
  • Tinea Pedis (Athlete's Foot): Infection of the feet and toe webs.
  • Candidiasis: Yeast infection caused by Candida species, often in skin folds.
  • Tinea Versicolor: A common fungal infection that causes small, discolored patches of skin.
  • Onychomycosis: Fungal infection of the fingernails or toenails.
View Interpretation
Microbiology

Skin Scraping for Culture & Sensitivity

Skin scraping for culture and sensitivity is a laboratory procedure used to identify the specific pathogens—bacteria or fungi—causing a skin infection and to determine which antimicrobial agents are most effective against them. While a visual examination or a KOH prep can provide immediate clues, a culture is the 'gold standard' for definitive identification of the infectious agent. This test is ordered when a patient presents with persistent or atypical skin lesions, such as rashes, ulcers, or plaques, that do not improve with empirical treatment. It is specifically used for:
  • Dermatophytosis (Ringworm): Identifying the specific fungus to determine the length of treatment.
  • Chronic Wound Infections: Especially in diabetic patients or those with venous stasis ulcers.
  • Refractory Folliculitis: To check for resistant strains of bacteria like MRSA.
  • Atypical Mycobacterial Infections: Which require specialized culture media and longer incubation periods.
The test is associated with various dermatological conditions including Tinea corporis, Tinea capitis, and Onychomycosis (nail fungus). It is also crucial in diagnosing bacterial pyodermas and secondary infections in chronic inflammatory conditions like eczema or psoriasis. By performing a 'sensitivity' or susceptibility test, the lab provides a roadmap for treatment, ensuring the clinician prescribes an antibiotic or antifungal that will actually kill the identified organism, thereby reducing the risk of antibiotic resistance.
View Interpretation
Infectious Disease

Slit Skin Smear (1 Site)

A Slit Skin Smear (SSS) is a specialized diagnostic procedure used to detect Acid-Fast Bacilli (AFB), specifically Mycobacterium leprae. Unlike a standard biopsy, this procedure involves making a small, shallow slit in the skin and scraping the internal edges to obtain tissue fluid (serum) and cells, which are then stained using the Ziehl-Neelsen method. This test is the definitive bedside tool for diagnosing and classifying Leprosy (Hansen’s Disease). It is ordered to:
  • Confirm Leprosy: When a patient presents with anesthetic skin patches or thickened nerves.
  • Classification: Differentiating between Paucibacillary (PB) leprosy (smear negative) and Multibacillary (MB) leprosy (smear positive).
  • Monitor Treatment: Assessing the reduction in bacterial load during Multi-Drug Therapy (MDT).
  • Assess Infectivity: Determining the bacterial index (BI) and Morphological Index (MI).
  • Hansen's Disease (Leprosy): The primary indication.
  • Atypical Mycobacterial Infections: Occasionally used if other skin infections are suspected, though less common.
  • Differential Diagnosis: Used to rule out Leishmaniasis or Sarcoidosis which can mimic leprosy clinically.
View Interpretation
Microbiology

Slit Skin Smear (2 Site)

The Slit Skin Smear (SSS) is a microscopic examination used to detect Acid-Fast Bacilli (AFB), specifically Mycobacterium leprae, the causative agent of Leprosy (Hansen's Disease). By taking samples from specific sites (often earlobes and active skin lesions), clinicians can visualize the density and morphology of the bacteria. This test is ordered when a patient presents with suspicious skin lesions characterized by loss of sensation, or thickened nerves. It is used to confirm a diagnosis of leprosy, classify the disease into Paucibacillary (PB) or Multibacillary (MB) types, and monitor the response to Multi-Drug Therapy (MDT). The Bacteriological Index (BI) provides a logarithmic scale of the bacterial density.
  • Lepromatous Leprosy: Usually shows high BI (many bacilli).
  • Tuberculoid Leprosy: Often shows zero or very low BI despite clinical symptoms.
  • Relapse: An increase in BI after successful treatment may indicate a relapse.
View Interpretation
Microbiology

Slit Skin Smear (3 Site)

The Slit Skin Smear (SSS) is a specialized diagnostic test used primarily for the detection and monitoring of Mycobacterium leprae, the bacterium that causes Leprosy (Hansen's Disease). Unlike many other infections, M. leprae cannot be grown in laboratory cultures, making the microscopic examination of skin smears a vital clinical tool. This test is ordered when a patient presents with suspicious skin lesions—such as pale or reddish patches with loss of sensation—or thickened nerves. The "3 Site" protocol usually involves taking samples from both earlobes and a prominent skin lesion. This increases the sensitivity of the test, as the bacterial load can vary across different parts of the body.
  • Lepromatous Leprosy: Characterized by high bacterial loads (Multibacillary).
  • Tuberculoid Leprosy: Characterized by low or absent bacterial loads on smears (Paucibacillary).
  • Hansen’s Disease reactions: SSS helps monitor the progress of Multidrug Therapy (MDT).
The results are reported as the Bacteriological Index (BI), a logarithmic scale ranging from 0 to 6+ that quantifies the density of bacilli in the smear. A Morphological Index (MI) may also be reported, which indicates the percentage of solid-staining (viable) bacilli versus fragmented (dead) bacilli, helping to assess the effectiveness of ongoing treatment.
View Interpretation
Infectious Disease

Slit Skin Smear (4 Site)

The Slit Skin Smear (SSS) is a specialized diagnostic test used primarily for the detection and quantification of Mycobacterium leprae, the causative agent of Leprosy (Hansen’s Disease). Unlike a standard biopsy, this test involves making small, shallow incisions at specific sites to collect tissue fluid and cells from the dermis, which are then stained and examined under a microscope. It is ordered when a patient presents with skin lesions showing loss of sensation, thickened nerves, or nodules suspicious of leprosy. The '4-site' protocol usually includes both earlobes and two active skin lesions (or the elbows/knees) to increase the diagnostic yield. It helps in:
  • Classification: Differentiating between Paucibacillary (PB) and Multibacillary (MB) leprosy.
  • Treatment Monitoring: Assessing the response to Multi-Drug Therapy (MDT).
  • Relapse Detection: Determining if a treated patient has active bacteria again.
  • Tuberculoid Leprosy: Low bacterial load, often negative smears.
  • Lepromatous Leprosy: High bacterial load, strongly positive smears.
  • Atypical Mycobacterial Infections: Occasionally can cause confusion, though clinical presentation differs.
Results are reported using the Bacterial Index (BI), a logarithmic scale ranging from 0 to 6+. A BI of 0 means no bacilli were found in 100 oil-immersion fields. A high BI (e.g., 4+ to 6+) indicates a high bacterial load. The Morphological Index (MI) may also be reported, which measures the percentage of solid-staining (viable) bacilli versus fragmented (dead) ones, helping to gauge the effectiveness of ongoing treatment.
View Interpretation
Pathology

Small Biopsy

A small biopsy involves the removal of a tiny piece of tissue from the body for microscopic examination by a pathologist. This procedure provides a definitive look at the cellular architecture of an organ or lesion, allowing for a level of diagnostic certainty that blood tests or imaging cannot provide. Biopsies are the 'gold standard' for diagnosing cancer. They are also ordered to investigate unexplained masses, persistent inflammation, or to determine the severity of organ disease (such as liver cirrhosis or kidney inflammation). If a screening test like a mammogram or a colonoscopy finds an abnormality, a small biopsy is the next logical step.
  • Malignancy: Identification of carcinomas, sarcomas, or lymphomas.
  • Benign Tumors: Differentiating non-cancerous growths from cancerous ones.
  • Autoimmune Diseases: Identifying patterns of tissue damage characteristic of conditions like Celiac disease or Lupus.
  • Infections: Detecting fungi, parasites, or specific bacterial signatures within tissue.
View Interpretation
Microbiology

Smear for AFB

The Acid-Fast Bacilli (AFB) smear is a rapid microscopic examination used to detect bacteria that have a 'waxy' cell wall containing mycolic acid. These bacteria do not stain well with standard Gram stains but retain red dye even after being washed with acid (hence 'acid-fast'). The most clinically relevant AFB is Mycobacterium tuberculosis. The test is ordered for patients presenting with symptoms of pulmonary tuberculosis (TB), such as a chronic cough (lasting more than 3 weeks), coughing up blood, night sweats, unexplained weight loss, and fever. It is a critical public health tool because a 'smear-positive' patient is generally highly infectious to others.
  • Tuberculosis (TB): The primary condition diagnosed via AFB smear.
  • Nontuberculous Mycobacteria (NTM): Other species like M. avium complex can cause lung disease, particularly in immunocompromised individuals (e.g., those with HIV/AIDS).
  • Leprosy: Caused by Mycobacterium leprae, though this usually requires a skin biopsy smear rather than sputum.
  • Treatment Monitoring: The test is repeated during TB treatment to ensure the bacterial load is decreasing and the patient is becoming non-infectious.
View Interpretation
Microbiology

Smear for Gram Stain

The Gram Stain is one of the most critical and rapid tests in microbiology. It uses a series of dyes (Crystal Violet, Iodine, Alcohol, and Safranin) to categorize bacteria into two large groups based on the chemical and physical properties of their cell walls: Gram-positive (which turn purple) and Gram-negative (which turn pink/red). Time is of the essence in treating severe infections like sepsis, meningitis, or pneumonia. While a culture can take 48-72 hours to yield results, a Gram Stain can be performed in minutes. It provides the physician with an immediate 'first look' at the type of bacteria present, allowing them to start 'empiric' antibiotic therapy—choosing a drug that specifically targets the visible category of bacteria. A Gram Stain is performed on samples from suspected infection sites, including:
  • Sputum: To diagnose bacterial pneumonia.
  • Cerebrospinal Fluid (CSF): To diagnose bacterial meningitis.
  • Wound/Abscess Pus: To identify skin infections like MRSA.
  • Urine: To identify complicated UTIs. Beyond just identifying bacteria, the smear also reports the presence of white blood cells (neutrophils), which confirms the body is currently fighting an inflammatory or infectious process at that site.
View Interpretation
Immunology

Smooth Muscle Antibody (ASMA)

ASMA is an autoantibody directed against the cytoskeleton of smooth muscle cells (primarily F-actin). In an Autoimmune Hepatitis Panel, it is a hallmark marker for Type 1 Autoimmune Hepatitis (AIH). High titers, especially in conjunction with elevated liver enzymes and IgG, are highly suggestive of AIH, an inflammatory liver condition where the immune system attacks hepatocytes.
View Interpretation
Metabolic

Sodium

Sodium is the primary extracellular cation and is essential for maintaining osmotic pressure, water distribution, and electrical signaling in nerves and muscles. In a Basic Kidney Profile, sodium levels reflect the balance between dietary intake, renal excretion, and total body water. Abnormalities often indicate issues with renal tubular function, hydration status, or hormonal regulation (specifically ADH and aldosterone).
View Interpretation
Metabolic

Sodium

Sodium is the primary extracellular cation and is critical for maintaining osmotic pressure, fluid balance, and transmembrane potential for nerve and muscle function. In the Serum Electrolyte panel, it is the most important indicator of water balance versus solute balance in the body.
View Interpretation
Metabolic

Sodium, Urine (24-Hour)

Urine Sodium measurement is a vital tool in assessing renal handling of electrolytes and volume status. In the Urine Electrolytes panel, it is primarily used to differentiate between renal and extra-renal causes of hyponatremia or acute kidney injury. It helps determine if the kidneys are appropriately conserving sodium (in response to depletion) or wasting it (due to tubular damage or hormonal imbalances like SIADH).
View Interpretation
Immunology

Soluble Liver Antigen (SLA) Antibody

The SLA antibody is a highly specific marker for Type 1 Autoimmune Hepatitis (AIH). While only present in about 10-30% of AIH patients, its presence is nearly 100% specific for the diagnosis. It is often the only marker present in 'seronegative' AIH patients and is frequently associated with a more severe disease course and a higher likelihood of relapse after corticosteroid withdrawal.
View Interpretation
Allergy and Immunology

Soybean Specific IgE

Measures IgE antibodies against soybean proteins. Soy is one of the 'Big Eight' food allergens. This component is vital in a comprehensive allergy profile to diagnose food-induced allergic rhinitis, asthma, or gastrointestinal symptoms. It is particularly important for pediatric patients and those on vegetarian diets where soy is a primary protein source.
View Interpretation
Immunology

Soybean Specific IgE

This test measures the concentration of Immunoglobulin E (IgE) antibodies directed specifically against soybean proteins. In an Allergy Profile, it identifies Type I hypersensitivity. Soy is a common allergen, and sensitization can lead to symptoms ranging from mild urticaria (hives) to life-threatening anaphylaxis. It is particularly relevant in pediatric populations and patients with atopic dermatitis.
View Interpretation
Metabolic

Specific Gravity

Specific Gravity (SG) measures the concentration of particles (solutes) in the urine compared to distilled water. It assesses the kidneys' ability to concentrate or dilute urine, reflecting hydration status and renal tubular function. Within a Complete Urine Examination, SG provides context for other findings; for instance, a high SG makes trace protein more significant than if the urine were highly dilute.
View Interpretation
Nephrology

Specific Gravity

Specific Gravity (SG) measures the ratio of the density of urine to the density of water. It is a key indicator of the kidney's ability to concentrate or dilute urine, reflecting the patient's hydration status and the functional integrity of the renal tubules. It is particularly useful in evaluating Diabetes Insipidus or the Syndrome of Inappropriate Antidiuretic Hormone (SIADH).
View Interpretation
Immunology

Specific IgE - Alternaria alternata (Mold)

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies in the serum directed against Alternaria alternata, one of the most common outdoor molds associated with asthma and allergic rhinitis. Alternaria spores are highly allergenic and often peak in late summer and autumn. High levels of specific IgE indicate 'sensitization' to this mold. Within an Allergy Profile, this result helps clinicians correlate respiratory symptoms with specific environmental triggers, allowing for targeted allergen avoidance or immunotherapy (allergy shots).
View Interpretation
Immunology

Specific IgE - Amoxicillin

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies to Amoxicillin in the serum. It is used to evaluate patients suspected of having a Type I immediate hypersensitivity reaction to this specific penicillin-class antibiotic. In an 'Allergy Profile With Drugs', this helps distinguish between a true IgE-mediated allergy (which carries a risk of anaphylaxis) and a non-allergic drug reaction (like a delayed maculopapular rash).
View Interpretation
Immunology

Specific IgE - Ampicillin

This test measures the concentration of allergen-specific IgE antibodies to Ampicillin in the serum. Ampicillin is a beta-lactam antibiotic, and Type I hypersensitivity reactions are mediated by IgE binding to mast cells and basophils. In the context of a drug allergy profile, this test helps differentiate between a true IgE-mediated allergy (which carries a risk of anaphylaxis) and non-immunological drug intolerances or delayed-type hypersensitivity (Type IV). A positive result suggests sensitization, meaning the immune system has identified the drug as a foreign invader.
View Interpretation
Immunology

Specific IgE - Cat Dander

This test measures the concentration of Immunoglobulin E (IgE) antibodies specific to cat dander proteins (primarily Fel d 1). Unlike a Total IgE, which indicates general allergic tendency, the Specific IgE confirms sensitization to a specific allergen, helping clinicians correlate symptoms with environmental triggers.
View Interpretation
Immunology

Specific IgE - Cefaclor (Cephalosporin)

This test measures the concentration of Immunoglobulin E (IgE) antibodies directed specifically against Cefaclor, a second-generation cephalosporin antibiotic. It is used to identify Type I (immediate) hypersensitivity reactions. In the context of an 'Allergy Profile With Drugs', it helps clinicians determine if a patient is sensitized and at risk for anaphylaxis, urticaria, or angioedema upon exposure to this specific drug.
View Interpretation
Immunology

Specific IgE - Chickpea

This test measures the concentration of IgE antibodies specific to chickpea (Cicer arietinum) proteins. In an Allergy Profile, it identifies Type I hypersensitivity. It is crucial for patients experiencing symptoms like urticaria, angioedema, or anaphylaxis after legume consumption, particularly in regions where chickpeas are a dietary staple.
View Interpretation
Immunology

Specific IgE - Codfish

This test measures the level of allergen-specific Immunoglobulin E (IgE) antibodies in the serum directed against Codfish (Gadus morhua). It is a diagnostic tool for Type I hypersensitivity (allergic) reactions. Within an allergy profile, it helps differentiate between food-based triggers and inhalant allergies. Detecting specific IgE is critical for assessing the risk of acute reactions ranging from urticaria (hives) to life-threatening anaphylaxis upon ingestion of fish proteins like parvalbumin.
View Interpretation
Immunology

Specific IgE - Cow's Milk

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies in the blood directed against cow's milk proteins (such as casein, alpha-lactalbumin, and beta-lactoglobulin). In the context of an Allergy Profile, it is used to identify Type I hypersensitivity reactions. Measuring these levels is crucial for distinguishing between true IgE-mediated food allergy and non-allergic food intolerance, helping clinicians guide dietary elimination and the risk assessment of anaphylaxis.
View Interpretation
Immunology

Specific IgE - Dermatophagoides Pteronyssinus (House Dust Mite)

This test measures the concentration of specific Immunoglobulin E (IgE) antibodies in the blood directed against Dermatophagoides pteronyssinus, one of the most common species of house dust mites. Within an allergy profile, this component is critical for identifying sensitization that may trigger allergic rhinitis, asthma, or atopic dermatitis. High levels indicate that the immune system perceives these mite proteins as a threat, leading to the release of histamine and other inflammatory mediators upon exposure.
View Interpretation
Immunology

Specific IgE - Egg White

This test measures the concentration of Immunoglobulin E (IgE) antibodies directed specifically against egg white proteins (such as ovomucoid and ovalbumin). Within an allergy profile, it identifies sensitization to one of the most common food allergens. High levels correlate with a higher probability of an allergic reaction upon ingestion, ranging from mild hives to life-threatening anaphylaxis.
View Interpretation
Immunology

Specific IgE - Ibuprofen

This component measures IgE-mediated sensitization to Ibuprofen. While most adverse reactions to NSAIDs are non-immunologic (related to COX-1 inhibition), a subset of patients develops true Type I IgE-mediated hypersensitivity. Testing is critical for differentiating between pharmacologic intolerance and a potentially life-threatening allergy, which dictates whether the patient must avoid all NSAIDs or just specific chemical classes.
View Interpretation
Immunology

Specific IgE - Insulin (Human)

This test detects IgE antibodies specifically reactive to human insulin. While modern recombinant human insulin has reduced the incidence of allergy, some diabetic patients still develop hypersensitivity. This component is vital in the 'Allergy Profile With Drugs' to investigate localized cutaneous reactions at injection sites or systemic urticaria/anaphylaxis following insulin administration.
View Interpretation
Immunology

Specific IgE - Lidocaine

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies in the blood directed against Lidocaine, a local anesthetic. In the context of a drug allergy profile, it helps identify Type I hypersensitivity reactions. While lidocaine allergies are rare (often being reactions to preservatives or epinephrine), a positive result suggests a risk of immediate hypersensitivity, including urticaria, angioedema, or anaphylaxis.
View Interpretation
Immunology

Specific IgE - Milk

This test measures the concentration of Immunoglobulin E (IgE) antibodies specific to cow's milk proteins. It is used to identify Type I hypersensitivity (allergy) to milk. Unlike total IgE, specific IgE confirms the exact allergen triggering the immune response. It is vital for pediatric populations to distinguish between milk protein allergy and lactose intolerance, as the management strategies differ significantly.
View Interpretation
Immunology

Specific IgE - Peanut

Measures IgE antibodies specific to peanut allergens (e.g., Ara h 1, 2, 3). Peanut allergy is one of the most common food allergies and is frequently associated with severe systemic reactions (anaphylaxis). Within a vegetable allergy profile, this helps quantify the level of sensitization, which often correlates with the likelihood of a clinical reaction.
View Interpretation
Immunology

Specific IgE - Penicillin G

This test detects IgE antibodies against the major/minor determinants of Penicillin G. It is used to assess the risk of immediate (Type I) hypersensitivity reactions, such as urticaria, angioedema, or anaphylaxis. Since many patients report penicillin allergies they do not actually have, this test helps in 'de-labeling' patients for better antibiotic stewardship.
View Interpretation
Immunology

Specific IgE - Penicillin V

Penicillin V specific IgE testing is a diagnostic tool for identifying drug-induced Type I hypersensitivity. This test helps determine if a patient is at risk for an immediate allergic reaction, including anaphylaxis, upon exposure to Penicillin V. It is often ordered for patients with a history of penicillin 'allergy' to confirm whether they can safely receive beta-lactam antibiotics.
View Interpretation
Immunology

Specific IgE - Potato

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies directed against potato proteins in the blood. Potato allergy, while less common than other food allergies, can manifest as oral allergy syndrome, urticaria, or even anaphylaxis. In the context of a 'Veg Allergy Profile', this helps distinguish between general IgE elevation and specific sensitization to Solanaceae family proteins (like patatin).
View Interpretation
Immunology

Specific IgE - Rice

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies in the blood directed against rice proteins. In an Allergy Profile, this component helps differentiate between a general high IgE state and a specific Type I hypersensitivity to rice. It is essential for patients presenting with urticaria, gastrointestinal distress, or respiratory symptoms following the ingestion of rice products.
View Interpretation
Immunology

Specific IgE - Shrimp

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies in the blood directed against shrimp proteins (notably Pen a 1, a tropomyosin). It is a critical component of an allergy profile used to identify Type I hypersensitivities. High levels indicate sensitization, which, when combined with clinical symptoms like urticaria, angioedema, or respiratory distress, confirms a food allergy. It is essential for distinguishing between true IgE-mediated allergy and food intolerance.
View Interpretation
Immunology

Specific IgE - Soy

This component measures IgE antibodies against soy (Glycine max) proteins. Within a comprehensive Allergy Profile, soy is a major allergen, especially in pediatric populations and those on vegetarian diets. Soy contains several allergenic proteins (like Gly m 4, 5, and 6). High levels help identify soy as a trigger for gastrointestinal distress, atopic dermatitis, or anaphylaxis. It is particularly important for patients with birch pollen allergies, as they may experience cross-reactivity with soy (oral allergy syndrome).
View Interpretation
Immunology

Specific IgE - Soybean

This test measures the concentration of IgE antibodies in the blood specifically directed against soybean proteins. It is used to identify sensitization to soy, one of the 'Big Eight' food allergens. While a positive result indicates sensitization, it must be interpreted alongside clinical symptoms, as not all sensitized individuals will experience an allergic reaction (anaphylaxis or hives) upon ingestion. It is a vital part of an allergy profile to distinguish between various food triggers.
View Interpretation
Immunology

Specific IgE - Sulfamethoxazole

This test measures the concentration of allergen-specific IgE antibodies to Sulfamethoxazole (a sulfonamide antibiotic). It is used to identify Type I hypersensitivity (immediate) allergic reactions. Detection is crucial for patients who have experienced hives, angioedema, or anaphylaxis after taking 'Sulfa' drugs, ensuring they avoid life-threatening reactions in future medical treatments.
View Interpretation
Immunology

Specific IgE - Timothy Grass (Pollen)

This test measures the concentration of Immunoglobulin E (IgE) antibodies specifically directed against Timothy Grass (Phleum pratense). It is used to confirm type I hypersensitivity (allergic rhinitis, asthma, or conjunctivitis) to this specific grass pollen, which is a major seasonal allergen.
View Interpretation
Immunology

Specific IgE - Tomato

This test measures the concentration of allergen-specific IgE antibodies directed against tomato proteins. It is used to diagnose Type I hypersensitivities to tomatoes. Clinical symptoms can range from Oral Allergy Syndrome (OAS)—itching/swelling of the lips and throat—to systemic urticaria or, rarely, anaphylaxis. This is often grouped in vegetarian allergy profiles as tomato proteins share cross-reactivity with various grass pollens.
View Interpretation
Immunology

Specific IgE - Wheat

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies in the blood directed against wheat proteins. It is used to diagnose IgE-mediated wheat allergy, which can manifest as urticaria, angioedema, asthma, or anaphylaxis. In the context of an Allergy Profile, it helps differentiate between food-induced systemic reactions and other conditions like Celiac disease (which is T-cell mediated) or non-celiac gluten sensitivity.
View Interpretation
Allergy and Immunology

Specific IgE: Fish (Cod)

This test measures the level of allergen-specific Immunoglobulin E (IgE) antibodies in the blood directed against Cod fish proteins (e.g., Gad c 1). In an Allergy Profile, this identifies Type I hypersensitivity. It helps distinguish between a true food allergy, which carries a risk of anaphylaxis, and non-immune mediated food intolerances.
View Interpretation
Reproductive Health

Sperm Concentration

Sperm Concentration is the number of spermatozoa per unit volume of semen. As a part of the Semen Analysis, it is a fundamental predictor of male fertility potential. It reflects the efficiency of the testes to produce sperm (spermatogenesis) and the patency of the male reproductive tract. Lower concentrations significantly reduce the statistical probability of natural conception.
View Interpretation
Reproductive Health

Sperm Morphology (Normal Forms)

Sperm morphology is an evaluation of the size and shape of sperm cells as part of a semen analysis. This specific component measures the percentage of sperm that possess a 'normal' appearance according to strict criteria (Kruger criteria). It is a critical predictor of the sperm's ability to penetrate and fertilize an egg. Abnormal shapes (teratozoospermia) often involve head defects, midpiece abnormalities, or tail defects, which can significantly impair motility and genetic delivery.
View Interpretation
Microbiology

Spore Stain

The Spore Stain, most commonly utilizing the Schaeffer-Fulton method, is a specialized differential staining technique used in microbiology to identify the presence of endospores in bacterial samples. Endospores are highly resistant, dormant structures produced by certain genera of bacteria, most notably Bacillus and Clostridium. These structures allow bacteria to survive extreme environmental stress, such as high heat, radiation, and chemical disinfectants, which would otherwise kill the vegetative (active) state of the cell. This test is typically ordered when a clinician suspects an infection caused by spore-forming pathogens. It is a critical tool for identifying Bacillus anthracis (the causative agent of Anthrax) or various Clostridium species that cause tetanus, botulism, and gas gangrene. Because endospores do not take up standard Gram stains easily, this specific method—which involves applying heat to drive a primary stain like Malachite Green into the spore—is necessary for definitive microscopic visualization. Conditions associated with a positive spore stain include:
  • Anthrax: Caused by B. anthracis, often involving cutaneous, pulmonary, or gastrointestinal symptoms.
  • Tetanus: Caused by C. tetani, leading to muscle rigidity and lockjaw.
  • Botulism: Caused by C. botulinum, leading to severe food poisoning or paralysis.
  • C. diff Infection: Identifying Clostridioides difficile in clinical or environmental samples.
In a clinical setting, identifying spores helps differentiate between environmental contaminants and highly pathogenic organisms. Since spores are often found in soil, their detection in a sterile body site or specialized culture can rapidly narrow down the differential diagnosis in cases of severe sepsis or localized tissue necrosis.
View Interpretation
Microbiology

Sputum Culture (Diphtheria & Pyogenic Organisms)

A Sputum Culture for Diphtheria and Pyogenic Organisms is a laboratory test used to identify pathogenic bacteria in the lower respiratory tract. 'Pyogenic' refers to bacteria that produce pus, such as Staphylococcus aureus or Streptococcus pneumoniae. This specific culture also uses specialized media (like Löffler's or Tellurite agar) to specifically look for Corynebacterium diphtheriae, the causative agent of Diphtheria. This test is ordered when a patient shows signs of a severe respiratory infection, including:
  • Persistent productive cough with discolored mucus.
  • High fever and chills.
  • Difficulty breathing or chest pain.
  • The presence of a thick, gray pseudomembrane in the throat (a hallmark sign of Diphtheria).
The primary condition of concern is Diphtheria, a serious infection that can lead to heart failure, paralysis, or death if the toxin enters the bloodstream. Furthermore, the test screens for common bacterial pneumonia, bronchitis, and lung abscesses caused by pyogenic organisms. Identifying the specific organism allows for 'sensitivity testing,' which tells the doctor exactly which antibiotic will be most effective in treating the infection.
View Interpretation
Microbiology

Sputum For Culture and Sensitivity

Sputum Culture and Sensitivity is a laboratory test used to detect and identify bacteria or fungi that infect the lungs or airways. Sputum is the thick mucus (phlegm) produced by the lungs. The 'Sensitivity' portion of the test determines which specific antibiotics are most effective at killing the identified pathogen. This test is crucial for patients presenting with symptoms of deep respiratory tract infections, such as persistent cough, fever, chills, and shortness of breath. It is commonly used to diagnose bacterial pneumonia, lung abscesses, or exacerbations of chronic obstructive pulmonary disease (COPD).
  • Bacterial Pneumonia: Caused by organisms like Streptococcus pneumoniae or Haemophilus influenzae.
  • Tuberculosis (TB): Requires specific 'Acid-Fast Bacillus' staining and culture.
  • Cystic Fibrosis: Patients often undergo routine sputum cultures to monitor for Pseudomonas colonization.
  • Fungal Infections: Such as aspergillosis in immunocompromised individuals.
A valid sample must come from deep within the lungs. Saliva is not sputum and will lead to inaccurate results. Laboratories often perform a 'Gram Stain' first to check if the sample contains enough white blood cells and few enough epithelial (mouth) cells to be considered high quality.
View Interpretation
Microbiology

Sputum for Acid-Fast Bacilli (AFB)

The Sputum for Acid-Fast Bacilli (AFB) test is a primary diagnostic tool used to detect the presence of mycobacteria, most notably Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). Mycobacteria are characterized by a unique waxy cell wall containing mycolic acid, which resists traditional Gram staining but retains specialized dyes even after washing with acid-alcohol, hence the term 'acid-fast.' Physicians order this test when a patient presents with symptoms suggestive of pulmonary TB or other chronic lung infections. Symptoms include a persistent cough lasting more than three weeks, coughing up blood (hemoptysis), chest pain, unexplained weight loss, night sweats, and fever. It is also used to monitor the effectiveness of anti-tubercular treatment; a conversion from 'Positive' to 'Negative' indicates that the therapy is working and the patient is becoming less infectious.
  • Tuberculosis (TB): The most common reason for a positive result.
  • Nontuberculous Mycobacteria (NTM): Such as Mycobacterium avium complex (MAC), often seen in immunocompromised individuals or those with underlying lung disease like COPD.
  • Leprosy: While primarily a skin/nerve disease (M. leprae), AFB staining is the gold standard for identification in various tissue types.
This test is vital for public health surveillance, as it helps identify infectious individuals who require isolation to prevent community spread.
View Interpretation
Microbiology

Sputum for Culture & Sensitivity

The Sputum Culture and Sensitivity test is a critical diagnostic tool used to identify pathogenic bacteria or fungi inhabiting the lower respiratory tract. Unlike saliva, sputum is the thick mucus (phlegm) produced in the lungs and airways during infection or chronic inflammation. The primary function of this test is to isolate the specific microorganism causing a respiratory illness and determine which antibiotics are most effective at inhibiting its growth (sensitivity). Physicians order this test when a patient presents with symptoms of a deep lung infection, such as:
  • Persistent cough producing discolored (yellow, green, or bloody) sputum.
  • Fever and chills accompanied by chest pain.
  • Shortness of breath or labored breathing.
  • Suspected pneumonia, bronchitis, or lung abscess.
  • Monitoring the effectiveness of treatment for chronic conditions like cystic fibrosis or bronchiectasis.
This test is vital in diagnosing various lower respiratory tract infections, including:
  • Bacterial Pneumonia: Often caused by Streptococcus pneumoniae, Haemophilus influenzae, or Staphylococcus aureus.
  • Tuberculosis (TB): Though specialized cultures are often required for Acid-Fast Bacilli (AFB).
  • Chronic Obstructive Pulmonary Disease (COPD) Exacerbations: Identifying bacterial triggers for worsening symptoms.
  • Fungal Infections: Such as Aspergillosis in immunocompromised individuals.
  • Nosocomial Infections: Identifying hospital-acquired pathogens that may be multi-drug resistant (e.g., Pseudomonas aeruginosa).
By matching the pathogen to the correct antibiotic, clinicians can practice antibiotic stewardship, ensuring the patient receives targeted therapy rather than broad-spectrum drugs that might contribute to resistance.
View Interpretation
Microbiology

Sputum for Fungal Elements

This test involves the microscopic examination and culture of sputum (deeply coughed-up phlegm) to identify the presence of pathogenic fungi. It uses specialized stains like KOH (Potassium Hydroxide), GMS (Grocott’s Methenamine Silver), or PAS (Periodic Acid-Schiff) to highlight fungal cell walls, hyphae, or budding yeasts. It is primarily ordered for patients with persistent respiratory symptoms (chronic cough, coughing up blood, chest pain) who do not respond to standard antibiotics. It is particularly crucial for immunocompromised individuals, such as those with HIV/AIDS, patients undergoing chemotherapy, or transplant recipients, who are at high risk for opportunistic fungal pneumonia.
  • Aspergillosis: Caused by Aspergillus mold, often forming 'fungus balls' in the lungs.
  • Histoplasmosis/Blastomycosis/Coccidioidomycosis: Geographically specific fungal infections (endemic mycoses) that can cause systemic disease.
  • Pneumocystis Pneumonia (PCP): A serious infection caused by Pneumocystis jirovecii, common in severe immunosuppression.
  • Candidiasis: While Candida is often a commensal (normal inhabitant) of the mouth, its presence in deep sputum samples can sometimes indicate infection in vulnerable patients.
View Interpretation
Microbiology

Sputum for Gram Stain

A Sputum Gram Stain is a laboratory test used to detect the presence of bacteria in a sample of sputum (phlegm coughed up from the lungs). It categorizes bacteria into two groups: Gram-positive (blue/purple) and Gram-negative (pink/red), and identifies their shape (cocci or bacilli). This provides immediate, preliminary information about the cause of a lower respiratory infection. It is primarily ordered for patients suspected of having bacterial pneumonia or bronchitis. Because bacterial cultures take 24–48 hours to grow, the Gram stain offers a 'quick look' that allows doctors to start targeted antibiotic therapy sooner. It also evaluates the quality of the sputum sample; if many epithelial (skin) cells are present, the sample is likely contaminated with saliva and not representative of the lungs.
  • Bacterial Pneumonia: Caused by organisms like Streptococcus pneumoniae or Haemophilus influenzae.
  • Community-Acquired Pneumonia (CAP): Often diagnosed via sputum analysis.
  • Chronic Obstructive Pulmonary Disease (COPD) Exacerbation: Often triggered by bacterial infections.
  • Cystic Fibrosis: Patients often require regular sputum monitoring for opportunistic pathogens like Pseudomonas.
View Interpretation
Pulmonology

Sputum for RBC

The Sputum for Red Blood Cells (RBC) test is a microscopic examination of expectorated phlegm to detect the presence of occult or visible blood. Under normal physiological conditions, the lower respiratory tract does not leak blood into the airway. This test is primarily ordered when a patient presents with hemoptysis (coughing up blood) or chronic cough. It helps clinicians differentiate between simple irritation and more severe underlying pathologies. It is a critical tool for identifying early signs of lung tissue erosion or vascular leakage in the pulmonary circuit. The presence of RBCs in sputum is associated with several serious conditions:
  • Infectious Diseases: Pulmonary tuberculosis, bacterial pneumonia, and fungal infections (like Aspergillosis) often cause tissue necrosis and bleeding.
  • Malignancy: Lung cancer or metastatic tumors can erode bronchial vessels.
  • Cardiovascular Issues: Congestive heart failure or mitral stenosis can lead to pulmonary edema where RBCs leak into alveoli.
  • Autoimmune Disorders: Wegener's granulomatosis or Goodpasture syndrome.
  • Pulmonary Embolism: An infarction in the lung tissue can result in bloody sputum.
View Interpretation
Nephrology

Squamous Epithelial Cells (Urine)

Squamous epithelial cells are large, flat cells that line the outermost part of the urethra and the vagina. In a routine urinalysis, their primary significance is to serve as a marker for specimen quality. Their presence in high numbers indicates that the urine sample was likely contaminated with skin or vaginal flora during collection.
View Interpretation
Gastroenterology

Stool Color

Stool color is a primary physical observation in a Complete Stool Examination. It provides immediate diagnostic clues regarding gastrointestinal (GI) health. Normal brown color is due to stercobilin, a byproduct of bilirubin. Deviations can signal pathology: Clay-colored (acholic) stools suggest biliary obstruction; black/tarry (melena) stools suggest upper GI bleeding; bright red (hematochezia) suggests distal GI bleeding.
View Interpretation
Microbiology

Stool Culture and Sensitivity

The Stool Culture and Sensitivity test is a primary diagnostic tool used to identify the presence of pathogenic bacteria in the digestive tract. Unlike the normal flora that resides in the gut and aids digestion, pathogenic bacteria can cause acute or chronic gastrointestinal distress. The 'Sensitivity' portion of the test determines which specific antibiotics are most effective at inhibiting the growth of the identified pathogen. Physicians typically order this test when a patient presents with symptoms of a gastrointestinal infection (gastroenteritis). These symptoms include:
  • Persistent or severe diarrhea (which may be bloody or mucoid).
  • Abdominal cramping and pain.
  • Nausea and vomiting.
  • Fever and fatigue. It is especially critical for patients who have recently traveled internationally, consumed potentially contaminated food or water, or have been in contact with others experiencing similar symptoms.
Several specific bacterial pathogens are targeted during this screen, including:
  • Salmonella: Often linked to contaminated poultry or eggs.
  • Shigella: Highly contagious and often causes dysentery.
  • Campylobacter: One of the most common causes of bacterial diarrhea worldwide.
  • Escherichia coli (STEC): Specifically the Shiga toxin-producing strains like O157:H7.
  • Vibrio: Often associated with raw or undercooked seafood.
By identifying the specific bacterium, healthcare providers can prevent the spread of infection (public health reporting) and avoid the misuse of antibiotics, as some GI infections are self-limiting or may even be worsened by certain antibiotic treatments.
View Interpretation
Microbiology

Stool For Culture And Sensitivity

A Stool Culture and Sensitivity test is used to identify harmful bacteria (pathogens) in the lower digestive tract. The 'Culture' part of the test involves placing the stool sample in a medium that encourages the growth of bacteria. The 'Sensitivity' part involves testing any grown pathogens against various antibiotics to see which medication will most effectively kill the infection. This test is essential for patients suffering from severe or persistent diarrhea, bloody stools, abdominal cramping, or fever. It is particularly important if the patient has recently traveled internationally, consumed potentially contaminated food or water, or has been in contact with others who have similar symptoms. It helps distinguish between viral gastroenteritis (which does not require antibiotics) and bacterial infections (which might).
  • Salmonellosis: Often caused by contaminated poultry or eggs.
  • Shigellosis: A highly contagious bacterial infection causing severe diarrhea.
  • Campylobacter Infection: One of the most common causes of 'food poisoning.'
  • E. coli O157:H7: A specific strain that can cause severe intestinal damage.
While the human gut is full of 'good' bacteria (normal flora), this test focuses specifically on identifying 'invaders.' By determining the 'sensitivity' of the bacteria to drugs, physicians can avoid the use of ineffective antibiotics, which helps prevent the development of antibiotic-resistant bacteria and ensures the patient recovers more quickly.
View Interpretation
Gastroenterology

Stool for Fat Globulins

The Stool for Fat Globulins test, often referred to as a qualitative fecal fat microscopic examination, is a primary screening tool used to detect the presence of undigested fat (neutral fats/triglycerides) in the stool. Under normal physiological conditions, the digestive system, specifically the pancreas and the small intestine, efficiently breaks down and absorbs dietary fats. When this process fails, fat is excreted in the feces, a condition known as steatorrhea. Physicians order this test when a patient presents with symptoms suggestive of malabsorption or maldigestion. These symptoms include chronic diarrhea, unexplained weight loss, abdominal cramping, and stools that are unusually foul-smelling, oily, or float in the toilet. It is a quick way to determine if the body is failing to process lipids correctly before proceeding to more invasive or time-consuming tests like the 72-hour quantitative fecal fat collection. Several conditions can lead to an increase in fecal fat globulins:
  • Exocrine Pancreatic Insufficiency (EPI): Common in cystic fibrosis or chronic pancreatitis, where the pancreas fails to produce enough lipase.
  • Celiac Disease: An autoimmune reaction to gluten that damages the small intestinal lining, preventing nutrient absorption.
  • Crohn's Disease: Inflammation of the digestive tract that interferes with normal absorption.
  • Biliary Obstruction: If bile cannot reach the small intestine, fats cannot be emulsified for digestion.
  • Small Intestinal Bacterial Overgrowth (SIBO): Bacteria can deconjugate bile salts, impairing fat uptake.
View Interpretation
Gastroenterology

Stool for Occult Blood

The Stool Occult Blood test (often abbreviated as FOBT or FIT) is a screening tool used to detect microscopic traces of blood in the stool that are not visible to the naked eye. 'Occult' means hidden. This test is a primary screening method for colorectal pathologies that cause slow, intermittent bleeding into the gastrointestinal tract. It is most commonly used as a routine screening for colorectal cancer in adults over the age of 45-50. It is also ordered when a patient has unexplained iron-deficiency anemia or changes in bowel habits but no visible blood in the stool.
  • Colorectal Polyps: Precancerous growths that may bleed occasionally.
  • Colorectal Cancer: Early-stage tumors often bleed into the lumen of the gut.
  • Peptic Ulcers: Sores in the stomach or duodenum.
  • Inflammatory Bowel Disease (IBD): Such as Crohn's disease or Ulcerative Colitis.
  • Diverticulosis: Small pouches in the colon wall that can become inflamed and bleed.
  • Guaiac-based (gFOBT): Detects heme through a chemical reaction. Requires dietary restrictions.
  • Immunochemical (FIT): Uses antibodies to detect human hemoglobin. It is more specific and does not require dietary changes.
View Interpretation
Microbiology

Stool for Ova & Cyst

The Stool for Ova and Parasites (O&P) test is a microscopic evaluation used to detect the presence of parasites, including protozoa (one-celled organisms) and helminths (worms), within the digestive tract. It specifically looks for the 'ova' (eggs) and the 'cysts' (the resting/infectious stage) of parasites that may be shed into the stool. Physicians order this test when a patient presents with persistent gastrointestinal symptoms such as chronic diarrhea, abdominal cramping, bloating, nausea, or bloody stools. It is particularly common for individuals who have recently traveled to regions with poor sanitation, consumed untreated water (e.g., from lakes or streams), or have been exposed to known outbreaks in daycare or communal living settings. Several parasitic infections are commonly identified via this panel:
  • Giardiasis: Caused by Giardia lamblia, leading to greasy stools and malabsorption.
  • Amebiasis: Caused by Entamoeba histolytica, which can cause severe dysentery.
  • Cryptosporidiosis: Often associated with waterborne outbreaks.
  • Hookworm and Roundworm: Common helminthic infections that may cause anemia or nutritional deficiencies.
Because parasites are shed intermittently, a single stool sample may not detect them. Clinical guidelines often recommend the 'three-specimen' rule, where samples are collected on three different days to increase the diagnostic yield. Modern labs may also use permanent stains (like trichrome) to visualize internal structures of the cysts for precise identification.
View Interpretation
Biochemistry

Stool for Reducing Substance

This test detects the presence of reducing sugars in the stool. Most carbohydrates are absorbed in the small intestine. If they are not absorbed (malabsorption), they pass into the large intestine where they can be detected as 'reducing substances.' These sugars include lactose, fructose, and galactose. It is primarily used to investigate diarrhea and failure to thrive in infants and children. It helps diagnose sugar malabsorption, which is often a result of enzyme deficiencies. Because unabsorbed sugars draw water into the intestine (osmosis), they cause watery, acidic diarrhea that can lead to rapid dehydration in young patients.
  • Lactose Intolerance: Deficiency of the lactase enzyme.
  • Sucrose Malabsorption: Although sucrose is not a reducing sugar, it can be broken down by bacteria into reducing sugars, sometimes giving a positive result.
  • Short Bowel Syndrome: Reduced surface area for absorption.
  • Viral Gastroenteritis: Can cause temporary, secondary lactose intolerance.
View Interpretation
Gastroenterology

Stool pH

Stool pH is measured as part of a Complete Stool Examination to evaluate for carbohydrate malabsorption. When sugars (like lactose) are not absorbed in the small intestine, they are fermented by colonic bacteria into short-chain fatty acids, which lowers the pH. This test is particularly useful in diagnosing lactase deficiency or other disaccharidase deficiencies in both children and adults.
View Interpretation
Microbiology

Swab for Culture and Sensitivity

The Swab Culture and Sensitivity test is designed to isolate and identify infectious microorganisms (bacteria or fungi) from various body sites, such as wounds, the throat, nasal passages, or surgical sites. Once an organism is grown, the laboratory tests various antimicrobial agents against it to determine which medications effectively inhibit its growth. This test is indispensable when an infection is suspected but the causative agent is unknown. It is ordered for:
  • Non-healing or purulent (pus-filled) wounds.
  • Sore throats suspected of being 'Strep throat'.
  • Suspected MRSA colonization in the nares.
  • Post-operative site redness or drainage.
  • Pyogenic Infections: Caused by Staphylococcus aureus or Streptococcus pyogenes.
  • Pharyngitis: Identifying Group A Strep to prevent complications like rheumatic fever.
  • Fungal Skin Infections: Identifying Candida species in skin folds.
  • Drug-Resistant Infections: Detecting MRSA or VRE to implement contact precautions and specific therapy.
Accurate culture results ensure that patients receive the correct antibiotic, preventing the development of antibiotic resistance and reducing the duration of illness.
View Interpretation
Metabolic

Synovial Fluid For ADA Levels

Adenosine Deaminase (ADA) is an enzyme involved in purine metabolism. It is primarily found in T-lymphocytes. In the context of synovial fluid (the fluid lubricating joints), the level of ADA reflects the local activation of the cellular immune system. This test is specifically used as a biomarker for Tuberculous Arthritis. While a definitive diagnosis of joint tuberculosis usually requires a culture (which takes weeks) or a biopsy, the ADA level provides a rapid indirect indicator. It is particularly useful in regions where TB is endemic.
  • Tuberculous Arthritis: Characterized by very high ADA levels (often >30-40 U/L).
  • Rheumatoid Arthritis (RA): Can cause moderately elevated ADA due to chronic inflammation.
  • Septic Arthritis: Bacterial infections can sometimes raise ADA.
  • Lymphoma: Rarely, certain cancers can elevate ADA levels in body fluids.
The ADA test has high sensitivity for TB. If the ADA is low, Tuberculous Arthritis is highly unlikely. If high, further specific testing like PCR or AFB culture is warranted to confirm the diagnosis.
View Interpretation
Microbiology

Synovial Fluid For AFB

This test involves the microscopic examination (smear) and culture of synovial fluid (joint fluid) to detect Acid-Fast Bacilli (AFB), primarily Mycobacterium tuberculosis. Tuberculous arthritis is a form of extrapulmonary tuberculosis that affects the joints, usually the knee or hip. It is ordered for patients with chronic monoarthritis (inflammation of a single joint) that does not respond to standard treatments for rheumatoid arthritis or common bacterial infections. Symptoms include joint swelling, pain, and restricted range of motion, often without significant fever.
  • Tuberculous Arthritis: A slow-progressing infection of the joint space.
  • Non-tuberculous Mycobacterial (NTM) Infection: Less common, but can occur after trauma or surgery.
  • Systemic Tuberculosis: If joint AFB is positive, it often indicates the patient has a primary focus of infection in the lungs.
Identifying AFB in synovial fluid is diagnostic for mycobacterial joint disease, which requires a specific and prolonged course of anti-tubercular medications compared to standard septic arthritis.
View Interpretation
Microbiology

Synovial Fluid For Culture And Sensitivity

The Synovial Fluid Culture and Sensitivity (C/S) test is a critical diagnostic procedure used to identify infectious organisms within a joint space. Synovial fluid acts as a lubricant for joints; however, when bacteria, fungi, or viruses infiltrate this space, it leads to septic arthritis—a medical emergency. This test involves inoculating the fluid into growth media to see if pathogens multiply and then testing those pathogens against various antibiotics. Physicians order this test when a patient presents with symptoms of an acutely inflamed joint, such as severe pain, swelling, warmth, and restricted range of motion. It is the gold standard for differentiating between infectious (septic) arthritis and non-infectious causes like gout, rheumatoid arthritis, or osteoarthritis. Timely diagnosis is vital to prevent permanent joint destruction or systemic sepsis.
  • Septic Arthritis: Most commonly caused by Staphylococcus aureus or Neisseria gonorrhoeae.
  • Chronic Granulomatous Infections: Such as fungal infections or tuberculosis in the joint.
  • Post-Surgical Infections: Infections following joint replacement (arthroplasty).
  • Crystal-Induced Synovitis: While C/S is for infection, the procedure often includes crystal analysis to rule out gout or pseudogout.
View Interpretation
Microbiology

Synovial Fluid for Gram Stain

The Synovial Fluid Gram Stain is a rapid diagnostic test used to identify the presence of bacteria and classify them based on their cell wall characteristics (Gram-positive or Gram-negative) within joint fluid. Synovial fluid acts as a lubricant and nutrient source for joint cartilage; however, when an infection occurs, the fluid becomes a medium for pathogens. This test provides immediate, preliminary information that is vital for acute clinical management. This test is primarily ordered when a clinician suspects septic arthritis, which is a medical emergency. Symptoms often include severe joint pain, swelling, warmth, and a significantly restricted range of motion. Because bacterial infections can rapidly destroy joint cartilage and bone, the Gram stain serves as a 'stat' test to guide initial antibiotic therapy while waiting for the more definitive, but slower, gold-standard culture results.
  • Septic Arthritis: Most commonly caused by Staphylococcus aureus, Streptococcus, or Neisseria gonorrhoeae.
  • Crystal-Induced Synovitis: Gout or pseudogout may mimic infection, but the Gram stain will typically be negative for bacteria.
  • Rheumatoid Arthritis: Inflammatory conditions may cause increased white blood cell counts in the fluid, but the Gram stain remains negative unless a secondary infection is present.
  • Traumatic Injury: Can lead to hemarthrosis (blood in the joint), which must be differentiated from infectious causes.
View Interpretation
Vital Signs

Systolic Blood Pressure

Systolic Blood Pressure (SBP) measures the force your heart exerts on the walls of your arteries each time it beats. It is the top number in a blood pressure reading. High SBP is a major risk factor for cardiovascular disease, stroke, and chronic kidney disease. In a Blood Pressure panel, the SBP is often more heavily weighted than diastolic pressure in assessing risk for individuals over age 50 due to increasing arterial stiffness.
View Interpretation
Endocrinology

T3 Uptake

T3 Uptake is an indirect measure of the available binding sites on Thyroxine-Binding Globulin (TBG). It is not a direct measurement of T3 hormone levels. Its primary clinical utility is to calculate the Free Thyroxine Index (FTI), which helps correct for variations in binding proteins that can occur due to pregnancy, medications, or liver disease. In modern practice, it is often replaced by direct Free T4 assays.
View Interpretation
Microbiology

TB GeneXpert (RT-PCR)

The TB GeneXpert is a molecular test that uses Real-Time Polymerase Chain Reaction (RT-PCR) to detect the DNA of Mycobacterium tuberculosis (MTB). Simultaneously, it identifies mutations in the rpoB gene, which are associated with resistance to Rifampicin, the most important first-line TB drug. It is used for the rapid diagnosis of pulmonary tuberculosis, especially in patients suspected of having drug-resistant TB or those co-infected with HIV. Unlike traditional cultures which take weeks, GeneXpert provides results in under two hours.
  • Pulmonary Tuberculosis: Active infection in the lungs.
  • Multidrug-Resistant TB (MDR-TB): TB that does not respond to standard treatments.
  • Extrapulmonary TB: Use of the test on lymph node tissue or CSF for non-pulmonary infections.
GeneXpert has revolutionized TB control by allowing for immediate initiation of appropriate therapy. Early detection of Rifampicin resistance ensures that patients are not started on ineffective treatments, thereby reducing the spread of resistant strains in the community.
View Interpretation
Immunology

TB Gold QuantiFERON

The QuantiFERON-TB Gold (QFT) is an Interferon-Gamma Release Assay (IGRA). It measures the cell-mediated immune response to specific proteins (ESAT-6, CFP-10) that are found in Mycobacterium tuberculosis but are absent from the BCG vaccine and most non-tuberculous mycobacteria. QFT is used for the detection of Mycobacterium tuberculosis infection, encompassing both latent TB infection (LTBI) and active tuberculosis disease. It is preferred over the Tuberculin Skin Test (TST) for individuals who have received the BCG vaccine or those unlikely to return for a skin test reading.
  • Latent TB: The patient is infected but asymptomatic and not contagious.
  • Active TB: The patient has symptomatic disease (pulmonary or extrapulmonary).
  • Screening: Often required for healthcare workers, individuals starting immunosuppressive therapy (like TNF-alpha inhibitors), or immigrants from high-prevalence areas.
View Interpretation
Infectious Disease

TB IgG

The TB IgG test detects Immunoglobulin G antibodies produced by the immune system in response to Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB). IgG is a 'long-term' antibody that typically appears weeks after infection and may persist for years. Unlike the skin test (Mantoux) or IGRA (QuantiFERON), which measure cellular immunity, this test looks for a humoral (antibody) response. While not the gold standard for diagnosing active TB (due to sensitivity and specificity issues), the TB IgG test is sometimes used as a supplementary tool in regions where other diagnostic methods are unavailable. It can help identify individuals who have been exposed to the bacteria in the past, aiding in the diagnosis of latent TB or assessing exposure in high-risk populations.
  • Latent Tuberculosis Infection (LTBI): The patient carries the bacteria but is not symptomatic or contagious.
  • Active Tuberculosis: In some cases of active disease, IgG levels will be significantly elevated.
  • Extrapulmonary TB: IgG testing is occasionally explored when TB is suspected outside the lungs and sputum samples are difficult to obtain.
  • Past Exposure: Reflects a prior infection that the immune system has successfully contained.
View Interpretation
Serology

TB IgM

The TB IgM test is a serological assay designed to detect Immunoglobulin M (IgM) antibodies against Mycobacterium tuberculosis, the causative agent of Tuberculosis (TB). IgM is typically the first antibody produced by the immune system following an acute infection or a recent reactivation of a dormant infection. This test is used as an adjunct in the diagnosis of active Tuberculosis, especially in cases where sputum samples are difficult to obtain (paucibacillary TB) or in extrapulmonary TB (TB outside the lungs). While cultures and PCR (GeneXpert) are the gold standards, serological tests like TB IgM can provide faster results to support a clinical suspicion of active disease.
  • Active Pulmonary Tuberculosis: Recent infection involving the lungs, characterized by cough, fever, and night sweats.
  • Extrapulmonary Tuberculosis: Infection in the lymph nodes (TB lymphadenitis), spine (Pott's disease), or abdomen.
  • Miliary Tuberculosis: A widespread, life-threatening form of TB where the bacteria spread through the bloodstream.
TB IgM testing is controversial in some medical circles because its sensitivity and specificity can be lower than other methods. However, in endemic regions, a positive IgM result in a symptomatic patient is often treated as a strong indicator of early-stage active infection. It is most useful when interpreted alongside chest X-rays and clinical symptoms.
View Interpretation
Serology

TB IgM, IgG, IgA

The TB Serology test measures the levels of different antibodies (IgM, IgG, and IgA) produced by the immune system in response to Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Unlike the T-SPOT or QuantiFERON tests which measure cell-mediated immunity, this test looks at the humoral (antibody) response.
  • IgM: Typically appears early in an infection and suggests an acute or recent exposure.
  • IgG: Represents a more mature immune response and can indicate past infection, chronic infection, or latent TB.
  • IgA: Often associated with mucosal immunity and can be elevated in active pulmonary tuberculosis.
This panel may be ordered as a supplementary diagnostic tool when healthcare providers are trying to differentiate between active and latent infection, or when other tests like sputum culture or molecular assays (GeneXpert) are inconclusive. It is also used in epidemiological studies to assess the prevalence of TB exposure in certain populations.
  • Active Pulmonary Tuberculosis: Often shows elevations in IgA and IgG.
  • Extrapulmonary TB: Infection in the kidneys, spine, or brain may show varying antibody profiles.
  • Latent TB Infection (LTBI): May show elevated IgG but no clinical symptoms.
  • Miliary TB: Disseminated infection throughout the body.
It is important to note that the WHO does not recommend commercial serological tests for the routine diagnosis of pulmonary TB due to issues with sensitivity and specificity, particularly in HIV-positive individuals. Results must always be interpreted alongside clinical findings, chest X-rays, and culture results.
View Interpretation
Hematology

TC & DC (Total Count & Differential Count)

The Total Count (TC) refers to the total number of White Blood Cells (WBCs/Leukocytes) in the blood, while the Differential Count (DC) breaks down these cells into five main types: Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils. These cells are the backbone of the immune system, defending the body against infections, foreign invaders, and abnormal cell growth. This is one of the most frequently ordered tests because it provides a snapshot of the body's immune status. It is used to:
  • Detect infection (bacterial, viral, or parasitic).
  • Evaluate bone marrow function.
  • Monitor the effects of chemotherapy or radiation.
  • Investigate inflammatory conditions or allergic reactions.
  • Leukocytosis (High TC): Often caused by acute infections, inflammation, or leukemia.
  • Leukopenia (Low TC): Seen in viral infections (like HIV), bone marrow failure, or certain drug toxicities.
  • Neutrophilia: Specifically suggests bacterial infection.
  • Lymphocytosis: Suggests viral infection (e.g., Mononucleosis) or chronic lymphocytic leukemia.
  • Eosinophilia: Associated with allergies, asthma, or parasitic infections.
View Interpretation
Genetics

TCF3-HLF Translocation [t(17;19)]

This is a molecular genetic test looking for the t(17;19)(q22;p13) chromosomal translocation, which results in the TCF3-HLF fusion gene. It is found in a very rare but extremely aggressive subtype of B-cell Acute Lymphoblastic Leukemia (B-ALL). Detection is critical for prognosis as this subtype is often resistant to conventional chemotherapy and is frequently associated with severe hypercalcemia and coagulopathy.
View Interpretation
Genetics

TCF3-PBX1 (E2A-PBX1) Translocation [t(1;19)]

This molecular test identifies the fusion gene TCF3-PBX1, resulting from the t(1;19)(q23;p13) translocation. Found in approximately 5-6% of pediatric B-cell Acute Lymphoblastic Leukemia (B-ALL) cases, it is a crucial diagnostic and prognostic biomarker. Historically, this translocation was associated with a poor prognosis; however, with modern intensive chemotherapy protocols, outcomes have significantly improved. Detecting this specific translocation helps in risk stratification and tailoring the intensity of treatment in oncology.
View Interpretation
Endocrinology

TFT, LH, FSH, and Prolactin Panel

This comprehensive endocrine panel evaluates the Hypothalamic-Pituitary-Thyroid (HPT) and Hypothalamic-Pituitary-Gonadal (HPG) axes. Thyroid Function Tests (TFT) measure the metabolic regulation, while Luteinizing Hormone (LH), Follicle-Stimulating Hormone (FSH), and Prolactin (PRL) assess reproductive health and pituitary integrity. Together, they provide a snapshot of the body's primary hormonal regulatory systems. This panel is frequently ordered for patients presenting with symptoms of hormonal imbalance, such as unexplained weight changes, fatigue, irregular menstrual cycles, infertility, or erectile dysfunction. It is crucial for distinguishing between primary organ failure (e.g., thyroid or ovary) and secondary failure caused by pituitary or hypothalamic dysfunction. It is also used to investigate suspected pituitary tumors (prolactinomas).
  • Hypothyroidism/Hyperthyroidism: Detected through TSH and T4 levels.
  • Polycystic Ovary Syndrome (PCOS): Often characterized by an elevated LH to FSH ratio.
  • Hyperprolactinemia: Elevated Prolactin which can cause galactorrhea or infertility.
  • Menopause/Premature Ovarian Failure: Indicated by high FSH and LH levels in females.
  • Hypogonadism: Low LH/FSH paired with low sex hormones in males.
Understanding the interplay between these hormones is vital because thyroid dysfunction can sometimes cause elevations in prolactin, which in turn suppresses LH and FSH, leading to secondary reproductive issues.
View Interpretation
Infectious Disease

TPHA (Treponema Pallidum Hemagglutination Assay)

The TPHA test is a specific treponemal test used to detect antibodies directed against Treponema pallidum, the causative agent of syphilis. Unlike non-treponemal tests (like RPR or VDRL), the TPHA measures antibodies that are specific to the bacteria itself. It is primarily used as a confirmatory test following a positive screening result from a non-treponemal test. It is also used to diagnose syphilis in later stages when non-treponemal tests might become negative. Because TPHA antibodies usually persist for life, it is an excellent marker for determining if a patient has ever been infected.
  • Primary Syphilis: TPHA may become positive within 1–4 weeks after the appearance of a chancre.
  • Secondary Syphilis: The test is almost 100% sensitive during this stage of active systemic infection.
  • Latent and Tertiary Syphilis: TPHA remains highly sensitive and is often the primary way to identify historical or late-stage infection.
  • Congenital Syphilis: Used to evaluate infants born to mothers with a history of infection.
TPHA is a cornerstone of syphilis diagnostics. While it cannot distinguish between an active infection and a successfully treated past infection, its high specificity makes it invaluable for confirming the presence of the disease and preventing false positives associated with other conditions.
View Interpretation
Endocrinology

TPO Antibodies

Thyroid Peroxidase (TPO) is an enzyme normally found in the thyroid gland that plays a crucial role in the production of thyroid hormones (T3 and T4). TPO Antibodies (anti-TPO) are autoantibodies produced by the immune system that mistakenly attack the thyroid gland. The presence of these antibodies indicates an autoimmune process where the body is targeting its own endocrine tissue. Physicians order the TPO antibody test primarily to diagnose autoimmune thyroid disorders. It is indicated when:
  • TSH levels are abnormal but T3/T4 are borderline.
  • A patient has symptoms of hypothyroidism (fatigue, weight gain, cold intolerance) or hyperthyroidism.
  • A goiter (enlarged thyroid) is detected during a physical exam.
  • Evaluating the risk of thyroid dysfunction in pregnant women with other autoimmune conditions.
The most significant association is with Hashimoto's Thyroiditis, the leading cause of hypothyroidism in iodine-sufficient regions; over 90% of these patients test positive. It is also found in about 75% of patients with Graves' Disease (hyperthyroidism). Beyond thyroid-specific issues, positive TPO antibodies can sometimes be found in patients with other autoimmune diseases like Type 1 Diabetes, Rheumatoid Arthritis, or Pernicious Anemia. Interestingly, a small percentage of the healthy population may have low levels of these antibodies without developing clinical disease, though they remain at higher risk for future thyroid issues.
View Interpretation
Endocrinology

TSH Receptor Antibody

TSH Receptor Antibodies (TRAb) are autoantibodies that bind to the thyroid-stimulating hormone (TSH) receptors on the thyroid gland. These antibodies can either stimulate the receptor (causing hyperthyroidism) or block the receptor (causing hypothyroidism). The most common form of TRAb is Thyroid Stimulating Immunoglobulin (TSI), which mimics the action of TSH, leading to the overproduction of thyroid hormones. This test is primarily ordered to confirm a diagnosis of Graves' disease in patients with symptoms of hyperthyroidism, such as rapid heartbeat, weight loss, and bulging eyes (exophthalmos). It is also used to differentiate Graves' disease from other forms of thyrotoxicosis, such as toxic multinodular goiter or thyroiditis. In pregnant women with a history of Graves', TRAb is measured to assess the risk of neonatal thyrotoxicosis, as these antibodies can cross the placenta. The primary condition associated with elevated TRAb is Graves' Disease, an autoimmune disorder that is the most common cause of hyperthyroidism. High levels are also linked to Graves' Ophthalmopathy (eye involvement). In some cases of Atrophic Thyroiditis or Hashimoto's Thyroiditis, 'blocking' antibodies (a subset of TRAb) may be present, contributing to a hypothyroid state.
View Interpretation
Therapeutic Drug Monitoring

Tacrolimus Levels

Tacrolimus (Prograf) is a potent calcineurin inhibitor used as an immunosuppressant. It prevents the body from rejecting transplanted organs (kidney, liver, heart, etc.) by inhibiting T-lymphocyte activation. Because it has a narrow therapeutic index, blood levels must be monitored precisely to balance efficacy with toxicity. Monitoring is essential to ensure the drug concentration is high enough to prevent organ rejection but low enough to avoid serious side effects like nephrotoxicity or neurotoxicity. It is ordered frequently immediately after transplant and periodically throughout the patient's life.
  • Organ Transplantation: Post-operative management for kidney, liver, or heart recipients.
  • Graft-versus-Host Disease (GVHD): Prevention in bone marrow transplant patients.
  • Nephrotoxicity Monitoring: Assessing if kidney damage is caused by the drug itself.
View Interpretation
Infectious Disease

Tb Platinum Igra, Blood

The Interferon-Gamma Release Assay (IGRA) is a modern blood test used to detect infection by Mycobacterium tuberculosis. Unlike the traditional skin test (Mantoux), IGRA measures the immune system's response to specific TB proteins. When white blood cells from an infected person are mixed with these proteins, they release a cytokine called Interferon-Gamma (IFN-g). This test specifically targets proteins that are not present in the BCG vaccine, reducing false positives. This test is ordered for individuals who have been exposed to someone with active TB, healthcare workers undergoing routine screening, or individuals beginning immunosuppressive therapy (like TNF-inhibitors). It is the preferred method for TB screening in individuals who have received the BCG vaccine, as it provides a more specific result than the skin test.
  • Latent TB Infection (LTBI): The person is infected but not contagious and has no symptoms.
  • Active TB Disease: The person is symptomatic and can spread the bacteria to others.
  • Extrapulmonary TB: Infection outside the lungs (e.g., kidneys, spine, or brain).
It is critical to note that the IGRA test cannot distinguish between latent and active TB. Diagnosis of active TB requires clinical symptoms, chest X-rays, and sputum cultures.
View Interpretation
Endocrinology

Testosterone

Testosterone is the primary androgenic steroid hormone. In males, it is mainly produced in the testes (Leydig cells), while in females, it is produced in the ovaries and adrenal glands. It is responsible for the development of secondary sexual characteristics, bone density, muscle mass, and libido. It also plays a vital role in mood regulation and red blood cell production. In men, it is ordered to investigate symptoms of 'Low T,' such as erectile dysfunction, fatigue, infertility, or decreased muscle mass. In women, it is frequently used to investigate signs of virilization or hormonal imbalance, such as hirsutism (excess hair growth), acne, or irregular menstrual cycles.
  • Hypogonadism (Male): Primary (testicular failure) or secondary (pituitary/hypothalamic issues).
  • Polycystic Ovary Syndrome (PCOS): A common cause of elevated testosterone in females.
  • Adrenal Hyperplasia: Can cause excess androgen production.
  • Pituitary Tumors: Can disrupt the signals (LH/FSH) that tell the body to produce testosterone.
  • Anabolic Steroid Use: Can cause artificially high levels (if current use) or extremely low levels (post-cycle suppression).
Total testosterone measures both free testosterone and testosterone bound to proteins (SHBG and albumin). Changes in protein levels can affect the 'Total' count without affecting the bioactive 'Free' portion.
View Interpretation
Microbiology

Throat Swab For Fungus

The Throat Swab for Fungus test is used to identify fungal overgrowth in the oropharynx. While the throat normally contains various bacteria and some yeasts, an imbalance can lead to an opportunistic infection. The swab captures cellular debris and microorganisms from the back of the throat and tonsils, which are then cultured in a lab to see if fungi, typically Candida species, grow. It is ordered when a patient has visible white patches on the tongue, inner cheeks, or throat (thrush), or experiences pain when swallowing (odynophagia) and a burning sensation in the mouth. It is common in infants, the elderly, and those with weakened immune systems.
  • Oral Candidiasis (Thrush): Overgrowth of Candida albicans.
  • Esophageal Candidiasis: Extension of the infection into the esophagus, common in HIV/AIDS patients.
  • Immunosuppression: Seen in patients undergoing chemotherapy or taking long-term corticosteroids.
View Interpretation
Microbiology

Throat Swab for Culture and Sensitivity

A Throat Swab Culture is used to detect the presence of harmful bacteria in the posterior pharynx and tonsillar area. While the throat is naturally colonized by many 'good' bacteria (normal flora), certain pathogens can cause significant infection and systemic complications if left untreated. The test involves streaking the swab across a growth medium to see if specific colonies develop. This test is most frequently ordered to distinguish between a viral sore throat and a bacterial infection, specifically 'Strep Throat.' Clinical symptoms often overlap, making the culture the gold standard for diagnosis. Indications include:
  • Severe sore throat with difficulty swallowing.
  • Swollen, red tonsils with white patches or pus (exudate).
  • Tiny red spots on the roof of the mouth (petechiae).
  • Swollen lymph nodes in the neck.
  • Absence of a cough (which usually points toward a viral cause).
The primary target of this culture is Streptococcus pyogenes, also known as Group A Beta-Hemolytic Streptococcus. If left untreated, Strep A can lead to serious complications such as:
  • Rheumatic Fever: A disease that can affect the heart, joints, brain, and skin.
  • Post-Streptococcal Glomerulonephritis: An inflammatory kidney disease.
  • Peritonsillar Abscess: A collection of pus behind the tonsils.
Other bacteria like Neisseria gonorrhoeae or Corynebacterium diphtheriae may be sought in specific clinical contexts, though they usually require specialized media.
View Interpretation
Endocrinology

Thyroglobulin Level

Thyroglobulin (Tg) is a protein produced only by thyroid follicular cells. It serves as the substrate for thyroid hormone synthesis. In healthy individuals, small amounts of Tg leak into the bloodstream. The primary use of this test is as a tumor marker for patients diagnosed with differentiated thyroid cancer (papillary or follicular). After a total thyroidectomy and/or radioactive iodine ablation, Thyroglobulin levels should be undetectable or very low.
  • Thyroid Cancer Monitoring: Post-operative rising levels suggest recurrence or metastasis.
  • Thyroiditis: Inflammation of the thyroid can cause a temporary spike in Tg levels.
  • Graves' Disease: Hyperthyroidism often results in elevated Tg.
  • Factitious Thyrotoxicosis: Used to distinguish between thyroid hormone ingestion (low Tg) and endogenous overproduction (high Tg).
View Interpretation
Endocrinology

Thyroglobulin Levels

Thyroglobulin (Tg) is a large glycoprotein produced exclusively by the follicular cells of the thyroid gland. It serves as a substrate for the synthesis of the thyroid hormones T3 and T4. Because it is only produced by thyroid tissue, it acts as a highly specific 'tumor marker' in individuals who have undergone treatment for thyroid cancer. The primary use of this test is the post-operative monitoring of patients with differentiated thyroid cancer (Papillary or Follicular). After the thyroid gland is surgically removed (thyroidectomy) and any remaining tissue is ablated with radioactive iodine, thyroglobulin levels should ideally be undetectable. A rise in Tg indicates the recurrence or persistence of thyroid tissue/cancer.
  • Differentiated Thyroid Cancer: Used for surveillance of recurrence.
  • Graves' Disease: Can cause elevated Tg due to hyperstimulation of the gland.
  • Thyroiditis: Inflammation causes the 'leakage' of Tg into the bloodstream.
  • Goiter: Benign enlargement of the thyroid increases the mass of Tg-producing cells.
View Interpretation
Endocrinology

Thyroid Function Panel (Free T3, Free T4, TSH)

The Thyroid Function Panel is a comprehensive group of tests used to evaluate the health and efficiency of the thyroid gland. The thyroid, a butterfly-shaped gland in the neck, produces hormones that regulate the body's metabolism, energy production, and sensitivity to other hormones. The primary regulator is Thyroid Stimulating Hormone (TSH), produced by the pituitary gland. When the pituitary senses low thyroid hormone levels, it releases TSH to stimulate the thyroid. Free T4 (Thyroxine) and Free T3 (Triiodothyronine) are the active forms of the hormones circulating in the blood. Free T3 is the most metabolically active, while T4 serves as a precursor. Together, these markers provide a snapshot of the Hypothalamic-Pituitary-Thyroid (HPT) axis. Physicians order this panel when a patient exhibits symptoms of an overactive thyroid (hyperthyroidism) or an underactive thyroid (hypothyroidism). Symptoms of hyperthyroidism include rapid heart rate, unexplained weight loss, anxiety, and heat intolerance. Conversely, hypothyroidism symptoms include fatigue, weight gain, depression, and cold intolerance. It is also used to monitor the effectiveness of thyroid replacement therapy (like levothyroxine) or anti-thyroid medications and to screen for subclinical thyroid disease where TSH is abnormal but T3/T4 levels remain within the reference range.
  • Hashimoto's Thyroiditis: An autoimmune disorder and the most common cause of hypothyroidism.
  • Graves' Disease: An autoimmune condition leading to hyperthyroidism.
  • Thyroiditis: Inflammation of the thyroid gland which may cause a temporary leak of hormones.
  • Pituitary Adenomas: Tumors that can cause secondary thyroid dysfunction by over or under-producing TSH.
  • Goiter and Nodules: Physical enlargements or growths that may alter hormone production.
View Interpretation
Endocrinology

Thyroid Function Test

The Thyroid Function Test (TFT) is a panel of blood tests used to evaluate how well the thyroid gland is working. The thyroid, a small butterfly-shaped gland in the neck, produces hormones—primarily Thyroxine (T4) and Triiodothyronine (T3)—that regulate the body's metabolism, energy production, and sensitivity to other hormones. The most sensitive marker in this panel is the Thyroid-Stimulating Hormone (TSH), produced by the pituitary gland to signal the thyroid to produce more or less T4/T3. Physicians order TFTs to diagnose or monitor several conditions:
  • Hypothyroidism: An underactive thyroid that slows metabolism.
  • Hyperthyroidism: An overactive thyroid that accelerates metabolism.
  • Thyroiditis: Inflammation of the thyroid gland.
  • Pituitary Gland Disorders: To see if the signal from the brain is reaching the gland.
  • Treatment Monitoring: Checking the efficacy of synthetic thyroid hormone or anti-thyroid medications.
Abnormal results are associated with various autoimmune and physiological states:
  • Hashimoto’s Disease: The leading cause of hypothyroidism in iodine-sufficient areas.
  • Graves’ Disease: An autoimmune cause of hyperthyroidism.
  • Goiters and Nodules: Physical enlargements that may or may not impact hormone output.
  • Postpartum Thyroiditis: Temporary dysfunction following pregnancy.
View Interpretation
Endocrinology

Thyroid Peroxidase Antibodies (TPOAb)

Thyroid Peroxidase (TPO) is an enzyme normally found in the thyroid gland that plays a crucial role in the production of thyroid hormones. The TPO Antibody test detects antibodies that the body's immune system mistakenly produces against this enzyme. These antibodies lead to inflammation and destruction of thyroid tissue. This test is ordered when a patient has abnormal TSH or T4 levels to determine if the cause is autoimmune. It is the hallmark test for diagnosing Hashimoto's thyroiditis (the leading cause of hypothyroidism) and is also found in Graves' disease. It may also be ordered for pregnant women with thyroid disease to assess the risk of postpartum thyroiditis.
  • Hashimoto's Thyroiditis: Chronic autoimmune thyroiditis causing an underactive thyroid.
  • Graves' Disease: Autoimmune hyperthyroidism.
  • Postpartum Thyroiditis: Thyroid dysfunction occurring after childbirth.
  • Other Autoimmune Disorders: Patients with Type 1 Diabetes or Rheumatoid Arthritis may show elevated TPOAb even without active thyroid disease.
View Interpretation
Endocrinology

Thyroid Stimulating Hormone

Thyroid Stimulating Hormone (TSH), also known as thyrotropin, is produced by the anterior pituitary gland. Its primary role is to regulate the production of hormones (T3 and T4) by the thyroid gland. The system operates on a negative feedback loop: when thyroid hormone levels drop, the pituitary releases more TSH to 'stimulate' the thyroid. Conversely, when thyroid hormones are high, TSH production is suppressed. TSH is the gold-standard screening test for thyroid dysfunction. It is ordered to:
  • Diagnose hypothyroidism (underactive thyroid) or hyperthyroidism (overactive thyroid).
  • Screen newborns for congenital hypothyroidism.
  • Monitor the effectiveness of thyroid hormone replacement therapy (e.g., Levothyroxine).
  • Evaluate pituitary gland function.
  • Hypothyroidism: Characterized by high TSH. Symptoms include fatigue, weight gain, and cold intolerance.
  • Hyperthyroidism: Characterized by low TSH. Symptoms include anxiety, weight loss, and heat intolerance.
  • Hashimoto's Thyroiditis: An autoimmune condition causing chronic hypothyroidism.
  • Graves' Disease: An autoimmune condition causing hyperthyroidism.
View Interpretation
Endocrinology

Thyroid Stimulating Hormone (TSH)

Thyroid Stimulating Hormone (TSH) is a glycoprotein produced by the anterior pituitary gland. Its primary role is to regulate the production of hormones (T3 and T4) by the thyroid gland. The system operates via a negative feedback loop: when thyroid hormone levels in the blood drop, the pituitary releases more TSH to stimulate the thyroid; when hormone levels are too high, the pituitary reduces TSH production. TSH is the gold-standard screening test for thyroid dysfunction. It is ordered for:
  • Hypothyroidism Screening: Symptoms like weight gain, cold intolerance, and depression.
  • Hyperthyroidism Screening: Symptoms like weight loss, rapid heartbeat, and anxiety.
  • Medication Monitoring: Ensuring patients on Levothyroxine or anti-thyroid drugs are receiving the correct dose.
Abnormal TSH levels are linked to several major conditions:
  • Hashimoto’s Thyroiditis: An autoimmune condition causing hypothyroidism (High TSH).
  • Grave’s Disease: An autoimmune condition causing hyperthyroidism (Low TSH).
  • Pituitary Adenomas: Rare tumors that can cause secondary thyroid issues.
  • Postpartum Thyroiditis: Inflammation of the thyroid after childbirth.
View Interpretation
Endocrinology

Thyroid Stimulating Hormone (TSH)

TSH is produced by the anterior pituitary gland to regulate the production of T4 and T3 by the thyroid gland. It is the most sensitive first-line screen for thyroid dysfunction because of the inverse logarithmic relationship between TSH and free thyroid hormones. In a Thyroid Function Panel, it determines whether the thyroid is overactive, underactive, or if the issue lies within the pituitary/hypothalamic feedback loop.
View Interpretation
Endocrinology

Thyroid Stimulating Hormone (TSH)

TSH is the most sensitive first-line screening tool for thyroid dysfunction. Produced by the anterior pituitary, it functions in a negative feedback loop with Free T4. Even subtle changes in thyroid hormone levels cause significant compensatory changes in TSH. It is used to diagnose primary hypothyroidism (high TSH) and hyperthyroidism (low TSH).
View Interpretation
Endocrinology

Thyroid Stimulating Hormone (TSH)

TSH, produced by the anterior pituitary, is the most sensitive marker for screening thyroid dysfunction. It operates via a negative feedback loop: when thyroid hormones (T3/T4) are low, TSH rises to stimulate the gland; when they are high, TSH drops. It is essential for diagnosing Hypothyroidism and Hyperthyroidism, and for titrating levothyroxine therapy.
View Interpretation
Endocrinology

Thyroid Stimulating Hormone (TSH)

TSH is a glycoprotein hormone secreted by the anterior pituitary gland to regulate the production of T4 and T3. In a Thyroid Function Test, TSH is the most sensitive first-line screening tool for thyroid dysfunction due to the inverse logarithmic relationship between TSH and free thyroid hormones. Small changes in thyroid hormone levels cause large changes in TSH, making it the primary marker for diagnosing subclinical and overt hypothyroidism or hyperthyroidism.
View Interpretation
Immunology

Timothy Grass Specific IgE

This test measures the concentration of Immunoglobulin E (IgE) antibodies specific to Phleum pratense (Timothy Grass) pollen. Within an Allergy Profile, it is used to diagnose seasonal allergic rhinitis (Hay Fever) and allergic conjunctivitis. Timothy grass is a highly potent allergen and one of the most common causes of grass pollen allergy worldwide. Results help determine eligibility for allergen-specific immunotherapy (AIT).
View Interpretation
Allergy and Immunology

Tomato Specific IgE

This test measures the concentration of allergen-specific immunoglobulin E (IgE) antibodies to tomato in the serum. Within an allergy profile, it helps identify Type I hypersensitivity reactions. Ingestion of tomatoes in sensitized individuals can lead to symptoms ranging from oral allergy syndrome (itching of the mouth) to systemic anaphylaxis. It is particularly relevant for patients with a suspected 'Latex-Fruit Syndrome' due to cross-reactive proteins.
View Interpretation
Metabolic

Total Bilirubin

Bilirubin is a yellowish pigment formed during the normal breakdown of red blood cells (hemolysis). Total Bilirubin measures the combination of 'unconjugated' (indirect) bilirubin, which travels in the blood to the liver, and 'conjugated' (direct) bilirubin, which has been processed by the liver for excretion into the bile. This test is a staple of Liver Function Tests (LFTs). It is used to diagnose and monitor liver diseases such as hepatitis or cirrhosis, evaluate potential bile duct obstructions (gallstones), and investigate the cause of jaundice (yellowing of the skin and eyes). It is also used to monitor newborns for neonatal jaundice.
  • Hepatitis: Viral or toxic inflammation of the liver.
  • Gilbert's Syndrome: A common, harmless genetic condition where the liver processes bilirubin slowly.
  • Hemolytic Anemia: Conditions causing rapid destruction of red blood cells.
  • Choledocholithiasis: Gallstones blocking the bile duct.
View Interpretation
Metabolic

Total Bilirubin

Total Bilirubin is a measurement of the sum of conjugated (direct) and unconjugated (indirect) bilirubin in the blood. Bilirubin is a yellowish pigment formed during the normal breakdown of red blood cells. It travels through the bloodstream to the liver, where it is processed (conjugated) and excreted into bile. This test is a primary indicator of how well the liver is functioning and whether the bile ducts are clear. Total bilirubin is a standard component of a Liver Function Test (LFT) panel. It is ordered to investigate jaundice (yellowing of the skin and eyes), monitor the progression of liver diseases like hepatitis or cirrhosis, and evaluate potential gallstones or bile duct obstructions. In newborns, it is used to monitor neonatal jaundice and prevent brain damage (kernicterus).
  • Hepatitis: Viral or toxic inflammation of the liver.
  • Cirrhosis: Long-term scarring of liver tissue.
  • Gilbert’s Syndrome: A common, harmless genetic condition where the liver doesn't process bilirubin properly.
  • Hemolysis: Conditions that cause rapid RBC destruction (e.g., sickle cell, G6PD deficiency).
  • Choledocholithiasis: Gallstones blocking the common bile duct.
While 'Total' bilirubin gives a baseline, if it is high, doctors will usually 'fractionate' it to see if the elevation is 'indirect' (suggesting blood breakdown or liver processing issues) or 'direct' (suggesting a physical blockage in the bile ducts).
View Interpretation
Metabolic

Total Bilirubin

Total Bilirubin measures the sum of conjugated (direct) and unconjugated (indirect) bilirubin in the blood. It is a primary indicator of the liver's ability to process and excrete breakdown products of hemoglobin. Within a Liver Function Test (LFT), it helps differentiate between hepatobiliary disease, hemolysis, and biliary obstruction. Elevated levels often manifest clinically as jaundice.
View Interpretation
Metabolic

Total Cholesterol

Cholesterol is a waxy, fat-like substance found in all cells of the body. It is essential for the production of hormones (estrogen, testosterone, cortisol), Vitamin D, and bile acids that help digest fat. The 'Total Cholesterol' measurement is a sum of your blood's cholesterol content, including High-Density Lipoprotein (HDL), Low-Density Lipoprotein (LDL), and Very-Low-Density Lipoprotein (VLDL). Total cholesterol is a key component of a lipid panel used to assess cardiovascular health. It is ordered to:
  • Screen for CVD Risk: Determine the risk of developing plaque in the arteries (atherosclerosis).
  • Monitor Lifestyle Changes: Evaluate the effectiveness of diet and exercise.
  • Check Medication Efficacy: Monitor patients on statins or other lipid-lowering therapies.
  • Hyperlipidemia: Elevated blood fats.
  • Atherosclerosis: Hardening of the arteries.
  • Hypothyroidism: Can lead to elevated cholesterol levels.
  • Liver Disease: Can affect cholesterol synthesis.
View Interpretation
Metabolic

Total Cholesterol

Total Cholesterol is a measurement of all the cholesterol components in the blood, including LDL (low-density lipoprotein), HDL (high-density lipoprotein), and VLDL (very-low-density lipoprotein). It is a primary screening tool for hyperlipidemia and an essential component in calculating the 10-year risk of atherosclerotic cardiovascular disease (ASCVD).
View Interpretation
Hematology

Total Count Differential Count (Tcdc-X)

The TCDC (Total Count and Differential Count) is a fundamental blood test that measures the total number of white blood cells (WBCs) and the percentage of each type (Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils). The 'X' typically refers to an automated or specific platform-specific methodology. This is one of the most common lab tests, ordered to:
  • Check for infection or inflammation.
  • Monitor the body's response to various treatments (like chemotherapy).
  • Screen for blood disorders such as leukemia or anemia.
  • Evaluate immune system health.
  • Leukocytosis: Elevated WBCs, often due to infection, stress, or leukemia.
  • Leukopenia: Low WBCs, possibly due to bone marrow failure, autoimmune diseases, or medication side effects.
  • Eosinophilia: Often linked to allergies or parasitic infections.
View Interpretation
Immunology

Total IgE

Immunoglobulin E (IgE) is a class of antibodies produced by the immune system that plays a pivotal role in Type I hypersensitivity reactions (allergic reactions) and the defense against parasitic infections. While IgE is typically present in the blood in very low concentrations, its production increases significantly when the body overreacts to environmental allergens or encounters specific pathogens. The Total IgE test is ordered as a preliminary screen for allergic diseases. It helps clinicians differentiate between allergic and non-allergic respiratory conditions (such as allergic vs. vasomotor rhinitis). It is also used in the diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA) and to screen for parasitic infestations. In some cases, it helps determine if a patient is a candidate for certain biologic therapies (like Omalizumab) for severe asthma.
  • Atopic Diseases: Including asthma, hay fever (allergic rhinitis), and atopic dermatitis (eczema).
  • Parasitic Infections: Specifically helminthic (worm) infestations like ascariasis or hookworm.
  • Hyper-IgE Syndrome (Job's Syndrome): A rare genetic primary immunodeficiency.
  • Multiple Myeloma: Rarely, an IgE-secreting myeloma can occur.
While a high Total IgE suggests an allergic predisposition (atopy), it does not identify the specific allergen responsible; further 'Specific IgE' or skin prick testing is required for targeted diagnosis.
View Interpretation
Immunology

Total IgE

Immunoglobulin E (IgE) is an antibody linked to allergic reactions and defense against parasites. In an Allergy Profile, the Total IgE provides an overview of the body's 'atopic' status—the general genetic predisposition to develop allergies. While it doesn't tell you what you are allergic to, it indicates the likelihood that symptoms are allergy-driven rather than irritant-driven.
View Interpretation
Immunology

Total IgE (Immunoglobulin E)

The Total IgE test measures the overall concentration of IgE antibodies in the blood. IgE is the antibody class primarily responsible for Type I hypersensitivity reactions (allergic reactions). In an 'Allergy Profile', it acts as a screening marker; elevated levels suggest an 'atopic' constitution—meaning the patient is prone to developing allergies, asthma, or eczema. It is also a critical marker for diagnosing parasitic infections and certain bronchopulmonary conditions like ABPA.
View Interpretation
Hematology

Total Iron Binding Capacity (TIBC)

TIBC is a functional measure of the maximum amount of iron that can be bound by serum proteins, primarily transferrin. In an Iron Deficiency Profile, TIBC is used alongside serum iron and ferritin to calculate Transferrin Saturation. It is a critical diagnostic tool: in iron deficiency, the body increases transferrin production to 'scavenge' for iron, leading to an elevated TIBC. This helps differentiate iron deficiency anemia from the anemia of chronic disease.
View Interpretation
Hematology

Total Leucocyte Count (TC)

The Total Leucocyte Count (TLC) measures the total number of white blood cells (WBCs) in a microliter of blood. Within the context of an Hb, Tc, Dc & Esr panel, it serves as a primary indicator of the body's immune response. Elevated levels typically suggest an active defense against bacterial infections, tissue necrosis, or inflammation, while low levels may indicate bone marrow suppression, viral infections, or autoimmune disorders. It is a critical baseline for monitoring systemic health.
View Interpretation
Hematology

Total Leucocyte Count (WBC)

Component of White Blood Cell differential.
View Interpretation
Hematology

Total Leucocyte Count (WBC)

The Total Leucocyte Count measures the total number of white blood cells (WBCs) per microliter of blood. In the TC & DC panel, it acts as a primary indicator of the body's immune response. It helps clinicians differentiate between bacterial infections, viral infections, and inflammatory states, while also monitoring the bone marrow's capacity to produce immune cells.
View Interpretation
Hematology

Total Leukocyte Count

The Total Leukocyte Count (WBC count) measures the total number of white blood cells in a microliter of blood. These cells are the primary defenders of the immune system, responsible for fighting infections, reacting to foreign substances, and responding to tissue injury. A WBC count is one of the most common lab tests, typically part of a Complete Blood Count (CBC). It is used to screen for infections, inflammation, allergies, and disorders of the bone marrow. It is also used to monitor the body's response to treatments like chemotherapy or radiation.
  • Infection: Bacterial infections typically cause an increase (leukocytosis), while certain viral infections can cause a decrease (leukopenia).
  • Inflammation: Conditions like rheumatoid arthritis or inflammatory bowel disease can raise the count.
  • Leukemia: Cancers of the blood-forming tissues can cause extremely high or abnormally low counts of dysfunctional white cells.
  • Bone Marrow Suppression: Caused by medications, toxins, or vitamin deficiencies (B12/Folate).
While the total count provides a snapshot of immune activity, it is often interpreted alongside a 'differential' count, which breaks down the specific types of white cells (neutrophils, lymphocytes, etc.) to pinpoint the exact nature of the physiological stressor.
View Interpretation
Hematology

Total Leukocyte Count (TC)

The Total Leukocyte Count (TLC) measures the total number of white blood cells (WBCs) in a volume of blood. Within a hematology panel, it acts as a primary indicator of the body's immune status. It is essential for diagnosing infections, inflammatory conditions, and hematologic malignancies like leukemia. A rise or fall in TLC provides the first clue to acute physiologic stress or bone marrow suppression.
View Interpretation
Hematology

Total Leukocyte Count (WBC)

The Total Leukocyte Count measures the sum of all white blood cell subtypes (neutrophils, lymphocytes, monocytes, eosinophils, and basophils). It serves as a primary indicator of immune system activation. In the context of the TCDC panel, it is the 'master number' used to screen for systemic infection, inflammation, bone marrow disorders, and immune status. A rapid shift in WBC is a hallmark of the body's defense mechanism against pathogens.
View Interpretation
Respiratory

Total Lung Capacity (TLC)

Total Lung Capacity (TLC) is the volume of air contained in the lungs at the end of a maximal inspiration. In a Pulmonary Function Test (PFT), TLC is the gold standard for diagnosing restrictive lung diseases. While spirometry (FVC/FEV1) suggests restriction, a measurement of TLC (via plethysmography or gas dilution) is required to confirm it. It helps differentiate between intrinsic lung diseases (like pulmonary fibrosis) and extrinsic factors (like chest wall deformities or obesity).
View Interpretation
Immunology

Total Lymphocyte Count

The Total Lymphocyte Count (TLC) measures the absolute number of lymphocytes (T-cells, B-cells, and Natural Killer cells) per microliter of blood. Within the context of a CD4 & CD8 Count panel, TLC is critical because absolute CD4/CD8 counts are often derived from the TLC and the percentage of specific T-cell subsets. It serves as a surrogate marker for immune competence, particularly in resource-limited settings for monitoring HIV progression or response to antiretroviral therapy (ART). Persistent lymphopenia is a significant predictor of opportunistic infections and mortality in immunocompromised patients.
View Interpretation
Reproductive Health

Total Motility

Total Motility represents the percentage of sperm showing any form of movement (both progressive and non-progressive). In a Semen Analysis, this is a critical determinant of male fertility potential. For natural conception, sperm must not only be present but must possess the kinetic energy to traverse the female reproductive tract to reach the oocyte.
View Interpretation
Metabolic

Total Protein

Total Protein measures the combined amount of albumin and globulins in the serum. Within a Liver Function Test (LFT), it provides insight into the liver's biosynthetic capacity and the body's overall nutritional status. Because the liver produces albumin and most globulins, a drop in total protein can signal advanced liver cirrhosis or chronic damage. It also reflects kidney function (protein loss) and immune system activity (globulin production).
View Interpretation
Metabolic

Total Protein

Serum Total Protein measures the combined amount of albumin and globulins. It is a vital marker of nutritional status and is used to screen for liver disease, kidney disease (nephrotic syndrome), and plasma cell dyscrasias like Multiple Myeloma. It is the 'denominator' used to calculate the A/G Ratio, which helps narrow down the cause of protein imbalances.
View Interpretation
Hematology

Total Protein

As part of Serum Electrophoresis, Total Protein represents the sum of Albumin and all Globulin fractions. It provides the quantitative baseline necessary to calculate the absolute concentration of electrophoretic bands (Alpha-1, Alpha-2, Beta, and Gamma). It is essential for screening for monoclonal gammopathies (like Multiple Myeloma), nutritional status, and liver/kidney function.
View Interpretation
Immunology

Total Protein

Total protein measures the combined amount of albumin and globulins in the serum. In the context of Serum Protein Electrophoresis (SPEP), it provides the baseline denominator required to calculate the absolute concentration of individual protein fractions. It is a vital indicator of nutritional status, hepatic synthesis capacity, and renal integrity.
View Interpretation
Metabolic

Total Proteins

The Total Protein test measures the cumulative amount of albumin and globulin in the blood serum. Albumin, produced by the liver, accounts for about 60% of the total protein and maintains oncotic pressure (keeping fluid from leaking out of blood vessels). Globulins are a diverse group of proteins including enzymes, antibodies, and transport proteins that play a vital role in immunity and clotting. This test is a staple of the Comprehensive Metabolic Panel (CMP). It is used to screen for nutritional status, liver disease, kidney disorders, and various blood cancers. It is often ordered when patients experience unexplained swelling (edema), fatigue, or symptoms of malnutrition.
  • Hyperproteinemia (High): Often seen in chronic inflammation, infections (like HIV or Hepatitis B/C), or bone marrow disorders such as Multiple Myeloma where the body overproduces monoclonal proteins.
  • Hypoproteinemia (Low): Commonly associated with severe liver disease (decreased production), nephrotic syndrome (loss through kidneys), or malabsorption syndromes (like Celiac disease).
The ratio between albumin and globulin (A/G ratio) is often calculated alongside total protein to provide deeper insight. For instance, a normal total protein with a low A/G ratio might suggest an autoimmune disease or a plasma cell dyscrasia.
View Interpretation
Reproductive Health

Total Sperm Number

Total Sperm Number represents the total count of spermatozoa in the entire volume of the ejaculate. Unlike concentration (sperm per mL), this value accounts for the total output of the testes and the patency of the male reproductive tract. It is a cornerstone metric in 'Semen Analysis' for assessing male fertility potential and is often used to calculate the Total Motile Sperm Count (TMSC), which is a strong predictor of pregnancy outcomes.
View Interpretation
Endocrinology

Total Thyroxine (T4)

Total Thyroxine (T4) is the primary hormone produced and released into the bloodstream by the thyroid gland. It exists in two forms: 'bound' (attached to proteins like thyroxine-binding globulin) and 'free' (unbound and active). The Total T4 test measures both. T4 is essential for regulating the body's basal metabolic rate, heart function, digestive health, muscle control, and brain development. It acts as a precursor to T3 (Triiodothyronine), the more potent thyroid hormone. Physicians order a Total T4 test to evaluate thyroid function and help diagnose conditions like hyperthyroidism or hypothyroidism. It is frequently part of a thyroid panel that includes TSH (Thyroid Stimulating Hormone) and Free T4. It is particularly useful when symptoms such as unexplained weight changes, rapid heart rate, fatigue, or sensitivity to cold or heat are present. It is also used to monitor the effectiveness of thyroid replacement therapy or anti-thyroid medications. Abnormal levels are associated with several key conditions:
  • Hyperthyroidism: Often caused by Graves' disease, toxic multinodular goiter, or thyroiditis, resulting in excessive T4 production.
  • Hypothyroidism: Typically caused by Hashimoto's thyroiditis, iodine deficiency, or pituitary gland dysfunction, leading to insufficient T4.
  • Thyroid Storm: A life-threatening condition of extreme hyperthyroidism.
  • Non-Thyroidal Illness: Severe systemic illness can sometimes temporarily lower T4 levels without primary thyroid disease.
View Interpretation
Endocrinology

Total Thyroxine (T4)

Total T4 measures the entire amount of thyroxine circulating in the blood, including the portion bound to transport proteins (like TBG) and the 'free' physiologically active portion. It is a cornerstone of the Thyroid Function Test panel to assess hyperthyroidism or hypothyroidism. It reflects the thyroid gland's secretory capacity under the regulation of TSH.
View Interpretation
Endocrinology

Total Triiodothyronine (T3)

Triiodothyronine (T3) is one of the two major hormones produced by the thyroid gland. While the thyroid produces more T4 (thyroxine), T3 is the much more metabolically active form. Most T3 in the blood is bound to proteins (like thyroid-binding globulin). The 'Total T3' test measures both the bound and the free (unbound) portions of the hormone. It is primarily used to diagnose and monitor hyperthyroidism (overactive thyroid). In many cases of hyperthyroidism, T3 levels rise before T4 levels do. It is also used to diagnose 'T3 Toxicosis,' a condition where T4 is normal but T3 is elevated. It is less useful for diagnosing hypothyroidism, as it is often the last value to drop.
  • Graves' Disease: An autoimmune cause of hyperthyroidism.
  • Toxic Nodular Goiter: Small masses in the thyroid that overproduce hormone.
  • Thyroiditis: Inflammation that causes a temporary leak of hormone into the blood.
  • Hypothyroidism: Underactive thyroid (though TSH and Free T4 are preferred for this).
View Interpretation
Endocrinology

Total Triiodothyronine (T3)

T3 is the metabolically active form of thyroid hormone. While T4 is more abundant, T3 is significantly more potent. In a Thyroid Function Test, Total T3 measures both bound and unbound forms. It is particularly useful for diagnosing T3 toxicosis, a form of hyperthyroidism where T4 is normal but T3 is elevated, and for monitoring the severity of hyperthyroid states.
View Interpretation
Hematology

Total White Blood Cell Count

Identical in clinical function to the WBC count, this measurement evaluates the total immune cell presence in the peripheral blood. In the context of a 'Hemoglobin and Differential' panel, it provides the denominator used to calculate the absolute counts of neutrophils, lymphocytes, monocytes, eosinophils, and basophils. It is the first line of defense assessment against pathogens.
View Interpretation
Hematology

Total White Blood Cell Count

The Total White Blood Cell (WBC) count measures the sum of all leukocytes in the blood, including neutrophils, lymphocytes, monocytes, eosinophils, and basophils. It serves as a primary indicator of the body's immune response. Within a CBC panel, the total count provides the first clue to underlying systemic issues such as acute bacterial or viral infections, chronic inflammatory conditions, bone marrow suppression, or hematologic malignancies like leukemia.
View Interpretation
Infectious Disease

Toxoplasma IgG

The Toxoplasma IgG test is a serological assay used to detect antibodies against Toxoplasma gondii, a protozoan parasite. The IgG (Immunoglobulin G) antibody is produced by the immune system to provide long-term protection after an initial exposure. This test determines whether an individual has been infected with the parasite at some point in their life. This test is primarily ordered for:
  • Prenatal Screening: To determine if a pregnant woman has immunity or is at risk of a primary infection, which can be transmitted to the fetus.
  • Immunocompromised Patients: Individuals with HIV/AIDS or those undergoing chemotherapy are at risk of reactivation of latent toxoplasmosis, which can cause encephalitis.
  • Symptomatic Individuals: Those presenting with flu-like symptoms, swollen lymph nodes, or vision issues (ocular toxoplasmosis).
  • Congenital Toxoplasmosis: Severe birth defects or miscarriage resulting from maternal infection during pregnancy.
  • Toxoplasmic Encephalitis: Brain inflammation typically seen in late-stage AIDS patients.
  • Chorioretinitis: Inflammation of the choroid and retina that can lead to permanent vision loss.
Exposure often occurs through contact with cat feces, consuming undercooked contaminated meat, or drinking contaminated water. A positive IgG result generally indicates past infection and immunity, provided the patient is immunocompetent.
View Interpretation
Infectious Disease

Toxoplasma IgM

Toxoplasma IgM is an antibody produced by the immune system in response to an acute infection with Toxoplasma gondii, a protozoan parasite. This parasite is commonly transmitted through undercooked meat, contact with infected cat feces, or mother-to-fetus during pregnancy. IgM antibodies are the first line of defense and typically appear within 1–2 weeks after exposure, peaking within a month. This test is primarily ordered to determine if a patient has a recent or current infection. It is critically important for:
  • Pregnant Women: To assess the risk of congenital toxoplasmosis, which can cause severe neurological or ocular damage to the fetus.
  • Immunocompromised Individuals: Such as those with HIV/AIDS or transplant recipients, where a reactivation of the parasite can lead to life-threatening encephalitis.
  • Symptomatic Patients: Those experiencing flu-like symptoms, swollen lymph nodes, or muscle aches with a history of exposure risk.
  • Acute Toxoplasmosis: The primary condition indicated by elevated IgM.
  • Congenital Toxoplasmosis: If detected in a newborn or via amniotic fluid.
  • Ocular Toxoplasmosis: Infection affecting the retina, potentially leading to vision loss.
  • Toxoplasmic Encephalitis: Central nervous system involvement, usually in severely immunocompromised patients.
View Interpretation
Infectious Disease

Toxoplasma PCR

The Toxoplasma PCR (Polymerase Chain Reaction) test is a molecular diagnostic tool used to detect the DNA of the parasite Toxoplasma gondii. Unlike serology, which looks for the body's immune response (antibodies), PCR identifies the presence of the pathogen itself by amplifying specific genetic sequences. This allows for the detection of the parasite during the acute phase of infection, even before an antibody response has fully developed. This test is critical in specific high-risk scenarios. It is frequently ordered for:
  • Immunocompromised Patients: Individuals with HIV/AIDS or those undergoing chemotherapy who are at risk for life-threatening toxoplasmic encephalitis.
  • Congenital Screening: Testing amniotic fluid if a pregnant woman has a suspected primary infection to determine if the parasite has crossed the placenta.
  • Ocular Toxoplasmosis: Testing vitreous fluid when a patient presents with severe eye inflammation suspected to be parasitic in origin.
  • Acute Toxoplasmosis: Usually mild in healthy adults but can cause 'flu-like' symptoms.
  • Congenital Toxoplasmosis: Can lead to neurological issues or vision loss in newborns.
  • Cerebral Toxoplasmosis: A major opportunistic infection in AIDS patients, characterized by brain lesions.
View Interpretation
Hematology

Transferrin Saturation

Transferrin Saturation (TSAT) is a calculated percentage [(Serum Iron / TIBC) x 100]. Within an Iron Deficiency Profile, it represents the amount of iron currently available to the bone marrow for erythropoiesis. It is often the most sensitive indicator of iron deficiency, frequently dropping before the hemoglobin or even ferritin in certain clinical contexts.
View Interpretation
Molecular Hematology

Translocation PML/RARa Quant. RT-PCR (MRD)

This is a highly sensitive molecular test using Quantitative Real-Time Polymerase Chain Reaction (RT-PCR) to detect the PML/RARa fusion transcript. This transcript results from a reciprocal translocation between chromosomes 15 and 17 [t(15;17)], which is the genetic hallmark of Acute Promyelocytic Leukemia (APL). This test is used for both initial diagnosis and long-term monitoring of APL patients. It is the gold standard for measuring Minimal Residual Disease (MRD).
  • Diagnosis: To confirm the specific subtype of leukemia and initiate targeted therapy (like ATRA and Arsenic Trioxide).
  • Monitoring: To see how well treatment is working.
  • Early Relapse Detection: To identify a molecular relapse (reappearance of the transcript) before a clinical relapse (reappearance of cancer cells in blood) occurs, allowing for early intervention.
  • Acute Promyelocytic Leukemia (APL): A specific, once-deadly but now highly curable form of AML.
  • Molecular Remission: When the RT-PCR can no longer detect the fusion transcript in the blood or bone marrow.
View Interpretation
Metabolic

Triglycerides

Triglycerides are a type of lipid (fat) found in the blood. When you eat, the body converts calories it doesn't need to use right away into triglycerides, which are stored in fat cells. Later, hormones release them for energy between meals. While essential for life, high levels in the bloodstream are a major marker for metabolic health. Triglycerides are measured as part of a lipid panel to:
  • Assess Cardiovascular Risk: High levels contribute to the hardening of arteries (atherosclerosis).
  • Monitor Metabolic Syndrome: Along with blood pressure, glucose, and waist circumference.
  • Screen for Pancreatitis Risk: Extremely high levels (>500 mg/dL) can cause acute inflammation of the pancreas.
  • Hypertriglyceridemia: Often caused by obesity, sedentary lifestyle, or high-sugar diets.
  • Type 2 Diabetes: Elevated levels are frequently seen with insulin resistance.
  • Hypothyroidism: Can slow lipid metabolism.
  • Kidney Disease: Nephrotic syndrome can alter lipid profiles.
View Interpretation
Body Fluids

Triglycerides

Measuring triglycerides in ascitic fluid is the definitive method for identifying 'chylous ascites.' Chylous ascites is the accumulation of lipid-rich lymph in the peritoneal cavity, usually resulting from lymphatic obstruction or trauma. In a biochemical analysis of ascitic fluid, this helps distinguish between cirrhosis (low triglycerides) and lymphatic-related pathologies (high triglycerides).
View Interpretation
Metabolic

Triglycerides

Triglycerides are the most common form of fat in the body, serving as a primary energy source. In a lipid profile, they are a key marker for cardiovascular risk. Elevated levels are associated with metabolic syndrome, insulin resistance, and an increased risk of coronary artery disease. Extremely high levels (>500 mg/dL) pose a significant risk for acute pancreatitis.
View Interpretation
Prenatal

Triple Screen Marker Test

The Triple Screen, also known as the Kettering test or Bart's test, is a prenatal blood test performed during the second trimester (usually between weeks 15 and 20). It measures three substances in the mother's blood: Alpha-fetoprotein (AFP), Human Chorionic Gonadotropin (hCG), and Unconjugated Estriol (uE3). This is a screening test (not a diagnostic test) used to evaluate the statistical risk that the fetus may have certain chromosomal abnormalities or neural tube defects. It is offered to all pregnant women but is particularly relevant for those over age 35 or with a family history of birth defects.
  • Neural Tube Defects (NTDs): Such as spina bifida or anencephaly (associated with high AFP).
  • Trisomy 21 (Down Syndrome): Often associated with low AFP, high hCG, and low uE3.
  • Trisomy 18 (Edwards Syndrome): Often associated with low levels of all three markers.
  • Multiple Gestation: Carrying twins or triplets can naturally elevate these levels.
View Interpretation
Cardiac Markers

Troponin I

Troponin I is a protein found specifically in heart muscle fibers. It is part of the mechanism that regulates heart contraction. In healthy individuals, Troponin I levels in the blood are so low they are often undetectable. However, when heart muscle cells (myocytes) are damaged or die, they leak Troponin I into the bloodstream. This is the 'gold standard' test for diagnosing a myocardial infarction (heart attack). It is ordered urgently for anyone presenting with chest pain, pressure, or other symptoms of Acute Coronary Syndrome (ACS). Doctors typically order a 'serial troponin' (a sequence of tests over several hours) to see if levels are rising or falling.
  • Myocardial Infarction: A sharp rise and fall in Troponin I confirms heart muscle death.
  • Myocarditis: Inflammation of the heart muscle due to infection.
  • Congestive Heart Failure: Chronic elevation can occur in advanced heart failure.
  • Pulmonary Embolism: A large blood clot in the lung can strain the heart, causing troponin release.
Because Troponin I is highly specific to the heart, it is preferred over older markers like CK-MB. A rising trend is highly diagnostic of acute injury, whereas a stable, slightly elevated level might indicate chronic kidney disease or structural heart issues.
View Interpretation
Radiology

Ultrasound Complete Abdomen

This imaging study utilizes high-frequency sound waves to visualize the morphology, size, and vascularity of the major abdominal organs, including the liver, gallbladder, spleen, pancreas, kidneys, and abdominal aorta. It is clinically significant for detecting cholelithiasis (gallstones), nephrolithiasis (kidney stones), hepatomegaly, splenomegaly, and abdominal aortic aneurysms (AAA). It is also the primary screening tool for ascites and localized masses or cysts within the abdominal cavity.
View Interpretation
Hematology

Unsaturated Iron Binding Capacity (UIBC)

UIBC measures the reserve capacity of transferrin (the primary iron transport protein) that is not yet bound to iron. In an Iron Deficiency Profile, it is calculated by subtracting the serum iron from the Total Iron Binding Capacity (TIBC). It is a sensitive marker for iron status: as iron stores deplete, the body increases transferrin production, leading to a higher UIBC. Conversely, in iron overload states, the UIBC decreases as more binding sites are occupied.
View Interpretation
Microbiology

Urethral Pus for Culture and Sensitivity

The Urethral Pus Culture and Sensitivity test is a diagnostic procedure used to identify the specific microorganism (bacteria or fungi) causing an infection in the urethra. Beyond identification, the 'sensitivity' portion determines which antibiotics are most effective at killing the specific pathogen found. This test is primarily ordered when a patient presents with symptoms of urethritis, such as discharge (pus) from the penis or vagina, painful urination (dysuria), or urethral itching. It is a gold-standard test for diagnosing Sexually Transmitted Infections (STIs) and complicated Urinary Tract Infections (UTIs).
  • Gonorrhea: Caused by Neisseria gonorrhoeae.
  • Non-Gonococcal Urethritis (NGU): Often caused by Chlamydia trachomatis or Mycoplasma genitalium.
  • Bacterial Prostatitis: In men, urethral pathogens can sometimes migrate to the prostate.
  • Antibiotic Resistance: The sensitivity report is crucial for managing 'superbugs' that do not respond to standard treatments.
View Interpretation
Microbiology

Urethral Pus for Z.N. Stain

The Ziehl-Neelsen (Z.N.) stain, also known as the acid-fast stain, is a bacteriological colorization technique used specifically to identify acid-fast organisms, most notably Mycobacterium tuberculosis. When applied to urethral pus or discharge, the primary objective is to detect the presence of Genitourinary Tuberculosis (GUTB), a form of extrapulmonary tuberculosis. This test relies on the unique properties of mycobacterial cell walls, which contain high amounts of mycolic acids that resist decolorization by acid-alcohol after being stained with carbol-fuchsin. Physicians order a Z.N. stain on urethral discharge when a patient presents with chronic symptoms of urethritis or cystitis that do not respond to standard antibiotic treatments for common sexually transmitted infections (STIs). Indications include:
  • Chronic urethral discharge without identified common pathogens (like Gonorrhea or Chlamydia).
  • Sterile pyuria (white blood cells in urine without bacterial growth on standard media).
  • Persistent lower urinary tract symptoms (LUTS) in patients with a history of TB exposure.
  • Suspected tuberculosis of the prostate or seminal vesicles.
The primary condition associated with a positive result is Genitourinary Tuberculosis. While less common than pulmonary TB, GUTB is a significant cause of morbidity and can lead to strictures in the urethra, scarring of the bladder (thimble bladder), and potential infertility due to involvement of the reproductive organs. In rare cases, other non-tuberculous mycobacteria (NTM) may also show acid-fast positivity, though clinical context usually points toward M. tuberculosis in the urogenital tract. Because TB is a systemic infection, a positive result necessitates a full investigation of the kidneys and lungs.
View Interpretation
Microbiology

Urethral Smear For Gram's Stain

A Gram's stain of a urethral smear is a rapid diagnostic tool used to identify the presence of bacteria and inflammatory cells (neutrophils) in the male urethra. The process involves staining a sample with crystal violet and safranin dyes to differentiate bacteria into Gram-positive (purple) or Gram-negative (pink) based on their cell wall composition. This test is primarily used for the rapid diagnosis of urethritis (inflammation of the urethra). It is a frontline test for:
  • Gonorrhea Screening: Identifying Gram-negative intracellular diplococci (GNID), which is highly presumptive for Neisseria gonorrhoeae in symptomatic males.
  • Non-Gonococcal Urethritis (NGU): Identifying inflammation (high white blood cell count) without visible diplococci, often suggesting Chlamydia trachomatis or Mycoplasma genitalium.
  • Symptomatic Evaluation: Investigation of penile discharge, painful urination (dysuria), or urethral itching.
  • Gonorrhea: A common sexually transmitted infection (STI).
  • Chlamydia: Often co-exists with gonorrhea.
  • Urethritis: General inflammation often caused by infection or irritation.
  • Prostatitis: In some cases, urethral discharge may be related to prostate involvement.
View Interpretation
Microbiology

Urethral Smear for Gram Stain

The Urethral Smear Gram Stain is a rapid diagnostic test used to identify bacteria in the urethra. It involves taking a swab of urethral discharge, staining it with Gram's reagents, and examining it under a microscope. This allows for the immediate visualization of bacterial morphology (shape) and Gram reaction (positive or negative). This test is primarily ordered when a patient presents with symptoms of urethritis, such as painful urination (dysuria) or discharge. It is a cornerstone for diagnosing Sexually Transmitted Infections (STIs), particularly gonorrhea. Unlike a culture, which takes days, a Gram stain can provide results within minutes.
  • Gonorrhea: Indicated by the presence of Gram-negative intracellular diplococci (GNID) within white blood cells.
  • Non-Gonococcal Urethritis (NGU): Characterized by the presence of inflammatory cells (neutrophils) but an absence of typical gonorrhea bacteria. Common causes include Chlamydia trachomatis.
  • General Bacterial Infection: Identification of other pathogens or an overgrowth of skin flora that has entered the urinary tract.
Rapid diagnosis through Gram staining allows for the immediate initiation of antibiotic therapy, which is crucial for preventing the spread of STIs and avoiding complications like pelvic inflammatory disease (PID) or epididymitis.
View Interpretation
Microbiology

Urethral Swab Culture and Sensitivity

Urethral Swab Culture and Sensitivity is a diagnostic laboratory procedure used to identify the specific microorganisms causing an infection in the urethra. This test involves taking a sample of discharge or cellular material and placing it in growth media to see if bacteria, fungi, or other pathogens multiply. Once a pathogen is identified, 'sensitivity' testing determines which antibiotics or antimicrobials are most effective at killing the organism. This test is typically ordered when a patient presents with symptoms of urethritis, such as painful urination (dysuria), discharge, or itching. It is a gold-standard method for diagnosing sexually transmitted infections (STIs) and non-gonococcal urethritis when molecular methods (like PCR) are unavailable or when drug resistance is suspected.
  • Gonorrhea: Caused by Neisseria gonorrhoeae.
  • Chlamydia: Though often diagnosed via NAAT, cultures can be used in specific clinical contexts.
  • Non-Gonococcal Urethritis (NGU): Caused by organisms like Mycoplasma genitalium or Ureaplasma.
  • Fungal Urethritis: Less common, usually caused by Candida species.
The sensitivity portion of the test is crucial for modern medicine, as it prevents the misuse of antibiotics and ensures that the patient receives the most targeted treatment for their specific strain of infection.
View Interpretation
Rheumatology

Uric Acid

Uric Acid is the metabolic byproduct of purine degradation. In an Arthritis Basic Screen, it is used primarily to diagnose and monitor Gout, where monosodium urate crystals deposit in joints. It also serves as a marker for renal function and tumor lysis syndrome risk.
View Interpretation
Nephrology

Urine - Fatty Casts & Droplets

The detection of fatty casts and lipid droplets in urine is a specific microscopic finding known as 'lipiduria.' Fatty casts are formed when fat droplets (cholesterol or triglycerides) are incorporated into a protein matrix (Tamm-Horsfall protein) within the renal tubules. Under a polarized microscope, these lipids often display a characteristic 'Maltese Cross' appearance. This test is ordered when a physician suspects glomerular disease. It is a hallmark finding in patients presenting with heavy proteinuria (excessive protein in the urine). It helps differentiate between different types of kidney disease, specifically pointing toward those that cause significant damage to the glomerular filtration barrier.
  • Nephrotic Syndrome: The most common cause, characterized by high protein loss, low blood albumin, and high cholesterol.
  • Minimal Change Disease: A common cause of nephrotic syndrome in children.
  • Membranous Nephropathy: A leading cause of nephrotic syndrome in adults.
  • Diabetic Nephropathy: Advanced kidney damage due to long-standing diabetes.
  • Fat Embolism Syndrome: Rarely, fatty droplets may appear after major bone fractures.
View Interpretation
Oncology

Urine Bence Jones Proteins

Bence Jones proteins are monoclonal globulin proteins (free light chains) produced by neoplastic plasma cells. Unlike whole antibodies, these are small enough to pass through the kidneys and into the urine. Detecting these proteins is a hallmark of certain hematological malignancies. This test is primarily ordered when a healthcare provider suspects Multiple Myeloma or Waldenström macroglobulinemia. Symptoms triggering this order include unexplained bone pain, frequent infections, anemia, or high calcium levels. It is a critical component of a 'protein gap' investigation, where total protein is high but albumin is normal.
  • Multiple Myeloma: The most common cause; characterized by the proliferation of malignant plasma cells in the bone marrow.
  • Monoclonal Gammopathy of Undetermined Significance (MGUS): A precursor condition that may progress to myeloma.
  • Amyloidosis: Where these proteins deposit in tissues, causing organ dysfunction.
  • Chronic Lymphocytic Leukemia (CLL): Occasionally associated with light chain production.
The presence of Bence Jones proteins indicates 'monoclonality,' meaning a single clone of cells is overproducing a specific protein fragment. This often leads to kidney damage (Myeloma Kidney) as the proteins are toxic to the renal tubules. Monitoring levels helps assess treatment efficacy; a decrease in urine protein concentration typically indicates a positive response to chemotherapy or stem cell transplantation.
View Interpretation
Metabolic

Urine Bicarbonate

Urine Bicarbonate (HCO3-) testing measures the amount of bicarbonate excreted in the urine. Under normal physiological conditions, the kidneys reabsorb almost all filtered bicarbonate to maintain the body's pH at approximately 7.4. The presence of significant bicarbonate in the urine usually indicates a failure in this reabsorption process or a systemic attempt to compensate for alkalosis. This test is primarily used in the workup of complex acid-base disturbances, particularly:
  • Renal Tubular Acidosis (RTA): Specifically Type 2 (Proximal) RTA, where the kidney's proximal tubule fails to reabsorb bicarbonate.
  • Metabolic Alkalosis: To determine if the kidneys are correctly excreting excess base.
  • Unexplained Acidosis: To differentiate between kidney-related and GI-related causes of low blood pH.
  1. Proximal RTA (Type 2): High urine bicarbonate levels despite low blood bicarbonate.
  2. Fanconi Syndrome: A generalized dysfunction of the proximal tubule.
  3. Metabolic Alkalosis: High levels of urine bicarbonate as the body tries to lower blood pH.
  4. Chronic Kidney Disease: May impair the ability to properly handle bicarbonate, though this is usually seen in later stages.
Diagnostic interpretation usually requires a simultaneous Blood Gas (ABG/VBG) or Serum Electrolyte panel to compare blood vs. urine levels.
View Interpretation
Metabolic

Urine Calcium

Urine calcium measures the amount of calcium excreted by the kidneys over a 24-hour period. Calcium is vital for bone health, nerve transmission, and muscle function. The body maintains blood calcium levels within a very tight range; the kidneys play a primary role in this by filtering calcium and either reabsorbing it into the blood or excreting the excess into the urine. The test is most frequently used to evaluate patients with recurrent kidney stones (nephrolithiasis), as high urine calcium is a major risk factor for stone formation. It is also used to diagnose parathyroid gland disorders, monitor the effects of Vitamin D supplementation, and investigate the causes of abnormal blood calcium levels. It helps clinicians distinguish between intestinal over-absorption of calcium and renal 'leaking' of calcium.
  • Hyperparathyroidism: Overactive parathyroid glands pull calcium from bones into the blood, leading to high urine excretion.
  • Sarcoidosis: An inflammatory disease that can increase Vitamin D sensitivity and calcium levels.
  • Renal Tubular Acidosis: A kidney condition that causes calcium to leach into the urine.
  • Osteoporosis: High urine calcium can sometimes indicate rapid bone loss.
  • Hypoparathyroidism: Results in low blood and urine calcium levels.
View Interpretation
Nephrology

Urine Clarity

Clarity (or turbidity) is a physical characteristic assessed during a routine urinalysis. Normal urine is clear. Turbidity occurs when suspended particles are present. While often benign (mucus or epithelial cells), it can be a primary indicator of infection (pyuria), presence of crystals (crystalluria), or even chyluria (lymph in urine).
View Interpretation
Nephrology

Urine Color

The color of urine is a primary physical characteristic evaluated during a Urine Routine examination. It is determined by the concentration of urochrome (urobilin) and is a direct indicator of hydration status. Beyond hydration, abnormal colors can signal the presence of blood (hematuria), bilirubin (liver disease), hemoglobin, or myoglobin (muscle breakdown).
View Interpretation
Metabolic

Urine Creatinine

Urine Creatinine measures the amount of creatinine (a byproduct of muscle metabolism) excreted in the urine over 24 hours. Within the context of a Creatinine Clearance Test, it is used as a denominator to calculate the Glomerular Filtration Rate (GFR). It helps clinicians determine if a 24-hour urine collection was 'complete' (since creatinine excretion is relatively constant) and is essential for diagnosing chronic kidney disease (CKD) and adjusting dosages for nephrotoxic drugs.
View Interpretation
Metabolic

Urine Electrolytes

Urine Electrolyte testing measures the concentration of minerals—specifically sodium (Na), potassium (K), and chloride (Cl)—excreted by the kidneys. These electrolytes are vital for maintaining fluid balance, nerve conduction, and muscle function. The kidneys' primary job is to adjust the excretion of these ions to maintain stable levels in the blood, making urine levels a direct reflection of renal response to systemic imbalances. This test is a cornerstone in the differential diagnosis of acute kidney injury (AKI) and hyponatremia (low blood sodium). It helps clinicians determine if the kidneys are conserving or wasting electrolytes. For example, in a dehydrated patient with low blood sodium, the kidneys should ideally conserve sodium (low urine sodium). If urine sodium is high, it suggests the kidneys themselves are the problem.
  • Hyponatremia: Differentiating between SIADH, heart failure, and dehydration.
  • Acute Tubular Necrosis (ATN): Characterized by the kidney's inability to concentrate urine and conserve sodium.
  • Adrenal Insufficiency (Addison’s Disease): Leads to excessive sodium loss and potassium retention.
  • Conn's Syndrome: Excessive potassium loss in urine.
  • Renal Tubular Acidosis: Affects the excretion of chloride and potassium.
While random urine samples provide a snapshot, 24-hour collections are the gold standard for metabolic evaluations as they account for diurnal variations and dietary intake throughout the day.
View Interpretation
Microbiology

Urine For A.F.B

The Urine for Acid-Fast Bacilli (AFB) test is a laboratory procedure used to detect mycobacteria, most notably Mycobacterium tuberculosis. Mycobacteria have a unique waxy cell wall that resists traditional staining; however, they retain red dyes even after being washed with acid (hence 'Acid-Fast'). This test typically involves a smear (microscopic exam) and a culture. This test is ordered when a doctor suspects Genitourinary Tuberculosis (GUTB). Symptoms might include blood in the urine (hematuria), frequent urination, or pain during urination that does not respond to standard antibiotics. It is particularly indicated if a patient has 'sterile pyuria'—the presence of white blood cells in the urine without a standard bacterial infection.
  • Genitourinary Tuberculosis: Infection of the kidneys, ureters, or bladder by M. tuberculosis.
  • Systemic Tuberculosis: Disseminated TB that has spread to the renal system.
  • Nontuberculous Mycobacteria (NTM) Infections: Infections by other species of mycobacteria that are not TB but are still acid-fast.
View Interpretation
Microbiology

Urine For AFB (3 Samples)

The Urine for AFB (Acid-Fast Bacilli) test is a specialized microbiological culture and microscopic examination used primarily to detect Mycobacterium tuberculosis within the genitourinary tract. Because the shedding of mycobacteria in urine can be intermittent, three separate early morning samples are typically required to maximize the diagnostic yield. This test is ordered when a patient presents with symptoms suggestive of renal or urogenital tuberculosis, such as:
  • Unexplained hematuria (blood in urine).
  • Sterile pyuria (white blood cells in urine without bacterial growth on standard cultures).
  • Chronic flank pain or dysuria.
  • Systemic symptoms like night sweats, weight loss, and low-grade fever.
Extrapulmonary tuberculosis specifically affecting the kidneys, ureters, or bladder is the primary condition associated with a positive result. It may also detect atypical mycobacteria in immunocompromised individuals (e.g., those with HIV/AIDS). Genitourinary TB is often a late manifestation of a primary pulmonary infection that spread via the bloodstream years earlier.
View Interpretation
Nephrology

Urine For Albumin

Albumin is a protein typically found in high concentrations in the blood. In healthy kidneys, the filtration system (glomeruli) prevents albumin from leaking into the urine. This test measures the amount of albumin present in a urine sample. Detecting even small amounts (microalbuminuria) is one of the earliest signs of kidney damage. This test is a cornerstone for monitoring patients with chronic conditions that risk damaging the kidneys, primarily Diabetes Mellitus (Type 1 and Type 2) and Hypertension. The American Diabetes Association recommends annual screening for albuminuria to catch early-stage diabetic nephropathy when it is still reversible or manageable through medication and lifestyle changes.
  • Diabetic Nephropathy: Kidney disease resulting from long-term diabetes.
  • Hypertensive Renal Disease: Damage to kidney vessels due to high blood pressure.
  • Glomerulonephritis: Inflammation of the kidney's filtering units.
  • Cardiovascular Disease: High urine albumin is also a marker for systemic vascular dysfunction and increased heart disease risk.
View Interpretation
Enzymes

Urine For Amylase

Amylase is an enzyme primarily produced by the pancreas and salivary glands to help digest carbohydrates. While serum amylase rises quickly during acute events, urine amylase levels remain elevated for several days after blood levels have returned to normal. This makes the urine test particularly useful for detecting pancreatic issues that occurred a few days prior. This test is ordered to diagnose or monitor acute pancreatitis, chronic pancreatitis, and other pancreatic disorders. It may also be used to distinguish between different causes of abdominal pain or to evaluate a patient with suspected salivary gland inflammation.
  • Acute Pancreatitis: Sudden inflammation of the pancreas.
  • Pancreatic Pseudocyst: A fluid-filled sac in the pancreas following an injury.
  • Salivadenitis: Inflammation of the salivary glands.
  • Macroamylasemia: A benign condition where amylase binds to proteins, slowing its clearance.
Pancreas health, amylase urine test, pancreatitis diagnosis, digestive enzymes.
View Interpretation
Urology

Urine For Chyle

The Urine for Chyle test detects the presence of chyle—a milky fluid consisting of lymph and emulsified fats (chylomicrons)—in the urine. This condition, known as chyluria, occurs when a communication (fistula) develops between the lymphatic vessels and the urinary tract. The test typically involves a physical inspection (milky appearance that doesn't clear with heat or acid) and chemical tests for triglycerides. This test is primarily ordered when a patient observes 'milky white' or 'cloudy' urine, especially after consuming a fatty meal. It is used to diagnose chyluria, which can lead to significant protein and fat loss, resulting in malnutrition and immunosuppression if left untreated.
  • Filariasis: The most common cause worldwide, where parasitic worms (Wuchereria bancrofti) obstruct lymphatic vessels.
  • Lymphatic Obstruction: Non-parasitic causes include abdominal tumors, trauma, or surgery that damages the lymphatic system.
  • Congenital Lymphatic Malformations: Rare structural issues in the lymphatic system present from birth.
  • Tuberculosis: In some cases, extrapulmonary TB can involve the retroperitoneal lymph nodes, leading to chyluria.
View Interpretation
Microbiology

Urine For Culture And Sensitivity

The Urine Culture and Sensitivity test is designed to identify specific bacteria or yeast causing a urinary tract infection (UTI) and to determine which antibiotics are most effective at inhibiting their growth. This 'Culture' identifies the organism, while 'Sensitivity' guides targeted therapy. This test is ordered when a patient exhibits symptoms of a UTI, such as painful urination (dysuria), frequent urination, urgency, or lower abdominal pain. It is also critical for:
  • Recurrent UTIs: To identify resistant strains.
  • Complicated Infections: Cases involving pregnancy, diabetes, or kidney stones.
  • Pyelonephritis: Suspected kidney infection indicated by flank pain and fever.
  • Post-Treatment: To ensure the eradication of a multidrug-resistant organism.
  • Cystitis: Infection of the bladder, commonly caused by E. coli.
  • Urethritis: Infection of the urethra.
  • Asymptomatic Bacteriuria: Presence of bacteria in urine without symptoms, critical to manage in pregnant women to prevent preterm labor.
  • Sepsis: If a UTI is left untreated, it can progress to a systemic bloodstream infection.
By matching the bacteria to the correct antibiotic, clinicians prevent the misuse of broad-spectrum drugs and reduce the risk of antibiotic resistance.
View Interpretation
Metabolic

Urine For GTT

The Urine Glucose Tolerance Test (GTT) is performed in conjunction with the oral blood glucose tolerance test. It measures the presence of glucose in the urine at specific intervals after a patient consumes a concentrated glucose beverage. Normally, the kidneys reabsorb almost all glucose from the filtrate; glucose only appears in the urine when blood levels exceed the 'renal threshold.' This test is primarily used to screen for gestational diabetes in pregnant women or to evaluate patients with suspected type 2 diabetes or renal glycosuria. It helps determine if the kidneys are leaking glucose at lower-than-expected blood sugar levels or if blood sugar is spiking so high that the kidneys cannot keep up.
  • Diabetes Mellitus: Persistent glycosuria during the test indicates high systemic blood sugar.
  • Gestational Diabetes: Critical for identifying pregnancy-induced glucose intolerance.
  • Renal Glycosuria: A condition where glucose is excreted in the urine despite normal blood glucose levels due to kidney tubule dysfunction.
  • Cushing’s Syndrome: Excess cortisol can lead to glucose intolerance.
While blood glucose testing is the gold standard, urine testing provides historical data on the 'spillover' effect during the test period. If glucose is found in the urine while blood levels are normal, it suggests a kidney-specific issue rather than a metabolic one.
View Interpretation
Reproductive Health

Urine For HCG (Pregnancy Test)

The Urine hCG test detects the presence of Human Chorionic Gonadotropin, a hormone produced by the placenta shortly after an embryo attaches to the uterine lining. This hormone rises rapidly in early pregnancy, doubling approximately every 48 to 72 hours. While blood tests are more sensitive, urine tests provide a rapid, non-invasive method for initial pregnancy screening. This test is primarily ordered to confirm pregnancy in individuals with a missed menstrual period. It is also used in emergency rooms and before surgical procedures or certain medical imaging (like X-rays or CT scans) to ensure that a patient is not pregnant, as treatments could potentially harm a developing fetus.
  • Normal Intrauterine Pregnancy: The most common cause of a positive result.
  • Ectopic Pregnancy: Pregnancy occurring outside the uterus; hCG levels may rise more slowly than normal.
  • Molar Pregnancy (Gestational Trophoblastic Disease): Abnormal tissue growth in the uterus that produces very high levels of hCG.
  • Germ Cell Tumors: Rarely, certain cancers of the ovaries or testes can produce hCG.
View Interpretation
Urinalysis

Urine For Microscopy

Urine microscopy is the physical examination of urine sediment under a microscope after centrifugation. It is the 'gold standard' for looking at the cellular components of the urinary tract that cannot be fully characterized by chemical dipsticks alone. It identifies Red Blood Cells (RBCs), White Blood Cells (WBCs), epithelial cells, bacteria, yeast, crystals, and casts. This test is a cornerstone of renal and urological health screening. It is ordered for:
  • Infection Detection: Identifying bacteria and high WBC counts (pyuria) indicating a Urinary Tract Infection (UTI).
  • Kidney Disease Screening: Looking for 'casts' (cylindrical structures formed in the kidney tubules) which are hallmarks of renal pathology like glomerulonephritis.
  • Stone Evaluation: Detecting crystals (calcium oxalate, uric acid) that may indicate a predisposition to kidney stones.
  • Hematuria Investigation: Identifying the source of blood in the urine.
Microscopy can reveal much about systemic health. The presence of dysmorphic RBCs suggests glomerular bleeding, whereas normal-looking RBCs might suggest a bladder stone or tumor. Large amounts of squamous epithelial cells usually indicate sample contamination. Crystals can point toward metabolic issues or dehydration. Hyaline casts may be normal after heavy exercise, but cellular casts (WBC/RBC casts) almost always signify serious underlying kidney inflammation.
View Interpretation
Urinalysis

Urine For Occult Blood

The Urine Occult Blood test (often part of a dipstick urinalysis) is designed to detect the presence of hemoglobin or myoglobin in the urine that is not visible to the naked eye. Hemoglobin is the protein in red blood cells that carries oxygen, and its presence in urine indicates the breakdown or leakage of blood cells into the urinary system. This test is a critical screening tool for identifying silent pathologies of the renal and urological systems. It is ordered during routine physicals, during pregnancy, or when evaluating:
  • Suspected kidney stones (nephrolithiasis).
  • Systemic hypertension.
  • New-onset edema or swelling.
  • Back or flank pain.
  • Hematuria: Presence of intact red blood cells caused by stones, tumors, or trauma.
  • Glomerulonephritis: Inflammation of the kidney's filtering units.
  • Myoglobinuria: Release of muscle protein into the urine following severe muscle injury (rhabdomyolysis).
  • Urinary Tract Malignancy: Bladder or kidney cancer can cause intermittent occult bleeding.
  • Prostatitis: Inflammation of the prostate in men.
View Interpretation
Endocrinology

Urine For Pregnancy

The Urine Pregnancy Test is a qualitative or semi-quantitative assay designed to detect the presence of Human Chorionic Gonadotropin (hCG). This hormone is produced by the syncytiotrophoblast cells of the developing placenta shortly after a fertilized egg implants into the uterine lining. The primary function of hCG is to maintain the corpus luteum, ensuring the continued production of progesterone, which is vital for sustaining the early stages of pregnancy. This test is ordered to confirm pregnancy in individuals experiencing missed periods, morning sickness, or breast tenderness. It is also routinely performed before medical procedures, surgeries, or the prescription of teratogenic medications (drugs that can harm a fetus) to ensure the patient is not pregnant. In emergency settings, it helps rule out ectopic pregnancy in patients presenting with abdominal pain.
  • Intrauterine Pregnancy: The normal presence of a developing embryo within the uterus.
  • Ectopic Pregnancy: A life-threatening condition where the embryo implants outside the uterus (usually in the fallopian tubes). While urine tests are positive, hCG levels often rise more slowly than in a normal pregnancy.
  • Gestational Trophoblastic Disease (GTD): Conditions like hydatidiform moles (molar pregnancy) or choriocarcinoma can produce extremely high levels of hCG.
  • Chemical Pregnancy: A very early miscarriage that occurs shortly after implantation.
  • HCG-Secreting Tumors: Rarely, certain germ cell tumors or cancers can produce hCG in non-pregnant individuals.
View Interpretation
Metabolic

Urine For Spot Creatinine

Creatinine is a waste product produced by muscle metabolism at a relatively constant rate. In the urine, creatinine serves as a marker of concentration. Because the kidneys filter creatinine consistently, measuring its concentration in a 'spot' (random) urine sample allows doctors to normalize other tests (like urine protein or albumin) to account for how dilute or concentrated the urine is at that specific moment. By itself, a spot urine creatinine has limited diagnostic value. However, it is essential for calculating ratios, such as the Albumin-to-Creatinine Ratio (ACR) or Protein-to-Creatinine Ratio (PCR). These ratios are the gold standard for detecting early kidney damage (microalbuminuria) in patients with diabetes or hypertension, as they are more convenient and often as accurate as 24-hour urine collections.
  • Chronic Kidney Disease (CKD): Used in ratios to monitor disease progression.
  • Diabetic Nephropathy: Spot creatinine is vital for early screening of kidney leakage.
  • Dehydration: Highly concentrated creatinine indicates low fluid intake.
  • Muscle Wasting Diseases: Very low creatinine levels can be seen in conditions like muscular dystrophy or severe malnutrition.
View Interpretation
Nephrology

Urine For Spot Protein

The Urine Spot Protein test measures the concentration of proteins, primarily albumin, in a single (random) urine sample. In a healthy physiological state, the kidneys' glomeruli filter waste products from the blood while retaining large molecules like proteins. Only trace amounts of protein typically escape into the urine. This test serves as a primary screening tool for assessing how well the renal filtration system is performing. Physicians order a spot urine protein test to screen for, monitor, or diagnose kidney disease. It is particularly crucial for individuals with chronic conditions like diabetes or hypertension, which are leading causes of renal damage. It is often preferred over a 24-hour urine collection in initial screenings because it is more convenient for the patient. It may also be used to monitor the efficacy of treatments for known kidney disorders or to investigate symptoms like swelling (edema), foamy urine, or unexplained fatigue. Elevated levels of protein in the urine (proteinuria) are associated with several clinical states:
  • Chronic Kidney Disease (CKD): Persistent damage over time.
  • Nephrotic Syndrome: Characterized by very high protein loss, low blood albumin, and edema.
  • Preeclampsia: A serious condition in pregnant women marked by high blood pressure and proteinuria.
  • Glomerulonephritis: Inflammation of the kidney's filtering units.
  • Transient Factors: Heavy exercise, high fever, or severe dehydration can cause temporary spikes in urine protein.
View Interpretation
Metabolic

Urine For Spot Sodium

Sodium is a critical electrolyte that regulates the amount of water in the body and plays a vital role in nerve and muscle function. The 'Spot Sodium' test measures the concentration of sodium in a single, random urine sample. Unlike a 24-hour collection, which measures total daily output, the spot test provides a 'snapshot' of how the kidneys are handling sodium at a specific moment. This is essential for maintaining osmotic pressure and acid-base balance. This test is primarily ordered to investigate the cause of abnormal blood sodium levels (hyponatremia or hypernatremia). It is a diagnostic cornerstone in differentiating between renal and extra-renal causes of fluid imbalance. Clinicians use it to evaluate acute kidney injury (AKI), assess volume status, and calculate the Fractional Excretion of Sodium (FENa), which helps determine if the kidney's tubule function is intact.
  • Hyponatremia Evaluation: Helps distinguish if sodium loss is occurring through the kidneys (e.g., diuretic use) or through other routes like the gastrointestinal tract (vomiting/diarrhea).
  • Acute Kidney Injury: Used to differentiate between pre-renal azotemia (dehydration) and acute tubular necrosis (ATN).
  • SIADH: Patients with the Syndrome of Inappropriate Antidiuretic Hormone often show inappropriately high urine sodium levels despite low blood sodium.
  • Adrenal Insufficiency: Conditions like Addison's disease can lead to excessive urinary sodium wasting due to lack of aldosterone.
View Interpretation
Endocrinology

Urine For Sugar

The 'Urine for Sugar' test, commonly referred to as a glucose urine test, measures the amount of glucose present in a urine sample. Under normal physiological conditions, the kidneys reabsorb almost all glucose from the filtrate back into the bloodstream. Glucosuria (sugar in the urine) occurs only when the blood glucose levels exceed the 'renal threshold'—typically around 180 mg/dL—at which point the kidneys can no longer reabsorb the excess, and it spills into the urine. This test is used as a quick, non-invasive screening tool for Diabetes Mellitus. It is often part of a routine urinalysis. While blood glucose testing is more accurate for monitoring diabetes, urine sugar remains relevant for screening in resource-limited settings, identifying 'Renal Glucosuria' (where the threshold is lower than normal), and monitoring patients taking SGLT2 inhibitors (a class of diabetes medication that intentionally causes glucosuria to lower blood sugar).
  • Diabetes Mellitus: High blood sugar leading to spillover.
  • Gestational Diabetes: Occurring during pregnancy.
  • Fanconi Syndrome: A disorder of kidney tubule function.
  • Cushing's Syndrome: Excess cortisol causing secondary hyperglycemia.
View Interpretation
Metabolic

Urine For Urea

Urea is the primary nitrogenous waste product of protein catabolism in humans. Produced in the liver via the urea cycle, it serves as the vehicle for removing excess nitrogen from the body. Once synthesized, urea circulates in the blood and is filtered by the kidneys, where it is subsequently excreted in urine. Measuring urine urea levels, particularly in a 24-hour collection, provides a window into the body's nitrogen balance and protein metabolic rate. Clinicians order a Urine Urea test primarily to evaluate protein metabolism and nutritional status. It is frequently used in critical care settings to determine if a patient is in a catabolic state (breaking down muscle tissue for energy). Furthermore, it helps differentiate between various causes of acute kidney injury. By comparing urea levels in the urine to those in the blood (BUN), doctors can determine if the kidneys are concentrating waste effectively or if there is an issue with renal perfusion or intrinsic damage. Several conditions influence urine urea levels:
  • High Urea Excretion: Associated with high protein intake, hyperthyroidism, post-surgical recovery, or major trauma where the body is breaking down tissue rapidly.
  • Low Urea Excretion: Linked to malnutrition, liver disease (where urea synthesis is impaired), pregnancy (due to increased protein utilization), and advanced kidney disease where filtration is compromised.
The test is often part of a 'nitrogen balance' study. If nitrogen intake (from food/IV) exceeds nitrogen output (urine urea), the patient is in an anabolic state (building tissue). If output exceeds intake, they are catabolic, which can lead to muscle wasting and poor wound healing.
View Interpretation
Endocrinology

Urine For VMA

Vanillylmandelic Acid (VMA) is a major metabolic end-product of the catecholamines epinephrine (adrenaline) and norepinephrine. These hormones are produced by the adrenal medulla and the nervous system to help the body respond to stress. After these hormones perform their functions, they are broken down into metabolites like VMA and excreted through the urine. This test is primarily utilized as a screening and diagnostic tool for tumors that secrete excess catecholamines. The most common of these include:
  • Pheochromocytoma: A rare, usually benign tumor of the adrenal gland.
  • Neuroblastoma: One of the most common solid tumors in infants and children, arising from immature nerve cells.
  • Paraganglioma: Tumors occurring outside the adrenal glands along the sympathetic nerve chain.
Physicians order a 24-hour VMA test when a patient presents with symptoms of catecholamine excess, such as persistent or episodic high blood pressure, severe headaches, rapid heart rate, and excessive sweating. Beyond the primary tumors mentioned, elevated VMA levels are associated with high-stress states and certain genetic conditions like Multiple Endocrine Neoplasia Type 2 (MEN 2). Monitoring VMA levels is also essential for assessing the effectiveness of treatment in patients undergoing surgery or chemotherapy for catecholamine-secreting tumors. While high levels are clinically significant for diagnosis, low levels are rarely of medical concern unless interpreted alongside other metabolic markers.
View Interpretation
Nephrology

Urine Glucose

The presence of glucose in the urine (glycosuria) occurs when the blood glucose level exceeds the kidneys' reabsorption capacity (renal threshold), typically around 180 mg/dL. In a Urine Routine panel, this serves as a screening tool for diabetes mellitus, gestational diabetes, or renal tubular disorders (where the threshold is abnormally low). It is a vital indicator of metabolic control and renal health.
View Interpretation
Immunology

Urine Immunofixation Electrophoresis Quantitative

Urine Immunofixation Electrophoresis (IFE) is a sensitive laboratory technique used to identify specific types of proteins called immunoglobulins (antibodies) in the urine. While standard protein tests might show total protein, IFE 'fixes' these proteins using specific antibodies to see if there is a 'monoclonal' (identical) population, which suggests a single clone of plasma cells is overproducing them. This test is a critical diagnostic tool when a physician suspects Multiple Myeloma, Waldenström's macroglobulinemia, or Amyloidosis. It is specifically used to detect Bence-Jones proteins (free light chains) in the urine, which may not show up on a standard blood protein electrophoresis because they are small enough to be filtered rapidly by the kidneys.
  • Multiple Myeloma: A cancer of the plasma cells in the bone marrow.
  • MGUS: Monoclonal Gammopathy of Undetermined Significance.
  • AL Amyloidosis: A condition where abnormal proteins build up in organs.
  • B-cell Lymphomas: Certain lymphomas can produce monoclonal proteins.
View Interpretation
Endocrinology

Urine Metanephrines

Urine metanephrines are the metabolites of catecholamines (epinephrine and norepinephrine). The adrenal glands normally produce these hormones in response to stress. However, certain rare tumors secrete these hormones continuously or in large bursts. Measuring metanephrines in a 24-hour urine collection is often more sensitive than measuring the hormones themselves, as the metabolites remain stable in the urine over a longer period. This test is the primary screening tool for catecholamine-secreting tumors. It is ordered for patients presenting with the classic triad of symptoms: episodic headaches, sweating (diaphoresis), and a racing heart (tachycardia), especially when accompanied by difficult-to-control high blood pressure. Key indications include:
  • Pheochromocytoma: A tumor of the adrenal gland.
  • Paraganglioma: A tumor of the extra-adrenal sympathetic or parasympathetic nervous system.
  • Incidentaloma: When an imaging study (CT or MRI) unexpectedly reveals an adrenal mass.
Elevated metanephrines are most commonly associated with pheochromocytoma, which, while rare, is a critical diagnosis because it is a surgically curable cause of hypertension. If missed, it can lead to severe cardiovascular events, including stroke or heart attack. Because some of these tumors are associated with genetic syndromes like Multiple Endocrine Neoplasia Type 2 (MEN2), Von Hippel-Lindau (VHL) disease, or Neurofibromatosis Type 1, a positive result may trigger genetic counseling and screening for other family members.
View Interpretation
Metabolic

Urine Microalbumin

The Urine Microalbumin test measures very small amounts of albumin, a protein typically found in the blood, that have leaked into the urine. Under normal physiological conditions, the kidneys' glomeruli (filtering units) prevent large molecules like albumin from passing into the urine. The presence of 'micro' amounts (too small to be detected by standard dipstick tests) serves as an early warning sign of glomerular dysfunction. This test is a cornerstone in the management of patients with Diabetes Mellitus (Type 1 and Type 2) and Hypertension. It is used to detect 'Diabetic Nephropathy' or hypertensive kidney disease in its earliest, most reversible stages. Current clinical guidelines recommend annual screening for all diabetic patients to ensure that interventions, such as ACE inhibitors or ARBs, can be started to protect kidney function.
  • Early Diabetic Nephropathy: Increased leakage is the first clinical sign of kidney damage from high blood sugar.
  • Hypertensive Renal Disease: High blood pressure can damage the delicate capillaries in the kidney.
  • Cardiovascular Disease: Microalbuminuria is now recognized as an independent risk factor for generalized vascular endothelial dysfunction and future heart disease.
Monitoring microalbumin levels allows clinicians to adjust glycemic control and blood pressure targets to prevent progression to end-stage renal disease (ESRD).
View Interpretation
Metabolic

Urine Osmolality

Urine Osmolality is a precise measurement of the concentration of dissolved particles in the urine, such as sodium, potassium, chloride, urea, and glucose. Unlike specific gravity, which measures the weight of particles, osmolality measures the number of particles. It is the most accurate way to assess the kidney's ability to concentrate or dilute urine in response to the body's hydration status and the influence of Antidiuretic Hormone (ADH). This test is a cornerstone in evaluating fluid and electrolyte imbalances. It is ordered to:
  • Evaluate Hyponatremia: Determining if low blood sodium is due to water excess or salt loss.
  • Diagnose Diabetes Insipidus: Differentiating between central (lack of ADH) and nephrogenic (kidney resistance to ADH) causes of excessive urination.
  • Assess Kidney Function: Checking for tubular damage or acute kidney injury.
  • Investigate SIADH: Syndrome of Inappropriate Antidiuretic Hormone secretion, where the body retains too much water.
  • SIADH: Characterized by inappropriately concentrated urine despite low serum osmolality.
  • Diabetes Insipidus: Characterized by very dilute urine despite high serum osmolality.
  • Dehydration: Leads to high urine osmolality as the kidneys conserve water.
  • Acute Tubular Necrosis: Often results in a 'fixed' osmolality close to that of plasma (~300 mOsm/kg).
View Interpretation
Metabolic

Urine Potassium

Potassium is a vital electrolyte essential for nerve conduction, muscle contraction, and maintaining normal heart rhythm. The kidneys are the primary regulators of potassium balance in the body. The Urine Potassium test measures the amount of potassium excreted in the urine over a 24-hour period. This helps clinicians understand whether the kidneys are handling potassium correctly or if there is an external factor causing an imbalance in blood potassium levels. This test is crucial for differentiating the causes of abnormal serum potassium levels (Hypokalemia or Hyperkalemia):
  • Investigating Hypokalemia: If blood potassium is low, this test determines if the loss is occurring through the kidneys (renal loss) or elsewhere, such as the gastrointestinal tract (extrarenal loss).
  • Evaluating Kidney Disease: To assess the health of the renal tubules.
  • Adrenal Disorders: To screen for conditions like Hyperaldosteronism, where the adrenal glands produce too much aldosterone, forcing the kidneys to waste potassium.
  • Acid-Base Imbalance: To help diagnose various forms of renal tubular acidosis.
Abnormal urine potassium levels are associated with:
  • Primary Hyperaldosteronism (Conn's Syndrome): High urine potassium despite low blood potassium.
  • Acute or Chronic Kidney Injury: Impaired ability to excrete or conserve potassium.
  • Cushing's Syndrome: Excess cortisol affecting electrolyte handling.
  • Diuretic Use: Medications that increase urine output often increase potassium excretion.
View Interpretation
Renal

Urine Protein / Creatinine Ratio

The Urine Protein/Creatinine Ratio (UPCR) is a diagnostic tool used to estimate the amount of protein excreted in the urine over a 24-hour period using a single random urine sample. This test is vital because the concentration of protein in urine can fluctuate throughout the day based on hydration levels; by comparing protein levels to creatinine (a waste product excreted at a relatively constant rate), clinicians can obtain a normalized value. Physicians order a UPCR primarily to screen for, monitor, or diagnose kidney disease. It is often requested for patients with risk factors such as diabetes, hypertension, or systemic lupus erythematosus. It is also a critical component in screening pregnant women for preeclampsia, where sudden onset proteinuria can indicate a medical emergency.
  • Chronic Kidney Disease (CKD): Persistent high levels indicate damage to the kidney's filtering units (glomeruli).
  • Nephrotic Syndrome: Characterized by very high protein loss, swelling (edema), and low serum albumin.
  • Preeclampsia: A pregnancy complication marked by high blood pressure and protein in the urine.
  • Diabetic Nephropathy: Kidney damage resulting specifically from long-term diabetes management issues.
View Interpretation
Nephrology

Urine Routine

A routine urinalysis (Urine Routine) is a fundamental diagnostic tool used to assess the chemical and physical properties of urine. It serves as a primary indicator of kidney health and metabolic function. By examining the color, clarity, and chemical composition (such as pH, specific gravity, protein, glucose, and nitrites), clinicians can gain immediate insights into the body's internal environment. This test is frequently ordered during routine check-ups, pregnancy screenings, or pre-surgical evaluations. It is also the first line of defense when a patient presents with symptoms such as abdominal pain, back pain, painful urination (dysuria), or blood in the urine (hematuria). It helps in the early detection of systemic metabolic diseases like diabetes and various forms of glomerulonephritis.
  • Urinary Tract Infections (UTIs): Indicated by the presence of nitrites, leukocyte esterase, or bacteria.
  • Kidney Disease: Suggested by persistent proteinuria (protein in urine) or abnormal casts.
  • Diabetes Mellitus: Often first suspected when glycosuria (glucose in urine) is detected.
  • Liver Disorders: Indicated by the presence of bilirubin or high levels of urobilinogen.
  • Dehydration: Reflected in a high specific gravity and deep amber color.
Urinalysis provides a snapshot of the renal system's ability to filter waste and maintain electrolyte balance. While simple, it is highly sensitive to changes in hydration and systemic health.
View Interpretation
Parasitology

Urine Schistosomiasis Test

This test involves the microscopic examination of urine sediment to identify eggs of Schistosoma haematobium, a parasitic flatworm. This parasite is primarily responsible for urinary schistosomiasis (Bilharzia), which affects millions of people in tropical and subtropical regions. It is ordered for patients who have traveled to endemic areas and present with hematuria (blood in urine), painful urination, or chronic pelvic pain. It is the primary diagnostic tool for assessing the intensity of infection.
  • Urogenital Schistosomiasis: The primary infection caused by the fluke.
  • Bladder Cancer: Chronic infection is a known risk factor for squamous cell carcinoma of the bladder.
  • Kidney Damage: Long-term infection can lead to obstructive uropathy and hydronephrosis.
  • Infertility: Granulomatous inflammation in the reproductive tract can cause secondary infertility.
View Interpretation
Metabolic

Urine Sodium

Sodium is the primary extracellular electrolyte responsible for maintaining osmotic pressure and fluid balance in the body. The kidneys are the main regulators of sodium, meticulously balancing the amount ingested in the diet with the amount excreted in urine. The Urine Sodium test measures the concentration of sodium in a urine sample, reflecting the kidney's response to the body's total sodium and water volume status. It is a critical tool for distinguishing between various causes of electrolyte imbalances, particularly hyponatremia (low blood sodium). This test is primarily ordered to evaluate kidney function and to diagnose the cause of abnormal blood sodium levels. It helps clinicians determine if the body is losing sodium through the kidneys (renal loss) or through other routes like the gastrointestinal tract or skin (extrarenal loss). It is also used in the management of acute kidney injury (AKI) to differentiate between 'prerenal' azotemia (where the kidneys are trying to conserve sodium due to low blood flow) and 'intrinsic' renal damage (where the kidneys have lost the ability to reabsorb sodium).
  • SIADH (Syndrome of Inappropriate Antidiuretic Hormone): Characterized by high urine sodium despite low blood sodium.
  • Dehydration: Usually results in very low urine sodium as the body attempts to conserve salt and water.
  • Adrenal Insufficiency (Addison's Disease): Lack of aldosterone leads to excessive sodium wasting in the urine.
  • Diuretic Use: Medications that increase urine output often increase urine sodium concentration.
  • Acute Tubular Necrosis (ATN): Kidney damage where the tubules cannot properly reabsorb sodium.
View Interpretation
Metabolic

Urine Specific Gravity

Urine Specific Gravity (USG) measures the concentration of particles in the urine compared to distilled water. It provides a quick assessment of the kidneys' ability to concentrate or dilute urine, which is a direct reflection of a person's hydration status and renal tubular function. USG is a core component of a routine urinalysis and is ordered to:
  • Evaluate hydration status in patients with vomiting, diarrhea, or excessive sweating.
  • Monitor patients with suspected Diabetes Insipidus.
  • Screen for kidney dysfunction or acute kidney injury.
  • Detect the presence of excess substances like glucose or protein in the urine.
  1. Dehydration: Leads to high specific gravity as the kidneys conserve water.
  2. Diabetes Insipidus: Characterized by very low specific gravity because the kidneys cannot concentrate urine.
  3. Kidney Failure: Often results in 'isosthenuria,' where the specific gravity is fixed at 1.010, matching the plasma.
  4. SIADH (Syndrome of Inappropriate Antidiuretic Hormone): Results in excessively concentrated urine despite normal fluid intake.
  5. Heart Failure: May cause increased USG due to decreased renal blood flow.
View Interpretation
Metabolic

Urine Uric Acid

Uric acid is the end-product of the metabolic breakdown of purines, which are nitrogenous bases found in DNA and RNA, as well as in many foods. The kidneys are responsible for excreting about two-thirds of the uric acid produced by the body. A 24-hour urine uric acid test measures the total amount of this substance cleared by the kidneys over a full day, providing a clearer picture of purine metabolism than a single random sample. Physicians order this test primarily to investigate the cause of recurrent kidney stones (urolithiasis). High levels of uric acid in the urine (hyperuricosuria) can lead to the formation of uric acid stones or contribute to calcium oxalate stones. It is also used to differentiate between 'over-producers' and 'under-excretors' of uric acid in patients with Gout, which helps in selecting the appropriate medication (e.g., Allopurinol vs. Probenecid). Additionally, it monitors patients undergoing chemotherapy to prevent Tumor Lysis Syndrome.
  • Gout: A form of inflammatory arthritis caused by urate crystal deposition.
  • Kidney Stones: Specifically uric acid lithiasis.
  • Lesch-Nyhan Syndrome: A rare genetic disorder causing massive uric acid overproduction.
  • Myeloproliferative Disorders: Such as leukemia or lymphoma, where high cell turnover increases purine breakdown.
View Interpretation
Microbiology

Urine for AFB Culture and Sensitivity

The Urine for AFB (Acid-Fast Bacilli) Culture and Sensitivity test is designed to identify the presence of Mycobacterium tuberculosis or other non-tuberculous mycobacteria in the urinary tract. Unlike standard bacteria, mycobacteria have a waxy cell wall that requires special staining (Ziehl-Neelsen) and long incubation periods. This test is ordered when a patient shows symptoms of Genitourinary Tuberculosis (GUTB), which include:
  • Chronic urinary tract symptoms (frequency, urgency) that do not respond to standard antibiotics.
  • Sterile pyuria (presence of white blood cells in urine but no growth on standard cultures).
  • Unexplained blood in the urine (hematuria).
  • Imaging evidence of renal scarring or cavitation.
  • Genitourinary TB: The most common site for extrapulmonary TB.
  • Renal Tuberculosis: Infection of the kidneys which can lead to organ failure.
  • Disseminated TB: In immunocompromised patients, TB can spread throughout the body via the bloodstream.
Because mycobacteria are shed intermittently into the urine, it is common practice to collect three separate early-morning urine samples on consecutive days. The culture can take 6-8 weeks for results, although newer liquid culture methods may yield results in 10-14 days.
View Interpretation
Microbiology

Urine for Culture & Sensitivity

The Urine Culture and Sensitivity (C&S) test is the gold standard for diagnosing Urinary Tract Infections (UTIs). Its primary function is to identify specific pathogenic bacteria or yeast growing in the urinary tract and determine which antibiotics are most effective at inhibiting their growth. This two-step process ensures that treatment is targeted and effective, reducing the risk of antibiotic resistance. Physicians order this test when a patient presents with symptoms suggestive of a UTI, such as:
  • Burning sensation during urination (dysuria).
  • Frequent or urgent need to urinate.
  • Cloudy, dark, or strong-smelling urine.
  • Lower abdominal pain or pelvic pressure.
  • Persistent fever or chills (suggesting a potential kidney infection).
  • Cystitis: Infection of the bladder, the most common form of UTI.
  • Pyelonephritis: A more serious infection that has reached the kidneys.
  • Urethritis: Infection of the urethra, often associated with sexually transmitted infections.
  • Asymptomatic Bacteriuria: The presence of bacteria in the urine without symptoms, which is clinically significant in pregnant women or patients undergoing urological surgery.
  • Recurrent UTIs: Identification of specific strains helps in managing chronic infection patterns.
View Interpretation
Metabolic

Urine for Ketone Bodies

Ketones are metabolic byproducts produced when the body burns fat for energy instead of glucose. This occurs when insulin levels are insufficient or when glucose is unavailable. The Urine Ketone test measures the presence of acetoacetate and sometimes acetone in the urine, providing a window into the body's metabolic state. This test is vital for individuals with Type 1 Diabetes to monitor for Diabetic Ketoacidosis (DKA). It is also ordered during:
  • Unexplained weight loss
  • Persistent vomiting or diarrhea
  • Pregnancy (to check for gestational ketonuria)
  • Monitoring the effects of ketogenic diets or prolonged fasting
  • Diabetic Ketoacidosis (DKA): A life-threatening complication where high ketone levels cause the blood to become acidic.
  • Starvation/Malnutrition: When the body lacks caloric intake, it shifts to fat stores, producing ketones.
  • Hyperemesis Gravidarum: Severe vomiting during pregnancy leading to starvation ketosis.
  • Isopropyl Alcohol Poisoning: Can lead to ketonemia without acidosis.
Understanding urine ketone levels helps in distinguishing between simple dietary ketosis and dangerous metabolic acidosis, especially when interpreted alongside blood glucose levels.
View Interpretation
Metabolic

Urine pH

Urine pH measures the acidity or alkalinity of a urine sample. The kidneys play a major role in maintaining the body's acid-base balance by excreting hydrogen ions and reabsorbing bicarbonate. The pH level of urine reflects this ongoing metabolic activity and can vary significantly based on diet and systemic health. Physicians monitor urine pH to:
  • Assist in the diagnosis of metabolic or respiratory acidosis/alkalosis.
  • Evaluate the risk of developing specific types of kidney stones (urolithiasis).
  • Monitor the effectiveness of medications intended to alkalinize the urine (e.g., for gout treatment).
  • Check for Urinary Tract Infections (UTIs), as certain bacteria alter the pH.
  • Acidic Urine (Low pH): Associated with high-protein diets, starvation, diabetic ketoacidosis, and uric acid stones.
  • Alkaline Urine (High pH): Associated with vegetarian diets, Urinary Tract Infections caused by urea-splitting bacteria (like Proteus), and Renal Tubular Acidosis (RTA).
  • Kidney Stones: Uric acid and cystine stones form in acidic environments; calcium phosphate and struvite stones form in alkaline environments.
Diet is the most common factor affecting urine pH; for example, citrus fruits, while acidic themselves, actually produce an alkaline urine after metabolism.
View Interpretation
Nephrology

Urine pH

Urine pH measures the acidity or alkalinity of a urine sample. It is a critical component of the Urine Routine (Urinalysis) used to evaluate the kidney's ability to maintain acid-base homeostasis. Clinically, it helps in the diagnosis of renal tubular acidosis, monitoring treatment for kidney stones (urolithiasis), and identifying risk factors for stone formation (e.g., uric acid stones form in acidic urine, while calcium phosphate stones form in alkaline urine). It also assists in identifying urinary tract infections caused by urea-splitting organisms like Proteus.
View Interpretation
Hepatology

Urobilinogen

Urobilinogen is a colorless byproduct of bilirubin reduction by intestinal bacteria. Most is excreted in feces, but a small amount is reabsorbed and excreted by the kidneys. Testing for urobilinogen in urine is a key step in differentiating between types of jaundice and assessing liver function or hemolytic disorders.
View Interpretation
Metabolic

Urobilinogen

Urobilinogen is a byproduct of bilirubin reduction by intestinal bacteria. In a Complete Urine Examination, it serves as a sensitive indicator of liver dysfunction and hemolytic disorders. Elevated levels suggest excessive bilirubin production (hemolysis) or a failure of the liver to re-extract urobilinogen from portal blood.
View Interpretation
Nephrology

Urobilinogen

Urobilinogen is a byproduct of bilirubin reduction by intestinal bacteria. Most is excreted in feces, but a small amount is reabsorbed and excreted in urine. In a Urine Routine panel, it serves as an early indicator of liver disease or hemolytic disorders. Its presence/absence helps differentiate between types of jaundice (e.g., biliary obstruction vs. hepatitis).
View Interpretation
Metabolic

Urobilinogen - Urine

Urobilinogen is a colorless byproduct of bilirubin reduction. It is formed in the intestines by bacterial action on bilirubin. While most urobilinogen is excreted in the feces as stercobilin, a small amount is reabsorbed into the bloodstream and eventually excreted by the kidneys into the urine. This 'enterohepatic circulation' makes urine urobilinogen a useful marker for liver and blood health. A urine urobilinogen test is part of a routine urinalysis. It is specifically used to detect early signs of liver disease, hepatitis, or hemolytic disorders (where red blood cells are destroyed prematurely). It is a vital tool for differentiating between types of jaundice.
  • Hepatitis and Cirrhosis: Damaged liver cells cannot efficiently re-process reabsorbed urobilinogen, leading to increased levels in the urine.
  • Hemolytic Anemia: Increased destruction of RBCs leads to high bilirubin production and subsequently high urobilinogen.
  • Biliary Obstruction: If bile cannot reach the intestines, no urobilinogen is formed, resulting in low or absent levels in the urine.
The presence of urobilinogen must be interpreted alongside urine bilirubin. For example, high urobilinogen with negative urine bilirubin usually points toward hemolysis rather than liver obstruction.
View Interpretation
Infectious Disease

VDRL Test

The Venereal Disease Research Laboratory (VDRL) test is a screening tool used to detect antibodies that the body produces in response to an infection with Treponema pallidum, the bacterium that causes syphilis. Unlike specific treponemal tests, the VDRL is a non-treponemal test; it measures substances (reagins) produced by cells damaged by the bacteria rather than the bacteria themselves. This test is primarily ordered for individuals suspected of having syphilis, those with active symptoms such as chancres (painless sores) or rashes, or as part of routine prenatal screening. Because syphilis is a 'great imitator' of other diseases, VDRL is essential in early diagnosis to prevent long-term complications involving the heart and nervous system.
  • Primary/Secondary Syphilis: High reactivity is typical in these stages.
  • Neurosyphilis: If performed on Cerebrospinal Fluid (CSF), it helps diagnose CNS involvement.
  • Biological False Positives (BFP): Conditions like Lupus (SLE), malaria, infectious mononucleosis, and certain viral pneumonia can cause a reactive result in the absence of syphilis.
  • Congenital Syphilis: Screened for in newborns of mothers with positive histories.
View Interpretation
Lipids

VLDL Cholesterol

Very Low-Density Lipoprotein (VLDL) is a type of lipoprotein produced by the liver to transport triglycerides (fats) to peripheral tissues for energy use or storage. VLDL is considered a 'bad' cholesterol because it is a precursor to LDL (Low-Density Lipoprotein). As VLDL travels through the bloodstream, enzymes strip away the triglycerides, causing the particle to become smaller, denser, and richer in cholesterol, eventually turning into LDL. VLDL is typically calculated as a percentage of the total triglyceride count (usually Triglycerides divided by 5). It is ordered as part of a Lipid Panel to assess a patient's risk of cardiovascular disease (CVD). While LDL is the primary focus of cholesterol management, elevated VLDL is an independent risk factor for the development of plaque in the arteries (atherosclerosis).
  • Atherosclerosis: High levels contribute to the buildup of fatty deposits in arterial walls.
  • Type 2 Diabetes: Insulin resistance often leads to overproduction of VLDL by the liver.
  • Metabolic Syndrome: A cluster of conditions including hypertension and obesity that increases heart disease risk.
  • Pancreatitis: Extremely high VLDL (associated with very high triglycerides) can trigger acute inflammation of the pancreas.
View Interpretation
Cytology

Vaginal Smear for Hormonal Assessment

The Vaginal Smear for Hormonal Assessment, often referred to as the Maturation Index (MI), is a cytological evaluation of the vaginal epithelium. The cells of the vaginal wall are highly sensitive to fluctuating levels of steroid hormones, particularly estrogen and progesterone. Estrogen promotes the maturation of vaginal squamous epithelial cells into 'superficial' cells, while progesterone (and certain androgens) leads to the predominance of 'intermediate' cells. In the absence of these hormones, such as in prepubertal girls or postmenopausal women, 'parabasal' cells dominate the smear. This test is primarily ordered to assess a woman's hormonal status indirectly. Clinicians use it to:
  • Evaluate estrogen deficiency in cases of suspected premature ovarian failure or menopause.
  • Investigate causes of abnormal uterine bleeding or amenorrhea (absence of periods).
  • Monitor the effectiveness of Hormone Replacement Therapy (HRT).
  • Diagnose precocious puberty in young girls by checking for unexpected estrogenic activity.
  • Assess the 'Maturation Index' which provides a ratio of parabasal to intermediate to superficial cells (e.g., 0/40/60).
Several conditions can be identified or monitored via this assessment. A high percentage of superficial cells in a prepubertal child suggests precocious puberty or exposure to exogenous estrogens. Conversely, a high parabasal cell count in a woman of reproductive age may indicate primary or secondary ovarian failure. Chronic inflammatory conditions of the vagina (vaginitis) can sometimes interfere with the interpretation, as inflammation can cause reactive changes in the cells that mimic certain hormonal patterns.
View Interpretation
Microbiology

Vaginal Swab For Culture and Sensitivity

The Vaginal Culture and Sensitivity test identifies pathogenic microorganisms (bacteria, yeast, or protozoa) in the vaginal canal. It evaluates the balance of the vaginal microbiome, which is normally dominated by protective Lactobacillus species. This test is ordered when a patient presents with symptoms such as unusual discharge, itching, odor, or pelvic pain. It helps distinguish between various types of vaginitis, which require different treatments (e.g., antifungals for yeast vs. antibiotics for bacteria).
  • Bacterial Vaginosis (BV): An overgrowth of anaerobic bacteria (e.g., Gardnerella vaginalis).
  • Candidiasis (Yeast Infection): Overgrowth of Candida albicans.
  • Trichomoniasis: A sexually transmitted parasitic infection.
  • Group B Streptococcus (GBS): Screened during pregnancy to prevent transmission to the newborn.
The sample is plated on specific media to see what grows. If a pathogen is found, it is tested against various medications. This is particularly important for recurrent infections where resistant strains of yeast or bacteria may be present.
View Interpretation
Metabolic

Very-Low-Density Lipoprotein (VLDL) Cholesterol

VLDL is a type of lipoprotein produced by the liver to carry triglycerides to tissues. Within a Lipid Profile, VLDL is often calculated as a percentage of the triglyceride count (TG/5). High levels are associated with an increased risk of atherosclerosis and coronary artery disease, as VLDL particles eventually transition into LDL (bad cholesterol).
View Interpretation
Reproductive Health

Vitality (Live Sperm)

Sperm vitality, or viability, is the assessment of the proportion of live spermatozoa in a semen sample. It is particularly important when a large percentage of sperm are immotile (asthenozoospermia). This test distinguishes between 'necrozoospermia' (dead sperm) and sperm that are alive but lack motility due to structural defects (such as primary ciliary dyskinesia). Vitality is typically determined via dye exclusion (e.g., Eosin-Nigrosin) or the hypo-osmotic swelling (HOS) test.
View Interpretation
Vitamins

Vitamin B12

Vitamin B12, also known as cobalamin, is a water-soluble vitamin that plays a critical role in the formation of red blood cells, cell metabolism, nerve function, and the production of DNA. It is unique among vitamins because it contains a metal ion (cobalt) and requires a specific protein called intrinsic factor, produced in the stomach, for absorption in the small intestine. This test is primarily ordered to diagnose the cause of anemia or neuropathy. It is also used to evaluate nutritional status in individuals with restrictive diets (like vegans), malabsorption syndromes, or those showing cognitive changes. Physicians often order it alongside a Folate test because the two vitamins work closely together.
  • Pernicious Anemia: An autoimmune condition where the body cannot produce intrinsic factor.
  • Megaloblastic Anemia: A condition where red blood cells are larger than normal and fewer in number.
  • Peripheral Neuropathy: Nerve damage often resulting in numbness or tingling in hands and feet.
  • Atrophic Gastritis: Thinning of the stomach lining which reduces acid and intrinsic factor production.
  • Crohn's Disease: An inflammatory bowel disease that can impair absorption in the terminal ileum.
View Interpretation
Vitamins

Vitamin D (25-Hydroxy)

Vitamin D is a fat-soluble vitamin that functions more like a pro-hormone in the body. The 25-hydroxyvitamin D [25(OH)D] form is the major circulating form and is the best indicator of overall Vitamin D status. Its primary role is to facilitate the absorption of calcium and phosphorus in the intestines, which is critical for bone mineralization and density. This test is ordered to diagnose Vitamin D deficiency or toxicity. It is frequently requested for patients with bone pain, muscle weakness, or those at high risk for osteoporosis. Additionally, research has linked Vitamin D to immune function, cardiovascular health, and mood regulation, leading many clinicians to screen for it during routine physicals, especially in northern latitudes.
  • Osteoporosis and Osteopenia: Thinning of the bones leading to fracture risk.
  • Rickets/Osteomalacia: Softening of the bones due to poor mineralization.
  • Hyperparathyroidism: Low Vitamin D can trigger the parathyroid glands to overproduce hormone to compensate for low calcium.
  • Autoimmune conditions: Low levels are often observed in patients with Multiple Sclerosis or Rheumatoid Arthritis.
Vitamin D is obtained through UVB sunlight exposure, diet (fatty fish, fortified milk), and supplementation. It undergoes hydroxylation in the liver to become 25(OH)D, and then in the kidneys to become the active 1,25-dihydroxyvitamin D.
View Interpretation
Vitamins

Vitamin D Total 25-Hydroxy (D2 & D3)

Vitamin D is a fat-soluble prohormone essential for calcium and phosphorus absorption in the gut. It exists in two primary forms: Vitamin D2 (ergocalciferol), derived from plants/fortified foods, and Vitamin D3 (cholecalciferol), synthesized in the skin via UV exposure. The 25-hydroxyvitamin D [25(OH)D] test measures the total concentration of both forms and is the gold standard for assessing a person's Vitamin D status because it has a long half-life in the blood. Vitamin D testing is requested to investigate bone pain, frequent fractures, or muscle weakness. It is a routine screening for individuals at risk of osteoporosis, those with malabsorption syndromes (like Celiac disease), or people with limited sun exposure. Recent research has also linked Vitamin D status to immune health, cardiovascular function, and mood regulation.
  • Deficiency (<20 ng/mL): Leads to Rickets in children and Osteomalacia in adults. Chronic deficiency is a major risk factor for Osteoporosis.
  • Insufficiency (21-29 ng/mL): Linked to increased parathyroid hormone (PTH) levels, which can lead to bone resorption.
  • Toxicity (>150 ng/mL): Rare, but can cause hypercalcemia, leading to kidney stones, nausea, and cardiac arrhythmias.
After entering the bloodstream, Vitamin D is converted in the liver to 25(OH)D. It then travels to the kidneys, where it is converted into its active form, 1,25-dihydroxyvitamin D. Because 25(OH)D is the storage form, it provides the most accurate reflection of long-term levels.
View Interpretation
Endocrinology

Vitamin D3 (1,25 Dihydroxycholecalciferol)

1,25-Dihydroxyvitamin D, also known as Calcitriol, is the biologically active form of Vitamin D. While the 25-hydroxy form is used to assess overall storage, this test measures the hormone produced by the kidneys through the action of 1-alpha-hydroxylase. Its primary function is to regulate calcium and phosphorus homeostasis by increasing intestinal absorption and modulating bone mineral density. This test is rarely used for screening general deficiency; instead, it is diagnostic for specific disorders. It is ordered when a patient has abnormal calcium levels, symptoms of hypercalcemia, or suspected sarcoidosis and other granulomatous diseases. It is also critical in monitoring patients with chronic kidney disease (CKD), as the failing kidney loses its ability to convert 25(OH)D into this active form.
  • Hypocalcemia: Investigating the cause of low calcium when PTH is elevated.
  • Chronic Kidney Disease: Monitoring secondary hyperparathyroidism.
  • Granulomatous Diseases: Conditions like sarcoidosis or tuberculosis can lead to extra-renal production of 1,25-D, causing high calcium.
  • Vitamin D-Dependent Rickets: Assessing genetic defects in the enzyme that converts Vitamin D.
View Interpretation
Serology

Western Blot

The Western Blot is a highly specific confirmatory test used to detect specific proteins (antigens) or antibodies in a blood sample. It works by separating proteins by size via electrophoresis and then using labeled antibodies to bind to specific target bands. Historically, it has been the definitive 'second-step' test to confirm results from a screening ELISA. It is primarily used as a confirmatory test following a positive screening result for HIV-1 or Lyme Disease. Because screening tests are designed to be 'highly sensitive' (prone to false positives to ensure no cases are missed), the Western Blot provides the 'specificity' needed to confirm that the infection is actually present.
  • HIV-1 Infection: Confirming the presence of viral proteins like p24, gp120, and gp41.
  • Lyme Disease: Confirming antibodies against Borrelia burgdorferi.
  • Bovine Spongiform Encephalopathy: In veterinary or specialized research contexts.
  • Autoimmune Disorders: Sometimes used in research for specific protein identification.
View Interpretation
Microbiology

Wet Mount

A Wet Mount, also known as a vaginal smear or saline mount, is a diagnostic test where a sample of vaginal or urethral discharge is placed on a slide with a saline solution and examined under a microscope. This allows for the immediate visualization of moving organisms and cellular structures. This is a frontline test for patients experiencing symptoms of vaginitis or urethritis, such as:
  • Abnormal vaginal discharge (unusual color, odor, or consistency).
  • Itching or irritation in the genital area.
  • Pain during intercourse (dyspareunia).
  • Burning during urination.
  • Bacterial Vaginosis (BV): Characterized by the presence of 'clue cells' (epithelial cells covered in bacteria) and a lack of normal lactobacilli.
  • Candidiasis (Yeast Infection): Identified by the presence of budding yeast cells or hyphae (branching structures).
  • Trichomoniasis: A sexually transmitted infection caused by the parasite Trichomonas vaginalis, which is visible due to its characteristic swimming motion.
  • Atrophic Vaginitis: Observed through changes in cell types, often in postmenopausal women.
The test is valued for its speed, providing a diagnosis within minutes during a clinical visit, allowing for immediate treatment initiation.
View Interpretation
Allergy and Immunology

Wheat Specific IgE

Similar to standard specific IgE tests, this component in a Veg+Non-Veg Profile assesses sensitization to wheat. It helps differentiate between food allergies and other GI issues like Celiac disease (which is IgG/IgA mediated, not IgE). In a comprehensive profile including Total IgE, the specific-to-total ratio can help determine if the wheat result is a specific sensitivity or a result of a globally overactive immune system.
View Interpretation
Immunology

Wheat Specific IgE

This test measures the concentration of allergen-specific Immunoglobulin E (IgE) antibodies directed against wheat proteins. It is used to identify Type I immediate hypersensitivity. Within an Allergy Profile, a high level of wheat-specific IgE indicates sensitization, meaning the immune system recognizes wheat as a threat. This is essential for diagnosing wheat allergy, which can manifest as urticaria, asthma, or life-threatening anaphylaxis.
View Interpretation
Hematology

White Blood Cell Count (WBC)

The WBC count measures the total number of leukocytes in the blood, which are the primary components of the immune system. Within a Complete Blood Count (CBC), it serves as a non-specific marker of inflammation, infection, and bone marrow health. It is critical for diagnosing leukemias and monitoring response to treatments like chemotherapy.
View Interpretation
Hematology

White Blood Cell Count (WBC)

The WBC count measures the total number of leukocytes in the blood and is a primary marker for infection, inflammation, and bone marrow function. Within a Complete Blood Picture, it serves as the 'first responder' indicator. High counts suggest the body is fighting an invader or reacting to tissue damage, while low counts suggest a vulnerability to infection or a failure in the production 'factory' (bone marrow).
View Interpretation
Hematology

White Blood Cell Count (WBC)

The WBC count measures the total number of leukocytes in the blood. In the context of a COVID-19 Hematology Panel, WBC counts are critical for monitoring the body's immune response. While COVID-19 often presents with normal or low-normal WBC counts (leukopenia), a rising WBC count may signal a secondary bacterial infection or a severe inflammatory 'cytokine storm' response.
View Interpretation
Hematology

White Blood Cell Count (WBC)

The White Blood Cell (WBC) count measures the total number of leukocytes in the blood. As a primary component of the Complete Blood Count (CBC), it serves as a non-specific marker of the body's immune status. It is essential for screening for infections, inflammation, leukemias, and bone marrow suppression. It must be interpreted alongside the differential count to determine which specific cell type is affected.
View Interpretation
Metabolic

White Blood Cells (Microscopic)

The presence of White Blood Cells (WBCs) in urine, known as pyuria, is a primary indicator of inflammation or infection within the urinary tract. In a microscopic examination (sediment analysis), finding significant numbers of leukocytes suggests that the immune system is responding to a pathogen (like bacteria in a UTI) or a physical irritant (like a kidney stone). Within a Complete Urine Examination, this component helps localize the source of symptoms such as dysuria or flank pain.
View Interpretation
Nephrology

White Blood Cells (Microscopic)

The microscopic evaluation of White Blood Cells (WBCs) in urine, known as pyuria, is a primary indicator of inflammation or infection within the urinary tract. In a healthy state, few or no WBCs are present. When the immune system responds to pathogens (bacteria, fungi) or physical trauma (calculi), neutrophils migrate to the site of irritation and are subsequently excreted. This component is critical in the 'Urine Routine' panel to differentiate between simple contamination and active pathology like Cystitis, Pyelonephritis, or Urethritis.
View Interpretation
Reproductive Health

White Blood Cells (Semen)

In the context of a Semen Analysis, the presence of White Blood Cells (WBCs), specifically neutrophils, is referred to as leukocytospermia or pyosemia. While a few WBCs are normal, concentrations above the threshold (1 million/mL) often indicate an underlying infection or inflammatory process within the male reproductive tract (such as prostatitis, epididymitis, or seminal vesiculitis). WBCs can generate Reactive Oxygen Species (ROS), which may lead to sperm DNA fragmentation and reduced motility, potentially impacting fertility.
View Interpretation
Serology

Widal Test (Slide Method)

The Widal test is a serological test used to diagnose enteric fever, which includes Typhoid and Paratyphoid fever. It detects antibodies (agglutinins) against the O (somatic) and H (flagellar) antigens of the bacteria Salmonella typhi and Salmonella paratyphi. The slide method is a rapid screening version of this test. In regions where typhoid is endemic, the Widal test is often used when a patient presents with a prolonged, step-ladder fever, abdominal pain, and malaise. It is a cost-effective diagnostic tool in resource-limited settings where blood cultures might not be readily available or affordable.
  • Typhoid Fever: Caused by Salmonella typhi.
  • Paratyphoid Fever: Caused by Salmonella paratyphi A, B, or C.
  • Salmonellosis: Other salmonella infections may occasionally cause cross-reactivity.
View Interpretation
Microbiology

Wound Pus for Culture and Sensitivity

A Wound Culture and Sensitivity test is a laboratory procedure used to identify the specific microorganisms (bacteria, fungi, or yeast) causing an infection in a wound and to determine which antibiotics will be most effective in treating the infection. This is the gold standard for managing localized infections that show signs of spreading or failing to heal. This test is critical when a wound (surgical, traumatic, or chronic like a diabetic ulcer) exhibits signs of infection, such as:
  • Redness (erythema) spreading from the wound site.
  • Warmth and localized swelling.
  • Purulent discharge (pus) or foul odor.
  • Fever or increased white blood cell count in the patient.
  • Cellulitis: Deep skin infection requiring targeted systemic antibiotics.
  • Osteomyelitis: Infection that has spread to the bone, requiring long-term therapy.
  • Sepsis: A life-threatening systemic response to infection originating from the wound.
  • MRSA Infections: Methicillin-resistant Staphylococcus aureus, which requires specific non-standard antibiotics.
  1. Culture: The sample is placed on nutrient-rich agar plates to encourage the growth of the pathogen.
  2. Identification: Microbiologists use chemical tests or mass spectrometry (MALDI-TOF) to name the organism.
  3. Sensitivity (Antibiogram): The organism is exposed to various antibiotics to see which ones inhibit its growth. This is reported as 'Sensitive,' 'Intermediate,' or 'Resistant.'
View Interpretation
Radiology

X-Ray

An X-ray (radiograph) is a non-invasive medical test that uses ionizing radiation to produce images of the inside of the body. Different tissues absorb different amounts of radiation; dense materials like bone appear white, while softer tissues like muscle or organs appear in shades of gray, and air-filled spaces (like lungs) appear black. X-rays are the first line of diagnostic imaging for a vast array of conditions:
  • Skeletal Assessment: To detect fractures, dislocations, or degenerative bone diseases like osteoporosis and arthritis.
  • Chest Evaluation: To diagnose pneumonia, lung cancer, or heart failure (by checking heart size).
  • Abdominal Issues: To find swallowed objects or identify intestinal blockages.
  • Dental Health: To visualize cavities or impacted wisdom teeth.
  • Procedural Support: To ensure correct placement of catheters or orthopedic hardware.
  • Fractures: Breaks or cracks in the bone.
  • Infections: Such as pneumonia in the lungs or osteomyelitis in the bone.
  • Tumors: Many types of bone and lung tumors are visible on X-ray.
  • Scoliosis: Abnormal curvature of the spine.
View Interpretation
Imaging

X-Ray Hysterosalpingogram

A Hysterosalpingogram (HSG) is a specialized fluoroscopic X-ray examination used primarily to examine the uterus and fallopian tubes. By injecting a radiopaque contrast medium through the cervix, radiologists can visualize the internal structure of the reproductive tract in real-time. The primary function of this procedure is to determine the 'patency' or openness of the fallopian tubes and the shape of the uterine cavity. HSG is a fundamental tool in the investigation of female infertility. It is ordered to:
  • Identify Tubal Blockage: Determine if fallopian tubes are blocked by scar tissue (often from PID) or endometriosis.
  • Uterine Evaluation: Detect structural abnormalities like uterine fibroids, endometrial polyps, or congenital anomalies (e.g., bicornuate uterus).
  • Post-Surgical Check: Verify the success of tubal ligation reversal or the effectiveness of tubal sterilization procedures.
  • Recurrent Miscarriage: Investigate if uterine defects are contributing to pregnancy loss.
Several conditions can be diagnosed via HSG. Hydrosalpinx, where a tube is blocked and filled with fluid, is a common finding. Uterine synechiae (Asherman’s syndrome) or scarring within the uterus can also be visualized. Additionally, HSG can sometimes have a therapeutic effect; the movement of the contrast dye can occasionally dislodge minor blockages, slightly increasing the chances of conception in the months immediately following the procedure.
View Interpretation
Gastroenterology

Yeasts

In a Complete Stool Examination, the microscopic identification of yeast (typically Candida species) is assessed. While small amounts of yeast can be part of the normal intestinal flora, an abundance of budding yeast or the presence of pseudohyphae indicates fungal overgrowth. This is often seen following broad-spectrum antibiotic therapy, in immunocompromised patients, or in individuals with diabetes.
View Interpretation
Metabolic

eGFR (Estimated Glomerular Filtration Rate)

The eGFR is the gold standard for assessing overall kidney function and staging Chronic Kidney Disease (CKD). It is a calculated value based on serum creatinine, age, sex, and sometimes race (depending on the formula used, such as CKD-EPI or MDRD). It estimates how much blood passes through the glomeruli each minute. Within a 'Basic Kidney Profile', it provides a more accurate assessment than creatinine alone, which is influenced significantly by muscle mass.
View Interpretation
Respiratory

pH

Arterial pH is a measure of the hydrogen ion concentration in the blood, indicating the acid-base status of the body. Within the context of an Arterial Blood Gas (ABG) panel, it is the primary indicator of acidemia or alkalemia. Maintaining pH within a narrow range (7.35–7.45) is critical for protein structure, enzyme function, and overall cellular metabolism. The pH value, when combined with $pCO_2$ and $HCO_3^-$ levels, allows clinicians to distinguish between respiratory and metabolic acid-base disturbances.
View Interpretation
Metabolic

pH

Urine pH measures the acidity or alkalinity of a urine sample. In a Complete Urine Examination, pH reflects the kidneys' ability to maintain systemic acid-base homeostasis by excreting hydrogen ions. It is vital for evaluating the risk of kidney stones (e.g., uric acid stones form in acidic urine, while calcium phosphate stones form in alkaline urine) and identifying certain metabolic or renal tubular disorders.
View Interpretation
Body Fluids

pH (Ascitic Fluid)

The pH of ascitic fluid is a critical marker in Ascitic Fluid Biochemical Analysis, primarily used to detect Spontaneous Bacterial Peritonitis (SBP). In the presence of bacterial infection, the pH of the fluid drops due to increased anaerobic metabolism and lactic acid production. A pH below 7.35, particularly when the Serum-Ascites Albumin Gradient (SAAG) is also considered, is highly suggestive of an infected state.
View Interpretation
Reproductive Health

pH (Semen)

Semen pH measures the balance between the acidic secretions of the prostate and the alkaline secretions of the seminal vesicles. This balance is vital for maintaining sperm viability and motility as they transit the acidic vaginal environment. A normal pH is slightly alkaline. Deviations can signal anatomical issues (like seminal vesicle agenesis) or physiological issues (like infection).
View Interpretation
Gastroenterology

pH Monitoring

Ambulatory pH monitoring is the gold standard for diagnosing Gastroesophageal Reflux Disease (GERD). It measures the frequency and duration of stomach acid backing up into the esophagus over a 24 to 48-hour period. This is typically done using a thin catheter passed through the nose or a wireless capsule (Bravo) attached to the esophageal wall. It is ordered when symptoms like heartburn, regurgitation, or chronic cough do not respond to Proton Pump Inhibitors (PPIs) or when a physician needs to confirm GERD before surgical intervention (like Nissen Fundoplication). It helps distinguish between true acid reflux, hypersensitive esophagus, and functional heartburn.
  • GERD: Chronic acid exposure causing tissue damage.
  • Laryngopharyngeal Reflux (LPR): Acid reaching the throat and larynx.
  • Barrett’s Esophagus: Pre-cancerous changes due to chronic acid exposure.
  • Non-Cardiac Chest Pain: Ruling out reflux as a cause for chest pain symptoms.
View Interpretation